FN Thomson Reuters Web of Science™
VR 1.0
PT J
AU HONJO, T
   IKEDA, M
   ANDREOLI, AJ
   HAYAISHI, O
   NISHIZUKA, Y
AF HONJO, T
   IKEDA, M
   ANDREOLI, AJ
   HAYAISHI, O
   NISHIZUKA, Y
TI ENZYMIC PREPARATION OF NICOTINATE ADENINE DINUCLEOTIDE ( DEAMIDO-NAD )
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Note
CR PREISS J, 1958, J BIOL CHEM, V233, P488
   PREISS J, 1958, J BIOL CHEM, V233, P493
   NISHIZUKA Y, 1963, J BIOL CHEM, V238, P3369
   BALLIO A, 1957, NATURE, V180, P1203
   COLOWICK SP, 1951, J BIOL CHEM, V191, P447
   IMSANDE J, 1961, J BIOL CHEM, V236, P1494
   KAPLAN NO, 1955, METHOD ENZYMOL, V2, P660, DOI 10.1016/S0076-6879(55)02277-5
   LAMBORG M, 1958, J BIOL CHEM, V231, P685
   LANGAN TA, 1959, J BIOL CHEM, V234, P2161
   NISHIZUKA Y, 1963, J BIOL CHEM, V238, pP483
NR 10
TC 20
Z9 20
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PY 1964
VL 89
IS 3
BP 549
EP &
DI 10.1016/0926-6569(64)90084-7
PG 0
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 6903A
UT WOS:A19646903A00009
PM 14209340
ER

PT J
AU REEDER, RH
   UEDA, K
   HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
AF REEDER, RH
   UEDA, K
   HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
TI STUDIES ON POLYMER OF ADENOSINE DIPHOSPHATE RIBOSE .2. CHARACTERIZATION
   OF POLYMER
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
CR CHAMBON P, 1966, BIOCHEM BIOPH RES CO, V25, P638, DOI 10.1016/0006-291X(66)90502-X
   MARMUR J, 1961, J MOL BIOL, V3, P208
   DIXON JS, 1954, ANAL CHEM, V26, P1092, DOI 10.1021/ac60090a046
   LEONARD NJ, 1965, BIOCHEMISTRY-US, V4, P354, DOI 10.1021/bi00878a027
   PENMAN S, 1966, J MOL BIOL, V17, P117
   Mejbaum W, 1939, H-S Z PHYSIOL CHEM, V258, P117, DOI 10.1515/bchm2.1939.258.2-3.117
   KAPLAN NO, 1952, J BIOL CHEM, V194, P579
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   NISHIZUKA Y, 1963, J BIOL CHEM, V238, P3369
   BURTON R, 1956, BIOCH J, V62, P315
   CHAMBERLIN M, 1963, COLD SPRING HARB SYM, V28, P67
   COLOWICK SP, 1957, METHODS ENZYMOLOG ED, V3, P904
   COLOWICK SP, 1963, METHODS ENZYMOLOG ED, V6, P757
   COLOWICK SP, 1957, METHODS ENZYMOLOG ED, V3, P929
   COLOWICK SP, 1957, METHODS ENZYMOLOG ED, V3, P905
   GILBERT WALTER, 1963, JOUR MOLECULAR BIOL, V6, P389
   GIRARD M, 1964, P NATL ACAD SCI USA, V51, P205, DOI 10.1073/pnas.51.2.205
   KAPLAN NO, 1957, METHOD ENZYMOL, V3, P904
   LEONARD NJ, 1965, J HETEROCYCLIC CHEM, V2, P291
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANDELL JD, 1960, ANAL BIOCHEM, V1, P66, DOI 10.1016/0003-2697(60)90020-8
   MOLDAVE K, 1963, METHOD ENZYMOL, V6, P757, DOI 10.1016/0076-6879(63)06243-1
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   SMITH WE, 1965, J BIOL CHEM, V240, P3056
   SUZUKI T, 1960, J PHARM SOC JPN, V80, P857
   WANG CH, 1959, BIOCHEM BIOPH RES CO, V1, P203, DOI 10.1016/0006-291X(59)90020-8
   WANG TP, 1957, METHOD ENZYMOL, V3, P929, DOI 10.1016/S0076-6879(57)03479-5
   WANG TP, 1957, METHOD ENZYMOL, V3, P905, DOI 10.1016/S0076-6879(57)03474-6
   WINDMUELLER H, 1961, J BIOL CHEM, V236, P2716
NR 29
TC 98
Z9 99
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1967
VL 242
IS 13
BP 3172
EP &
PG 0
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 96025
UT WOS:A19679602500022
PM 4291073
ER

PT J
AU UEDA, K
   REEDER, RH
   HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
AF UEDA, K
   REEDER, RH
   HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
TI POLY ADENOSINE DIPHOSPHATE RIBOSE SYNTHESIS ASSOCIATED WITH CHROMATIN
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
CR SUGIMURA T, 1967, BIOCHIM BIOPHYS ACTA, V138, P438, DOI 10.1016/0005-2787(67)90507-2
   CHAMBON P, 1966, BIOCHEM BIOPH RES CO, V25, P638, DOI 10.1016/0006-291X(66)90502-X
   FUJIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V145, P247, DOI 10.1016/0005-2787(67)90043-3
   CHAMBON P, 1965, BIOCHEM BIOPH RES CO, V21, P156, DOI 10.1016/0006-291X(65)90102-6
   CHAUVEAU J, 1956, EXP CELL RES, V11, P317, DOI 10.1016/0014-4827(56)90107-0
   DOLY J, 1967, CR ACAD SCI D NAT, V264, P2687
   FUTAI M, 1967, BIOCHEM BIOPH RES CO, V28, P395, DOI 10.1016/0006-291X(67)90324-5
   GEORGIEV GP, 1966, J MOL BIOL, V22, P365, DOI 10.1016/0022-2836(66)90140-9
   GOLDBERG IH, 1961, BIOCHIM BIOPHYS ACTA, V51, P201, DOI 10.1016/0006-3002(61)91042-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARUSHIG.K, 1966, J MOL BIOL, V15, P160
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   OTH A, 1957, J POLYM SCI, V23, P713, DOI 10.1002/pol.1957.1202310415
   WIDNELL CC, 1966, BIOCHIM BIOPHYS ACTA, V123, P478, DOI 10.1016/0005-2787(66)90216-4
NR 14
TC 69
Z9 69
U1 1
U2 1
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PY 1968
VL 31
IS 3
BP 379
EP &
DI 10.1016/0006-291X(68)90486-5
PG 0
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA B1199
UT WOS:A1968B119900015
PM 5653649
ER

PT J
AU NAKAZAWA, K
   UEDA, K
   HONJO, T
   YOSHIHAR.K
   NISHIZUK.Y
   HAYAISHI, O
AF NAKAZAWA, K
   UEDA, K
   HONJO, T
   YOSHIHAR.K
   NISHIZUK.Y
   HAYAISHI, O
TI NICOTINAMIDE ADENINE DINUCLEOTIDE GLYCOHYDROLASES AND POLY ADENOSINE
   DIPHOSPHATE RIBOSE SYNTHESIS IN RAT LIVER
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
CR SUGIMURA T, 1967, BIOCHIM BIOPHYS ACTA, V138, P438, DOI 10.1016/0005-2787(67)90507-2
   SCHNEIDER WC, 1950, J BIOL CHEM, V183, P123
   NISHIZUKA Y, 1963, J BIOL CHEM, V238, P3369
   BOCK K, IN PRESS
   CHAMBON R, 1966, BIOCHEM BIOPHYS RES, V25, P638
   CHAUVEAU J, 1962, J CELL BIOL, V12, P17, DOI 10.1083/jcb.12.1.17
   CHAUVEAU J, 1956, EXP CELL RES, V11, P317, DOI 10.1016/0014-4827(56)90107-0
   COLOWICK SP, 1955, METHOD ENZYMOL, V2, P660
   JACOBSON KB, 1957, J BIOPHYS BIOCHEM CY, V3, P31, DOI 10.1083/jcb.3.1.31
   KAPLAN NO, 1955, METHOD ENZYMOL, V2, P660, DOI 10.1016/S0076-6879(55)02277-5
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   NISHIZUKA Y, IN PRESS
   ROEMER V, 1967, 8 INT C BIOCH TOK, V4, P810
   UEDA K, IN PRESS
   WANG K, 1954, J BIOL CHEM, V206, P311
   ZATMAN LJ, 1953, J BIOL CHEM, V200, P197
NR 16
TC 37
Z9 37
U1 1
U2 1
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PY 1968
VL 32
IS 2
BP 143
EP &
DI 10.1016/0006-291X(68)90360-4
PG 0
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA B6023
UT WOS:A1968B602300006
PM 5672131
ER

PT J
AU HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
   KATO, I
AF HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
   KATO, I
TI DIPHTHERIA TOXIN-DEPENDENT ADENOSINE DIPHOSPHATE RIBOSYLATION OF
   AMINOACYL TRANSFERASE 2 AND INHIBITION OF PROTEIN SYNTHESIS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Note
CR HASEGAWA S, 1967, BIOCHIM BIOPHYS ACTA, V149, P369, DOI 10.1016/0005-2787(67)90165-7
   CHAMBON P, 1966, BIOCHEM BIOPH RES CO, V25, P638, DOI 10.1016/0006-291X(66)90502-X
   COLLIER RJ, 1964, J EXP MED, V120, P1019, DOI 10.1084/jem.120.6.1019
   COLLIER RJ, 1967, J MOL BIOL, V25, P83, DOI 10.1016/0022-2836(67)90280-X
   COLOWICK SP, 1963, METHODS ENZYMOLOG ED, V6, P757
   KATO I, 1960, J EXP MED, V112, P329, DOI 10.1084/jem.112.2.329
   KATO I, 1962, JPN J EXP MED, V32, P335
   KATO IWAO, 1960, JAPANESE JOUR EXPTL MED, V30, P129
   MOLDAVE K, 1963, METHOD ENZYMOL, V6, P757, DOI 10.1016/0076-6879(63)06243-1
   MONTANAR.L, 1967, BIOCHEM J, V105, P635
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   PAPPENHEIMER ALWIN M., 1938, JOUR BIOL CHEM, V125, P201
   REEDER RH, 1967, J BIOL CHEM, V242, P3164
   SKOGERSO.L, 1967, BIOCHEM BIOPH RES CO, V27, P568, DOI 10.1016/S0006-291X(67)80025-1
   STRAUSS N, 1959, J EXP MED, V109, P145, DOI 10.1084/jem.109.2.145
NR 15
TC 415
Z9 415
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1968
VL 243
IS 12
BP 3553
EP &
PG 0
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA B3399
UT WOS:A1968B339900055
PM 4297784
ER

PT J
AU NISHIZUK.Y
   UEDA, K
   HONJO, T
   HAYAISHI, O
AF NISHIZUK.Y
   UEDA, K
   HONJO, T
   HAYAISHI, O
TI ENZYMIC ADENOSINE DIPHOSPHATE RIBOSYLATION OF HISTONE AND POLY ADENOSINE
   DIPHOSPHATE RIBOSE SYNTHESIS IN RAT LIVER NUCLEI
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Note
CR HASEGAWA S, 1967, BIOCHIM BIOPHYS ACTA, V149, P369, DOI 10.1016/0005-2787(67)90165-7
   REEDER RH, 1967, J BIOL CHEM, V242, P3172
   SUGIMURA T, 1967, BIOCHIM BIOPHYS ACTA, V138, P438, DOI 10.1016/0005-2787(67)90507-2
   CHAMBON P, 1966, BIOCHEM BIOPH RES CO, V25, P638, DOI 10.1016/0006-291X(66)90502-X
   FUJIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V145, P247, DOI 10.1016/0005-2787(67)90043-3
   BONNER J, 1964, NUCLEOHISTONES    ED, P200
   CHAUVEAU J, 1956, EXP CELL RES, V11, P317, DOI 10.1016/0014-4827(56)90107-0
   JOHNS EW, 1960, BIOCHEM J, V77, P631
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   STEELE WJ, 1963, CANCER RES, V23, P1153
   UEDA K, 1968, BIOCHEM BIOPH RES CO, V31, P379, DOI 10.1016/0006-291X(68)90486-5
   UMANA R, 1964, NUCLEOHISTONES, P200
   ZATMAN LJ, 1953, J BIOL CHEM, V200, P197
NR 14
TC 162
Z9 162
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1968
VL 243
IS 13
BP 3765
EP &
PG 0
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA B4148
UT WOS:A1968B414800030
PM 4298073
ER

PT J
AU NISHIZUK.Y
   UEDA, K
   NAKAZAWA, K
   REEDER, RH
   HONJO, T
   HAYAISHI, O
AF NISHIZUK.Y
   UEDA, K
   NAKAZAWA, K
   REEDER, RH
   HONJO, T
   HAYAISHI, O
TI POLY ADENOSINE DIPHOSPHATE RIBOSE SYNTHESIS AND NICOTINAMIDE ADENINE
   DINUCLEOTIDE TRANSGLYCOSIDASES
SO JOURNAL OF VITAMINOLOGY
LA English
DT Meeting Abstract
CR FUJIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V134, P496, DOI 10.1016/0005-2787(67)90036-6
   CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X
   REEDER RH, 1967, J BIOL CHEM, V242, P3172
   SUGIMURA T, 1967, BIOCHIM BIOPHYS ACTA, V138, P438, DOI 10.1016/0005-2787(67)90507-2
   FUJIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V145, P247, DOI 10.1016/0005-2787(67)90043-3
   DOLY J, 1966, CR ACAD SCI D NAT, V263, P1341
   CHAMBON P, 1965, BIOCHEM BIOPH RES CO, V21, P156, DOI 10.1016/0006-291X(65)90102-6
   CHAMBON R, 1966, BIOCHEM BIOPHYS RES, V25, P638
   GEORGIEV GP, 1966, J MOL BIOL, V22, P365, DOI 10.1016/0022-2836(66)90140-9
   MARUSHIG.K, 1966, J MOL BIOL, V15, P160
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   ROEMER V, 1967, 7 INT C BIOCH TOK, V4, P810
   SIEBERT G, 1966, J BIOL CHEM, V241, P71
   SWISLOCK.NI, 1967, J BIOL CHEM, V242, P1083
   WIDNELL CC, 1966, BIOCHIM BIOPHYS ACTA, V123, P478, DOI 10.1016/0005-2787(66)90216-4
   ZATMAN LJ, 1953, J BIOL CHEM, V200, P197
NR 16
TC 8
Z9 8
U1 0
U2 0
SN 0022-5398
J9 J VITAMINOL
PY 1968
VL S 14
SU S
BP 143
EP &
PG 0
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA A8111
UT WOS:A1968A811100035
ER

PT J
AU HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
AF HONJO, T
   NISHIZUK.Y
   HAYAISHI, O
TI ADENOSINE DIPHOSPHORIBOSYLATION OF AMINOACYL TRANSFERASE-II BY
   DIPHTHERIA TOXIN
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
CR MARTIN JB, 1949, ANAL CHEM, V21, P965, DOI 10.1021/ac60032a024
   HONJO T, 1968, J BIOL CHEM, V243, P3553
   GILL DM, 1969, J EXP MED, V129, P1, DOI 10.1084/jem.129.1.1
   COLLIER RJ, 1964, J EXP MED, V120, P1019, DOI 10.1084/jem.120.6.1019
   COLLIER RJ, 1967, J MOL BIOL, V25, P83, DOI 10.1016/0022-2836(67)90280-X
   FELICETT.L, 1968, ARCH BIOCHEM BIOPHYS, V125, P548, DOI 10.1016/0003-9861(68)90613-9
   GOOR RS, 1967, J EXP MED, V126, P923, DOI 10.1084/jem.126.5.923
   GOOR RS, 1967, J EXP MED, V126, P899, DOI 10.1084/jem.126.5.899
   KATO I, 1960, J EXP MED, V112, P329, DOI 10.1084/jem.112.2.329
   KATO I, 1962, JPN J EXP MED, V32, P335
   NISHIZUK.Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212
   NISHIZUK.Y, 1966, ARCH BIOCHEM BIOPHYS, V116, P344, DOI 10.1016/0003-9861(66)90040-3
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   PAPPENHEIMER ALWIN M., 1938, JOUR BIOL CHEM, V125, P201
   RAEBURN S, 1968, P NATL ACAD SCI USA, V61, P1428, DOI 10.1073/pnas.61.4.1428
   SCHNEIDE.JA, 1968, BIOCHEM BIOPH RES CO, V33, P177, DOI 10.1016/0006-291X(68)90275-1
   SKOGERSO.L, 1968, J BIOL CHEM, V243, P5361
   SKOGERSO.L, 1967, BIOCHEM BIOPH RES CO, V27, P568, DOI 10.1016/S0006-291X(67)80025-1
   STRAUSS N, 1959, J EXP MED, V109, P145, DOI 10.1084/jem.109.2.145
NR 19
TC 39
Z9 40
U1 0
U2 2
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1969
VL 34
BP 603
EP &
PG 0
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA F9457
UT WOS:A1969F945700065
PM 4314916
ER

PT J
AU HONJO, T
   NISHIZUK.Y
   KATO, I
   HAYAISHI, O
AF HONJO, T
   NISHIZUK.Y
   KATO, I
   HAYAISHI, O
TI ADENOSINE DIPHOSPHATE RIBOSYLATION OF AMINOACYL TRANSFERASE-II AND
   INHIBITION OF PROTEIN SYNTHESIS BY DIPHTHERIA TOXIN
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
CR REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0
   HASEGAWA S, 1967, BIOCHIM BIOPHYS ACTA, V149, P369, DOI 10.1016/0005-2787(67)90165-7
   REEDER RH, 1967, J BIOL CHEM, V242, P3172
   CHAMBON P, 1966, BIOCHEM BIOPH RES CO, V25, P638, DOI 10.1016/0006-291X(66)90502-X
   KAPLAN NO, 1951, J BIOL CHEM, V191, P461
   TASHIRO Y, 1965, J MOL BIOL, V11, P149
   HONJO T, 1968, J BIOL CHEM, V243, P3553
   Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036
   GILL DM, 1969, J EXP MED, V129, P1, DOI 10.1084/jem.129.1.1
   COLLIER RJ, 1964, J EXP MED, V120, P1019, DOI 10.1084/jem.120.6.1019
   RYLE AP, 1955, BIOCHEM J, V60, P541
   COLLIER RJ, 1967, J MOL BIOL, V25, P83, DOI 10.1016/0022-2836(67)90280-X
   ATKINSON MR, 1961, BIOCHEM J, V79, P12
   BURTON K, 1953, BIOCHEM J, V54, P94
   COLLIER RJ, 1969, COLD SPRING HARB SYM, V34, P589
   COLLIER RJ, 1969, SCIENCE, V164, P1179, DOI 10.1126/science.164.3884.1179
   EVERSE J, 1970, J BIOL CHEM, V245, P899
   FELICETT.L, 1968, ARCH BIOCHEM BIOPHYS, V125, P548, DOI 10.1016/0003-9861(68)90613-9
   GALASINS.W, 1969, J BIOL CHEM, V244, P6527
   GOOR RS, 1967, J EXP MED, V126, P923, DOI 10.1084/jem.126.5.923
   GOOR RS, 1967, J EXP MED, V126, P899, DOI 10.1084/jem.126.5.899
   GOOR RS, 1970, J BIOL CHEM, V245, P616
   GOOR RS, 1967, J EXP MED, V126, P913, DOI 10.1084/jem.126.5.913
   HONJO T, 1969, COLD SPRING HARB SYM, V34, P603
   HONJO T, 1971, THESIS KYOTO U
   HONJO T, 1964, BIOCHIM BIOPHYS ACTA, V89, P549, DOI 10.1016/0926-6569(64)90084-7
   KALCKAR HM, 1954, S MECHANISM ENZYME A, P675
   KATO I, 1960, J EXP MED, V112, P329, DOI 10.1084/jem.112.2.329
   KATO I, 1962, JPN J EXP MED, V32, P335
   KSPLAN NO, 1951, J BIOL CHEM, V191, P473
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MOLDAVE K, 1963, METHOD ENZYMOL, V6, P757, DOI 10.1016/0076-6879(63)06243-1
   MONTANAR.L, 1967, BIOCHEM J, V105, P635
   NAKAZAWA K, 1968, BIOCHEM BIOPH RES CO, V32, P143, DOI 10.1016/0006-291X(68)90360-4
   NISHIZUKA Y, 1968, METHOD ENZYMOL, V12, P708
   NISHIZUK.Y, 1967, J BIOL CHEM, V242, P3164
   RAEBURN S, 1968, P NATL ACAD SCI USA, V61, P1428, DOI 10.1073/pnas.61.4.1428
   SCHNEIDE.JA, 1968, BIOCHEM BIOPH RES CO, V33, P177, DOI 10.1016/0006-291X(68)90275-1
   SKOGERSO.L, 1968, J BIOL CHEM, V243, P5361
   SKOGERSO.L, 1967, BIOCHEM BIOPH RES CO, V27, P568, DOI 10.1016/S0006-291X(67)80025-1
   SPERTI S, 1968, BIOCHEM J, V107, P730
   STRAUSS N, 1959, J EXP MED, V109, P145, DOI 10.1084/jem.109.2.145
   SUZUKI T, 1960, J PHARM SOC JPN, V80, P857
   WANG CH, 1959, BIOCHEM BIOPH RES CO, V1, P203, DOI 10.1016/0006-291X(59)90020-8
   WANG TP, 1955, METHOD ENZYMOL, V2, P652, DOI 10.1016/S0076-6879(55)02275-1
   WARBURG O, 1941, BIOCHEM Z, V310, P384
   ZATMAN LJ, 1953, J BIOL CHEM, V200, P197
   ZIMMERMA.SB, 1967, P NATL ACAD SCI USA, V57, P1841, DOI 10.1073/pnas.57.6.1841
NR 48
TC 141
Z9 141
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1971
VL 246
IS 13
BP 4251
EP &
PG 0
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA J8060
UT WOS:A1971J806000019
PM 4326212
ER

PT J
AU HONJO, T
   REEDER, RH
AF HONJO, T
   REEDER, RH
TI XENOPUS-MULLERI RIBOSOMAL GENES ARE REPRESSED IN XENOPOS-LAEVIS X X
   XENOPUS-MULLERI HYBRID FROGS
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 CARNEGIE INST WASHINGTON,DEPT EMBRYOL,BALTIMORE,MD 21210.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0014-9446
J9 FED PROC
PY 1973
VL 32
IS 3
BP 656
EP &
PG 0
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA YY908
UT WOS:A1973YY90800300
ER

PT J
AU HONJO, T
   REEDER, RH
AF HONJO, T
   REEDER, RH
TI PREFERENTIAL TRANSCRIPTION OF XENOPUS-LAEVIS RIBOSOMAL-RNA IN
   INTERSPECIES HYBRIDS BETWEEN XENOPUS-LAEVIS AND XENOPUS-MULLERI
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
C1 CARNEGIE INST WASHINGTON,DEPT EMBRYOL,115 W UNIVERSITY PARKWAY,BALTIMORE,MD 21210.
CR BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9
   BLACKLER AW, 1972, DEV BIOL, V27, P385, DOI 10.1016/0012-1606(72)90177-7
   WALLACE H, 1966, BIOCHIM BIOPHYS ACTA, V114, P296, DOI 10.1016/0005-2787(66)90311-X
   Birnstiel M L, 1971, Prog Nucleic Acid Res Mol Biol, V11, P351, DOI 10.1016/S0079-6603(08)60332-3
   BRAMWELL ME, 1971, BIOCHIM BIOPHYS ACTA, V232, P580, DOI 10.1016/0005-2787(71)90611-3
   BROWN DD, 1964, J MOL BIOL, V8, P669
   BROWN DD, 1972, J MOL BIOL, V63, P75, DOI 10.1016/0022-2836(72)90522-0
   BROWN DD, 1968, J MOL BIOL, V34, P661, DOI 10.1016/0022-2836(68)90188-5
   CASTROSI.E, 1968, BIOCHEM GENET, V1, P323, DOI 10.1007/BF00491488
   CROSBY AR, 1957, AM J BOT, V44, P813, DOI 10.2307/2438902
   DAWID IB, 1970, J MOL BIOL, V51, P341, DOI 10.1016/0022-2836(70)90147-6
   ELICEIRI GL, 1969, J MOL BIOL, V41, P253, DOI 10.1016/0022-2836(69)90390-8
   ELSDALE TR, 1958, EXP CELL RES, V14, P642, DOI 10.1016/0014-4827(58)90175-7
   EMERSON CP, 1970, DEV BIOL, V23, P86, DOI 10.1016/S0012-1606(70)80008-2
   EMERSON CP, 1971, SCIENCE, V171, P898, DOI 10.1126/science.171.3974.898
   HONJO T, 1973, FED PROC, V32, P656
   KEEP E, 1962, CAN J GENET CYTOL, V4, P206
   KLEBE RJ, 1970, P NATL ACAD SCI USA, V66, P1220, DOI 10.1073/pnas.66.4.1220
   NAVASHIN M., 1934, CYTOLOGIA, V5, P169
   Nieuwkoop P., 1956, NORMAL TABLE XENOPUS
   REEDER RH, 1972, J MOL BIOL, V67, P433, DOI 10.1016/0022-2836(72)90461-5
   WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66
   Wilkinson J, 1944, ANN BOT-LONDON, V8, P269
NR 23
TC 125
Z9 125
U1 0
U2 2
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PY 1973
VL 80
IS 2
BP 217
EP 228
DI 10.1016/0022-2836(73)90168-X
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA R1449
UT WOS:A1973R144900002
PM 4763983
ER

PT J
AU HONJO, T
   REEDER, RH
AF HONJO, T
   REEDER, RH
TI TRANSCRIPTION OF XENOPUS CHROMATIN BY HOMOLOGOUS RIBONUCLEIC-ACID
   POLYMERASE - ABERRANT SYNTHESIS OF RIBOSOMAL AND 5S-RIBONUCLEIC ACID
SO BIOCHEMISTRY
LA English
DT Article
C1 CARNEGIE INST WASHINGTON,DEPT EMBRYOL,BALTIMORE,MD 21210.
CR BOLLUM FJ, 1968, METHODS ENZYMOLOGY B, V12, P169
   BROWN DD, 1973, J MOL BIOL, V78, P397, DOI 10.1016/0022-2836(73)90464-6
   BROWN DD, 1968, J MOL BIOL, V34, P661, DOI 10.1016/0022-2836(68)90188-5
   BROWNLEE GG, 1972, FEBS LETT, V25, P8, DOI 10.1016/0014-5793(72)80442-3
   BUTTERWO.PH, 1971, EUR J BIOCHEM, V23, P229, DOI 10.1111/j.1432-1033.1971.tb01613.x
   CEDAR H, 1973, J MOL BIOL, V77, P237, DOI 10.1016/0022-2836(73)90334-3
   DAWID IB, 1970, J MOL BIOL, V51, P341, DOI 10.1016/0022-2836(70)90147-6
   KESHGEGI.AA, 1972, BIOCHEM BIOPH RES CO, V48, P757, DOI 10.1016/0006-291X(72)90671-7
   MARYANKA D, 1973, P NATL ACAD SCI USA, V70, P1161, DOI 10.1073/pnas.70.4.1161
   PRICE R, 1972, J MOL BIOL, V70, P435, DOI 10.1016/0022-2836(72)90551-7
   REEDER RH, 1972, J MOL BIOL, V67, P433, DOI 10.1016/0022-2836(72)90461-5
   REEDER RH, 1973, J MOL BIOL, V80, P229, DOI 10.1016/0022-2836(73)90169-1
   ROEDER RG, 1970, COLD SPRING HARB SYM, V35, P727
   WEGNEZ M, 1972, FEBS LETT, V25, P13, DOI 10.1016/0014-5793(72)80443-5
   ZYLBER EA, 1971, P NATL ACAD SCI USA, V68, P2861, DOI 10.1073/pnas.68.11.2861
NR 15
TC 55
Z9 55
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PY 1974
VL 13
IS 9
BP 1896
EP 1899
DI 10.1021/bi00706a018
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA S7448
UT WOS:A1974S744800018
PM 4857734
ER

PT J
AU PACKMAN, S
   HONJO, T
   SWAN, D
   NAU, M
   LEDER, P
AF PACKMAN, S
   HONJO, T
   SWAN, D
   NAU, M
   LEDER, P
TI CHARACTERIZATION AND GENETIC REPRESENTATION OF IMMUNOGLOBULIN
   MESSENGER-RNA
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 NICHHD,LAB MOLEC GENET,BETHESDA,MD 20014.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0014-9446
J9 FED PROC
PY 1974
VL 33
IS 5
BP 1542
EP 1542
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA S9698
UT WOS:A1974S969801796
ER

PT J
AU HONJO, T
   PACKMAN, S
   SWAN, D
   NAU, M
   LEDER, P
AF HONJO, T
   PACKMAN, S
   SWAN, D
   NAU, M
   LEDER, P
TI ORGANIZATION OF IMMUNOGLOBULIN GENES - REITERATION FREQUENCY OF MOUSE
   KAPPA-CHAIN CONSTANT REGION GENE
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 NICHHD,LAB MOLEC GENET,BETHESDA,MD 20014.
CR MAGE RG, 1971, NATURE-NEW BIOL, V230, P63
   TONEGAWA S, 1974, FEBS LETT, V40, P92, DOI 10.1016/0014-5793(74)80901-4
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   TOSI SL, 1970, J IMMUNOL, V104, P641
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649
   BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529
   ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330
   ANDO T, 1966, BIOCHIM BIOPHYS ACTA, V114, P158, DOI 10.1016/0005-2787(66)90263-2
   DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864
   APPELLA E, 1971, P NATL ACAD SCI USA, V68, P590, DOI 10.1073/pnas.68.3.590
   AVIV H, 1973, NATURE-NEW BIOL, V241, P174
   BERNARDI.A, 1974, FEBS LETT, V41, P73, DOI 10.1016/0014-5793(74)80957-9
   BIRNSTIE.ML, 1972, J MOL BIOL, V63, P21, DOI 10.1016/0022-2836(72)90519-0
   BISHOP JO, 1969, BIOCHEM J, V113, P805
   BRITTEN RJ, 1970, CARNEGIE I WASH YEAR, V68, P378
   BROWN DD, 1972, MOL GENETICS DEV BIO, P101
   BROWNLEE GG, 1973, NATURE-NEW BIOL, V244, P236
   BROWNLEE GG, 1972, FEBS LETT, V23, P242
   BURNET F, 1959, CLONAL SELECTION THE
   COHEN M, 1971, ANN NY ACAD SCI, V190, P529
   DELOVITC.TL, 1973, P NATL ACAD SCI USA, V70, P173, DOI 10.1073/pnas.70.1.173
   EDELMAN GM, 1967, P NATL ACAD SCI USA, V57, P353, DOI 10.1073/pnas.57.2.353
   EFRON D, 1973, FEBS LETT, V33, P23, DOI 10.1016/0014-5793(73)80150-4
   GALLY JA, 1970, NATURE, V227, P341, DOI 10.1038/227341a0
   GRAY WR, 1967, SCIENCE, V155, P465, DOI 10.1126/science.155.3761.465
   HAMERS R, 1967, COLD SPRING HARB SYM, V32, P129
   HERZENBERG LA, 1968, ANNU REV GENET, V2, P209, DOI 10.1146/annurev.ge.02.120168.001233
   HOOD L, 1970, SCIENCE, V168, P325, DOI 10.1126/science.168.3929.325
   HOOD LE, 1972, FED PROC, V31, P177
   INMAN JK, 1974, P ICNUCLA S MOLECULA
   Jerne Niels K., 1970, IMMUNE SURVEILLANCE, P345
   JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102
   KOSHLAND ME, 1967, COLD SPRING HARB SYM, V32, P119
   KUNKEL HG, 1969, P NATL ACAD SCI USA, V62, P145
   LEDER P, 1974, P ICNUCLA S MOLECULA
   LEDER P, 1973, COLD SPRING HARB SYM, V38, P753
   LENNOX ES, 1967, ANNU REV BIOCHEM, V36, P365, DOI 10.1146/annurev.bi.36.070167.002053
   LIBERMAN R, 1966, J MOL BIOL, V18, P516
   MACH B, 1973, P NATL ACAD SCI USA, V70, P451, DOI 10.1073/pnas.70.2.451
   MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117
   NATVIG JB, 1967, COLD SPRING HARB SYM, V32, P173
   PACKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P813, DOI 10.1016/0006-291X(72)90483-4
   PREMKUMA.E, 1974, P NATL ACAD SCI USA, V71, P99, DOI 10.1073/pnas.71.1.99
   RABBITTS TH, 1974, FEBS LETT, V40, P157, DOI 10.1016/0014-5793(74)80917-8
   ROSS J, IN PRESS
   ROSS J, 1972, P NATL ACAD SCI USA, V69, P264, DOI 10.1073/pnas.69.1.264
   ROSS J, 1972, P NATL ACAD SCI USA, V69, P3620, DOI 10.1073/pnas.69.12.3620
   ROSS J, 1973, ARCH BIOCHEM BIOPHYS, V158, P494, DOI 10.1016/0003-9861(73)90541-9
   SCHECHTE.I, 1973, P NATL ACAD SCI USA, V70, P2256, DOI 10.1073/pnas.70.8.2256
   SHAPIRO HS, 1968, HDB BIOCHEMISTRY, pH58
   SMITH GP, 1973, SCIENCE, V181, P941, DOI 10.1126/science.181.4103.941
   SMITH M, 1973, J MOL BIOL, V80, P553, DOI 10.1016/0022-2836(73)90422-1
   SMITHIES O, 1970, SCIENCE, V169, P882, DOI 10.1126/science.169.3948.882
   SMITHIES O, 1963, NATURE, V199, P1231, DOI 10.1038/1991231a0
   SMITHIES O, 1967, SCIENCE, V157, P267, DOI 10.1126/science.157.3786.267
   STAVNEZE.J, 1971, NATURE-NEW BIOL, V230, P172
   STAYNOV DZ, 1972, NATURE-NEW BIOL, V235, P108
   STEVENS RH, 1972, NATURE, V239, P143, DOI 10.1038/239143a0
   STORB U, 1972, J IMMUNOL, V108, P755
   STORB U, 1974, BIOCHEM BIOPH RES CO, V57, P31, DOI 10.1016/S0006-291X(74)80353-0
   SUTTON WD, 1971, BIOCHIM BIOPHYS ACTA, V240, P522, DOI 10.1016/0005-2787(71)90709-X
   SWAN D, 1972, P NATL ACAD SCI USA, V69, P1967, DOI 10.1073/pnas.69.7.1967
   SZILARD L, 1960, P NATL ACAD SCI USA, V46, P293, DOI 10.1073/pnas.46.3.293
   TONEGAWA S, 1973, BIOCHEM BIOPH RES CO, V51, P81, DOI 10.1016/0006-291X(73)90510-X
   WANG AC, 1969, IMMUNOCHEMISTRY, V6, P451, DOI 10.1016/0019-2791(69)90301-2
NR 66
TC 94
Z9 94
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PY 1974
VL 71
IS 9
BP 3659
EP 3663
DI 10.1073/pnas.71.9.3659
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA U3976
UT WOS:A1974U397600074
PM 4215083
ER

PT J
AU LEDER, P
   HONJO, T
   PACKMAN, S
   SWAN, D
   NAU, M
   NORMAN, B
AF LEDER, P
   HONJO, T
   PACKMAN, S
   SWAN, D
   NAU, M
   NORMAN, B
TI ORGANIZATION AND DIVERSITY OF IMMUNOGLOBULIN GENES
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 NICHHD,LAB MOLEC GENET,BETHESDA,MD 20014.
CR MAGE RG, 1971, NATURE-NEW BIOL, V230, P63
   TONEGAWA S, 1974, FEBS LETT, V40, P92, DOI 10.1016/0014-5793(74)80901-4
   TOSI SL, 1970, J IMMUNOL, V104, P641
   BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529
   DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864
   AVIV H, 1973, NATURE-NEW BIOL, V241, P174
   BERNARDI.A, 1974, FEBS LETT, V41, P73, DOI 10.1016/0014-5793(74)80957-9
   BRITTEN RJ, 1970, CARNEGIE I WASH YEAR, V68, P378
   BROWNLEE GG, 1972, FEBS LETT, V23, P242
   DELOVITC.TL, 1973, P NATL ACAD SCI USA, V70, P173, DOI 10.1073/pnas.70.1.173
   FAUST CH, 1974, P NATL ACAD SCI USA, V71, P2491, DOI 10.1073/pnas.71.6.2491
   GALLY JA, 1970, NATURE, V227, P341, DOI 10.1038/227341a0
   GIELEN J, 1974, ARCH BIOCHEM BIOPHYS, V163, P146, DOI 10.1016/0003-9861(74)90464-0
   HAMERS R, 1967, COLD SPRING HARB SYM, V32, P129
   HERZENBERG LA, 1968, ANNU REV GENET, V2, P209, DOI 10.1146/annurev.ge.02.120168.001233
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   INMAN JK, 1974, IMMUNE SYSTEM GENES, P37
   KOSHLAND ME, 1967, COLD SPRING HARB SYM, V32, P119
   KUNKEL HG, 1969, P NATL ACAD SCI USA, V62, P145
   LEDER P, 1973, COLD SPRING HARB SYM, V38, P753
   LEDER P, 1974, IMMUNE SYSTEM GENES, P299
   LIBERMAN R, 1966, J MOL BIOL, V18, P516
   MACH B, 1973, P NATL ACAD SCI USA, V70, P451, DOI 10.1073/pnas.70.2.451
   MELLI M, 1971, NATURE-NEW BIOL, V231, P8
   MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117
   NATVIG JB, 1967, COLD SPRING HARB SYM, V32, P173
   PACKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P813, DOI 10.1016/0006-291X(72)90483-4
   PREMKUMA.E, 1974, P NATL ACAD SCI USA, V71, P99, DOI 10.1073/pnas.71.1.99
   PRENSKY W, 1973, P NATL ACAD SCI USA, V70, P1860, DOI 10.1073/pnas.70.6.1860
   RABBITTS TH, 1974, FEBS LETT, V40, P157, DOI 10.1016/0014-5793(74)80917-8
   SCHECHTE.I, 1973, P NATL ACAD SCI USA, V70, P2256, DOI 10.1073/pnas.70.8.2256
   SMITH M, 1973, J MOL BIOL, V80, P553, DOI 10.1016/0022-2836(73)90422-1
   SMITHIES O, 1970, SCIENCE, V169, P882, DOI 10.1126/science.169.3948.882
   STAVNEZE.J, 1971, NATURE-NEW BIOL, V230, P172
   STAYNOV DZ, 1972, NATURE-NEW BIOL, V235, P108
   STEVENS RH, 1972, NATURE, V239, P143, DOI 10.1038/239143a0
   STORB U, 1972, J IMMUNOL, V108, P755
   STORB U, 1974, BIOCHEM BIOPH RES CO, V57, P31, DOI 10.1016/S0006-291X(74)80353-0
   SWAN D, 1972, P NATL ACAD SCI USA, V69, P1967, DOI 10.1073/pnas.69.7.1967
   TONEGAWA S, 1973, BIOCHEM BIOPH RES CO, V51, P81, DOI 10.1016/0006-291X(73)90510-X
NR 40
TC 41
Z9 41
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PY 1974
VL 71
IS 12
BP 5109
EP 5114
DI 10.1073/pnas.71.12.5109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V1970
UT WOS:A1974V197000099
PM 4531042
ER

PT J
AU KUEHL, WM
   KAPLAN, BA
   SCHARFF, MD
   NAU, M
   HONJO, T
   LEDER, P
AF KUEHL, WM
   KAPLAN, BA
   SCHARFF, MD
   NAU, M
   HONJO, T
   LEDER, P
TI CHARACTERIZATION OF LIGHT CHAIN AND LIGHT CHAIN CONSTANT REGION FRAGMENT
   MESSENGER-RNAS IN MPC-11 MOUSE MYELOMA CELLS AND VARIANTS
SO CELL
LA English
DT Article
C1 ALBERT EINSTEIN COLL MED,DEPT CELL BIOL,BRONX,NY 10461.
   NICHHD,LAB MOLEC GENET,BETHESDA,MD 20014.
   ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461.
CR ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330
   SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9
   AVIV H, 1973, NATURE-NEW BIOL, V241, P174
   BAGLIONI C, 1971, NATURE-NEW BIOL, V232, P8
   BASES R, 1973, BIOCHIM BIOPHYS ACTA, V312, P574, DOI 10.1016/0005-2787(73)90455-3
   BAUMAL R, 1973, SCIENCE, V182, P164, DOI 10.1126/science.182.4108.164
   COFFINO P, 1971, P NATL ACAD SCI USA, V68, P219, DOI 10.1073/pnas.68.1.219
   COFFINO P, 1972, J CELL PHYSIOL, V79, P429, DOI 10.1002/jcp.1040790313
   Dayhoff M. O., 1972, ATLAS PROTEIN SEQUEN, V5
   GALLY JA, 1970, NATURE, V227, P341, DOI 10.1038/227341a0
   GANEM D, 1973, P NATL ACAD SCI USA, V70, P3165, DOI 10.1073/pnas.70.11.3165
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   HORWITZ MS, 1969, FUNDAMENTAL TECHNIQU, P253
   KUEHL WM, 1974, J MOL BIOL, V89, P409, DOI 10.1016/0022-2836(74)90472-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKOV R, 1970, Journal of Experimental Medicine, V131, P515, DOI 10.1084/jem.131.3.515
   LEDER P, 1973, COLD SPRING HARB SYM, V38, P753
   MACH B, 1973, P NATL ACAD SCI USA, V70, P451, DOI 10.1073/pnas.70.2.451
   Maizel JV, 1971, METHOD VIROL, V5, P179
   MCKEAN D, 1973, BIOCHEMISTRY-US, V12, P749, DOI 10.1021/bi00728a027
   MCKEAN D, 1973, BIOCHEMISTRY-US, V12, P760, DOI 10.1021/bi00728a028
   METAFORA S, 1972, P NATL ACAD SCI USA, V69, P1299, DOI 10.1073/pnas.69.5.1299
   MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117
   MILSTEIN C, 1974, NATURE, V252, P354, DOI 10.1038/252354a0
   RHOADS RE, 1973, J BIOL CHEM, V248, P2031
   SCHECHTE.I, 1973, P NATL ACAD SCI USA, V70, P2256, DOI 10.1073/pnas.70.8.2256
   SMITH GP, 1973, SCIENCE, V181, P941, DOI 10.1126/science.181.4103.941
   STAVNEZE.J, 1971, NATURE-NEW BIOL, V230, P172
   SVASTI J, 1972, BIOCHEM J, V128, P427
   SWAN D, 1972, P NATL ACAD SCI USA, V69, P1967, DOI 10.1073/pnas.69.7.1967
   TONEGAWA S, 1973, BIOCHEM BIOPH RES CO, V51, P81, DOI 10.1016/0006-291X(73)90510-X
NR 31
TC 57
Z9 57
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138
SN 0092-8674
J9 CELL
JI Cell
PY 1975
VL 5
IS 2
BP 139
EP 147
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AH328
UT WOS:A1975AH32800006
PM 806346
ER

PT J
AU HONJO, T
   SWAN, D
   NAU, M
   NORMAN, B
   PACKMAN, S
   POLSKY, F
   LEDER, P
AF HONJO, T
   SWAN, D
   NAU, M
   NORMAN, B
   PACKMAN, S
   POLSKY, F
   LEDER, P
TI PURIFICATION AND TRANSLATION OF AN IMMUNOGLOBULIN LAMBDA CHAIN
   MESSENGER-RNA FROM MOUSE MYELOMA
SO BIOCHEMISTRY
LA English
DT Article
C1 NICHHD,MOLEC GENET LAB,BETHESDA,MD 20014.
CR TONEGAWA S, 1974, FEBS LETT, V40, P92, DOI 10.1016/0014-5793(74)80901-4
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   GALLY JA, 1972, ANNU REV GENET, V6, P1, DOI 10.1146/annurev.ge.06.120172.000245
   ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330
   ANDO T, 1966, BIOCHIM BIOPHYS ACTA, V114, P158, DOI 10.1016/0005-2787(66)90263-2
   TONEGAWA S, 1974, P NATL ACAD SCI USA, V71, P4027, DOI 10.1073/pnas.71.10.4027
   APELLA E, 1971, P NATL ACAD SCI USA, V68, P590
   BIRNSTIE.ML, 1972, J MOL BIOL, V63, P21, DOI 10.1016/0022-2836(72)90519-0
   BISHOP JO, 1969, BIOCHEM J, V113, P805
   BLATTLER DP, 1972, J CHROMATOGR, V64, P147, DOI 10.1016/S0021-9673(00)92958-3
   Cohn M, 1974, IMMUNE SYSTEM GENES, P89
   EFRON D, 1973, FEBS LETT, V33, P23, DOI 10.1016/0014-5793(73)80150-4
   FAUST CH, 1974, P NATL ACAD SCI USA, V71, P2491, DOI 10.1073/pnas.71.6.2491
   GRAY WR, 1967, SCIENCE, V155, P465, DOI 10.1126/science.155.3761.465
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   HONJO T, 1976, BIOCHEMISTRY-US, V15, P2780, DOI 10.1021/bi00658a012
   HOOD L, 1974, IMMUNE SYSTEM, P119
   LEDER P, 1974, P NATL ACAD SCI US, V71, P5103
   LEDER P, 1974, IMMUNE SYSTEM GENES, P299
   MACH B, 1973, P NATL ACAD SCI USA, V70, P451, DOI 10.1073/pnas.70.2.451
   MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117
   MILSTEIN C, 1974, NATURE, V252, P354, DOI 10.1038/252354a0
   ORKIN SH, 1975, J BIOL CHEM, V250, P8753
   RABBITTS TH, 1975, CELL, V6, P5, DOI 10.1016/0092-8674(75)90067-7
   RABBITTS TH, 1974, FEBS LETT, V42, P324
   RABBITTS TH, 1975, EUR J BIOCHEM, V52, P125, DOI 10.1111/j.1432-1033.1975.tb03980.x
   ROBERTS BE, 1975, P NATL ACAD SCI USA, V72, P1922, DOI 10.1073/pnas.72.5.1922
   ROSS J, 1972, P NATL ACAD SCI USA, V69, P264, DOI 10.1073/pnas.69.1.264
   ROSS J, 1973, ARCH BIOCHEM BIOPHYS, V158, P494, DOI 10.1016/0003-9861(73)90541-9
   SCHECHTE.I, 1973, P NATL ACAD SCI USA, V70, P2256, DOI 10.1073/pnas.70.8.2256
   SCHECHTER I, 1975, SCIENCE, V188, P160, DOI 10.1126/science.803715
   STAVNEZE.J, 1974, J MOL BIOL, V88, P43, DOI 10.1016/0022-2836(74)90294-0
   STAYNOV DZ, 1972, NATURE-NEW BIOL, V235, P108
   SUTTON WD, 1971, BIOCHIM BIOPHYS ACTA, V240, P522, DOI 10.1016/0005-2787(71)90709-X
   SWAN D, 1972, P NATL ACAD SCI USA, V69, P1967, DOI 10.1073/pnas.69.7.1967
   TONEGAWA S, 1973, BIOCHEM BIOPH RES CO, V51, P81, DOI 10.1016/0006-291X(73)90510-X
   WIGZELL H, 1973, SCAND J IMMUNOL, V2, P199, DOI 10.1111/j.1365-3083.1973.tb02030.x
NR 37
TC 24
Z9 24
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PY 1976
VL 15
IS 13
BP 2775
EP 2779
DI 10.1021/bi00658a011
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BV802
UT WOS:A1976BV80200011
PM 59605
ER

PT J
AU HONJO, T
   PACKMAN, S
   SWAN, D
   LEDER, P
AF HONJO, T
   PACKMAN, S
   SWAN, D
   LEDER, P
TI QUANTITATION OF CONSTANT AND VARIABLE REGION GENES FOR MOUSE
   IMMUNOGLOBULIN LAMBDA CHAINS
SO BIOCHEMISTRY
LA English
DT Article
C1 NICHHD,MOLEC GENET LAB,BETHESDA,MD 20014.
CR TONEGAWA S, 1974, FEBS LETT, V40, P92, DOI 10.1016/0014-5793(74)80901-4
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0
   BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529
   GALLY JA, 1972, ANNU REV GENET, V6, P1, DOI 10.1146/annurev.ge.06.120172.000245
   ANDO T, 1966, BIOCHIM BIOPHYS ACTA, V114, P158, DOI 10.1016/0005-2787(66)90263-2
   APPELLA E, 1971, P NATL ACAD SCI USA, V68, P590, DOI 10.1073/pnas.68.3.590
   BERNARDI.A, 1974, FEBS LETT, V41, P73, DOI 10.1016/0014-5793(74)80957-9
   Cohn M, 1974, IMMUNE SYSTEM GENES, P89
   DELOVITC.TL, 1973, P NATL ACAD SCI USA, V70, P173, DOI 10.1073/pnas.70.1.173
   DUGGAN E, 1973, BIOCHEMISTRY-US, V12, P5400
   FAUST CH, 1974, P NATL ACAD SCI USA, V71, P2491, DOI 10.1073/pnas.71.6.2491
   HARRISON PR, 1974, J MOL BIOL, V84, P539, DOI 10.1016/0022-2836(74)90115-6
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   HONJO T, 1976, BIOCHEMISTRY-US, V15, P2775, DOI 10.1021/bi00658a011
   HOOD L, 1974, IMMUNE SYSTEM, P119
   LEDER P, 1974, P NATL ACAD SCI US, V71, P5103
   LEDER P, 1975, MOLECULAR APPROACHES, V9, P173
   LEDER P, 1974, IMMUNE SYSTEM GENES, P299
   MILSTEIN C, 1974, NATURE, V252, P354, DOI 10.1038/252354a0
   PACKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P813, DOI 10.1016/0006-291X(72)90483-4
   PREMKUMA.E, 1974, P NATL ACAD SCI USA, V71, P99, DOI 10.1073/pnas.71.1.99
   RABBITTS TH, 1974, FEBS LETT, V40, P157, DOI 10.1016/0014-5793(74)80917-8
   RABBITTS TH, 1975, CELL, V6, P5, DOI 10.1016/0092-8674(75)90067-7
   RABBITTS TH, 1975, EUR J BIOCHEM, V52, P125, DOI 10.1111/j.1432-1033.1975.tb03980.x
   ROSS J, 1974, J MOL BIOL, V87, P697, DOI 10.1016/0022-2836(74)90079-5
   SCHULENB.EP, 1971, P NATL ACAD SCI USA, V68, P2623, DOI 10.1073/pnas.68.11.2623
   STAVNEZE.J, 1974, J MOL BIOL, V88, P43, DOI 10.1016/0022-2836(74)90294-0
   STORB U, 1974, BIOCHEM BIOPH RES CO, V57, P31, DOI 10.1016/S0006-291X(74)80353-0
   WIGZELL H, 1973, SCAND J IMMUNOL, V2, P199, DOI 10.1111/j.1365-3083.1973.tb02030.x
NR 30
TC 36
Z9 36
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PY 1976
VL 15
IS 13
BP 2780
EP 2785
DI 10.1021/bi00658a012
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BV802
UT WOS:A1976BV80200012
PM 820372
ER

PT J
AU LEDER, P
   HONJO, T
   SEIDMAN, J
   SWAN, D
AF LEDER, P
   HONJO, T
   SEIDMAN, J
   SWAN, D
TI ORIGIN OF IMMUNOGLOBULIN GENE DIVERSITY - EVIDENCE AND A
   RESTRICTION-MODIFICATION MODEL
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
C1 NICHHD,MOLEC GENET LAB,BETHESDA,MD 20014.
CR NATHANS D, 1975, ANNU REV BIOCHEM, V44, P273, DOI 10.1146/annurev.bi.44.070175.001421
   PTASHNE M, 1976, SCIENCE, V194, P156, DOI 10.1126/science.959843
   WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0
   GILBERT W, 1973, P NATL ACAD SCI USA, V70, P3581, DOI 10.1073/pnas.70.12.3581
   MAIZELS NM, 1973, P NATL ACAD SCI USA, V70, P3585, DOI 10.1073/pnas.70.12.3585
   TONEGAWA S, 1974, P NATL ACAD SCI USA, V71, P4027, DOI 10.1073/pnas.71.10.4027
   DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864
   BAAS PD, 1976, J MOL BIOL, V102, P633, DOI 10.1016/0022-2836(76)90339-9
   BLAKESLEY RW, 1975, NATURE, V257, P421, DOI 10.1038/257421a0
   Cohn M, 1974, IMMUNE SYSTEM GENES, P89
   FARACE MG, 1976, P NATL ACAD SCI USA, V73, P727, DOI 10.1073/pnas.73.3.727
   FAUST CH, 1974, P NATL ACAD SCI USA, V71, P2491, DOI 10.1073/pnas.71.6.2491
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   HONJO T, 1976, BIOCHEMISTRY-US, V15, P2775, DOI 10.1021/bi00658a011
   HONJO T, 1976, BIOCHEMISTRY-US, V15, P2780, DOI 10.1021/bi00658a012
   HOOD L, 1973, BIOCHEMISTRY-US, V12, P741, DOI 10.1021/bi00728a026
   LEDER P, 1974, P NATL ACAD SCI USA, V71, P5109, DOI 10.1073/pnas.71.12.5109
   LEDER P, 1975, MOLECULAR APPROACHES, P173
   MAXAM A, IN PRESS
   MILSTEIN C, 1974, NATURE, V252, P354, DOI 10.1038/252354a0
   MONAHAN JJ, 1976, BIOCHEMISTRY-US, V15, P223, DOI 10.1021/bi00646a034
   RABBITTS TH, 1975, CELL, V6, P5, DOI 10.1016/0092-8674(75)90067-7
   RABBITTS TH, 1975, EUR J BIOCHEM, V52, P125, DOI 10.1111/j.1432-1033.1975.tb03980.x
   STAVNEZE.J, 1974, J MOL BIOL, V88, P43, DOI 10.1016/0022-2836(74)90294-0
   STORB U, 1974, BIOCHEM BIOPH RES CO, V57, P31, DOI 10.1016/S0006-291X(74)80353-0
   TONEGAWA S, 1976, P NATL ACAD SCI USA, V73, P203, DOI 10.1073/pnas.73.1.203
   YANG RCA, 1976, EUR J BIOCHEM, V61, P101, DOI 10.1111/j.1432-1033.1976.tb10002.x
NR 27
TC 17
Z9 17
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1976
VL 41
BP 855
EP 862
PG 8
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA DF787
UT WOS:A1976DF78700046
ER

PT J
AU KATAOKA, T
   YAMAWAKIKATAOKA, Y
   YAMAGISHI, H
   HONJO, T
AF KATAOKA, T
   YAMAWAKIKATAOKA, Y
   YAMAGISHI, H
   HONJO, T
TI CLONING IMMUNOGLOBULIN GAMMA-2B CHAIN GENE OF MOUSE - CHARACTERIZATION
   AND PARTIAL SEQUENCE DETERMINATION
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.
RP KATAOKA, T (reprint author), UNIV TOKYO,FAC MED,DEPT PHYSIOL CHEM & NUTR,TOKYO 113,JAPAN.
CR WHITE RL, 1977, CELL, V10, P177, DOI 10.1016/0092-8674(77)90213-6
   BRACK C, 1977, P NATL ACAD SCI USA, V74, P5652, DOI 10.1073/pnas.74.12.5652
   EARLY PW, 1979, P NATL ACAD SCI USA, V76, P857, DOI 10.1073/pnas.76.2.857
   THOMAS M, 1976, P NATL ACAD SCI USA, V73, P2294, DOI 10.1073/pnas.73.7.2294
   PEARSON RL, 1971, BIOCHIM BIOPHYS ACTA, V228, P770, DOI 10.1016/0005-2787(71)90748-9
   BOLIVAR F, 1977, GENE, V2, P95
   STERNBERG N, 1977, GENE, V1, P255, DOI 10.1016/0378-1119(77)90049-X
   PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853
   MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2
   GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0
   DARNELL JE, 1978, SCIENCE, V202, P1257, DOI 10.1126/science.364651
   TAYLOR JM, 1976, BIOCHIM BIOPHYS ACTA, V442, P324, DOI 10.1016/0005-2787(76)90307-5
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   BIRSHTEI.BK, 1971, BIOCHEMISTRY-US, V10, P18
   BLATTNER FR, 1978, SCIENCE, V202, P1279, DOI 10.1126/science.725603
   CEBRA JJ, 1968, BIOCHEM J, V107, P79
   CEBRA JJ, 1966, J EXP MED, V123, P547, DOI 10.1084/jem.123.3.547
   COOPER SM, 1972, SCIENCE, V176, P187, DOI 10.1126/science.176.4031.187
   EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78
   FOUGEREAU M, 1976, ANN INST PASTEUR IMM, VC127, P607
   FRANCUS T, 1978, BIOCHEMISTRY-US, V17, P4324, DOI 10.1021/bi00613a033
   FRANGION.B, 1973, P NATL ACAD SCI USA, V70, P1073, DOI 10.1073/pnas.70.4.1073
   FRANGION.B, 1969, NATURE, V224, P597, DOI 10.1038/224597a0
   FRANKLIN EC, 1971, P NATL ACAD SCI USA, V68, P187, DOI 10.1073/pnas.68.1.187
   FRUCHTER RG, 1970, BIOCHEM J, V116, P249
   HELLING RB, 1974, J VIROL, V14, P1235
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   HONJO T, 1978, IMMUNOLOGY 78, P75
   Honjo T., 1979, Oncogenic viruses and host cell genes., P461
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HONJO T, 1976, BIOCHEMISTRY-US, V15, P2780, DOI 10.1021/bi00658a012
   JEFFREYS AJ, 1977, CELL, V12, P429, DOI 10.1016/0092-8674(77)90119-2
   KINDT TJ, 1970, BIOCHEMISTRY-US, V9, P2028, DOI 10.1021/bi00811a026
   Knight K L, 1975, Contemp Top Mol Immunol, V4, P55
   KUNKEL HG, 1969, P NATL ACAD SCI USA, V62, P144, DOI 10.1073/pnas.62.1.144
   LANDUCCITOSI S, 1970, J IMMUNOL, V104, P641
   LEDER P, 1977, SCIENCE, V196, P175, DOI 10.1126/science.322278
   Mäkelä O, 1970, Prog Allergy, V14, P145, DOI 10.1159/000289379
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   MILSTEIN C, 1974, PROGR IMMUNOLOGY, V1, P157
   NATVIG JB, 1974, J IMMUNOL, V112, P1277
   ONO M, 1977, J BIOCHEM-TOKYO, V81, P949
   POLSKY F, 1978, ANAL BIOCHEM, V87, P397, DOI 10.1016/0003-2697(78)90689-9
   RICHARDS.CC, 1965, P NATL ACAD SCI USA, V54, P158, DOI 10.1073/pnas.54.1.158
   ROBBINSON EA, 1974, J BIOL CHEM, V249, P6605
   SAKANO H, 1979, NATURE, V277, P627, DOI 10.1038/277627a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKANAMI M, 1973, FEBS LETT, V34, P318, DOI 10.1016/0014-5793(73)80821-X
   TIEMEIER DC, 1977, GENE, V2, P173, DOI 10.1016/0378-1119(77)90016-6
   TILGHMAN SM, 1977, P NATL ACAD SCI USA, V74, P4406, DOI 10.1073/pnas.74.10.4406
   TILGHMAN SM, 1978, P NATL ACAD SCI USA, V75, P725, DOI 10.1073/pnas.75.2.725
   TURNER KJ, 1971, BIOCHEMISTRY-US, V10, P9
   WOOD WB, 1966, J MOL BIOL, V16, P118
   YAMAGISHI H, 1976, J VIROL, V18, P1016
   YAMAWAKIKATAOKA Y, 1979, BIOCHEMISTRY-US, V18, P490, DOI 10.1021/bi00570a018
   Yoshimori R., 1971, THESIS U CALIFORNIA
   1976, FED REG         0909
   1978, JPN SCI MONTHLY, V31, P626
NR 59
TC 40
Z9 40
U1 1
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PY 1979
VL 76
IS 9
BP 4240
EP 4244
DI 10.1073/pnas.76.9.4240
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM886
UT WOS:A1979HM88600020
PM 116231
ER

PT J
AU OBATA, M
   YAMAWAKIKATAOKA, Y
   TAKAHASHI, N
   KATAOKA, T
   SHIMIZU, A
   MANO, Y
   SEIDMAN, JG
   PETERLIN, BM
   LEDER, P
   HONJO, T
AF OBATA, M
   YAMAWAKIKATAOKA, Y
   TAKAHASHI, N
   KATAOKA, T
   SHIMIZU, A
   MANO, Y
   SEIDMAN, JG
   PETERLIN, BM
   LEDER, P
   HONJO, T
TI IMMUNOGLOBULIN GAMMA-1 HEAVY-CHAIN GENE - STRUCTURAL GENE-SEQUENCES
   CLONED IN A BACTERIAL PLASMID
SO GENE
LA English
DT Article
C1 NICHHD,MOLEC GENET LAB,BETHESDA,MD 20205.
RP OBATA, M (reprint author), UNIV TOKYO,FAC MED,DEPT PHYSIOL CHEM & NUTR,TOKYO 113,JAPAN.
CR ADETUGBO K, 1978, J BIOL CHEM, V253, P6068
   SEIDMAN JG, 1978, NATURE, V271, P582, DOI 10.1038/271582a0
   EFSTRATIADIS A, 1977, CELL, V10, P571, DOI 10.1016/0092-8674(77)90090-3
   ROYCHOUDHURY R, 1976, NUCLEIC ACIDS RES, V3, P863
   SEEBURG PH, 1977, NATURE, V270, P486, DOI 10.1038/270486a0
   NEEDLEMA.SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0
   MCREYNOLDS L, 1978, NATURE, V273, P723, DOI 10.1038/273723a0
   SHINE J, 1977, NATURE, V270, P494, DOI 10.1038/270494a0
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   ARMSTRONG KA, 1977, SCIENCE, V196, P172, DOI 10.1126/science.322277
   COMMERFO.SL, 1971, BIOCHEMISTRY-US, V10, P1993, DOI 10.1021/bi00787a005
   FUDENBERG HH, 1978, BASIC IMMUNOGENETICS, P15
   GREENE PJ, 1978, NUCLEIC ACIDS RES, V5, P2373, DOI 10.1093/nar/5.7.2373
   GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961
   HAMLYN PH, 1978, CELL, V15, P1067, DOI 10.1016/0092-8674(78)90290-8
   HONJO T, CELL
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   HONJO T, 1978, IMMUNOLOGY 78, P75
   MIDDLETO.JH, 1972, J VIROL, V10, P42
   KATAOKA T, P NATL ACAD SCI US
   MODRICH P, 1976, J BIOL CHEM, V251, P5866
   ONO M, 1977, J BIOCHEM-TOKYO, V81, P949
   PROUDFOOT NJ, 1977, CELL, V11, P807, DOI 10.1016/0092-8674(77)90293-8
   RABBITTS TH, 1978, NATURE, V275, P291, DOI 10.1038/275291a0
   ROGERS J, 1979, NUCLEIC ACIDS RES, V6, P3305, DOI 10.1093/nar/6.10.3305
   SANGER F, 1978, FEBS LETT, V87, P107, DOI 10.1016/0014-5793(78)80145-8
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKANAMI M, 1974, METHODS MOLECULAR BI, V7, P113
   TILGHMAN SM, 1978, P NATL ACAD SCI USA, V75, P725, DOI 10.1073/pnas.75.2.725
NR 31
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PY 1980
VL 9
IS 1-2
BP 87
EP 97
DI 10.1016/0378-1119(80)90168-7
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA JL277
UT WOS:A1980JL27700006
PM 6769752
ER

PT J
AU NAKAI, S
   YAMAGISHI, H
   HONJO, T
AF NAKAI, S
   YAMAGISHI, H
   HONJO, T
TI HOMOLOGY OF IMMUNOGLOBULIN GENE BY HETERODUPLEX ANALYSIS
SO JAPANESE JOURNAL OF GENETICS
LA Japanese
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GENETICS SOC JAPAN
PI SHIZUOKA
PA NATL INST GENETICS, YATA, MISHIMA, SHIZUOKA 411, JAPAN
SN 0021-504X
J9 JPN J GENET
JI Jpn. J. Genet.
PY 1980
VL 55
IS 6
BP 478
EP 478
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA KU874
UT WOS:A1980KU87400133
ER

PT J
AU OBATA, M
   KATAOKA, T
   NAKAI, S
   YAMAGISHI, H
   TAKAHASHI, N
   YAMAWAKIKATAOKA, Y
   NIKAIDO, T
   SHIMIZU, A
   HONJO, T
AF OBATA, M
   KATAOKA, T
   NAKAI, S
   YAMAGISHI, H
   TAKAHASHI, N
   YAMAWAKIKATAOKA, Y
   NIKAIDO, T
   SHIMIZU, A
   HONJO, T
TI STRUCTURE OF A REARRANGED GAMMA-1 CHAIN GENE AND ITS IMPLICATION TO
   IMMUNOGLOBULIN CLASS-SWITCH MECHANISM
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA-BIOLOGICAL SCIENCES
LA English
DT Article
C1 KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.
RP OBATA, M (reprint author), OSAKA UNIV,SCH MED,DEPT GENET,KITA KU,OSAKA 530,JAPAN.
CR BRACK C, 1978, CELL, V15, P1, DOI 10.1016/0092-8674(78)90078-8
   KABACK DB, 1979, NUCLEIC ACIDS RES, V6, P2499, DOI 10.1093/nar/6.7.2499
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   COLECLOUGH C, 1980, P NATL ACAD SCI-BIOL, V77, P1422, DOI 10.1073/pnas.77.3.1422
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   EARLY PW, 1980, NATURE LONDON, V283, P733
   GEARHART PJ, 1975, P NATL ACAD SCI USA, V72, P1707, DOI 10.1073/pnas.72.5.1707
   GEARHART PJ, 1980, P NATL ACAD SCI-BIOL, V77, P5424, DOI 10.1073/pnas.77.9.5424
   GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HONJO T, 1976, BIOCHEMISTRY-US, V15, P2780, DOI 10.1021/bi00658a012
   HONJO T, 1980, COLD SPRING HARBOR S, V45
   KATAOKA T, 1979, P NATL ACAD SCI USA, V76, P4240, DOI 10.1073/pnas.76.9.4240
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   KINDT TJ, 1970, BIOCHEMISTRY-US, V9, P2028, DOI 10.1021/bi00811a026
   Knight K L, 1975, Contemp Top Mol Immunol, V4, P55
   LANDUCCITOSI S, 1970, J IMMUNOL, V104, P641
   LAWTON AR, 1977, PROGR IMMUNOLOGY, V3, P171
   NISHIDA Y, 1981, P NATL ACAD SCI-BIOL, V78, P1581, DOI 10.1073/pnas.78.3.1581
   OBATA M, 1980, GENE, V9, P87, DOI 10.1016/0378-1119(80)90168-7
   OKA A, 1978, NATURE, V276, P845, DOI 10.1038/276845a0
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   RABBITTS TH, 1978, CELL, V13, P319, DOI 10.1016/0092-8674(78)90200-3
   RADBRUCH A, 1980, P NATL ACAD SCI-BIOL, V77, P2909, DOI 10.1073/pnas.77.5.2909
   SEIDMAN JG, 1978, NATURE, V276, P790, DOI 10.1038/276790a0
   SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0
   SUTCLIFFE JG, 1978, COLD SPRING HARB SYM, V42, P77
   TAKAHASHI N, 1980, GENE, V11, P117
   VANDERLOO W, 1979, J IMMUNOL, V122, P1203
   YAMAGISHI H, 1976, J VIROL, V18, P1016
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 41
TC 115
Z9 115
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI-BIOL
PY 1981
VL 78
IS 4
BP 2437
EP 2441
DI 10.1073/pnas.78.4.2437
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA LP040
UT WOS:A1981LP04000085
PM 6787603
ER

PT J
AU NAKAI, S
   OI, V
   HERZENBERG, LA
   YAMAGISHI, H
   HONJO, T
AF NAKAI, S
   OI, V
   HERZENBERG, LA
   YAMAGISHI, H
   HONJO, T
TI NUCLEOTIDE-SEQUENCES ENCODING MEMBRANE DOMAINS ARE CONSERVED AMONG
   IMMUNOGLOBULIN GAMMA-SUBCLASS GENES
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
C1 STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305.
   KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.
RP NAKAI, S (reprint author), OSAKA UNIV,SCH MED,DEPT GENET,KITA KU,OSAKA 530,JAPAN.
CR ABNEY ER, 1978, J IMMUNOL, V120, P2041
   ADAMS JM, 1980, NUCLEIC ACIDS RES, V8, P6019, DOI 10.1093/nar/8.24.6019
   KABACK DB, 1979, NUCLEIC ACIDS RES, V6, P2499, DOI 10.1093/nar/6.7.2499
   ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7
   ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9
   EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0
   Davis R. W., 1971, METHOD ENZYMOL, V21, P413
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1974, P NATL ACAD SCI USA, V71, P3659, DOI 10.1073/pnas.71.9.3659
   Honjo T, 1981, Cold Spring Harb Symp Quant Biol, V45 Pt 2, P913
   JEFFREYS AJ, 1977, CELL, V12, P429, DOI 10.1016/0092-8674(77)90119-2
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   LIU CP, 1980, SCIENCE, V209, P1348, DOI 10.1126/science.6774414
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   MATHER EL, 1981, CELL, V23, P369, DOI 10.1016/0092-8674(81)90132-X
   MIYATA T, 1980, P NATL ACAD SCI-BIOL, V77, P2143, DOI 10.1073/pnas.77.4.2143
   NISHIDA Y, 1981, P NATL ACAD SCI-BIOL, V78, P1581, DOI 10.1073/pnas.78.3.1581
   OI VT, 1980, J EXP MED, V151, P1260, DOI 10.1084/jem.151.5.1260
   OKUMURA K, 1976, EUR J IMMUNOL, V6, P467, DOI 10.1002/eji.1830060704
   OLLO R, 1981, P NATL ACAD SCI-BIOL, V78, P2442, DOI 10.1073/pnas.78.4.2442
   ROEDER W, 1981, P NATL ACAD SCI-BIOL, V78, P474, DOI 10.1073/pnas.78.1.474
   ROTCHER I, 1978, NATURE, V275, P761
   SHIMIZU A, 1982, CELL
   SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1981, P ICN UCLA S IMMUNOG, V20, P123
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TUCKER PW, 1979, SCIENCE, V206, P1301
   TYLER BM, 1980, NUCLEIC ACIDS RES, V8, P5579, DOI 10.1093/nar/8.23.5579
   TYLER BM, 1981, NATURE, V293, P406, DOI 10.1038/293406a0
   VASALLI P, 1979, P NATL ACAD SCI US, V76, P5515
   WORD CJ, 1981, MOL IMMUNOL, V18, P311, DOI 10.1016/0161-5890(81)90055-9
   YAMAGISHI H, 1976, J VIROL, V18, P1016
   YAMAWAKIKATAOKA Y, 1981, NUCLEIC ACIDS RES, V9, P1365, DOI 10.1093/nar/9.6.1365
   YAMAWAKIKATAOKA Y, 1980, NATURE, V283, P786, DOI 10.1038/283786a0
NR 35
TC 5
Z9 5
U1 0
U2 0
PU BIOMED RES FOUND
PI TOKYO
PA KANDA PO BOX 182 CHIYODAKU, TOKYO 101-91, JAPAN
SN 0388-6107
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PY 1982
VL 3
IS 1
BP 37
EP 45
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA NF139
UT WOS:A1982NF13900006
ER

PT J
AU NAKAI, S
   UEDA, S
   NISHIDA, Y
   HISAJIMA, H
   HONJO, T
AF NAKAI, S
   UEDA, S
   NISHIDA, Y
   HISAJIMA, H
   HONJO, T
TI HETERODUPLEX ANALYSIS OF HUMAN IMMUNOGLOBULIN-EPSILON GENES
SO JAPANESE JOURNAL OF GENETICS
LA Japanese
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GENETICS SOC JAPAN
PI SHIZUOKA
PA NATL INST GENETICS, YATA, MISHIMA,, SHIZUOKA, 411, JAPAN
SN 0021-504X
J9 JPN J GENET
JI Jpn. J. Genet.
PY 1982
VL 57
IS 6
BP 690
EP 690
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA PX702
UT WOS:A1982PX70200123
ER

PT J
AU KOBAYASHI, N
   KONISHI, H
   SABE, H
   SHIGESADA, K
   NOMA, T
   HONJO, T
   HATANAKA, M
AF KOBAYASHI, N
   KONISHI, H
   SABE, H
   SHIGESADA, K
   NOMA, T
   HONJO, T
   HATANAKA, M
TI GENOMIC STRUCTURE OF HTLV (HUMAN T-CELL LEUKEMIA-VIRUS) - DETECTION OF
   DEFECTIVE GENOME AND ITS AMPLIFICATION IN MT-2 CELLS
SO EMBO JOURNAL
LA English
DT Article
C1 OSAKA UNIV,SCH MED,DEPT GENET,OSAKA 530,JAPAN.
RP KOBAYASHI, N (reprint author), KYOTO UNIV,INST VIRUS RES,DEPT SEROL & IMMUNOL,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR AARONSON SA, 1976, BIOCHIM BIOPHYS ACTA, V458, P323, DOI 10.1016/0304-419X(76)90006-8
   KALYANARAMAN VS, 1981, J VIROL, V38, P906
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   REITZ MS, 1981, P NATL ACAD SCI-BIOL, V78, P1887, DOI 10.1073/pnas.78.3.1887
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   UCHIYAMA T, 1977, BLOOD, V50, P481
   MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0
   POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   CATOVSKY D, 1982, LANCET, V1, P639
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   WONGSTAAL F, 1983, NATURE, V302, P626, DOI 10.1038/302626a0
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   HATTORI S, 1983, GANN, V74, P790
   HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606
   KALYANARAMAN VS, 1981, NATURE, V294, P271, DOI 10.1038/294271a0
   KOBAYASHI N, 1984, EMBO J, V3, P321
   MANZARI V, 1983, P NATL ACAD SCI-BIOL, V80, P1574, DOI 10.1073/pnas.80.6.1574
   OROSZLAN S, 1982, P NATL ACAD SCI-BIOL, V79, P1291, DOI 10.1073/pnas.79.4.1291
   POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519
   POSNER LE, 1981, J EXP MED, V154, P333, DOI 10.1084/jem.154.2.333
   ROBERTGUROFF M, 1981, J EXP MED, V154, P1957, DOI 10.1084/jem.154.6.1957
   SCHNEIDER J, 1984, VIROLOGY, V132, P1, DOI 10.1016/0042-6822(84)90086-2
   Takatsuki K, 1977, TOPICS HEMATOLOGY, P73
   TANAKA Y, 1983, GANN, V74, P327
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   YAMAMOTO N, 1982, Z NATURFORSCH C, V37, P731
   YAMAMOTO N, 1982, INT J CANCER, V30, P289, DOI 10.1002/ijc.2910300306
NR 30
TC 97
Z9 97
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PY 1984
VL 3
IS 6
BP 1339
EP 1343
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA SU710
UT WOS:A1984SU71000019
PM 6086318
ER

PT J
AU FUKUI, K
   HAMAGUCHI, Y
   SHIMIZU, A
   NAKAI, S
   MORIWAKI, K
   WANG, CH
   HONJO, T
AF FUKUI, K
   HAMAGUCHI, Y
   SHIMIZU, A
   NAKAI, S
   MORIWAKI, K
   WANG, CH
   HONJO, T
TI DUPLICATED IMMUNOGLOBULIN GAMMA-2A GENES IN WILD MICE
SO JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   OSAKA UNIV,SCH MED,DEPT GENET,OSAKA 530,JAPAN.
   LANZHOU INST BIOL PROD,LANZHOU,PEOPLES R CHINA.
CR YAMAWAKIKATAOKA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2623, DOI 10.1073/pnas.79.8.2623
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   BLATTNER FR, 1978, SCIENCE, V202, P1279, DOI 10.1126/science.725603
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   Davis R. W., 1971, METHOD ENZYMOL, V21, P413
   HERZENBE.LA, 1964, COLD SPRING HARB SYM, V29, P455
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HUANG CM, 1982, J IMMUNOL, V128, P661
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   LIEBERMA.R, 1966, J MOL BIOL, V18, P516
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   MINEZAWA M, 1981, JPN J GENET, V56, P27, DOI 10.1266/jjg.56.27
   MIYATA T, 1980, P NATL ACAD SCI-BIOL, V77, P2143, DOI 10.1073/pnas.77.4.2143
   MORIWAKI K, 1979, J IMMUNOGENET, V6, P99
   NAKAI S, 1982, BIOMED RES-TOKYO, V3, P37
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   OLLO R, 1982, NATURE, V296, P761, DOI 10.1038/296761a0
   OLLO R, 1983, CELL, V32, P515, DOI 10.1016/0092-8674(83)90471-3
   OLLO R, 1981, P NATL ACAD SCI-BIOL, V78, P2442, DOI 10.1073/pnas.78.4.2442
   Potter M, 1967, Adv Immunol, V7, P91, DOI 10.1016/S0065-2776(08)60127-3
   SCHREIER PH, 1981, P NATL ACAD SCI-BIOL, V78, P4495, DOI 10.1073/pnas.78.7.4495
   SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0
   SHIMIZU A, 1982, NATURE, V298, P82, DOI 10.1038/298082a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   YAMAWAKIKATAOKA Y, 1981, NUCLEIC ACIDS RES, V9, P1365, DOI 10.1093/nar/9.6.1365
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   YONEKAWA H, 1982, DIFFERENTIATION, V22, P222, DOI 10.1111/j.1432-0436.1982.tb01255.x
   YONEKAWA H, 1981, GENETICS, V98, P801
NR 36
TC 7
Z9 7
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0724-6803
J9 J MOL CELL IMMUNOL
PY 1984
VL 1
IS 5
BP 321
EP 330
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA TZ683
UT WOS:A1984TZ68300006
PM 6336561
ER

PT J
AU NIKAIDO, T
   SHIMIZU, A
   ISHIDA, N
   SABE, H
   TESHIGAWARA, K
   MAEDA, M
   UCHIYAMA, T
   YODOI, J
   HONJO, T
AF NIKAIDO, T
   SHIMIZU, A
   ISHIDA, N
   SABE, H
   TESHIGAWARA, K
   MAEDA, M
   UCHIYAMA, T
   YODOI, J
   HONJO, T
TI MOLECULAR-CLONING OF CDNA-ENCODING HUMAN INTERLEUKIN-2 RECEPTOR
SO NATURE
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED,SAKYO KU,KYOTO 606,JAPAN.
RP NIKAIDO, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   HATTORI T, 1981, BLOOD, V58, P645
   DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   WALLACE RB, 1981, NUCLEIC ACIDS RES, V9, P879, DOI 10.1093/nar/9.4.879
   HEWICK RM, 1981, J BIOL CHEM, V256, P7990
   ISHIDA N, 1982, EMBO J, V1, P1117
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317
   GALLO RC, 1983, BLOOD, V62, P510
   GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HEMLER ME, 1984, P NATL ACAD SCI US, V81, P2171
   HIMUNA Y, 1981, P NATL ACAD SCI USA, V78, P6476
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   LEONARD WJ, 1983, P NATL ACAD SCI-BIOL, V80, P6957, DOI 10.1073/pnas.80.22.6957
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   Maxam A M, 1980, Methods Enzymol, V65, P499
   MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0
   MOYOSHI I, 1980, GANN, V71, P155
   NIELSEN DA, 1983, P NATL ACAD SCI-BIOL, V80, P5198, DOI 10.1073/pnas.80.17.5198
   OKAYAMA H, 1982, MOL CELL BIOL, V2, P161
   OSAWA H, 1983, J IMMUNOL, V30, P51
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   ROBB RJ, 1983, J EXP MED, V158, P1332, DOI 10.1084/jem.158.4.1332
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKATSUKI K, 1982, GANN MONOGRAPH CANCE, V28, P13
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TSUDO M, 1983, BLOOD, V61, P1014
   TSUDO M, 1982, J IMMUNOL, V129, P592
   WANO Y, J IMMUN
   YACHIE A, 1983, J IMMUNOL, V131, P731
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, THYMIC HORMONES LYMP
   YODOI J, CANCER CELLS, V3
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, MOL BIOL MED
NR 49
TC 587
Z9 589
U1 1
U2 5
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PY 1984
VL 311
IS 5987
BP 631
EP 635
DI 10.1038/311631a0
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA TN962
UT WOS:A1984TN96200038
PM 6090949
ER

PT J
AU KOHNO, M
   YAMADA, T
   HONJO, T
   OKAMURA, M
   HIROSE, K
   AOTA, K
AF KOHNO, M
   YAMADA, T
   HONJO, T
   OKAMURA, M
   HIROSE, K
   AOTA, K
TI MECHANICAL-PROPERTIES OF NI-BASE 718 ALLOY DISK MANUFACTURED FROM
   ELECTRON-SPIN-RESONANCE INGOT
SO TRANSACTIONS OF THE IRON AND STEEL INSTITUTE OF JAPAN
LA English
DT Meeting Abstract
C1 KOBE STEEL LTD,DIV STEEL CASTING & FORGING,CHUO KU,KOBE 651,JAPAN.
   KOBE STEEL LTD,CENT RES LAB,KOBE 651,JAPAN.
CR KUWABARA K, 1982, 282013 EN ENV LAB RE
   MOON DP, 1968, ASTM DS7S1 DAT SER, P213
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IRON STEEL INST JAPAN KEIDANREN KAIKAN
PI TOKYO
PA 9-4 OTEMACHI 1-CHOME CHIYODA-KU, TOKYO 100, JAPAN
SN 0021-1583
J9 T IRON STEEL I JPN
PY 1984
VL 24
IS 5
BP B161
EP B161
PG 1
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA TC088
UT WOS:A1984TC08800039
ER

PT J
AU HONJO, T
   HABU, S
AF HONJO, T
   HABU, S
TI ORIGIN OF IMMUNE DIVERSITY - GENETIC-VARIATION AND SELECTION
SO ANNUAL REVIEW OF BIOCHEMISTRY
LA English
DT Review
C1 TOKAI UNIV,SCH MED,DEPT CELL BIOL,ISEHARA,KANAGAWA 25911,JAPAN.
RP HONJO, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172
   FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   MAX EE, 1979, P NATL ACAD SCI USA, V76, P3450, DOI 10.1073/pnas.76.7.3450
   BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   ZINKERNAGEL RM, 1978, NATURE, V271, P251, DOI 10.1038/271251a0
   ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7
   KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   MCBRIDE OW, 1982, J EXP MED, V155, P1480, DOI 10.1084/jem.155.5.1480
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   KABAT EA, 1978, P NATL ACAD SCI USA, V75, P2429, DOI 10.1073/pnas.75.5.2429
   ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118
   ALT FW, 1984, EMBO J, V3, P1209
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211
   CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923
   MCINTYRE BW, 1983, CELL, V34, P739, DOI 10.1016/0092-8674(83)90530-5
   CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2
   ACUTO O, 1984, P NATL ACAD SCI-BIOL, V81, P3851, DOI 10.1073/pnas.81.12.3851
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0
   KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764
   CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8
   PECH M, 1981, NATURE, V291, P668, DOI 10.1038/291668a0
   SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6
   KLEIN J, 1983, ANNU REV IMMUNOL, V1, P119, DOI 10.1146/annurev.iy.01.040183.001003
   VANNESS BG, 1982, P NATL ACAD SCI-BIOL, V79, P262
   CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0
   ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0
   BLOMBERG B, 1982, P NATL ACAD SCI-BIOL, V79, P530, DOI 10.1073/pnas.79.2.530
   GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0
   MOSTOV KE, 1984, NATURE, V308, P37, DOI 10.1038/308037a0
   BANKHURS.AD, 1973, LANCET, V1, P226
   BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1
   BENTLEY DL, 1984, NATURE, V307, P77, DOI 10.1038/307077a0
   BENTLEY DL, 1980, NATURE, V288, P730, DOI 10.1038/288730a0
   BERNSTEIN KE, 1982, NATURE, V300, P74, DOI 10.1038/300074a0
   BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x
   BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0
   BLACKWELL TK, 1984, UCLA S MOL CELL BIOL, V19
   BLACKWELL TK, 1984, CELL, V37, P105
   CACCIA N, 1984, CELL, V37, P1091, DOI 10.1016/0092-8674(84)90443-4
   CAREL S, 1983, P NATL ACAD SCI-BIOL, V80, P4832, DOI 10.1073/pnas.80.15.4832
   COHEN JB, 1983, EMBO J, V2, P2013
   COHEN JB, 1982, NUCLEIC ACIDS RES, V10, P3353, DOI 10.1093/nar/10.11.3353
   COHN M, 1983, CELL, V33, P657, DOI 10.1016/0092-8674(83)90009-0
   COLECLOUGH C, 1983, NATURE, V303, P23, DOI 10.1038/303023a0
   COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0
   CORY S, 1981, Journal of Molecular and Applied Genetics, V1, P103
   CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4
   DESIDERIO S, 1984, NATURE, V308, P860, DOI 10.1038/308860a0
   DEUSTACHIO P, 1980, J EXP MED, V151, P1545, DOI 10.1084/jem.151.6.1545
   DEUSTACHIO P, 1981, J EXP MED, V153, P793, DOI 10.1084/jem.153.4.793
   ELLIOTT BW, 1982, NATURE, V299, P559, DOI 10.1038/299559a0
   ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984
   FATHMAN CG, 1979, P NATL ACAD SCI USA, V76, P5863, DOI 10.1073/pnas.76.11.5863
   FEIZI T, 1973, BLOOD, V42, P753
   GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0
   GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439
   GEBHARD W, 1983, J MOL BIOL, V170, P567, DOI 10.1016/S0022-2836(83)80161-2
   GEBHARD W, 1983, J MOL BIOL, V170, P255, DOI 10.1016/S0022-2836(83)80147-8
   GERSHENFELD HK, 1981, P NATL ACAD SCI-BIOL, V78, P7674, DOI 10.1073/pnas.78.12.7674
   GIVOL D, 1981, NATURE, V292, P426, DOI 10.1038/292426a0
   GORSKI J, 1983, SCIENCE, V220, P1179, DOI 10.1126/science.6857243
   HABU S, 1984, EUR J IMMUNOL
   HIETER PA, 1981, NATURE, V290, P368, DOI 10.1038/290368a0
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   HIETER PA, 1981, NATURE, V294, P536, DOI 10.1038/294536a0
   HOCHTL J, 1983, NATURE, V302, P260, DOI 10.1038/302260a0
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HOWARD M, 1983, ANNU REV IMMUNOL, V1, P307, DOI 10.1146/annurev.iy.01.040183.001515
   HOZUMI N, 1981, P NATL ACAD SCI-BIOL, V78, P7019, DOI 10.1073/pnas.78.11.7019
   HUANG H, 1981, Journal of Molecular and Applied Genetics, V1, P93
   HUNIG TR, 1982, J EXP MED, V155, P111, DOI 10.1084/jem.155.1.111
   JAENICHEN HR, 1984, NUCLEIC ACID RES
   JOHNSON ML, 1984, P NATL ACAD SCI US
   KATAOKA T, 1984, NUCLEIC ACIDS RES, V12, P5995, DOI 10.1093/nar/12.15.5995
   KATAOKA T, 1983, PROGR IMMUNOLOGY, V5, P123
   KATAOKA T, 1982, J BIOL CHEM, V257, P277
   KAVALER J, 1984, NATURE, V310, P421, DOI 10.1038/310421a0
   KEMP D J, 1981, Journal of Molecular and Applied Genetics, V1, P245
   KONDO S, 1984, COLD SPRING HARBOR S, V49
   KORSMEYER SJ, 1982, J EXP MED, V156, P975, DOI 10.1084/jem.156.4.975
   KRONENBERG M, 1983, CELL, V34, P327, DOI 10.1016/0092-8674(83)90365-3
   KWAN SP, 1981, CELL, V26, P57, DOI 10.1016/0092-8674(81)90033-7
   LEE NE, 1984, J EXP MED, V160, P905, DOI 10.1084/jem.160.3.905
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LEWIS S, 1984, NATURE, V308, P425, DOI 10.1038/308425a0
   LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9
   LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9
   MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6
   MELCHERS F, 1984, CELL, V37, P715, DOI 10.1016/0092-8674(84)90407-0
   MEUER SC, 1984, P NATL ACAD SCI-BIOL, V81, P1509, DOI 10.1073/pnas.81.5.1509
   MILLER J, 1982, NATURE, V295, P428, DOI 10.1038/295428a0
   MITCHISO.NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093
   MITSUYA H, 1984, SCIENCE, V225, P1484, DOI 10.1126/science.6206569
   MIYATA T, 1980, P NATL ACAD SCI-BIOL, V77, P2143, DOI 10.1073/pnas.77.4.2143
   NAKANISHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6984, DOI 10.1073/pnas.79.22.6984
   NATALI PG, 1981, IMMUNOGENETICS, V14, P359, DOI 10.1007/BF00373316
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OLLO R, 1983, CELL, V32, P515, DOI 10.1016/0092-8674(83)90471-3
   OLLO R, 1981, P NATL ACAD SCI-BIOL, V78, P2442, DOI 10.1073/pnas.78.4.2442
   OWEN JA, 1982, NATURE, V295, P347, DOI 10.1038/295347a0
   PECH M, 1984, J MOL BIOL, V176, P189, DOI 10.1016/0022-2836(84)90420-0
   PERLMUTTER RM, 1984, ADV IMMUNOL
   RAO A, 1984, CELL, V36, P889, DOI 10.1016/0092-8674(84)90038-2
   RAO A, 1984, CELL, V36, P879, DOI 10.1016/0092-8674(84)90037-0
   RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   ROCCASERRA J, 1983, NATURE, V304, P353, DOI 10.1038/304353a0
   ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9
   ROYER HD, 1984, CELL, V39, P261, DOI 10.1016/0092-8674(84)90003-5
   RUDIKOFF S, 1984, P NATL ACAD SCI-BIOL, V81, P2162, DOI 10.1073/pnas.81.7.2162
   SAITO H, 1984, NATURE, V312, P36, DOI 10.1038/312036a0
   SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972
   SCHREIER PH, 1981, P NATL ACAD SCI-BIOL, V78, P4495, DOI 10.1073/pnas.78.7.4495
   SCHWARTZ RH, 1984, FUNDAMENTAL IMMUNOLO, P379
   SEIDMAN JG, 1979, NATURE, V280, P370, DOI 10.1038/280370a0
   SEIDMAN JG, 1980, P NATL ACAD SCI-BIOL, V77, P6022, DOI 10.1073/pnas.77.10.6022
   SELSING E, 1981, CELL, V25, P47, DOI 10.1016/0092-8674(81)90230-0
   SELSING E, 1984, NUCLEIC ACIDS RES, V12, P4229, DOI 10.1093/nar/12.10.4229
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SINGER A, 1982, IMMUNOL REV, V64, P137, DOI 10.1111/j.1600-065X.1982.tb00422.x
   SIU G, 1984, NATURE, V311, P344, DOI 10.1038/311344a0
   STEINMETZ M, 1980, NUCLEIC ACIDS RES, V8, P1709, DOI 10.1093/nar/8.8.1709
   STRAUBINGER B, 1984, NUCLEIC ACIDS RES, V12, P5265, DOI 10.1093/nar/12.13.5265
   SUGIYAMA H, 1983, NATURE, V303, P812, DOI 10.1038/303812a0
   SWAN D, 1979, P NATL ACAD SCI USA, V76, P2735, DOI 10.1073/pnas.76.6.2735
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TSUKAMOTO A, 1984, EMBO J, V3, P975
   WEIGLE WO, 1971, CLIN EXP IMMUNOL, V9, P437
   WU TT, 1982, P NATL ACAD SCI-BIOL, V79, P5031, DOI 10.1073/pnas.79.16.5031
   YACHIE A, 1983, J IMMUNOL, V131, P731
   YAOITA Y, 1983, NUCLEIC ACIDS RES, V11, P7303, DOI 10.1093/nar/11.21.7303
   ZEELON EP, 1981, NUCLEIC ACIDS RES, V9, P3809, DOI 10.1093/nar/9.15.3809
   ZIEGLER SF, 1984, P NATL ACAD SCI-BIOL, V81, P1529, DOI 10.1073/pnas.81.5.1529
   ZINKERNAGEL RM, 1978, IMMUNOGENETICS, V7, P73, DOI 10.1007/BF01843990
   ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882
NR 143
TC 126
Z9 127
U1 0
U2 1
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0066-4154
J9 ANNU REV BIOCHEM
JI Annu. Rev. Biochem.
PY 1985
VL 54
BP 803
EP 830
DI 10.1146/annurev.biochem.54.1.803
PG 28
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ALY02
UT WOS:A1985ALY0200026
PM 3927822
ER

PT J
AU HONJO, T
   NISHI, M
   NIKAIDO, T
   SABE, H
   YODOI, J
   MATSUNAMI, N
   SUZUKI, N
   KONDO, S
   SHIMIZU, A
   YAOITA, Y
AF HONJO, T
   NISHI, M
   NIKAIDO, T
   SABE, H
   YODOI, J
   MATSUNAMI, N
   SUZUKI, N
   KONDO, S
   SHIMIZU, A
   YAOITA, Y
TI ORGANIZATION AND EXPRESSION OF LYMPHOCYTE RECEPTOR GENES
SO DEVELOPMENT GROWTH & DIFFERENTIATION
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU BLACKWELL SCIENCE
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA
SN 0012-1592
J9 DEV GROWTH DIFFER
JI Dev. Growth Diff.
PY 1985
VL 27
IS 4
BP 470
EP 470
PG 1
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA AQQ68
UT WOS:A1985AQQ6800007
ER

PT J
AU YODOI, J
   NIKAIDO, T
   SABE, H
   TESHIGAWARA, K
   OKADA, M
   TAGAYA, Y
   ISHIDA, N
   SHIMIZU, A
   MAEDA, M
   UCHIYAMA, T
   HONJO, T
AF YODOI, J
   NIKAIDO, T
   SABE, H
   TESHIGAWARA, K
   OKADA, M
   TAGAYA, Y
   ISHIDA, N
   SHIMIZU, A
   MAEDA, M
   UCHIYAMA, T
   HONJO, T
TI ROLE OF IL-2-R INDUCING FACTOR (ADF) IN THE CONSTITUTIVE IL-2-R
   GENE-EXPRESSION IN ADULT T-CELL LEUKEMIA (ATL)
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 KYOTO UNIV,SCH MED,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0014-9446
J9 FED PROC
PY 1985
VL 44
IS 3
BP 799
EP 799
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA ADF61
UT WOS:A1985ADF6102301
ER

PT J
AU HORIUCHI, Y
   HONJO, T
   ONO, M
AF HORIUCHI, Y
   HONJO, T
   ONO, M
TI IGE HEAVY-CHAIN CONSTANT REGION GENES IN ATOPIC-DERMATITIS AND SENILE
   ERYTHRODERMA PATIENTS
SO IMMUNOGENETICS
LA English
DT Article
C1 KITASATO UNIV,SCH MED,DEPT DERMATOL,SAGAMIHARA,KANAGAWA 228,JAPAN.
   KYOTO UNIV,FAC MED,SAKYO KU,KYOTO 606,JAPAN.
CR BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303
   BAZARAL M, 1974, J ALLERGY CLIN IMMUN, V54, P288, DOI 10.1016/0091-6749(74)90015-3
   CHAMPION RH, 1979, TXB DERMATOLOGY, V1, P349
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   ISHIZAKA K, 1984, ANNU REV IMMUNOL, V2, P159, DOI 10.1146/annurev.immunol.2.1.159
   LUEDERS K, 1982, NATURE, V295, P426, DOI 10.1038/295426a0
   MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   NISHIOKA Y, 1980, P NATL ACAD SCI-BIOL, V77, P2806, DOI 10.1073/pnas.77.5.2806
   ONO M, 1980, CELL, V21, P465, DOI 10.1016/0092-8674(80)90483-3
   ROOK A, 1979, TXB DERMATOLOGY, V1, P299
   SARYAN JA, 1983, J IMMUNOL, V130, P242
   UEDA S, 1982, EMBO J, V1, P1539
NR 13
TC 8
Z9 8
U1 1
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0093-7711
J9 IMMUNOGENETICS
JI Immunogenetics
PY 1985
VL 22
IS 3
BP 241
EP 246
DI 10.1007/BF00404483
PG 6
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA ARP45
UT WOS:A1985ARP4500005
PM 2995248
ER

PT J
AU HONJO, T
   YAMATO, K
   KATO, C
   ICHIDA, T
AF HONJO, T
   YAMATO, K
   KATO, C
   ICHIDA, T
TI IMPROVING PAINTABILITY WITH FE-P COATING OF ZN-FE AND ZN-NI ALLOY
   ELECTROPLATED STEELS
SO INTERNATIONAL JOURNAL OF VEHICLE DESIGN
LA English
DT Article
RP HONJO, T (reprint author), KAWASAKI STEEL CORP,RES LAB,CHIBA 260,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0143-3369
J9 INT J VEHICLE DES
JI Int. J. Veh. Des.
PY 1985
VL 6
IS 4-5
BP 496
EP 500
PG 5
WC Engineering, Mechanical; Transportation Science & Technology
SC Engineering; Transportation
GA AUC89
UT WOS:A1985AUC8900025
ER

PT J
AU YODOI, J
   OKADA, M
   TAGAYA, Y
   TESHIGAWARA, K
   FUKUI, K
   ISHIDA, N
   IKUTA, KI
   MAEDA, M
   HONJO, T
   OSAWA, H
   DIAMANTSTEIN, T
   TATENO, M
   YOSHIKI, T
AF YODOI, J
   OKADA, M
   TAGAYA, Y
   TESHIGAWARA, K
   FUKUI, K
   ISHIDA, N
   IKUTA, KI
   MAEDA, M
   HONJO, T
   OSAWA, H
   DIAMANTSTEIN, T
   TATENO, M
   YOSHIKI, T
TI RAT LYMPHOID-CELL LINES PRODUCING HUMAN T-CELL LEUKEMIA-VIRUS .2.
   CONSTITUTIVE EXPRESSION OF RAT INTERLEUKIN-2 RECEPTOR
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
   FREE UNIV BERLIN,KLINIKUM STEGLITZ,IMMUNOL RES UNIT,D-1000 BERLIN 45,FED REP GER.
   SAPPORO CITY HOSP,SAPPORO,JAPAN.
RP YODOI, J (reprint author), KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
CR HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   BOLTON AE, 1973, BIOCHEM J, V133, P529
   HATTORI T, 1981, BLOOD, V58, P645
   DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   MIYOSHI I, 1980, GANN, V71, P155
   TATENO M, 1984, J EXP MED, V159, P1105, DOI 10.1084/jem.159.4.1105
   UCHIYAMA T, 1977, BLOOD, V50, P481
   ARYA SK, 1984, SCIENCE, V223, P1086, DOI 10.1126/science.6320374
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Fukui K, 1983, Mol Biol Med, V1, P447
   GALLO RC, 1982, BLOOD, V60, P545
   HASELTINE WA, 1984, SCIENCE, V225, P419, DOI 10.1126/science.6330894
   JELINEK WR, 1980, P NATL ACAD SCI US, V77, P919
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OSAWA H, 1983, J IMMUNOL, V130, P51
   OSAWA H, 1984, EUR J IMMUNOL
   TESHIGAWARA K, 1985, J MOL CELL IMMUNOL
   TSUDO M, 1983, BLOOD, V61, P1014
   TSUDO M, 1982, J IMMUNOL, V129, P592
   WANO Y, 1984, J IMMUNOL, V132, P3005
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1984, CANCER CELLS, V3, P255
NR 30
TC 27
Z9 27
U1 0
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PY 1985
VL 161
IS 5
BP 924
EP 934
DI 10.1084/jem.161.5.924
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA AGW20
UT WOS:A1985AGW2000004
PM 2985731
ER

PT J
AU MAEDA, M
   SHIMIZU, A
   IKUTA, K
   OKAMOTO, H
   KASHIHARA, M
   UCHIYAMA, T
   HONJO, T
   YODOI, J
AF MAEDA, M
   SHIMIZU, A
   IKUTA, K
   OKAMOTO, H
   KASHIHARA, M
   UCHIYAMA, T
   HONJO, T
   YODOI, J
TI ORIGIN OF HUMAN T-LYMPHOTROPHIC VIRUS-I-POSITIVE T-CELL LINES IN ADULT
   T-CELL LEUKEMIA - ANALYSIS OF T-CELL RECEPTOR GENE REARRANGEMENT
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Note
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT DERMATOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
RP MAEDA, M (reprint author), KYOTO UNIV,FAC MED,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
CR SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6
   Hahn B, 1984, Mol Biol Med, V2, P29
   IKUTA K, 1985, P NATL ACAD SCI US
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   TSUDO M, 1983, BLOOD, V61, P1014
   UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J EXP MED, V161, P924, DOI 10.1084/jem.161.5.924
NR 20
TC 154
Z9 154
U1 0
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PY 1985
VL 162
IS 6
BP 2169
EP 2174
DI 10.1084/jem.162.6.2169
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA AWN63
UT WOS:A1985AWN6300030
PM 2866223
ER

PT J
AU YODOI, J
   TESHIGAWARA, K
   NIKAIDO, T
   FUKUI, K
   NOMA, T
   HONJO, T
   TAKIGAWA, M
   SASAKI, M
   MINATO, N
   TSUDO, M
   UCHIYAMA, T
   MAEDA, M
AF YODOI, J
   TESHIGAWARA, K
   NIKAIDO, T
   FUKUI, K
   NOMA, T
   HONJO, T
   TAKIGAWA, M
   SASAKI, M
   MINATO, N
   TSUDO, M
   UCHIYAMA, T
   MAEDA, M
TI TCGF (IL 2)-RECEPTOR INDUCING FACTOR(S) .1. REGULATION OF IL-2 RECEPTOR
   ON A NATURAL KILLER-LIKE CELL-LINE (YT-CELLS)
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   HAMAMATSU UNIV,SCH MED,DEPT DERMATOL,HAMAMATSU,SHIZUOKA 43131,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED 1,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR RADIAT BIOL,KYOTO 606,JAPAN.
   KYOTO UNIV,CHEST DIS RES INST,KYOTO 606,JAPAN.
   JICHI MED SCH,DEPT ALLERGY & CONNECT TISSUE DIS,MINAMIKAWACHI,TOCHIGI 32904,JAPAN.
RP YODOI, J (reprint author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.
CR HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172
   SHINDELMAN JE, 1981, INT J CANCER, V27, P329, DOI 10.1002/ijc.2910270311
   ABO T, 1983, J IMMUNOL, V131, P1822
   RABIN H, 1981, J IMMUNOL, V127, P1852
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   HATTORI T, 1981, BLOOD, V58, P645
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208
   LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895
   CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923
   KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337
   TIMONEN T, 1981, J EXP MED, V153, P569, DOI 10.1084/jem.153.3.569
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   ABO T, 1981, J IMMUNOL, V127, P1024
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   DOMZIG W, 1983, J IMMUNOL, V130, P1970
   FUKUI K, 1984, MOL BIOL MED
   HAUGER RL, 1978, NATURE, V271, P176, DOI 10.1038/271176a0
   HEBERMAN RB, 1975, INT J CANCER, V16, P230
   KORSMEYER SJ, 1983, P NATL ACAD SCI-BIOL, V80, P4522, DOI 10.1073/pnas.80.14.4522
   LEONARD WJ, 1984, NATURE
   MCCONAHEY PJ, 1966, INT ARCH ALLERGY APP, V29, P1885
   MCDEVITT HO, 1963, J IMMUNOL, V90, P634
   MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4
   NIKAIDO T, 1984, NATURE
   POSNER BI, 1975, SCIENCE, V188, P57, DOI 10.1126/science.163493
   ROBB RJ, 1983, J EXP MED, V158, P1322
   RYFFEL B, 1982, P NATL ACAD SCI-BIOL, V79, P7336, DOI 10.1073/pnas.79.23.7336
   SVEDMYR E, 1975, P NATL ACAD SCI USA, V72, P1622, DOI 10.1073/pnas.72.4.1622
   TSUDO M, 1983, BLOOD, V61, P1014
   TSUDO M, 1982, J IMMUNOL, V129, P592
   WANO Y, 1984, J IMMUNOL, V132, P3005
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, 1982, J IMMUNOL, V128, P888
   YODOI J, 1984, THYMIC HORMONES LYMP
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1979, J IMMUNOL, V123, P455
   YODOI J, 1984, HUMAN T CELL LEUKEMI, P255
NR 43
TC 363
Z9 365
U1 1
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PY 1985
VL 134
IS 3
BP 1623
EP 1630
PG 8
WC Immunology
SC Immunology
GA ACH97
UT WOS:A1985ACH9700050
PM 2578514
ER

PT J
AU OKADA, M
   MAEDA, M
   TAGAYA, Y
   TANIGUCHI, Y
   TESHIGAWARA, K
   YOSHIKI, T
   DIAMANTSTEIN, T
   SMITH, KA
   UCHIYAMA, T
   HONJO, T
   YODOI, J
AF OKADA, M
   MAEDA, M
   TAGAYA, Y
   TANIGUCHI, Y
   TESHIGAWARA, K
   YOSHIKI, T
   DIAMANTSTEIN, T
   SMITH, KA
   UCHIYAMA, T
   HONJO, T
   YODOI, J
TI TCGF(IL-2)-RECEPTOR INDUCING FACTOR(S) .2. POSSIBLE ROLE OF ATL-DERIVED
   FACTOR (ADF) ON CONSTITUTIVE IL-2 RECEPTOR EXPRESSION OF HTLV-I(+)
   T-CELL LINES
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
   SAPPORO CITY HOSP,SAPPORO,JAPAN.
   FREE UNIV BERLIN,KLINIKUM STEGLITZ,IMMUNOL RES UNIT,D-1000 BERLIN 45,FED REP GER.
   DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT MED,HANOVER,NH 03755.
   KYOTO UNIV,FAC MED,DEPT MED 1,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864
   HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   ASSOIAN RK, 1984, CELL, V36, P35, DOI 10.1016/0092-8674(84)90071-0
   BOLTON AE, 1973, BIOCHEM J, V133, P529
   HATTORI T, 1981, BLOOD, V58, P645
   REEM GH, 1984, SCIENCE, V225, P429, DOI 10.1126/science.6429853
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   TATENO M, 1984, J EXP MED, V159, P1105, DOI 10.1084/jem.159.4.1105
   UCHIYAMA T, 1977, BLOOD, V50, P481
   ARYA SK, 1984, SCIENCE, V223, P1086, DOI 10.1126/science.6320374
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   DEPPER JM, 1984, J IMMUNOL, V133, P3054
   KAYE J, 1984, J IMMUNOL, V133, P1339
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MARQUARDT H, 1983, P NATL ACAD SCI-BIOL, V80, P4684
   MITSUYA H, 1984, SCIENCE, V225, P1484, DOI 10.1126/science.6206569
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OSAWA H, 1983, J IMMUNOL, V130, P51
   SCALA G, 1984, J EXP MED, V159, P1637, DOI 10.1084/jem.159.6.1637
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SCHMIDT JA, 1984, J EXP MED, V160, P772, DOI 10.1084/jem.160.3.772
   TESHIGAWARA K, 1985, J MOL CELL IMMUNOL, V2, P17
   TSUDO M, 1983, BLOOD, V61, P1014
   TSUDO M, 1982, J IMMUNOL, V129, P592
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, 1984, THYMIC HORMONES LYMP, P273
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J EXP MED, V161, P924, DOI 10.1084/jem.161.5.924
   YODOI J, 1985, J IMMUNOL, V134, P1623
   YODOI J, 1984, HUMAN T CELL LEUKEMI, P255
NR 36
TC 85
Z9 85
U1 0
U2 2
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PY 1985
VL 135
IS 6
BP 3995
EP 4003
PG 9
WC Immunology
SC Immunology
GA AUL14
UT WOS:A1985AUL1400055
PM 2999237
ER

PT J
AU ONO, T
   OKADA, S
   KAWAKAMI, T
   HONJO, T
   GETZ, MJ
AF ONO, T
   OKADA, S
   KAWAKAMI, T
   HONJO, T
   GETZ, MJ
TI ABSENCE OF GROSS CHANGE IN PRIMARY DNA-SEQUENCE DURING AGING PROCESS OF
   MICE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV TOKYO,FAC MED,DEPT PHYSIOL CHEM NUTR,BUNKYO KU,TOKYO 113,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   MAYO CLIN & MAYO FDN,DEPT CELL BIOL,ROCHESTER,MN 55901.
RP ONO, T (reprint author), KYOTO UNIV,CTR RADIAT BIOL,DEPT LATE EFFECT STUDIES,SAKYO KU,KYOTO 606,JAPAN.
RI Kawakami, Toshiaki/O-1616-2015
CR EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333
   HERR W, 1982, NATURE, V296, P865, DOI 10.1038/296865a0
   GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1
   BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505
   SCHIMKE RT, 1984, CELL, V37, P705, DOI 10.1016/0092-8674(84)90406-9
   JENKINS NA, 1982, J VIROL, V43, P26
   CHANG ACY, 1978, NATURE, V275, P617, DOI 10.1038/275617a0
   CHATTOPADHYAY SK, 1982, NATURE, V296, P361, DOI 10.1038/296361a0
   COURTNEY MG, 1982, J VIROL, V43, P511
   COURTNEY MG, 1982, CANCER RES, V42, P569
   ELLIS RW, 1980, J VIROL, V36, P408
   ENGEL JD, 1978, J BIOL CHEM, V253, P8239
   GIRI CP, 1983, NUCLEIC ACIDS RES, V11, P305, DOI 10.1093/nar/11.2.305
   HODGSON CP, 1983, MOL CELL BIOL, V3, P2221
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   KOMINAMI R, 1981, NUCLEIC ACIDS RES, V9, P3219, DOI 10.1093/nar/9.14.3219
   KOMINAMI R, 1983, J MOL BIOL, V165, P209, DOI 10.1016/S0022-2836(83)80254-X
   LEE F, 1981, NATURE, V294, P228, DOI 10.1038/294228a0
   LEVINE M, 1981, P NATL ACAD SCI-BIOL, V78, P2417, DOI 10.1073/pnas.78.4.2417
   MANIATIS T., 1982, MOL CLONING LABORATO, P382
   MASSIE HR, 1972, ARCH BIOCHEM BIOPHYS, V153, P736, DOI 10.1016/0003-9861(72)90392-X
   MINTY AJ, 1981, J BIOL CHEM, V256, P1008
   MINTY AJ, 1983, J MOL BIOL, V167, P77, DOI 10.1016/S0022-2836(83)80035-7
   ONO T, 1976, EXP GERONTOL, V11, P127, DOI 10.1016/0531-5565(76)90022-X
   SCHIMKE RT, 1982, GENE AMPLIFICATION, P317
   SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889
   SHAPIRO JA, 1983, MOBILE GENETIC ELEME, P11
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Shmookler Reis R J, 1983, Nature, V301, P394
   SU CM, 1984, MECH AGEING DEV, V10, P239
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TRAINA VL, 1981, J VIROL, V40, P735
   TSUJIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P1644, DOI 10.1073/pnas.81.6.1644
   VARMUS HE, 1983, MOBILE GENETIC ELEME, P411
NR 35
TC 33
Z9 33
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PY 1985
VL 32
IS 2-3
BP 227
EP 234
DI 10.1016/0047-6374(85)90082-X
PG 8
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA AWS99
UT WOS:A1985AWS9900008
PM 4087943
ER

PT J
AU SHIMUZU, A
   KONDO, S
   TAKEDA, S
   YODOI, J
   ISHIDA, N
   SABE, H
   OSAWA, H
   DIAMANTSTEIN, T
   NIKAIDO, T
   HONJO, T
AF SHIMUZU, A
   KONDO, S
   TAKEDA, S
   YODOI, J
   ISHIDA, N
   SABE, H
   OSAWA, H
   DIAMANTSTEIN, T
   NIKAIDO, T
   HONJO, T
TI NUCLEOTIDE-SEQUENCE OF MOUSE IL-2 RECEPTOR CDNA AND ITS COMPARISON WITH
   THE HUMAN IL-2-RECEPTOR SEQUENCE
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.
   FREE UNIV BERLIN,KLINIKUM STEGLITZ,IMMUNOL RES UNIT,D-1000 BERLIN 45,FED REP GER.
   OSAKA UNIV,SCH MED,DEPT GENET,OSAKA 530,JAPAN.
RP SHIMUZU, A (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172
   YAMAWAKIKATAOKA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2623, DOI 10.1073/pnas.79.8.2623
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   HATTORI T, 1981, BLOOD, V58, P645
   MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   ISHIDA N, 1982, EMBO J, V1, P1117
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   CENTRELL DA, 1983, J EXP MED, V158, P1895
   CIKES M, 1973, J NATL CANCER I, V50, P347
   GALLO RC, 1983, BLOOD, V62, P510
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HONJO T, 1979, CELL, V18, P557
   HUNTER H, 1984, NATURE, V311, P480
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LEONARD WJ, 1983, P NATL ACAD SCI-BIOL, V80, P6957, DOI 10.1073/pnas.80.22.6957
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OKAYAMA H, 1983, MOL CELL BIOL, V3, P280
   OSAWA H, 1985, EUR J IMMUNOL
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   SHACKELFORD DA, 1984, J BIOL CHEM, V259, P1706
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TSUDO M, 1983, BLOOD, V61, P1014
   WANO Y, UNPUB J CLIN INVEST
   WANO Y, 1984, J IMMUNOL, V132, P3005
   WORD CJ, 1983, EMBO J, V2, P887
   YACHIE A, 1983, J IMMUNOL, V131, P731
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, MOL BIOL MED
NR 35
TC 110
Z9 111
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PY 1985
VL 13
IS 5
BP 1505
EP 1516
DI 10.1093/nar/13.5.1505
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ADH69
UT WOS:A1985ADH6900006
PM 2987826
ER

PT J
AU ISHIDA, N
   KANAMORI, H
   NOMA, T
   NIKAIDO, T
   SABE, H
   SUZUKI, N
   SHIMIZU, A
   HONJO, T
AF ISHIDA, N
   KANAMORI, H
   NOMA, T
   NIKAIDO, T
   SABE, H
   SUZUKI, N
   SHIMIZU, A
   HONJO, T
TI MOLECULAR-CLONING AND STRUCTURE OF THE HUMAN INTERLEUKIN-2 RECEPTOR GENE
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
RP ISHIDA, N (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   HATTORI T, 1981, BLOOD, V58, P645
   MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6
   YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   CHAMBON P, 1984, RECENT PROG HORM RES, V40, P1
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   DAVIS MM, 1985, ANNU REV IMMUNOL, V3, P537
   FUJITA T, 1983, P NATL ACAD SCI-BIOL, V80, P7437, DOI 10.1073/pnas.80.24.7437
   GALLO RC, 1983, BLOOD, V62, P510
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   KATAOKA T, 1982, J BIOL CHEM, V257, P277
   KRONKE M, 1985, SCIENCE, V228, P1215, DOI 10.1126/science.2988127
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   PFEFFER S, 1985, NATURE, V313, P184, DOI 10.1038/313184a0
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TSUDO M, 1983, BLOOD, V61, P1014
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 27
TC 61
Z9 62
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PY 1985
VL 13
IS 21
BP 7579
EP 7589
DI 10.1093/nar/13.21.7579
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AUD17
UT WOS:A1985AUD1700004
PM 2999698
ER

PT J
AU UEDA, S
   TAKENAKA, O
   HONJO, T
AF UEDA, S
   TAKENAKA, O
   HONJO, T
TI A TRUNCATED IMMUNOGLOBULIN-EPSILON PSEUDOGENE IS FOUND IN GORILLA AND
   MAN BUT NOT IN CHIMPANZEE
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 OSAKA UNIV,SCH MED,DEPT GENET,OSAKA 530,JAPAN.
   KYOTO UNIV,PRIMATE RES INST,DEPT BIOCHEM,AICHI 484,JAPAN.
RP UEDA, S (reprint author), UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,TOKYO 113,JAPAN.
CR FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980
   YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861
   TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.2307/2408332
   BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759
   FLANAGAN JG, 1982, EMBO J, V1, P655
   FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9
   FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432
   BATTEY J, 1982, P NATL ACAD SCI-BIOL, V79, P5956, DOI 10.1073/pnas.79.19.5956
   BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952
   Brown W.M., 1983, P62
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984
   GOODMAN M, 1983, NATURE, V303, P546, DOI 10.1038/303546a0
   HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   Kluge A.G., 1983, P151
   KRAWINKEL U, 1982, EMBO J, V1, P403
   LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4
   MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   UEDA S, 1982, EMBO J, V1, P1539
NR 28
TC 33
Z9 33
U1 0
U2 0
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PY 1985
VL 82
IS 11
BP 3712
EP 3715
DI 10.1073/pnas.82.11.3712
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AKB79
UT WOS:A1985AKB7900040
PM 2987940
ER

PT J
AU NISHI, M
   KATAOKA, T
   HONJO, T
AF NISHI, M
   KATAOKA, T
   HONJO, T
TI PREFERENTIAL REARRANGEMENT OF THE IMMUNOGLOBULIN KAPPA-CHAIN JOINING
   REGION J-KAPPA-1 AND J-KAPPA-2 SEGMENTS IN MOUSE SPLEEN DNA
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
RP NISHI, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALTENBURGER W, 1980, NATURE, V287, P603, DOI 10.1038/287603a0
   MAX EE, 1979, P NATL ACAD SCI USA, V76, P3450, DOI 10.1073/pnas.76.7.3450
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309
   PECH M, 1981, NATURE, V291, P668, DOI 10.1038/291668a0
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   CORY S, 1981, Journal of Molecular and Applied Genetics, V1, P103
   HAMLYN PH, 1981, NUCLEIC ACIDS RES, V9, P4485, DOI 10.1093/nar/9.18.4485
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HOCHTL J, 1982, P NATL ACAD SCI-BIOL, V79, P1383, DOI 10.1073/pnas.79.5.1383
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0
   KABAT EA, 1983, SEQUENCES PROTEINS I, P45
   KATAOKA T, 1984, NUCLEIC ACIDS RES, V12, P5995, DOI 10.1093/nar/12.15.5995
   KEMP D J, 1981, Journal of Molecular and Applied Genetics, V1, P245
   KWAN SP, 1981, J EXP MED, V153, P1366, DOI 10.1084/jem.153.5.1366
   KWAN SP, 1981, CELL, V26, P57, DOI 10.1016/0092-8674(81)90033-7
   MAX EE, 1980, CELL, V21, P793, DOI 10.1016/0092-8674(80)90442-0
   MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180
   NISHIOKA Y, 1980, J BIOL CHEM, V255, P3691
   OKAYAMA H, 1982, MOL CELL BIOL, V2, P161
   RABBITTS TH, 1980, CAN J BIOCHEM CELL B, V58, P176
   SCHIFF C, 1983, EMBO J, V2, P1771
   SEIDMAN JG, 1980, NATURE, V286, P779, DOI 10.1038/286779a0
   SEIDMAN JG, 1978, P NATL ACAD SCI USA, V75, P3881, DOI 10.1073/pnas.75.8.3881
   SEIDMAN JG, 1979, NATURE, V280, P370, DOI 10.1038/280370a0
   SELSING E, 1981, CELL, V25, P47, DOI 10.1016/0092-8674(81)90230-0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 31
TC 48
Z9 48
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PY 1985
VL 82
IS 19
BP 6399
EP 6403
DI 10.1073/pnas.82.19.6399
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ARZ48
UT WOS:A1985ARZ4800008
PM 3931074
ER

PT J
AU IKUTA, K
   OGURA, T
   SHIMIZU, A
   HONJO, T
AF IKUTA, K
   OGURA, T
   SHIMIZU, A
   HONJO, T
TI LOW-FREQUENCY OF SOMATIC MUTATION IN BETA-CHAIN VARIABLE REGION GENES OF
   HUMAN T-CELL RECEPTORS
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
RP IKUTA, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1
   MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7
   KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6
   MIYOSHI I, 1980, GANN, V71, P155
   MCINTYRE BW, 1983, CELL, V34, P739, DOI 10.1016/0092-8674(83)90530-5
   CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2
   BERNARD O, 1978, CELL, V15, P1133, DOI 10.1016/0092-8674(78)90041-7
   YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0
   YOSHIKAI Y, 1984, NATURE, V312, P521, DOI 10.1038/312521a0
   CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0
   PECH M, 1981, NATURE, V291, P668, DOI 10.1038/291668a0
   SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6
   AUGUSTIN AA, 1984, CELL, V39, P5, DOI 10.1016/0092-8674(84)90186-7
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   BOTHWELL ALM, 1982, NATURE, V298, P380, DOI 10.1038/298380a0
   COLECLOUGH C, 1980, P NATL ACAD SCI-BIOL, V77, P1422, DOI 10.1073/pnas.77.3.1422
   GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0
   GERSHENFELD HK, 1981, P NATL ACAD SCI-BIOL, V78, P7674, DOI 10.1073/pnas.78.12.7674
   GOVERMAN J, 1985, CELL, V40, P859, DOI 10.1016/0092-8674(85)90345-9
   Hahn B, 1984, Mol Biol Med, V2, P29
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   MAEDA M, J EXP MED
   MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6
   PATTEN P, 1984, NATURE, V312, P40, DOI 10.1038/312040a0
   SEIDMAN JG, 1979, NATURE, V280, P370, DOI 10.1038/280370a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STEINMETZ M, 1979, NUCLEIC ACIDS RES, V6, P3213, DOI 10.1093/nar/6.10.3213
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 33
TC 126
Z9 126
U1 0
U2 0
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PY 1985
VL 82
IS 22
BP 7701
EP 7705
DI 10.1073/pnas.82.22.7701
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AVA01
UT WOS:A1985AVA0100047
PM 3865189
ER

PT J
AU UEDA, S
   WATANABE, Y
   HAYASHIDA, H
   MIYATA, T
   MATSUDA, F
   HONJO, T
AF UEDA, S
   WATANABE, Y
   HAYASHIDA, H
   MIYATA, T
   MATSUDA, F
   HONJO, T
TI HOMINOID EVOLUTION BASED ON THE STRUCTURES OF IMMUNOGLOBULIN
   EPSILON-GENES AND ALPHA-GENES
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
C1 KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP UEDA, S (reprint author), UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,TOKYO 113,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR ANDREWS P, 1982, NATURE, V295, P185, DOI 10.1038/295185a0
   FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980
   BENVENISTE RE, 1976, NATURE, V261, P101, DOI 10.1038/261101a0
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9
   KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945
   FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432
   BATTEY J, 1982, P NATL ACAD SCI-BIOL, V79, P5956, DOI 10.1073/pnas.79.19.5956
   BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   KOOP BF, 1986, NATURE, V319, P234, DOI 10.1038/319234a0
   KRAWINKEL U, 1982, EMBO J, V1, P403
   LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0
   MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4
   MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   UEDA S, 1985, P NATL ACAD SCI USA, V82, P3712, DOI 10.1073/pnas.82.11.3712
   UEDA S, 1982, EMBO J, V1, P1539
NR 22
TC 5
Z9 5
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1986
VL 51
BP 429
EP 432
PN 1
PG 4
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA H0352
UT WOS:A1986H035200050
PM 3107878
ER

PT J
AU KANAMORI, H
   KONDO, S
   KINOSHITA, M
   SUZUKI, N
   SAITO, Y
   SABE, H
   MATSUNAMI, N
   ISHIDA, N
   SHIMIZU, A
   HONJO, T
AF KANAMORI, H
   KONDO, S
   KINOSHITA, M
   SUZUKI, N
   SAITO, Y
   SABE, H
   MATSUNAMI, N
   ISHIDA, N
   SHIMIZU, A
   HONJO, T
TI INTERLEUKIN-2 RECEPTOR - STRUCTURE, FUNCTION, AND EXPRESSION
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
RP KANAMORI, H (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SHIMIZU A, 1986, IMMUNOL REV, V92, P103, DOI 10.1111/j.1600-065X.1986.tb01496.x
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   HATTORI T, 1981, BLOOD, V58, P645
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0
   ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   CHAMBON P, 1984, RECENT PROG HORM RES, V40, P1
   FUJII M, 1986, J IMMUNOL, V137, P1552
   GALLO RC, 1983, BLOOD, V62, P510
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   ISHIDA N, 1985, NUCLEIC ACIDS RES, V13, P7579, DOI 10.1093/nar/13.21.7579
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MILLER J, 1985, J IMMUNOL, V134, P4212
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8
   ROBB RJ, 1984, IMMUNOL TODAY, V5, P203, DOI 10.1016/0167-5699(84)90224-X
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHACKELFORD DA, 1984, J BIOL CHEM, V259, P1706
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   TANAKA Y, 1985, MICROBIOL IMMUNOL, V29, P959
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TSUDO M, 1983, BLOOD, V61, P1014
   YACHIE A, 1983, J IMMUNOL, V131, P731
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 38
TC 2
Z9 2
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1986
VL 51
BP 739
EP 749
PN 2
PG 11
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA H0501
UT WOS:A1986H050100005
PM 3107885
ER

PT J
AU SHIMIZU, A
   KONDO, S
   SABE, H
   ISHIDA, N
   HONJO, T
AF SHIMIZU, A
   KONDO, S
   SABE, H
   ISHIDA, N
   HONJO, T
TI STRUCTURE AND FUNCTION OF THE INTERLEUKIN-2 RECEPTOR - AFFINITY
   CONVERSION MODEL
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review
RP SHIMIZU, A (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR YAMAWAKIKATAOKA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2623, DOI 10.1073/pnas.79.8.2623
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   HATTORI T, 1981, BLOOD, V58, P645
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   FEAN JC, 1985, CELL, V40, P991
   GALLO RC, 1983, BLOOD, V62, P510
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   HEMLER ME, 1984, P NATL ACAD SCI US, V81, P2171
   ISHIDA N, 1985, NUCLEIC ACIDS RES, V13, P7579, DOI 10.1093/nar/13.21.7579
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   LEONARD WJ, 1983, P NATL ACAD SCI US, V80, P6975
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MCCLELLAND A, 1984, CELL, V39, P267, DOI 10.1016/0092-8674(84)90004-7
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHACKELFORD DA, 1984, J BIOL CHEM, V259, P1706
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   TANAKA Y, 1985, MICROBIOL IMMUNOL, V29, P959
   TSUDO M, 1983, BLOOD, V61, P1014
   WANO Y, 1984, J IMMUNOL, V132, P3005
   YACHIE A, 1983, J IMMUNOL, V131, P731
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1986, IMMUNOL REV, V92, P135, DOI 10.1111/j.1600-065X.1986.tb01498.x
NR 33
TC 19
Z9 19
U1 0
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0105-2896
J9 IMMUNOL REV
JI Immunol. Rev.
PY 1986
VL 92
BP 103
EP 120
DI 10.1111/j.1600-065X.1986.tb01496.x
PG 18
WC Immunology
SC Immunology
GA D9513
UT WOS:A1986D951300006
PM 3091479
ER

PT J
AU KOYASU, S
   YODOI, J
   NIKAIDO, T
   TAGAYA, Y
   TANIGUCHI, Y
   HONJO, T
   YAHARA, I
AF KOYASU, S
   YODOI, J
   NIKAIDO, T
   TAGAYA, Y
   TANIGUCHI, Y
   HONJO, T
   YAHARA, I
TI EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON INTERLEUKIN 3-DEPENDENT
   CELL-LINES
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RP KOYASU, S (reprint author), TOKYO METROPOLITAN INST MED SCI,DEPT CELL BIOL,3-18-22 HONKOMAGOME,BUNKYO KU,TOKYO 113,JAPAN.
RI Koyasu, Shigeo/J-5583-2015
OI Koyasu, Shigeo/0000-0001-9585-3038
CR AKIYAMA H, 1983, J IMMUNOL, V130, P1759
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   BALL PE, 1983, DIFFERENTIATION, V24, P74, DOI 10.1111/j.1432-0436.1983.tb01305.x
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036
   GOUGH NM, 1984, NATURE, V309, P763, DOI 10.1038/309763a0
   HABU S, 1985, EUR J IMMUNOL, V15, P456, DOI 10.1002/eji.1830150508
   KITAMURA K, 1984, J IMMUNOL, V133, P1371
   KOYASU S, 1985, J IMMUNOL, V134, P3130
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   NAKAUCHI H, 1984, J IMMUNOL, V132, P88
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   VONBOEHMER H, 1985, NATURE, V314, P539, DOI 10.1038/314539a0
   YODOI J, 1985, J EXP MED, V161, P924, DOI 10.1084/jem.161.5.924
   YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070
NR 21
TC 44
Z9 44
U1 0
U2 3
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD FEB 1
PY 1986
VL 136
IS 3
BP 984
EP 987
PG 4
WC Immunology
SC Immunology
GA AYB17
UT WOS:A1986AYB1700037
PM 3079807
ER

PT J
AU NOMA, Y
   SIDERAS, P
   NAITO, T
   BERGSTEDTLINDQUIST, S
   AZUMA, C
   SEVERINSON, E
   TANABE, T
   KINASHI, T
   MATSUDA, F
   YAOITA, Y
   HONJO, T
AF NOMA, Y
   SIDERAS, P
   NAITO, T
   BERGSTEDTLINDQUIST, S
   AZUMA, C
   SEVERINSON, E
   TANABE, T
   KINASHI, T
   MATSUDA, F
   YAOITA, Y
   HONJO, T
TI CLONING OF CDNA-ENCODING THE MURINE IGG1 INDUCTION FACTOR BY A NOVEL
   STRATEGY USING SP6 PROMOTER
SO NATURE
LA English
DT Article
C1 KAROLINSKA INST,WALLENBERG LAB,DEPT IMMUNOBIOL,S-10405 STOCKHOLM 50,SWEDEN.
RP NOMA, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR Aarden L. A., 1979, J IMMUNOL, V123, P2928
   ALTENBURGER W, 1980, NATURE, V287, P603, DOI 10.1038/287603a0
   ANDERSSON J, 1981, P NATL ACAD SCI-BIOL, V78, P2497, DOI 10.1073/pnas.78.4.2497
   LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0
   PERLMUTTER RM, 1978, J IMMUNOL, V121, P566
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   IZUI S, 1981, J EXP MED, V153, P324, DOI 10.1084/jem.153.2.324
   KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8
   GRONOWICZ E, 1976, EUR J IMMUNOL, V6, P588, DOI 10.1002/eji.1830060812
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X
   NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149
   KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057
   BERGSTEDTLINDQVIST S, 1984, IMMUNOL REV, V78, P25, DOI 10.1111/j.1600-065X.1984.tb00475.x
   CEBRA JJ, 1984, ANNU REV IMMUNOL, V2, P493, DOI 10.1146/annurev.immunol.2.1.493
   COUTINHO A, 1983, EUR J IMMUNOL, V13, P269, DOI 10.1002/eji.1830130319
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   GOUGH NM, 1985, EMBO J, V4, P645
   GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HOWARD M, 1983, ANNU REV IMMUNOL, V1, P307, DOI 10.1146/annurev.iy.01.040183.001515
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   LEANDERSON T, 1982, P NATL ACAD SCI-BIOL, V79, P7455, DOI 10.1073/pnas.79.23.7455
   MAKMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MOLLER G, 1984, IMMUN REV, V78
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   OKAYAMA H, 1983, MOL CELL BIOL, V3, P280
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   SCHIMPL A, 1975, TRANSPLANT REV, V23, P176
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P593, DOI 10.1002/eji.1830150612
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P586, DOI 10.1002/eji.1830150611
   SLACK J, 1980, J EXP MED, V151, P853, DOI 10.1084/jem.151.4.853
   SWAIN SL, 1982, J EXP MED, V156, P1821, DOI 10.1084/jem.156.6.1821
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YOKOTA T, 1985, P NATL ACAD SCI USA, V82, P68, DOI 10.1073/pnas.82.1.68
   YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070
NR 42
TC 539
Z9 540
U1 1
U2 3
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD FEB 20
PY 1986
VL 319
IS 6055
BP 640
EP 646
DI 10.1038/319640a0
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA A0796
UT WOS:A1986A079600045
PM 3005865
ER

PT J
AU TATEISHI, H
   NISHISHO, I
   MIKI, T
   TAKAI, S
   HONJO, T
AF TATEISHI, H
   NISHISHO, I
   MIKI, T
   TAKAI, S
   HONJO, T
TI AN ANONYMOUS SINGLE COPY CHROMOSOME 18 PROBE ASSOCIATED WITH A FREQUENT
   RFLP (D18S5)
SO NUCLEIC ACIDS RESEARCH
LA English
DT Note
C1 OSAKA UNIV,SCH MED,DEPT MED & GERIATR,OSAKA 553,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP TATEISHI, H (reprint author), OSAKA UNIV,SCH MED,DEPT SURG 2,FUKUSHIMA KU,OSAKA 553,JAPAN.
CR MIKI, 1985, JAPANESE J HUMAN GEN
NR 1
TC 16
Z9 16
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB 25
PY 1986
VL 14
IS 4
BP 1926
EP 1926
DI 10.1093/nar/14.4.1926
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA A2925
UT WOS:A1986A292500038
PM 3005991
ER

PT J
AU KONDO, S
   SHIMIZU, A
   MAEDA, M
   TAGAYA, Y
   YODOI, J
   HONJO, T
AF KONDO, S
   SHIMIZU, A
   MAEDA, M
   TAGAYA, Y
   YODOI, J
   HONJO, T
TI EXPRESSION OF FUNCTIONAL HUMAN INTERLEUKIN-2 RECEPTOR IN MOUSE T-CELLS
   BY CDNA TRANSFECTION
SO NATURE
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
RP KONDO, S (reprint author), KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   BOLTON AE, 1973, BIOCHEM J, V133, P529
   HATTORI T, 1981, BLOOD, V58, P645
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MAEDA M, 1985, J EXP MED, V162, P1269
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OSAWA H, 1985, EUR J IMMUNOL, V15, P299, DOI 10.1002/eji.1830150317
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   SABE H, MOL BIOL MED
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   TSUDO M, 1983, BLOOD, V61, P1014
   VONBOEHMER H, 1985, NATURE, V314, P539, DOI 10.1038/314539a0
   YODOI J, 1983, BLOOD, V62, P509
NR 23
TC 87
Z9 86
U1 0
U2 2
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD MAR 6
PY 1986
VL 320
IS 6057
BP 75
EP 77
DI 10.1038/320075a0
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA A3324
UT WOS:A1986A332400063
PM 3081815
ER

PT J
AU MIKI, T
   TAKAI, S
   TATEISHI, H
   NISHISHO, I
   YAMAMOTO, K
   IKEUCHI, T
   MORI, T
   HONJO, T
   KUMAHARA, Y
AF MIKI, T
   TAKAI, S
   TATEISHI, H
   NISHISHO, I
   YAMAMOTO, K
   IKEUCHI, T
   MORI, T
   HONJO, T
   KUMAHARA, Y
TI STUDIES ON KINDREDS AT HIGH-RISK FOR HEREDITARY CANCERS USING
   POLYMORPHIC DNA MARKERS
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 OSAKA UNIV,DEPT MED GERIATR,OSAKA,JAPAN.
   OSAKA UNIV,DEPT SURG 2,OSAKA,JAPAN.
   TOKYO MED & DENT UNIV,MED RES INST,DEPT CYTOGENET,TOKYO 113,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1986
VL 31
IS 2
BP 137
EP 137
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA E8036
UT WOS:A1986E803600024
ER

PT J
AU OTSU, M
   YAOITA, Y
   KATAMINE, S
   UNO, M
   YAMAKI, M
   ONO, Y
   SASAKI, MS
   HONJO, T
AF OTSU, M
   YAOITA, Y
   KATAMINE, S
   UNO, M
   YAMAKI, M
   ONO, Y
   SASAKI, MS
   HONJO, T
TI EPSTEIN-BAR VIRUS TRANSFORMANT WITH RECIPROCAL TRANSLOCATION T(6 - 14)
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
   NAGASAKI UNIV,DEPT BACTERIOL,NAGASAKI 852,JAPAN.
   NIHON UNIV,DEPT MICROBIOL,TOKYO 101,JAPAN.
   KYOTO UNIV,CTR RADIAT BIOL,KYOTO 606,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1986
VL 31
IS 2
BP 152
EP 153
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA E8036
UT WOS:A1986E803600049
ER

PT J
AU UEDA, S
   HONJO, T
AF UEDA, S
   HONJO, T
TI DNA POLYMORPHISM IN JAPANESE
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA Japanese
DT Meeting Abstract
C1 UNIV TOKYO,DEPT ANTHROPOL,TOKYO 113,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1986
VL 31
IS 2
BP 176
EP 176
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA E8036
UT WOS:A1986E803600091
ER

PT J
AU NAKURA, J
   MIKI, T
   FUKUCHI, K
   SHIMIZU, K
   NOSE, O
   NISHISHO, I
   TATEISHI, H
   TAKAI, S
   HONJO, T
   KUMAHARA, Y
AF NAKURA, J
   MIKI, T
   FUKUCHI, K
   SHIMIZU, K
   NOSE, O
   NISHISHO, I
   TATEISHI, H
   TAKAI, S
   HONJO, T
   KUMAHARA, Y
TI ANALYSIS OF GENES-CODING FOR 21-HYDROXYLASE IN PATIENTS WITH CONGENITAL
   ADRENAL-HYPERPLASIA DUE TO THE DEFICIENCY OF THIS ENZYME
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 OSAKA UNIV,DEPT MED GERIAT,OSAKA,JAPAN.
   OSAKA UNIV,DEPT PEDIAT,OSAKA,JAPAN.
   OSAKA UNIV,DEPT SURG 2,OSAKA,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1986
VL 31
IS 2
BP 193
EP 194
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA E8036
UT WOS:A1986E803600121
ER

PT J
AU KINASHI, T
   MATSUDA, F
   LEE, KH
   KODAIRA, M
   NOMA, T
   HONJO, T
AF KINASHI, T
   MATSUDA, F
   LEE, KH
   KODAIRA, M
   NOMA, T
   HONJO, T
TI STRUCTURE AND ORGANIZATION OF HUMAN-IMMUNOGLOBULIN VARIABLE REGION OF
   THE HEAVY-CHAIN
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
   RADIAT EFFECTS RES FDN,HIROSHIMA 730,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1986
VL 31
IS 2
BP 203
EP 203
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA E8036
UT WOS:A1986E803600139
ER

PT J
AU MATSUNAMI, N
   SIOMI, H
   HATANAKA, M
   YAOITA, Y
   HONJO, T
AF MATSUNAMI, N
   SIOMI, H
   HATANAKA, M
   YAOITA, Y
   HONJO, T
TI PREFERENTIAL TRANSCRIPTION OF HTLV-I LTR IN CELL-FREE-EXTRACTS OF HUMAN
   T-CELLS PRODUCING HTLV-I VIRAL-PROTEINS
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
C1 KYOTO UNIV,INST VIRUS RES,DEPT SEROL & IMMUNOL,KYOTO 606,JAPAN.
RP MATSUNAMI, N (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Siomi, Haruhiko/A-7020-2015
OI Siomi, Haruhiko/0000-0001-8690-3822
CR WEIL PA, 1979, CELL, V18, P469
   MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   PARKER CS, 1984, CELL, V37, P273, DOI 10.1016/0092-8674(84)90323-4
   MIYOSHI I, 1980, GANN, V71, P155
   UCHIYAMA T, 1977, BLOOD, V50, P481
   MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0
   FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   SODROSKI J, 1985, SCIENCE, V228, P1430, DOI 10.1126/science.2990028
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891
   CHEN ISY, 1984, NATURE, V309, P276, DOI 10.1038/309276a0
   DERSE D, 1985, SCIENCE, V227, P317, DOI 10.1126/science.2981431
   FUJISAWA J, 1985, P NATL ACAD SCI USA, V82, P2277, DOI 10.1073/pnas.82.8.2277
   HASELTINE WA, 1984, SCIENCE, V225, P419, DOI 10.1126/science.6330894
   KATAOKA T, 1982, J BIOL CHEM, V257, P277
   KOBAYASHI N, 1984, EMBO J, V3, P1339
   LUSE DS, 1980, CELL, V20, P691, DOI 10.1016/0092-8674(80)90315-3
   MURAGUCHI A, 1981, J IMMUNOL, V127, P412
   ROSEN CA, 1985, SCIENCE, V227, P320, DOI 10.1126/science.2981432
   TSUDA M, 1981, CELL, V27, P175, DOI 10.1016/0092-8674(81)90371-8
NR 22
TC 3
Z9 3
U1 1
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 25
PY 1986
VL 14
IS 12
BP 4779
EP 4786
DI 10.1093/nar/14.12.4779
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA C9492
UT WOS:A1986C949200007
PM 3014437
ER

PT J
AU IKUTA, K
   OGURA, T
   SHIMIZU, A
   HONJO, T
AF IKUTA, K
   OGURA, T
   SHIMIZU, A
   HONJO, T
TI A JOINING-DIVERSITY-JOINING COMPLEX GENERATED BY INVERSION MECHANISM AND
   A VARIABLE-DIVERSITY COMPLEX IN THE BETA-CHAIN GENE OF THE HUMAN T-CELL
   RECEPTOR
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
RP IKUTA, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207
   ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7
   KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118
   ALT FW, 1984, EMBO J, V3, P1209
   MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6
   MCINTYRE BW, 1983, CELL, V34, P739, DOI 10.1016/0092-8674(83)90530-5
   HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0
   YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0
   YOSHIKAI Y, 1984, NATURE, V312, P521, DOI 10.1038/312521a0
   CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0
   SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6
   VANNESS BG, 1982, P NATL ACAD SCI-BIOL, V79, P262
   KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201
   BEHLKE MA, 1985, SCIENCE, V229, P566, DOI 10.1126/science.3875151
   BARTH RK, 1985, NATURE, V316, P517, DOI 10.1038/316517a0
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   CLARK SP, 1984, NATURE, V311, P387, DOI 10.1038/311387a0
   DUBY AD, 1985, SCIENCE, V228, P1204, DOI 10.1126/science.3839095
   GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0
   HATTORI M, ANAL BIOCH
   HAYDAY AC, 1985, NATURE, V316, P828, DOI 10.1038/316828a0
   HOCHTL J, 1982, P NATL ACAD SCI-BIOL, V79, P1383, DOI 10.1073/pnas.79.5.1383
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   KRONENBERG M, 1985, NATURE, V313, P647, DOI 10.1038/313647a0
   KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0
   LEWIS S, 1985, SCIENCE, V228, P677, DOI 10.1126/science.3158075
   MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6
   MALISSEN M, 1986, NATURE, V319, P28, DOI 10.1038/319028a0
   OKAMOTO H, 1986, EMBO J, V5, P589
   PATTEN P, 1984, NATURE, V312, P40, DOI 10.1038/312040a0
   SEIDMAN JG, 1980, P NATL ACAD SCI-BIOL, V77, P6022, DOI 10.1073/pnas.77.10.6022
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TUNNACLIFFE A, 1985, NUCLEIC ACIDS RES, V13, P6651, DOI 10.1093/nar/13.18.6651
   WINOTO A, 1985, NATURE, V316, P832, DOI 10.1038/316832a0
   YAOITA Y, 1983, NUCLEIC ACIDS RES, V11, P7303, DOI 10.1093/nar/11.21.7303
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 40
TC 5
Z9 6
U1 1
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 25
PY 1986
VL 14
IS 12
BP 4899
EP 4909
DI 10.1093/nar/14.12.4899
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA C9492
UT WOS:A1986C949200015
PM 3487774
ER

PT J
AU KAMESAKI, H
   FUKUHARA, S
   TATSUMI, E
   UCHINO, H
   YAMABE, H
   MIWA, H
   SHIRAKAWA, S
   HATANAKA, M
   HONJO, T
AF KAMESAKI, H
   FUKUHARA, S
   TATSUMI, E
   UCHINO, H
   YAMABE, H
   MIWA, H
   SHIRAKAWA, S
   HATANAKA, M
   HONJO, T
TI CYTOCHEMICAL, IMMUNOLOGICAL, CHROMOSOMAL, AND MOLECULAR GENETIC-ANALYSIS
   OF A NOVEL CELL-LINE DERIVED FROM HODGKINS-DISEASE
SO BLOOD
LA English
DT Article
C1 KYOTO UNIV,INST VIRUS RES,FAC MED,DEPT CLIN PATHOL,KYOTO 606,JAPAN.
   KYOTO UNIV,INST VIRUS RES,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   MIE UNIV,DEPT INTERNAL MED 2,TSU,MIE 514,JAPAN.
RP KAMESAKI, H (reprint author), KYOTO UNIV,INST VIRUS RES,FAC MED,DIV INTERNAL MED 1,SAKYO KU,KYOTO 606,JAPAN.
CR NADLER LM, 1981, J CLIN INVEST, V67, P134, DOI 10.1172/JCI110005
   MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207
   HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0
   FRIEND C, 1978, CANCER RES, V38, P2581
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   HSU SM, 1985, AM J PATHOL, V118, P209
   BETTELHEIM P, 1982, BLOOD, V60, P1392
   REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588
   SCHAADT M, 1980, INT J CANCER, V26, P723, DOI 10.1002/ijc.2910260605
   SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0
   YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0
   ABO T, 1981, J IMMUNOL, V127, P1024
   REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302
   ARNOLD A, 1983, NEW ENGL J MED, V309, P1593, DOI 10.1056/NEJM198312293092601
   BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741
   BERNARD A, 1984, LEUCOCYTE TYPING, P519
   BINIAMIN.M, 1974, LANCET, V1, P368
   BOLLUM FJ, 1975, P NATL ACAD SCI USA, V72, P4119, DOI 10.1073/pnas.72.10.4119
   BRAUNSTEIN H, 1962, CANCER, V15, P139, DOI 10.1002/1097-0142(196201/02)15:1<139::AID-CNCR2820150120>3.0.CO;2-U
   BREARD J, 1980, J IMMUNOL, V124, P1943
   CARBONE A, 1983, AM J CLIN PATHOL, V79, P553
   CURRAN RC, 1977, LANCET, V2, P349
   DORREEN MS, 1984, BRIT J CANCER, V49, P465, DOI 10.1038/bjc.1984.74
   ENGLEMAN EG, 1981, P NATL ACAD SCI-BIOL, V78, P1791, DOI 10.1073/pnas.78.3.1791
   FITHIAN E, 1981, P NATL ACAD SCI-BIOL, V78, P2541, DOI 10.1073/pnas.78.4.2541
   GARVIN AJ, 1974, J EXP MED, V139, P1077, DOI 10.1084/jem.139.5.1077
   GODING JW, 1981, J IMMUNOL, V127, P1256
   GREAVES MF, 1983, BLOOD, V61, P645
   GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348
   HANJAN SNS, 1982, CLIN IMMUNOL IMMUNOP, V23, P172, DOI 10.1016/0090-1229(82)90106-4
   HARRIS NL, 1981, NATURE, V289, P228, DOI 10.1038/289228a0
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577
   HSU SM, 1982, J HISTOCHEM CYTOCHEM, V30, P157
   HSU SM, 1984, AM J CLIN PATHOL, V82, P29
   HUBER C, 1975, EUR J IMMUNOL, V5, P432, DOI 10.1002/eji.1830050616
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   ITO Y, 1968, J NATL CANCER I, V41, P1367
   KADIN ME, 1982, CANCER TREAT REP, V66, P601
   KAMOUN M, 1981, J EXP MED, V153, P207, DOI 10.1084/jem.153.1.207
   KAPLAN HS, 1977, INT J CANCER, V19, P511, DOI 10.1002/ijc.2910190412
   KORSMEYER SJ, 1982, J EXP MED, V156, P975, DOI 10.1084/jem.156.4.975
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   LINCH DC, 1985, LANCET, V1, P78
   MINDEN MD, 1985, P NATL ACAD SCI USA, V82, P1224, DOI 10.1073/pnas.82.4.1224
   MORETTA L, 1975, EUR J IMMUNOL, V5, P565, DOI 10.1002/eji.1830050812
   NAIEM M, 1983, J CLIN PATHOL, V36, P167, DOI 10.1136/jcp.36.2.167
   OCONNOR NTJ, 1985, LANCET, V1, P1295
   OLSSON L, 1984, J NATL CANCER I, V73, P809
   PALUMBO A, 1984, BLOOD, V64, P1059
   PHILLIPS JH, 1983, IMMUNOL LETT, V6, P143, DOI 10.1016/0165-2478(83)90096-2
   PIZZOLO G, 1980, CANCER, V46, P2640, DOI 10.1002/1097-0142(19801215)46:12<2640::AID-CNCR2820461218>3.0.CO;2-S
   POPPEMA S, 1982, BLOOD, V59, P226
   POPPEMA S, 1985, CANCER, V55, P683, DOI 10.1002/1097-0142(19850215)55:4<683::AID-CNCR2820550402>3.0.CO;2-O
   REINHERZ EL, 1979, J EXP MED, V150, P1472, DOI 10.1084/jem.150.6.1472
   RITZ J, 1980, NATURE, V283, P583, DOI 10.1038/283583a0
   ROVIGATTI U, 1984, BLOOD, V63, P1023
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STEIN H, 1982, INT J CANCER, V29, P283, DOI 10.1002/ijc.2910290310
   STEIN H, 1982, INT J CANCER, V30, P445, DOI 10.1002/ijc.2910300411
   TAYLOR CR, 1976, EUR J CANCER, V12, P61, DOI 10.1016/0014-2964(76)90125-0
   TOMONAGA M, 1963, ACTA HAEMATOL JAPON, V26, P179
   WATANABE S, 1983, CANCER, V51, P1412, DOI 10.1002/1097-0142(19830415)51:8<1412::AID-CNCR2820510815>3.0.CO;2-L
NR 62
TC 137
Z9 138
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD JUL
PY 1986
VL 68
IS 1
BP 285
EP 292
PG 8
WC Hematology
SC Hematology
GA D0527
UT WOS:A1986D052700042
PM 3013343
ER

PT J
AU IKUTA, K
   HATTORI, M
   WAKE, K
   KANO, S
   HONJO, T
   YODOI, J
   MINATO, N
AF IKUTA, K
   HATTORI, M
   WAKE, K
   KANO, S
   HONJO, T
   YODOI, J
   MINATO, N
TI EXPRESSION AND REARRANGEMENT OF THE ALPHA-CHAIN, BETA-CHAIN, AND
   GAMMA-CHAIN GENES OF THE T-CELL RECEPTOR IN CLONED MURINE LARGE
   ANTIGRANULOCYTES LYMPHOCYTE LINES - NO CORRELATION WITH THE CYTOTOXIC
   SPECTRUM
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
C1 TORAY IND INC,BASIC RES LABS,KANAGAWA,JAPAN.
   TOKYO MED & DENT UNIV,SCH MED,DEPT ANAT,TOKYO 113,JAPAN.
   JICHI MED SCH,DEPT MED,MINAMIKAWACHI,TOCHIGI 32904,JAPAN.
   KYOTO UNIV,INST IMMUNOL,KYOTO 606,JAPAN.
RP IKUTA, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0
   ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   KANEDA K, 1983, BIOMED RES-TOKYO, V4, P567
   KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9
   HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204
   ALLISON JP, 1982, J IMMUNOL, V129, P2293
   PIONTEK GE, 1985, J IMMUNOL, V135, P4281
   KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208
   GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0
   MCINTYRE BW, 1983, CELL, V34, P739, DOI 10.1016/0092-8674(83)90530-5
   HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0
   YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
   CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0
   GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823
   CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   KASAHARA T, 1983, J IMMUNOL, V131, P2379
   BROOKS CG, 1983, IMMUNOL REV, V72, P43, DOI 10.1111/j.1600-065X.1983.tb01072.x
   DORSHKIND K, 1985, J IMMUNOL, V134, P3798
   GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0
   GRIMM EA, 1983, J EXP MED, V157, P884, DOI 10.1084/jem.157.3.884
   GROSSI CE, 1982, NK CELLS OTHER NATUR
   HANDA K, 1983, J IMMUNOL, V130, P988
   HEILIG JS, 1985, NATURE, V317, P68, DOI 10.1038/317068a0
   Herberman R. B., 1978, The nude mouse in experimental and clinical research., P135
   HERBERMAN RB, 1978, J IMMUNOL, V121, P304
   HERCEND T, 1983, NATURE, V301, P158, DOI 10.1038/301158a0
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   KANEDA K, 1985, ANAT REC, V211, P192, DOI 10.1002/ar.1092110211
   KRANZ DM, 1985, NATURE, V313, P752, DOI 10.1038/313752a0
   KURIBAYASHI K, 1981, J IMMUNOL, V126, P2321
   LOHMANNMATTHES ML, 1979, J IMMUNOL, V123, P1883
   MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   MINATO N, 1985, J EXP MED, V162, P1161, DOI 10.1084/jem.162.4.1161
   MINATO N, 1981, J EXP MED, V154, P750, DOI 10.1084/jem.154.3.750
   MINATO N, 1979, J EXP MED, V149, P1117, DOI 10.1084/jem.149.5.1117
   REYNOLDS CW, 1985, J EXP MED, V161, P1249, DOI 10.1084/jem.161.5.1249
   RITZ J, 1985, SCIENCE, V228, P1540, DOI 10.1126/science.2409597
   ROMANI N, 1985, J EXP MED, V161, P1368, DOI 10.1084/jem.161.6.1368
   SIU G, 1984, NATURE, V311, P344, DOI 10.1038/311344a0
   SNODGRASS HR, 1985, NATURE, V315, P232, DOI 10.1038/315232a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAGLIABUE A, 1982, J EXP MED, V155, P1785, DOI 10.1084/jem.155.6.1785
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   WINOTO A, 1985, NATURE, V316, P832, DOI 10.1038/316832a0
   YANAGI Y, 1985, NATURE, V314, P631, DOI 10.1038/314631a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 50
TC 39
Z9 39
U1 0
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD AUG 1
PY 1986
VL 164
IS 2
BP 428
EP 442
DI 10.1084/jem.164.2.428
PG 15
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA D4032
UT WOS:A1986D403200004
PM 3723079
ER

PT J
AU KODAIRA, M
   KINASHI, T
   UMEMURA, I
   MATSUDA, F
   NOMA, T
   ONO, Y
   HONJO, T
AF KODAIRA, M
   KINASHI, T
   UMEMURA, I
   MATSUDA, F
   NOMA, T
   ONO, Y
   HONJO, T
TI ORGANIZATION AND EVOLUTION OF VARIABLE REGION GENES OF THE
   HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   NIHON UNIV,SCH MED,DEPT MICROBIOL,ITABASHI KU,TOKYO 173,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303
   FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4
   FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0
   ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989
   MESSING J, 1983, METHOD ENZYMOL, V101, P20
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211
   PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650
   KENTEN JH, 1982, P NATL ACAD SCI-BIOL, V79, P6661, DOI 10.1073/pnas.79.21.6661
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
   KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8
   BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012
   BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
   BALTIMORE D, 1983, PROGR IMMUNOLOGY, V5, P115
   BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9
   BENTLEY DL, 1981, CELL, V24, P613, DOI 10.1016/0092-8674(81)90088-X
   BOTHWELL ALM, 1981, CELL, V24, P635
   COHEN JB, 1983, EMBO J, V2, P1795
   CORY S, 1981, Journal of Molecular and Applied Genetics, V1, P103
   FOSTER J, 1985, NATURE, V315, P423, DOI 10.1038/315423a0
   GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439
   GIVOL D, 1981, NATURE, V292, P426, DOI 10.1038/292426a0
   GORSKI J, 1983, SCIENCE, V220, P1179, DOI 10.1126/science.6857243
   GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6
   GROSVELD FG, 1981, GENE, V13, P227, DOI 10.1016/0378-1119(81)90028-7
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HUANG H, 1981, Journal of Molecular and Applied Genetics, V1, P93
   Kabat EA, 1983, SEQUENCES PROTEINS I
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KATAOKA T, 1982, J BIOL CHEM, V257, P277
   KEMP D J, 1981, Journal of Molecular and Applied Genetics, V1, P245
   LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9
   MANIATIS T, 1982, MOL CLONING LABORATO
   MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180
   NISHI M, 1985, P NATL ACAD SCI USA, V82, P6399, DOI 10.1073/pnas.82.19.6399
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   Noma Y, 1984, Mol Biol Med, V2, P337
   PECH M, 1984, NUCLEIC ACIDS RES, V12, P9229, DOI 10.1093/nar/12.24.9229
   PECH M, 1984, J MOL BIOL, V176, P189, DOI 10.1016/0022-2836(84)90420-0
   RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   SAKOYAMA Y, 1986, P NAT ACAD SCI US, V83
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SCHIFF C, 1985, EMBO J, V4, P1225
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V24, P5983
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WOOD C, 1983, P NATL ACAD SCI-BIOL, V80, P3030, DOI 10.1073/pnas.80.10.3030
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 57
TC 222
Z9 222
U1 0
U2 2
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 20
PY 1986
VL 190
IS 4
BP 529
EP 541
DI 10.1016/0022-2836(86)90239-1
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA D8596
UT WOS:A1986D859600002
PM 3097326
ER

PT J
AU NOMA, T
   NAKAMURA, T
   MAEDA, M
   OKADA, M
   TANIGUCHI, Y
   TAGAYA, Y
   YAOITA, Y
   YODOI, J
   HONJO, T
AF NOMA, T
   NAKAMURA, T
   MAEDA, M
   OKADA, M
   TANIGUCHI, Y
   TAGAYA, Y
   YAOITA, Y
   YODOI, J
   HONJO, T
TI INTERLEUKIN 1A MESSENGER-RNA IN VIRUS-TRANSFORMED T-CELLS AND B-CELLS
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CHEST DIS RES INST,KYOTO 606,JAPAN.
CR COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0
   MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128
   MIYOSHI I, 1980, GANN, V71, P155
   SODROSKI J, 1985, SCIENCE, V228, P1430, DOI 10.1126/science.2990028
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907
   FURUTANI Y, 1985, NUCLEIC ACIDS RES, V13, P5869, DOI 10.1093/nar/13.16.5869
   HEMLER ME, 1984, P NATL ACAD SCI US, V81, P2171
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MURAGUCHI A, 1981, J IMMUNOL, V127, P412
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OKADA M, 1985, J IMMUNOL, V135, P3995
   OKAYAMA H, 1983, MOL CELL BIOL, V3, P280
   OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6
   SCALA G, 1984, J EXP MED, V159, P1637, DOI 10.1084/jem.159.6.1637
   SEIKI M, 1986, EMBO J, V5, P561
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   TESHIGAWARA K, 1985, J MOL CELL IMMUNOL, V2, P17
   YAMAMOTO S, 1986, BLOOD
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 24
TC 27
Z9 27
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 29
PY 1986
VL 139
IS 1
BP 353
EP 360
DI 10.1016/S0006-291X(86)80121-8
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA D9688
UT WOS:A1986D968800051
PM 3021130
ER

PT J
AU NISHISHO, I
   MIKI, T
   TATEISHI, H
   TAKAI, SI
   MOTOMURA, K
   NAKURA, J
   KUMAHARA, Y
   MORI, T
   HONJO, T
AF NISHISHO, I
   MIKI, T
   TATEISHI, H
   TAKAI, SI
   MOTOMURA, K
   NAKURA, J
   KUMAHARA, Y
   MORI, T
   HONJO, T
TI ISOLATION OF DNA CLONES REVEALING
   RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN THE HUMAN GENOME
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Article
C1 OSAKA UNIV,SCH MED,DEPT GENET,OSAKA 553,JAPAN.
   OSAKA UNIV,SCH MED,DEPT MED & GERIATR,OSAKA 553,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP NISHISHO, I (reprint author), OSAKA UNIV,SCH MED,DEPT SURG 2,OSAKA 553,JAPAN.
CR BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3
   REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0
   BOTSTEIN D, 1980, AM J HUM GENET, V32, P314
   COOPER DN, 1983, HUM GENET, V64, P315, DOI 10.1007/BF00292363
   KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0
   GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0
   GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0
   HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364
   BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759
   BALAZS I, 1984, HUM GENET, V68, P57, DOI 10.1007/BF00293873
   CAVENEE W, 1984, AM J HUM GENET, V36, P10
   COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024
   de Martinville B, 1983, Mol Biol Med, V1, P415
   FEDER J, 1985, AM J HUM GENET, V37, P635
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HELENTJARIS T, 1983, Journal of Molecular and Applied Genetics, V2, P237
   LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206
   NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TATEISHI H, 1986, NUCLEIC ACIDS RES, V14, P1926, DOI 10.1093/nar/14.4.1926
   ULLRICH A, 1980, SCIENCE, V209, P612, DOI 10.1126/science.6248962
   VANDERPLOEG LHT, 1980, CELL, V19, P947, DOI 10.1016/0092-8674(80)90086-0
   VOGEL F, 1972, J MOL EVOL, V1, P334, DOI 10.1007/BF01653962
   VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746
   WAINWRIGHT BJ, 1985, NATURE, V318, P348
   WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0
   WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180
   WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754
NR 28
TC 25
Z9 25
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD SEP
PY 1986
VL 31
IS 3
BP 249
EP 258
DI 10.1007/BF01870755
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA F2054
UT WOS:A1986F205400002
PM 2882041
ER

PT J
AU KINASHI, T
   HARADA, N
   SEVERINSON, E
   TANABE, T
   SIDERAS, P
   KONISHI, M
   AZUMA, C
   TOMINAGA, A
   BERGSTEDTLINDQVIST, S
   TAKAHASHI, M
   MATSUDA, F
   YAOITA, Y
   TAKATSU, K
   HONJO, T
AF KINASHI, T
   HARADA, N
   SEVERINSON, E
   TANABE, T
   SIDERAS, P
   KONISHI, M
   AZUMA, C
   TOMINAGA, A
   BERGSTEDTLINDQVIST, S
   TAKAHASHI, M
   MATSUDA, F
   YAOITA, Y
   TAKATSU, K
   HONJO, T
TI CLONING OF COMPLEMENTARY-DNA ENCODING T-CELL REPLACING FACTOR AND
   IDENTITY WITH B-CELL GROWTH FACTOR-II
SO NATURE
LA English
DT Article
C1 KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,KUMAMOTO 860,JAPAN.
   UNIV STOCKHOLM,DEPT IMMUNOL,S-10691 STOCKHOLM,SWEDEN.
RP KINASHI, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   GRONOWICZ E, 1976, EUR J IMMUNOL, V6, P588, DOI 10.1002/eji.1830060812
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   BERGSTEDTLINDQVIST S, 1984, IMMUNOL REV, V78, P25, DOI 10.1111/j.1600-065X.1984.tb00475.x
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   FUNG MC, 1984, NATURE, V307, P233, DOI 10.1038/307233a0
   GOUGH NM, 1984, NATURE, V309, P763, DOI 10.1038/309763a0
   GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HOWARD M, 1984, IMMUNOL REV, V78, P185, DOI 10.1111/j.1600-065X.1984.tb00482.x
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MAGE MG, 1977, J IMMUNOL METHODS, V15, P47, DOI 10.1016/0022-1759(77)90016-3
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P586, DOI 10.1002/eji.1830150611
   SWAIN SL, 1983, J EXP MED, V158, P822, DOI 10.1084/jem.158.3.822
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   TOMINAGA A, MICROBIOL IMMUN
   YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070
NR 24
TC 427
Z9 428
U1 0
U2 1
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD NOV 6
PY 1986
VL 324
IS 6092
BP 70
EP 73
DI 10.1038/324070a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA E7095
UT WOS:A1986E709500058
PM 3024009
ER

PT J
AU AZUMA, C
   TANABE, T
   KONISHI, M
   KINASHI, T
   NOMA, T
   MATSUDA, F
   YAOITA, Y
   TAKATSU, K
   HAMMARSTROM, L
   SMITH, CIE
   SEVERINSON, E
   HONJO, T
AF AZUMA, C
   TANABE, T
   KONISHI, M
   KINASHI, T
   NOMA, T
   MATSUDA, F
   YAOITA, Y
   TAKATSU, K
   HAMMARSTROM, L
   SMITH, CIE
   SEVERINSON, E
   HONJO, T
TI CLONING OF CDNA FOR HUMAN T-CELL REPLACING FACTOR (INTERLEUKIN-5) AND
   COMPARISON WITH THE MURINE HOMOLOG
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
C1 INST MED IMMUNOL,DEPT BIOL,KUMAMOTO 860,JAPAN.
RP AZUMA, C (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X
   KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   FALKOFF RJM, 1982, J IMMUNOL, V129, P97
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HARADA N, 1986, UNPUB
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HIRANO T, 1984, J IMMUNOL, V132, P229
   KINASHI T, 1986, NATURE
   KISHIMOTO T, 1986, Patent No. 115025
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   OKAYAMA H, 1983, MOL CELL BIOL, V3, P280
   SAIKI O, 1983, EUR J IMMUNOL, V13, P31, DOI 10.1002/eji.1830130108
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SEVERINSON E, 1986, UNPUB
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P586, DOI 10.1002/eji.1830150611
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   SWAIN SL, 1985, J IMMUNOL, V134, P3934
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 30
TC 194
Z9 195
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD NOV 25
PY 1986
VL 14
IS 22
BP 9149
EP 9158
DI 10.1093/nar/14.22.9149
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA E9844
UT WOS:A1986E984400030
PM 3024129
ER

PT J
AU KONDO, S
   SHIMIZU, A
   SAITO, Y
   KINOSHITA, M
   HONJO, T
AF KONDO, S
   SHIMIZU, A
   SAITO, Y
   KINOSHITA, M
   HONJO, T
TI MOLECULAR-BASIS FOR 2 DIFFERENT AFFINITY STATES OF THE INTERLEUKIN-2
   RECEPTOR - AFFINITY CONVERSION MODEL
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
RP KONDO, S (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   BOLTON AE, 1973, BIOCHEM J, V133, P529
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   FUJII M, 1986, J IMMUNOL
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   HELMER ME, 1984, P NATL ACAD SCI USA, V81, P2171
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MILLER J, 1985, J IMMUNOL, V134, P4212
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   ROBB RJ, 1986, P NATL ACAD SCI USA, V83, P3992, DOI 10.1073/pnas.83.11.3992
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   TANAKA Y, 1985, MICROBIOL IMMUNOL, V29, P959
   YACHIE A, 1983, J IMMUNOL, V131, P731
NR 25
TC 74
Z9 74
U1 0
U2 0
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC
PY 1986
VL 83
IS 23
BP 9026
EP 9029
DI 10.1073/pnas.83.23.9026
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA F1471
UT WOS:A1986F147100044
PM 3097640
ER

PT J
AU SEVERINSON, E
   NAITO, T
   TOKUMOTO, H
   FUKUSHIMA, D
   HIRANO, A
   HAMA, K
   HONJO, T
AF SEVERINSON, E
   NAITO, T
   TOKUMOTO, H
   FUKUSHIMA, D
   HIRANO, A
   HAMA, K
   HONJO, T
TI INTERLEUKIN-4 (IGG1 INDUCTION FACTOR) - A MULTIFUNCTIONAL LYMPHOKINE
   ACTING ALSO ON T-CELLS
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 ONO PHARMACEUT CO LTD,RES INST,MISHIMA,OSAKA 618,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP SEVERINSON, E (reprint author), UNIV STOCKHOLM,DEPT IMMUNOL,BIOL BLDG F5,S-10691 STOCKHOLM,SWEDEN.
CR LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x
   KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   GRONOWICZ E, 1976, EUR J IMMUNOL, V6, P588, DOI 10.1002/eji.1830060812
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149
   BERGSTEDTLINDQVIST S, 1984, IMMUNOL REV, V78, P25, DOI 10.1111/j.1600-065X.1984.tb00475.x
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   FERNANDEZBOTRAN R, 1986, J EXP MED, V164, P580, DOI 10.1084/jem.164.2.580
   HARADA N, 1985, J IMMUNOL, V134, P3944
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   KELSO A, 1984, J IMMUNOL, V132, P2932
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MARSHAKROTHSTEIN A, 1979, J IMMUNOL, V122, P2491
   METCALF D, 1986, BLOOD, V67, P257
   MOLLER G, 1984, IMMUNOL REV, V78
   MOLLER G, 1980, IMMUNOL REV, V51
   NAKANISHI K, 1984, J EXP MED, V160, P1605, DOI 10.1084/jem.160.6.1605
   OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P586, DOI 10.1002/eji.1830150611
   SMITH CA, 1986, P NATL ACAD SCI USA, V83, P1857, DOI 10.1073/pnas.83.6.1857
   TSUDO M, 1984, J EXP MED, V160, P612, DOI 10.1084/jem.160.2.612
   ZUBLER RH, 1984, J EXP MED, V160, P1070
NR 30
TC 93
Z9 94
U1 0
U2 1
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JAN
PY 1987
VL 17
IS 1
BP 67
EP 72
DI 10.1002/eji.1830170112
PG 6
WC Immunology
SC Immunology
GA G6452
UT WOS:A1987G645200011
PM 3493156
ER

PT J
AU HAMAGUCHI, Y
   KANAKURA, Y
   FUJITA, J
   TAKEDA, S
   NAKANO, T
   TARUI, S
   HONJO, T
   KITAMURA, Y
AF HAMAGUCHI, Y
   KANAKURA, Y
   FUJITA, J
   TAKEDA, S
   NAKANO, T
   TARUI, S
   HONJO, T
   KITAMURA, Y
TI INTERLEUKIN-4 AS AN ESSENTIAL FACTOR FOR INVITRO CLONAL GROWTH OF MURINE
   CONNECTIVE TISSUE-TYPE MAST-CELLS
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Note
C1 OSAKA UNIV,SCH MED,INST CANC RES,OSAKA 530,JAPAN.
   OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,OSAKA 530,JAPAN.
RP HAMAGUCHI, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR GALLI SJ, 1984, PROG ALLERGY, V34, P1
   NAKAHATA T, 1986, NATURE, V324, P65, DOI 10.1038/324065a0
   GUYGRAND D, 1984, J EXP MED, V160, P12, DOI 10.1084/jem.160.1.12
   NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   FUNG MC, 1984, NATURE, V307, P233, DOI 10.1038/307233a0
   IHLE JN, 1982, J IMMUNOL, V129, P2431
   KATZ HR, 1985, J ALLERGY CLIN IMMUN, V76, P250, DOI 10.1016/0091-6749(85)90638-4
   KITAMURA Y, 1985, INT ARCH ALLER A IMM, V77, P144
   KOBAYASHI T, 1986, J IMMUNOL, V136, P1378
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654
   NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843
   RUITENBER EJ, 1976, NATURE, V264, P258, DOI 10.1038/264258a0
   SMITH CA, 1986, P NATL ACAD SCI USA, V83, P1857, DOI 10.1073/pnas.83.6.1857
   SONODA T, 1984, J EXP MED, V160, P138, DOI 10.1084/jem.160.1.138
   SUDA T, 1985, J CELL PHYSIOL, V124, P182, DOI 10.1002/jcp.1041240203
   YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070
   YURT RW, 1977, J BIOL CHEM, V252, P518
NR 19
TC 293
Z9 293
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JAN 1
PY 1987
VL 165
IS 1
BP 268
EP 273
DI 10.1084/jem.165.1.268
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA F4388
UT WOS:A1987F438800023
PM 3491870
ER

PT J
AU OTSU, M
   KATAMINE, S
   UNO, M
   YAMAKI, M
   ONO, Y
   KLEIN, G
   SASAKI, MS
   YAOITA, Y
   HONJO, T
AF OTSU, M
   KATAMINE, S
   UNO, M
   YAMAKI, M
   ONO, Y
   KLEIN, G
   SASAKI, MS
   YAOITA, Y
   HONJO, T
TI MOLECULAR CHARACTERIZATION OF NOVEL RECIPROCAL TRANSLOCATION T(6-14) IN
   AN EPSTEIN-BARR VIRUS-TRANSFORMED B-CELL PRECURSOR
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR RADIAT BIOL,KYOTO 606,JAPAN.
   NAGASAKI UNIV,SCH MED,DEPT BACTERIOL,NAGASAKI 852,JAPAN.
   NIHON UNIV,SCH MED,DEPT MICROBIOL,TOKYO 173,JAPAN.
   KAROLINSKA INST,DEPT TUMOR BIOL,S-10401 STOCKHOLM 60,SWEDEN.
CR ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982
   BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382
   TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0
   Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0
   NAGARAJAN L, 1986, P NATL ACAD SCI USA, V83, P6568, DOI 10.1073/pnas.83.17.6568
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DYSON PJ, 1985, P NATL ACAD SCI USA, V82, P1984, DOI 10.1073/pnas.82.7.1984
   GERONDAKIS S, 1984, CELL, V36, P973, DOI 10.1016/0092-8674(84)90047-3
   GOODFELLOW PN, 1982, P NATL ACAD SCI-BIOL, V79, P1190, DOI 10.1073/pnas.79.4.1190
   HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   HIETER PA, 1981, NATURE, V294, P536, DOI 10.1038/294536a0
   HOLLIS GF, 1984, NATURE, V307, P752, DOI 10.1038/307752a0
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HOPE RM, 1982, CYTOGENET CELL GENET, V33, P204, DOI 10.1159/000131756
   JARVIS JE, 1974, INT J CANCER, V14, P716, DOI 10.1002/ijc.2910140604
   KATAOKA T, 1983, P NATL ACAD SCI-BIOL, V80, P2666, DOI 10.1073/pnas.80.9.2666
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KENTER AL, 1981, NATURE, V293, P402, DOI 10.1038/293402a0
   KLEIN G, 1985, IMMUNOL TODAY, V6, P208, DOI 10.1016/0167-5699(85)90036-2
   MANIATIS T, 1982, MOL CLONING LABORATO
   MANOLOV G, 1981, CANCER GENET CYTOGEN, V4, P179, DOI 10.1016/0165-4608(81)90082-0
   MANOLOVA Y, 1979, HEREDITAS, V90, P5
   MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519
   MARK J, 1979, CANCER GENET CYTOGEN, V1, P39, DOI 10.1016/0165-4608(79)90009-8
   MARSHALL C, 1985, RNA TUMOR VIRUSES, P487
   MITELMAN F, 1981, HEREDITAS, V95, P79
   MORTEN JEN, 1984, INT J CANCER, V34, P463, DOI 10.1002/ijc.2910340406
   MOULDING D, 1985, NUCLEIC ACIDS RES, V13, P2141
   NILSSON K, 1982, ADV CANCER RES, V37, P319, DOI 10.1016/S0065-230X(08)60886-6
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   Noma Y, 1984, Mol Biol Med, V2, P337
   REEDMAN BM, 1973, INT J CANCER, V11, P971
   SAKAGUCHI AY, 1984, MOL CELL BIOL, V4, P989
   SEABRIGH.M, 1971, LANCET, V2, P971
   SEMBA K, 1985, SCIENCE, V227, P1038, DOI 10.1126/science.2983418
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837
   YAMAMOTO N, 1976, INT J CANCER, V17, P191, DOI 10.1002/ijc.2910170207
   YANDELL DW, 1986, CANCER GENET CYTOGEN, V20, P231, DOI 10.1016/0165-4608(86)90078-6
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108
   1985, CYTOGENET CELL GENET, V40, P1
NR 54
TC 21
Z9 21
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD FEB
PY 1987
VL 7
IS 2
BP 708
EP 717
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA F8526
UT WOS:A1987F852600018
PM 3029565
ER

PT J
AU IKUTA, K
   TAKAMI, M
   KIM, CW
   HONJO, T
   MIYOSHI, T
   TAGAYA, Y
   KAWABE, T
   YODOI, J
AF IKUTA, K
   TAKAMI, M
   KIM, CW
   HONJO, T
   MIYOSHI, T
   TAGAYA, Y
   KAWABE, T
   YODOI, J
TI HUMAN-LYMPHOCYTE FC RECEPTOR FOR IGE - SEQUENCE HOMOLOGY OF ITS CLONED
   CDNA WITH ANIMAL LECTINS
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,SCH MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,SCH MED,INST IMMUNOL,KYOTO 606,JAPAN.
CR ADACHI M, 1985, IMMUNOGENETICS, V22, P77, DOI 10.1007/BF00430596
   ADACHI M, 1983, J IMMUNOL, V131, P1246
   CLAESSON L, 1983, P NATL ACAD SCI-BIOL, V80, P7395, DOI 10.1073/pnas.80.24.7395
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   BOSS JJ, 1984, P NATL ACAD SCI US, V81, P2327
   DRICKAMER K, 1981, J BIOL CHEM, V256, P5827
   DRICKAMER K, 1986, J BIOL CHEM, V261, P6878
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HOLLAND EC, 1984, P NATL ACAD SCI-BIOL, V81, P7338, DOI 10.1073/pnas.81.23.7338
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HUFF TF, 1984, J IMMUNOL, V132, P406
   LIU FT, 1985, P NATL ACAD SCI USA, V82, P4100, DOI 10.1073/pnas.82.12.4100
   MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184
   MARTENS CL, 1985, P NATL ACAD SCI USA, V82, P2460, DOI 10.1073/pnas.82.8.2460
   NAGAI T, 1985, CLIN IMMUNOL IMMUNOP, V35, P261, DOI 10.1016/0090-1229(85)90088-1
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NORO N, 1986, J IMMUNOL, V137, P1258
   OKA S, 1986, J BIOCH TOKYO
   OKAYAMA H, 1982, MOL CELL BIOL, V2, P161
   PETERSON LH, 1985, J IMMUNOL, V135, P2654
   SARFATI M, 1984, IMMUNOLOGY, V53, P207
   SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0
   SPIEGELBERG HL, 1979, J CLIN INVEST, V64, P714, DOI 10.1172/JCI109514
   SPIESS M, 1985, J BIOL CHEM, V260, P1979
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   YODOI J, 1981, J IMMUNOL, V126, P877
   YODOI J, 1980, J IMMUNOL, V124, P934
   YODOI J, 1979, J IMMUNOL, V122, P2577
   YODOI J, 1979, J IMMUNOL, V123, P455
   ZERIAL M, 1986, EMBO J, V5, P1543
NR 31
TC 241
Z9 243
U1 0
U2 3
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB
PY 1987
VL 84
IS 3
BP 819
EP 823
DI 10.1073/pnas.84.3.819
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA F9763
UT WOS:A1987F976300044
PM 2949326
ER

PT J
AU SUZUKI, N
   MATSUNAMI, N
   KANAMORI, H
   ISHIDA, N
   SHIMIZU, A
   YAOITA, Y
   NIKAIDO, T
   HONJO, T
AF SUZUKI, N
   MATSUNAMI, N
   KANAMORI, H
   ISHIDA, N
   SHIMIZU, A
   YAOITA, Y
   NIKAIDO, T
   HONJO, T
TI THE HUMAN IL-2 RECEPTOR GENE CONTAINS A POSITIVE REGULATORY ELEMENT THAT
   FUNCTIONS IN CULTURED-CELLS AND CELL-FREE-EXTRACTS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MOLEC & CELLULAR BIOL,KYOTO 606,JAPAN.
RP SUZUKI, N (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR WEIL PA, 1979, CELL, V18, P469
   BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
   SEIKI M, 1984, NATURE, V309, P640, DOI 10.1038/309640a0
   MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855
   HATTORI T, 1981, BLOOD, V58, P645
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044
   MIYOSHI I, 1980, GANN, V71, P155
   MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0
   WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6
   FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   FUJISAWA J, 1985, P NATL ACAD SCI USA, V82, P2277, DOI 10.1073/pnas.82.8.2277
   GALLO RC, 1983, BLOOD, V62, P510
   GARCIA JV, 1986, NATURE, V322, P383, DOI 10.1038/322383a0
   GREENE WC, 1986, SCIENCE, V232, P877, DOI 10.1126/science.3010456
   ISHIDA N, 1985, NUCLEIC ACIDS RES, V13, P7579, DOI 10.1093/nar/13.21.7579
   KATAOKA T, 1982, J BIOL CHEM, V257, P277
   LAIMINS L, 1986, P NATL ACAD SCI USA, V83, P3151, DOI 10.1073/pnas.83.10.3151
   LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LUSE DS, 1980, CELL, V20, P691, DOI 10.1016/0092-8674(80)90315-3
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MATSUNAMI N, 1986, NUCLEIC ACIDS RES, V14, P4779, DOI 10.1093/nar/14.12.4779
   MILLER J, 1985, J IMMUNOL, V134, P4212
   MURAGUCHI A, 1981, J IMMUNOL, V127, P412
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NOMA T, 1986, BIOCHEM BIOPH RES CO, V139, P353, DOI 10.1016/S0006-291X(86)80121-8
   QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8
   SEIKI M, 1986, EMBO J, V5, P561
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   TSUDA M, 1981, CELL, V27, P175, DOI 10.1016/0092-8674(81)90371-8
   TSUDO M, 1983, BLOOD, V61, P1014
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 40
TC 34
Z9 34
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 15
PY 1987
VL 262
IS 11
BP 5079
EP 5086
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA G8823
UT WOS:A1987G882300025
PM 3031040
ER

PT J
AU KONDO, S
   KINOSHITA, M
   SHIMIZU, A
   SAITO, Y
   KONISHI, M
   SABE, H
   HONJO, T
AF KONDO, S
   KINOSHITA, M
   SHIMIZU, A
   SAITO, Y
   KONISHI, M
   SABE, H
   HONJO, T
TI EXPRESSION AND FUNCTIONAL-CHARACTERIZATION OF ARTIFICIAL MUTANTS OF
   INTERLEUKIN-2 RECEPTOR
SO NATURE
LA English
DT Article
RP KONDO, S (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR SHIMIZU A, 1986, IMMUNOL REV, V92, P103, DOI 10.1111/j.1600-065X.1986.tb01496.x
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   CAPKO CL, 1984, CELL, V37, P1053
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   CREDIG R, 1985, NATURE, V314, P98
   FUJII M, 1986, J IMMUNOL, V137, P1552
   GALLIS B, 1986, J BIOL CHEM, V261, P5075
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   ROBB RJ, 1986, P NATL ACAD SCI USA, V83, P3992, DOI 10.1073/pnas.83.11.3992
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHACKELFORD DA, 1986, J BIOL CHEM, V261, P8334
   ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468
NR 22
TC 42
Z9 42
U1 0
U2 0
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD MAY 7
PY 1987
VL 327
IS 6117
BP 64
EP 67
DI 10.1038/327064a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA H1726
UT WOS:A1987H172600055
PM 3106825
ER

PT J
AU NAKURA, J
   MIKI, T
   FUKUCHI, K
   SHIMIZU, K
   NOSE, O
   TAKAI, S
   WHITE, PC
   HONJO, T
   KUMAHARA, Y
AF NAKURA, J
   MIKI, T
   FUKUCHI, K
   SHIMIZU, K
   NOSE, O
   TAKAI, S
   WHITE, PC
   HONJO, T
   KUMAHARA, Y
TI ANALYSIS OF STEROID 21-HYDROXYLASE GENE IN 5 UNRELATED JAPANESE PATIENTS
   WITH 21-HYDROXYLASE DEFICIENCY
SO ENDOCRINOLOGIA JAPONICA
LA English
DT Article
C1 OSAKA UNIV,SCH MED,DEPT PEDIAT,FUKUSHIMA KU,OSAKA 553,JAPAN.
   OSAKA UNIV,SCH MED,DEPT SURG 2,FUKUSHIMA KU,OSAKA 553,JAPAN.
   OSAKA UNIV,SCH MED,DEPT GENET,FUKUSHIMA KU,OSAKA 553,JAPAN.
   MEM SLOAN KETTERING CANC CTR,HUMAN IMMUNOGENET LAB,NEW YORK,NY 10021.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP NAKURA, J (reprint author), OSAKA UNIV,SCH MED,DEPT MED & GERIATR,FUKUSHIMA KU,OSAKA 553,JAPAN.
CR CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521
   TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0
   HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841
   WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505
   WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089
   CARROLL MC, 1985, EMBO J, V4, P2547
   DONOHOUE PA, 1986, BIOCHEM BIOPH RES CO, V136, P722, DOI 10.1016/0006-291X(86)90499-7
   DUPONT B, 1977, LANCET, V2, P1309
   EVANS MI, 1985, JAMA-J AM MED ASSOC, V253, P1015, DOI 10.1001/jama.253.7.1015
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   KOLATA G, 1983, SCIENCE, V221, P1031, DOI 10.1126/science.6879201
   NEW MI, 1982, METABOLIC BASIS INHE, P937
   ONEILL GJ, 1982, CLIN IMMUNOL IMMUNOP, V23, P312, DOI 10.1016/0090-1229(82)90117-9
   ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0
   RUMSBY G, 1986, J MED GENET, V23, P204, DOI 10.1136/jmg.23.3.204
   SAITO N, 1980, CLIN ENDOCRINOLOGY, V28, P767
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111
   WHITEHEAD AS, 1984, NEW ENGL J MED, V310, P88, DOI 10.1056/NEJM198401123100204
   YANG TP, 1984, NATURE, V310, P412, DOI 10.1038/310412a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 21
TC 0
Z9 0
U1 0
U2 0
PU JAPAN ENDOCRINE SOCIETY
PI TOKYO
PA C/O DEPT VETERINARY PHYSIOL, VET MED SCI, UNIV TOKYO, 1-1-1 YAYOI,
   BUNKYO-KU, TOKYO 113, JAPAN
SN 0013-7219
J9 ENDOCRINOL JAPON
PD JUN
PY 1987
VL 34
IS 3
BP 373
EP 379
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA J0888
UT WOS:A1987J088800007
PM 3498630
ER

PT J
AU KONDO, I
   YAMAKAWA, K
   HAMAGUCHI, H
   NOMA, T
   MIZUTA, R
   TANAKA, H
   HONJO, T
AF KONDO, I
   YAMAKAWA, K
   HAMAGUCHI, H
   NOMA, T
   MIZUTA, R
   TANAKA, H
   HONJO, T
TI MOLECULAR-CLONING OF THE LYMPHOCYTE CYTOSOL POLYPEPTIDE-1 (LCP1)
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 INST CHEM TECHNOL,IBARAKI,JAPAN.
   UNIV TSUKUBA,DEPT HUMAN GENET,SAKURA,IBARAKI 305,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Yamakawa-Kobayashi, Kimiko/C-1698-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1987
VL 32
IS 2
BP 147
EP 148
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA K8544
UT WOS:A1987K854400057
ER

PT J
AU TAKATSU, K
   KIKUCHI, Y
   TAKAHASHI, T
   HONJO, T
   MATSUMOTO, M
   HARADA, N
   YAMAGUCHI, N
   TOMINAGA, A
AF TAKATSU, K
   KIKUCHI, Y
   TAKAHASHI, T
   HONJO, T
   MATSUMOTO, M
   HARADA, N
   YAMAGUCHI, N
   TOMINAGA, A
TI INTERLEUKIN-5, A T-CELL-DERIVED B-CELL DIFFERENTIATION FACTOR ALSO
   INDUCES CYTOTOXIC LYMPHOCYTES-T
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED SCI,SAKYO KU,KYOTO 606,JAPAN.
RP TAKATSU, K (reprint author), KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,2-2-1 HONJO,KUMAMOTO 860,JAPAN.
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   ERARD F, 1984, J EXP MED, V160, P584, DOI 10.1084/jem.160.2.584
   FALK W, 1985, J IMMUNOL, V135, P1160
   FINKE JH, 1977, NATURE, V267, P353, DOI 10.1038/267353a0
   FINKE JH, 1983, J IMMUNOL, V130, P763
   HAMAOKA T, 1981, J IMMUNOL, V126, P659
   HARA Y, 1985, LYMPHOKINE RES, V4, P368
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HARDT C, 1985, EUR J IMMUNOL, V15, P472, DOI 10.1002/eji.1830150511
   HOWARD M, 1984, IMMUNOL REV, V78, P185, DOI 10.1111/j.1600-065X.1984.tb00482.x
   KANAGAWA O, 1983, J IMMUNOL, V131, P606
   KIKUCHI Y, 1986, J IMMUNOL, V136, P3553
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   OGARRA A, 1986, P NATL ACAD SCI USA, V83, P5228, DOI 10.1073/pnas.83.14.5228
   OKADA M, 1979, J IMMUNOL, V122, P2527
   OKUNO K, 1986, JPN J CANCER RES, V77, P711
   RAULET DH, 1982, NATURE, V296, P754, DOI 10.1038/296754a0
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SWAIN SL, 1983, J EXP MED, V158, P822, DOI 10.1084/jem.158.3.822
   SWAIN SL, 1985, J IMMUNOL, V134, P3934
   TAKATSU K, 1975, J IMMUNOL, V114, P1838
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1986, J IMMUNOL, V136, P1161
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   THOMAS PS, 1974, METHODS ENZYMOL, V100, P255
NR 31
TC 153
Z9 153
U1 0
U2 2
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN
PY 1987
VL 84
IS 12
BP 4234
EP 4238
DI 10.1073/pnas.84.12.4234
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA H7601
UT WOS:A1987H760100063
PM 3495803
ER

PT J
AU LEE, KH
   MATSUDA, F
   KINASHI, T
   KODAIRA, M
   HONJO, T
AF LEE, KH
   MATSUDA, F
   KINASHI, T
   KODAIRA, M
   HONJO, T
TI A NOVEL FAMILY OF VARIABLE REGION GENES OF THE HUMAN-IMMUNOGLOBULIN
   HEAVY-CHAIN
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
RP LEE, KH (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303
   FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2
   KENTEN JH, 1982, P NATL ACAD SCI-BIOL, V79, P6661, DOI 10.1073/pnas.79.21.6661
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3
   BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012
   BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
   BENTLEY DL, 1980, NATURE, V288, P730, DOI 10.1038/288730a0
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   BRODEUR PH, 1984, REGULATION IMMUNE SY, V18, P445
   COHEN JB, 1982, NUCLEIC ACIDS RES, V10, P3353, DOI 10.1093/nar/10.11.3353
   CORY S, 1981, Journal of Molecular and Applied Genetics, V1, P103
   GIVOL D, 1981, NATURE, V292, P426, DOI 10.1038/292426a0
   HARTMAN AB, 1984, EMBO J, V3, P3023
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HUANG H, 1981, Journal of Molecular and Applied Genetics, V1, P93
   Kabat EA, 1983, SEQUENCES PROTEINS I
   KEMP D J, 1981, Journal of Molecular and Applied Genetics, V1, P245
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9
   MANIATIS T, 1982, MOL CLONING LABORATO
   MATTHYSSENS G, 1980, P NATL ACAD SCI-BIOL, V77, P6561, DOI 10.1073/pnas.77.11.6561
   MENSINK EJBM, 1986, EUR J IMMUNOL, V16, P963, DOI 10.1002/eji.1830160815
   NEAR RI, 1984, P NATL ACAD SCI-BIOL, V81, P2167, DOI 10.1073/pnas.81.7.2167
   NISHI M, 1985, P NATL ACAD SCI USA, V82, P6399, DOI 10.1073/pnas.82.19.6399
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   Noma Y, 1984, Mol Biol Med, V2, P337
   OLLO R, 1981, NUCLEIC ACIDS RES, V9, P4099, DOI 10.1093/nar/9.16.4099
   PECH M, 1984, J MOL BIOL, V176, P189, DOI 10.1016/0022-2836(84)90420-0
   RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STRAUBINGER B, 1984, NUCLEIC ACIDS RES, V12, P5265, DOI 10.1093/nar/12.13.5265
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WINTER E, 1985, EMBO J, V4, P2861
   ZEELON EP, 1981, NUCLEIC ACIDS RES, V9, P3809, DOI 10.1093/nar/9.15.3809
NR 44
TC 197
Z9 197
U1 0
U2 1
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 20
PY 1987
VL 195
IS 4
BP 761
EP 768
DI 10.1016/0022-2836(87)90482-7
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA J0683
UT WOS:A1987J068300001
PM 3116265
ER

PT J
AU KINASHI, T
   GODAL, T
   NOMA, Y
   LING, NR
   YAOITA, Y
   HONJO, T
AF KINASHI, T
   GODAL, T
   NOMA, Y
   LING, NR
   YAOITA, Y
   HONJO, T
TI HUMAN NEOPLASTIC B-CELLS EXPRESS MORE THAN 2 ISOTYPES OF IMMUNOGLOBULINS
   WITHOUT DELETION OF HEAVY-CHAIN CONSTANT-REGION GENES
SO GENES & DEVELOPMENT
LA English
DT Article
C1 NORWEGIAN RADIUM HOSP,IMMUNOL LAB,OSLO 3,NORWAY.
   UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND.
RP KINASHI, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ADACHI M, 1985, IMMUNOGENETICS, V22, P77, DOI 10.1007/BF00430596
   FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   KATONA IM, 1985, P NATL ACAD SCI USA, V82, P511, DOI 10.1073/pnas.82.2.511
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   MAKMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   Noma Y, 1984, Mol Biol Med, V2, P337
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 25
TC 29
Z9 29
U1 0
U2 2
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0890-9369
J9 GENE DEV
JI Genes Dev.
PD JUL
PY 1987
VL 1
IS 5
BP 465
EP 470
DI 10.1101/gad.1.5.465
PG 6
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA J2732
UT WOS:A1987J273200006
PM 2824283
ER

PT J
AU HARADA, N
   MATSUMOTO, M
   KOYAMA, N
   SHIMIZU, A
   HONJO, T
   TOMINAGA, A
   TAKATSU, K
AF HARADA, N
   MATSUMOTO, M
   KOYAMA, N
   SHIMIZU, A
   HONJO, T
   TOMINAGA, A
   TAKATSU, K
TI T-CELL REPLACING FACTOR INTERLEUKIN-5 INDUCES NOT ONLY B-CELL GROWTH AND
   DIFFERENTIATION, BUT ALSO INCREASED EXPRESSION OF INTERLEUKIN-2 RECEPTOR
   ON ACTIVATED B-CELLS
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,KUMAMOTO 860,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   ZUBLER RH, 1984, J EXP MED, V160, P1170, DOI 10.1084/jem.160.4.1170
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   MURAGUCHI A, 1985, J EXP MED, V161, P181, DOI 10.1084/jem.161.1.181
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   ARMITAGE RJ, 1986, CLIN EXP IMMUNOL, V63, P298
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DUTTON RW, 1975, TRANSPLANT REV, V23, P66
   HAMAOKA T, 1986, ANNU REV IMMUNOL, V4, P167, DOI 10.1146/annurev.immunol.4.1.167
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HARADA N, 1986, 6TH INT C IMM
   HAYASHI SI, 1986, J IMMUNOL, V136, P2069
   HOWARD M, 1983, ANNU REV IMMUNOL, V1, P307, DOI 10.1146/annurev.iy.01.040183.001515
   KIKUCHI Y, 1986, J IMMUNOL, V136, P3553
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KORSMEYER SJ, 1983, P NATL ACAD SCI-BIOL, V80, P4522, DOI 10.1073/pnas.80.14.4522
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LEIBSON HJ, 1981, J EXP MED, V154, P1681, DOI 10.1084/jem.154.5.1681
   LEIBSON HJ, 1984, NATURE, V309, P799, DOI 10.1038/309799a0
   LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0
   MARRACK P, 1982, IMMUNOL REV, V63, P33, DOI 10.1111/j.1600-065X.1982.tb00410.x
   MELCHERS F, 1980, EUR J IMMUNOL, V10, P679, DOI 10.1002/eji.1830100905
   MELCHERS F, 1986, ANNU REV IMMUNOL, V4, P13, DOI 10.1146/annurev.immunol.4.1.13
   NAKANISHI K, 1983, J IMMUNOL, V130, P2219
   NAKANISHI K, 1984, J EXP MED, V160, P1605, DOI 10.1084/jem.160.6.1605
   OGARRA A, 1986, P NATL ACAD SCI USA, V83, P5228, DOI 10.1073/pnas.83.14.5228
   PARKER DC, 1979, J IMMUNOL, V123, P931
   PIKE BL, 1984, P NATL ACAD SCI-BIOL, V81, P7917, DOI 10.1073/pnas.81.24.7917
   PURE E, 1982, J IMMUNOL, V131, P794
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SATO T, 1982, EXP CELL RES, V138, P127, DOI 10.1016/0014-4827(82)90098-2
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SIDMAN CL, 1984, NATURE, V309, P801, DOI 10.1038/309801a0
   SINGER A, 1983, ANNU REV IMMUNOL, V1, P211, DOI 10.1146/annurev.iy.01.040183.001235
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   SMITH KA, 1983, GENETICS IMMUNE RESP, P151
   SWAIN SL, 1982, J EXP MED, V156, P1821, DOI 10.1084/jem.156.6.1821
   SWAIN SL, 1981, P NATL ACAD SCI-BIOL, V78, P2517, DOI 10.1073/pnas.78.4.2517
   SWAIN SL, 1985, J IMMUNOL, V134, P3934
   TAKATSU K, 1987, IN PRESS P NATL ACAD
   TAKATSU K, 1982, IMMUNOL REV, V64, P25, DOI 10.1111/j.1600-065X.1982.tb00417.x
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   THOMAS PS, 1974, METHODS ENZYMOL, V100, P255
   TSUDO M, 1984, J EXP MED, V160, P612, DOI 10.1084/jem.160.2.612
   VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726
NR 51
TC 39
Z9 39
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUL
PY 1987
VL 15
IS 3
BP 205
EP 215
DI 10.1016/0165-2478(87)90026-5
PG 11
WC Immunology
SC Immunology
GA J5147
UT WOS:A1987J514700005
PM 3117678
ER

PT J
AU TAGAYA, Y
   TANIGUCHI, Y
   NARAMURA, M
   OKADA, M
   SUZUKI, N
   KANAMORI, H
   NIKAIDO, T
   HONJO, T
   YODOI, J
AF TAGAYA, Y
   TANIGUCHI, Y
   NARAMURA, M
   OKADA, M
   SUZUKI, N
   KANAMORI, H
   NIKAIDO, T
   HONJO, T
   YODOI, J
TI TRANSCRIPTION OF IL-2 RECEPTOR GENE IS STIMULATED BY ATL-DERIVED FACTOR
   PRODUCED BY HTLV-I(+) T-CELL LINES
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
OI Naramura, Mayumi/0000-0003-3658-0767
CR SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   HATTORI T, 1981, BLOOD, V58, P645
   REEM GH, 1984, SCIENCE, V225, P429, DOI 10.1126/science.6429853
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044
   TATENO M, 1984, J EXP MED, V159, P1105, DOI 10.1084/jem.159.4.1105
   LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   ARYA SK, 1984, SCIENCE, V223, P1086, DOI 10.1126/science.6320374
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   ARIMA N, 1986, BLOOD, V68, P779
   ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   HASELTINE WA, 1984, SCIENCE, V225, P419, DOI 10.1126/science.6330894
   ISHIDA N, 1985, NUCLEIC ACIDS RES, V13, P7579, DOI 10.1093/nar/13.21.7579
   KAYE J, 1984, J IMMUNOL, V133, P1339
   KORSMEYER SJ, 1983, P NATL ACAD SCI-BIOL, V80, P4522, DOI 10.1073/pnas.80.14.4522
   LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5
   MINATO N, 1985, J EXP MED, V162, P1161, DOI 10.1084/jem.162.4.1161
   MUELLER R, 1985, Nature (London), V314, P546
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NOMA T, 1986, BIOCHEM BIOPH RES CO, V139, P353, DOI 10.1016/S0006-291X(86)80121-8
   OKADA M, 1985, J IMMUNOL, V135, P3995
   QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHIRAKAWA F, 1986, J IMMUNOL, V137, P551
   SUZUKI N, 1987, IN PRESS J BIOL CHEM
   TESHIGAWARA K, 1985, J MOL CELL IMMUNOL, V2, P17
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TSUDO M, 1983, BLOOD, V61, P1014
   TSUDO M, 1982, J IMMUNOL, V129, P592
   TSUJIMOTO H, 1985, INT J CANCER, V35, P377, DOI 10.1002/ijc.2910350314
   UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992
   WANO Y, 1985, MICROBIOL IMMUNOL, V29, P451
   WANO Y, 1984, J IMMUNOL, V132, P3005
   YAMAMOTO S, 1986, BLOOD, V67, P1714
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, 1984, THYMIC HORMONES LYMP, P273
   YODOI J, 1983, BLOOD, V62, P509
   YODOI J, 1985, J EXP MED, V161, P924, DOI 10.1084/jem.161.5.924
   YODOI J, 1985, J IMMUNOL, V134, P1623
   YODOI J, 1984, HUMAN T CELL LEUKEMI, P255
NR 48
TC 27
Z9 27
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUL
PY 1987
VL 15
IS 3
BP 221
EP 228
DI 10.1016/0165-2478(87)90028-9
PG 8
WC Immunology
SC Immunology
GA J5147
UT WOS:A1987J514700007
PM 2889666
ER

PT J
AU NOMA, T
   MIZUTA, T
   ROSEN, A
   HIRANO, T
   KISHIMOTO, T
   HONJO, T
AF NOMA, T
   MIZUTA, T
   ROSEN, A
   HIRANO, T
   KISHIMOTO, T
   HONJO, T
TI ENHANCEMENT OF THE INTERLEUKIN-2 RECEPTOR EXPRESSION ON T-CELLS BY
   MULTIPLE B-LYMPHOTROPIC LYMPHOKINES
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KAROLINSKA INST,DEPT TUMOR BIOL,S-10401 STOCKHOLM 60,SWEDEN.
   OSAKA UNIV,INST MOLEC & CELLULAR BIOL,OSAKA,JAPAN.
RI Hirano, Toshio/C-8194-2009; Kishimoto, Tadamitsu/C-8470-2009; Rosen,
   Anders/H-1893-2011
OI Rosen, Anders/0000-0001-5082-6423
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   HAEGEMAN G, 1986, EUR J BIOCHEM, V159, P625, DOI 10.1111/j.1432-1033.1986.tb09931.x
   HAMAGUCHI Y, 1987, J EXP MED, V165, P268, DOI 10.1084/jem.165.1.268
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133
   NAKANISHI K, 1987, IN PRESS J IMMUNOL
   NOMA T, 1986, BIOCHEM BIOPH RES CO, V139, P353, DOI 10.1016/S0006-291X(86)80121-8
   OGARRA A, 1986, P NATL ACAD SCI USA, V83, P5228, DOI 10.1073/pnas.83.14.5228
   OKADA M, 1985, J IMMUNOL, V135, P3995
   OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6
   ROSEN A, 1986, LYMPHOKINE RES, V5, P185
   SCHRADER JW, 1986, ANNU REV IMMUNOL, V4, P205, DOI 10.1146/annurev.immunol.4.1.205
   SEVERINSON E, 1987, EUR J IMMUNOL, V17, P67, DOI 10.1002/eji.1830170112
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   TESHIGAWARA K, 1985, J MOL CELL IMMUNOL, V2, P17
   VILCEK J, 1985, LYMPHOKINES, V11, P1
   WAKASUGI H, 1987, P NATL ACAD SCI USA, V84, P804, DOI 10.1073/pnas.84.3.804
   YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894
   ZILBERSTEIN A, 1986, EMBO J, V5, P2529
NR 26
TC 96
Z9 97
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUL
PY 1987
VL 15
IS 3
BP 249
EP 253
DI 10.1016/0165-2478(87)90032-0
PG 5
WC Immunology
SC Immunology
GA J5147
UT WOS:A1987J514700011
PM 2889667
ER

PT J
AU HARADA, N
   TAKAHASHI, T
   MATSUMOTO, M
   KINASHI, T
   OHARA, J
   KIKUCHI, Y
   KOYAMA, N
   SEVERINSON, E
   YAOITA, Y
   HONJO, T
   YAMAGUCHI, N
   TOMINAGA, A
   TAKATSU, K
AF HARADA, N
   TAKAHASHI, T
   MATSUMOTO, M
   KINASHI, T
   OHARA, J
   KIKUCHI, Y
   KOYAMA, N
   SEVERINSON, E
   YAOITA, Y
   HONJO, T
   YAMAGUCHI, N
   TOMINAGA, A
   TAKATSU, K
TI PRODUCTION OF A MONOCLONAL-ANTIBODY USEFUL IN THE MOLECULAR
   CHARACTERIZATION OF MURINE T-CELL-REPLACING FACTOR B-CELL GROWTH
   FACTOR-II
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   NIAID,IMMUNOL LAB,BETHESDA,MD 20892.
   UNIV STOCKHOLM,DEPT IMMUNOL,S-10691 STOCKHOLM,SWEDEN.
RP HARADA, N (reprint author), KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,KUMAMOTO 860,JAPAN.
CR ANDERSSON J, 1980, P NATL ACAD SCI-BIOL, V77, P1612, DOI 10.1073/pnas.77.3.1612
   KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490
   ZUBLER RH, 1984, J EXP MED, V160, P1170, DOI 10.1084/jem.160.4.1170
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   MIZEL SB, 1982, IMMUNOL REV, V63, P51, DOI 10.1111/j.1600-065X.1982.tb00411.x
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   HAMAOKA T, 1986, ANNU REV IMMUNOL, V4, P167, DOI 10.1146/annurev.immunol.4.1.167
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HOWARD M, 1984, IMMUNOL REV, V78, P185, DOI 10.1111/j.1600-065X.1984.tb00482.x
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   KIKUCHI Y, 1986, J IMMUNOL, V136, P3553
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LEIBSON HJ, 1984, NATURE, V309, P799, DOI 10.1038/309799a0
   LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0
   MELCHERS F, 1986, ANNU REV IMMUNOL, V4, P13, DOI 10.1146/annurev.immunol.4.1.13
   NAKANISHI K, 1983, J IMMUNOL, V130, P2219
   NAKANISHI K, 1984, J EXP MED, V160, P1605, DOI 10.1084/jem.160.6.1605
   PAIGE CJ, 1982, P NATL ACAD SCI-BIOL, V79, P4756, DOI 10.1073/pnas.79.15.4756
   PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P6350, DOI 10.1073/pnas.79.20.6350
   PURE E, 1981, J IMMUNOL, V127, P1953
   SWAIN SL, 1983, J EXP MED, V158, P822, DOI 10.1084/jem.158.3.822
   SWAIN SL, 1985, J IMMUNOL, V134, P3934
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   YOSHIZAKI K, 1982, J IMMUNOL, V128, P1296
NR 32
TC 119
Z9 119
U1 0
U2 1
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL
PY 1987
VL 84
IS 13
BP 4581
EP 4585
DI 10.1073/pnas.84.13.4581
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA J0700
UT WOS:A1987J070000049
PM 2440025
ER

PT J
AU TAKAI, S
   TATEISHI, H
   NISHISHO, I
   MIKI, T
   MOTOMURA, K
   MIYAUCHI, A
   KATO, M
   IKEUCHI, T
   YAMAMOTO, K
   OKAZAKI, M
   YAMAMOTO, M
   HONJO, T
   KUMAHARA, Y
   MORI, T
AF TAKAI, S
   TATEISHI, H
   NISHISHO, I
   MIKI, T
   MOTOMURA, K
   MIYAUCHI, A
   KATO, M
   IKEUCHI, T
   YAMAMOTO, K
   OKAZAKI, M
   YAMAMOTO, M
   HONJO, T
   KUMAHARA, Y
   MORI, T
TI LOSS OF GENES ON CHROMOSOME-22 IN MEDULLARY-THYROID CARCINOMA AND
   PHEOCHROMOCYTOMA
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
C1 OSAKA UNIV,SCH MED,DEPT MED & GERIATR,OSAKA 553,JAPAN.
   TOKYO MED & DENT UNIV,MED RES INST,DEPT CYTOGENET,BUNKYO KU,TOKYO 113,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KAGAWA MED SCH,DEPT SURG,MIKI,KAGAWA 76107,JAPAN.
   NAGOYA FIRST HOSP,JAPANESE RED CROSS,DEPT SURG,NAGOYA 453,JAPAN.
RP TAKAI, S (reprint author), OSAKA UNIV,SCH MED,DEPT SURG 2,1-1-50 FUKUSHIMA,OSAKA 553,JAPAN.
CR CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0
   MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0
   SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0
   STEINER AL, 1968, MEDICINE, V47, P371, DOI 10.1097/00005792-196809000-00001
   KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820
   MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0
   SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0
   BABU VR, 1984, P NATL ACAD SCI-BIOL, V81, P2525, DOI 10.1073/pnas.81.8.2525
   BUTLER MG, 1987, CANCER GENET CYTOGEN, V24, P129, DOI 10.1016/0165-4608(87)90089-6
   DOZIER C, 1986, NUCLEIC ACIDS RES, V14, P1928, DOI 10.1093/nar/14.4.1928
   EMMERTSEN K, 1983, CANCER GENET CYTOGEN, V9, P251, DOI 10.1016/0165-4608(83)90009-2
   IKEUCHI T, 1985, 44TH P JPN CANC ASS, P226
   JACKSON CE, 1979, AM J HUM GENET, V31, P704
   KEYNES WM, 1971, Q J MED, V40, P443
   KIDD KK, 1986, HUM HERED, V36, P243, DOI 10.1159/000153634
   KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0
   NISHISHO I, 1986, JPN J HUM GENET, V31, P249, DOI 10.1007/BF01870755
   NISHISHO I, 1987, JPN J HUM GENET, V32, P1, DOI 10.1007/BF01876521
   SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060
   SIMPSON NE, 1987, IN PRESS H FORD HOSP
   SIZEMORE GW, 1983, SURGERY THYROID PARA, P75
   SOUTHERN EM, 1982, CYTOGENET CELL GENET, V32, P52, DOI 10.1159/000131686
   TATEISHI H, 1987, IN PRESS H FORD HOSP
   WURSTERHILL DH, 1986, CANCER GENET CYTOGEN, V20, P247, DOI 10.1016/0165-4608(86)90080-4
   1985, CYTOGENET CELL GENET, V40
NR 25
TC 27
Z9 27
U1 0
U2 0
PU JAPANESE CANCER ASSOCIATION
PI TOKYO
PA EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PD SEP
PY 1987
VL 78
IS 9
BP 894
EP 898
PG 5
WC Oncology
SC Oncology
GA K5246
UT WOS:A1987K524600004
PM 2889715
ER

PT J
AU AZUMA, M
   HIRANO, T
   MIYAJIMA, H
   WATANABE, N
   YAGITA, H
   ENOMOTO, S
   FURUSAWA, S
   OVARY, Z
   KINASHI, T
   HONJO, T
   OKUMURA, K
AF AZUMA, M
   HIRANO, T
   MIYAJIMA, H
   WATANABE, N
   YAGITA, H
   ENOMOTO, S
   FURUSAWA, S
   OVARY, Z
   KINASHI, T
   HONJO, T
   OKUMURA, K
TI REGULATION OF MURINE IGE PRODUCTION IN SJA/9 AND NUDE-MICE -
   POTENTIATION OF IGE PRODUCTION BY RECOMBINANT INTERLEUKIN-4
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,2-1-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.
   JUNTENDO UNIV,SCH MED,DEPT INTERNAL MED & RHEUMATOL,BUNKYO KU,TOKYO 113,JAPAN.
   TOKYO MED & DENT UNIV,DEPT ORAL & MAXILLOFACIAL SURG,TOKYO 113,JAPAN.
   JIKEI UNIV SCH MED,DEPT PARASITOL,TOKYO 105,JAPAN.
   NYU,SCH MED,DEPT PATHOL,NEW YORK,NY 10016.
   KAPLAN CANC CTR,NEW YORK,NY 10016.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ADACHI M, 1985, IMMUNOGENETICS, V22, P77, DOI 10.1007/BF00430596
   KATONA IM, 1985, P NATL ACAD SCI USA, V82, P511, DOI 10.1073/pnas.82.2.511
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   COFFMAN RL, 1986, J IMMUNOL, V136, P949
   OGILVIE BM, 1964, NATURE, V204, P91, DOI 10.1038/204091a0
   JARRETT EEE, 1982, PROG ALLERGY, V31, P178
   SPIEGELBERG HL, 1984, ADV IMMUNOL, V35, P61, DOI 10.1016/S0065-2776(08)60574-X
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149
   KIKUTANI H, 1986, J EXP MED, V164, P1455, DOI 10.1084/jem.164.5.1455
   ARAI K, 1987, FED PROC, V46, P1498
   BLOCH KJ, 1973, J IMMUNOL, V110, P197
   BORGES MS, 1981, IMMUNOGENETICS, V13, P499, DOI 10.1007/BF00343718
   CHEN SS, 1981, J IMMUNOL, V127, P166
   FINKELMAN FD, 1986, P NATL ACAD SCI US, V83, P1986
   HIRANO T, 1983, P NATL ACAD SCI-BIOL, V80, P3435, DOI 10.1073/pnas.80.11.3435
   KATONA IM, 1984, J IMMUNOL, V133, P1521
   KATZ DH, 1980, IMMUNOLOGY, V41, P1
   KOJIMA S, 1975, CELL IMMUNOL, V15, P274, DOI 10.1016/0008-8749(75)90006-4
   KOJIMA S, 1980, CELL IMMUNOL, V50, P327, DOI 10.1016/0008-8749(80)90287-7
   KOJIMA S, 1975, CELL IMMUNOL, V17, P383, DOI 10.1016/S0008-8749(75)80042-6
   KUMAGAI Y, 1983, IMMUNOGENETICS, V18, P147, DOI 10.1007/BF00368543
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156
   MATHUR A, 1986, MOL IMMUNOL, V23, P1193, DOI 10.1016/0161-5890(86)90151-3
   MICHAEL JG, 1973, J IMMUNOL, V111, P1600
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   ROEHM NW, 1984, J EXP MED, V160, P679, DOI 10.1084/jem.160.3.679
   SANTOMAURO JF, 1980, CELL IMMUNOL, V51, P273, DOI 10.1016/0008-8749(80)90259-2
   SUEMURA M, 1986, J IMMUNOL, V137, P1214
   SUEMURA M, 1979, J IMMUNOL, V123, P918
   WATANABE N, 1976, J EXP MED, V143, P833, DOI 10.1084/jem.143.4.833
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YODOI J, 1979, J IMMUNOL, V122, P2577
NR 34
TC 63
Z9 63
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD OCT 15
PY 1987
VL 139
IS 8
BP 2538
EP 2544
PG 7
WC Immunology
SC Immunology
GA K3207
UT WOS:A1987K320700005
PM 3498762
ER

PT J
AU MAEDA, M
   ARIMA, N
   DAITOKU, Y
   KASHIHARA, M
   OKAMOTO, H
   UCHIYAMA, T
   SHIRONO, K
   MATSUOKA, M
   HATTORI, T
   TAKATSUKI, K
   IKUTA, K
   SHIMIZU, A
   HONJO, T
   YODOI, J
AF MAEDA, M
   ARIMA, N
   DAITOKU, Y
   KASHIHARA, M
   OKAMOTO, H
   UCHIYAMA, T
   SHIRONO, K
   MATSUOKA, M
   HATTORI, T
   TAKATSUKI, K
   IKUTA, K
   SHIMIZU, A
   HONJO, T
   YODOI, J
TI EVIDENCE FOR THE INTERLEUKIN-2 DEPENDENT EXPANSION OF LEUKEMIC-CELLS IN
   ADULT T-CELL LEUKEMIA
SO BLOOD
LA English
DT Article
C1 KYOTO UNIV,FAC MED,INST IMMUNOL,DEPT DERMATOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,INST IMMUNOL,DEPT MED 3,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,INST IMMUNOL,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT INTERNAL MED 1,KAGOSHIMA 890,JAPAN.
   KUMAMOTO UNIV,SCH MED,DEPT INTERNAL MED 2,KUMAMOTO 860,JAPAN.
RP MAEDA, M (reprint author), KYOTO UNIV,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
OI Matsuoka, Masao/0000-0002-0473-754X
CR INOUE J, 1986, EMBO J, V5, P2883
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P6815, DOI 10.1073/pnas.77.11.6815
   HATTORI T, 1981, BLOOD, V58, P645
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   POPOVIC M, 1983, P NATL ACAD SCI-BIOL, V80, P5402, DOI 10.1073/pnas.80.17.5402
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   ARIMA N, 1986, BLOOD, V68, P779
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   Fukui K, 1983, Mol Biol Med, V1, P447
   GAZDAR AF, 1980, BLOOD, V55, P409
   GOTOH YI, 1982, P NATL ACAD SCI-BIOL, V79, P4780, DOI 10.1073/pnas.79.15.4780
   GREENE WC, 1986, SCIENCE, V232, P877, DOI 10.1126/science.3010456
   HAHN B, 1984, MOL BIOL MED, V3, P39
   HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MORGAN DA, 1976, SCIENCE, V193, P107
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   SHOW S, 1987, IMMUNOL TODAY, V8, P1
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   Takatsuki K, 1977, TOPICS HEMATOLOGY, P73
   TSUDO M, 1983, BLOOD, V61, P1014
   UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
   YODOI J, 1974, NEW ENGL J MED, V290, P572
   YODOI J, 1986, IMMUNOL REV, V92, P136
   YODOI J, 1983, BLOOD, V62, P509
NR 30
TC 76
Z9 77
U1 0
U2 1
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV
PY 1987
VL 70
IS 5
BP 1407
EP 1411
PG 5
WC Hematology
SC Hematology
GA K7806
UT WOS:A1987K780600025
PM 2889484
ER

PT J
AU DOI, S
   OHNO, H
   TATSUMI, E
   ARITA, Y
   KAMESAKI, H
   FUKUHARA, S
   NISHIKORI, M
   MIWA, H
   KITA, K
   HATANAKA, M
   HONJO, T
   FUJII, H
   UCHINO, H
AF DOI, S
   OHNO, H
   TATSUMI, E
   ARITA, Y
   KAMESAKI, H
   FUKUHARA, S
   NISHIKORI, M
   MIWA, H
   KITA, K
   HATANAKA, M
   HONJO, T
   FUJII, H
   UCHINO, H
TI LYMPHOMA CELL-LINE (FL-18) AND EPSTEIN-BARR-VIRUS CARRYING CELL-LINE
   (FL-18-EB) OBTAINED FROM A PATIENT WITH FOLLICULAR LYMPHOMA - MONOCLONAL
   DERIVATION AND DIFFERENT PROPERTIES
SO BLOOD
LA English
DT Article
C1 KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KOBE UNIV,DEPT LAB MED,KOBE 657,JAPAN.
   MIE UNIV,DEPT INTERNAL MED 2,TSU,MIE 514,JAPAN.
   KYOTO FIRST RED CROSS HOSP,KYOTO,JAPAN.
RP DOI, S (reprint author), KYOTO UNIV,FAC MED,DEPT INTERNAL MED 1,SAKYO KU,KYOTO 606,JAPAN.
CR AMAN P, 1985, J IMMUNOL, V135, P2362
   ANDERSON KC, 1983, J IMMUNOL, V130, P1132
   [Anonymous], 1982, CANCER, V49, P2112
   MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207
   WISLOCKI GB, 1949, BLOOD, V4, P562
   ANDERSON KC, 1984, BLOOD, V63, P1424
   KAMESAKI H, 1986, BLOOD, V68, P285
   REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302
   TAKADA K, 1980, INTERVIROLOGY, V13, P223, DOI 10.1159/000149129
   FUKUHARA S, 1978, INT J CANCER, V22, P14, DOI 10.1002/ijc.2910220105
   CHANG RS, 1976, P SOC EXP BIOL MED, V153, P193
   CLEMENTS GB, 1975, INT J CANCER, V16, P125, DOI 10.1002/ijc.2910160114
   EPSTEIN MA, 1978, PROG EXP TUMOR RES, V21, P72
   FINERTY S, 1982, INT J CANCER, V30, P1, DOI 10.1002/ijc.2910300102
   FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510
   FRADE R, 1985, P NATL ACAD SCI USA, V82, P1490, DOI 10.1073/pnas.82.5.1490
   FRESEN KO, 1976, INT J CANCER, V17, P161, DOI 10.1002/ijc.2910170203
   FUKUHARA S, 1979, CANCER RES, V39, P3119
   HUBER C, 1975, EUR J IMMUNOL, V5, P432, DOI 10.1002/eji.1830050616
   KARANDE A, 1980, INT J CANCER, V26, P551, DOI 10.1002/ijc.2910260505
   KLEIN G, 1983, J IMMUNOL, V130, P1985
   LI CY, 1973, J HISTOCHEM CYTOCHEM, V21, P1
   MARTIN PJ, 1981, J IMMUNOL, V127, P1920
   MENDELSOHN J, 1983, BLOOD, V62, P821
   NADLER LM, 1981, J IMMUNOL, V126, P1941
   NILSSON K, 1975, INT J CANCER, V15, P321, DOI 10.1002/ijc.2910150217
   OHNO H, 1985, JPN J CANCER RES, V76, P563
   RICKINSON AB, 1982, CLIN EXP IMMUNOL, V50, P347
   RITZ J, 1980, NATURE, V283, P583, DOI 10.1038/283583a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   SUGDEN B, 1983, J VIROL, V46, P800
   TATSUMI E, 1986, LEUKEMIA RES, V10, P167, DOI 10.1016/0145-2126(86)90039-1
   TATSUMI E, 1979, BLOOD, V54, P524
NR 33
TC 16
Z9 16
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV
PY 1987
VL 70
IS 5
BP 1619
EP 1623
PG 5
WC Hematology
SC Hematology
GA K7806
UT WOS:A1987K780600057
PM 2822175
ER

PT J
AU HAMA, T
   HONJO, T
AF HAMA, T
   HONJO, T
TI PHOTOSYNTHETIC PRODUCTS AND NUTRIENT AVAILABILITY IN PHYTOPLANKTON
   POPULATION FROM GOKASHO BAY, JAPAN
SO JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY
LA English
DT Article
RP HAMA, T (reprint author), NAGOYA UNIV,WATER RES INST,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN.
CR GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0
   HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282
   MYKLESTAD S, 1977, J EXP MAR BIOL ECOL, V29, P161, DOI 10.1016/0022-0981(77)90046-6
   KAISER FE, 1974, J CHROMATOGR, V94, P113, DOI 10.1016/S0021-9673(01)92361-1
   HANDA N, 1969, MAR BIOL, V2, P228, DOI 10.1007/BF00351145
   REDALJE DG, 1981, MAR BIOL, V62, P73, DOI 10.1007/BF00396953
   BARLOW RG, 1982, J EXP MAR BIOL ECOL, V63, P209, DOI 10.1016/0022-0981(82)90179-4
   PRISCU JC, 1984, MAR BIOL, V81, P31, DOI 10.1007/BF00397622
   CUHEL RL, 1984, LIMNOL OCEANOGR, V29, P731
   VARUM KM, 1986, J EXP MAR BIOL ECOL, V102, P249, DOI 10.1016/0022-0981(86)90180-2
   SHUTER B, 1979, J THEOR BIOL, V78, P519, DOI 10.1016/0022-5193(79)90189-9
   MORRIS I, 1974, MAR BIOL, V27, P1, DOI 10.1007/BF00394754
   EPPLEY RW, 1968, J PHYCOL, V4, P333, DOI 10.1111/j.1529-8817.1968.tb04704.x
   BARLOW RG, 1982, J EXP MAR BIOL ECOL, V63, P229, DOI 10.1016/0022-0981(82)90180-0
   BARLOW RG, 1982, J EXP MAR BIOL ECOL, V63, P239, DOI 10.1016/0022-0981(82)90181-2
   BARLOW RG, 1980, J EXP MAR BIOL ECOL, V45, P83, DOI 10.1016/0022-0981(80)90071-4
   Carpenter E. J., 1980, PRIMARY PRODUCTIVITY, P161
   COOK JR, 1966, PLANT PHYSL, V42, P821
   Eppley RW, 1981, CAN B FISH AQUAT SCI, V210, P251
   GOLDMAN JC, 1981, MAR ECOL PROG SER, V6, P137, DOI 10.3354/meps006137
   HAMA J, 1986, RES ORG GEOCHEM, V5, P41
   HAMA T, 1987, IN PRESS DEEP SEA RE
   HAMA T, 1987, ARCH HYDROBIOL, V109, P107
   HAMA T, 1987, LIMNOL OCEANOGR, V35, P1146
   MYKLESTAD S, 1972, Journal of Experimental Marine Biology and Ecology, V9, P125, DOI 10.1016/0022-0981(72)90041-X
   HAUG A, 1973, Journal of Experimental Marine Biology and Ecology, V11, P15, DOI 10.1016/0022-0981(73)90016-6
   HITCHCOCK GL, 1983, J EXP MAR BIOL ECOL, V69, P21, DOI 10.1016/0022-0981(83)90170-3
   HITCHCOCK GL, 1980, MAR BIOL, V57, P271, DOI 10.1007/BF00387570
   Iizuka S., 1966, B FAC FISH NAGASAKI, V21, P67
   KONOPKA A, 1980, MICROBIAL ECOL, V6, P291, DOI 10.1007/BF02010492
   LEWIN JC, 1963, ANNU REV MICROBIOL, V17, P373, DOI 10.1146/annurev.mi.17.100163.002105
   MORRIS I, 1978, MAR BIOL, V47, P303
   Morris I., 1981, CAN B FISH AQUAT SCI, V210, P83
   MYKLESTA.S, 1974, J EXP MAR BIOL ECOL, V15, P261, DOI 10.1016/0022-0981(74)90049-5
   OTSUKI A, 1983, INT J MASS SPECTROM, V48, P343, DOI 10.1016/0020-7381(83)87098-3
   Parsons TR, 1984, MANUAL CHEM BIOL MET
   RIVKIN RB, 1985, MAR BIOL, V89, P135, DOI 10.1007/BF00392884
   SAKSHAUG E, 1977, J EXP MAR BIOL ECOL, V29, P1, DOI 10.1016/0022-0981(77)90118-6
NR 38
TC 17
Z9 17
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0981
J9 J EXP MAR BIOL ECOL
JI J. Exp. Mar. Biol. Ecol.
PD NOV 3
PY 1987
VL 112
IS 3
BP 251
EP 266
DI 10.1016/0022-0981(87)90072-4
PG 16
WC Ecology; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA K8499
UT WOS:A1987K849900004
ER

PT J
AU TANABE, T
   KONISHI, M
   MIZUTA, T
   NOMA, T
   HONJO, T
AF TANABE, T
   KONISHI, M
   MIZUTA, T
   NOMA, T
   HONJO, T
TI MOLECULAR-CLONING AND STRUCTURE OF THE HUMAN INTERLEUKIN-5 GENE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
RP TANABE, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR NAGATA S, 1986, EMBO J, V5, P575
   BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853
   FUJITA T, 1986, CELL, V46, P401, DOI 10.1016/0092-8674(86)90660-4
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3
   GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   FUJITA T, 1983, P NATL ACAD SCI-BIOL, V80, P7437, DOI 10.1073/pnas.80.24.7437
   FURUTANI Y, 1986, NUCLEIC ACIDS RES, V14, P3167, DOI 10.1093/nar/14.8.3167
   HAMAGUCHI Y, 1987, J EXP MED, V165, P268, DOI 10.1084/jem.165.1.268
   HOWARD M, 1984, IMMUNOL REV, V78, P185, DOI 10.1111/j.1600-065X.1984.tb00482.x
   KAUSHANSKY K, 1986, P NATL ACAD SCI USA, V83, P3101, DOI 10.1073/pnas.83.10.3101
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MIYATAKE S, 1985, P NATL ACAD SCI USA, V82, P316, DOI 10.1073/pnas.82.2.316
   MIYATAKE S, 1985, EMBO J, V4, P2561
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   OTSUKA T, 1987, NUCLEIC ACIDS RES, V15, P333, DOI 10.1093/nar/15.1.333
   Sabe H, 1984, Mol Biol Med, V2, P379
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SEVERINSON E, 1987, EUR J IMMUNOL, V17, P67, DOI 10.1002/eji.1830170112
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894
NR 31
TC 84
Z9 85
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 5
PY 1987
VL 262
IS 34
BP 16580
EP 16584
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA L1293
UT WOS:A1987L129300048
PM 2824500
ER

PT J
AU FUJITA, J
   NAKAYAMA, H
   ONOUE, H
   KANAKURA, Y
   NAKANO, T
   ASAI, H
   TAKEDA, SI
   HONJO, T
   KITAMURA, Y
AF FUJITA, J
   NAKAYAMA, H
   ONOUE, H
   KANAKURA, Y
   NAKANO, T
   ASAI, H
   TAKEDA, SI
   HONJO, T
   KITAMURA, Y
TI FIBROBLAST-DEPENDENT GROWTH OF MOUSE MAST-CELLS INVITRO - DUPLICATION OF
   MAST-CELL DEPLETION IN MUTANT MICE OF W/WV GENOTYPE
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
C1 SHIZUOKA LAB ANIM CTR,HAMAMATSU 435,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP FUJITA, J (reprint author), OSAKA UNIV,INST CANC RES,OSAKA 530,JAPAN.
CR TERTIAN G, 1981, J IMMUNOL, V127, P788
   NAPARSTEK E, 1986, BLOOD, V67, P1395
   GALLI SJ, 1984, PROG ALLERGY, V34, P1
   STEVENS RL, 1986, J IMMUNOL, V137, P291
   KITAMURA Y, 1978, BLOOD, V52, P447
   LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454
   COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9
   RAZIN E, 1981, P NATL ACAD SCI-BIOL, V78, P2559, DOI 10.1073/pnas.78.4.2559
   NABEL G, 1981, NATURE, V291, P332, DOI 10.1038/291332a0
   DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573
   NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0
   DAVIDSON S, 1983, IMMUNOLOGY, V48, P439
   DEXTER TM, 1977, NATURE, V269, P412, DOI 10.1038/269412a0
   ENERBACK L, 1974, HISTOCHEMISTRY, V42, P301, DOI 10.1007/BF00492678
   ENERBACK L, 1985, BIOCHEM J, V227, P661
   Enerback L., 1981, MONOGR ALLERGY, V17, P222
   FUNG MC, 1984, NATURE, V307, P233, DOI 10.1038/307233a0
   GINSBURG H, 1978, IMMUNOLOGY, V35, P485
   GINSBURG H, 1963, J NATL CANCER I, V31, P1
   GINSBURG H, 1982, IMMUNOLOGY, V45, P371
   HASTHORPE S, 1980, J CELL PHYSIOL, V105, P379, DOI 10.1002/jcp.1041050221
   JAINCHIL.JL, 1969, J VIROL, V4, P549
   KANAKURA Y, IN PRESS AM J PATHOL
   KELLER R, 1976, EXPERIENTIA, V32, P171, DOI 10.1007/BF01937747
   KITAMURA Y, 1985, INT ARCH ALLER A IMM, V77, P144
   KITAMURA Y, 1979, NATURE, V281, P154, DOI 10.1038/281154a0
   KOBAYASHI T, 1986, J IMMUNOL, V136, P1378
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LEE JC, 1982, J IMMUNOL, V128, P2393
   LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485
   LI CL, 1985, NATURE, V316, P633, DOI 10.1038/316633a0
   NAGAO K, 1981, SCIENCE, V212, P333, DOI 10.1126/science.7209531
   NAKAHATA T, 1982, BLOOD, V60, P352
   PIERCE JH, 1985, CELL, V41, P685, DOI 10.1016/S0092-8674(85)80049-0
   RAZIN E, 1982, J BIOL CHEM, V257, P7229
   RUITENBER EJ, 1976, NATURE, V264, P258, DOI 10.1038/264258a0
   SCHRADER JW, 1986, ANNU REV IMMUNOL, V4, P205, DOI 10.1146/annurev.immunol.4.1.205
   SCHRADER JW, 1981, P NATL ACAD SCI-BIOL, V78, P323, DOI 10.1073/pnas.78.1.323
   SMITH CA, 1986, P NATL ACAD SCI USA, V83, P1857, DOI 10.1073/pnas.83.6.1857
   SONODA T, 1984, J EXP MED, V160, P138, DOI 10.1084/jem.160.1.138
   SUDA T, 1985, J CELL PHYSIOL, V122, P187, DOI 10.1002/jcp.1041220204
   YUNG YP, 1982, J IMMUNOL, V129, P1256
NR 44
TC 79
Z9 79
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9541
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JAN
PY 1988
VL 134
IS 1
BP 78
EP 84
DI 10.1002/jcp.1041340109
PG 7
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA L7030
UT WOS:A1988L703000008
PM 3275680
ER

PT J
AU UEDA, S
   MATSUDA, F
   HONJO, T
AF UEDA, S
   MATSUDA, F
   HONJO, T
TI MULTIPLE RECOMBINATIONAL EVENTS IN PRIMATE IMMUNOGLOBULIN EPSILON-GENES
   AND ALPHA-GENES SUGGEST CLOSER RELATIONSHIP OF HUMANS TO CHIMPANZEES
   THAN TO GORILLAS
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP UEDA, S (reprint author), UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,TOKYO 113,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   MESSING J, 1983, METHOD ENZYMOL, V101, P20
   TUCKER PW, 1981, P NATL ACAD SCI-BIOL, V78, P7684, DOI 10.1073/pnas.78.12.7684
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9
   BATTEY J, 1982, P NATL ACAD SCI-BIOL, V79, P5956, DOI 10.1073/pnas.79.19.5956
   BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952
   ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   KOOP BF, 1986, NATURE, V319, P234, DOI 10.1038/319234a0
   KRAWINKEL U, 1982, EMBO J, V1, P403
   LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0
   LOENEN WAM, 1980, GENE, V20, P249
   MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4
   MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   TORANO A, 1978, P NATL ACAD SCI USA, V75, P966, DOI 10.1073/pnas.75.2.966
   UEDA S, 1985, P NATL ACAD SCI USA, V82, P3712, DOI 10.1073/pnas.82.11.3712
   UEDA S, 1982, EMBO J, V1, P1539
   UEDA S, 1986, COLD SPRING HARB SYM, V51, P429
NR 23
TC 33
Z9 33
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0022-2844
J9 J MOL EVOL
JI J. Mol. Evol.
PY 1988
VL 27
IS 1
BP 77
EP 83
DI 10.1007/BF02099732
PG 7
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA M4905
UT WOS:A1988M490500009
PM 3133489
ER

PT J
AU NISHI, M
   ISHIDA, Y
   HONJO, T
AF NISHI, M
   ISHIDA, Y
   HONJO, T
TI EXPRESSION OF FUNCTIONAL INTERLEUKIN-2 RECEPTORS IN HUMAN LIGHT CHAIN
   TAC TRANSGENIC MICE
SO NATURE
LA English
DT Article
RP NISHI, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   BOLTON AE, 1973, BIOCHEM J, V133, P529
   MIYOSHI I, 1980, GANN, V71, P155
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   CREDIG R, 1985, NATURE, V314, P98
   DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   Hogan B, 1986, MANIPULATING MOUSE E
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   KVIST S, 1983, EMBO J, V2, P245
   LIFSON J, 1986, J BIOL RESP MODIF, V5, P61
   LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0
   Maniatis T., 1982, MOL CLONING
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OGURA T, IN PRESS MOL BIOL ME
   RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   VONBOEHMER H, 1985, NATURE, V314, P539, DOI 10.1038/314539a0
NR 24
TC 79
Z9 79
U1 0
U2 0
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD JAN 21
PY 1988
VL 331
IS 6153
BP 267
EP 269
DI 10.1038/331267a0
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA L7140
UT WOS:A1988L714000064
PM 2827038
ER

PT J
AU SIDERAS, P
   NOMA, T
   HONJO, T
AF SIDERAS, P
   NOMA, T
   HONJO, T
TI STRUCTURE AND FUNCTION OF INTERLEUKIN-4 AND INTERLEUKIN-5
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review
RP SIDERAS, P (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ALBALAGHI S, 1984, IMMUNOL REV, V78, P7, DOI 10.1111/j.1600-065X.1984.tb00474.x
   ANDERSSO.J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410
   DEFRANCE T, 1987, J EXP MED, V165, P1459, DOI 10.1084/jem.165.6.1459
   ZUBLER RH, 1984, J EXP MED, V160, P1170, DOI 10.1084/jem.160.4.1170
   CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   OHARA J, 1987, NATURE, V325, P537, DOI 10.1038/325537a0
   VITETTA ES, 1984, IMMUNOL REV, V78, P137, DOI 10.1111/j.1600-065X.1984.tb00480.x
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   AUGUSTIN AA, 1980, J EXP MED, V151, P587, DOI 10.1084/jem.151.3.587
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   BERGSTEDTLINDQV.S, 1984, IMMUNOL REV, V78, P26
   CORBEL C, 1984, IMMUNOL REV, V78, P51, DOI 10.1111/j.1600-065X.1984.tb00476.x
   DEFRANCE T, 1987, J IMMUNOL, V139, P1135
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   FERRAR J, 1983, J IMMUNOL, V131, P1838
   GARLAND JM, 1984, LYMPHOKINES, V9, P153
   GOSPODAROWICZ D, 1976, ANNU REV BIOCHEM, V45, P531, DOI 10.1146/annurev.bi.45.070176.002531
   GRABSTEIN K, 1986, J EXP MED, V163, P1405, DOI 10.1084/jem.163.6.1405
   HAMAGUCHI Y, 1987, J EXP MED, V165, P268, DOI 10.1084/jem.165.1.268
   HARADA N, 1987, IMMUNOL LETT, V15, P205, DOI 10.1016/0165-2478(87)90026-5
   HOWARD M, 1981, P NATL ACAD SCI-BIOL, V78, P5788, DOI 10.1073/pnas.78.9.5788
   HOWARD M, 1984, IMMUNOL REV, V78, P185, DOI 10.1111/j.1600-065X.1984.tb00482.x
   HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   KEARNEY JF, 1979, B LYMPHOCYTES IMMUNE, V3
   KEHRL JH, 1984, IMMUNOL RES, V78
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KISHIMOTO T, 1984, IMMUNOL REV, V78, P97, DOI 10.1111/j.1600-065X.1984.tb00478.x
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MARTINEZALONSO C, 1980, EUR J IMMUNOL, V10, P698, DOI 10.1002/eji.1830100908
   OHARA J, 1985, J IMMUNOL, V135, P2518
   OKAYAMA H, 1983, MOL CELL BIOL, V3, P280
   OTSUKA T, 1987, NUCLEIC ACIDS RES, V15, P333, DOI 10.1093/nar/15.1.333
   PALACIOS R, 1987, EMBO J, V6, P91
   PARKER DC, 1980, IMMUNOL REV, V52, P115, DOI 10.1111/j.1600-065X.1980.tb00333.x
   PERLMUTTER RM, 1987, J IMMUNOL, V121, P566
   PRIMI D, 1982, J EXP MED, V156, P181, DOI 10.1084/jem.156.1.181
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SCHRADER JW, 1985, CONTEMP TOP MOLEC IM, V10, P121
   SEVERINSON E, 1987, EUR J IMMUNOL, V17, P67, DOI 10.1002/eji.1830170112
   SEVERINSONGRONOWICZ E, 1979, J IMMUNOL, V123, P2049
   SIDERAS P, 1987, EUR J IMMUNOL, V17, P217, DOI 10.1002/eji.1830170211
   SIDERAS P, 1987, IN PRESS P NATL ACAD
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P586, DOI 10.1002/eji.1830150611
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P594
   SIDERAS P, 1987, MECHANISMS LYMPHOCYT
   SJOBERG O, 1972, J IMMUNOL, V109, P1379
   SLACK J, 1980, J EXP MED, V151, P853, DOI 10.1084/jem.151.4.853
   SPITS H, 1987, J IMMUNOL, V139, P1142
   SVEDERSKY LP, 1984, J EXP MED, V159, P812, DOI 10.1084/jem.159.3.812
   SWAIN SL, 1981, P NATL ACAD SCI-BIOL, V78, P2517, DOI 10.1073/pnas.78.4.2517
   SWAIN SL, 1983, J EXP MED, V158, P822, DOI 10.1084/jem.158.3.822
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TANABE T, 1987, J BIOL CHEM, V262, P16580
   VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726
   WOOD CD, 1984, J IMMUNOL, V132, P616
   ZLOTNIK A, 1983, J IMMUNOL, V131, P794
NR 64
TC 41
Z9 41
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0105-2896
J9 IMMUNOL REV
JI Immunol. Rev.
PD FEB
PY 1988
VL 102
BP 189
EP 210
DI 10.1111/j.1600-065X.1988.tb00745.x
PG 22
WC Immunology
SC Immunology
GA M9195
UT WOS:A1988M919500007
PM 3284814
ER

PT J
AU OKAZAKI, M
   NISHISHO, I
   TATEISHI, H
   MOTOMURA, K
   YAMAMOTO, M
   MIKI, T
   HAYAKAWA, T
   TAKAI, S
   HONJO, T
   MORI, T
AF OKAZAKI, M
   NISHISHO, I
   TATEISHI, H
   MOTOMURA, K
   YAMAMOTO, M
   MIKI, T
   HAYAKAWA, T
   TAKAI, S
   HONJO, T
   MORI, T
TI LOSS OF GENES ON THE LONG ARM OF CHROMOSOME-22 IN HUMAN MENINGIOMAS
SO MOLECULAR BIOLOGY & MEDICINE
LA English
DT Article
C1 OSAKA UNIV,DEPT SURG 2,1-1-50 FUKUSHIMA,OSAKA 553,JAPAN.
   OSAKA UNIV,DEPT MED & GERIAT,OSAKA 553,JAPAN.
   OSAKA UNIV,DEPT NEUROSURG,OSAKA 553,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0
   SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0
   SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419
   ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0
   BOLGER GB, 1985, NEW ENGL J MED, V312, P564, DOI 10.1056/NEJM198502283120907
   DOZIER C, 1986, NUCLEIC ACIDS RES, V14, P1928, DOI 10.1093/nar/14.4.1928
   KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0
   LITT M, 1987, NUCLEIC ACIDS RES, V15, P2783, DOI 10.1093/nar/15.6.2783
   LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372
   NISHISHO I, 1986, JPN J HUM GENET, V31, P249, DOI 10.1007/BF01870755
   NISHISHO I, 1987, JPN J HUM GENET, V32, P1, DOI 10.1007/BF01876521
   SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060
   SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0
   WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180
   ZANG KD, 1982, CANCER GENET CYTOGEN, V6, P249, DOI 10.1016/0165-4608(82)90063-2
   ZANKL H, 1972, HUMANGENETIK, V14, P167, DOI 10.1007/BF00273305
NR 16
TC 18
Z9 18
U1 0
U2 0
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0735-1313
J9 MOL BIOL MED
PD FEB
PY 1988
VL 5
IS 1
BP 15
EP 22
PG 8
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA M9125
UT WOS:A1988M912500002
PM 2897611
ER

PT J
AU NAKANISHI, K
   YOSHIMOTO, T
   KATOH, Y
   ONO, S
   MATSUI, K
   HIROISHI, K
   NOMA, T
   HONJO, T
   TAKATSU, K
   HIGASHINO, K
   HAMAOKA, T
AF NAKANISHI, K
   YOSHIMOTO, T
   KATOH, Y
   ONO, S
   MATSUI, K
   HIROISHI, K
   NOMA, T
   HONJO, T
   TAKATSU, K
   HIGASHINO, K
   HAMAOKA, T
TI BOTH B151-T-CELL REPLACING FACTOR-I AND IL-5 REGULATE IG SECRETION AND
   IL-2 RECEPTOR EXPRESSION ON A CLONED B-LYMPHOMA LINE
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 OSAKA UNIV,SCH MED,INST CANC RES,FUKUSHIMA KU,OSAKA 553,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,KUMAMOTO 860,JAPAN.
RP NAKANISHI, K (reprint author), HYOGO COLL MED,DEPT INTERNAL MED 3,NISHINOMIYA,HYOGO 663,JAPAN.
CR TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2
   Dutton RW, 1971, PROG IMMUNOL, V1, P355, DOI 10.1016/B978-0-12-057550-3.50033-8
   HAMAOKA T, 1986, ANNU REV IMMUNOL, V4, P167, DOI 10.1146/annurev.immunol.4.1.167
   HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HARADA N, 1987, IMMUNOL LETT, V15, P205, DOI 10.1016/0165-2478(87)90026-5
   HOWARD M, 1984, IMMUNOL REV, V78, P185, DOI 10.1111/j.1600-065X.1984.tb00482.x
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KISHIMOT.T, 1973, J IMMUNOL, V111, P1194
   KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P135
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LOUGHNAN MS, 1987, P NATL ACAD SCI USA, V84, P5399, DOI 10.1073/pnas.84.15.5399
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   NAKANISHI K, 1983, J IMMUNOL, V130, P2219
   NAKANISHI K, 1984, J EXP MED, V160, P1736, DOI 10.1084/jem.160.6.1736
   NAKANISHI K, 1987, J IMMUNOL, V138, P1817
   NAKANISHI K, 1984, J EXP MED, V160, P1605, DOI 10.1084/jem.160.6.1605
   ONO S, 1986, J IMMUNOL, V137, P187
   PARKER DC, 1982, J IMMUNOL, V129, P469
   SWAIN SL, 1982, J EXP MED, V156, P1821, DOI 10.1084/jem.156.6.1821
   SWAIN SL, 1985, J IMMUNOL, V134, P3934
   TAKAHAMA Y, 1985, J IMMUNOL, V135, P2534
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   TOMASKA LD, 1981, EUR J IMMUNOL, V11, P181, DOI 10.1002/eji.1830110305
   WALDMANN TA, 1984, J EXP MED, V160, P1450, DOI 10.1084/jem.160.5.1450
   YOSHIZAKI K, 1982, J IMMUNOL, V128, P1296
NR 32
TC 28
Z9 28
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD FEB 15
PY 1988
VL 140
IS 4
BP 1168
EP 1174
PG 7
WC Immunology
SC Immunology
GA M2992
UT WOS:A1988M299200026
PM 3125248
ER

PT J
AU MATSUDA, F
   LEE, KH
   NAKAI, S
   SATO, T
   KODAIRA, M
   ZONG, SQ
   OHNO, H
   FUKUHARA, S
   HONJO, T
AF MATSUDA, F
   LEE, KH
   NAKAI, S
   SATO, T
   KODAIRA, M
   ZONG, SQ
   OHNO, H
   FUKUHARA, S
   HONJO, T
TI DISPERSED LOCALIZATION OF D-SEGMENTS IN THE HUMAN-IMMUNOGLOBULIN
   HEAVY-CHAIN LOCUS
SO EMBO JOURNAL
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED,SAKYO KU,KYOTO 606,JAPAN.
   OSAKA UNIV,SCH MED,DEPT GENET,TOYONAKA,OSAKA 560,JAPAN.
RP MATSUDA, F (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   HINDS KR, 1986, NATURE, V320, P546, DOI 10.1038/320546a0
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764
   KENTEN JH, 1982, P NATL ACAD SCI-BIOL, V79, P6661, DOI 10.1073/pnas.79.21.6661
   DEUSTACHIO P, 1980, J EXP MED, V151, P1545, DOI 10.1084/jem.151.6.1545
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HONJO T, 1979, CELL, V18, P559, DOI 10.1016/0092-8674(79)90072-2
   HONJO T, 1981, IMMUNOL REV, V59, P33, DOI 10.1111/j.1600-065X.1981.tb00455.x
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   MANIATIS T, 1982, MOL CLONING LABORATO
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   OTSU M, 1987, MOL CELL BIOL, V7, P708
   POUSTKA A, 1987, NATURE, V325, P353, DOI 10.1038/325353a0
   PURRELLO M, 1987, CYTOGENET CELL GENET, V44, P32, DOI 10.1159/000132337
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WOOD C, 1983, P NATL ACAD SCI-BIOL, V80, P3030, DOI 10.1073/pnas.80.10.3030
   ZONG SQ, 1988, IN PRESS IMMUNOL LET
NR 26
TC 99
Z9 100
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD APR
PY 1988
VL 7
IS 4
BP 1047
EP 1051
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA M8861
UT WOS:A1988M886100022
PM 2841108
ER

PT J
AU SHINKAI, Y
   NAKAUCHI, H
   HONJO, T
   OKUMURA, K
AF SHINKAI, Y
   NAKAUCHI, H
   HONJO, T
   OKUMURA, K
TI MOUSE IMMUNOGLOBULIN ALLOTYPES - MULTIPLE DIFFERENCES BETWEEN THE
   NUCLEIC-ACID SEQUENCES OF THE IGEA AND IGEB ALLELES
SO IMMUNOGENETICS
LA English
DT Article
C1 JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,2-1-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.
   RIKEN,INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,FRONTIER RES PROGRAM,MOLEC REGULAT AGING LAB,IBARAKI 305,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Shinkai, Yoichi/N-3909-2014
OI Shinkai, Yoichi/0000-0002-6051-2484
CR YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   LIU FT, 1982, P NATL ACAD SCI-BIOL, V79, P7852, DOI 10.1073/pnas.79.24.7852
   ISHIDA N, 1982, EMBO J, V1, P1117
   CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   BORGES MS, 1981, IMMUNOGENETICS, V13, P499, DOI 10.1007/BF00343718
   DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8
   DOGNIN MJ, 1981, P NATL ACAD SCI-BIOL, V78, P4031, DOI 10.1073/pnas.78.7.4031
   MANIATIS T, 1983, MOL CLONING LABORATO, P1
   OLLO R, 1982, NATURE, V296, P761, DOI 10.1038/296761a0
   OLLO R, 1983, CELL, V32, P515, DOI 10.1016/0092-8674(83)90471-3
   PARSONS M, 1986, HDB EXPT IMMUNOLOGY, pCH97
   SCHREIER PH, 1986, NUCLEIC ACIDS RES, V14, P2381, DOI 10.1093/nar/14.5.2381
   SCHREIER PH, 1981, P NATL ACAD SCI-BIOL, V78, P4495, DOI 10.1073/pnas.78.7.4495
NR 14
TC 14
Z9 14
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0093-7711
J9 IMMUNOGENETICS
JI Immunogenetics
PD APR
PY 1988
VL 27
IS 4
BP 288
EP 292
DI 10.1007/BF00376124
PG 5
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA M1647
UT WOS:A1988M164700008
PM 3346043
ER

PT J
AU ZONG, SQ
   NAKAI, S
   MATSUDA, F
   LEE, KH
   HONJO, T
AF ZONG, SQ
   NAKAI, S
   MATSUDA, F
   LEE, KH
   HONJO, T
TI HUMAN IMMUNOGLOBULIN-D SEGMENTS - ISOLATION OF A NEW D-SEGMENT AND
   POLYMORPHIC DELETION OF THE D1-SEGMENT
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   OSAKA UNIV,SCH MED,DEPT GENET,OSAKA 560,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   Noma Y, 1984, Mol Biol Med, V2, P337
   OHNO H, 1986, CANCER RES, V46, P6400
   OHTSU M, 1987, MOL CELL BIOL, V7, P708
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SIEBENLIST U, 1981, NATURE, V294, P632
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 11
TC 29
Z9 29
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD APR
PY 1988
VL 17
IS 4
BP 329
EP 333
PG 5
WC Immunology
SC Immunology
GA N3754
UT WOS:A1988N375400006
PM 3372011
ER

PT J
AU MIWA, H
   NOSAKA, T
   KITA, K
   OHNO, T
   MATSUOKA, N
   SHIRAKAWA, S
   ARITA, Y
   DOI, S
   NISHIKORI, M
   HONJO, T
   HATANAKA, M
AF MIWA, H
   NOSAKA, T
   KITA, K
   OHNO, T
   MATSUOKA, N
   SHIRAKAWA, S
   ARITA, Y
   DOI, S
   NISHIKORI, M
   HONJO, T
   HATANAKA, M
TI IMMUNOGENOTYPES OF LYMPHOID MALIGNANCIES - THE REARRANGEMENT OF T-CELL
   RECEPTOR BETA-CHAIN GENE CAN OCCUR BEFORE THE GAMMA-CHAIN GENE
   REARRANGEMENT
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
C1 MIE UNIV,FAC MED,DEPT INTERNAL MED 2,2-174 ENDOBASHI,TSU,MIE 514,JAPAN.
   KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED 1,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM 1,KYOTO 606,JAPAN.
CR BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0
   REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588
   DAVEY MP, 1986, P NATL ACAD SCI USA, V83, P8759, DOI 10.1073/pnas.83.22.8759
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0
   BORN W, 1986, SCIENCE, V234, P479, DOI 10.1126/science.3020688
   BORST J, 1987, NATURE, V325, P683, DOI 10.1038/325683a0
   BRENNER MB, 1987, NATURE, V325, P689, DOI 10.1038/325689a0
   GOORHA R, 1987, P NATL ACAD SCI USA, V84, P4547, DOI 10.1073/pnas.84.13.4547
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   KITA K, 1985, BLOOD, V66, P47
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   LEFRANC MP, 1985, NATURE, V316, P464, DOI 10.1038/316464a0
   Miwa H, 1987, J Mol Cell Immunol, V3, P37
   NADLER LM, 1984, J CLIN INVEST, V74, P332, DOI 10.1172/JCI111428
   ROYER HD, 1984, CELL, V39, P261, DOI 10.1016/0092-8674(84)90003-5
   ROYER HD, 1985, P NATL ACAD SCI USA, V82, P5510, DOI 10.1073/pnas.82.16.5510
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
NR 20
TC 9
Z9 9
U1 0
U2 0
PU JAPANESE CANCER ASSOCIATION
PI TOKYO
PA EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PD APR
PY 1988
VL 79
IS 4
BP 484
EP 490
PG 7
WC Oncology
SC Oncology
GA N5978
UT WOS:A1988N597800012
PM 3133337
ER

PT J
AU OGURA, T
   KONISHI, M
   SUZUKI, N
   KONDO, S
   SABE, H
   HONJO, T
AF OGURA, T
   KONISHI, M
   SUZUKI, N
   KONDO, S
   SABE, H
   HONJO, T
TI MOLECULAR MECHANISM FOR THE FORMATION OF THE HIGH-AFFINITY COMPLEX OF
   INTERLEUKIN-2 AND ITS RECEPTOR
SO MOLECULAR BIOLOGY & MEDICINE
LA English
DT Article
RP OGURA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864
   SHIMIZU A, 1986, IMMUNOL REV, V92, P103, DOI 10.1111/j.1600-065X.1986.tb01496.x
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   NILSEN TW, 1985, CELL, V41, P719, DOI 10.1016/S0092-8674(85)80052-0
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0
   FUJII M, 1986, J IMMUNOL, V137, P1552
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   KOYASU S, 1986, J IMMUNOL, V136, P984
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MILLER J, 1985, J IMMUNOL, V134, P4212
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NISHI M, 1988, IN PRESS NATURE LOND
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   ROBB RJ, 1986, P NATL ACAD SCI USA, V83, P3992, DOI 10.1073/pnas.83.11.3992
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHACKELFORD DA, 1986, EMBO J, V5, P3275
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
NR 38
TC 12
Z9 13
U1 0
U2 1
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0735-1313
J9 MOL BIOL MED
PD APR
PY 1988
VL 5
IS 2
BP 123
EP 138
PG 16
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA N7169
UT WOS:A1988N716900006
PM 3135461
ER

PT J
AU ENOKIHARA, H
   NAGASHIMA, S
   NOMA, T
   KAJITANI, H
   HAMAGUCHI, H
   SAITO, K
   FURUSAWA, S
   SHISHIDO, H
   HONJO, T
AF ENOKIHARA, H
   NAGASHIMA, S
   NOMA, T
   KAJITANI, H
   HAMAGUCHI, H
   SAITO, K
   FURUSAWA, S
   SHISHIDO, H
   HONJO, T
TI EFFECT OF HUMAN RECOMBINANT INTERLEUKIN-5 AND G-CSF ON EOSINOPHIL COLONY
   FORMATION
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP ENOKIHARA, H (reprint author), DOKKYO UNIV,SCH MED,DEPT INTERNAL MED 3,880 KITAKOBAYASHI,MIBU,TOCHIGI 32102,JAPAN.
CR SANDERSON CJ, 1985, J EXP MED, V162, P60, DOI 10.1084/jem.162.1.60
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   BARTELMEZ SH, 1980, BLOOD, V55, P489
   CAMPBELL HD, 1987, P NATL ACAD SCI USA, V84, P6629, DOI 10.1073/pnas.84.19.6629
   ENOKIHARA H, 1985, BRIT J HAEMATOL, V59, P85, DOI 10.1111/j.1365-2141.1985.tb02967.x
   ENOKIHARA H, 1988, IN PRESS BRIT J HAEM
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KONWALINKA G, 1980, EXP HEMATOL, V8, P434
   METCALF D, 1986, BLOOD, V67, P37
   SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437
   SUDA T, 1987, EXP HEMATOL, V15, P958
   SUDA T, 1983, P NATL ACAD SCI-BIOL, V80, P6689, DOI 10.1073/pnas.80.21.6689
   YAMAGUCHI Y, COMMUNICATION
NR 13
TC 19
Z9 19
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD MAY
PY 1988
VL 18
IS 1
BP 73
EP 76
DI 10.1016/0165-2478(88)90073-9
PG 4
WC Immunology
SC Immunology
GA N7284
UT WOS:A1988N728400014
PM 3259945
ER

PT J
AU TOMINAGA, N
   KATAGIRI, S
   HAMAGUCHI, Y
   NISHIURA, T
   KANAKURA, Y
   KANAYAMA, Y
   NAGAO, K
   KAKIUCHI, Y
   NISHIDA, K
   ABE, T
   HONJO, T
   YONEZAWA, T
   TARUI, S
AF TOMINAGA, N
   KATAGIRI, S
   HAMAGUCHI, Y
   NISHIURA, T
   KANAKURA, Y
   KANAYAMA, Y
   NAGAO, K
   KAKIUCHI, Y
   NISHIDA, K
   ABE, T
   HONJO, T
   YONEZAWA, T
   TARUI, S
TI PLASMA-CELL LEUKEMIA OF NON-PRODUCER TYPE WITH MISSING LIGHT CHAIN GENE
   REARRANGEMENT
SO BRITISH JOURNAL OF HAEMATOLOGY
LA English
DT Article
C1 SENTO HOSP,OSAKA,JAPAN.
   KYOTO PREFECTURAL UNIV MED,DEPT INTERNAL MED 3,KYOTO 602,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP TOMINAGA, N (reprint author), OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,1-1-50 FUKUSHIMA,FUKUSHIMA KU,OSAKA 553,JAPAN.
CR JOYNER MV, 1979, BRIT J HAEMATOL, V43, P559, DOI 10.1111/j.1365-2141.1979.tb03788.x
   KYLE RA, 1975, MAYO CLIN PROC, V50, P29
   SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459
   KORSMEYER SJ, 1983, J CLIN INVEST, V71, P301, DOI 10.1172/JCI110770
   DEWALD GW, 1985, BLOOD, V66, P380
   ROWLEY JD, 1982, SCIENCE, V216, P749, DOI 10.1126/science.7079737
   LIANG W, 1979, CANCER, V44, P630
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   DJALDETTI M, 1984, HUMAN LEUKEMIAS CYTO, P309
   FERRARIS AM, 1979, ACTA HAEMATOL-BASEL, V62, P257
   FERTI A, 1984, CANCER GENET CYTOGEN, V12, P247, DOI 10.1016/0165-4608(84)90036-0
   FRANCHI F, 1986, BLUT, V52, P281, DOI 10.1007/BF00320791
   GALE RP, 1987, BRIT J HAEMATOL, V65, P261, DOI 10.1111/j.1365-2141.1987.tb06851.x
   KANAYAMA Y, 1983, ACTA HAEMATOL-BASEL, V70, P220
   KATAGIRI S, 1985, INT J CANCER, V36, P241, DOI 10.1002/ijc.2910360217
   KATAGIRI S, 1983, BLUT, V46, P73, DOI 10.1007/BF00320661
   KATAGIRI S, 1984, ACTA HAEMATOL-BASEL, V72, P372
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   KUBAGAWA H, 1979, J EXP MED, V150, P792, DOI 10.1084/jem.150.4.792
   Lewis J P, 1984, Hematol Oncol, V2, P307
   MAEKAWA T, 1984, BLOOD, V63, P310
   MELLSTEDT H, 1976, SCAND J HAEMATOL, V16, P112
   MELLSTED.H, 1974, CLIN EXP IMMUNOL, V17, P371
   NAGAI K, 1981, SCAND J IMMUNOL, V14, P99, DOI 10.1111/j.1365-3083.1981.tb00189.x
   PARREIRA A, 1985, SCAND J HAEMATOL, V35, P570
   PHILIP P, 1980, CANCER GENET CYTOGEN, V2, P243, DOI 10.1016/0165-4608(80)90031-X
   PHILIP P, 1980, HEREDITAS, V93, P185
   SANDBERG AA, 1981, HUM PATHOL, V12, P531, DOI 10.1016/S0046-8177(81)80067-6
   San Miguel J F, 1986, Br J Haematol, V62, P75
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   WALDMANN TA, 1985, ANN INTERN MED, V102, P497
   WANG HC, 1972, NATURE-NEW BIOL, V235, P52
   WEST WH, 1977, J IMMUNOL, V119, P548
   YONEZAWA T, 1982, BLUT, V45, P121, DOI 10.1007/BF00319940
NR 34
TC 19
Z9 19
U1 1
U2 1
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0007-1048
J9 BRIT J HAEMATOL
JI Br. J. Haematol.
PD JUN
PY 1988
VL 69
IS 2
BP 213
EP 218
DI 10.1111/j.1365-2141.1988.tb07624.x
PG 6
WC Hematology
SC Hematology
GA N7331
UT WOS:A1988N733100010
PM 3134042
ER

PT J
AU MATSUDA, F
   LEE, KH
   NAKAI, S
   SATO, T
   ZONG, SQ
   HONJO, T
AF MATSUDA, F
   LEE, KH
   NAKAI, S
   SATO, T
   ZONG, SQ
   HONJO, T
TI ORGANIZATION OF HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN GENES
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
   OSAKA UNIV,SCH MED,DEPT GENET,OSAKA,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD JUN
PY 1988
VL 33
IS 2
BP 235
EP 235
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA P2106
UT WOS:A1988P210600055
ER

PT J
AU NOSAKA, T
   OHNO, H
   DOI, S
   FUKUHARA, S
   MIWA, H
   KITA, K
   SHIRAKAWA, S
   HONJO, T
   HATANAKA, M
AF NOSAKA, T
   OHNO, H
   DOI, S
   FUKUHARA, S
   MIWA, H
   KITA, K
   SHIRAKAWA, S
   HONJO, T
   HATANAKA, M
TI PHENOTYPIC CONVERSION OF T-LYMPHOBLASTIC LYMPHOMA TO ACUTE BIPHENOTYPIC
   LEUKEMIA COMPOSED OF LYMPHOBLASTS AND MYELOBLASTS - MOLECULAR
   GENETIC-EVIDENCE OF THE SAME CLONAL ORIGIN
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
C1 KYOTO UNIV,INST VIRUS RES,DEPT SEROL & IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DIV INTERNAL MED 1,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   MIE UNIV,FAC MED,DEPT INTERNAL MED 2,TSU,MIE 514,JAPAN.
CR BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x
   STASS S, 1984, BLOOD, V64, P701
   OGAWA M, 1983, BLOOD, V61, P823
   REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588
   GREAVES MF, 1986, BLOOD, V67, P1
   LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0
   HERRMANN R, 1980, CANCER, V46, P1383, DOI 10.1002/1097-0142(19800915)46:6<1383::AID-CNCR2820460616>3.0.CO;2-Y
   HERSHFIELD MS, 1984, P NATL ACAD SCI-BIOL, V81, P253, DOI 10.1073/pnas.81.1.253
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   KITA K, 1985, BLOOD, V66, P47
   KJELDSBERG CR, 1979, CANCER, V44, P2316, DOI 10.1002/1097-0142(197912)44:6<2316::AID-CNCR2820440647>3.0.CO;2-6
   KOBAYASHI N, 1984, EMBO J, V3, P1339
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   LEFRANC MP, 1985, NATURE, V316, P464, DOI 10.1038/316464a0
   MINDEN MD, 1985, P NATL ACAD SCI USA, V82, P1224, DOI 10.1073/pnas.82.4.1224
   Miwa H, 1987, J Mol Cell Immunol, V3, P37
   MURPHY SB, 1983, BRIT J HAEMATOL, V55, P285, DOI 10.1111/j.1365-2141.1983.tb01249.x
   NATHWANI BN, 1976, CANCER, V38, P964, DOI 10.1002/1097-0142(197608)38:2<964::AID-CNCR2820380248>3.0.CO;2-V
   OHNO H, 1986, INT J CANCER, V37, P761, DOI 10.1002/ijc.2910370518
   PALUMBO A, 1984, BLOOD, V64, P1059
   PERENTESIS J, 1983, J PEDIATR-US, V102, P63, DOI 10.1016/S0022-3476(83)80288-1
   POSNER MR, 1982, CANCER, V50, P118, DOI 10.1002/1097-0142(19820701)50:1<118::AID-CNCR2820500122>3.0.CO;2-8
   SOBOL RE, 1985, BLOOD, V65, P730
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   UEDA T, 1984, LEUKEMIA RES, V8, P63, DOI 10.1016/0145-2126(84)90032-8
   ZARRABI MH, 1983, CANCER, V52, P1712, DOI 10.1002/1097-0142(19831101)52:9<1712::AID-CNCR2820520927>3.0.CO;2-I
NR 27
TC 29
Z9 30
U1 0
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0021-9738
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUN
PY 1988
VL 81
IS 6
BP 1824
EP 1828
DI 10.1172/JCI113526
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA N9256
UT WOS:A1988N925600026
PM 2838522
ER

PT J
AU KINASHI, T
   INABA, K
   TSUBATA, T
   TASHIRO, K
   PALACIOS, R
   HONJO, T
AF KINASHI, T
   INABA, K
   TSUBATA, T
   TASHIRO, K
   PALACIOS, R
   HONJO, T
TI DIFFERENTIATION OF AN INTERLEUKIN 3-DEPENDENT PRECURSOR B-CELL CLONE
   INTO IMMUNOGLOBULIN-PRODUCING CELLS-INVITRO
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT INTERNAL MED,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.
RP KINASHI, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   NUSSENZWEIG MC, 1980, J EXP MED, V151, P1196, DOI 10.1084/jem.151.5.1196
   SPALDING DM, 1986, CELL, V44, P507, DOI 10.1016/0092-8674(86)90472-1
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8
   WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   Coffman R L, 1982, Immunol Rev, V69, P5
   COLECLOUGH C, 1983, NATURE, V303, P23, DOI 10.1038/303023a0
   GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KINCADE PW, 1976, J EXP MED, V143, P1265, DOI 10.1084/jem.143.5.1265
   MAKMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414
   NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976
   PALACIOS R, 1987, EMBO J, V6, P3687
   SARMIENTO M, 1982, IMMUNOL REV, V68, P135, DOI 10.1111/j.1600-065X.1982.tb01063.x
   SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Takahashi N., 1981, Immunoglobulin idiotypes., P123
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WINOTO A, 1985, NATURE, V316, P832, DOI 10.1038/316832a0
   YAMAWAKIKATAOKA Y, 1980, NATURE, V283, P786, DOI 10.1038/283786a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 33
TC 62
Z9 62
U1 0
U2 1
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN
PY 1988
VL 85
IS 12
BP 4473
EP 4477
DI 10.1073/pnas.85.12.4473
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA N9869
UT WOS:A1988N986900077
PM 3260035
ER

PT J
AU SATO, T
   MATSUDA, F
   KWANG, HL
   EUY, KS
   HONJO, T
AF SATO, T
   MATSUDA, F
   KWANG, HL
   EUY, KS
   HONJO, T
TI PHYSICAL LINKAGE OF A VARIABLE REGION SEGMENT AND THE JOINING REGION
   SEGMENT OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
RP SATO, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   RETH MG, 1986, EMBO J, V5, P2131
   BERMAN JE, 1988, EMBO J, V7, P727
   GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   MATSUDA F, 1988, EMBO J, V7, P1047
   NISHI M, 1985, P NATL ACAD SCI USA, V82, P6399, DOI 10.1073/pnas.82.19.6399
   RATHBUN GA, 1987, EMBO J, V6, P2931
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   ZONG SQ, 1988, IMMUNOL LETT, V17, P329
NR 16
TC 16
Z9 16
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 15
PY 1988
VL 154
IS 1
BP 265
EP 271
DI 10.1016/0006-291X(88)90679-1
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA P2389
UT WOS:A1988P238900039
PM 2840067
ER

PT J
AU MAEDA, M
   NOMA, T
   HAMA, K
   HONJO, T
AF MAEDA, M
   NOMA, T
   HAMA, K
   HONJO, T
TI APPLICATION OF A HUMAN T-CELL LINE DERIVED FROM A SEZARY SYNDROME
   PATIENT FOR HUMAN INTERLEUKIN-4 ASSAY
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   ONO PHARMACEUT CO LTD,MISHIMA,OSAKA 618,JAPAN.
RP MAEDA, M (reprint author), KYOTO UNIV,FAC MED,CHEST DIS RES INST,SAKYO KU,KYOTO 606,JAPAN.
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   CONLON PJ, 1983, J IMMUNOL, V131, P1280
   DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036
   FERNANDEZBOTRAN R, 1986, J EXP MED, V164, P580, DOI 10.1084/jem.164.2.580
   FURUTANI Y, 1985, NUCLEIC ACIDS RES, V13, P5869, DOI 10.1093/nar/13.16.5869
   GRABSTEIN K, 1986, J EXP MED, V163, P1405, DOI 10.1084/jem.163.6.1405
   HO SN, 1987, J IMMUNOL METHODS, V98, P99, DOI 10.1016/0022-1759(87)90441-8
   IKAI K, 1987, ARCH DERMATOL, V123, P1351, DOI 10.1001/archderm.123.10.1351
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MOSMANN TR, 1987, J IMMUNOL, V138, P1813
   MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654
   NAMIUCHI S, 1986, J IMMUNOL METHODS, V94, P215, DOI 10.1016/0022-1759(86)90236-X
   NOMA T, 1987, IMMUNOL LETT, V15, P249, DOI 10.1016/0165-2478(87)90032-0
   ROEHM NW, 1984, J EXP MED, V160, P679, DOI 10.1084/jem.160.3.679
   ROSEN A, 1986, LYMPHOKINE RES, V5, P185
   SEVERINSON E, 1987, EUR J IMMUNOL, V17, P67, DOI 10.1002/eji.1830170112
   SIDERAS P, 1985, EUR J IMMUNOL, V15, P586, DOI 10.1002/eji.1830150611
   VIETTA ES, 1984, IMMUNOL REV, V78, P137
   YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894
NR 30
TC 19
Z9 19
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD AUG
PY 1988
VL 18
IS 4
BP 247
EP 253
DI 10.1016/0165-2478(88)90170-8
PG 7
WC Immunology
SC Immunology
GA Q1265
UT WOS:A1988Q126500002
PM 3263317
ER

PT J
AU OHNO, H
   FUKUHARA, S
   ARITA, Y
   DOI, S
   TAKAHASHI, R
   FUJII, H
   HONJO, T
   SUGIYAMA, T
   UCHINO, H
AF OHNO, H
   FUKUHARA, S
   ARITA, Y
   DOI, S
   TAKAHASHI, R
   FUJII, H
   HONJO, T
   SUGIYAMA, T
   UCHINO, H
TI ESTABLISHMENT OF A PERIPHERAL T-CELL LYMPHOMA CELL-LINE SHOWING
   AMPLIFICATION OF THE C-MYC ONCOGENE
SO CANCER RESEARCH
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 1,54 SHOGOIN KAWARAMACHI,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KOBE UNIV,SCH MED,DEPT PATHOL,KOBE 650,JAPAN.
   KYOTO 1ST RED CROSS HOSP,KYOTO 605,JAPAN.
CR DALLAFAVERA R, 1982, NATURE, V299, P61
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213
   NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   SAKSELA K, 1985, CANCER RES, V45, P1823
   BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137
   ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707
   NOWELL P, 1983, NATURE, V306, P494, DOI 10.1038/306494a0
   FUKUHARA S, 1978, INT J CANCER, V22, P14, DOI 10.1002/ijc.2910220105
   BARKER PE, 1982, CANCER GENET CYTOGEN, V5, P81, DOI 10.1016/0165-4608(82)90043-7
   CROCE CM, 1985, SCIENCE, V227, P1044, DOI 10.1126/science.3919442
   CROCE CM, 1985, BLOOD, V65, P1
   DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824
   ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820
   FILMUS J, 1986, CANCER RES, V46, P5179
   FUJITA K, 1986, INT J CANCER, V37, P517, DOI 10.1002/ijc.2910370408
   HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061
   IKUTA K, 1986, NUCLEIC ACIDS RES, V14, P4899, DOI 10.1093/nar/14.12.4899
   KNOWLES DM, 1986, HUM PATHOL, V17, P14, DOI 10.1016/S0046-8177(86)80151-4
   KOZBOR D, 1984, CANCER RES, V44, P438
   LACY J, 1987, P NATL ACAD SCI USA, V84, P5838, DOI 10.1073/pnas.84.16.5838
   MINOWADA J, 1984, LEUKOCYTE TYPING, P519
   Miwa H, 1987, J Mol Cell Immunol, V3, P43
   MODJTAHEDI N, 1985, CANCER RES, V45, P4372
   OHNO H, 1987, INT J CANCER, V39, P785, DOI 10.1002/ijc.2910390622
   OHNO H, 1986, INT J CANCER, V37, P761, DOI 10.1002/ijc.2910370518
   REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0
   RITZ J, 1980, NATURE, V283, P583, DOI 10.1038/283583a0
   SADAMORI N, 1985, CANCER GENET CYTOGEN, V17, P279, DOI 10.1016/0165-4608(85)90019-6
   SAGLIO G, 1986, CANCER RES, V46, P1413
   SHIBUYA M, 1985, MOL CELL BIOL, V5, P414
   SHIMA EA, 1986, P NATL ACAD SCI USA, V83, P3439, DOI 10.1073/pnas.83.10.3439
   SHIMOYAMA M, 1984, LEUCOCYTE TYPING, P534
   SMITH SD, 1984, CANCER RES, V44, P5657
   TAX WJM, 1984, CLIN EXP IMMUNOL, V55, P427
   TAYA Y, 1984, EMBO J, V3, P2943
   UESHIMA Y, 1984, BLOOD, V63, P1028
   WEISS LM, 1985, AM J PATHOL, V118, P316
   YOSHIMOTO K, 1986, JPN J CANCER RES, V77, P731
   ZECH L, 1984, NATURE, V308, P858, DOI 10.1038/308858a0
   1982, CANCER PHILA, V49, P2112
NR 42
TC 14
Z9 14
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W.,
   PHILADELPHIA, PA 19106
SN 0008-5472
J9 CANCER RES
JI Cancer Res.
PD SEP 1
PY 1988
VL 48
IS 17
BP 4959
EP 4963
PG 5
WC Oncology
SC Oncology
GA P8066
UT WOS:A1988P806600040
PM 3261629
ER

PT J
AU KANAI, Y
   YAOITA, Y
   IMAOKA, K
   HONJO, T
AF KANAI, Y
   YAOITA, Y
   IMAOKA, K
   HONJO, T
TI A UNIQUE MONOCLONAL-ANTIBODY DERIVED FROM A LUPUS-PRONE MOUSE WITH
   MULTIPLE BINDINGS TO AUTO-ANTIGENS ASSOCIATED WITH RHEUMATIC DISEASE
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 UNIV TOKYO,INST MED SCI,LAB ANIM RES CTR,TOKYO 108,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP KANAI, Y (reprint author), UNIV TOKYO,INST MED SCI,DEPT MOLEC ONCOL,MINATO KU,TOKYO 108,JAPAN.
CR AGNELLO V, 1980, J EXP MED, V151, P1514, DOI 10.1084/jem.151.6.1514
   KANAI Y, 1974, BIOCHEM BIOPH RES CO, V59, P300, DOI 10.1016/S0006-291X(74)80206-8
   MARMUR J, 1961, J MOL BIOL, V3, P208
   ANDRESCHWARTZ J, 1984, CLIN IMMUNOL IMMUNOP, V31, P261, DOI 10.1016/0090-1229(84)90246-0
   SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150
   DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841
   STOLLAR BD, 1980, J CLIN INVEST, V66, P210, DOI 10.1172/JCI109846
   LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495
   KUBOTA T, 1986, IMMUNOL LETT, V14, P53, DOI 10.1016/0165-2478(86)90020-9
   LAFER EM, 1981, J EXP MED, V153, P897, DOI 10.1084/jem.153.4.897
   PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3
   HOLMAN HR, 1957, SCIENCE, V126, P162, DOI 10.1126/science.126.3265.162
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CAIRNS E, 1984, J CLIN INVEST, V74, P880, DOI 10.1172/JCI111505
   DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496
   FAIFERMAN I, 1987, ARTHRITIS RHEUM, V30, P814, DOI 10.1002/art.1780300712
   HANNESTAD K, 1978, NATURE, V275, P671, DOI 10.1038/275671a0
   HOCH S, 1987, J IMMUNOL, V139, P1689
   ISONISHI S, 1988, IMMUNOL LETT, V18, P61, DOI 10.1016/0165-2478(88)90071-5
   JACOB L, 1984, P NATL ACAD SCI-BIOL, V81, P3843, DOI 10.1073/pnas.81.12.3843
   KABURAKI J, 1987, J IMMUNOL, V139, P385
   KANAI Y, 1981, IMMUNOLOGY, V43, P101
   KANAI Y, 1985, CLIN EXP IMMUNOL, V59, P139
   KANAI Y, 1981, P NATL ACAD SCI-BIOL, V78, P2801, DOI 10.1073/pnas.78.5.2801
   KANAI Y, 1985, CLIN EXP IMMUNOL, V59, P132
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANGE A, 1978, CLIN EXP IMMUNOL, V31, P472
   RUBIN RL, 1984, J EXP MED, V159, P1429, DOI 10.1084/jem.159.5.1429
   SCHWARTZ RS, 1985, J CLIN INVEST, V75, P321, DOI 10.1172/JCI111704
   YAOITA Y, 1988, IN PRESS J BIOCH TOK
NR 30
TC 15
Z9 15
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD SEP
PY 1988
VL 19
IS 1
BP 15
EP 20
DI 10.1016/0165-2478(88)90113-7
PG 6
WC Immunology
SC Immunology
GA Q2935
UT WOS:A1988Q293500003
PM 2461346
ER

PT J
AU YAOITA, Y
   TAKAHASHI, M
   AZUMA, C
   KANAI, Y
   HONJO, T
AF YAOITA, Y
   TAKAHASHI, M
   AZUMA, C
   KANAI, Y
   HONJO, T
TI BIASED EXPRESSION OF VARIABLE REGION GENE FAMILIES OF THE IMMUNOGLOBULIN
   HEAVY-CHAIN IN AUTOIMMUNE-PRONE MICE
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   UNIV TOKYO,INST MED SCI,DEPT MOLEC ONCOL,MINATO KU,TOKYO 108,JAPAN.
CR GLEICHMANN E, 1982, EUR J IMMUNOL, V12, P152, DOI 10.1002/eji.1830120210
   BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   WOFSY D, 1981, J EXP MED, V154, P1671, DOI 10.1084/jem.154.5.1671
   DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841
   HANG L, 1983, J EXP MED, V157, P874, DOI 10.1084/jem.157.3.874
   WU GE, 1986, EMBO J, V5, P3475
   LAWLER AM, 1987, P NATL ACAD SCI USA, V84, P2454, DOI 10.1073/pnas.84.8.2454
   KUBOTA T, 1986, IMMUNOL LETT, V14, P53, DOI 10.1016/0165-2478(86)90020-9
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   IZUI S, 1977, J EXP MED, V145, P1115, DOI 10.1084/jem.145.5.1115
   THEOFILOPOULOS AN, 1981, IMMUNOL REV, V55, P179, DOI 10.1111/j.1600-065X.1981.tb00343.x
   BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012
   IZUI S, 1979, J IMMUNOL, V122, P2096
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   BLATTNER FR, 1984, NATURE, V307, P417, DOI 10.1038/307417a0
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DIGHIERO G, 1986, J IMMUNOL, V136, P4000
   GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025
   IZUI S, 1977, J IMMUNOL, V119, P2151
   KANAI Y, 1985, CLIN EXP IMMUNOL, V59, P139
   KANAI Y, 1985, CLIN EXP IMMUNOL, V59, P132
   KANG CY, 1987, J EXP MED, V165, P1332, DOI 10.1084/jem.165.5.1332
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   KEHRY MR, 1982, BIOCHEMISTRY-US, V21, P5415, DOI 10.1021/bi00265a006
   KELLEY VE, 1986, EUR J IMMUNOL, V16, P464, DOI 10.1002/eji.1830160425
   KIMURA M, 1987, CLIN EXP IMMUNOL, V69, P385
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   MORROW WJW, 1982, ANN RHEUM DIS, V41, P396, DOI 10.1136/ard.41.4.396
   NAKANISHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6984, DOI 10.1073/pnas.79.22.6984
   NEAR RI, 1984, P NATL ACAD SCI-BIOL, V81, P2167, DOI 10.1073/pnas.81.7.2167
   NEUBERGER MS, 1983, EMBO J, V2, P1373
   OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945
   PAINTER C, 1986, IMMUNOL REV, V94, P75, DOI 10.1111/j.1600-065X.1986.tb01165.x
   PORTANOVA JP, 1985, J IMMUNOL, V135, P3850
   PRIMI D, 1986, J EXP MED, V164, P357, DOI 10.1084/jem.164.1.357
   PRUDHOMME GJ, 1984, IMMUNOL REV, V78, P159, DOI 10.1111/j.1600-065X.1984.tb00481.x
   PRUDHOMME GJ, 1983, J EXP MED, V157, P730, DOI 10.1084/jem.157.2.730
   SANTORO TJ, 1983, J IMMUNOL, V131, P265
   SANTORO TJ, 1987, EUR J IMMUNOL, V17, P1131, DOI 10.1002/eji.1830170809
   SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2
   SCHILLING J, 1980, NATURE, V283, P35, DOI 10.1038/283035a0
   SHLOMCHIK M, 1987, J EXP MED, V165, P970, DOI 10.1084/jem.165.4.970
   SHLOMCHIK MJ, 1986, J EXP MED, V164, P407, DOI 10.1084/jem.164.2.407
   SLACK J, 1980, J EXP MED, V151, P853, DOI 10.1084/jem.151.4.853
   SMITH HR, 1983, ANNU REV IMMUNOL, V1, P175, DOI 10.1146/annurev.iy.01.040183.001135
   SMITH HR, 1982, J IMMUNOL, V129, P2332
   THEOFILOPOULOS AN, 1980, J EXP MED, V151, P446, DOI 10.1084/jem.151.2.446
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   VANRAPPARDVANDERVEEN FM, 1984, J IMMUNOL, V132, P1814
   VANSNICK JL, 1982, J EXP MED, V155, P219, DOI 10.1084/jem.155.1.219
   WORD CJ, 1983, EMBO J, V2, P887
   YAMAWAKIKATAOKA Y, 1980, NATURE, V283, P786, DOI 10.1038/283786a0
   YAOITA Y, 1983, NUCLEIC ACIDS RES, V11, P7303, DOI 10.1093/nar/11.21.7303
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 57
TC 5
Z9 5
U1 0
U2 0
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD SEP
PY 1988
VL 104
IS 3
BP 337
EP 343
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA P8832
UT WOS:A1988P883200007
PM 2467902
ER

PT J
AU HONJO, T
   KINASHI, T
   PALACIOS, R
   INABA, K
   TSUBATA, T
   TASHIRO, K
AF HONJO, T
   KINASHI, T
   PALACIOS, R
   INABA, K
   TSUBATA, T
   TASHIRO, K
TI DIFFERENTIATION OF AN INTERLEUKIN-3-DEPENDENT PRECURSOR B-CELL CLONE
   INTO IMMUNOGLOBULIN-PRODUCING CELLS-INVITRO
SO LYMPHOKINE RESEARCH
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 0277-6766
J9 LYMPHOKINE RES
PD FAL
PY 1988
VL 7
IS 3
BP 257
EP 257
PG 1
WC Immunology
SC Immunology
GA Q0379
UT WOS:A1988Q037900015
ER

PT J
AU KINASHI, T
   TASHIRO, K
   PALACIOS, R
   HONJO, T
AF KINASHI, T
   TASHIRO, K
   PALACIOS, R
   HONJO, T
TI IL-4-DEPENDENT B PRECURSOR CELL-LINES DERIVED FROM THE IL-3-DEPENDENT
   CELL-LINE LYD9
SO LYMPHOKINE RESEARCH
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 0277-6766
J9 LYMPHOKINE RES
PD FAL
PY 1988
VL 7
IS 3
BP 304
EP 304
PG 1
WC Immunology
SC Immunology
GA Q0379
UT WOS:A1988Q037900178
ER

PT J
AU BEAGLEY, KW
   ELDRIDGE, JH
   KIYONO, H
   EVERSON, MP
   KOOPMAN, WJ
   HONJO, T
   MCGHEE, JR
AF BEAGLEY, KW
   ELDRIDGE, JH
   KIYONO, H
   EVERSON, MP
   KOOPMAN, WJ
   HONJO, T
   MCGHEE, JR
TI RECOMBINANT MURINE IL-5 INDUCES HIGH-RATE IGA SYNTHESIS IN CYCLING
   IGA-POSITIVE PEYERS PATCH B-CELLS
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 UNIV ALABAMA,DEPT MICROBIOL,UNIV STN,BIRMINGHAM,AL 35294.
   UNIV ALABAMA,DEPT ORAL BIOL,BIRMINGHAM,AL 35294.
   UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294.
   UNIV ALABAMA,DIV CLIN IMMUNOL & RHEUMATOL,BIRMINGHAM,AL 35294.
   UNIV ALABAMA,HOSP VET ADM,BIRMINGHAM,AL 35294.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   KURTJONES EA, 1987, J EXP MED, V166, P1774, DOI 10.1084/jem.166.6.1774
   KIYONO H, 1982, P NATL ACAD SCI-BIOL, V79, P596, DOI 10.1073/pnas.79.2.596
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   CZERKINSKY C, 1987, P NATL ACAD SCI USA, V84, P2449, DOI 10.1073/pnas.84.8.2449
   MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0
   PAUL WE, 1987, FASEB J, V1, P456
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   OHARA J, 1987, NATURE, V325, P537, DOI 10.1038/325537a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149
   BOND MW, 1987, J IMMUNOL, V139, P3691
   COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0
   COFFMAN RL, 1987, J IMMUNOL, V139, P3685
   FERNANDEZBOTRAN R, 1986, P NATL ACAD SCI USA, V83, P9689, DOI 10.1073/pnas.83.24.9689
   HAMAOKA T, 1986, ANNU REV IMMUNOL, V4, P167, DOI 10.1146/annurev.immunol.4.1.167
   HARRIMAN GR, 1987, J IMMUNOL, V139, P3553
   HOFFMANN MK, 1980, J IMMUNOL, V125, P2076
   HUNTER WM, 1978, HDB EXPT IMMUNOLOGY, P141
   KAPLAN JG, 1974, EXP CELL RES, V88, P388, DOI 10.1016/0014-4827(74)90257-2
   KIMURA S, 1987, J IMMUNOL, V138, P4387
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KISHIMOTO T, 1987, J CLIN IMMUNOL, V7, P343, DOI 10.1007/BF00917012
   LANIER LL, 1982, HYBRIDOMA, V1, P125, DOI 10.1089/hyb.1.1982.1.125
   LEBMAN DA, 1987, J EXP MED, V166, P1405, DOI 10.1084/jem.166.5.1405
   LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x
   LICHTMAN AH, 1987, P NATL ACAD SCI USA, V84, P824, DOI 10.1073/pnas.84.3.824
   LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2
   MELCHERS F, 1986, ANNU REV IMMUNOL, V4, P13, DOI 10.1146/annurev.immunol.4.1.13
   MELCHERS F, 1985, P NATL ACAD SCI USA, V82, P7681, DOI 10.1073/pnas.82.22.7681
   MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654
   MURRAY PD, 1987, J IMMUNOL, V139, P2669
   NAKAJIMA K, 1987, J IMMUNOL, V139, P774
   Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115
   OLIVER K, 1985, P NATL ACAD SCI USA, V82, P2465, DOI 10.1073/pnas.82.8.2465
   PESCHEL C, 1987, BLOOD, V70, P254
   RABIN EM, 1985, P NATL ACAD SCI USA, V82, P2935, DOI 10.1073/pnas.82.9.2935
   ROBB RJ, 1986, J IMMUNOL, V137, P142
   SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0
   SNAPPER CM, 1987, J IMMUNOL, V139, P10
   SWAIN SL, 1982, J EXP MED, V156, P1821, DOI 10.1084/jem.156.6.1821
   SWAIN SL, 1983, J EXP MED, V158, P822, DOI 10.1084/jem.158.3.822
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726
   WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510
NR 49
TC 215
Z9 217
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD SEP 15
PY 1988
VL 141
IS 6
BP 2035
EP 2042
PG 8
WC Immunology
SC Immunology
GA Q1022
UT WOS:A1988Q102200034
PM 3262647
ER

PT J
AU SAITO, Y
   SABE, H
   SUZUKI, N
   KONDO, S
   OGURA, T
   SHIMIZU, A
   HONJO, T
AF SAITO, Y
   SABE, H
   SUZUKI, N
   KONDO, S
   OGURA, T
   SHIMIZU, A
   HONJO, T
TI A LARGER NUMBER OF L-CHAINS (TAC) ENHANCE THE ASSOCIATION RATE OF
   INTERLEUKIN-2 TO THE HIGH-AFFINITY SITE OF THE INTERLEUKIN-2 RECEPTOR
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
RP SAITO, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   NILSEN TW, 1985, CELL, V41, P719, DOI 10.1016/S0092-8674(85)80052-0
   CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   KANAMORI H, 1986, COLD SPRING HARB SYM, V51, P739
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   LOWENTHAL JW, 1987, J EXP MED, V166, P1156, DOI 10.1084/jem.166.4.1156
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   OGURA T, 1988, MOL BIOL MED, V5, P123
   ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
NR 19
TC 48
Z9 48
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD NOV 1
PY 1988
VL 168
IS 5
BP 1563
EP 1572
DI 10.1084/jem.168.5.1563
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA Q9043
UT WOS:A1988Q904300005
PM 3263463
ER

PT J
AU KONDO, N
   KONDO, S
   SHIMIZU, A
   HONJO, T
   HAMURO, J
AF KONDO, N
   KONDO, S
   SHIMIZU, A
   HONJO, T
   HAMURO, J
TI A SOLUBLE ANCHORMINUS INTERLEUKIN-2 RECEPTOR SUPPRESSES INVITRO
   INTERLEUKIN-2-MEDIATED IMMUNE-RESPONSES
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RP KONDO, N (reprint author), AJINOMOTO CO INC,CENT RES LAB,1-1 SUZUKI CHO,KAWASAKI KU,KAWASAKI,KANAGAWA 210,JAPAN.
CR GILLIS S, 1978, J IMMUNOL, V120, P2027
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0
   RUBIN LA, 1985, J IMMUNOL, V135, P3172
   SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   KUPIECWEGLINSKI JW, 1986, P NATL ACAD SCI USA, V83, P2624, DOI 10.1073/pnas.83.8.2624
   KIRKMAN RL, 1985, J EXP MED, V162, P358, DOI 10.1084/jem.162.1.358
   HENNEY CS, 1981, NATURE, V291, P335, DOI 10.1038/291335a0
   BUNJES D, 1981, EUR J IMMUNOL, V11, P657, DOI 10.1002/eji.1830110812
   GILLIS S, 1980, J IMMUNOL, V124, P1954
   GRIMM EA, 1983, J EXP MED, V158, P1356, DOI 10.1084/jem.158.4.1356
   HESS AD, 1982, J IMMUNOL, V128, P355
   HESS AD, 1982, J IMMUNOL, V128, P360
   HONDA M, 1987, JPN J CANCER RES, V78, P883
   IHLE JN, 1982, J IMMUNOL, V129, P1377
   JACQUES Y, 1987, J IMMUNOL, V139, P2308
   KONDO N, 1985, RATIONALE BIOL RESPO, P96
   KUPIECWEGLINSKI JW, 1987, EUR J IMMUNOL, V17, P313, DOI 10.1002/eji.1830170303
   LEIBSON HJ, 1981, J EXP MED, V154, P1681, DOI 10.1084/jem.154.5.1681
   LOTZE MT, 1987, CANCER RES, V47, P2188
   RESKEKUNZ AB, 1987, J IMMUNOL, V138, P192
   SHIMIZU A, 1986, MOL BIOL MED, V3, P509
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   YOSHIMOTO R, 1985, EUR J IMMUNOL, V15, P325, DOI 10.1002/eji.1830150404
NR 26
TC 19
Z9 19
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD DEC
PY 1988
VL 19
IS 4
BP 299
EP 308
DI 10.1016/0165-2478(88)90159-9
PG 10
WC Immunology
SC Immunology
GA R7930
UT WOS:A1988R793000008
PM 2977379
ER

PT J
AU INABA, K
   INABA, M
   KINASHI, T
   TASHIRO, K
   WITMERPACK, M
   CROWLEY, M
   KAPLAN, G
   VALINSKY, J
   ROMANI, N
   IKEHARA, S
   MURAMATSU, S
   HONJO, T
   STEINMAN, RM
AF INABA, K
   INABA, M
   KINASHI, T
   TASHIRO, K
   WITMERPACK, M
   CROWLEY, M
   KAPLAN, G
   VALINSKY, J
   ROMANI, N
   IKEHARA, S
   MURAMATSU, S
   HONJO, T
   STEINMAN, RM
TI MACROPHAGES PHAGOCYTOSE THYMIC LYMPHOCYTES WITH PRODUCTIVELY REARRANGED
   T-CELL RECEPTOR ALPHA-GENES AND BETA-GENES
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   ROCKEFELLER UNIV,NEW YORK,NY 10021.
   NEW YORK BLOOD CTR,NEW YORK,NY 10021.
   KANSAI MED COLL,DEPT PATHOL,MORIGUCHI,OSAKA 570,JAPAN.
   IRVINGTON HOUSE INST,NEW YORK,NY 10021.
RP INABA, K (reprint author), KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
RI Steinman, Ralph/F-7729-2012
CR BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0
   CHEN LL, 1978, J CELL BIOL, V79, P184, DOI 10.1083/jcb.79.1.184
   HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   NUSSENZWEIG MC, 1980, J EXP MED, V151, P1196, DOI 10.1084/jem.151.5.1196
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X
   VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172
   GOOD RA, 1962, J EXP MED, V116, P773, DOI 10.1084/jem.116.5.773
   CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x
   ARDEN B, 1985, NATURE, V316, P783, DOI 10.1038/316783a0
   ARNASON BG, 1962, J EXP MED, V116, P177, DOI 10.1084/jem.116.2.177
   BARTH RK, 1985, NATURE, V316, P517, DOI 10.1038/316517a0
   BENNETT B, 1963, NATURE, V198, P10, DOI 10.1038/198010a0
   BORN W, 1986, SCIENCE, V234, P479, DOI 10.1126/science.3020688
   BORUM K, 1973, CELL TISSUE KINET, V6, P545, DOI 10.1111/j.1365-2184.1973.tb01645.x
   BRYANT BJ, 1972, EUR J IMMUNOL, V2, P38, DOI 10.1002/eji.1830020109
   CEREDIG R, 1982, J EXP MED, V155, P358, DOI 10.1084/jem.155.2.358
   CHEN WF, 1985, TYYMUS, V5, P149
   CLAESSON MH, 1976, CELL TISSUE KINET, V9, P273, DOI 10.1111/j.1365-2184.1976.tb01275.x
   CROWLEY M, 1989, IN PRESS CELL IMMUNO
   FARR AG, 1985, CELL, V43, P543, DOI 10.1016/0092-8674(85)90183-7
   FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766
   FLEIDNER TM, 1964, ANN NY ACAD SCI, V113, P578
   FURLEY AJ, 1986, CELL, V46, P75, DOI 10.1016/0092-8674(86)90861-5
   HAARS R, 1986, J EXP MED, V164, P1, DOI 10.1084/jem.164.1.1
   HANNUM C, 1987, J EXP MED, V166, P874, DOI 10.1084/jem.166.4.874
   HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452
   HOOD LE, 1984, IMMUNOLOGY, P267
   IKUTA K, 1986, J EXP MED, V164, P428, DOI 10.1084/jem.164.2.428
   JANKOVIC BD, 1962, J EXP MED, V116, P159, DOI 10.1084/jem.116.2.159
   KAST WM, 1984, J EXP MED, V160, P1752, DOI 10.1084/jem.160.6.1752
   LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0
   MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6
   MATSUYAM.M, 1966, J EXP MED, V123, P559, DOI 10.1084/jem.123.3.559
   MAX EE, 1981, J BIOL CHEM, V256, P5116
   MILLER JFA, 1962, P R SOC LOND B, V15, P6415
   PARROTT DMV, 1966, J EXP MED, V123, P191, DOI 10.1084/jem.123.1.191
   PATERSON DJ, 1987, J EXP MED, V165, P1, DOI 10.1084/jem.165.1.1
   PENIT C, 1986, J IMMUNOL, V137, P2115
   PESTALOZZI B, 1987, J EXP MED, V166, P295, DOI 10.1084/jem.166.1.295
   RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0
   READY AR, 1984, NATURE, V310, P231, DOI 10.1038/310231a0
   ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9
   RYGAARD J, 1973, THYMUS SELF
   SCOLLAY R, 1980, J IMMUNOL, V124, P2845
   MCPHEE D, 1979, THYMUS, V1, P151
   SHORTMAN K, 1974, CELL IMMUNOL, V12, P230, DOI 10.1016/0008-8749(74)90075-6
   SIU G, 1984, NATURE, V311, P344, DOI 10.1038/311344a0
   SNODGRASS HR, 1985, NATURE, V315, P232, DOI 10.1038/315232a0
   SPRINGER TA, 1982, HYBRIDOMA, V1, P257, DOI 10.1089/hyb.1.1982.1.257
   VONBOEHMER H, 1984, EUR J IMMUNOL, V14, P1048, DOI 10.1002/eji.1830141116
   WAKSMAN BH, 1962, J EXP MED, V116, P187, DOI 10.1084/jem.116.2.187
   WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284
   WINOTO A, 1985, NATURE, V316, P832, DOI 10.1038/316832a0
   WITMERPACK MD, 1988, J INVEST DERMATOL, V90, P387, DOI 10.1111/1523-1747.ep12456460
   WYSOCKI L, 1986, P NATL ACAD SCI USA, V83, P1847, DOI 10.1073/pnas.83.6.1847
NR 60
TC 22
Z9 22
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD DEC 1
PY 1988
VL 168
IS 6
BP 2279
EP 2294
DI 10.1084/jem.168.6.2279
PG 16
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA R3620
UT WOS:A1988R362000025
PM 3264326
ER

PT J
AU KINASHI, T
   INABA, K
   TSUBATA, T
   TASHIRO, K
   PALACIOS, R
   HONJO, T
AF KINASHI, T
   INABA, K
   TSUBATA, T
   TASHIRO, K
   PALACIOS, R
   HONJO, T
TI DIFFERENTIATION OF A PRECURSOR CELL WITH THE GERMLINE CONTEXT OF
   IMMUNOGLOBULIN GENE INTO IMMUNOGLOBULIN-PRODUCING CELLS-INVITRO
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
C1 KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED,KYOTO 606,JAPAN.
RP KINASHI, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   NUSSENZWEIG MC, 1980, J EXP MED, V151, P1196, DOI 10.1084/jem.151.5.1196
   SPALDING DM, 1986, CELL, V44, P507, DOI 10.1016/0092-8674(86)90472-1
   JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   CAMPBELL HD, 1987, P NATL ACAD SCI USA, V84, P6629, DOI 10.1073/pnas.84.19.6629
   GOUGH NM, 1984, NATURE, V309, P763, DOI 10.1038/309763a0
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   MAKMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414
   NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976
   PALACIOS R, 1987, EMBO J, V6, P3687
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 15
TC 0
Z9 0
U1 0
U2 0
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 E 63RD ST, NEW YORK, NY 10021
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD DEC 30
PY 1988
VL 546
BP 1
EP 8
DI 10.1111/j.1749-6632.1988.tb21613.x
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE247
UT WOS:A1988DE24700001
PM 3073688
ER

PT J
AU SHIMIZU, A
   KINASHI, T
   NUSSENZWEIG, MC
   MIZUTA, TR
   LEDER, P
   HONJO, T
AF SHIMIZU, A
   KINASHI, T
   NUSSENZWEIG, MC
   MIZUTA, TR
   LEDER, P
   HONJO, T
TI MOLECULAR MECHANISM FOR IMMUNOGLOBULIN DOUBLE-ISOTYPE EXPRESSION
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
ID CONSTANT-REGION ALLOTYPES; HEAVY-CHAIN GENES; B-CELLS; TRANSGENIC MICE;
   SWITCH RECOMBINATION; ALLELIC EXCLUSION; MU; DELETION; REARRANGEMENTS;
   INTERLEUKIN-4
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115.
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3
   MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1
   SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183
   NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   PERNIS B, 1973, IMMUNOCHEMISTRY, V10, P281, DOI 10.1016/0019-2791(73)90023-2
   RADBRUCH A, 1983, EMBO J, V2, P1929
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   KOLLER B, 1987, CELL, V48, P111, DOI 10.1016/0092-8674(87)90361-8
   UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DURDIK J, 1989, P NATL ACAD SCI USA, V86, P2346, DOI 10.1073/pnas.86.7.2346
   HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1
   KAUSE M, 1987, CELL, V49, P753
   KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887
   KNIGHT KL, 1974, P NATL ACAD SCI USA, V71, P1169, DOI 10.1073/pnas.71.4.1169
   LANDUCCI.S, 1973, IMMUNOCHEMISTRY, V10, P65, DOI 10.1016/0019-2791(73)90232-2
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175
   ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037
   VANDERPLOEG LHT, 1986, CELL, V47, P479, DOI 10.1016/0092-8674(86)90608-2
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 35
TC 7
Z9 7
U1 0
U2 3
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1989
VL 54
BP 175
EP 181
PN 1
PG 7
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA JX745
UT WOS:A1989JX74500020
PM 2639752
ER

PT J
AU ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   MINATO, N
   KAWAICHI, M
   HONJO, T
AF ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   MINATO, N
   KAWAICHI, M
   HONJO, T
TI IMMUNE DYSFUNCTIONS AND ACTIVATION OF NATURAL-KILLER-CELLS IN HUMAN IL-2
   AND IL-2/IL-2 RECEPTOR L-CHAIN TRANSGENIC MICE
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
ID GROWTH-FACTOR RECEPTOR; INTERLEUKIN-2 RECEPTOR; EPIDERMAL-CELLS;
   EXPRESSION; DISTINCT; COMPLEX; NK; PROLIFERATION; LYMPHOCYTES; MECHANISM
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,NAGOYA,AICHI 464,JAPAN.
   KYOTO UNIV,FAC MED,DEPT ZOOL,KYOTO 606,JAPAN.
   JICHI MED SCH,DEPT MED,MINAMI KAWACHI,TOCHIGI 32904,JAPAN.
CR CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   LOTZE MT, 1986, JAMA-J AM MED ASSOC, V256, P3117, DOI 10.1001/jama.256.22.3117
   BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   HANSSON M, 1979, NATURE, V278, P174, DOI 10.1038/278174a0
   HERBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651, DOI 10.1146/annurev.immunol.4.1.651
   HERCEND T, 1988, IMMUNOL TODAY, V9, P291, DOI 10.1016/0167-5699(88)91317-5
   HERSEY P, 1987, IMMUNOL TODAY, V8, P233, DOI 10.1016/0167-5699(87)90173-3
   Ishida Y, 1989, Int Immunol, V1, P113, DOI 10.1093/intimm/1.2.113
   ISHIDA Y, 1989, IN PRESS J EXP MED
   KUZIEL WA, 1987, NATURE, V328, P263, DOI 10.1038/328263a0
   MAEDA M, 1987, BLOOD, V70, P1407
   MERRILL JE, 1984, SCIENCE, V224, P1428, DOI 10.1126/science.6610212
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   NIXONFULTON JL, 1986, J IMMUNOL, V136, P2776
   OGURA T, 1988, MOL BIOL MED, V5, P123
   ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002
   Sabe H, 1984, Mol Biol Med, V2, P379
   SAITO Y, 1988, J EXP MED, V168, P1563, DOI 10.1084/jem.168.5.1563
   SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1987, P NATL ACAD SCI USA, V84, P5394, DOI 10.1073/pnas.84.15.5394
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   YODOI J, 1983, BLOOD, V62, P509
NR 31
TC 2
Z9 2
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1989
VL 54
BP 695
EP 704
PN 2
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA JX746
UT WOS:A1989JX74600011
PM 2640624
ER

PT J
AU TAKAHASHI, M
   YOSHIDA, MC
   SATOH, H
   HILGERS, J
   YAOITA, Y
   HONJO, T
AF TAKAHASHI, M
   YOSHIDA, MC
   SATOH, H
   HILGERS, J
   YAOITA, Y
   HONJO, T
TI CHROMOSOMAL MAPPING OF THE MOUSE IL-4 AND HUMAN IL-5 GENES
SO GENOMICS
LA English
DT Article
RP TAKAHASHI, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
NR 0
TC 31
Z9 32
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD JAN
PY 1989
VL 4
IS 1
BP 47
EP 52
DI 10.1016/0888-7543(89)90313-3
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA R5101
UT WOS:A1989R510100008
PM 2563351
ER

PT J
AU Kinashi, T
   Tashiro, K
   Inaba, K
   Takeda, T
   Palacios, R
   Honjo, T
AF Kinashi, Tatsuo
   Tashiro, Kel
   Inaba, Kayo
   Takeda, Toshio
   Palacios, Ronald
   Honjo, Tasuku
TI An interleukin-4-dependent precursor clone is an intermediate of the
   differentiation pathway from an interleukin-3-dependent precursor clone
   into myeloid cells as well as B lymphocytes
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE multipotential stem cell; bone marrow stroma cells; GM-CSF;
   fluorescence-activated cell sorting
ID COLONY-STIMULATING FACTOR; MONOCLONAL-ANTIBODY; IN-VITRO;
   COMPLEMENTARY-DNA; PROGENITOR CELLS; IMMUNOGLOBULIN; MACROPHAGE;
   ANTIGEN; CDNA; GENE
AB An interleukin-3-dependent progenitor clone LyD9 and its Interleukin-4-dependent derivative clone K-4 were shown to differentiate Into myeloid cells as well as B lymphocytes by coculture with bone marrow stroma cells. The K-4 clone is an Intermediate between myeloid/lymphoid cells and the LyD9 clone that requires interleukin-4 for differentiation into B lymphocytes and myeloid cells. Granulocyte-macrophage colony stimulating factor-dependent derivatives (L8-1 and K-GM) were also established from induced LyD9 cells. LS-1 and K-GM were myeloid-committed cells.
C1 [Kinashi, Tatsuo; Tashiro, Kel; Honjo, Tasuku] Kyoto Univ, Dept Med Chem, Fac Med, Kyoto 606, Japan.
   [Inaba, Kayo] Kyoto Univ, Dept Zool, Fac Sci, Kyoto 606, Japan.
   [Takeda, Toshio] Kyoto Univ, Chest Dis Res Inst, Kyoto 606, Japan.
   [Palacios, Ronald] Basel Inst Immunol, Basel, Switzerland.
RP Kinashi, T (reprint author), Kyoto Univ, Dept Med Chem, Fac Med, Kyoto 606, Japan.
FU Ministry of Education, Culture and Science of Japan; F Hoffmann-La
   Roche, Ltd Co
FX We would like to thank Drs Atsushi Miyajima, Toshio Hirano, Tetsuo Sudo,
   and Shigekazu Nagata for supplying growth factors. We are grateful to Ms
   J Kuno S Okazaki, and K Fujiseki for their skilful assistance and to Ms
   K. Hirano for her help in preparation of the manuscript. We would like
   to thank Dr R. Reeves, Dr P Sideras for their critical comments to the
   manuscript This investigation was supported by the Ministry of
   Education, Culture and Science of Japan, The Basel Institute for
   Immunology was founded and is supported by F Hoffmann-La Roche, Ltd Co
CR BRUCE J, 1981, J IMMUNOL, V127, P2496
   NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   GREAVES MF, 1986, BLOOD, V67, P1
   OGAWA M, 1988, EMBO J, V7, P1337
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   Coffman L R, 1981, NATURE, V289, P681
   COLECLOUGH C, 1983, NATURE, V303, P23, DOI 10.1038/303023a0
   Davidson F. W., 1988, J EXP MED, V168, P389
   GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0
   GOUD TJLM, 1975, J EXP MED, V142, P1180, DOI 10.1084/jem.142.5.1180
   KAJIGAYA S, 1986, J EXP MED, V164, P1102, DOI 10.1084/jem.164.4.1102
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976
   Palacios R, 1988, IMMUNOL REV, V104, P1
   PALACIOS R, 1987, EMBO J, V6, P3687
   PESCHEL C, 1987, BLOOD, V70, P254
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SIDERAS P, 1988, IMMUNOL REV, V102, P189, DOI 10.1111/j.1600-065X.1988.tb00745.x
   SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327
   Unkeless C J, 1979, J EXP MED, V150, P580
   Yancopoulous D. G., 1986, CELL, P44
NR 30
TC 18
Z9 18
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
EI 1460-2377
J9 INT IMMUNOL
JI Int. Immunol.
PY 1989
VL 1
IS 1
BP 11
EP +
DI 10.1093/intimm/1.1.11
PG 9
WC Immunology
SC Immunology
GA V31YW
UT WOS:000208919900002
PM 2487673
ER

PT J
AU UEDA, S
   WATANABE, Y
   SAITOU, N
   OMOTO, K
   HAYASHIDA, H
   MIYATA, T
   HISAJIMA, H
   HONJO, T
AF UEDA, S
   WATANABE, Y
   SAITOU, N
   OMOTO, K
   HAYASHIDA, H
   MIYATA, T
   HISAJIMA, H
   HONJO, T
TI NUCLEOTIDE-SEQUENCES OF IMMUNOGLOBULIN-EPSILON PSEUDOGENES IN MAN AND
   APES AND THEIR PHYLOGENETIC-RELATIONSHIPS
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
C1 KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP UEDA, S (reprint author), UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,TOKYO 113,JAPAN.
CR LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0
   BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006
   MESSING J, 1983, METHOD ENZYMOL, V101, P20
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   NEI M, 1985, MOL BIOL EVOL, V2, P66
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9
   KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945
   BATTEY J, 1982, P NATL ACAD SCI USA, V79, P5958
   Jukes T. H., 1969, MAMMALIAN PROTEIN ME, V3, P21
   KOOP BF, 1986, NATURE, V319, P234, DOI 10.1038/319234a0
   MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   PICKFORD M, 1985, J HUM EVOL, V14, P113, DOI 10.1016/S0047-2484(85)80002-6
   RAZA SM, 1983, NATURE, V306, P52, DOI 10.1038/306052a0
   RIMM DL, 1980, GENE, V12, P301, DOI 10.1016/0378-1119(80)90113-4
   SAKOYAMA Y, 1987, P NATL ACAD SCI USA, V84, P1080, DOI 10.1073/pnas.84.4.1080
   SIBLEY CG, 1987, J MOL EVOL, V26, P99, DOI 10.1007/BF02111285
   SOKAL RR, 1983, PRINCIPLES NUMERICAL
   Thomas H., 1985, P42
   UEDA S, 1985, P NATL ACAD SCI USA, V82, P3712, DOI 10.1073/pnas.82.11.3712
   UEDA S, 1982, EMBO J, V1, P1539
   UEDA S, 1986, COLD SPRING HARB SYM, V51, P429
   UEDA S, 1988, J MOL EVOL, V27, P77, DOI 10.1007/BF02099732
   WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741
   WU R, 1984, YB PHYS ANTHR, V27, P1
NR 27
TC 42
Z9 42
U1 0
U2 0
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 5
PY 1989
VL 205
IS 1
BP 85
EP 90
DI 10.1016/0022-2836(89)90366-5
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA R9142
UT WOS:A1989R914200006
PM 2926810
ER

PT J
AU KUZE, K
   SHIMIZU, A
   HONJO, T
AF KUZE, K
   SHIMIZU, A
   HONJO, T
TI A NEW VECTOR AND RNASE H METHOD FOR THE SUBTRACTIVE HYBRIDIZATION
SO NUCLEIC ACIDS RESEARCH
LA English
DT Note
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
RP KUZE, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5
NR 2
TC 2
Z9 3
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 25
PY 1989
VL 17
IS 2
BP 807
EP 807
DI 10.1093/nar/17.2.807
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA R9701
UT WOS:A1989R970100034
PM 2536926
ER

PT J
AU KANAMORI, H
   SUZUKI, N
   ISHIDA, N
   HONJO, T
AF KANAMORI, H
   SUZUKI, N
   ISHIDA, N
   HONJO, T
TI TRANSCRIPTIONAL REGULATION ALONE DOES NOT EXPLAIN THE CONSTITUTIVE
   EXPRESSION OF THE INTERLEUKIN-2 RECEPTOR (TAC/L-CHAIN) IN HTLV-1
   INFECTED-CELLS
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR INOUE J, 1986, EMBO J, V5, P2883
   SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044
   DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230
   MIYOSHI I, 1980, GANN, V71, P155
   LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0
   WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191
   CHAMBON P, 1984, RECENT PROG HORM RES, V40, P1
   DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0
   GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403
   ISHIDA N, 1985, NUCLEIC ACIDS RES, V13, P7579, DOI 10.1093/nar/13.21.7579
   LEONARD WJ, 1985, P NATL ACAD SCI USA, V82, P6281, DOI 10.1073/pnas.82.18.6281
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5
   Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89
   MURAGUCHI A, 1981, J IMMUNOL, V127, P412
   NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   NOMA T, 1986, BIOCHEM BIOPH RES CO, V139, P353, DOI 10.1016/S0006-291X(86)80121-8
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   Sabe H, 1984, Mol Biol Med, V2, P379
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   SUZUKI N, 1987, J BIOL CHEM, V262, P5079
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 39
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD MAR
PY 1989
VL 20
IS 4
BP 293
EP 298
DI 10.1016/0165-2478(89)90037-0
PG 6
WC Immunology
SC Immunology
GA U1123
UT WOS:A1989U112300007
PM 2469652
ER

PT J
AU ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   MINATO, N
   KAWAICHI, M
   HONJO, T
AF ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   MINATO, N
   KAWAICHI, M
   HONJO, T
TI DERMATOLOGICAL AND IMMUNOLOGICAL ABNORMALITIES IN HUMAN IL-2 AND
   IL-2/IL-2 RECEPTOR L-CHAIN TRANSGENIC MICE
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,NAGOYA,AICHI 464,JAPAN.
   JICHI MED SCH,DEPT MED,MINAMIKAWACHI,TOCHIGI 32904,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD MAR
PY 1989
VL 92
IS 3
BP 450
EP 450
PG 1
WC Dermatology
SC Dermatology
GA T6903
UT WOS:A1989T690300358
ER

PT J
AU ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   MINATO, N
   KAWAICHI, M
   HONJO, T
AF ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   MINATO, N
   KAWAICHI, M
   HONJO, T
TI DERMATOLOGICAL AND IMMUNOLOGICAL ABNORMALITIES IN HUMAN IL-2 AND
   IL-2/IL-2 RECEPTOR L-CHAIN TRANSGENIC MICE
SO CLINICAL RESEARCH
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,NAGOYA,AICHI 464,JAPAN.
   JICHI MED SCH,DEPT MED,MINAMI KAWACHI,TOCHIGI 32904,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PD APR
PY 1989
VL 37
IS 2
BP A691
EP A691
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA U0044
UT WOS:A1989U004402702
ER

PT J
AU MITA, S
   TOMINAGA, A
   HITOSHI, Y
   SAKAMOTO, K
   HONJO, T
   AKAGI, M
   KIKUCHI, Y
   YAMAGUCHI, N
   TAKATSU, K
AF MITA, S
   TOMINAGA, A
   HITOSHI, Y
   SAKAMOTO, K
   HONJO, T
   AKAGI, M
   KIKUCHI, Y
   YAMAGUCHI, N
   TAKATSU, K
TI CHARACTERIZATION OF HIGH-AFFINITY RECEPTORS FOR INTERLEUKIN-5 ON
   INTERLEUKIN-5-DEPENDENT CELL-LINES
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,2-2-1 HONGO,KUMAMOTO 860,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED SCI,SAKYO KU,KYOTO 760,JAPAN.
   KUMAMOTO UNIV,SCH MED,DEPT SURG 2,KUMAMOTO 860,JAPAN.
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388
   TAKATSU K, 1988, IMMUNOL REV, V102, P107, DOI 10.1111/j.1600-065X.1988.tb00743.x
   YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HARADA N, 1987, IMMUNOL LETT, V15, P205, DOI 10.1016/0165-2478(87)90026-5
   HOWARD M, 1983, ANNU REV IMMUNOL, V1, P307, DOI 10.1146/annurev.iy.01.040183.001515
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOUGHNAN MS, 1987, P NATL ACAD SCI USA, V84, P5399, DOI 10.1073/pnas.84.15.5399
   MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863
   NAKANISHI K, 1988, J IMMUNOL, V140, P1168
   NOMA T, 1987, IMMUNOL LETT, V15, P249, DOI 10.1016/0165-2478(87)90032-0
   OGAWA M, 1988, EMBO J, V7, P1132
   RASMUSSEN R, 1988, J IMMUNOL, V140, P705
   SABE H, 1988, INT J CANCER, V41, P880, DOI 10.1002/ijc.2910410619
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TAKATSU K, 1988, B CELL DEV, P173
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   TAKATSU K, 1980, J IMMUNOL, V125, P2646
   TAKATSU K, 1988, P SOC EXP BIOL MED, V188, P243
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   TOMINAGA A, 1988, J IMMUNOL, V140, P1175
NR 26
TC 112
Z9 112
U1 1
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR
PY 1989
VL 86
IS 7
BP 2311
EP 2315
DI 10.1073/pnas.86.7.2311
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA U0423
UT WOS:A1989U042300040
PM 2784567
ER

PT J
AU NOMA, T
   NAKAKUBO, H
   SUGITA, M
   KUMAGAI, S
   MAEDA, M
   SHIMIZU, A
   HONJO, T
AF NOMA, T
   NAKAKUBO, H
   SUGITA, M
   KUMAGAI, S
   MAEDA, M
   SHIMIZU, A
   HONJO, T
TI EXPRESSION OF DIFFERENT COMBINATIONS OF INTERLEUKINS BY HUMAN T-CELL
   LEUKEMIC-CELL LINES THAT ARE CLONALLY RELATED
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Note
C1 KYOTO UNIV,FAC MED,DEPT MED 2,KYOTO 606,JAPAN.
   KYOTO UNIV,CHEST DIS RES INST,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
RP NOMA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   PALIARD X, 1988, J IMMUNOL, V141, P849
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   MIYOSHI I, 1980, GANN, V71, P155
   YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0
   CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   MAEDA M, 1987, BLOOD, V70, P1407
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MAEDA S, 1983, BIOCHEM BIOPH RES CO, V115, P1040, DOI 10.1016/S0006-291X(83)80040-0
   MANIATIS T, 1982, MOL CLONING LABORATO
   MARUYAMA M, 1987, JCELL, V48, P493
   NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133
   NOMA T, 1986, BIOCHEM BIOPH RES CO, V139, P353, DOI 10.1016/S0006-291X(86)80121-8
   OGARRA A, 1988, IMMUNOL TODAY, V9, P45, DOI 10.1016/0167-5699(88)91259-5
   SIDERAS P, 1988, IMMUNOL REV, V102, P189, DOI 10.1111/j.1600-065X.1988.tb00745.x
NR 21
TC 75
Z9 75
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 1
PY 1989
VL 169
IS 5
BP 1853
EP 1858
DI 10.1084/jem.169.5.1853
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA U3666
UT WOS:A1989U366600030
PM 2469771
ER

PT J
AU ENOKIHARA, H
   FURUSAWA, S
   NAKAKUBO, H
   KAJITANI, H
   NAGASHIMA, S
   SAITO, K
   SHISHIDO, H
   HITOSHI, Y
   TAKATSU, K
   NOMA, T
   SHIMIZU, A
   HONJO, T
AF ENOKIHARA, H
   FURUSAWA, S
   NAKAKUBO, H
   KAJITANI, H
   NAGASHIMA, S
   SAITO, K
   SHISHIDO, H
   HITOSHI, Y
   TAKATSU, K
   NOMA, T
   SHIMIZU, A
   HONJO, T
TI T-CELLS FROM EOSINOPHILIC PATIENTS PRODUCE INTERLEUKIN-5 WITH
   INTERLEUKIN-2 STIMULATION
SO BLOOD
LA English
DT Article
C1 KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,KUMAMOTO 860,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP ENOKIHARA, H (reprint author), DOKKYO UNIV,SCH MED,DEPT INTERNAL MED 3,880 KITAKOBAYASHI,MIBU,TOCHIGI 32102,JAPAN.
CR CLUTTERBUCK EJ, 1988, BLOOD, V71, P646
   YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   BARTELMEZ SH, 1980, BLOOD, V55, P489
   CAMPBELL HD, 1987, P NATL ACAD SCI USA, V84, P6629, DOI 10.1073/pnas.84.19.6629
   ENOKIHARA H, 1988, BRIT J HAEMATOL, V69, P431, DOI 10.1111/j.1365-2141.1988.tb02393.x
   ENOKIHARA H, 1985, BRIT J HAEMATOL, V59, P85, DOI 10.1111/j.1365-2141.1985.tb02967.x
   ENOKIHARA H, 1988, IMMUNOL LETT, V18, P37
   FURUSAWA S, 1980, P SOC EXP BIOL MED, V163, P76
   HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581
   MAHMOUD AAF, 1977, J CLIN INVEST, V60, P675, DOI 10.1172/JCI108819
   METCALF D, 1986, BLOOD, V67, P37
   NARUO K, 1985, BIOCHEM BIOPH RES CO, V128, P257, DOI 10.1016/0006-291X(85)91672-9
   RAGHAVACHAR A, 1987, J IMMUNOL, V139, P3753
   RENNICK DM, 1985, J IMMUNOL, V134, P910
   RUSCETTI FW, 1976, BLOOD, V47, P757
   TAKAHASHI M, 1988, EXP HEMATOL, V16, P226
   WALLS RS, 1971, BRIT MED J, V3, P157
NR 19
TC 107
Z9 107
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD MAY 15
PY 1989
VL 73
IS 7
BP 1809
EP 1813
PG 5
WC Hematology
SC Hematology
GA U5457
UT WOS:A1989U545700009
PM 2785414
ER

PT J
AU YAMAMOTO, M
   TAKAI, SI
   MIKI, T
   MOTOMURA, K
   OKAZAKI, M
   NISHISHO, I
   TATEISHI, H
   MIYAUCHI, A
   HONJO, T
   PAKSTIS, AJ
   MORI, T
AF YAMAMOTO, M
   TAKAI, SI
   MIKI, T
   MOTOMURA, K
   OKAZAKI, M
   NISHISHO, I
   TATEISHI, H
   MIYAUCHI, A
   HONJO, T
   PAKSTIS, AJ
   MORI, T
TI CLOSE LINKAGE OF MEN2A WITH RBP3 LOCUS IN JAPANESE KINDREDS
SO HUMAN GENETICS
LA English
DT Note
C1 OSAKA UNIV,SCH MED,DEPT MED & GERIAT,OSAKA 553,JAPAN.
   KAGAWA MED SCH,DEPT SURG 2,MIKI,KAGAWA 76107,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510.
RP YAMAMOTO, M (reprint author), OSAKA UNIV,SCH MED,DEPT SURG 2,1-1-50 FUKUSHIMA,FUKUSHIMA KU,OSAKA 553,JAPAN.
CR MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0
   SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0
   LIOU GI, 1987, NUCLEIC ACIDS RES, V15, P3196, DOI 10.1093/nar/15.7.3196
   OTT J, 1974, AM J HUM GENET, V26, P588
   SOBOL H, 1988, LANCET, V1, P62
   TAKAGI H, 1984, IEEE T COMMUN, V32, P246, DOI 10.1109/TCOM.1984.1096061
NR 6
TC 28
Z9 28
U1 1
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-6717
J9 HUM GENET
JI Hum. Genet.
PD JUN
PY 1989
VL 82
IS 3
BP 287
EP 288
DI 10.1007/BF00291173
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA AA742
UT WOS:A1989AA74200020
PM 2567278
ER

PT J
AU NOMA, T
   NAKAKUBO, H
   HAMA, K
   HONJO, T
AF NOMA, T
   NAKAKUBO, H
   HAMA, K
   HONJO, T
TI MULTIPLE EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-4 ON HUMAN MYELOID
   MONOCYTE CELL-LINES
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   ONO PHARMACEUT CO LTD,RES UNIT,MISHIMA,OSAKA 618,JAPAN.
CR PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   GALLAGHER R, 1979, BLOOD, V54, P713
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   HURME M, 1988, BIOCHEM BIOPH RES CO, V157, P861, DOI 10.1016/S0006-291X(88)80954-9
   LAMPSON LA, 1980, J IMMUNOL, V125, P293
   YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DIMITRIUBONA A, 1983, J IMMUNOL, V130, P145
   GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876
   IKUTA K, 1987, P NATL ACAD SCI USA, V84, P819, DOI 10.1073/pnas.84.3.819
   KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MACINTYRE EA, 1987, LEUKOCYTE TYPING 3, P723
   MACMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MAEDA M, 1988, IMMUNOL LETT, V18, P247, DOI 10.1016/0165-2478(88)90170-8
   MAEDA S, 1983, BIOCHEM BIOPH RES CO, V115, P1040, DOI 10.1016/S0006-291X(83)80040-0
   NOMA T, 1986, BIOCHEM BIOPH RES CO, V139, P353, DOI 10.1016/S0006-291X(86)80121-8
   NOMA T, 1989, IN PRESS J EXP MED
   NORO N, 1986, J IMMUNOL, V137, P1258
   ROUSSET F, 1988, J IMMUNOL, V140, P2625
   SHIMMONS DL, 1989, BLOOD, V73, P284
   VERICELL D, 1988, J EXP MED, V167, P1406
   YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894
NR 31
TC 10
Z9 10
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUN 15
PY 1989
VL 21
IS 4
BP 323
EP 328
DI 10.1016/0165-2478(89)90027-8
PG 6
WC Immunology
SC Immunology
GA AC614
UT WOS:A1989AC61400010
PM 2475440
ER

PT J
AU NOSAKA, T
   KITA, K
   MIWA, H
   KAWAKAMI, K
   IKEDA, T
   OHNO, T
   MATSUOKA, N
   ARITA, Y
   DOI, S
   NISHIKORI, M
   MATSUDA, F
   LEE, KH
   SHIRAKAWA, S
   HONJO, T
   HATANAKA, M
AF NOSAKA, T
   KITA, K
   MIWA, H
   KAWAKAMI, K
   IKEDA, T
   OHNO, T
   MATSUOKA, N
   ARITA, Y
   DOI, S
   NISHIKORI, M
   MATSUDA, F
   LEE, KH
   SHIRAKAWA, S
   HONJO, T
   HATANAKA, M
TI CROSS-LINEAGE GENE REARRANGEMENTS IN HUMAN-LEUKEMIC B-PRECURSOR CELLS
   OCCUR FREQUENTLY WITH V-DJ REARRANGEMENTS OF IGH GENES
SO BLOOD
LA English
DT Article
C1 KYOTO UNIV,INST VIRUS RES,DEPT SEROL & IMMUNOL,KYOTO 606,JAPAN.
   MIE UNIV,FAC MED,DEPT INTERNAL MED,TSU,MIE 514,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DIV INTERNAL MED 1,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x
   FLUG F, 1985, P NATL ACAD SCI USA, V82, P3460, DOI 10.1073/pnas.82.10.3460
   RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   ALT FW, 1982, MOL CELL BIOL, V2, P386
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588
   GREAVES MF, 1986, BLOOD, V67, P1
   DAVEY MP, 1986, P NATL ACAD SCI USA, V83, P8759, DOI 10.1073/pnas.83.22.8759
   KORSMEYER SJ, 1983, J CLIN INVEST, V71, P301, DOI 10.1172/JCI110770
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0
   WALDMANN TA, 1985, NEW ENGL J MED, V313, P776, DOI 10.1056/NEJM198509263131303
   SMITH LJ, 1983, BLOOD, V61, P1138
   YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2
   ASOU N, 1987, BLOOD, V69, P968
   BERMAN JE, 1988, EMBO J, V7, P727
   BOEHM TLJ, 1987, MOL BIOL MED, V4, P51
   CHEN Z, 1987, J EXP MED, V165, P1000, DOI 10.1084/jem.165.4.1000
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   FOA R, 1987, J EXP MED, V165, P879, DOI 10.1084/jem.165.3.879
   GOORHA R, 1987, P NATL ACAD SCI USA, V84, P4547, DOI 10.1073/pnas.84.13.4547
   GREENBERG JM, 1986, J IMMUNOL, V137, P2043
   HA K, 1984, J CLIN INVEST, V73, P1232, DOI 10.1172/JCI111310
   HAGIYA M, 1986, P NATL ACAD SCI USA, V83, P145, DOI 10.1073/pnas.83.1.145
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   KITA K, 1985, BLOOD, V66, P47
   KOBAYASHI N, 1984, EMBO J, V3, P1339
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   LEFRANC MP, 1985, NATURE, V316, P464, DOI 10.1038/316464a0
   MATSUDA F, 1988, EMBO J, V7, P1047
   MIWA H, 1988, JPN J CANCER RES, V79, P484
   Miwa H, 1987, J Mol Cell Immunol, V3, P37
   MIZUTANI S, 1986, EMBO J, V5, P3467
   NADLER LM, 1984, J CLIN INVEST, V74, P332, DOI 10.1172/JCI111428
   NELSON KJ, 1983, MOL CELL BIOL, V3, P1317
   PALUMBO A, 1984, BLOOD, V64, P1059
   PARK YH, 1987, J EXP MED, V165, P444, DOI 10.1084/jem.165.2.444
   PELICCI PG, 1985, J EXP MED, V162, P1015, DOI 10.1084/jem.162.3.1015
   RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0
   ROVIGATTI U, 1984, BLOOD, V63, P1023
   SATO T, 1988, BIOCHEM BIOPH RES CO, V154, P265, DOI 10.1016/0006-291X(88)90679-1
   SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   TAWA A, 1985, NEW ENGL J MED, V313, P1033, DOI 10.1056/NEJM198510243131701
NR 52
TC 34
Z9 34
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD JUL
PY 1989
VL 74
IS 1
BP 361
EP 368
PG 8
WC Hematology
SC Hematology
GA AE781
UT WOS:A1989AE78100051
PM 2546622
ER

PT J
AU OHNO, H
   FUKUHARA, S
   DOI, S
   AMAKAWA, R
   HORII, M
   AKIYAMA, Y
   FUKUDA, W
   HONJO, T
   SUGIYAMA, T
   UCHINO, H
AF OHNO, H
   FUKUHARA, S
   DOI, S
   AMAKAWA, R
   HORII, M
   AKIYAMA, Y
   FUKUDA, W
   HONJO, T
   SUGIYAMA, T
   UCHINO, H
TI INVOLVEMENT OF C-MYC ONCOGENE IN LYMPHOMA CELL-LINES WITH NO DETECTABLE
   CHROMOSOME REARRANGEMENT OF BAND-8Q24
SO CANCER GENETICS AND CYTOGENETICS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 1,54 SHOGOIN KAWARAMACHI,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO 2ND RED CROSS HOSP,DEPT MED,KYOTO,JAPAN.
   KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KOBE UNIV,SCH MED,DEPT PATHOL,KOBE 650,JAPAN.
CR [Anonymous], 1982, CANCER, V49, P2112
   DALLAFAVERA R, 1982, NATURE, V299, P61
   TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263
   PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984
   FUKUHARA S, 1978, INT J CANCER, V22, P14, DOI 10.1002/ijc.2910220105
   BLOOMFIELD CD, 1983, CANCER RES, V43, P2975
   CROCE CM, 1985, BLOOD, V65, P1
   DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824
   FUKUHARA S, 1984, ACTA HAEMATOL JAPON, V47, P1579
   HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0
   HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0
   IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030
   LACY J, 1987, P NATL ACAD SCI USA, V84, P5838, DOI 10.1073/pnas.84.16.5838
   LIPFORD E, 1987, BLOOD, V70, P1816
   MINTY AJ, 1983, J MOL BIOL, V167, P77, DOI 10.1016/S0022-2836(83)80035-7
   NACHEVA E, 1987, CANCER GENET CYTOGEN, V28, P145, DOI 10.1016/0165-4608(87)90364-5
   OHNO H, 1986, INT J CANCER, V37, P761, DOI 10.1002/ijc.2910370518
   OHNO H, 1988, CANCER RES, V48, P4959
   ROTHBERG PG, 1984, MOL CELL BIOL, V4, P1096
   SELDEN JR, 1983, P NATL ACAD SCI-BIOL, V80, P7289, DOI 10.1073/pnas.80.23.7289
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837
   TAYA Y, 1984, EMBO J, V3, P2943
   TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211
   YUNIS JJ, 1984, CANCER GENET CYTOGEN, V13, P17, DOI 10.1016/0165-4608(84)90084-0
   1985, BIRTH DEFECTS ORIGIN, V21
NR 27
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0165-4608
J9 CANCER GENET CYTOGEN
JI Cancer Genet. Cytogenet.
PD JUL 1
PY 1989
VL 40
IS 1
BP 73
EP 82
DI 10.1016/0165-4608(89)90147-7
PG 10
WC Oncology; Genetics & Heredity
SC Oncology; Genetics & Heredity
GA AN288
UT WOS:A1989AN28800009
PM 2547511
ER

PT J
AU AOKI, T
   KIKUCHI, H
   MIYATAKE, S
   ODA, Y
   IWASAKI, K
   YAMASAKI, T
   KINASHI, T
   HONJO, T
AF AOKI, T
   KIKUCHI, H
   MIYATAKE, S
   ODA, Y
   IWASAKI, K
   YAMASAKI, T
   KINASHI, T
   HONJO, T
TI INTERLEUKIN-5 ENHANCES INTERLEUKIN 2-MEDIATED LYMPHOKINE-ACTIVATED
   KILLER ACTIVITY
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Note
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RP AOKI, T (reprint author), KYOTO UNIV,FAC MED,DEPT NEUROSURG,SAKYO KU,KYOTO 606,JAPAN.
CR KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823
   YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43
   DAMLE NK, 1986, J IMMUNOL, V137, P2814
   HERGEN S, 1988, J IMMUNOL, V141, P29
   ITOH K, 1985, J IMMUNOL, V134, P802
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LOTS MT, 1981, CANCER RES, V41, P4420
   LOUGHNAN MS, 1987, P NATL ACAD SCI USA, V84, P5399, DOI 10.1073/pnas.84.15.5399
   MULE JJ, 1987, J EXP MED, V166, P792, DOI 10.1084/jem.166.3.792
   PHILLIPS JH, 1986, J EXP MED, V164, P814, DOI 10.1084/jem.164.3.814
   ROSENSTEIN M, 1984, CANCER RES, V44, P1946
   SWAN SL, 1982, J EXP MED, V156, P1821
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   TOMINAGA A, 1980, J IMMUNOL, V126, P2646
   YUJI K, 1986, J IMMUNOL, V136, P1161
NR 18
TC 34
Z9 34
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD AUG 1
PY 1989
VL 170
IS 2
BP 583
EP 588
DI 10.1084/jem.170.2.583
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA AK034
UT WOS:A1989AK03400017
PM 2787831
ER

PT J
AU TAKEMOTO, Y
   MIKI, T
   NAKURA, J
   NISHIKAWA, K
   KAMINO, K
   TAKEDA, S
   KUZU, K
   OSAME, M
   NAKAGAWA, M
   HIGUCHI, I
   YAMADA, T
   TAKAYANAGI, T
   MATSUBARA, S
   SAITA, K
   TAKAI, S
   HONJO, T
   OGIHARA, T
AF TAKEMOTO, Y
   MIKI, T
   NAKURA, J
   NISHIKAWA, K
   KAMINO, K
   TAKEDA, S
   KUZU, K
   OSAME, M
   NAKAGAWA, M
   HIGUCHI, I
   YAMADA, T
   TAKAYANAGI, T
   MATSUBARA, S
   SAITA, K
   TAKAI, S
   HONJO, T
   OGIHARA, T
TI PRECLINICAL DETECTION IN JAPANESE FAMILIES WITH MYOTONIC-DYSTROPHY USING
   POLYMORPHIC DNA MARKERS
SO JAPANESE JOURNAL OF HUMAN GENETICS
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KAGOSHIMA UNIV,SCH MED,DEPT INTERNAL MED 3,USHU KU,KAGOSHIMA 890,JAPAN.
   NATL SANATORIUM OKINAWA HOSP,OKINAWA 90122,JAPAN.
   KYUSHU UNIV,SCH MED,DEPT NEUROL,HIGASHI KU,FUKUOKA 812,JAPAN.
   NARA MED UNIV,DEPT NEUROL,KASHIWARA,NARA 634,JAPAN.
   KANAZAWA UNIV,SCH MED,DEPT NEUROL,KANAZAWA,ISHIKAWA 920,JAPAN.
   NATL SANATORIUM UTANO HOSP,UKYO KU,KYOTO 616,JAPAN.
   OSAKA UNIV,SCH MED,DEPT SURG 2,FUKUSHIMA KU,OSAKA 553,JAPAN.
RP TAKEMOTO, Y (reprint author), OSAKA UNIV,SCH MED,DEPT GERIATR MED,FUKUSHIMA KU,OSAKA 553,JAPAN.
CR GRIGGS RC, 1989, NEUROLOGY, V39, P420
   BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876
   JOHNSON K, 1988, HUM GENET, V80, P379, DOI 10.1007/BF00273655
   LUNT PW, 1986, LANCET, V2, P350
   MEREDITH AL, 1986, BRIT MED J, V293, P1353
   MYKLEBOST O, 1984, J BIOL CHEM, V259, P4401
   NISHISHO I, 1986, JPN J HUM GENET, V31, P249, DOI 10.1007/BF01870755
   OSAME M, 1983, CLIN NEUROL, V23, P1067
   ROMEO G, 1988, LANCET, V2, P8
   SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406
   SHAW DJ, 1985, HUM GENET, V70, P271
   Streib E W, 1987, Electromyogr Clin Neurophysiol, V27, P443
   TAKEMOTO Y, 1989, IN PRESS GENOMICS
NR 13
TC 0
Z9 0
U1 0
U2 1
PU TOKYO MEDICAL DENTAL UNIV
PI TOKYO
PA MED RES INST-DEPT CYTOGENETICS YUSHIMA 1 BUNKYO-KU, TOKYO 113, JAPAN
SN 0916-8478
J9 JPN J HUM GENET
JI Jpn. J. Hum. Genet.
PD SEP
PY 1989
VL 34
IS 3
BP 189
EP 194
DI 10.1007/BF01900720
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA CK977
UT WOS:A1989CK97700001
PM 2576756
ER

PT J
AU ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   HATTORI, M
   MINATO, N
   KAWAICHI, M
   HONJO, T
AF ISHIDA, Y
   NISHI, M
   TAGUCHI, O
   INABA, K
   HATTORI, M
   MINATO, N
   KAWAICHI, M
   HONJO, T
TI EXPANSION OF NATURAL-KILLER CELLS BUT NOT T-CELLS IN HUMAN INTERLEUKIN-2
   INTERLEUKIN-2 RECEPTOR (TAC) TRANSGENIC MICE
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
C1 KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,NAGOYA,AICHI 464,JAPAN.
   JICHI MED SCH,DEPT MED,MINAMI KAWACHI,TOCHIGI 32904,JAPAN.
   HOKKAIDO UNIV,DEPT VET MED,SAPPORO 061,JAPAN.
RP ISHIDA, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   LOTZE MT, 1986, JAMA-J AM MED ASSOC, V256, P3117, DOI 10.1001/jama.256.22.3117
   BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   GATLEY MK, 1988, J IMMUNOL, V141, P189
   HANSSON M, 1979, NATURE, V278, P174, DOI 10.1038/278174a0
   Hattori M, 1989, Int Immunol, V1, P151, DOI 10.1093/intimm/1.2.151
   HERBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651, DOI 10.1146/annurev.immunol.4.1.651
   HERCEND T, 1988, IMMUNOL TODAY, V9, P291, DOI 10.1016/0167-5699(88)91317-5
   HERSEY P, 1987, IMMUNOL TODAY, V8, P233, DOI 10.1016/0167-5699(87)90173-3
   Ishida Y, 1989, Int Immunol, V1, P113, DOI 10.1093/intimm/1.2.113
   JENKINSON EJ, 1987, NATURE, V329, P160, DOI 10.1038/329160a0
   MAEDA M, 1987, BLOOD, V70, P1407
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MERRILL JE, 1984, SCIENCE, V224, P1428, DOI 10.1126/science.6610212
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   SHARON M, 1988, J EXP MED, V167, P1265, DOI 10.1084/jem.167.3.1265
   SMITH KA, 1988, SCIENCE, V240, P116
   TENTORI L, 1988, J EXP MED, V168, P1741, DOI 10.1084/jem.168.5.1741
   TSUDO M, 1987, P NATL ACAD SCI USA, V84, P5394, DOI 10.1073/pnas.84.15.5394
   WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   YODOI J, 1983, BLOOD, V62, P509
NR 28
TC 49
Z9 49
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD OCT 1
PY 1989
VL 170
IS 4
BP 1103
EP 1115
DI 10.1084/jem.170.4.1103
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA AU293
UT WOS:A1989AU29300004
PM 2571665
ER

PT J
AU SHIMIZU, A
   NUSSENZWEIG, MC
   MIZUTA, TR
   LEDER, P
   HONJO, T
AF SHIMIZU, A
   NUSSENZWEIG, MC
   MIZUTA, TR
   LEDER, P
   HONJO, T
TI IMMUNOGLOBULIN DOUBLE-ISOTYPE EXPRESSION BY TRANS-MESSENGER RNA IN A
   HUMAN-IMMUNOGLOBULIN TRANSGENIC MOUSE
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   HARVARD UNIV,SCH MED,DEPT GENET,HOWARD HUGHES MED INST,BOSTON,MA 02115.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3
   MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1
   SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183
   NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   PERNIS B, 1973, IMMUNOCHEMISTRY, V10, P281, DOI 10.1016/0019-2791(73)90023-2
   RADBRUCH A, 1983, EMBO J, V2, P1929
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   KOLLER B, 1987, CELL, V48, P111, DOI 10.1016/0092-8674(87)90361-8
   UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DURDIK J, 1989, P NATL ACAD SCI USA, V86, P2346, DOI 10.1073/pnas.86.7.2346
   HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1
   KAUSE M, 1987, CELL, V49, P753
   KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887
   KNIGHT KL, 1974, P NATL ACAD SCI USA, V71, P1169, DOI 10.1073/pnas.71.4.1169
   LANDUCCI.S, 1973, IMMUNOCHEMISTRY, V10, P65, DOI 10.1016/0019-2791(73)90232-2
   NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175
   ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037
   VANDERPLOEG LHT, 1986, CELL, V47, P479, DOI 10.1016/0092-8674(86)90608-2
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 34
TC 67
Z9 67
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT
PY 1989
VL 86
IS 20
BP 8020
EP 8023
DI 10.1073/pnas.86.20.8020
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AV529
UT WOS:A1989AV52900076
PM 2510157
ER

PT J
AU HAMAGUCHI, Y
   MATSUNAMI, N
   YAMAMOTO, Y
   HONJO, T
AF HAMAGUCHI, Y
   MATSUNAMI, N
   YAMAMOTO, Y
   HONJO, T
TI PURIFICATION AND CHARACTERIZATION OF A PROTEIN THAT BINDS TO THE
   RECOMBINATION SIGNAL SEQUENCE OF THE IMMUNOGLOBULIN-J-ALEPH SEGMENT
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
RP HAMAGUCHI, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AGUILERA RJ, 1987, CELL, V51, P909, DOI 10.1016/0092-8674(87)90578-2
   ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   BLACKWELL TK, 1984, CELL, V37, P105
   CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6
   Ferrier P, 1989, INT IMMUNOL, V1, P66, DOI 10.1093/intimm/1.1.66
   HALLIGAN BD, 1987, P NATL ACAD SCI USA, V84, P7019, DOI 10.1073/pnas.84.20.7019
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   KAVALER J, 1984, NATURE, V310, P421, DOI 10.1038/310421a0
   KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEWIS S, 1984, NATURE, V308, P425, DOI 10.1038/308425a0
   LEWIS S, 1985, SCIENCE, V228, P677, DOI 10.1126/science.3158075
   PELKONEN J, 1987, J EXP MED, V166, P1245, DOI 10.1084/jem.166.5.1245
   SEIDMAN JG, 1979, NATURE, V280, P370, DOI 10.1038/280370a0
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 27
TC 55
Z9 55
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD NOV 25
PY 1989
VL 17
IS 22
BP 9015
EP 9026
DI 10.1093/nar/17.22.9015
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CB883
UT WOS:A1989CB88300008
PM 2511556
ER

PT J
AU MITA, S
   HOSOYA, Y
   KUBOTA, I
   NISHIHARA, T
   HONJO, T
   TAKAHASHI, T
   TAKATSU, K
AF MITA, S
   HOSOYA, Y
   KUBOTA, I
   NISHIHARA, T
   HONJO, T
   TAKAHASHI, T
   TAKATSU, K
TI RAPID METHODS FOR PURIFICATION OF HUMAN RECOMBINANT INTERLEUKIN-5 (IL-5)
   USING THE ANTI-MURINE IL-5 ANTIBODY-COUPLED IMMUNOAFFINITY COLUMN
SO JOURNAL OF IMMUNOLOGICAL METHODS
LA English
DT Article
C1 KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,DEPT BIOL,2-2-1 HONJO,KUMAMOTO 860,JAPAN.
   SUNTORY,INST BIOMED RES,OSAKA 618,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED SCI,KYOTO 780,JAPAN.
CR KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133
   YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388
   TAKATSU K, 1988, IMMUNOL REV, V102, P107, DOI 10.1111/j.1600-065X.1988.tb00743.x
   NAMBU JR, 1983, CELL, V35, P47, DOI 10.1016/0092-8674(83)90206-4
   HEWICK RM, 1981, J BIOL CHEM, V256, P7990
   AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149
   FREEMAN GJ, 1983, P NATL ACAD SCI-BIOL, V80, P4094, DOI 10.1073/pnas.80.13.4094
   HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581
   HARADA N, 1985, J IMMUNOL, V134, P3944
   HAYNES J, 1983, NUCLEIC ACIDS RES, V11, P687, DOI 10.1093/nar/11.3.687
   HOWARD M, 1983, ANNU REV IMMUNOL, V1, P307, DOI 10.1146/annurev.iy.01.040183.001515
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TAKATSU K, 1988, P SOC EXP BIOL MED, V188, P243
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   TANABE T, 1987, J BIOL CHEM, V262, P16580
   TOMINAGA A, 1989, GROWTH FACTORS, V1, P137
   TOMINAGA A, 1988, J IMMUNOL, V140, P1175
   TSUJIMOTO M, 1989, J BIOCHEM-TOKYO, V106, P23
   YAMAGUCHI Y, 1988, J EXP MED, V163, P46
NR 22
TC 17
Z9 17
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-1759
J9 J IMMUNOL METHODS
JI J. Immunol. Methods
PD DEC 20
PY 1989
VL 125
IS 1-2
BP 233
EP 241
PG 9
WC Biochemical Research Methods; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA CF029
UT WOS:A1989CF02900029
PM 2607155
ER

PT J
AU MATSUNAMI, N
   HAMAGUCHI, Y
   YAMAMOTO, Y
   KUZE, K
   KANGAWA, K
   MATSUO, H
   KAWAICHI, M
   HONJO, T
AF MATSUNAMI, N
   HAMAGUCHI, Y
   YAMAMOTO, Y
   KUZE, K
   KANGAWA, K
   MATSUO, H
   KAWAICHI, M
   HONJO, T
TI A PROTEIN-BINDING TO THE J-KAPPA RECOMBINATION SEQUENCE OF
   IMMUNOGLOBULIN GENES CONTAINS A SEQUENCE RELATED TO THE INTEGRASE MOTIF
SO NATURE
LA English
DT Article
C1 MIYAZAKI UNIV,DEPT BIOCHEM,MIYAZAKI 880,JAPAN.
RP MATSUNAMI, N (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   MILLER J, 1985, EMBO J, V4, P1609
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678
   PABO CO, 1984, ANNU REV BIOCHEM, V53, P293
   UTATSU I, 1987, J BACTERIOL, V169, P5537
   KLEMM P, 1986, EMBO J, V5, P1389
   PIERSON LS, 1987, J MOL BIOL, V196, P487, DOI 10.1016/0022-2836(87)90026-X
   ARGOS P, 1986, EMBO J, V5, P433
   HARTLEY JL, 1980, NATURE, V286, P860, DOI 10.1038/286860a0
   CRAIG NL, 1988, ANNU REV GENET, V22, P77
   VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5
   ARAKI H, 1985, J MOL BIOL, V182, P191, DOI 10.1016/0022-2836(85)90338-9
   HALL RM, 1987, NUCLEIC ACIDS RES, V15, P7491, DOI 10.1093/nar/15.18.7491
   CHEN XJ, 1986, NUCLEIC ACIDS RES, V14, P4471, DOI 10.1093/nar/14.11.4471
   HAMAGUCHI Y, IN PRESS NUCLEIC ACI
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117
   MURPHY E, 1985, EMBO J, V4, P3357
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OKAYAMA H, 1982, MOL CELL BIOL, V2, P161
   PARSONS RL, 1988, MOL CELL BIOL, V8, P3303
   PASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189
   TOHE A, 1985, NUCLEIC ACIDS RES, V13, P4267, DOI 10.1093/nar/13.12.4267
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 26
TC 148
Z9 150
U1 0
U2 0
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA 4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF
SN 0028-0836
J9 NATURE
JI Nature
PD DEC 21
PY 1989
VL 342
IS 6252
BP 934
EP 937
DI 10.1038/342934a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CF637
UT WOS:A1989CF63700067
PM 2556644
ER

PT J
AU TAKEMOTO, Y
   MIKI, T
   NISHIKAWA, K
   NAKURA, J
   KAMINO, K
   TAKAI, S
   HONJO, T
   OGIHARA, T
AF TAKEMOTO, Y
   MIKI, T
   NISHIKAWA, K
   NAKURA, J
   KAMINO, K
   TAKAI, S
   HONJO, T
   OGIHARA, T
TI THE LOCUS FOR JAPANESE MYOTONIC-DYSTROPHY IS ALSO LINKED TO D19S19 ON
   THE LONG ARM OF CHROMOSOME-19
SO GENOMICS
LA English
DT Note
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   OSAKA UNIV,SCH MED,DEPT SURG 2,FUKUSHIMA KU,OSAKA 553,JAPAN.
RP TAKEMOTO, Y (reprint author), OSAKA UNIV,SCH MED,DEPT GERIATR MED,FUKUSHIMA KU,OSAKA 553,JAPAN.
CR GRIGGS RC, 1989, NEUROLOGY, V39, P420
   LATHROP GM, 1984, AM J HUM GENET, V36, P460
   BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876
   MYKLEBOST O, 1984, J BIOL CHEM, V259, P4401
   OSAME M, 1983, CLIN NEUROL, V23, P1067
   SAITA K, 1986, EPIDEMIOLOGY PATHOGE, P91
   SHAW DJ, 1985, HUM GENET, V70, P271
NR 7
TC 4
Z9 4
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD JAN
PY 1990
VL 6
IS 1
BP 195
EP 196
PG 2
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA CQ070
UT WOS:A1990CQ07000027
PM 2303261
ER

PT J
AU IKEDA, T
   KITA, K
   MIWA, H
   KAWAKAMI, K
   ANAZAWA, H
   OHNO, T
   NOSAKA, T
   HATANAKA, M
   HONJO, T
   SHIRAKAWA, S
AF IKEDA, T
   KITA, K
   MIWA, H
   KAWAKAMI, K
   ANAZAWA, H
   OHNO, T
   NOSAKA, T
   HATANAKA, M
   HONJO, T
   SHIRAKAWA, S
TI GENETIC-HETEROGENEITY IN BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA
SO LEUKEMIA RESEARCH
LA English
DT Article
C1 MIE UNIV,FAC MED,DEPT INT MED 2,TSU,MIE 514,JAPAN.
   KYOTO UNIV,INST VIRUS RES,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ADACHI K, 1988, J LAB CLIN MED, V111, P125
   AISENBERG AC, 1985, BLOOD, V66, P1215
   GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1
   BAKHSHI A, 1983, NEW ENGL J MED, V309, P826, DOI 10.1056/NEJM198310063091404
   BIRD J, 1988, J EXP MED, V168, P229, DOI 10.1084/jem.168.1.229
   CHEN Z, 1987, J EXP MED, V165, P1000, DOI 10.1084/jem.165.4.1000
   FOA R, 1984, J CLIN INVEST, V74, P1756, DOI 10.1172/JCI111594
   FORD AM, 1983, EMBO J, V2, P997
   GOORHA R, 1987, P NATL ACAD SCI USA, V84, P4547, DOI 10.1073/pnas.84.13.4547
   GREAVES MF, 1982, CHRONIC GRANULOCYTIC, P15
   GRIFFIN JD, 1983, BLOOD, V61, P85
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   JANOSSY G, 1976, BRIT J HAEMATOL, V34, P179, DOI 10.1111/j.1365-2141.1976.tb00189.x
   KITA K, 1985, BLOOD, V66, P47
   KITCHINGMAN GR, 1986, BLOOD, V67, P698
   LEFRANC MP, 1985, NATURE, V316, P464, DOI 10.1038/316464a0
   LUDWIG WD, 1988, BLOOD, V71, P1518
   MIWA H, 1988, JPN J CANCER RES, V79, P484
   RECHAVI G, 1988, LEUKEMIA, V2, P347
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   TAWA A, 1985, NEW ENGL J MED, V313, P1033, DOI 10.1056/NEJM198510243131701
NR 23
TC 9
Z9 9
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0145-2126
J9 LEUKEMIA RES
JI Leuk. Res.
PY 1990
VL 14
IS 2
BP 195
EP 201
DI 10.1016/0145-2126(90)90049-F
PG 7
WC Oncology; Hematology
SC Oncology; Hematology
GA CR516
UT WOS:A1990CR51600011
PM 2156114
ER

PT J
AU OHNO, H
   FURUKAWA, T
   FUKUHARA, S
   ZONG, SQ
   KAMESAKI, H
   SHOWS, TB
   LEBEAU, MM
   MCKEITHAN, TW
   KAWAKAMI, T
   HONJO, T
AF OHNO, H
   FURUKAWA, T
   FUKUHARA, S
   ZONG, SQ
   KAMESAKI, H
   SHOWS, TB
   LEBEAU, MM
   MCKEITHAN, TW
   KAWAKAMI, T
   HONJO, T
TI MOLECULAR ANALYSIS OF A CHROMOSOMAL TRANSLOCATION, T(9-14)(P13-Q32), IN
   A DIFFUSE LARGE-CELL LYMPHOMA CELL-LINE EXPRESSING THE KI-1 ANTIGEN
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT INTERNAL MED,KYOTO 606,JAPAN.
   UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637.
   UNIV CHICAGO,DEPT MED,HEMATOL ONCOL SECT,CHICAGO,IL 60637.
   NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263.
RP OHNO, H (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Kawakami, Toshiaki/O-1616-2015
CR FISCHER P, 1988, BLOOD, V72, P234
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263
   LEBEAU MM, 1989, LEUKEMIA, V3, P866
   SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0
   STEIN H, 1985, BLOOD, V66, P848
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748
   FUKUHARA S, 1978, INT J CANCER, V22, P14, DOI 10.1002/ijc.2910220105
   COSSMAN J, 1988, ARCH PATHOL LAB MED, V112, P117
   DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824
   FUKUHARA S, 1984, ACTA HAEMATOL JAPON, V47, P1579
   HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0
   HARNDEN D, 1985, ISCN 1985 INT SYSTEM
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   KAMESAKI H, 1988, JPN J CANCER RES, V79, P1193
   KANEKO Y, 1989, BLOOD, V73, P806
   LEBEAU MM, 1984, NATURE, V312, P70, DOI 10.1038/312070a0
   NATHWANI BN, 1982, BLOOD, V60, P1068
   OHNO H, 1988, CANCER RES, V48, P4959
   PELLET P, 1989, ONCOGENE, V4, P653
   RIMOKH R, 1989, BRIT J HAEMATOL, V71, P31, DOI 10.1111/j.1365-2141.1989.tb06270.x
   ROWLEY JD, 1988, J CLIN ONCOL, V6, P919
   SHOWS T, 1984, SOMAT CELL MOLEC GEN, V10, P315, DOI 10.1007/BF01535253
   SHOWS TB, 1982, ADV HUM GENET, V12, P341
   SHOWS TB, 1983, ISOZYMES-CURR T BIOL, V10, P323
   SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   SUCHI T, 1987, J CLIN PATHOL, V40, P995, DOI 10.1136/jcp.40.9.995
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837
   TAYA Y, 1984, EMBO J, V3, P2943
   1987, BLOOD, V70, P1554
NR 35
TC 44
Z9 44
U1 0
U2 0
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN
PY 1990
VL 87
IS 2
BP 628
EP 632
DI 10.1073/pnas.87.2.628
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK378
UT WOS:A1990CK37800026
PM 2153959
ER

PT J
AU KINASHI, T
   TASHIRO, K
   LEE, KH
   INABA, K
   TOYAMA, K
   PALACIOS, R
   HONJO, T
AF KINASHI, T
   TASHIRO, K
   LEE, KH
   INABA, K
   TOYAMA, K
   PALACIOS, R
   HONJO, T
TI GROWTH-FACTORS INVOLVED IN LYMPHOCYTE DIFFERENTIATION
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES
   B-BIOLOGICAL SCIENCES
LA English
DT Article
C1 KYOTO UNIV,FAC SCI,DEPT ZOOL,KYOTO 606,JAPAN.
   BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.
RP KINASHI, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR GREAVES MF, 1986, BLOOD, V67, P1
   OGAWA M, 1988, EMBO J, V7, P1337
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389
   GOUD TJLM, 1975, J EXP MED, V142, P1180, DOI 10.1084/jem.142.5.1180
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   KINCADE PW, 1976, J EXP MED, V143, P1265, DOI 10.1084/jem.143.5.1265
   MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414
   NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976
   Palacios R, 1988, IMMUNOL REV, V104, P1
   PALACIOS R, 1987, EMBO J, V6, P3687
   PESCHEL C, 1987, BLOOD, V70, P254
   SIDERAS P, 1988, IMMUNOL REV, V102, P189, DOI 10.1111/j.1600-065X.1988.tb00745.x
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 17
TC 5
Z9 5
U1 1
U2 1
PU ROYAL SOC LONDON
PI LONDON
PA 6 CARLTON HOUSE TERRACE, LONDON, ENGLAND SW1Y 5AG
SN 0962-8436
J9 PHILOS T ROY SOC B
JI Philos. Trans. R. Soc. Lond. Ser. B-Biol. Sci.
PD MAR 12
PY 1990
VL 327
IS 1239
BP 117
EP &
DI 10.1098/rstb.1990.0048
PG 0
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CU574
UT WOS:A1990CU57400006
PM 1969653
ER

PT J
AU IKEDA, T
   KITA, K
   KAWAKAMI, K
   OHNO, T
   SEKI, S
   NASU, K
   UEDA, T
   HONJO, T
   SHIRAKAWA, S
AF IKEDA, T
   KITA, K
   KAWAKAMI, K
   OHNO, T
   SEKI, S
   NASU, K
   UEDA, T
   HONJO, T
   SHIRAKAWA, S
TI OLIGOCLONAL IMMUNOGLOBULIN GENE REARRANGEMENTS IN PHILADELPHIA
   CHROMOSOME-POSITIVE COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
C1 MIE UNIV,SCH MED,DEPT INTERNAL MED 2,2-174 EDOBASHI,TSU,MIE 514,JAPAN.
   SAKU GEN HOSP,DEPT INTERNAL MED,MINAMISAKI,NAGANO 38403,JAPAN.
   OSAKA RED CROSS HOSP,DEPT INTERNAL MED,TENNOHJI KU,OSAKA 543,JAPAN.
   FUKUI MED SCH,DEPT INTERNAL MED 1,YOSHIDA,FUKUI 91011,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0
   WALDMANN TA, 1985, NEW ENGL J MED, V313, P776, DOI 10.1056/NEJM198509263131303
   ARNOLD A, 1983, NEW ENGL J MED, V309, P1593, DOI 10.1056/NEJM198312293092601
   BIRD J, 1988, J EXP MED, V168, P229, DOI 10.1084/jem.168.1.229
   CHEN SJ, 1988, LEUKEMIA, V2, P261
   FOA R, 1984, J CLIN INVEST, V74, P1756, DOI 10.1172/JCI111594
   GRIESSER H, 1986, BLOOD, V68, P592
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   HIRSCHGINSBERG C, 1988, BLOOD, V71, P186
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   KITA K, 1985, BLOOD, V66, P47
   KITCHINGMAN GR, 1986, BLOOD, V67, P698
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   LEFRANC MP, 1985, NATURE, V316, P464, DOI 10.1038/316464a0
   LUDWIG WD, 1988, BLOOD, V71, P1518
   NOSAKA T, 1989, BLOOD, V74, P361
   RAGHAVACHAR A, 1986, BLOOD, V68, P658
   RECHAVI G, 1988, LEUKEMIA, V2, P347
   SOBOL RE, 1987, NEW ENGL J MED, V316, P1111, DOI 10.1056/NEJM198704303161802
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
NR 21
TC 0
Z9 0
U1 0
U2 0
PU JAPANESE CANCER ASSOCIATION
PI TOKYO
PA EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PD APR
PY 1990
VL 81
IS 4
BP 340
EP 344
PG 5
WC Oncology
SC Oncology
GA DD530
UT WOS:A1990DD53000008
PM 2114388
ER

PT J
AU OKAMOTO, M
   HONJO, T
AF OKAMOTO, M
   HONJO, T
TI NUCLEOTIDE-SEQUENCES OF THE GENE/CDNA CODING FOR ANTIMURINE ERYTHROCYTE
   AUTOANTIBODY PRODUCED BY A HYBRIDOMA FROM NZB MOUSE
SO NUCLEIC ACIDS RESEARCH
LA English
DT Note
RP OKAMOTO, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150
   CLAFLIN JL, 1987, J IMMUNOL, V138, P3060
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
NR 3
TC 8
Z9 8
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 11
PY 1990
VL 18
IS 7
BP 1895
EP 1895
DI 10.1093/nar/18.7.1895
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CZ684
UT WOS:A1990CZ68400036
PM 2336368
ER

PT J
AU HATTORI, M
   OKAZAKI, H
   ISHIDA, Y
   ONUMA, M
   KANO, S
   HONJO, T
   MINATO, N
AF HATTORI, M
   OKAZAKI, H
   ISHIDA, Y
   ONUMA, M
   KANO, S
   HONJO, T
   MINATO, N
TI EXPRESSION OF MURINE IL-2-RECEPTOR BETA-CHAIN ON THYMIC AND SPLENIC
   LYMPHOCYTE SUBPOPULATIONS AS REVEALED BY THE IL-2-INDUCED PROLIFERATIVE
   RESPONSE IN HUMAN IL-2-RECEPTOR ALPHA-CHAIN TRANSGENIC MICE
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 JICHI MED SCH,DEPT MED,MINAMI KAWACHI,TOCHIGI 32904,JAPAN.
   HOKKAIDO UNIV,DEPT VET MED,SAPPORO,HOKKAIDO 060,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
CR SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1398
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   ROBB RJ, 1987, J EXP MED, V165, P1201, DOI 10.1084/jem.165.4.1201
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0
   CEREDIG R, 1987, P NATL ACAD SCI USA, V84, P8578, DOI 10.1073/pnas.84.23.8578
   CRON RQ, 1989, J IMMUNOL, V142, P3754
   DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252
   DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   Hattori M, 1989, Int Immunol, V1, P151, DOI 10.1093/intimm/1.2.151
   ISHIDA Y, 1989, J EXP MED, V170, P1103, DOI 10.1084/jem.170.4.1103
   ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094
   KUBO RT, 1989, J IMMUNOL, V142, P2736
   MACDONALD HR, 1988, IMMUNOL REV, V104, P157, DOI 10.1111/j.1600-065X.1988.tb00762.x
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   OKAZAKI H, 1989, J IMMUNOL, V143, P2917
   OSAWA H, 1984, J IMMUNOL, V132, P2445
   RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0
   ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   TAKESHITA T, 1989, J EXP MED, V169, P1323, DOI 10.1084/jem.169.4.1323
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TORIBIO ML, 1989, NATURE, V342, P82, DOI 10.1038/342082a0
   TSUDO M, 1987, P NATL ACAD SCI USA, V84, P4215, DOI 10.1073/pnas.84.12.4215
   TSUDO M, 1987, P NATL ACAD SCI USA, V84, P5394, DOI 10.1073/pnas.84.15.5394
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   WATSON J, 1979, IMMUNOL REV, V51, P215
   YAGITA H, 1989, J EXP MED, V170, P1445, DOI 10.1084/jem.170.4.1445
NR 30
TC 27
Z9 27
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD MAY 15
PY 1990
VL 144
IS 10
BP 3809
EP 3815
PG 7
WC Immunology
SC Immunology
GA DC931
UT WOS:A1990DC93100022
PM 2332632
ER

PT J
AU TOHYAMA, K
   LEE, KH
   TASHIRO, K
   KINASHI, T
   HONJO, T
AF TOHYAMA, K
   LEE, KH
   TASHIRO, K
   KINASHI, T
   HONJO, T
TI ESTABLISHMENT OF AN INTERLEUKIN-5-DEPENDENT SUBCLONE FROM AN
   INTERLEUKIN-3-DEPENDENT MURINE HEMATOPOIETIC PROGENITOR-CELL LINE, LYD9,
   AND ITS MALIGNANT TRANSFORMATION BY AUTOCRINE SECRETION OF INTERLEUKIN-5
SO EMBO JOURNAL
LA English
DT Article
RP TOHYAMA, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4
   NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388
   DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883
   KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0
   KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7
   DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1
   YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0
   OGAWA M, 1988, EMBO J, V7, P1337
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   CANAANI E, 1983, P NATL ACAD SCI-BIOL, V80, P7118, DOI 10.1073/pnas.80.23.7118
   CHRISTY RJ, 1985, NUCLEIC ACIDS RES, V13, P289, DOI 10.1093/nar/13.1.289
   COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x
   COLE MD, 1981, J VIROL, V38, P680
   DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036
   HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581
   KAJIGAYA S, 1986, J EXP MED, V164, P1102, DOI 10.1084/jem.164.4.1102
   KAPLAN PL, 1982, P NATL ACAD SCI-BIOL, V79, P485, DOI 10.1073/pnas.79.2.485
   KARASUYAMA H, 1989, J EXP MED, V169, P13, DOI 10.1084/jem.169.1.13
   Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   KODAMA H, 1984, J CELL PHYSIOL, V118, P233, DOI 10.1002/jcp.1041180303
   KODAMA HA, 1982, J CELL PHYSIOL, V112, P89, DOI 10.1002/jcp.1041120114
   LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5
   MAKMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863
   Mizuta T R, 1988, Growth Factors, V1, P51, DOI 10.3109/08977198809000246
   NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0
   PALACIOS R, 1987, EMBO J, V6, P3687
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STOCKING C, 1988, CELL, V53, P869, DOI 10.1016/S0092-8674(88)90329-7
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   WAHEED A, 1979, J LAB CLIN MED, V94, P180
   WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 48
TC 33
Z9 33
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUN
PY 1990
VL 9
IS 6
BP 1823
EP 1830
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DF980
UT WOS:A1990DF98000017
PM 2112086
ER

PT J
AU YAO, L
   NAKAUCHI, H
   HONJO, T
   KAWAKAMI, T
AF YAO, L
   NAKAUCHI, H
   HONJO, T
   KAWAKAMI, T
TI THE CYTOPLASMIC DOMAIN OF THE CD8 ALPHA-CHAIN IS REQUIRED FOR ITS
   INTERACTION WITH P56LCK
SO IMMUNOLOGY LETTERS
LA English
DT Article
C1 KYOTO UNIV,SCH MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   INST PHYS & CHEM RES,FRONTIER RES PROGRAM,MOLEC REGULAT AGING LAB,IBARAKI,JAPAN.
RI Kawakami, Toshiaki/O-1616-2015
CR ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190
   EMMRICH F, 1986, P NATL ACAD SCI USA, V83, P8298, DOI 10.1073/pnas.83.21.8298
   HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0
   LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.immunol.5.1.561
   COOPER JA, 1989, IN PRESS PEPTIDES PR
   DISANTO JP, 1988, EMBO J, V7, P3465
   EMMRICH F, 1987, EUR J IMMUNOL, V17, P529, DOI 10.1002/eji.1830170415
   KAWAKAMI T, 1990, UNPUB
   MARTH JD, 1989, J IMMUNOL, V142, P2430
   MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2
   NAKAUCHI H, 1985, P NATL ACAD SCI USA, V82, P5126, DOI 10.1073/pnas.82.15.5126
   NORMENT AM, 1988, EMBO J, V7, P3433
   SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x
   TAGAWA M, 1986, P NATL ACAD SCI USA, V83, P3422, DOI 10.1073/pnas.83.10.3422
   TAKADA S, 1987, J IMMUNOL, V139, P3231
   VEILLETTE A, 1988, CELL, V55, P310
   VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353
   WALKER C, 1987, EUR J IMMUNOL, V17, P873, DOI 10.1002/eji.1830170622
NR 22
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUL
PY 1990
VL 24
IS 4
BP 267
EP 271
DI 10.1016/0165-2478(90)90011-E
PG 5
WC Immunology
SC Immunology
GA DP819
UT WOS:A1990DP81900011
PM 2118122
ER

PT J
AU IWASATO, T
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
AF IWASATO, T
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
TI CIRCULAR DNA IS EXCISED BY IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION
SO CELL
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
RP IWASATO, T (reprint author), KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.
CR AKIRA S, 1983, CELL, V34, P545, DOI 10.1016/0092-8674(83)90387-2
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   RADBRUCH A, 1983, EMBO J, V2, P1929
   BERNARD O, 1978, CELL, V15, P1133, DOI 10.1016/0092-8674(78)90041-7
   FUJIMOTO S, 1987, NATURE, V327, P242, DOI 10.1038/327242a0
   DAVIS MM, 1980, CELL, V22, P1, DOI 10.1016/0092-8674(80)90145-2
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   VITETTA ES, 1984, IMMUNOL REV, V78, P137, DOI 10.1111/j.1600-065X.1984.tb00480.x
   SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   BERGSTEDTLINDQVIST S, 1984, IMMUNOL REV, V78, P25, DOI 10.1111/j.1600-065X.1984.tb00475.x
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DUNNICK W, 1980, NATURE, V286, P669, DOI 10.1038/286669a0
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   KOBAYASHI M, 1979, GENE, V6, P123, DOI 10.1016/0378-1119(79)90067-2
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MAKI R, 1980, P NATL ACAD SCI-BIOL, V77, P2138, DOI 10.1073/pnas.77.4.2138
   Maniatis T., 1982, MOL CLONING
   MOWATT MR, 1986, J IMMUNOL, V136, P2674
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437
   OKAZAKI K, 1987, CELL, V49, P477, DOI 10.1016/0092-8674(87)90450-8
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7705
   TODA M, 1989, IMMUNOL LETT, V21, P311, DOI 10.1016/0165-2478(89)90025-4
   YAMAGISHI H, 1983, GENE, V26, P317
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 35
TC 211
Z9 211
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138
SN 0092-8674
J9 CELL
JI Cell
PD JUL 13
PY 1990
VL 62
IS 1
BP 143
EP 149
DI 10.1016/0092-8674(90)90248-D
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DN533
UT WOS:A1990DN53300019
PM 2364432
ER

PT J
AU MATSUDA, F
   SHIN, EK
   HIRABAYASHI, Y
   NAGAOKA, H
   YOSHIDA, MC
   ZONG, SQ
   HONJO, T
AF MATSUDA, F
   SHIN, EK
   HIRABAYASHI, Y
   NAGAOKA, H
   YOSHIDA, MC
   ZONG, SQ
   HONJO, T
TI ORGANIZATION OF VARIABLE REGION SEGMENTS OF THE HUMAN-IMMUNOGLOBULIN
   HEAVY-CHAIN - DUPLICATION OF THE D5 CLUSTER WITHIN THE LOCUS AND
   INTERCHROMOSOMAL TRANSLOCATION OF VARIABLE REGION SEGMENTS
SO EMBO JOURNAL
LA English
DT Article
C1 HOKKAIDO UNIV,FAC SCI,CHROMOSOMAL RES UNIT,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN.
RP MATSUDA, F (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014
   RETH MG, 1986, EMBO J, V5, P2131
   BECKER RS, 1989, FASEB J, V3, pA1272
   BERMAN JE, 1988, EMBO J, V7, P727
   BRODEUR PH, 1988, J EXP MED, V168, P2261, DOI 10.1084/jem.168.6.2261
   GUNNING P, 1984, CELL, V36, P709, DOI 10.1016/0092-8674(84)90351-9
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0
   ICHIHARA Y, 1988, EUR J IMMUNOL, V18, P649, DOI 10.1002/eji.1830180426
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667
   LOTSCHER E, 1988, GENE, V69, P215, DOI 10.1016/0378-1119(88)90432-5
   MAEDA T, 1987, J IMMUNOL, V138, P2305
   Maniatis T., 1982, MOL CLONING
   MATSUDA F, 1988, EMBO J, V7, P1047
   NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3122, DOI 10.1093/nar/16.7.3122
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   OTSU M, 1987, MOL CELL BIOL, V7, P708
   PURRELLO M, 1987, CYTOGENET CELL GENET, V44, P32, DOI 10.1159/000132337
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037
   ZONG SQ, 1988, IMMUNOL LETT, V17, P329
NR 33
TC 99
Z9 99
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD AUG
PY 1990
VL 9
IS 8
BP 2501
EP 2506
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DP595
UT WOS:A1990DP59500021
PM 2114977
ER

PT J
AU NAKATANI, T
   HORIGOME, K
   NOMURA, N
   KONDO, T
   OHTSUKA, H
   NOGUCHI, H
   HONJO, T
AF NAKATANI, T
   HORIGOME, K
   NOMURA, N
   KONDO, T
   OHTSUKA, H
   NOGUCHI, H
   HONJO, T
TI DELETION OF HUMAN JK SEGMENTS BY SITE-SPECIFIC RECOMBINATION RECOGNIZING
   THE CONSERVED NONAMER AND HEPTAMER SEQUENCES
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
C1 SUMITOMO CHEM CO LTD,TAKARAZUKA RES CTR,BIOTECHNOL LAB,4-2-1 TAKATSUKASA,TAKARAZUKA,HYOGO 665,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AGUILERA RJ, 1987, CELL, V51, P909, DOI 10.1016/0092-8674(87)90578-2
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   SIMINOVITCH KA, 1985, NATURE, V316, P260, DOI 10.1038/316260a0
   FUJIMOTO S, 1987, NATURE, V327, P242, DOI 10.1038/327242a0
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   FEDDERSEN RM, 1990, J IMMUNOL, V144, P1088
   GRANINGER WB, 1988, J EXP MED, V167, P488, DOI 10.1084/jem.167.2.488
   HALLIGAN BD, 1987, P NATL ACAD SCI USA, V84, P7019, DOI 10.1073/pnas.84.20.7019
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HIETER HA, 1981, NATURE, V209, P368
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   KELLEY DE, 1985, MOL CELL BIOL, V5, P1660
   KLOBECK HG, 1986, NUCLEIC ACIDS RES, V14, P4591, DOI 10.1093/nar/14.11.4591
   Maniatis T., 1982, MOL CLONING
   NAKATANI T, 1989, BIO-TECHNOL, V7, P805, DOI 10.1038/nbt0889-805
   OKAZAKI K, 1987, CELL, V49, P477, DOI 10.1016/0092-8674(87)90450-8
   SANDRIGOLDIN RM, 1981, MOL CELL BIOL, V1, P743
   SCHNELL H, 1980, NATURE, V286, P170, DOI 10.1038/286170a0
   SEIDMAN JG, 1980, NATURE, V286, P779, DOI 10.1038/286779a0
NR 20
TC 3
Z9 3
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD SEP 25
PY 1990
VL 18
IS 18
BP 5529
EP 5532
DI 10.1093/nar/18.18.5529
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EA882
UT WOS:A1990EA88200027
PM 2120678
ER

PT J
AU PLAETINCK, G
   COMBE, MC
   CORTHESY, P
   SPERISEN, P
   KANAMORI, H
   HONJO, T
   NABHOLZ, M
AF PLAETINCK, G
   COMBE, MC
   CORTHESY, P
   SPERISEN, P
   KANAMORI, H
   HONJO, T
   NABHOLZ, M
TI CONTROL OF IL-2 RECEPTOR-ALPHA EXPRESSION BY IL-1,
   TUMOR-NECROSIS-FACTOR, AND IL-2 - COMPLEX REGULATION VIA ELEMENTS IN THE
   5' FLANKING REGION
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 SWISS INST EXPTL CANC RES,GENET UNIT,CH-1066 EPALINGES,SWITZERLAND.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2
   CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9
   DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230
   VONBOEHMER H, 1979, EUR J IMMUNOL, V9, P592, DOI 10.1002/eji.1830090804
   Ausubel FM, 1987, CURRENT PROTOCOLS MO
   BISMUTH G, 1985, EUR J IMMUNOL, V15, P723, DOI 10.1002/eji.1830150716
   BRUNET JF, 1986, NATURE, V322, P268, DOI 10.1038/322268a0
   CONZELMANN A, 1982, NATURE, V298, P170, DOI 10.1038/298170a0
   ERARD F, 1984, J EXP MED, V160, P584, DOI 10.1084/jem.160.2.584
   ESPEL E, 1990, EMBO J, V9, P929
   FALK W, 1989, J IMMUNOL, V143, P513
   FREIMUTH WW, 1989, J IMMUNOL, V143, P3064
   GEERING G, 1966, J EXP MED, V124, P753, DOI 10.1084/jem.124.4.753
   GILLIS S, 1981, P NATL ACAD SCI-BIOL, V78, P1133, DOI 10.1073/pnas.78.2.1133
   HOLSTI MA, 1989, J IMMUNOL, V143, P2514
   HOUSSIAU FA, 1989, J IMMUNOL, V143, P2520
   HOWE RC, 1988, J IMMUNOL, V140, P1047
   JONGENEEL CV, 1988, J IMMUNOL, V140, P1916
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P319
   LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141
   LOPEZBOTET M, 1986, REV DOYMA INMUN, V5, P46
   LOWENTHAL JW, 1986, J IMMUNOL, V137, P1226
   LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988
   LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331
   MACDONALD HR, 1982, CYTOMETRY, V3, P55, DOI 10.1002/cyto.990030112
   MALEK TR, 1985, J EXP MED, V161, P1575, DOI 10.1084/jem.161.6.1575
   MANNEL DN, 1985, J IMMUNOL, V134, P3108
   MASSON D, 1986, EMBO J, V5, P1595
   MASSON D, 1985, EMBO J, V4, P2533
   MIKSICEK R, 1986, CELL, V46, P283, DOI 10.1016/0092-8674(86)90745-2
   MILLER J, 1985, J IMMUNOL, V134, P4212
   MUKAIDA N, 1987, J IMMUNOL, V139, P3321
   NABHOLZ M, 1980, IMMUNOL REV, V51, P125, DOI 10.1111/j.1600-065X.1980.tb00319.x
   PLAETINCK G, 1987, EUR J IMMUNOL, V17, P1835, DOI 10.1002/eji.1830171224
   PLAETINCK G, 1989, EUR J IMMUNOL, V19, P897, DOI 10.1002/eji.1830190517
   QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8
   SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505
   SILVA A, 1983, IMMUNOL REV, V76, P105, DOI 10.1111/j.1600-065X.1983.tb01099.x
   SMITH MR, 1989, P NATL ACAD SCI USA, V86, P8526, DOI 10.1073/pnas.86.21.8526
   SUZUKI N, 1987, J BIOL CHEM, V262, P5079
NR 40
TC 53
Z9 53
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD NOV 15
PY 1990
VL 145
IS 10
BP 3340
EP 3347
PG 8
WC Immunology
SC Immunology
GA EG889
UT WOS:A1990EG88900027
PM 2230118
ER

PT J
AU KANAMORI, H
   SUZUKI, N
   SIOMI, H
   NOSAKA, T
   SATO, A
   SABE, H
   HATANAKA, M
   HONJO, T
AF KANAMORI, H
   SUZUKI, N
   SIOMI, H
   NOSAKA, T
   SATO, A
   SABE, H
   HATANAKA, M
   HONJO, T
TI HTLV-1 P27REX STABILIZES HUMAN INTERLEUKIN-2 RECEPTOR ALPHA-CHAIN
   MESSENGER-RNA
SO EMBO JOURNAL
LA English
DT Article
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012; Siomi, Haruhiko/A-7020-2015
OI Siomi, Haruhiko/0000-0001-8690-3822
CR BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2
   INOUE J, 1986, EMBO J, V5, P2883
   RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0
   SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213
   HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
   FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495
   CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9
   ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   MIYOSHI I, 1980, GANN, V71, P155
   LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0
   UCHIYAMA T, 1977, BLOOD, V50, P481
   MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0
   TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891
   MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   HIDAKA M, 1988, EMBO J, V7, P519
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   Favaloro J, 1980, Methods Enzymol, V65, P718
   FUJISAWA J, 1985, P NATL ACAD SCI USA, V82, P2277, DOI 10.1073/pnas.82.8.2277
   GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   HIRAKI DD, 1986, J IMMUNOL, V136, P4291
   ISHIDA N, 1985, NUCLEIC ACIDS RES, V13, P7579, DOI 10.1093/nar/13.21.7579
   KANAMORI H, 1989, IMMUNOL LETT, V20, P293, DOI 10.1016/0165-2478(89)90037-0
   KIYOKAWA T, 1985, P NATL ACAD SCI USA, V82, P8359, DOI 10.1073/pnas.82.24.8359
   KUHN LC, 1984, CELL, V37, P95, DOI 10.1016/0092-8674(84)90304-0
   LEE TH, 1984, SCIENCE, V226, P57, DOI 10.1126/science.6089350
   LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LUSCHER B, 1985, P NATL ACAD SCI USA, V82, P4389, DOI 10.1073/pnas.82.13.4389
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5
   MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0
   NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   NOSAKA T, 1989, P NATL ACAD SCI USA, V86, P9798, DOI 10.1073/pnas.86.24.9798
   SABE H, 1988, INT J CANCER, V41, P880, DOI 10.1002/ijc.2910410619
   SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0
   SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8
   SLAMON DJ, 1984, SCIENCE, V226, P61, DOI 10.1126/science.6089351
   SUZUKI N, 1987, J BIOL CHEM, V262, P5079
   YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 48
TC 44
Z9 45
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD DEC
PY 1990
VL 9
IS 12
BP 4161
EP 4166
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EK538
UT WOS:A1990EK53800042
PM 2249670
ER

PT J
AU SAITO, Y
   OGURA, T
   KAMIO, M
   SABE, H
   UCHIYAMA, T
   HONJO, T
AF SAITO, Y
   OGURA, T
   KAMIO, M
   SABE, H
   UCHIYAMA, T
   HONJO, T
TI STEPWISE FORMATION OF THE HIGH-AFFINITY COMPLEX OF THE INTERLEUKIN-2
   RECEPTOR
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE AFFINITY CONVERSION; STEPWISE BINDING MODEL
ID COLONY-STIMULATING FACTOR; EXPRESSION CLONING; MOLECULAR-CLONING;
   CELL-LINES; BINDING; GROWTH; CHAIN; ASSOCIATION; CONSEQUENCES; MEMBRANES
AB The interleukin 2 receptor (IL-2R) is composed of at least two polypeptides-a 55 kd protein (the L chain, p55, or alpha chain) and a 75 kd protein (the H chain, p75 or beta chain).  The high-affinity binding of IL-2 results in the formation of a ternary complex consisting of IL-2 and the L and H chains.  We found that the rate of high-affinity complex formation at 0-degrees-C was about one-third of that at 37-degrees-C.  The reduction of high-affinity complex formation rate at lower temperatures correlates with the reduction of lateral diffusion within the membrane at lower temperatures.  An anti-H chain antibody (2RB) inhibited the formation of the high-affinity complex at 0-degrees-C but not at 37-degrees-C.  We studied the kinetics of the high-affinity complex formation at 37-degrees-C after the preincubation of ATL-2 cells with the 2RB antibody and IL-2 at 0-degrees-C.  We found that the amount of IL-2.L complex formed initially at 0-degrees-C was almost equivalent to the amount of high-affinity complex formed by subsequent incubation at 37-degrees-C.  These results suggest that the IL-2.L complex might be converted to the high-affinity IL-2R complex.  Similar experiments using YTC3 cells, which express a smaller number of L chains, showed slower rates of high-affinity complex formation, in agreement with the affinity conversion/stepwise binding model.
C1 KYOTO UNIV,FAC MED,DIV INTERNAL MED 1,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
RP SAITO, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR GEARING DP, 1989, EMBO J, V8, P3667
   TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8
   AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594
   CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   VAZ WLC, 1979, P NATL ACAD SCI USA, V76, P5645, DOI 10.1073/pnas.76.11.5645
   CHAO MV, 1986, SCIENCE, V232, P519
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   GREENFIELD C, 1989, EMBO J, V8, P4115
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   HATAKEYAMA M, 1987, J EXP MED, V166, P362, DOI 10.1084/jem.166.2.362
   KAMIO M, 1990, INT IMMUNOL, V2, P521, DOI 10.1093/intimm/2.6.521
   KAMIO M, 1990, BLOOD, V75, P415
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   KOYASU S, 1986, J IMMUNOL, V136, P984
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LOWENTHAL JW, 1986, J EXP MED, V164, P1060, DOI 10.1084/jem.164.4.1060
   LOWENTHAL JW, 1987, J EXP MED, V166, P1156, DOI 10.1084/jem.166.4.1156
   MITA S, 1989, P NATL ACAD SCI USA, V86, P2311, DOI 10.1073/pnas.86.7.2311
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   OGURA T, 1988, MOL BIOL MED, V5, P123
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   Sabe H, 1984, Mol Biol Med, V2, P379
   SAITO Y, 1988, J EXP MED, V168, P1563, DOI 10.1084/jem.168.5.1563
   SARAGOVI H, 1988, J IMMUNOL, V141, P476
   SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4
   SCHLESSINGER J, 1976, P NATL ACAD SCI USA, V73, P2409, DOI 10.1073/pnas.73.7.2409
   SCHREURS J, 1989, GROWTH FACTORS, V2, P221
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618
   TAGA T, 1987, J EXP MED, V166, P967, DOI 10.1084/jem.166.4.967
   TAKESHITA T, 1989, J EXP MED, V169, P1323, DOI 10.1084/jem.169.4.1323
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   WALKER F, 1985, EMBO J, V4, P933
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   Yamaguchi A, 1989, Int Immunol, V1, P160, DOI 10.1093/intimm/1.2.160
   YODOI J, 1985, J IMMUNOL, V134, P1623
   ZIDOVETZKI R, 1981, P NATL ACAD SCI-BIOL, V78, P6981, DOI 10.1073/pnas.78.11.6981
NR 44
TC 13
Z9 13
U1 0
U2 2
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD DEC
PY 1990
VL 2
IS 12
BP 1167
EP 1177
DI 10.1093/intimm/2.12.1167
PG 11
WC Immunology
SC Immunology
GA ET499
UT WOS:A1990ET49900006
PM 2090200
ER

PT J
AU HONJO, T
   MATSUDA, F
   SHIN, EK
   NAGAOKA, H
   FUKITA, Y
   TAKAISHI, S
   IMAI, T
   YOKOYAMA, K
   SOEDA, E
AF HONJO, T
   MATSUDA, F
   SHIN, EK
   NAGAOKA, H
   FUKITA, Y
   TAKAISHI, S
   IMAI, T
   YOKOYAMA, K
   SOEDA, E
TI STRUCTURAL-ANALYSIS OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS USING
   THE YEAST ARTIFICIAL CHROMOSOME (YAC) SYSTEM
SO CYTOGENETICS AND CELL GENETICS
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   INST PHYS & CHEM RES,TSUKUBA UFE SCI CTR,TSUKUBA 305,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0171
J9 CYTOGENET CELL GENET
JI Cytogenet. Cell Genet.
PY 1991
VL 58
IS 3-4
BP 1987
EP 1987
PG 1
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HE949
UT WOS:A1991HE94900355
ER

PT J
AU ERA, T
   OGAWA, M
   NISHIKAWA, SI
   OKAMOTO, M
   HONJO, T
   AKAGI, K
   MIYAZAKI, JI
   YAMAMURA, KI
AF ERA, T
   OGAWA, M
   NISHIKAWA, SI
   OKAMOTO, M
   HONJO, T
   AKAGI, K
   MIYAZAKI, JI
   YAMAMURA, KI
TI DIFFERENTIATION OF GROWTH SIGNAL REQUIREMENT OF LYMPHOCYTE-B PRECURSOR
   IS DIRECTED BY EXPRESSION OF IMMUNOGLOBULIN
SO EMBO JOURNAL
LA English
DT Article
DE B-CELL DEVELOPMENT; IG GENE REARRANGEMENT; INTERLEUKIN-7; STROMAL CELL;
   TRANSGENIC MOUSE
ID TRANSGENIC MICE; GENE REARRANGEMENT; ALLELIC EXCLUSION; CELL
   DEVELOPMENT; PRE-B; SOMATIC RECOMBINATION; MURINE INTERLEUKIN-7; CHAIN
   GENES; MOUSE; IGM
AB During B cell differentiation, at least three stages can be defined in terms of their growth signal requirement by using two different growth signals, which are recombinant interleukin 7 (IL-7) and a stromal cell clone PA6 which does not produce IL-7; first a PA6 dependent stage, second a PA6 + IL-7 dependent stage and third an IL-7 dependent stage. In order to test the possibility that this differentiation of growth signal requirement is controlled by the expression of functional immunoglobulin molecules, we have investigated the frequencies of PA6 + IL-7 dependent and IL-7 dependent cells which are present in the bone marrow of either mu-chain or kappa-chain gene transgenic mice.  In a mu-chain gene transgenic mouse, the frequency of PA6 + IL-7 dependent cells is selectively reduced, while that of IL-7 dependent cells is selectively reduced in a kappa-chain gene transgenic mouse.  This result suggests that expression of a functional mu-chain gene drives PA6 + IL-7 dependent cells to differentiate into the subsequent IL-7 dependent stage.  Likewise, when mu-chain positive IL-7 dependent cells express a functional light-chain gene, their growth signal requirement changes into an IL-7 unreactive stage.
C1 KUMAMOTO UNIV,SCH MED,INST MED GENET,KUMAMOTO 862,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 520,JAPAN.
RP ERA, T (reprint author), KUMAMOTO UNIV,SCH MED,INST MED IMMUNOL,HONJO 2-2-1,KUMAMOTO 860,JAPAN.
RI Miyazaki, Jun-ichi/N-1976-2015
OI Miyazaki, Jun-ichi/0000-0003-2475-589X
CR SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118
   KUDO A, 1987, EMBO J, V6, P2267
   LEE G, 1989, J IMMUNOL, V142, P3875
   SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0
   WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0
   HOMBACH J, 1988, EMBO J, V7, P3451
   MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9
   ARAKI K, 1989, P NATL ACAD SCI USA, V86, P207, DOI 10.1073/pnas.86.1.207
   LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9
   COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x
   COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0
   HAYASHI SI, 1990, J EXP MED, V171, P1683, DOI 10.1084/jem.171.5.1683
   HENDRICKSON EA, 1988, GENE DEV, V2, P817, DOI 10.1101/gad.2.7.817
   HERZENBERG LA, 1987, NATURE, V329, P71, DOI 10.1038/329071a0
   KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969
   KINCADE PW, 1987, ADV IMMUNOL, V41, P181, DOI 10.1016/S0065-2776(08)60032-2
   KODAMA HA, 1982, J CELL PHYSIOL, V112, P89, DOI 10.1002/jcp.1041120114
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   MELCHERS F, 1989, IMMUNOGLOBULIN GENES, P23
   MULLER W, 1989, EUR J IMMUNOL, V19, P923, DOI 10.1002/eji.1830190520
   NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0
   NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138
   NEUBERGER MS, 1983, EMBO J, V2, P1373
   NISHIKAWA S, 1989, CURR TOP MICROBIOL, V152, P39
   NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976
   NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969
   OKAZAKI K, 1988, J IMMUNOL, V141, P1348
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   RATH S, 1989, J IMMUNOL, V143, P2074
   SAKAGUCHI N, 1988, EMBO J, V7, P3457
   SHERWOOD PJ, 1990, INT IMMUNOL, V2, P399, DOI 10.1093/intimm/2.5.399
   SHULER W, 1986, CELL, V46, P963
   STALL AM, 1988, P NATL ACAD SCI USA, V85, P3546, DOI 10.1073/pnas.85.10.3546
   STORB U, 1989, IMMUNOGLOBULIN GENES, P303
   SUDA T, 1989, BLOOD, V74, P1936
   SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333
   TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973
   WHITLOCK CA, 1983, CELL, V32, P903, DOI 10.1016/0092-8674(83)90075-2
   YAMAMURA K, 1984, J BIOCHEM-TOKYO, V96, P357
   YELTON DE, 1981, HYBRIDOMA, V1, P5, DOI 10.1089/hyb.1.1981.1.5
NR 44
TC 90
Z9 90
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD FEB
PY 1991
VL 10
IS 2
BP 337
EP 342
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EX360
UT WOS:A1991EX36000012
PM 1899373
ER

PT J
AU KINOSHITA, K
   SHIMIZU, A
   HONJO, T
AF KINOSHITA, K
   SHIMIZU, A
   HONJO, T
TI THE MEMBRANE EXONS OF THE PSEUDO-GAMMA-CHAIN GENE OF THE
   HUMAN-IMMUNOGLOBULIN ARE APPARENTLY FUNCTIONAL AND HIGHLY HOMOLOGOUS TO
   THOSE OF THE GAMMA-1 GENE
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE IMMUNOGLOBULIN HEAVY CHAIN GENE; HUMAN IMMUNOGLOBULIN PSEUDO-GAMMA CHAIN
   GENE; NUCLEOTIDE SEQUENCE; S-REGION; I-REGION
AB Nucleotide sequences of the membrane exons of human immunoglobulin pseudo-gamma gene and gamma-1 chain cDNA were determined and compared.  The sequences of the membrane exons of the pseudo-gamma gene had no defective mutations in the coding regions or the exon-intron boundaries.  The translated amino acid sequence was highly homologous to that of the active gamma-1 gene, with only one substitution, at the 16th amino acid of the M2 exon (valine/isoleucine).  Our findings together with previous data strongly support the idea that the absence of product of the pseudo-gamma gene is attributable to deletion of 5' flanking regions responsible for class switch recombination (S region) and transcription of the germline C(H) gene (I region).  The S and I regions are, therefore, likely to be indispensable for the expression of the immunoglobulin gamma, epsilon and alpha-genes.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
RP KINOSHITA, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589
   BENSMANA M, 1988, NUCLEIC ACIDS RES, V16, P3108, DOI 10.1093/nar/16.7.3108
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   Honjo T., 1989, Immunoglobulin genes., P123
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   Maniatis T., 1982, MOL CLONING
   MATSUOKA K, 1990, CELL, V62, P135
   MIZUTA TR, 1991, UNPUB
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   SHIMIZU A, 1991, UNPUB
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   WORD CJ, 1989, INT IMMUNOL, V1, P269
NR 15
TC 12
Z9 12
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD FEB
PY 1991
VL 27
IS 2
BP 151
EP 156
DI 10.1016/0165-2478(91)90143-X
PG 6
WC Immunology
SC Immunology
GA EZ393
UT WOS:A1991EZ39300012
PM 2026457
ER

PT J
AU WHITE, KN
   NOSAKA, T
   KANAMORI, H
   HATANAKA, M
   HONJO, T
AF WHITE, KN
   NOSAKA, T
   KANAMORI, H
   HATANAKA, M
   HONJO, T
TI THE NUCLEOLAR LOCALIZATION SIGNAL OF THE HTLV-I PROTEIN-P27REX IS
   IMPORTANT FOR STABILIZATION OF IL-2 RECEPTOR ALPHA-SUBUNIT MESSENGER-RNA
   BY P27REX
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID CELL GROWTH-FACTOR; VIRUS TYPE-I; EXPRESSION; P40X
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN.
CR INOUE J, 1986, EMBO J, V5, P2883
   HATTORI T, 1981, BLOOD, V58, P645
   DEAK I, 1972, J CELL SCI, V11, P379
   DEPPER JM, 1984, J IMMUNOL, V133, P1691
   GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403
   HIDAKA M, 1988, EMBO J, V8, P7124
   HIRAKI DD, 1986, J IMMUNOL, V136, P4291
   IRMSKY L, 1989, NATURE, V341, P453
   KANAMORI H, 1990, EMBO J, V9, P4161
   MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0
   NOSAKA T, 1989, P NATL ACAD SCI USA, V86, P9798, DOI 10.1073/pnas.86.24.9798
   SEIKI M, 1986, EMBO J, V5, P561
   SIDEBOTT.E, 1969, J CELL SCI, V5, P351
   SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8
   TSUDO M, 1983, BLOOD, V62, P509
NR 15
TC 9
Z9 9
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 28
PY 1991
VL 175
IS 1
BP 98
EP 103
DI 10.1016/S0006-291X(05)81205-7
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA EZ636
UT WOS:A1991EZ63600015
PM 1998523
ER

PT J
AU AMAKAWA, R
   FUKUHARA, S
   OHNO, H
   MATSUYAMA, F
   KATO, I
   TANABE, S
   SIDERAS, P
   MIZUTA, TR
   HONJO, T
   OKUMA, M
AF AMAKAWA, R
   FUKUHARA, S
   OHNO, H
   MATSUYAMA, F
   KATO, I
   TANABE, S
   SIDERAS, P
   MIZUTA, TR
   HONJO, T
   OKUMA, M
TI GENOMIC ORGANIZATION OF IGH GENE COMPARED WITH THE EXPRESSION OF BCL-2
   GENE IN T(14-18)-POSITIVE LYMPHOMA
SO BLOOD
LA English
DT Article
ID C-MYC ONCOGENE; BREAKPOINT-CLUSTER REGION; HUMAN FOLLICULAR LYMPHOMA;
   NEOPLASTIC B-CELLS; HEAVY-CHAIN LOCUS; CHROMOSOME-TRANSLOCATION;
   BURKITT-LYMPHOMA; TRANSCRIPTS; CLONING; PROTEIN
C1 KYOTO UNIV,FAC MED,DEPT INTERNAL MED,54 SHOGOIN KAWARAMACHI,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ABE M, 1988, CANCER, V61, P483, DOI 10.1002/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L
   AMAKAWA R, 1990, CANCER RES, V50, P2423
   NISHIKURA K, 1985, P NATL ACAD SCI USA, V82, P2900, DOI 10.1073/pnas.82.9.2900
   OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H
   TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430
   TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263
   OHNO H, 1990, P NATL ACAD SCI USA, V87, P628, DOI 10.1073/pnas.87.2.628
   CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8
   HALDAR S, 1989, NATURE, V342, P195, DOI 10.1038/342195a0
   NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748
   BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2
   TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214
   CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701
   FUKUHARA S, 1978, INT J CANCER, V22, P14, DOI 10.1002/ijc.2910220105
   BORZILLO GV, 1988, J IMMUNOL, V141, P3625
   CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4
   CLEARY ML, 1986, J EXP MED, V164, P315, DOI 10.1084/jem.164.1.315
   DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867
   FUKUHARA S, 1990, JPN J CLIN ONCOL, V20, P16
   GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235
   GRIMALDI JC, 1989, BLOOD, V73, P2081
   GURFINKEL N, 1987, EUR J IMMUNOL, V17, P567, DOI 10.1002/eji.1830170421
   HALUSKA FG, 1987, P NATL ACAD SCI USA, V84, P6835, DOI 10.1073/pnas.84.19.6835
   LUTZKER S, 1988, MOL CELL BIOL, V8, P1849
   MATSUDA F, 1988, EMBO J, V7, P1047
   MURPHY W, 1986, P NATL ACAD SCI USA, V83, P2939, DOI 10.1073/pnas.83.9.2939
   OHNO H, 1987, INT J CANCER, V39, P785, DOI 10.1002/ijc.2910390622
   OTSU M, 1987, MOL CELL BIOL, V7, P708
   PELLET P, 1989, ONCOGENE, V4, P653
   REED JC, 1987, SCIENCE, V236, P1295, DOI 10.1126/science.3495884
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   TSUJIMOTO Y, 1989, P NATL ACAD SCI USA, V86, P1958, DOI 10.1073/pnas.86.6.1958
   WINAN KG, 1984, P NATL ACAD SCI USA, V81, P6798
NR 37
TC 14
Z9 15
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD MAY 1
PY 1991
VL 77
IS 9
BP 1970
EP 1976
PG 7
WC Hematology
SC Hematology
GA FJ957
UT WOS:A1991FJ95700017
PM 1902122
ER

PT J
AU TASHIRO, K
   KINASHI, T
   ANDERSON, SJ
   LEE, KH
   TOHYAMA, K
   OGAWA, M
   TAKAHASHI, M
   KAWAICHI, M
   HONJO, T
AF TASHIRO, K
   KINASHI, T
   ANDERSON, SJ
   LEE, KH
   TOHYAMA, K
   OGAWA, M
   TAKAHASHI, M
   KAWAICHI, M
   HONJO, T
TI GERMLINE TRANSCRIPTS OF THE IMMUNOGLOBULIN HEAVY-CHAIN AND T-CELL
   RECEPTOR GENES IN A MURINE HEMATOPOIETIC STEM-CELL LINE LYD9 AND ITS
   DERIVATIVE CELL-LINES
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE IMMUNOGLOBULIN; T CELL RECEPTOR; GERMLINE TRANSCRIPT; HEMATOPOIETIC
   PROGENITOR; DIFFERENTIATION MARKER
ID GROWTH REQUIREMENTS; ANTIGEN RECEPTOR; LYMPHOCYTES-B; MU-GENE;
   EXPRESSION; DIFFERENTIATION; REGION; REARRANGEMENT; RECOMBINATION;
   ORGANIZATION
AB We compared germline transcript levels of immunoglobulin heavy chain and T cell receptor (TcR) genes in a murine hematopoietic stem cell line, LyD9, and its derivative cell lines.  LyD9 cells can be induced to differentiate into at least three lineages, namely, B lymphocyte, macrophage, and granulocyte lineages.  Although C-mu-transcripts were found in stem cells to B lymphocytes, other myeloid-committed cells also expressed significant amounts of C-mu-transcripts.  Germline TcR transcripts did not show good correlation with differentiation potential and stages of hematopoietic cells.  During this search we identified a novel germline transcript containing the J(H)-C-mu-1 sequence in LyD9 and some of its derivative cells.  Expression of mRNAs for immunoglobulin- and TcR-associated molecules (lambda-5, MB1 and CD3-delta) was widespread except for lambda-5 mRNA.  Among three mRNAs encoding putative recombinase proteins, RAG-1 and RAG-2 mRNAs were not expressed in any cell lines tested, while RBP-2 mRNA was expressed ubiquitously.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.immunol.4.1.529
   LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HURWITZ JL, 1986, J IMMUNOL, V137, P1757
   IKUTA K, 1986, J EXP MED, V164, P428, DOI 10.1084/jem.164.2.428
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   KEMP DJ, 1980, P NATL ACAD SCI-BIOL, V77, P2876, DOI 10.1073/pnas.77.5.2876
   KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887
   Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   KINASHI T, 1990, UNPUB
   KISHIHARA K, 1988, EUR J IMMUNOL, V18, P841, DOI 10.1002/eji.1830180603
   KUDO A, 1987, EMBO J, V6, P103
   LECLERCQ L, 1989, NUCLEIC ACIDS RES, V17, P6809, DOI 10.1093/nar/17.17.6809
   LEE KM, 1990, UNPUB
   MAKMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835
   MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6
   MATSUNAMI N, 1989, NATURE, V342, P937
   PALACIOS R, 1987, EMBO J, V6, P3687
   PALACIOS R, 1988, IMMUNOL REV, V104, P5, DOI 10.1111/j.1600-065X.1988.tb00757.x
   PERRY RP, 1980, P NATL ACAD SCI-BIOL, V77, P1937, DOI 10.1073/pnas.77.4.1937
   PERRY RP, 1979, CELL, V18, P1333, DOI 10.1016/0092-8674(79)90243-5
   SAKAGUCHI N, 1988, EMBO J, V7, P3457
   TOHYAMA K, 1990, EMBO J, V9, P1823
   VANDENELSEN P, 1985, NATURE, V314, P542, DOI 10.1038/314542a0
   VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3
   VONBOEHMER H, 1987, EUR J IMMUNOL, V16, P2
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 41
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD MAY
PY 1991
VL 28
IS 2
BP 147
EP 154
DI 10.1016/0165-2478(91)90113-O
PG 8
WC Immunology
SC Immunology
GA FM997
UT WOS:A1991FM99700011
PM 1909302
ER

PT J
AU LEE, KH
   KINASHI, T
   TOHYAMA, K
   TASHIRO, K
   FUNATO, N
   HAMA, K
   HONJO, T
AF LEE, KH
   KINASHI, T
   TOHYAMA, K
   TASHIRO, K
   FUNATO, N
   HAMA, K
   HONJO, T
TI DIFFERENT STROMAL CELL-LINES SUPPORT LINEAGE-SELECTIVE DIFFERENTIATION
   OF THE MULTIPOTENTIAL BONE-MARROW STEM-CELL CLONE LYD9
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID DEPENDENT GRANULOCYTIC DIFFERENTIATION; CONDITIONS CONTROLLING
   PROLIFERATION; COLONY-STIMULATING FACTOR; MONOCLONAL-ANTIBODY;
   LYMPHOCYTES-B; COMPLEMENTARY-DNA; MOUSE MACROPHAGE; POSSIBLE ROLES;
   GROWTH; INVITRO
AB An interleukin 3-dependent multipotential stem cell clone, LyD9, has been shown to generate mature B lymphocytes, macrophages, and neutrophils by coculture with primary bone marrow stromal cells.  We report here that coculture with the cloned stromal cell lines PA6 and ST2 can support differentiation of LyD9 cells predominantly into granulocyte/macrophage colony-stimulating factor (GM-CSF)- and granulocyte (G)-CSF-responsive cells, respectively.  However, these stromal cell lines were unable to support lymphopoiesis of LyD9 cells.  The GM-CSF-dependent line, L-GM, which was derived from LyD9 cells cocultured with PA6 stromal cells, could differentiate into macrophages and granulocytes in the presence of GM-CSF.  The L-GM line can further differentiate predominantly into neutrophils by coculture with ST2 stromal cells.  The G-CSF-dependent line, L-G, which was derived from LyD9 cells cocultured with ST2 stromal cells, differentiated into neutrophils in response to G-CSF.  Although the stromal cell-supported differentiation of LyD9 cells required the direct contact between LyD9 and stromal cells, a small fraction of LyD9 cells that were pretreated with 5-azacytidine could differentiate into neutrophils and macrophages without direct contact with stromal cells.  These results indicate that different stromal cell lines support lineage-selective  differentiation of the LyD9 stem cell and that 5-azacytidine treatment can bypass the requirement of direct contact with stromal cells, albeit with a lower frequency.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   OHNO PHARMACEUT CO LTD,MINASE RES LAB,KYOTO 618,JAPAN.
CR NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   CONSTANTINIDES PG, 1977, NATURE, V267, P364, DOI 10.1038/267364a0
   NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117
   WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608
   VALTIERI M, 1987, J IMMUNOL, V138, P3829
   DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303
   OGAWA M, 1988, EMBO J, V7, P1337
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   HARA K, 1988, EXP HEMATOL, V16, P256
   METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   BENTLEY SA, 1981, EXP HEMATOL, V9, P308
   CASTELLAZZI M, 1986, EUR J IMMUNOL, V16, P1081, DOI 10.1002/eji.1830160909
   COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0
   DARMON M, 1984, EMBO J, V3, P961
   DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423
   DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036
   Heyworth C M, 1990, Growth Factors, V2, P197, DOI 10.3109/08977199009071506
   IHLE JN, 1982, IMMUNOL REV, V63, P5, DOI 10.1111/j.1600-065X.1982.tb00409.x
   KAJIGAYA S, 1986, J EXP MED, V164, P1102, DOI 10.1084/jem.164.4.1102
   Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KINASHI T, 1991, J EXP MED, V173, P1267, DOI 10.1084/jem.173.5.1267
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   KINCADE PW, 1989, ANNU REV IMMUNOL, V7, P111, DOI 10.1146/annurev.immunol.7.1.111
   KODAMA HA, 1982, J CELL PHYSIOL, V112, P83, DOI 10.1002/jcp.1041120113
   NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45
   TAKEDA S, 1989, P NATL ACAD SCI USA, V86, P1634, DOI 10.1073/pnas.86.5.1634
   TOHYAMA K, 1990, EMBO J, V9, P1823
NR 34
TC 34
Z9 34
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 222 E 70TH STREET, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 1
PY 1991
VL 173
IS 5
BP 1257
EP 1266
DI 10.1084/jem.173.5.1257
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FH752
UT WOS:A1991FH75200024
PM 1708811
ER

PT J
AU SAKAI, Y
   FUKUOKA, T
   HONJO, T
AF SAKAI, Y
   FUKUOKA, T
   HONJO, T
TI CHARACTERIZATION OF LEAD IN THE TISSUES OF HEAVY-METAL TOLERANT PLANT,
   ATHYRIUM-YOKOSCENSE (FR ET SAV) CHRIST
SO NIPPON KAGAKU KAISHI
LA Japanese
DT Article
AB The distribution and chemical form of lead in vegetative organs of Athyrium yokoscense (Fr. et Sav.) growing in the polluted areas resulting from lead tiles of the ruins of Kanazawa Castle, now on the campus of Kanawaza University have been investigated.  The content of lead (by dry weight) in tissues of this fern species increases in the order of spores (approximately 81 ppm) < sporangium (approximately 740 ppm) < leaf blade (approximately 2080 ppm) > petiol (approximately 1530 ppm) < rhizome (approximately 2890 ppm) << root (approximately 22400 ppm).  It was also found that the roots of this fern accumulated a large amount of lead over the cell walls of cortex, while in the case of the petiol and leaf blade of the fern, lead was distributed over the cell walls of sieve tube of most of the stele.  The content of lead (by dry weight) in the section of the fern roots increases in the order of stele (with endodermis, 3340 ppm) << cortex (with inner cortex, 12900 ppm) < epidermis (with outer cortex, 18000 ppm).  The accumulation of lead and its tolerance have some correlation with the concentration of sulfur in the tissues of this fern and its associated growing soils.  The content of amino acids (by dry weight) in stele (with xylem and pholoem, 114 nmol/mg) is higher about two point fivefold than that in cortex and epidermis (45 nmol/mg).  On the basis of these findings, main chemical species of lead in the tissues of Athyrium yokoscense are considered to be lead sulfate (cortex and epidermis parts) and metal complexes with pectic acid and some amino acids (stele part).
C1 KANAZAWA UNIV,FAC SCI,DEPT BIOL,KANAZAWA,ISHIKAWA 920,JAPAN.
RP SAKAI, Y (reprint author), KANAZAWA UNIV,FAC SCI,DEPT CHEM,1-1 MARUNOUCHI,KANAZAWA,ISHIKAWA 920,JAPAN.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO 101, JAPAN
SN 0369-4577
J9 NIPPON KAGAKU KAISHI
JI Nippon Kagaku Kaishi
PD MAY
PY 1991
IS 5
BP 416
EP 421
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA FQ088
UT WOS:A1991FQ08800012
ER

PT J
AU SHIMIZU, A
   NUSSENZWEIG, MC
   HAN, H
   SANCHEZ, M
   HONJO, T
AF SHIMIZU, A
   NUSSENZWEIG, MC
   HAN, H
   SANCHEZ, M
   HONJO, T
TI TRANSSPLICING AS A POSSIBLE MOLECULAR MECHANISM FOR THE MULTIPLE ISOTYPE
   EXPRESSION OF THE IMMUNOGLOBULIN GENE
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID HEAVY-CHAIN GENES; CLASS-SWITCH RECOMBINATION; CONSTANT-REGION
   ALLOTYPES; MESSENGER-RNA PRECURSORS; B-CELLS; CIRCULAR DNA; MEMBRANE
   FORM; C-ELEGANS; MOUSE; DELETION
AB We analyzed the molecular mechanism for the immunoglobulin (Ig) multiple isotype expression using a transgenic mouse (TG.SA) model system.  Though most of the endogenous mu-chain expression was excluded by the expression of the human rearranged mu-transgene in the TG.SA mouse, a significant portion of splenic B lymphocytes could express the transgenic human IgM and endogenous mouse IgG simultaneously after stimulation with lipopolysaccharide and interleukin 4.  The fluorescence-activated cell sorter(R)-purified population of the human IgM+/mouse IgG+ cells expressed mRNA that consisted of properly spliced sequences of the transgenic V(H)DJ(H) and the endogenous mouse C-gamma-genes (trans-mRNA), together with the transgenic human-mu mRNA and germline transcripts of the mouse C-gamma-gene, without apparent rearrangement of the transgene.  We also found that a lymphoma tumor, derived from the cross between the TG.SA mouse and another transgenic mouse carrying Ig H chain enhancer-driven c-myc oncogene, expressed about equal levels of the trans-mRNA and the transgenic-mu mRNA without DNA rearrangement in either the transgene or the endogenous mouse switch region.  These findings strongly support our previous proposal that the trans-splicing can account for the multiple isotype expression in this transgenic model and also suggest that novel molecular mechanism(s) might be involved in this reaction.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   HOWARD HUGHES MED INST,NEW YORK,NY 10021.
   ROCKEFELLER UNIV,NEW YORK,NY 10021.
RP SHIMIZU, A (reprint author), KYOTO UNIV,FAC MED,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
CR CHOQUET Y, 1988, CELL, V52, P903, DOI 10.1016/0092-8674(88)90432-1
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1
   SOLNICK D, 1985, CELL, V42, P157, DOI 10.1016/S0092-8674(85)80111-2
   NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126
   KONARSKA MM, 1985, CELL, V42, P165, DOI 10.1016/S0092-8674(85)80112-4
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   KATONA IM, 1985, P NATL ACAD SCI USA, V82, P511, DOI 10.1073/pnas.82.2.511
   CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599
   NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0
   BEKTESH SL, 1988, NUCLEIC ACIDS RES, V16, P5692, DOI 10.1093/nar/16.12.5692
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   PERNIS B, 1973, IMMUNOCHEMISTRY, V10, P281, DOI 10.1016/0019-2791(73)90023-2
   RADBRUCH A, 1983, EMBO J, V2, P1929
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   KOLLER B, 1987, CELL, V48, P111, DOI 10.1016/0092-8674(87)90361-8
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2
   BUCHBERG AM, 1988, ONCOGENE RES, V2, P149
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DURDIK J, 1989, P NATL ACAD SCI USA, V86, P2346, DOI 10.1073/pnas.86.7.2346
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   FRIEDLANDER RM, 1990, NUCLEIC ACIDS RES, V18, P4278, DOI 10.1093/nar/18.14.4278
   GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   KNIGHT KL, 1974, P NATL ACAD SCI USA, V71, P1169, DOI 10.1073/pnas.71.4.1169
   KOMINAMI R, 1981, NUCLEIC ACIDS RES, V9, P3219, DOI 10.1093/nar/9.14.3219
   KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1
   KUMAGAI K, 1975, J IMMUNOL, V115, P982
   LANDUCCI.S, 1973, IMMUNOCHEMISTRY, V10, P65, DOI 10.1016/0019-2791(73)90232-2
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MOWATT MR, 1986, J IMMUNOL, V136, P2674
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175
   SHARP PA, 1987, CELL, V50, P147, DOI 10.1016/0092-8674(87)90207-8
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   SHIMIZU A, 1989, COLD SH Q B, V54, P175
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   VANDERPLOEG LHT, 1986, CELL, V47, P479, DOI 10.1016/0092-8674(86)90608-2
   Xu M, 1990, Dev Immunol, V1, P11, DOI 10.1155/1990/47659
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   ZAITA N, 1987, FEBS LETT, V210, P153, DOI 10.1016/0014-5793(87)81326-1
NR 60
TC 68
Z9 68
U1 0
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 222 E 70TH STREET, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JUN 1
PY 1991
VL 173
IS 6
BP 1385
EP 1393
DI 10.1084/jem.173.6.1385
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FN859
UT WOS:A1991FN85900010
PM 1903429
ER

PT J
AU KUZE, K
   SHIMIZU, A
   HONJO, T
AF KUZE, K
   SHIMIZU, A
   HONJO, T
TI CHARACTERIZATION OF THE ENHANCER REGION FOR GERMLINE TRANSCRIPTION OF
   THE GAMMA-3 CONSTANT REGION GENE OF HUMAN-IMMUNOGLOBULIN
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE RNASE PROTECTION; INTERLEUKIN-4; TRANSFECTION; I-REGION UPSTREAM
ID HEAVY-CHAIN GENES; CLASS-SWITCH RECOMBINATION; B-CELLS; CIRCULAR DNA;
   REPETITIVE SEQUENCES; EXPRESSION; REARRANGEMENT; DELETION;
   INTERLEUKIN-4; INDUCTION
AB A constant region gene (C) of the immunoglobulin heavy chain can be transcribed as germline transcripts from a promoter located upstream of a switch region.  We have studied the structure and function of the human C-gamma-3 promoter region.  When the human IgM-producing cell line SSK41 is stimulated with interleukin 4 (IL-4) in the presence of phorbol myristate acetate (PMA) or Staphylococcus aureus Cowan I, expression of germline C-gamma-3 transcripts was specifically augmented within 4 h.  Upstream DNA fragments flanking the I-gamma-3 exon were fused with a reporter gene and tested for IL-4-induced promoter/enhancer activity by transfection of SSK41 cells.  The DNA fragment between 450 and 250 bp upstream of the transcription initiation site of the C-gamma-3 gene was shown to be required for transcriptional up-regulation by PMA and IL-4.  The upstream 514 bp fragment of the I-gamma-3 flanking region was shown to contain an enhancer activity in response to PMA and IL-4.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
RP KUZE, K (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463
   ESSER C, 1989, EMBO J, V8, P483
   LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0
   BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952
   BERGSTEDTLINDQVIST S, 1984, IMMUNOL REV, V78, P25, DOI 10.1111/j.1600-065X.1984.tb00475.x
   BOOTHBY M, 1988, SCIENCE, V242, P1559, DOI 10.1126/science.3144043
   CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   Favaloro J, 1980, Methods Enzymol, V65, P718
   GERONDAKIS S, 1990, P NATL ACAD SCI USA, V87, P1581, DOI 10.1073/pnas.87.4.1581
   HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   LAYTON JE, 1984, J EXP MED, V160, P1850, DOI 10.1084/jem.160.6.1850
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LUTZKER S, 1988, MOL CELL BIOL, V8, P1849
   MAEDA S, 1983, BIOCHEM BIOPH RES CO, V115, P1040, DOI 10.1016/S0006-291X(83)80040-0
   MAKI R, 1980, P NATL ACAD SCI-BIOL, V77, P2138, DOI 10.1073/pnas.77.4.2138
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0
   NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   NISHIDA Y, 1983, HUMORAL FACTORS HOST, P323
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509
   RADCLIFFE G, 1990, MOL CELL BIOL, V10, P382
   REVETCH JV, 1981, CELL, V27, P583
   Schmitz J, 1989, Int Immunol, V1, P570, DOI 10.1093/intimm/1.6.570
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   Xu M, 1990, Dev Immunol, V1, P11, DOI 10.1155/1990/47659
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 47
TC 20
Z9 20
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUL
PY 1991
VL 3
IS 7
BP 647
EP 655
DI 10.1093/intimm/3.7.647
PG 9
WC Immunology
SC Immunology
GA FX137
UT WOS:A1991FX13700005
PM 1911538
ER

PT J
AU MIZUTA, TR
   SUZUKI, N
   SHIMIZU, A
   HONJO, T
AF MIZUTA, TR
   SUZUKI, N
   SHIMIZU, A
   HONJO, T
TI DUPLICATED VARIABLE REGION GENES ACCOUNT FOR DOUBLE ISOTYPE EXPRESSION
   IN A HUMAN LEUKEMIC B-CELL LINE THAT GIVES RISE TO SINGLE
   ISOTYPE-EXPRESSING CELLS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HEAVY-CHAIN GENES; CLASS-SWITCH RECOMBINATION; CIRCULAR DNA;
   EPSILON-GENES; GAMMA-GENES; C-EPSILON; IMMUNOGLOBULIN; DELETION;
   REARRANGEMENT; MOUSE
AB The SSK41 cell is an immunoglobulin IgM+ human neoplastic B-cell line that switches to IgG+ cells (SSK-gamma) spontaneously. We isolated a derivative of SSK41 (SSKWB) that expressed both IgM and IgG. Studies on the Ig heavy chain gene organization have shown that the SSKWB cell had two identical VDJ genes on the same chromosome; one linked to the C-mu-gene and the other to the C-gamma-1 gene, both of which are transcribed to produce mu- and gamma-mRNAs with the same VDJ sequence. We also isolated the two switch variants derived from the SSKWB cell by cell sorter: 1G (IgG+) and 11M (IgM+). The 1G cells contained two populations; one had a similar genetic organization as SSK-gamma and expressed only IgG1, and the other carried the same genetic organization as the SSKWB cell but produced aberrantly spliced mu-chain mRNA, in which the hydrophobic signal sequence exon is directly joined to the C-mu/exon . Te 11M cell deleted the VDJ-C-gamma-1, segment of the SSKWB cell and expressed IgM. These results raise the interesting possibility of another mechanism for class switching.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET SAKYO KU,KYOTO 606,JAPAN.
RP MIZUTA, TR (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALEXANDER EL, 1977, J IMMUNOL, V119, P1084
   ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x
   JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   RADBRUCH A, 1983, EMBO J, V2, P1929
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115
   SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0
   WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S
   GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3
   HANAHAN D, 1983, METHOD ENZYMOL, V100, P333
   HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995
   HOLLIDAY R, 1989, TRENDS GENET, V5, P355, DOI 10.1016/0168-9525(89)90150-9
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KEYEUX G, 1989, GENOMICS, V5, P431, DOI 10.1016/0888-7543(89)90006-2
   LUTZKER S, 1988, MOL CELL BIOL, V8, P1849
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   Noma Y, 1984, Mol Biol Med, V2, P337
   OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SMITH GR, 1983, CELL, V34, P709, DOI 10.1016/0092-8674(83)90525-1
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   UEDA S, 1982, EMBO J, V1, P1539
   WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164
NR 47
TC 10
Z9 10
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 5
PY 1991
VL 266
IS 19
BP 12514
EP 12521
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FV180
UT WOS:A1991FV18000066
PM 1712020
ER

PT J
AU KAWAICHI, M
   OKA, C
   REEVES, R
   KINOSHITA, M
   HONJO, T
AF KAWAICHI, M
   OKA, C
   REEVES, R
   KINOSHITA, M
   HONJO, T
TI RECOMBINATION OF EXOGENOUS INTERLEUKIN-2 RECEPTOR GENE FLANKED BY
   IMMUNOGLOBULIN RECOMBINATION SIGNAL SEQUENCES IN A PRE-B CELL-LINE AND
   TRANSGENIC MICE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID VARIABLE REGION GENE; HEAVY-CHAIN GENES; V(D)J RECOMBINATION; SEGMENTS;
   REARRANGEMENT; VECTOR; DNA; IDENTIFICATION; TRANSCRIPTION; DIVERSITY
AB We have constructed a plasmid, pLTR100, which contains human interleukin 2 receptor light (IL-2R L) chain cDNA in the inverted orientation relative to the upstream SV40 promoter.  The cDNA segment is flanked by the immunoglobulin gene recombination signal sequences so that the cDNA segment can invert and the human IL-2R L chain is subsequently expressed under the control of the SV40 promoter.  A murine pre-B cell line, 38B9, transfected with pLTR100 began to express the human IL-2R L chain on the cell surface.  The frequency of human IL-2R L chain positive cells increased almost linearly up to 50% for 60 days of culture after transfection.  Southern blot analysis and sequencing of the DNA fragments at the recombination junction confirmed that the cDNA segment was inverted in a signal sequence-dependent manner by the variable-diversity-joining recombination process.  Transgenic mice bearing the recombination substrate DNA similar to pLTR100 expressed the human IL-2 L chain in the spleen, thymus, and bone marrow, but no tin the other tissues examined at the detectable level.  Both IgM- and CD3-positive cells expressed the human IL-2R L chain, indicating that this artificial DNA can serve as a substrate for recombination both in B- and T-cells and that another DNA segment may be necessary to confer the cell-type specificity on the substrate DNA.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.immunol.4.1.529
   BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   REIF AE, 1964, J EXP MED, V120, P413, DOI 10.1084/jem.120.3.413
   MIYAZAKI J, 1989, GENE, V79, P269
   HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9
   CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S
   BLACKWELL TK, 1984, CELL, V37, P105
   CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9
   CORY S, 1980, P NATL ACAD SCI-BIOL, V77, P4943, DOI 10.1073/pnas.77.8.4943
   FARRAR WL, 1987, IMMUNOL REV, V100, P361, DOI 10.1111/j.1600-065X.1987.tb00539.x
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   FERRIER P, 1990, EMBO J, V9, P117
   Ferrier P, 1989, INT IMMUNOL, V1, P66, DOI 10.1093/intimm/1.1.66
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   Harlow E., 1988, ANTIBODIES LAB MANUA, P319
   Hogan B, 1986, MANIPULATING MOUSE E
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0
   LEWIS S, 1984, NATURE, V308, P425, DOI 10.1038/308425a0
   LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OHARE K, 1981, P NATL ACAD SCI-BIOL, V78, P1527, DOI 10.1073/pnas.78.3.1527
   PALACIOS R, 1987, EMBO J, V6, P3687
   Sambrook J, 1989, MOL CLONING LABORATO
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 40
TC 16
Z9 16
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 25
PY 1991
VL 266
IS 27
BP 18387
EP 18394
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GG553
UT WOS:A1991GG55300101
PM 1917962
ER

PT J
AU SABE, H
   KUNO, J
   KOROMILAS, A
   SAITO, Y
   KINASHI, T
   UEDA, M
   TAKAMATSU, T
   HAMAGUCHI, M
   KAWAKAMI, T
   HONJO, T
AF SABE, H
   KUNO, J
   KOROMILAS, A
   SAITO, Y
   KINASHI, T
   UEDA, M
   TAKAMATSU, T
   HAMAGUCHI, M
   KAWAKAMI, T
   HONJO, T
TI COMPARISON OF PROTEIN TYROSINE PHOSPHORYLATION AND MORPHOLOGICAL-CHANGES
   INDUCED BY IL-2 AND IL-3
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE WESTERN BLOT; IL-2R-P75; F-ACTIN; TUBULIN; CDNA TRANSFECTION; PROTEIN
   TYROSINE PHOSPHORYLATION
ID HUMAN INTERLEUKIN-2 RECEPTOR; MYELOID CELL-LINES; GROWTH-FACTOR; KINASE
   P56LCK; T-CELLS; MOLECULAR-CLONING; PLASMA-MEMBRANE; LYMPHOCYTES-T;
   BETA-CHAIN; EXPRESSION
AB We constructed cell lines which can proliferate in response to IL-2 or IL-3 by introducing a wild-type and mutant forms of cDNAs encoding the human IL-2R p75 chain into an IL-3 dependent hematopoietic cell line which expresses the p55 chain of the IL-2R.  We compared early events that were induced in these cells by IL-2 and IL-3.  Analysis of protein tyrosine phosphorylation showed that two common protein bands, pp95 and pp90, were phosphorylated by stimulation of either IL-2 or IL-3, suggesting the possible sharing of part of a signal transduction pathway between IL-2R and IL-3R.  Comparison of protein tyrosine phosphorylation profiles induced by IL-2 and IL-3 among a variety of cell lines revealed that the pp90 band is the common tyrosine phosphorylation substrate in the cell lines examined, although the general tyrosine phosphorylation pattern differed in each cell line.  Mutant p75 molecules incapable of inducing tyrosine phosphorylation could bind and internalize IL-2, but could not support cell growth.  We also found that swift changes of cytoskeletal protein organization are one of the early events caused by signal transduction through either IL-2R and IL-3R.  Reorganization of cytoskeletal proteins seems to be associated with protein phosphorylation, as a significant portion of pp90 was found in a detergent-soluble fraction in IL-2 or IL-3 treated cells.
C1 KYOTO UNIV,FAC MED,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   NAGOYA UNIV,SCH MED,DIS MECHANISM & CONTROL RES INST,NAGOYA,AICHI 466,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO PREFECTURAL UNIV MED,DEPT PATHOL,KYOTO 602,JAPAN.
   KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012; Kawakami, Toshiaki/O-1616-2015
CR GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0
   RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190
   LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T
   HAMAGUCHI M, 1987, P NATL ACAD SCI USA, V84, P2312, DOI 10.1073/pnas.84.8.2312
   CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923
   BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277
   ROBB RJ, 1987, J EXP MED, V165, P1201, DOI 10.1084/jem.165.4.1201
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   BENZEEV A, 1979, CELL, V17, P859, DOI 10.1016/0092-8674(79)90326-X
   BOCKUS BJ, 1984, EXP CELL RES, V153, P186, DOI 10.1016/0014-4827(84)90460-9
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   CREDIG R, 1985, NATURE, V314, P98
   FARRAR WL, 1989, J BIOL CHEM, V264, P12562
   FARRIS DK, 1989, J IMMUNOL, V143, P870
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7
   HATEKEYAMA M, 1989, SCIENCE, V244, P551
   HUHN RD, 1987, P NATL ACAD SCI USA, V84, P4408, DOI 10.1073/pnas.84.13.4408
   ISFORT R, 1988, J BIOL CHEM, V263, P19203
   ISFORT RJ, 1988, P NATL ACAD SCI USA, V85, P7982, DOI 10.1073/pnas.85.21.7982
   ISHII T, 1987, BIOCHEM J, V242, P211
   ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337
   IZUMI T, 1988, J BIOL CHEM, V263, P10386
   KAMIO M, 1990, INT IMMUNOL, V2, P415
   KOYASU S, 1987, EMBO J, V6, P3979
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEGRUE SJ, 1988, LYMPHOKINE RES, V7, P187
   LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LOEB DM, 1987, J VIROL, V61, P2420
   MACDONALD HR, 1986, ANNU REV CELL BIOL, V2, P231
   MESCHER MF, 1981, NATURE, V289, P139, DOI 10.1038/289139a0
   MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8
   MILLS GB, 1986, J IMMUNOL, V136, P3019
   MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0
   MIYATA Y, 1988, EXP CELL RES, V175, P286, DOI 10.1016/0014-4827(88)90193-0
   MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0
   MORLA AO, 1988, MOL CELL BIOL, V8, P2214
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   PALACIOS R, 1987, EMBO J, V6, P3687
   ROHRSCHNIDER LR, 1980, P NATL ACAD SCI USA, V85, P5190
   Sabe H, 1984, Mol Biol Med, V2, P379
   SAITO Y, 1988, J EXP MED, V168, P1563, DOI 10.1084/jem.168.5.1563
   SALTZMAN EM, 1989, J BIOL CHEM, V264, P19979
   SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956
   SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876
   TAKAMATSU T, 1988, J MICROSC-OXFORD, V149, P167
   TASHIRO K, 1991, IN PRESS IMMUNOL LET
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2
   VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   YAHARA I, 1978, CELL, V15, P251, DOI 10.1016/0092-8674(78)90100-9
   YODOI J, 1985, J IMMUNOL, V134, P1623
NR 59
TC 16
Z9 16
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD NOV
PY 1991
VL 3
IS 11
BP 1137
EP 1148
DI 10.1093/intimm/3.11.1137
PG 12
WC Immunology
SC Immunology
GA GQ763
UT WOS:A1991GQ76300010
PM 1760408
ER

PT J
AU SAITO, Y
   TADA, H
   SABE, H
   HONJO, T
AF SAITO, Y
   TADA, H
   SABE, H
   HONJO, T
TI BIOCHEMICAL-EVIDENCE FOR A 3RD CHAIN OF THE INTERLEUKIN-2 RECEPTOR
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BETA-CHAIN; IL-2 RECEPTOR; MONOCLONAL-ANTIBODIES; SIGNAL TRANSDUCTION;
   MOLECULAR-CLONING; LIGAND-BINDING; CROSS-LINKING; SIMIAN CELLS;
   ALPHA-CHAIN; TAC PEPTIDE
AB Two receptor proteins that specifically bind interleukin-2 (IL-2) have been identified previously. The L (Tac or alpha) chain can bind IL-2 with a K(d) value of 10 nM (low affinity). Although the H (beta) chain expressed on lymphocytes can bind IL-2 with a K(d) value of 1 nM (intermediate affinity), transfected fibroblasts expressing the H chain cannot bind IL-2, suggesting the involvement of other lymphocyte-specific factors for the function of the H chain. To obtain direct evidence for the presence of a third component of the IL-2 receptor, we examined the IL-2 binding activity of detergent-solubilized cell membrane preparations. We found that lysates of transfected Cos7 cells expressing H chains can bind IL-2 when mixed with lysates from lymphocytes that cannot bind IL-2. Chemical cross-linking of I-125-IL-2-bound lysate mixture and subsequent immunoprecipitation with a noncompetitive anti-H chain antibody gave rise to two I-125-IL-2-bound proteins, a 56-kDa protein (p56) and the H chain, although neither the H chain nor p56 alone is able to bind IL-2. These results indicate that p56 is the IL-2 receptor third chain that is required for IL-2 binding to the H chain. A similar lysate mixing experiment also showed that p56 is involved in IL-2 binding to the high affinity IL-2 receptor by forming the quaternary complex of IL-2, p56, L chain, and H chain.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
RP SAITO, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   SZOLLOSI J, 1987, P NATL ACAD SCI USA, V84, P7246, DOI 10.1073/pnas.84.20.7246
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   ROBB RJ, 1987, J EXP MED, V165, P1201, DOI 10.1084/jem.165.4.1201
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   COLAMONICI OR, 1990, J IMMUNOL, V145, P155
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0
   GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8
   HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   HATAKEYAMA M, 1987, J EXP MED, V166, P362, DOI 10.1084/jem.166.2.362
   HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   HERMANN T, 1988, MOL IMMUNOL, V25, P1201
   HERMANN T, 1988, EUR J IMMUNOL, V18, P1051
   HIRAKI DD, 1986, J IMMUNOL, V136, P4291
   KAMIO M, 1990, BLOOD, V75, P415
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   KONO T, 1990, P NATL ACAD SCI USA, V87, P1806, DOI 10.1073/pnas.87.5.1806
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MINAMOTO S, 1990, J IMMUNOL, V145, P2177
   MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OGURA T, 1988, MOL BIOL MED, V5, P123
   Sabe H, 1984, Mol Biol Med, V2, P379
   SABE H, IN PRESS INT IMMUNOL
   SAITO Y, 1988, J EXP MED, V168, P1563, DOI 10.1084/jem.168.5.1563
   SAITO Y, 1990, INT IMMUNOL, V2, P1167, DOI 10.1093/intimm/2.12.1167
   SARAGOVI H, 1990, P NATL ACAD SCI USA, V87, P11, DOI 10.1073/pnas.87.1.11
   SARAGOVI H, 1987, J IMMUNOL, V139, P1918
   SHARON M, 1990, P NATL ACAD SCI USA, V87, P4869, DOI 10.1073/pnas.87.12.4869
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   TAKESHITA T, 1990, INT IMMUNOL, V2, P477, DOI 10.1093/intimm/2.5.477
   TANAKA Y, 1985, MICROBIOL IMMUNOL, V29, P959
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1990, J IMMUNOL, V145, P599
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   TSUI LC, 1982, CELL, V30, P499, DOI 10.1016/0092-8674(82)90247-1
   VOSS SD, 1990, J EXP MED, V172, P1101, DOI 10.1084/jem.172.4.1101
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   YODOI J, 1985, J IMMUNOL, V134, P1623
   ZURAWSKI SM, 1990, EMBO J, V9, P3899
NR 43
TC 32
Z9 32
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 25
PY 1991
VL 266
IS 33
BP 22186
EP 22191
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GR564
UT WOS:A1991GR56400022
PM 1939240
ER

PT J
AU AOKI, T
   TASHIRO, K
   MIYATAKE, S
   NAKANO, T
   ODA, Y
   KIKUCHI, H
   HONJO, T
AF AOKI, T
   TASHIRO, K
   MIYATAKE, S
   NAKANO, T
   ODA, Y
   KIKUCHI, H
   HONJO, T
TI EXPRESSION OF THE RAG-2 GENE IN MURINE CENTRAL-NERVOUS-SYSTEM TUMOR-CELL
   LINES
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID IMMUNOGLOBULIN GENES; V(D)J RECOMBINATION; SELECTION; SEQUENCE; PROTEIN;
   CLONES; BRAIN
RP AOKI, T (reprint author), KYOTO UNIV HOSP,FAC MED,DEPT NEUROSURG & MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   BOSMA GC, 1989, IMMUNOGENETICS, V29, P54, DOI 10.1007/BF02341614
   CARLSON LM, 1991, CELL, V64, P201, DOI 10.1016/0092-8674(91)90221-J
   DUNKAN LC, 1953, J NATL CANCER I, V13, P1299
   FARRAR WL, 1987, IMMUNOL REV, V100, P361, DOI 10.1111/j.1600-065X.1987.tb00539.x
   FILDER I, 1978, ADV CANCER RES, V28, P149
   FURUKAWA T, 1991, IN PRESS J BIOL CHEM
   GOETZL EJ, 1990, ADV IMMUNOL, V44, P1
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   ICHIKAWA T, 1989, CANCER RES, V49, P367
   KAWAICHI M, 1991, IN PRESS J BIOL CHEM
   KURIBAYASHI K, 1988, J IMMUNOL, V141, P4074
   Maniatis T., 1982, MOL CLONING
   MINTY AJ, 1983, J MOL BIOL, V167, P77, DOI 10.1016/S0022-2836(83)80035-7
   PARNES JR, 1987, IMMUNOL REV, V100, P109, DOI 10.1111/j.1600-065X.1987.tb00529.x
   YAMASAKI T, 1984, CANCER RES, V44, P1776
   YAMASAKI T, 1983, CANCER RES, V43, P4610
   YAMASAKI T, 1988, CANCER RES, V48, P2981
NR 26
TC 6
Z9 6
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 27
PY 1991
VL 181
IS 1
BP 151
EP 158
DI 10.1016/S0006-291X(05)81394-4
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GR961
UT WOS:A1991GR96100022
PM 1683534
ER

PT J
AU SHIN, EK
   MATSUDA, F
   NAGAOKA, H
   FUKITA, Y
   IMAI, T
   YOKOYAMA, K
   SOEDA, E
   HONJO, T
AF SHIN, EK
   MATSUDA, F
   NAGAOKA, H
   FUKITA, Y
   IMAI, T
   YOKOYAMA, K
   SOEDA, E
   HONJO, T
TI PHYSICAL MAP OF THE 3' REGION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN
   LOCUS - CLUSTERING OF AUTOANTIBODY-RELATED VARIABLE SEGMENTS IN ONE
   HAPLOTYPE
SO EMBO JOURNAL
LA English
DT Article
ID ARTIFICIAL-CHROMOSOME LIBRARIES; GERM-LINE GENES; B-CELL LINES;
   UNMUTATED COPIES; LIGHT-CHAINS; DNA; ORGANIZATION; ANTIBODY; YEAST;
   DEFINITION
AB We have constructed the physical map of the 3' region of the human immunoglobulin heavy chain variable region (V(H)) genes. DNA segments extending to 200 kb upstream of the J(H) segment were isolated in two YAC clones. Five V(H) segments were identified in this region in the 5' to 3' order, V(II-5), V(IV-4), V(I-3), V(I-2), and V(VI-1) segments which were all structurally normal and orientated in the same direction as the J(H) segments. From DNA of a different cell line we have isolated a cosmid contig containing the same DNA region which has extraordinary polymorphism. The YAC and cosmid DNAs were called haplotypes A and B, respectively. Haplotype B contained an additional V(H-I) segment (VI-4.1b) between the V(II-5) and V(IV-4) segments. V(I-4.1b) segment is almost identical to a previously published V(H) sequence encoding a rheumatoid factor. Another V(H) segment in the B haplotype (V(I-3b)) corresponding to the V(I-3) segment also showed 99.7% nucleotide sequence homology with an anti-DNA autoantibody V(H) sequence. However, none of the V(H) sequences in haplotype A showed such strong homology with autoantibody V(H) sequences. The results suggest that V(H) haplotypes may have linkage with autoantibody production.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN.
RP SHIN, EK (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
   HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053
   BERMAN JE, 1988, EMBO J, V7, P727
   CAIRNS E, 1989, J IMMUNOL, V143, P685
   CHEN PP, 1986, P NATL ACAD SCI USA, V83, P8318, DOI 10.1073/pnas.83.21.8318
   CUISINIER A-M, 1990, New Biologist, V2, P689
   DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496
   GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3
   GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213
   HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3
   KABAT EA, 1987, NIH PUBLICATIONS
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   Logtenberg T, 1989, Int Immunol, V1, P362, DOI 10.1093/intimm/1.4.362
   LOGTENBERG T, 1989, J AUTOIMMUN, V2, P203, DOI 10.1016/0896-8411(89)90132-7
   LOGTENBERG T, 1989, J EXP MED, V170, P1347, DOI 10.1084/jem.170.4.1347
   MATSUDA F, 1988, EMBO J, V7, P1047
   MATSUDA F, 1990, EMBO J, V9, P2501
   Noma Y, 1984, Mol Biol Med, V2, P337
   PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841
   RADOUX V, 1986, J EXP MED, V164, P2119, DOI 10.1084/jem.164.6.2119
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SANZ I, 1989, J IMMUNOL, V142, P883
   SATO T, 1988, BIOCHEM BIOPH RES CO, V154, P265, DOI 10.1016/0006-291X(88)90679-1
   SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WALTER MA, 1990, EMBO J, V9, P3303
NR 34
TC 114
Z9 114
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD DEC
PY 1991
VL 10
IS 12
BP 3641
EP 3645
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GQ588
UT WOS:A1991GQ58800009
PM 1935893
ER

PT J
AU HAN, H
   OKAMOTO, M
   HONJO, T
   SHIMIZU, A
AF HAN, H
   OKAMOTO, M
   HONJO, T
   SHIMIZU, A
TI REGULATED EXPRESSION OF IMMUNOGLOBULIN TRANS-MESSENGER RNA CONSISTING OF
   THE VARIABLE REGION OF A TRANSGENIC-MU CHAIN AND CONSTANT REGIONS OF
   ENDOGENOUS ISOTYPES
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE IG CLASS SWITCHING; LYMPHOKINE CYTOKINE; MULTIPLE ISOTYPE EXPRESSION;
   TRANSSPLICING; PCR
ID GROWTH FACTOR-BETA; HEAVY-CHAIN; B-CELLS; SWITCH RECOMBINATION; CIRCULAR
   DNA; LYMPHOCYTES-B; MEMBRANE FORM; GENES; TRANSCRIPTS; MOUSE
AB Our previous work demonstrated that chimeric immunoglobulin mRNAs (trans-mRNAs) composed of a transgenic V(H)DJ(H) region and endogenous C(H) sequences could be synthesized, most likely by a trans-splicing mechanism, in a transgenic line carrying a rearranged human membrane-type mu chain gene.  In this study we further investigated regulation of trans-mRNA expression.  Regulated expression of different gamma subclasses of trans-mRNA was similar to that of class switching:  IL-4 together with lipopolysaccharide (LPS) predominantly increased the amount of gamma-1 trans-mRNA whereas LPS alone mainly induced gamma-3 and gamma-2b trans-mRNAs.  Expression of the gamma class trans-mRNAs was preceded by germline transcription from the corresponding C(H) genes, but the co-existence of such germline transcripts and transgene transcripts was not sufficient for trans-mRNA production.  Transforming growth factor-beta induced germline transcripts of the alpha chain C(H) gene but had no obvious effects on alpha trans-mRNA induction.  Both C-alpha gene alleles were used in trans-mRNA but in different frequencies.  We could also detect trans-mRNA expression in another transgenic mouse line which carries a rearranged mouse V(H)DJ(H)-C-mu gene.  These results indicate that trans-mRNA synthesis is not restricted to either a particular transgenic line or an isotype, but is a general mechanism to express a second isotype with the V(H) regions of rearranged mu chain transgenes.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   MOORE KW, 1981, P NATL ACAD SCI-BIOL, V78, P1800, DOI 10.1073/pnas.78.3.1800
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   ESSER C, 1989, EMBO J, V8, P483
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   RADBRUCH A, 1983, EMBO J, V2, P1929
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672
   MAKI R, 1981, CELL, V24, P353, DOI 10.1016/0092-8674(81)90325-1
   BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4
   FRIEDLANDER RM, 1990, NUCLEIC ACIDS RES, V18, P4278, DOI 10.1093/nar/18.14.4278
   Fritsch E., 1989, MOL CLONING
   GAFF C, 1990, INT IMMUNOL, V2, P1143, DOI 10.1093/intimm/2.12.1143
   GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S
   HERZENBE.LA, 1967, COLD SPRING HARB SYM, V32, P181
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Kabat E. A., 1987, SEQUENCES PROTEINS I
   KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   LEBMAN DA, 1990, J IMMUNOL, V144, P952
   LEBMAN DA, 1990, P NATL ACAD SCI USA, V87, P3962, DOI 10.1073/pnas.87.10.3962
   LUTZKER S, 1988, MOL CELL BIOL, V8, P1849
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   OKAMOTO M, 1990, NUCLEIC ACIDS RES, V18, P1895, DOI 10.1093/nar/18.7.1895
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175
   POTTER M, 1967, COLD SPRING HARB SYM, V32, P187
   SHIMIZU A, 1991, J EXP MED, V173, P1385, DOI 10.1084/jem.173.6.1385
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   SHIMIZU A, 1989, COLD SH Q B, V54, P175
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   Xu M, 1990, Dev Immunol, V1, P11, DOI 10.1155/1990/47659
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 45
TC 13
Z9 18
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD DEC
PY 1991
VL 3
IS 12
BP 1197
EP 1206
DI 10.1093/intimm/3.12.1197
PG 10
WC Immunology
SC Immunology
GA GV851
UT WOS:A1991GV85100001
PM 1777416
ER

PT J
AU FURUKAWA, T
   KAWAICHI, M
   MATSUNAMI, N
   RYO, H
   NISHIDA, Y
   HONJO, T
AF FURUKAWA, T
   KAWAICHI, M
   MATSUNAMI, N
   RYO, H
   NISHIDA, Y
   HONJO, T
TI THE DROSOPHILA RBP-J-KAPPA GENE ENCODES THE BINDING-PROTEIN FOR THE
   IMMUNOGLOBULIN J-KAPPA RECOMBINATION SIGNAL SEQUENCE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SITE-SPECIFIC RECOMBINATION; V(D)J RECOMBINATION; CODING SEGMENTS;
   NUCLEAR-PROTEIN; DNA; LOCUS; MELANOGASTER; PRODUCT; ACID; ORGANIZATION
AB We previously isolated a cDNA encoding the 60-kDa murine protein (RBP-J(K) protein) that specifically binds to the immunoglobulin J. recombination signal sequence. The RBP-J(K) gene is highly conserved in a wide variety of organisms including man, Xenopus, Drosophila, and yeast. We have isolated and characterized the Drosophila homologue of the RBP-J(K) gene. The Drosophila RBP-J(K) gene was mapped to the polytene region 35BC of chromosome 2. The nucleotide sequence of this gene indicates that it is not one of the known genes located in the 35 BC region. The nucleotide and amino acid sequences of the Drosophila and mouse RBP-J(K) genes are 60 and 75% homologous, respectively. The central 248-residue regions of RBP-J(K) proteins of the two species are 93% homologous and include the 40-residue integrase motif. The Drosophila RBP-J(K) protein expressed in COS cells bound to the J(K) recognition sequence with the same specificity as the murine counterpart. These results suggest that Drosophila may have a site-specific recombination system which utilizes the immunoglobulin recombination signal sequence. Implications for evolution of immunoglobulin gene rearrangement were also discussed.
C1 OSAKA UNIV,FAC MED,DEPT RADIAT BIOL,SUITA,OSAKA 565,JAPAN.
   AICHI CANC CTR,RES INST,MOLEC BIOL UNIT,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN.
RP FURUKAWA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P844, DOI 10.1073/pnas.82.3.844
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678
   FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P2082, DOI 10.1073/pnas.82.7.2082
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0
   REGULSKI M, 1987, EMBO J, V6, P767
   HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4
   MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381
   CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353
   MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3
   HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053
   CRAIG NL, 1988, ANNU REV GENET, V22, P77
   VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5
   FRYBERG EA, 1983, CELL, V33, P115
   GUBB D, 1984, CHROMOSOMA, V91, P54, DOI 10.1007/BF00286485
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045
   MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OKAZAKI K, 1988, J IMMUNOL, V141, P1348
   PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612
   PIRROTTA V, 1987, EMBO J, V6, P791
   POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHNEUWLY S, 1986, EMBO J, V5, P733
   SCHUEPBACH T, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P302
   SCHWAGER J, 1988, EMBO J, V7, P2409
   SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0
   SEIDMAN JG, 1979, NATURE, V280, P370, DOI 10.1038/280370a0
   SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688
   SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WILLIAMS AF, 1989, IMMUNOGLOBULIN GENES, P361
   WOODRUFF RC, 1979, GENETICS, V92, P117
NR 54
TC 58
Z9 59
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 5
PY 1991
VL 266
IS 34
BP 23334
EP 23340
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GT483
UT WOS:A1991GT48300084
PM 1744127
ER

PT J
AU OKAMOTO, M
   MURAKAMI, M
   SHIMIZU, A
   OZAKI, S
   TSUBATA, T
   KUMAGAI, S
   HONJO, T
AF OKAMOTO, M
   MURAKAMI, M
   SHIMIZU, A
   OZAKI, S
   TSUBATA, T
   KUMAGAI, S
   HONJO, T
TI A TRANSGENIC MODEL OF AUTOIMMUNE HEMOLYTIC-ANEMIA
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID IMMUNOGLOBULIN HEAVY-CHAIN; B-CELL TOLERANCE; LYMPHOCYTE-B; MICE;
   EXPRESSION; ANTIBODY; GENES; MOUSE; REARRANGEMENT; HYBRIDOMA
AB We made double transgenic mice bearing immunoglobulin heavy and light chain genes encoding an autoantibody against the mouse erythrocyte by the cross of C57BL/6 mice carrying the transgene for each chain of the immunoglobulin. Although no obvious disorders were found in the single-chain transgenic mice, severely anemic symptoms were found in some of the double transgenic mice, in which most B cells express, at least on their surface, the autoantibody reactive to self-antigens on the erythrocyte. Individual double-transgenic mice showed a wide variation of phenotypes between severe anemia and no symptoms. Both deletion and anergy of autoreactive B cells were seen in each individual mouse, but their relative contribution to self-tolerance was variable and not directly related to the severity of anemia or the amount of the autoantibody produced. This transgenic system provides a good autoimmune disease model for exploring its onset mechanism, and means of its treatment and prevention.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED 2,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
CR ADAMS TE, 1990, MOL BIOL MED, V7, P341
   GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   ADAMS E, 1990, P NATL ACAD SCI USA, V87, P5687, DOI 10.1073/pnas.87.15.5687
   SHIBATA T, 1990, INT IMMUNOL, V2, P1133, DOI 10.1093/intimm/2.12.1133
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   Coffman R L, 1982, Immunol Rev, V69, P5
   COX KO, 1974, CLIN EXP IMMUNOL, V17, P199
   GAUSE A, 1987, EUR J IMMUNOL, V17, P981, DOI 10.1002/eji.1830170714
   HARLOW E, 1988, ANTIBODIES LABORATOR
   HERZENBERG LA, 1987, NATURE, V329, P71, DOI 10.1038/329071a0
   Hogan B, 1986, MANIPULATING MOUSE E
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KUZE K, 1991, INT IMMUNOL, V3, P647, DOI 10.1093/intimm/3.7.647
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   NEUBERGER MS, 1983, EMBO J, V2, P1373
   NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976
   OKAMOTO M, 1990, NUCLEIC ACIDS RES, V18, P1895, DOI 10.1093/nar/18.7.1895
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   PIKE BL, 1980, J EXP MED, V152, P1407, DOI 10.1084/jem.152.5.1407
   PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013
   RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   STALL AM, 1988, P NATL ACAD SCI USA, V85, P3546, DOI 10.1073/pnas.85.10.3546
NR 29
TC 208
Z9 209
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JAN 1
PY 1992
VL 175
IS 1
BP 71
EP 79
DI 10.1084/jem.175.1.71
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GY436
UT WOS:A1992GY43600010
PM 1730928
ER

PT J
AU KAWAKAMI, K
   KITA, K
   MIWA, H
   IKEDA, T
   NISHII, K
   MASUYA, M
   MORITA, N
   OHNO, T
   TANAKA, I
   NOSAKA, T
   HONJO, T
   SHIRAKAWA, S
AF KAWAKAMI, K
   KITA, K
   MIWA, H
   IKEDA, T
   NISHII, K
   MASUYA, M
   MORITA, N
   OHNO, T
   TANAKA, I
   NOSAKA, T
   HONJO, T
   SHIRAKAWA, S
TI REARRANGEMENT PATTERNS OF IMMUNOGLOBULIN HEAVY-CHAIN (IGH) AND LIGHT
   CHAIN GENES IN ACUTE LYMPHOBLASTIC-LEUKEMIA AND CHRONIC
   MYELOCYTIC-LEUKEMIA LYMPHOID CRISIS CELLS SHOWING OLIGOCLONAL IGH GENE
   REARRANGEMENTS
SO INTERNATIONAL JOURNAL OF HEMATOLOGY
LA English
DT Article
DE ACUTE LYMPHOBLASTIC LEUKEMIA; CHRONIC MYELOCYTIC LEUKEMIA BLAST CRISIS;
   OLIGOCLONALITY; IMMUNOGLOBULIN GENE REARRANGEMENT; PRE-B-CELL
   DIFFERENTIATION
AB We investigated leukemic cells with multiple immunoglobulin heavy chain (IgH) gene rearrangements from nine B-precursor cell acute lymphoblastic leukemia (ALL) patients and three chronic myelocytic leukemia lymphoid crisis (CML.Ly-BC) patients in order to determine detailed recombination patterns of the variable (V), diversity (D), and joining (J) region genes. Southern blot study, using DNA probes for DQ52 and 5'D region genes, was useful to distinguish VDJ recombination from DJ recombination at the level of each allele. Leukemic cells from seven out of eight CD10-positive ALL patients showed biallelic VDJ recombinations. Rearrangements of Ig kappa-genes were found in only one case. Leukemic cells from all of the CML.Ly-BC patients had a DJ/(V)DJ IgH genotype. These findings suggest that the multiple IgH gene rearrangements in B-precursor cell ALL occurred as a consequence of continuing V-(V)DJ rearrangements after neoplastic transformation, and were closely related to the stage of bone marrow B-precursor cell differentiation. Multiple IgH gene rearrangements in CML.Ly-BC might take place earlier in the process of IgH gene rearrangements than is the case in B-precursor cell ALL. In this sense, the genotypic oligoclonality observed in ALL and CML.Ly-BC should be regarded not as 'true', but as 'pseudo' oligoclonal leukemia.
C1 MIE UNIV,SCH MED,DEPT INTERNAL MED 2,2-174 EDOBASHI,TSU,MIE 514,JAPAN.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0925-5710
J9 INT J HEMATOL
JI Int. J. Hematol.
PD FEB
PY 1992
VL 55
IS 1
BP 61
EP 69
PG 9
WC Hematology
SC Hematology
GA HF741
UT WOS:A1992HF74100006
PM 1581585
ER

PT J
AU KAWAICHI, M
   OKA, C
   SHIBAYAMA, S
   KOROMILAS, AE
   MATSUNAMI, N
   HAMAGUCHI, Y
   HONJO, T
AF KAWAICHI, M
   OKA, C
   SHIBAYAMA, S
   KOROMILAS, AE
   MATSUNAMI, N
   HAMAGUCHI, Y
   HONJO, T
TI GENOMIC ORGANIZATION OF MOUSE J(KAPPA) RECOMBINATION SIGNAL
   BINDING-PROTEIN (RBP-J) GENE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SITE-SPECIFIC RECOMBINASES; IMMUNOGLOBULIN GENES; V(D)J RECOMBINATION;
   ANTIGEN RECEPTOR; NUCLEAR-PROTEIN; SEQUENCES; TRANSCRIPTION; DIVERSITY;
   REARRANGEMENT; PURIFICATION
AB We have isolated a cDNA clone (RBP-2) for the protein (RBP-J(kappa)) which binds to immunoglobulin recombination signals with 23-base pair spacers (Matsunami, N., Hamaguchi, Y., Yamamoto, Y., Kuze, K., Kangawa, K., Matsuo, H., Kawaichi, M., and Honjo, T. (1989) Nature 342, 934-937). During further screening of a cDNA library from the same mouse pre-B cell line (38B9), we have isolated a second cDNA clone (RBP-2N) which differs from RBP-2 in its 5' sequence. RNase protection assays indicated that the RBP-2N type mRNA was produced in 10-20 times the quantity as RBP-2 mRNA. To elucidate the relationship between these two mRNAs, we analyzed the genomic organization of the RBP-J(kappa) gene. Southern hybridization of mouse genomic DNA detected at least 7 EcoRI fragments hybridizing to an RBP-2 cDNA probe, suggesting a complex structure for the RBP-J(kappa) gene. Cloning of each EcoRI fragment revealed one functional RBP-J(kappa) gene and three related genes. The functional gene was composed of 11 exons and spanned at least 50 kilobase pairs. The sequence of exon 1 and its 5'-flanking region contained a GC-rich promoter-like region but no apparent TATA box. The initiation site of transcription was heterogeneous, and the two types of mRNA are produced from the same exon by transcription initiation at different sites and by different usage of splice signals. Two of the three related genes were processed pseudogenes with scattered stop codons. The other was also a processed gene with a sequence exactly the same as that of RBP-2, except that this gene lacked the sequence corresponding to the first exon of the functional gene.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AGUILERA RJ, 1987, CELL, V51, P909, DOI 10.1016/0092-8674(87)90578-2
   ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   SEHGAL A, 1988, MOL CELL BIOL, V8, P3160
   LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7
   THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.immunol.4.1.529
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0
   JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267
   ARGOS P, 1986, EMBO J, V5, P433
   SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459
   VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DESIDERIO S, 1984, NATURE, V308, P860, DOI 10.1038/308860a0
   FULOP GM, 1990, NATURE, V308, P425
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HALLIGAN BD, 1987, P NATL ACAD SCI USA, V84, P7019, DOI 10.1073/pnas.84.20.7019
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HOPE TJ, 1986, SCIENCE, V231, P1141, DOI 10.1126/science.3003919
   POYARTSALMERON C, 1989, EMBO J, V8, P2425
   Sambrook J, 1989, MOL CLONING LABORATO
   SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0
   SUN SC, 1990, SCIENCE, V250, P1929
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 35
TC 39
Z9 40
U1 1
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 25
PY 1992
VL 267
IS 6
BP 4016
EP 4022
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HE607
UT WOS:A1992HE60700071
PM 1740450
ER

PT J
AU TAKAHASHI, Y
   SHIMIZU, A
   SAKAI, T
   ENDO, Y
   OSAWA, N
   SHISA, H
   HONJO, T
AF TAKAHASHI, Y
   SHIMIZU, A
   SAKAI, T
   ENDO, Y
   OSAWA, N
   SHISA, H
   HONJO, T
TI MAPPING OF THE NU-GENE USING CONGENIC NUDE STRAINS AND INSITU
   HYBRIDIZATION
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Note
ID CDNA; DNA; CHROMOSOME-11; EVI-2
AB The chromosomal location of the nu gene, which is responsible for hairlessness and athymus, was determined using six DNA markers (interleukin 3 [Il-3], Myhs, Acrb, Evi-2, Mpo, and Hox-2) on mouse chromosome 11. We constructed the high-resolution physical mapping of the six DNA markers on chromosome 11 by in situ hybridization using fluorescence-labeled cosmid probes. The results indicate the order of centromere-(41cM)-Il-3-(3cM)-Myhs-(4cM)-Acrb-(6cM)-Evi-2-(3cM)-Mpo-(5cM)-Hox-2. We have used congenic nude strains and examined which of the six DNA markers were derived from the original nude mouse. We found the Evi-2 locus is linked to the nu gene in all the informative, independent congenic nude strains. From these data, we could estimate the location of the nu gene, not only genetically but also physically within a region that spans approximately 17 megabases (9 cM) between the Acrb and Mpo genes.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   OSAKA UNIV,SCH MED,DEPT LAB MED,FUKUSHIMA KU,OSAKA 553,JAPAN.
   KITASATO UNIV,SCH MED,DEPT MICROBIOL,SAGAMIHARA,KANAGAWA 228,JAPAN.
   SAITAMA CANC CTR,RES INST,DEPT PATHOL,INA,SAITAMA 362,JAPAN.
CR BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303
   LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592
   BUCHBERG AM, 1988, ONCOGENE RES, V2, P149
   FLANAGAN SP, 1986, GENET RES, V8, P295
   GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3
   MORISHITA K, 1987, J BIOL CHEM, V262, P3844
   OCONNELL P, 1990, GENOMICS, V7, P547, DOI 10.1016/0888-7543(90)90198-4
   Pantelouris E M, 1973, Differentiation, V1, P437, DOI 10.1111/j.1432-0436.1973.tb00143.x
   RYGAARD J, 1974, ACTA PATH MICRO IM A, VA 82, P48
   SHULTZ LD, 1978, ANIMAL MODELS COMP D, P211
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TANABE T, 1984, EUR J BIOCHEM, V144, P11, DOI 10.1111/j.1432-1033.1984.tb08424.x
   WATANABE T, 1988, BIOCH GENET, V26, P2
   WEYDERT A, 1985, P NATL ACAD SCI USA, V82, P7183, DOI 10.1073/pnas.82.21.7183
   YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070
NR 15
TC 27
Z9 27
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAR 1
PY 1992
VL 175
IS 3
BP 873
EP 876
DI 10.1084/jem.175.3.873
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HF640
UT WOS:A1992HF64000027
PM 1346798
ER

PT J
AU AOKI, T
   TASHIRO, K
   MIYATAKE, S
   KINASHI, T
   NAKANO, T
   ODA, Y
   KIKUCHI, H
   HONJO, T
AF AOKI, T
   TASHIRO, K
   MIYATAKE, S
   KINASHI, T
   NAKANO, T
   ODA, Y
   KIKUCHI, H
   HONJO, T
TI EXPRESSION OF MURINE INTERLEUKIN-7 IN A MURINE GLIOMA CELL-LINE RESULTS
   IN REDUCED TUMORIGENICITY INVIVO
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE GENE THERAPY; TUMOR REGRESSION
ID ACTIVATED KILLER-CELLS; TOXIC LYMPHOCYTES-T; GROWTH-FACTOR; RECOMBINANT
   INTERLEUKIN-2; MOUSE; INTERFERON; GENERATION; CDNA; GENE;
   DIFFERENTIATION
AB We have examined the immunoregulatory effect of local and continuous secretion of interleukin 7 (IL-7) from murine glioma cells (203-glioma) engineered by murine IL-7 gene transfection. Secretion of IL-7 from glioma cells did not result in morphology or growth rate changes but did reduce tumorigenicity in vivo in proportion to the amount of IL-7 produced. This reduction in tumorigenicity could be reversed in a dose-dependent fashion by injection of anti-IL-7 neutralizing monoclonal antibody at the tumor site. Mice immunized with IL-7-producing glioma cells showed a specific immune response to 203-glioma but not to two other syngeneic cell lines (B-16, a melanoma, and YM-12, a fibrosarcoma). IL-7-producing glioma cells were not rejected in mice depleted of CD8+ cells but were rejected in mice depleted of CD4+ or NK1.1+ cells. These results suggest that CD8+ T cells may play an important role in tumor rejection.
C1 KYOTO UNIV,FAC MED,DEPT NEUROSURG,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AHSER AL, 1991, J IMMUNOL, V146, P3227
   ALDERSON MR, 1990, J EXP MED, V172, P577, DOI 10.1084/jem.172.2.577
   BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0
   FONTANA A, 1984, J IMMUNOL, V132, P1837
   FEARON ER, 1990, CELL, V60, P397, DOI 10.1016/0092-8674(90)90591-2
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   WATANABE Y, 1989, P NATL ACAD SCI USA, V86, P9456, DOI 10.1073/pnas.86.23.9456
   NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988
   BLANKENSTEIN T, 1991, J EXP MED, V173, P1047, DOI 10.1084/jem.173.5.1047
   TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2
   ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923
   HAVELL EA, 1988, J EXP MED, V167, P1067, DOI 10.1084/jem.167.3.1067
   MORRISSEY PJ, 1991, J IMMUNOL, V147, P561
   GANSBACHER B, 1990, J EXP MED, V172, P1217, DOI 10.1084/jem.172.4.1217
   ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735
   RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   KOO GC, 1986, J IMMUNOL, V137, P3742
   CHAZEN GD, 1989, P NATL ACAD SCI USA, V86, P5923, DOI 10.1073/pnas.86.15.5923
   COLOMBO MP, 1991, J EXP MED, V173, P889, DOI 10.1084/jem.173.4.889
   COBBOLD SP, 1986, NATURE, V323, P164, DOI 10.1038/323164a0
   WELCH PA, 1989, J IMMUNOL, V143, P3562
   AOKI T, 1991, BIOCHEM BIOPH RES CO, V181, P151, DOI 10.1016/S0006-291X(05)81394-4
   AOKI T, 1989, J EXP MED, V170, P583, DOI 10.1084/jem.170.2.583
   Davis R W, 1980, Methods Enzymol, V65, P404
   FILDER I, 1978, ADV CANCER RES, V28, P149
   FREI K, 1985, J IMMUNOL, V135, P4044
   GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302
   Holub M., 1991, Immunological disorders in mice., P23
   Hoskin D. W., 1991, Immunological disorders in mice., P251
   HUI K, 1984, NATURE, V311, P750, DOI 10.1038/311750a0
   KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768
   LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5
   LARSSON I, 1978, INFECT IMMUN, V22, P786
   LYNCH DH, 1990, J IMMUNOL, V145, P1983
   Maniatis T., 1982, MOL CLONING
   MARTIN R, 1987, EMBO J, V6, P3673
   NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0
   NISHIMURA T, 1986, CANCER IMMUNOL IMMUN, V21, P12
   POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161
   SCALA G, 1990, J EXP MED, V172, P61, DOI 10.1084/jem.172.1.61
   SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333
   TANAKA K, 1988, ANNU REV IMMUNOL, V6, P359
   TOHYAMA K, 1990, EMBO J, V9, P1823
   TRIBOLET N, 1990, CANCER RES, V50, P6683
   YAMADA G, 1987, EMBO J, V6, P2705
   YAMASAKI T, 1988, CANCER RES, V48, P2981
NR 47
TC 132
Z9 134
U1 0
U2 1
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 1
PY 1992
VL 89
IS 9
BP 3850
EP 3854
DI 10.1073/pnas.89.9.3850
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HR853
UT WOS:A1992HR85300037
PM 1570303
ER

PT J
AU MURAKAMI, M
   TSUBATA, T
   OKAMOTO, M
   SHIMIZU, A
   KUMAGAI, S
   IMURA, H
   HONJO, T
AF MURAKAMI, M
   TSUBATA, T
   OKAMOTO, M
   SHIMIZU, A
   KUMAGAI, S
   IMURA, H
   HONJO, T
TI ANTIGEN-INDUCED APOPTOTIC DEATH OF LY-1 B-CELLS RESPONSIBLE FOR
   AUTOIMMUNE-DISEASE IN TRANSGENIC MICE
SO NATURE
LA English
DT Article
ID ANTIBODY-SECRETING CELLS; LYMPHOCYTES-B; RHEUMATOID-FACTOR; SOMATIC
   MUTATION; CLONAL DELETION; DNA; MOUSE; AUTOANTIBODIES; ENUMERATION;
   LINEAGE
AB STUDIES on transgenic mice expressing immunoglobulins against self-antigens 1-6 have shown that self-tolerance is maintained by active elimination (clonal deletion) 1-3,7, functional inactivation (clonal anergy) 4,5,8 of self-reactive B cells, or a combination of both 6. We have established and characterized a transgenic mouse line expressing an anti-erythrocyte autoantibody 6. In contrast to other autoantibody transgenic lies, about 50% of the animals of this transgenic line suffer from autoimmune disease, indicating a loss of self-tolerance. Here we show that peritoneal Ly-1 B cells (also known as B-1 cells 9) are responsible for this autoimmune disease in our transgenic mice. A few self-reactive Ly-1 B cells that have somehow escaped the deletion mechanism expand in the peritoneum because of the absence of self-antigen. These Ly-1 B cells are eliminated in vivo by apoptosis once exposed to self-antigen. On the basis of these results we propose a novel autoantibody production mechanism whereby self-reactive B cells sequestered in compartments free of self-antigens may survive, proliferate and be activated for generation of pathogenic autoantibodies in autoimmune diseases.
C1 KYOTO UNIV,FAC MED,DEPT INTERNAL MED 2,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
RP MURAKAMI, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265
   HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057
   SEDGWICK JD, 1983, J IMMUNOL METHODS, V57, P301, DOI 10.1016/0022-1759(83)90091-1
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   BURNET F, 1959, CLONAL SELECTION THE
   CASALI P, 1989, J IMMUNOL, V143, P3476
   DIANOND B, 1984, P NATL ACAD SCI USA, V81, P5841
   GIUSTI AM, 1987, P NATL ACAD SCI USA, V84, P2926, DOI 10.1073/pnas.84.9.2926
   GOLDSTEIN P, 1991, IMMUNOL REV, V121, P30
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810
   KANTOR A B, 1991, Immunology Today, V12, P388, DOI 10.1016/0167-5699(91)90135-G
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013
   RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0
   Schwartz R, 1989, FUNDAMENTAL IMMUNOLO, P819
   SMITH HR, 1983, ANNU REV IMMUNOL, V1, P175, DOI 10.1146/annurev.iy.01.040183.001135
   WILLIAMS JR, 1974, NATURE, V252, P754, DOI 10.1038/252754a0
NR 32
TC 253
Z9 253
U1 0
U2 2
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD MAY 7
PY 1992
VL 357
IS 6373
BP 77
EP 80
DI 10.1038/357077a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HT229
UT WOS:A1992HT22900062
PM 1574128
ER

PT J
AU IWASATO, T
   ARAKAWA, H
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
AF IWASATO, T
   ARAKAWA, H
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
TI BIASED DISTRIBUTION OF RECOMBINATION SITES WITHIN S-REGIONS UPON
   IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION INDUCED BY TRANSFORMING
   GROWTH-FACTOR-BETA AND LIPOPOLYSACCHARIDE
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID HEAVY-CHAIN GENES; CIRCULAR DNA; NUCLEOTIDE-SEQUENCES; IGA PRODUCTION;
   LYMPHOCYTES-B; DELETION; CELLS; REARRANGEMENT; MU; ORGANIZATION
AB We have characterized extrachromosomal circular DNAs from adult mouse spleen cells that were induced to switch to immunoglobulin A (IgA) with bacterial lipopolysaccharide (LPS) and transforming growth factor-beta (TGF-beta), and identified breakpoints of S-mu/S-gamma-3, S-mu/S-gamma-2, S-mu/S-alpha, S-gamma-3/S-alpha, and S-gamma-2/S-alpha recombinants. The S-mu recombination donor sites clustered in the 3' half of the S-mu region, while the S-alpha recombination acceptor sites clustered in the 5' half of the S-alpha region. In addition, donor and acceptor sites of S-gamma regions also clustered in the 3' and 5' parts, respectively. These site preferences are in sharp contrast to the dispersed distribution of S-mu/S-gamma-1 breakpoints within both S-mu and S-gamma-1 regions upon IgG1 switch induced by LPS and interleukin 4. Our results support the hypotheses that TGF-beta increases the frequency of switch recombination events to IgA and that the switch recombination to IgA often proceeds by successive recombination of S-mu/S-gamma and S-gamma/S-alpha.
C1 KYOTO UNIV,FAC SCI,DEPT BIOPHYS,MOLEC BIOL LAB,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR AKIRA S, 1983, CELL, V34, P545, DOI 10.1016/0092-8674(83)90387-2
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   ROTH DB, 1986, MOL CELL BIOL, V6, P4295
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   RADBRUCH A, 1983, EMBO J, V2, P1929
   YOSHIDA K, 1990, P NATL ACAD SCI USA, V87, P7829, DOI 10.1073/pnas.87.20.7829
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415
   SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   HAN H, 1991, INT IMMUNOL, V3, P1197, DOI 10.1093/intimm/3.12.1197
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   Honjo T., 1989, Immunoglobulin genes., P123
   HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   LEBMAN DA, 1990, P NATL ACAD SCI USA, V87, P3962, DOI 10.1073/pnas.87.10.3962
   MAKI R, 1980, P NATL ACAD SCI-BIOL, V77, P2138, DOI 10.1073/pnas.77.4.2138
   Maniatis T., 1982, MOL CLONING
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   WINTER E, 1987, EMBO J, V6, P1663
   YAMAGISHI H, 1983, GENE, V26, P317
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894
NR 35
TC 52
Z9 52
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JUN 1
PY 1992
VL 175
IS 6
BP 1539
EP 1546
DI 10.1084/jem.175.6.1539
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HV676
UT WOS:A1992HV67600015
PM 1588279
ER

PT J
AU FURUKAWA, T
   MARUYAMA, S
   KAWAICHI, M
   HONJO, T
AF FURUKAWA, T
   MARUYAMA, S
   KAWAICHI, M
   HONJO, T
TI THE DROSOPHILA HOMOLOG OF THE IMMUNOGLOBULIN RECOMBINATION SIGNAL
   BINDING-PROTEIN REGULATES PERIPHERAL NERVOUS-SYSTEM DEVELOPMENT
SO CELL
LA English
DT Article
ID SMALL AUTOSOMAL REGION; LARGE TRANSPOSING ELEMENT; SCUTE GENE-COMPLEX;
   LOOP-HELIX PROTEINS; ALCOHOL-DEHYDROGENASE; STRUCTURAL GENE; NEGATIVE
   REGULATOR; MELANOGASTER; DNA; MUTATIONS
AB The J(kappa) RBP binds to the immunoglobulin recombination signal sequence flanking the kappa-type J segment. We previously isolated the highly conserved homolog of the J(kappa) RBP gene from D. melanogaster, which is not thought to have immunoglobulin molecules. Using many deficiency mutants and in situ hybridization, we mapped the Drosophila J(kappa) RBP gene in a region containing two recessive lethal mutations, i.e., br26 and br7, which shows the dominant Suppressor of Hairless (Su(H)) phenotype in heterozygotes. All six Su(H) alleles analyzed at the DNA level contained mutations in the Drosophila J(kappa) RBP gene. Since the Su(H) mutation affects peripheral nervous system development, the Drosophila J(kappa) RBP gene product is involved in gene regulation of peripheral nervous system development. The results also imply that the immunoglobulin recombination signal sequence and the target sequence of the Drosophila J(kappa) RBP protein might have a common evolutionary origin.
RP FURUKAWA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P844, DOI 10.1073/pnas.82.3.844
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P2082, DOI 10.1073/pnas.82.7.2082
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8
   MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848
   CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3
   EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6
   MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0
   BANG AG, 1991, DEVELOPMENT, V111, P89
   ASHBURNER M, 1982, GENETICS, V102, P421
   RUSHLOW CA, 1989, EMBO J, V8, P3095
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053
   CRAIG NL, 1988, ANNU REV GENET, V22, P77
   BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y
   ALONSO MC, 1988, EMBO J, V7, P2585
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   MOHLER J, 1984, GENETICS, V106, P249
   ASHBURNER M, 1982, GENETICS, V101, P447
   ASHBURNER M, 1989, DROSOPHILA LABORATOR
   ASHBURNER M, 1982, GENETICS, V102, P401
   ASHBURNER M, 1990, GENETICS, V126, P679
   ASHBURNER M, 1983, GENETICS, V104, P405
   CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242
   EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7
   ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   GARCIABE.A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9
   GUBB D, 1985, CHROMOSOMA, V92, P116, DOI 10.1007/BF00328463
   GUBB D, 1984, CHROMOSOMA, V91, P54, DOI 10.1007/BF00286485
   GUBB D, 1986, GENETICS, V112, P551
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389
   KAWAICHI M, 1991, J BIOL CHEM, V266, P18387
   NASH D, 1990, GENETICS, V64, P471
   NISHIDA Y, 1986, BIOCHEM BIOPH RES CO, V141, P474, DOI 10.1016/S0006-291X(86)80197-8
   ODONNELL JD, 1977, GENETICS, V86, P533
   Plunkett CR, 1926, J EXP ZOOL, V46, P181, DOI 10.1002/jez.1400460204
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHWAGER J, 1988, EMBO J, V7, P2409
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0
   WOODRUFF RC, 1979, GENETICS, V92, P133
   WOODRUFF RC, 1979, GENETICS, V92, P117
NR 50
TC 107
Z9 109
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138
SN 0092-8674
J9 CELL
JI Cell
PD JUN 26
PY 1992
VL 69
IS 7
BP 1191
EP 1197
DI 10.1016/0092-8674(92)90640-X
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA JA431
UT WOS:A1992JA43100013
PM 1617729
ER

PT J
AU AOKI, T
   KIKUCHI, H
   MIYATAKE, SI
   ODA, Y
   OTSUKA, SI
   KINASHI, T
   HONJO, T
AF AOKI, T
   KIKUCHI, H
   MIYATAKE, SI
   ODA, Y
   OTSUKA, SI
   KINASHI, T
   HONJO, T
TI SYNERGY OF INTERLEUKIN-5 WITH INTERLEUKIN-2 IN THE GENERATION OF
   LYMPHOKINE-ACTIVATED KILLER-CELLS
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE INTERLEUKIN-5; LYMPHOKINE-ACTIVATED KILLER CELLS
ID REPLACING FACTOR TRF; GROWTH FACTOR-II; B-CELLS; RECOMBINANT
   INTERLEUKIN-2; TUMORICIDAL ACTIVITY; IL-2 RECEPTOR; TUMOR-CELLS; LAK
   CELLS; T-CELLS; INDUCTION
AB IL-5 synergies with IL-2 to produce increased LAK activity, although IL-5 alone induced little cytotoxic activity. The most dramatic synergy occurred with a suboptimal IL-2 concentration. The kinetics of LAK activity induced by IL-2 plus IL-5 were similar to those induced by IL-2. IL-5 exerted its effects during the late stage of IL-2 induced LAK generation. In the precursor phase, depletion of asialo-GM1+ cells preceding culture eliminated IL-2 plus IL-5 induced LAK activity. In the effector phase, IL-2 plus IL-5 induced LAK activity was eliminated by depletion of Thy1.2+ cells following culture.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RP AOKI, T (reprint author), KYOTO UNIV,FAC MED,DEPT NEUROSURG,SAKYO KU,KYOTO 606,JAPAN.
CR COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531
   OKADA M, 1988, J IMMUNOL, V141, P1543
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   TAKATSU K, 1988, IMMUNOL REV, V102, P107, DOI 10.1111/j.1600-065X.1988.tb00743.x
   ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   GRABSTEIN KH, 1986, SCIENCE, V232, P506, DOI 10.1126/science.3083507
   ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735
   CRUMP WL, 1989, CANCER RES, V49, P149
   SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668
   GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823
   YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43
   AOKI T, IN PRESS P NATL ACAD
   AOKI T, 1989, J EXP MED, V170, P583, DOI 10.1084/jem.170.2.583
   BALLAS ZK, 1990, J IMMUNOL, V144, P386
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   DAMLE NK, 1986, J IMMUNOL, V137, P2814
   ELLIS TM, 1989, J IMMUNOL, V143, P4282
   ESPEVIK T, 1988, J IMMUNOL, V140, P2312
   HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581
   HARADA N, 1985, J IMMUNOL, V134, P3944
   ITO K, 1985, J IMMUNOL, V134, P3124
   KALLAND T, 1987, J IMMUNOL, V138, P3640
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   LOTS MT, 1981, CANCER RES, V41, P4420
   LOUGHNAN MS, 1989, NATURE, V340, P76, DOI 10.1038/340076a0
   MITA S, 1989, P NATL ACAD SCI USA, V86, P2311, DOI 10.1073/pnas.86.7.2311
   MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863
   MULE J, 1989, J IMMUNOL, V143, P726
   MULE JJ, 1987, J EXP MED, V166, P792, DOI 10.1084/jem.166.3.792
   MULE JJ, 1987, IMMUNE RESPONSE META, P77
   PEACE DJ, 1988, J IMMUNOL, V140, P3679
   ROLINK AG, 1989, J EXP MED, V169, P1693, DOI 10.1084/jem.169.5.1693
   ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327
   SAMPSONJOHANNES A, 1988, J IMMUNOL, V141, P3680
   SIEGEL JP, 1987, SCIENCE, V139, P10
   SUTTLES J, 1986, J IMMUNOL, V136, P1586
   SWAIN SL, 1988, J IMMUNOL, V141, P3445
   SWAIN SL, 1985, J IMMUNOL, V134, P3934
   TAKATSU K, 1987, P NATL ACAD SCI USA, V84, P4234, DOI 10.1073/pnas.84.12.4234
   TAKATSU K, 1980, J IMMUNOL, V124, P2414
   TAKATSU K, 1985, J IMMUNOL, V134, P382
   TANABE T, 1987, J BIOL CHEM, V262, P16580
   TING CC, 1986, CANCER RES, V46, P513
   TSUJIMOTO M, 1988, J BIOCH, V264, P13369
   YANG JC, 1986, J IMMUNOL, V137, P715
   YUJI K, 1986, J IMMUNOL, V136, P1161
NR 47
TC 0
Z9 0
U1 0
U2 0
PU INT JOURNAL ONCOLOGY
PI ATHENS
PA C/O PROFESSOR D A SPANDIDOS, EDITORIAL OFFICE, 1, S MERKOURI ST, ATHENS
   116 35, GREECE
SN 1019-6439
J9 INT J ONCOL
JI Int. J. Oncol.
PD JUL
PY 1992
VL 1
IS 2
BP 165
EP 174
PG 10
WC Oncology
SC Oncology
GA JR827
UT WOS:A1992JR82700011
PM 21584527
ER

PT J
AU HAMAGUCHI, Y
   YAMAMOTO, Y
   IWANARI, H
   MARUYAMA, S
   FURUKAWA, T
   MATSUNAMI, N
   HONJO, T
AF HAMAGUCHI, Y
   YAMAMOTO, Y
   IWANARI, H
   MARUYAMA, S
   FURUKAWA, T
   MATSUNAMI, N
   HONJO, T
TI BIOCHEMICAL AND IMMUNOLOGICAL CHARACTERIZATION OF THE DNA-BINDING
   PROTEIN (RBP-J-KAPPA) TO MOUSE J-KAPPA RECOMBINATION SIGNAL SEQUENCE
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
ID IMMUNOGLOBULIN GENES; V(D)J RECOMBINATION; DIVERSITY; ANTIBODY;
   RECEPTOR; LEUKEMIA; ANTIGEN; CLONES; CELLS; RAG-1
AB We have investigated whether J(kappa) recombination signal sequence (RS) binding protein (RBP-J(kappa)) has any partial catalytic activities involved in the VDJ recombination reaction, such as cleavage, ligation, and bending of DNA. Murine RBP-J(kappa) protein purified by J(kappa)-RS affinity chromatography did not show DNA cleavage activities but contained a strong DNA ligase activity. To obtain a large amount of purified RBP-J(kappa)protein, recombinant RBP-J(kappa) was synthesized in Escherichia coli as a fusion protein and also in silkworm cells. Although recombinant RBP-J(kappa) produced in silkworm cells could bind J-kappa(RS), it failed to show either ligase or DNA bending activity. Since the DNA affinity-purified RBP-J(kappa) has the ligase activity, the RBP-J(kappa) protein may form a complex with a ligase in vivo. We have raised monoclonal antibodies against the RBP-J(kappa) fusion protein which was synthesized in E. coli and unable to bind J(kappa)-RS. Using the anti-RBP-J(kappa) monoclonal antibody we have shown that the RBP-J(kappa) protein is expressed ubiquitously in mammalian tissues. The ubiquitous expression of the RBP-J(kappa) protein is consistent with the hypothesis that the RBP-J(kappa) protein may have dual function [Furukawa et al. (1991) J. Biol. Chem. 266, 23334-23340].
C1 INST IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN.
RP HAMAGUCHI, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.immunol.4.1.529
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   CHAUVEAU J, 1956, EXP CELL RES, V11, P317, DOI 10.1016/0014-4827(56)90107-0
   FULOP GM, 1990, NATURE, V342, P934
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   JAINCHIL.JL, 1969, J VIROL, V4, P549
   KAWAICHI M, IN PRESS J BIOL CHEM
   KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7
   KOTLARZ D, 1986, EMBO J, V5, P799
   MARUMOTO Y, 1987, J GEN VIROL, V68, P2599, DOI 10.1099/0022-1317-68-10-2599
   METCALF D, 1969, J NATL CANCER I, V43, P983
   OGAWA M, 1989, LEUKEMIA, V3, P282
   Oi V. T., 1980, SELECTED METHODS CEL, P351
   OKADA M, 1983, J EXP MED, V157, P583, DOI 10.1084/jem.157.2.583
   PELKONEN J, 1987, J EXP MED, V166, P1245, DOI 10.1084/jem.166.5.1245
   Sambrook J., 1989, MOL CLONING
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WATT RA, 1985, MOL CELL BIOL, V5, P448
NR 30
TC 61
Z9 61
U1 0
U2 0
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD SEP
PY 1992
VL 112
IS 3
BP 314
EP 320
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JL745
UT WOS:A1992JL74500004
PM 1429518
ER

PT J
AU MIWA, H
   KITA, K
   NOSAKA, T
   IKEDA, T
   KAWAKAMI, K
   ANAZAWA, H
   HOSHINO, K
   OHNO, T
   HONJO, T
   HATANAKA, M
   SHIRAKAWA, S
AF MIWA, H
   KITA, K
   NOSAKA, T
   IKEDA, T
   KAWAKAMI, K
   ANAZAWA, H
   HOSHINO, K
   OHNO, T
   HONJO, T
   HATANAKA, M
   SHIRAKAWA, S
TI MATURATIONAL STAGE SPECIFIC IMMUNOGLOBULIN HEAVY-CHAIN GENE
   REARRANGEMENTS, DETERMINED BY D AND D UPSTREAM REGION GENE STRUCTURES
SO LEUKEMIA RESEARCH
LA English
DT Article
DE B-CELL MALIGNANCIES; IGH GENE REARRANGEMENT; IGH D GENES; B-CELL
   DIFFERENTIATION
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL RECEPTOR; PRE-B-CELLS;
   MULTIPLE-MYELOMA; BETA-CHAIN; DIVERSITY; SEGMENTS; ANTIGEN;
   DIFFERENTIATION; ORGANIZATION
AB In 43 cases of various B-cell lineage tumors, precise gene structures of rearranged immunoglobulin heavy chain (IgH) were studied. By Southern-blot analysis of D upstream (5'D) gene of IgH, biallelic rearrangement structures, D-J or V-D-J, were determined and consequently maturational stage specific IgH rearrangement patterns were investigated. B-precursor ALL cases (especially stage IV of Nadler's criteria) have V-D-J rearranged IgH genes on both alleles. In contrast, most of the mature B-cell malignancies, excluding multiple myeloma, have IgH genotype of D-J/V-D-J. In addition, in case of D-J/V-D-J, the D gene used in D-J joining has been speculated by Southern-blot of D genes. So, these approaches for inquiring precise structures of rearranged IgH genes are supposed to provide new information of lymphocyte differentiation and leukemogenesis.
C1 KYOTO UNIV,INST VIRUS RES,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RP MIWA, H (reprint author), MIE UNIV,SCH MED,DEPT INTERNAL MED 2,2-174 EDOBASHI,TSU,MIE 514,JAPAN.
CR OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2
   SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6
   BERMAN JE, 1988, EMBO J, V7, P727
   CALIGARISCAPPIO F, 1985, J CLIN INVEST, V76, P1243, DOI 10.1172/JCI112080
   CHEN Z, 1987, J EXP MED, V165, P1000, DOI 10.1084/jem.165.4.1000
   EPSTEIN J, 1988, BLOOD, V71, P861
   GOORHA R, 1987, P NATL ACAD SCI USA, V84, P4547, DOI 10.1073/pnas.84.13.4547
   HAGIYA M, 1986, P NATL ACAD SCI USA, V83, P145, DOI 10.1073/pnas.83.1.145
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   IKUTA K, 1985, P NATL ACAD SCI USA, V82, P7701, DOI 10.1073/pnas.82.22.7701
   KITA K, 1985, BLOOD, V66, P47
   KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096
   LEFRANC MP, 1985, NATURE, V316, P464, DOI 10.1038/316464a0
   MATSUDA F, 1988, EMBO J, V7, P1047
   MIWA H, 1988, JPN J CANCER RES, V79, P484
   MIZUTANI S, 1986, EMBO J, V5, P3467
   NADLER LM, 1984, J CLIN INVEST, V74, P332, DOI 10.1172/JCI111428
   NOSAKA T, 1989, BLOOD, V74, P361
   ROYER HD, 1984, CELL, V39, P261, DOI 10.1016/0092-8674(84)90003-5
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 25
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0145-2126
J9 LEUKEMIA RES
JI Leuk. Res.
PD SEP
PY 1992
VL 16
IS 9
BP 861
EP 871
DI 10.1016/0145-2126(92)90032-3
PG 11
WC Oncology; Hematology
SC Oncology; Hematology
GA JQ569
UT WOS:A1992JQ56900003
PM 1405717
ER

PT J
AU HONJO, T
AF HONJO, T
TI SEPPUKU AND AUTOIMMUNITY
SO SCIENCE
LA English
DT Editorial Material
ID PROGRAMMED CELL-DEATH; MICE
RP HONJO, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   OWENS GP, 1991, MOL CELL BIOL, V11, P4177
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   GOLSTEIN P, 1991, IMMUNOL REV, V121, P29, DOI 10.1111/j.1600-065X.1991.tb00822.x
   VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   BRETSCHE.P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042
   DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   HEMAZEE DA, 1989, NATURE, V337, P562
   ISHIDA Y, IN PRESS EMBO J
   KRAMMER PH, COMMUNICATION
   PARKER DC, 1980, IMMUNOL REV, V52, P115, DOI 10.1111/j.1600-065X.1980.tb00333.x
   SCHWARTZ LM, 1990, P NATL ACAD SCI USA, V87, P6594, DOI 10.1073/pnas.87.17.6594
   TSUBATA T, UNPUB
NR 15
TC 8
Z9 8
U1 2
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD OCT 23
PY 1992
VL 258
IS 5082
BP 591
EP 592
DI 10.1126/science.1384132
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JU745
UT WOS:A1992JU74500044
PM 1384132
ER

PT J
AU ISHIDA, Y
   AGATA, Y
   SHIBAHARA, K
   HONJO, T
AF ISHIDA, Y
   AGATA, Y
   SHIBAHARA, K
   HONJO, T
TI INDUCED EXPRESSION OF PD-1, A NOVEL MEMBER OF THE IMMUNOGLOBULIN GENE
   SUPERFAMILY, UPON PROGRAMMED CELL-DEATH
SO EMBO JOURNAL
LA English
DT Article
DE APOPTOSIS; GROWTH FACTOR DEPRIVATION; IMMUNOGLOBULIN SUPERFAMILY;
   PROGRAMMED CELL DEATH; SUBTRACTIVE HYBRIDIZATION
ID TUMOR NECROSIS FACTOR; NEURONAL DEATH; RNA-SYNTHESIS; T-CELLS;
   ACTIVATION; APOPTOSIS; ANTIGEN; THYMOCYTES; RECEPTOR; CDNA
AB The classical type of programmed cell death is characterized by its dependence on de novo RNA and protein synthesis and morphological features of apoptosis. We confirmed that stimulated 2B4.11 (a murine T-cell hybridoma) and interleukin-3 (IL-3)-deprived LyD9 (a murine haematopoietic progenitor cell line) died by the classical type of programmed cell death. Assuming that common biochemical pathways might be involved in the deaths of 2B4.11 and LyD9, we isolated the PD-1 gene, a novel member of the immunoglobulin gene superfamily, by using subtractive hybridization technique. The predicted PD-1 protein has a variant form of the consensus sequence found in cytoplasmic tails of signal transducing polypeptides associated with immune recognition receptors. The PD-1 gene was activated in both stimulated 2B4.11 and IL-3-deprived LyD9 cells, but not in other death-induced cell lines that did not show the characteristic features of the classical programmed cell death. Expression of the PD-1 mRNA in mouse was restricted to the thymus and increased when thymocyte death was augmented by in vivo injection of anti-CD3 antibody. These results suggest that activation of the PD-1 gene may be involved in the classical type of programmed cell death.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALLEN RD, 1990, J EXP MED, V172, P1367, DOI 10.1084/jem.172.5.1367
   OPPENHEIM RW, 1990, DEV BIOL, V138, P104, DOI 10.1016/0012-1606(90)90180-Q
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3
   SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456
   TATA JR, 1966, DEV BIOL, V13, P77, DOI 10.1016/0012-1606(66)90050-9
   GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0
   WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121
   YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747
   SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2
   GOLSTEIN P, 1991, IMMUNOL REV, V121, P29, DOI 10.1111/j.1600-065X.1991.tb00822.x
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0
   NUNEZ G, 1990, J IMMUNOL, V144, P3602
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5
   RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0
   ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   Britten R J, 1974, Methods Enzymol, V29, P363
   COHEN JJ, 1984, J IMMUNOL, V132, P38
   HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311
   Kerr J.F.R., 1991, APOPTOSIS MOL BASIS, P5
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   LANIER LL, 1981, J IMMUNOL, V126, P626
   Lockshin R, 1991, APOPTOSIS MOL BASIS, P47
   MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0
   MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   PALACIOS R, 1987, EMBO J, V6, P3687
   ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8
   RUBIN BY, 1988, CANCER RES, V48, P6006
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHWARTZ LM, 1990, P NATL ACAD SCI USA, V87, P6594, DOI 10.1073/pnas.87.17.6594
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   TRUMAN JW, 1984, ANNU REV NEUROSCI, V7, P171
   UCKER DS, 1989, J IMMUNOL, V143, P3461
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
   WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0
   WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T
NR 44
TC 643
Z9 705
U1 7
U2 22
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD NOV
PY 1992
VL 11
IS 11
BP 3887
EP 3895
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA JT328
UT WOS:A1992JT32800010
PM 1396582
ER

PT J
AU SHIMIZU, A
   HONJO, T
AF SHIMIZU, A
   HONJO, T
TI SYNTHESIS AND REGULATION OF TRANS-MESSENGER RNA ENCODING THE
   IMMUNOGLOBULIN-EPSILON HEAVY-CHAIN
SO FASEB JOURNAL
LA English
DT Article
DE POLYMERASE CHAIN REACTION; TRANSGENIC MU-CHAIN; TRANSCRIPTION
ID SWITCH CIRCULAR DNA; ISOTYPE EXPRESSION; MEMBRANE FORM; B-CELLS;
   REARRANGEMENT; RECOMBINATION; MOUSE; INTERLEUKIN-4; GENES; MU
AB We have detected an immunoglobulin heavy-chain trans-mRNA of the epsilon class in which the variable region of the human transgenic mu chain is correctly spliced to the first exon of the endogenous mouse epsilon constant region. Together with our previous observations, all the endogenous isotypes that are targets of class switching have proved to be expressed as trans-mRNA. This indicates that immunoglobulin trans-mRNA synthesis is a general mechanism to express a second heavy-chain isotype with the variable region of the transgenic mu chain. Synthesis of epsilon trans-mRNA is regulated in a way similar to the trans-mRNAs of the gamma subclasses or class switching to epsilon, i.e., interleukin-4 can induce the germline transcript of the epsilon constant region, but costimulation with lipopolysaccharide is necessary for epsilon trans-mRNA expression. The amount of epsilon trans-mRNA induced is similar to that of gamma1 and higher than expected as judged from the rate of class switching to epsilon. All these data are consistent with our previous hypothesis that trans-mRNA is synthesized by a trans-splicing mechanism and that this mechanism is involved in the simultaneous multiple-isotype expression of immunoglobulin in a single B lymphocyte.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 60601,JAPAN.
RP SHIMIZU, A (reprint author), KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 60601,JAPAN.
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   MOORE KW, 1981, P NATL ACAD SCI-BIOL, V78, P1800, DOI 10.1073/pnas.78.3.1800
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183
   NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126
   KINASHI T, 1987, GENE DEV, V1, P465, DOI 10.1101/gad.1.5.465
   YOSHIDA K, 1990, P NATL ACAD SCI USA, V87, P7829, DOI 10.1073/pnas.87.20.7829
   ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672
   MAKI R, 1981, CELL, V24, P353, DOI 10.1016/0092-8674(81)90325-1
   CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562
   ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.immunol.8.1.717
   FRIEDLANDER RM, 1990, NUCLEIC ACIDS RES, V18, P4278, DOI 10.1093/nar/18.14.4278
   GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S
   Guise J. W., 1989, Immunoglobulin genes., P275
   HAN H, 1991, INT IMMUNOL, V3, P1197, DOI 10.1093/intimm/3.12.1197
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   NOLANWILLARD M, 1992, P NATL ACAD SCI USA, V89, P1234, DOI 10.1073/pnas.89.4.1234
   PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189
   PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175
   SHIMIZU A, 1991, J EXP MED, V173, P1385, DOI 10.1084/jem.173.6.1385
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   SHIMIZU A, 1989, COLD SH Q B, V54, P175
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SHINKAI Y, 1988, IMMUNOGENETICS, V27, P288, DOI 10.1007/BF00376124
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SIEBENKOTTEN G, 1992, EUR J IMMUNOL, V22, P1827, DOI 10.1002/eji.1830220723
   VANHOVE B, 1991, MOL IMMUNOL, V29, P1
   YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0
NR 30
TC 34
Z9 34
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JAN
PY 1993
VL 7
IS 1
BP 149
EP 154
PG 6
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA KH880
UT WOS:A1993KH88000022
PM 7916698
ER

PT J
AU NAZAREA, M
   SAITO, Y
   OKAZAKI, S
   SUZUKI, N
   HONJO, T
AF NAZAREA, M
   SAITO, Y
   OKAZAKI, S
   SUZUKI, N
   HONJO, T
TI A MONOCLONAL-ANTIBODY WHICH INHIBITS GROWTH OF T-CELL LINES
SO GROWTH FACTORS
LA English
DT Article
DE IL-2-ASSOCIATION MOLECULE; T-CELL GROWTH INHIBITION; FACS PROFILE OF
   CELL LINES
ID HUMAN INTERLEUKIN-2 RECEPTOR; IL-2 RECEPTOR; BETA-CHAIN; TYROSINE
   PHOSPHORYLATION; BIOCHEMICAL-EVIDENCE; MOLECULAR-CLONING; ALPHA-CHAIN;
   ASSOCIATION; EXPRESSION; GENE
AB In an attempt to elucidate the intricate structure and possibly the signal transduction pathway of the interleukin-2 receptor (IL-2R) we tried to produce monoclonal antibodies against putative human IL-2R-associated molecules which precipitated from YT2C2 cells with a monoclonal antibody (Mikbeta3) against the human IL-2R beta chain. One of the antibodies obtained (7xA10) recognizes a cell surface molecule of about 120 kDa (p120). Cross-linking of [I-125]-IL-2 and immunoprecipitation with 7xA10 suggest that the p120 protein may somehow associate physically with the IL-2R beta chain. Although p120 itself did not bind IL-2, and 7xA10 did not inhibit IL-2 binding to the IL-2R, growth of the human IL-2-dependent cell lines ED40515 and Kit225 was completely inhibited by adding 7xA10 to the culture at a relatively low concentration (0.2 mug/ml). At a higher concentration (2 mug/ml) 7xA10 inhibited the growth of YTC3 and YT2C2 cells expressing IL-2Rs with high and intermediate affinities, respectively. The B cell line FLEB-14 and the erythroid cell line K562, which both express pl 20 as determined by flow cytometry, but no IL-2R alpha or beta chains showed only slight proliferation changes at high 7xA10 concentrations. Out of 16 lymphocyte cell lines tested so far, only Molt-4, Raji and Daudi did not express p120, and therefore 7xA10 did not influence their growth behavior. p120 might be a new IL-2R association molecule which seems to play a certain role in the growth regulation of various lymphoid cell lines.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KOBE UNIV,SCH MED,DEPT PHYSIOL,KOBE 650,JAPAN.
CR HORI T, 1987, BLOOD, V70, P1069
   SZOLLOSI J, 1987, P NATL ACAD SCI USA, V84, P7246, DOI 10.1073/pnas.84.20.7246
   BURTON J, 1990, P NATL ACAD SCI USA, V87, P7329, DOI 10.1073/pnas.87.18.7329
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   HERRMANN T, 1988, MOL IMMUNOL, V25, P1201, DOI 10.1016/0161-5890(88)90156-3
   TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559
   ROSENSTEIN Y, 1991, NATURE, V354, P233, DOI 10.1038/354233a0
   COLAMONICI OR, 1990, J IMMUNOL, V145, P155
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   DAUTRY F, 1988, J BIOL CHEM, V263, P17615
   HARLOW E, 1988, ANTIBODIES LAB MANUA, P288
   HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   HATAKEYAMA M, 1992, P NATL ACAD SCI USA, V89, P2022, DOI 10.1073/pnas.89.6.2022
   Honjo T, 1991, Curr Biol, V1, P201, DOI 10.1016/0960-9822(91)90055-2
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   SABE H, 1991, INT IMMUNOL, V3, P1137, DOI 10.1093/intimm/3.11.1137
   Sabe H, 1984, Mol Biol Med, V2, P379
   SAITO Y, 1991, J BIOL CHEM, V266, P22186
   SAITO Y, 1990, Progress in Growth Factor Research, V2, P207, DOI 10.1016/0955-2235(90)90019-G
   Saito Y, 1992, Growth Factors, V7, P297, DOI 10.3109/08977199209046412
   SHARON M, 1990, P NATL ACAD SCI USA, V87, P4869, DOI 10.1073/pnas.87.12.4869
   SHIMIZU S, 1988, BLOOD, V72, P1826
   TAKESHITA T, 1990, INT IMMUNOL, V2, P477, DOI 10.1093/intimm/2.5.477
   TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227
   WALDMANN TA, 1991, J BIOL CHEM, V266, P2681
   YODOI J, 1985, J IMMUNOL, V134, P1623
   ZMUIDZINAS A, 1991, MOL CELL BIOL, V11, P2794
NR 31
TC 1
Z9 1
U1 0
U2 0
PU HARWOOD ACAD PUBL GMBH
PI READING
PA C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL
SN 0897-7194
J9 GROWTH FACTORS
JI Growth Factors
PY 1993
VL 9
IS 2
BP 139
EP 147
DI 10.3109/08977199309010829
PG 9
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA MD289
UT WOS:A1993MD28900006
PM 8217217
ER

PT J
AU MATSUDA, F
   SHIN, EK
   NAGAOKA, H
   MATSUMURA, R
   HAINO, M
   FUKITA, Y
   TAKAISHI, S
   IMAI, T
   RILEY, JH
   ANAND, R
   SOEDA, E
   HONJO, T
AF MATSUDA, F
   SHIN, EK
   NAGAOKA, H
   MATSUMURA, R
   HAINO, M
   FUKITA, Y
   TAKAISHI, S
   IMAI, T
   RILEY, JH
   ANAND, R
   SOEDA, E
   HONJO, T
TI STRUCTURE AND PHYSICAL MAP OF 64 VARIABLE SEGMENTS IN THE
   3(I)0.8-MEGABASE REGION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS
SO NATURE GENETICS
LA English
DT Article
ID ARTIFICIAL-CHROMOSOME LIBRARIES; HUMAN MONOCLONAL-ANTIBODY; VH GENE
   SUBGROUPS; GERM-LINE GENES; B-CELL LINES; NUCLEOTIDE-SEQUENCES;
   PREFERENTIAL UTILIZATION; RHEUMATOID-ARTHRITIS; GEL-ELECTROPHORESIS; DNA
   AUTOANTIBODIES
AB We have constructed the physical map of the 0.8 megabase DNA fragment which contains the 3' 64 variable region (V) gene segments of the human immunoglobulin heavy chain (H) locus. The organization of the V(H) locus showed several features that indicate dynamic reshuffling of this locus. The sequenced 64 V(H) segments include 31 pseudogenes, of which 24 are highly conserved except for a few point mutations. Comparison of the 64 germline V(H) sequences shows that each V(H) family has conserved sequences, suggesting that there might be some genetic or selection mechanisms involved in maintenance of each family. The total number of the human V(H) segments was estimated to be about 120, including at least 7 orphons.
C1 KYOTO UNIV,FAC MED,CTR MOLEC BIOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN.
   ICI PHARMACEUT PLC,DEPT BIOTECHNOL,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND.
RI Matsuda, Fumihiko/B-9893-2009
CR ADDERSON EE, 1991, J IMMUNOL, V147, P1667
   AKAHORI Y, 1990, J CLIN INVEST, V85, P1722, DOI 10.1172/JCI114627
   ALEXANDER A, 1988, J CLIN INVEST, V82, P1244, DOI 10.1172/JCI113722
   ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425
   SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825
   WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
   SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146
   BERMAN JE, 1988, EMBO J, V7, P723
   BRODEUR PH, 1988, J EXP MED, V168, P2261, DOI 10.1084/jem.168.6.2261
   CAIRNS E, 1989, J IMMUNOL, V143, P685
   CHEN PP, 1990, SCAND J IMMUNOL, V31, P257, DOI 10.1111/j.1365-3083.1990.tb02767.x
   CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205
   DERSIMONIAN H, 1989, J IMMUNOL, V142, P4027
   DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496
   EBELING SB, 1992, INT IMMUNOL, V4, P313, DOI 10.1093/intimm/4.3.313
   FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927
   FRIEDMAN DF, 1991, J EXP MED, V174, P525, DOI 10.1084/jem.174.3.525
   GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3
   GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213
   HARINDRANATH N, 1991, INT IMMUNOL, V3, P865, DOI 10.1093/intimm/3.9.865
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HUGHESJONES NC, 1990, BIOCHEM J, V268, P135
   HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0
   IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KISHIMOTO T, 1989, NUCLEIC ACIDS RES, V17, P4385, DOI 10.1093/nar/17.11.4385
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667
   MATSUDA F, 1988, EMBO J, V7, P1047
   MATSUDA F, 1990, EMBO J, V9, P2501
   MATTHYSSENS G, 1980, P NATL ACAD SCI-BIOL, V77, P6561, DOI 10.1073/pnas.77.11.6561
   MILLI M, 1991, MOL IMMUNOL, V28, P753
   MORTARI F, 1992, EUR J IMMUNOL, V22, P241, DOI 10.1002/eji.1830220135
   NICKERSON KG, 1989, J EXP MED, V169, P1391, DOI 10.1084/jem.169.4.1391
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841
   RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   Sambrook J, 1989, MOL CLONING LABORATO
   SANZ I, 1989, J IMMUNOL, V142, P4054
   SANZ I, 1989, J IMMUNOL, V142, P883
   SANZ I, 1989, EMBO J, V8, P3471
   SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563
   SHIN EK, 1991, EMBO J, V10, P3641
   SILVERSTEIN LE, 1989, J EXP MED, V169, P1631
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WALTER MA, 1990, EMBO J, V9, P3303
   YANG PH, 1990, P NATL ACAD SCI USA, V88, P7907
NR 54
TC 327
Z9 327
U1 1
U2 3
PU NATURE PUBLISHING CO
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707
SN 1061-4036
J9 NAT GENET
JI Nature Genet.
PD JAN
PY 1993
VL 3
IS 1
BP 88
EP 94
DI 10.1038/ng0193-88
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA KF372
UT WOS:A1993KF37200019
PM 8490662
ER

PT J
AU SEVERINSON, E
   LUNDGREN, M
   MIZUTA, TR
   STAVNEZER, J
   HONJO, T
   SHIMIZU, A
AF SEVERINSON, E
   LUNDGREN, M
   MIZUTA, TR
   STAVNEZER, J
   HONJO, T
   SHIMIZU, A
TI MOLECULAR-CLONING OF A PROTEIN-BINDING TO THE PROMOTER OF IG C-GAMMA-1
   GERM LINE IN THE MOUSE
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 KAROLINSKA INST,DEPT CELL & MOLEC BIOL,S-10401 STOCKHOLM 60,SWEDEN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   UNIV MASSACHUSETTS,DEPT MOLEC GENET & MICROBIOL,AMHERST,MA 01003.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JAN 9
PY 1993
SU 17A
BP 173
EP 173
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA KN464
UT WOS:A1993KN46400638
ER

PT J
AU TSUBATA, T
   WU, J
   HONJO, T
AF TSUBATA, T
   WU, J
   HONJO, T
TI T-CELL-DERIVED COSTIMULATORY SIGNAL THROUGH THE CD40 MOLECULE RESCUES
   B-CELLS FROM SURFACE IMMUNOGLOBULIN-MEDIATED CELL-DEATH
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JAN 26
PY 1993
SU 17B
BP 215
EP 215
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA KN465
UT WOS:A1993KN46500765
ER

PT J
AU ARAKAWA, H
   IWASATO, T
   HAYASHIDA, H
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
AF ARAKAWA, H
   IWASATO, T
   HAYASHIDA, H
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
TI THE COMPLETE MURINE IMMUNOGLOBULIN CLASS SWITCH REGION OF THE
   ALPHA-HEAVY CHAIN GENE-HIERARCHICAL REPETITIVE STRUCTURE AND
   RECOMBINATION BREAKPOINTS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID C-MYC ONCOGENE; CIRCULAR DNA; NUCLEOTIDE-SEQUENCES; GAMMA-GENES;
   PLASMACYTOMAS; MECHANISM; EPSILON; REARRANGEMENT; TRANSLOCATION;
   DUPLICATION
AB A 7255-base pair (bp) sequence, including the previously sequenced murine segments of Ialpha, Salpha, and Calpha, has been completed. Homology matrix comparison revealed a switch repetitive region of 4.2 kilobases (kb) composed of 20-80-bp homology runs, including the previously assigned Salpha region. We distinguished several stretches of duplication, i.e. the central 0.8-kb repetitive region, with some 80-bp staggered consensus repeats containing 20-30-bp subsets, made up of the primordial pentamers CTG(A/G)G. All the breakpoints of the Salpha switch recombination, including those generated by the translocation of the c-myc protooncogene and those catalyzed by bacterial extracts, are located within the consensus sequence subsets of the 4.2-kb repetitive region.
C1 KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR AGUILERA RJ, 1985, EMBO J, V4, P3689
   AKIRA S, 1983, CELL, V34, P545, DOI 10.1016/0092-8674(83)90387-2
   FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   YOSHIDA K, 1990, P NATL ACAD SCI USA, V87, P7829, DOI 10.1073/pnas.87.20.7829
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8
   SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1
   SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589
   CALAME K, 1982, P NATL ACAD SCI-BIOL, V79, P6994, DOI 10.1073/pnas.79.22.6994
   COLLIER DA, 1988, J BIOL CHEM, V263, P7397
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DUNNICK W, 1989, MOL CELL BIOL, V9, P1850
   FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746
   GERONDAKIS S, 1984, CELL, V36, P973, DOI 10.1016/0092-8674(84)90047-3
   GUO LH, 1983, METHOD ENZYMOL, V100, P60
   HAYASHIDA H, 1984, EMBO J, V3, P2047
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539
   KATAOKA T, 1983, P NATL ACAD SCI-BIOL, V80, P2666, DOI 10.1073/pnas.80.9.2666
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   LANG RB, 1982, NUCLEIC ACIDS RES, V10, P611, DOI 10.1093/nar/10.2.611
   MARCU KB, 1980, CELL, V22, P187, DOI 10.1016/0092-8674(80)90167-1
   MARCU KB, 1982, NATURE, V298, P87, DOI 10.1038/298087a0
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Miyata T, 1985, Interferon, V6, P1
   MOWATT MR, 1986, J IMMUNOL, V136, P2674
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437
   Ott D E, 1989, Int Immunol, V1, P582, DOI 10.1093/intimm/1.6.582
   PICCOLI SP, 1984, NATURE, V310, P327, DOI 10.1038/310327a0
   SZUREK P, 1985, J IMMUNOL, V135, P620
   WINTER E, 1987, EMBO J, V6, P1663
   WU TT, 1984, EMBO J, V3, P2033
NR 36
TC 24
Z9 24
U1 1
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 5
PY 1993
VL 268
IS 7
BP 4651
EP 4655
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KP884
UT WOS:A1993KP88400017
PM 8444838
ER

PT J
AU MIZUTA, TR
   FUKITA, Y
   MIYOSHI, T
   SHIMIZU, A
   HONJO, T
AF MIZUTA, TR
   FUKITA, Y
   MIYOSHI, T
   SHIMIZU, A
   HONJO, T
TI ISOLATION OF CDNA-ENCODING A BINDING-PROTEIN SPECIFIC TO
   5'-PHOSPHORYLATED SINGLE-STRANDED-DNA WITH G-RICH SEQUENCES
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID HEAVY-CHAIN GENES; HYPERVARIABLE MINISATELLITE DNA; IMMUNOGLOBULIN
   SWITCH REGIONS; CIRCULAR DNA; REPETITIVE SEQUENCES; LYMPHOCYTES-B;
   RECOMBINATION; DELETION; CELLS; RNA
AB We have isolated the cDNA encoding a binding protein to the sequence motif of the immunoglobulin Smu region by the southwestern method. The binding protein designated Smubp-2 specifically binds to 5'-phosphorylated single-stranded DNA containing 5'-G and GGGG stretches. The amino acid sequence deduced from the the cDNA sequence showed that the Smubp-2 belongs to the putative helicase superfamily which is involved in replication, recombination and repair. Expression of Smubp-2 mRNA is ubiquitous and augmented in spleen cells stimulated with lipopolysaccharide and interleukin 4 which also induce class switching. The Smubp-2 gene is conserved among vertebrates. Possible involvement of Smubp-2 in class switching is discussed.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 60601,JAPAN.
CR CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713
   MILLS FC, 1990, NUCLEIC ACIDS RES, V18, P7305, DOI 10.1093/nar/18.24.7305
   RADBRUCH A, 1983, EMBO J, V2, P1929
   YOSHIDA K, 1990, P NATL ACAD SCI USA, V87, P7829, DOI 10.1073/pnas.87.20.7829
   WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269
   CRAIG NL, 1988, ANNU REV GENET, V22, P77
   SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   COLLICK A, 1990, NUCLEIC ACIDS RES, V18, P625, DOI 10.1093/nar/18.3.625
   COLLICK A, 1991, NUCLEIC ACIDS RES, V19, P6399, DOI 10.1093/nar/19.23.6399
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DRESSLER D, 1982, ANN REV BIOCH, V51, P757
   FOURY F, 1987, EMBO J, V6, P1441
   GILCHRIST CA, 1987, NUCLEIC ACIDS RES, V15, P465, DOI 10.1093/nar/15.2.465
   HAN H, 1991, INT IMMUNOL, V3, P1197, DOI 10.1093/intimm/3.12.1197
   HODGMAN TC, 1986, NUCLEIC ACIDS RES, V14, P6769, DOI 10.1093/nar/14.16.6769
   HODGMAN TC, 1988, NATURE, V333, P578
   HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P498
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1
   Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KERR D, 1991, J BIOL CHEM, V266, P15876
   KINOSHITA K, 1991, IMMUNOL LETT, V27, P151, DOI 10.1016/0165-2478(91)90143-X
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MURNANE JP, 1990, BIOESSAYS, V12, P577, DOI 10.1002/bies.950121204
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SMITH GR, 1983, CELL, V34, P709, DOI 10.1016/0092-8674(83)90525-1
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801
   WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U
   WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353
   WUERFFEL RA, 1990, MOL CELL BIOL, V10, P1714
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
NR 51
TC 49
Z9 51
U1 0
U2 2
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 25
PY 1993
VL 21
IS 8
BP 1761
EP 1766
DI 10.1093/nar/21.8.1761
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LC210
UT WOS:A1993LC21000012
PM 8493094
ER

PT J
AU SHIN, EK
   MATSUDA, F
   OZAKI, S
   KUMAGAI, S
   OLERUP, O
   STROM, H
   MELCHERS, I
   HONJO, T
AF SHIN, EK
   MATSUDA, F
   OZAKI, S
   KUMAGAI, S
   OLERUP, O
   STROM, H
   MELCHERS, I
   HONJO, T
TI POLYMORPHISM OF THE HUMAN-IMMUNOGLOBULIN VARIABLE REGION SEGMENT V1-4.1
SO IMMUNOGENETICS
LA English
DT Article
ID MULTIPLE-SCLEROSIS; CHAIN; SUSCEPTIBILITY; GENES; LOCUS
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED 2,SAKYO KU,KYOTO 606,JAPAN.
   KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN IMMUNOL,HUDDINGE,SWEDEN.
   UNIV FREIBURG,MED KLIN,FORSCHERGRUPPE RHEUMATOL KLIN,W-7800 FREIBURG,GERMANY.
RI Matsuda, Fumihiko/B-9893-2009
CR WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   PASCUAL V, 1991, ADV IMMUNOL, V49, P1, DOI 10.1016/S0065-2776(08)60774-9
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   FUGGER L, 1990, IMMUNOGENETICS, V31, P278
   HILLERT J, 1991, J NEUROIMMUNOL, V31, P141
   HILLERT J, 1992, NEUROLOGY, V42, P80
   RILEY E, 1992, IMMUNOL TODAY, V13, P333, DOI 10.1016/0167-5699(92)90165-4
   SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9
   SHIN EK, 1991, EMBO J, V10, P3641
   SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595
   SMILEK DE, 1990, IMMUNOL REV, V118, P37, DOI 10.1111/j.1600-065X.1990.tb00813.x
NR 12
TC 10
Z9 10
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0093-7711
J9 IMMUNOGENETICS
JI Immunogenetics
PD JUN
PY 1993
VL 38
IS 4
BP 304
EP 306
PG 3
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA LK004
UT WOS:A1993LK00400011
PM 8319982
ER

PT J
AU SHIMADA, MO
   YAMADA, Y
   NAKAKUKI, Y
   OKAMOTO, K
   FUKUMOTO, M
   HONJO, T
   HIAI, H
AF SHIMADA, MO
   YAMADA, Y
   NAKAKUKI, Y
   OKAMOTO, K
   FUKUMOTO, M
   HONJO, T
   HIAI, H
TI SL/KH STRAIN OF MICE - A MODEL OF SPONTANEOUS PRE-B-LYMPHOMAS
SO LEUKEMIA RESEARCH
LA English
DT Article
DE PRE-B-LYMPHOMA; B-CELL DIFFERENTIATION; SPONTANEOUS TUMORS; ANIMAL MODEL
ID IMMUNOGLOBULIN HEAVY-CHAIN; MYC TRANSGENIC MICE; SOMATIC RECOMBINATION;
   V(D)J RECOMBINATION; GENES; CELLS; VIRUS; DNA; TRANSFORMATION;
   REARRANGEMENT
AB The SL/Kh strain of mice spontaneously develop two types of non-thymic lymphomas at a high incidence and very short latency. The major type of lymphomas induce systemic lymph node enlargement and hepatosplenomegaly, and the minor type, proliferation predominantly in bone marrow often associated with spinal paralysis. Phenotypes of both types of lymphomas are indistinguishable: they express B220, 6C3, c-kit but not Thy-1.1, Mac-1 and surface Ig. In both types of lymphomas, the immunoglobulin heavy chain gene is found clonally rearranged in the order of V(H)-D-J(H), whereas the light chain gene remains in germ line configuration. About half of the primary lymphomas are dual or oligoclonal in origin. R-PCR also demonstrates expression of lambda 5, RAG-1 and RAG-2, which are specifically associated with pre-B stage lymphocytes. All these observations indicate that both types of the SL/Kh lymphomas are pre-B-lymphomas.
C1 KYOTO UNIV, FAC MED, DEPT PATHOL, YOSHIDA KONOE CHO, SAKYO KU, KYOTO 606, JAPAN.
   KYOTO UNIV, FAC MED, DEPT MED CHEM, SAKYO KU, KYOTO 606, JAPAN.
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833
   HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353
   VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9
   BALTIMORE D, 1979, IMMUNOL REV, V48, P3, DOI 10.1111/j.1600-065X.1979.tb00296.x
   Coffman R L, 1982, Immunol Rev, V69, P5
   GROSSBEL.M, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x
   HARANGHE.N, 1967, J NATL CANCER I, V39, P653
   HAYAMA T, 1984, J NATL CANCER I, V72, P321
   HIAI H, 1982, GANN, V73, P704
   HIAI H, 1987, J NATL CANCER I, V79, P781
   HIAI H, 1992, INT CONGR SER, V966, P171
   ICHIKAWA Y, 1962, ANN REP VIRUS RES KY, V5, P113
   IHLE JN, 1982, J IMMUNOL, V129, P2431
   JOHNSON CD, 1986, HDB EXPT IMMUNOLOGY, pCH28
   KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887
   KUDO A, 1987, EMBO J, V6, P103
   MURPHY EDWIN D., 1963, PROC AMER ASSOC CANCER RES, V4, P46
   NAKAUCHI H, 1987, J IMMUNOL, V139, P2803
   NISHIKAWA S, 1991, EMBO J, V10, P2111
   NISHIZUKA Y, 1979, EXP ANIMALS, V28, P185
   PALACIOS R, 1987, EMBO J, V6, P3687
   PATTENGALE P K, 1983, American Journal of Pathology, V113, P237
   PILLEMER E, 1984, P NATL ACAD SCI-BIOL, V81, P4434, DOI 10.1073/pnas.81.14.4434
   SAKANO H, 1979, NATURE, V277, P627, DOI 10.1038/277627a0
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
NR 33
TC 18
Z9 19
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0145-2126
J9 LEUKEMIA RES
JI Leuk. Res.
PD JUL
PY 1993
VL 17
IS 7
BP 573
EP 578
DI 10.1016/0145-2126(93)90087-2
PG 6
WC Oncology; Hematology
SC Oncology; Hematology
GA LL471
UT WOS:A1993LL47100005
PM 8326739
ER

PT J
AU TASHIRO, K
   TADA, H
   HEILKER, R
   SHIROZU, M
   NAKANO, T
   HONJO, T
AF TASHIRO, K
   TADA, H
   HEILKER, R
   SHIROZU, M
   NAKANO, T
   HONJO, T
TI SIGNAL SEQUENCE TRAP - A CLONING STRATEGY FOR SECRETED PROTEINS AND
   TYPE-I MEMBRANE-PROTEINS
SO SCIENCE
LA English
DT Article
ID STROMAL CELL CLONE; MOLECULAR-CLONING; DIFFERENTIATION; CDNA;
   EXPRESSION; RECEPTOR; GROWTH; IDENTIFICATION; CULTURE; INVITRO
AB A method was developed to clone, without the use of specific functional assays, complementary DNAs (cDNAs) that carry specific amino-terminal signal sequences, such as those encoding intercellular signal-transducing molecules and receptors. The vector used in this system directed the cell surface expression of interleukin-2 receptor fusion proteins when inserts with signal sequences were cloned in-frame with the correct orientation. An expression cDNA library was constructed from a bone marrow stromal cell line, which contained 5' portion-enriched cDNAs (the average size was 400 base pairs). Two cDNAs that encoded putative cytokine molecules, stromal cell-derived factor-1alpha (SDF-1alpha) and SDF-1beta, which belong to the intercrine-macrophage inflammatory protein superfamily, were cloned.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0
   NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0
   NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   WOLPE SD, 1989, FASEB J, V3, P2565
   PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245
   OGAWA M, 1988, EMBO J, V7, P1337
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   BROXMEYER HE, 1990, BLOOD, V76, P1110
   GRAHAM GJ, 1990, NATURE, V344, P442, DOI 10.1038/344442a0
   IKEDA T, 1991, J BONE MINER RES, V6, P1013
   JAINCHIL.JL, 1969, J VIROL, V4, P549
   Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11
   LEE KH, 1991, J EXP MED, V173, P1257, DOI 10.1084/jem.173.5.1257
   MORITA M, 1991, BLOOD, V77, P1766
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   PALACIOS R, 1987, EMBO J, V6, P3687
   RALPH P, 1973, J IMMUNOL, V110, P1470
   ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738
   SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   Sambrook J, 1989, MOL CLONING LABORATO
   SHIROZU M, UNPUB
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333
   TASHIRO K, 1991, IMMUNOL LETT, V28, P147, DOI 10.1016/0165-2478(91)90113-O
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
NR 31
TC 575
Z9 600
U1 0
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD JUL 30
PY 1993
VL 261
IS 5121
BP 600
EP 603
DI 10.1126/science.8342023
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP728
UT WOS:A1993LP72800036
PM 8342023
ER

PT J
AU MCGARRY, MP
   LEE, N
   HONJO, T
   LACY, E
   COSTANTINI, F
   LEE, J
AF MCGARRY, MP
   LEE, N
   HONJO, T
   LACY, E
   COSTANTINI, F
   LEE, J
TI EOSINOPHILIA IN MICE TRANSGENIC FOR IL-5 DRIVEN BY T-LYMPHOCYTE SPECIFIC
   CD3-DELTA PROMOTER
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
C1 ROSWELL PK CANC INST,BUFFALO,NY.
   MAYO CLIN SCOTTSDALE,SAMUEL C JOHNSON MED RES CTR,SCOTTSDALE,AZ.
   KYOTO UNIV,FAC MED,KYOTO 606,KYOTO,JAPAN.
   COLUMBIA UNIV,COLL PHYSICIANS & SURGEONS,NEW YORK,NY.
   MEM SLOAN KETTERING CANC CTR,NEW YORK,NY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CARDEN JENNINGS PUBL CO LTD
PI CHARLOTTESVILLE
PA BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD AUG
PY 1993
VL 21
IS 8
BP 1174
EP 1174
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA MW613
UT WOS:A1993MW61300606
ER

PT J
AU AMAKAWA, R
   JING, W
   OZAWA, K
   MATSUNAMI, N
   HAMAGUCHI, Y
   MATSUDA, F
   KAWAICHI, M
   HONJO, T
AF AMAKAWA, R
   JING, W
   OZAWA, K
   MATSUNAMI, N
   HAMAGUCHI, Y
   MATSUDA, F
   KAWAICHI, M
   HONJO, T
TI HUMAN-JK RECOMBINATION SIGNAL BINDING-PROTEIN GENE (IGKJRB) - COMPARISON
   WITH ITS MOUSE HOMOLOG
SO GENOMICS
LA English
DT Article
ID SITE-SPECIFIC RECOMBINASES; RBP-J-KAPPA; IMMUNOGLOBULIN GENES; V(D)J
   RECOMBINATION; DROSOPHILA HOMOLOG; CODING SEGMENTS; RECEPTOR GENE;
   ORGANIZATION; DIVERSITY; SEQUENCE
C1 KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT INTERNAL MED 1,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,WAKO,SAITAMA 351,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   AMAKAWA R, 1990, CANCER RES, V50, P2423
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P844, DOI 10.1073/pnas.82.3.844
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   SETO M, 1988, EMBO J, V7, P123
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   SEHGAL A, 1988, MOL CELL BIOL, V8, P3160
   FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P2082, DOI 10.1073/pnas.82.7.2082
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   OZAWA K, 1992, GENOMICS, V12, P214, DOI 10.1016/0888-7543(92)90368-3
   ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.immunol.4.1.529
   ARGOS P, 1986, EMBO J, V5, P433
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053
   CRAIG NL, 1988, ANNU REV GENET, V22, P77
   VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9
   BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   Frohman M.A., 1988, P NATL ACAD SCI USA, V85, P8988
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   KAWAICHI M, 1991, J BIOL CHEM, V266, P18387
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   POYARTSALMERON C, 1989, EMBO J, V8, P2425
   Sambrook J, 1989, MOL CLONING LABORATO
   SATO T, 1988, BIOCHEM BIOPH RES CO, V154, P265, DOI 10.1016/0006-291X(88)90679-1
   SCHWAGER J, 1988, EMBO J, V7, P2409
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 40
TC 57
Z9 58
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD AUG
PY 1993
VL 17
IS 2
BP 306
EP 315
DI 10.1006/geno.1993.1326
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA LP815
UT WOS:A1993LP81500006
PM 8406481
ER

PT J
AU TSUBATA, T
   WU, J
   HONJO, T
AF TSUBATA, T
   WU, J
   HONJO, T
TI B-CELL APOPTOSIS INDUCED BY ANTIGEN RECEPTOR CROSS-LINKING IS BLOCKED BY
   A T-CELL SIGNAL THROUGH CD40
SO NATURE
LA English
DT Article
ID INVITRO TOLERANCE INDUCTION; LYMPHOCYTES-B; TRANSGENIC MOUSE;
   ACTIVATION; IMMUNOGLOBULIN; LIGAND; EXPRESSION; PROTEIN; DEATH;
   PROLIFERATION
AB IN mice transgenic for an autoantibody, self-reactive B cells have been shown to be eliminated upon interaction with membrane-bound self-antigens in the periphery1,2 as well as in the bone marrow3,5, suggesting that both immature and mature B cells are eliminated by multimerization of surface immunoglobulins (sIg). Activation of mature B cells by antigens may thus require a second signal that inhibits sIg-mediated apoptosis. Such a second signal is likely to be provided by T helper cells, because B-cell tolerance is more easily induced in the absence of T helper cells6-9. To assess the molecular nature of the signal that inhibits sIg-mediated apoptosis, we used anti-IgM-induced apoptotic death of WEHI-231 B lymphoma cells10,11 as a model system. Here we report that the signal for abrogating sIg-mediated apoptosis is generated by association of the CD40L molecule on T cells with the CD40 molecule on WEHI-231 cells. T-cell help through CD40 may thus determine whether B cells are eliminated or activated upon interaction with antigens.
RP TSUBATA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705
   HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3
   ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   PAULIE S, 1989, J IMMUNOL, V142, P590
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   STAMENKOVIC I, 1989, EMBO J, V8, P1403
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494
   ARMITAGE RJ, 1992, EUR J IMMUNOL, V22, P2071, DOI 10.1002/eji.1830220817
   ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   CUENDE E, 1993, EMBO J, V12, P1555
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810
   METCALF ES, 1977, J IMMUNOL, V118, P2111
   METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327
   MOND JJ, 1981, J IMMUNOL, V127, P881
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550
   ODAKA C, 1990, J IMMUNOL, V144, P2096
   OGASAWARA K, 1989, J IMMUNOL, V142, P1448
   OZAKI S, 1988, J IMMUNOL, V141, P71
   ROBB RJ, 1986, P NATL ACAD SCI USA, V83, P3992, DOI 10.1073/pnas.83.11.3992
   RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0
   SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020
   SUBBARAO B, 1983, J IMMUNOL, V130, P2033
   SUBBARAO B, 1984, J EXP MED, V159, P1796, DOI 10.1084/jem.159.6.1796
   VANDEVELDE H, 1991, NATURE, V351, P662
NR 35
TC 369
Z9 373
U1 2
U2 2
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD AUG 12
PY 1993
VL 364
IS 6438
BP 645
EP 648
DI 10.1038/364645a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LR771
UT WOS:A1993LR77100058
PM 7688865
ER

PT J
AU FUKITA, Y
   MIZUTA, TR
   SHIROZU, M
   OZAWA, K
   SHIMIZU, A
   HONJO, T
AF FUKITA, Y
   MIZUTA, TR
   SHIROZU, M
   OZAWA, K
   SHIMIZU, A
   HONJO, T
TI THE HUMAN S-MU-BP-2, A DNA-BINDING PROTEIN-SPECIFIC TO THE
   SINGLE-STRANDED GUANINE-RICH SEQUENCE RELATED TO THE IMMUNOGLOBULIN-MU
   CHAIN SWITCH REGION
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HYPERVARIABLE MINISATELLITE DNA; REPETITIVE SEQUENCES; NUCLEAR-PROTEIN;
   GENE; RECOMBINATION; RNA; IDENTIFICATION; REPLICATION; ELEMENT;
   DIFFERENTIATION
AB We have cloned the cDNA encoding the human homologue of Smubp-2, which binds to single-stranded DNA with 5'-phosphorylated guanine-rich sequences related to the immunoglobulin mu chain switch (S(mu)) region. The deduced amino acid sequences of the mouse and human Smubp-2 are 76.5% homologous and contain motifs conserved among helicases. We have identified a domain essential for DNA binding at residues 638-786. The binding domain is less conserved (63% homologous) than the putative catalytic domain of N-terminal half containing most of the helicase motifs (85% homologous). The human and mouse SmuAbp-2 have similar, although slightly different, binding specificities. Although the mouse Smubp-2 preferentially binds to the mouse S(mu) motif (GGGGT), the human Smubp-2 binds equally well to the human (GGGCT) and mouse S(mu) motifs. The human Smubp-2 gene was mapped to chromosome 11 q13.2-q13.4 by in situ hybridization.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 60601,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 60601,JAPAN.
   INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN.
CR RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   OZAWA K, 1992, GENOMICS, V12, P214, DOI 10.1016/0888-7543(92)90368-3
   ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932
   KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125
   BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713
   MILLS FC, 1990, NUCLEIC ACIDS RES, V18, P7305, DOI 10.1093/nar/18.24.7305
   LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566
   WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269
   SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0
   BRUNEL F, 1991, NUCLEIC ACIDS RES, V19, P5237, DOI 10.1093/nar/19.19.5237
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   COLLICK A, 1991, NUCLEIC ACIDS RES, V19, P6399, DOI 10.1093/nar/19.23.6399
   COOKSON WOCM, 1989, LANCET, V1, P1292
   EDELMANN W, 1989, CELL, V57, P937, DOI 10.1016/0092-8674(89)90332-2
   FEAVERS IM, 1989, J BIOL CHEM, V264, P9114
   FOURCADEPERONNET F, 1992, J VIROL, V66, P1682
   GAILLARD C, 1988, J VIROL, V62, P2380
   GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A
   GUALBERTO A, 1992, GENE DEV, V6, P815, DOI 10.1101/gad.6.5.815
   HODGMAN TC, 1988, NATURE, V333, P578
   HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0
   Honjo T., 1989, Immunoglobulin genes., P123
   ILGES H, 1992, MOL IMMUNOL, V29, P1265
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KERR D, 1991, J BIOL CHEM, V266, P15876
   KITAMINE S, 1984, NATURE, V309, P369
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9
   MARSH DG, 1992, NAT GENET, V2, P252, DOI 10.1038/ng1292-252
   MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761
   NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   PAN WT, 1990, J BIOL CHEM, V265, P7022
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHMIDT AMA, 1991, EMBO J, V10, P981
   SCHULTZ CL, 1991, INT IMMUNOL, V3, P109, DOI 10.1093/intimm/3.2.109
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   SMITH GR, 1983, CELL, V34, P709, DOI 10.1016/0092-8674(83)90525-1
   TANIGAMI A, 1992, GENOMICS, V13, P21, DOI 10.1016/0888-7543(92)90196-Y
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TRAUT W, 1988, MOL CELL BIOL, V8, P903
   VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X
   VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801
   WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U
   WALSH K, 1992, J BIOL CHEM, V267, P13714
   WATERS SH, 1989, MOL CELL BIOL, V9, P5594
   WILKISON WO, 1990, J BIOL CHEM, V265, P477
   WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353
   WUERFFEL RA, 1990, MOL CELL BIOL, V10, P1714
   YAMAZAKI H, 1992, J BIOL CHEM, V267, P12311
   YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861
NR 54
TC 57
Z9 59
U1 1
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 15
PY 1993
VL 268
IS 23
BP 17463
EP 17470
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LQ988
UT WOS:A1993LQ98800085
PM 8349627
ER

PT J
AU SHIN, EK
   MATSUDA, F
   FUJIKURA, J
   AKAMIZU, T
   SUGAWA, H
   MORI, T
   HONJO, T
AF SHIN, EK
   MATSUDA, F
   FUJIKURA, J
   AKAMIZU, T
   SUGAWA, H
   MORI, T
   HONJO, T
TI CLONING OF A HUMAN-IMMUNOGLOBULIN GENE FRAGMENT CONTAINING BOTH V(H)-D
   AND D-J(H) REARRANGEMENTS - IMPLICATION FOR V(H)-D AS AN INTERMEDIATE TO
   V(H)-D-J(H) FORMATION
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Note
DE IMMUNOGLOBULIN GENES; HEAVY CHAIN GENE REARRANGEMENT; NUCLEOTIDE
   SEQUENCES OF V(H)-D AND D-J(H) JOINTS
ID HEAVY-CHAIN DIVERSITY; D SEGMENTS; ORGANIZATION; GENERATION; FAMILIES;
   FUSIONS; LOCI
AB In an Epstein-Barr virus-transformed human B cell line we found an unusual immunoglobulin heavy chain gene rearrangement. Restriction mapping and sequencing analysis led us to conclude that V(H)-D and D-J(H) recombination took place in a single allele. Both V(H)-D and D-J(H) complexes still had their recombination signal sequences adjacent and the DNA sandwiched by these two complexes retained a germ-line configuration, suggesting the potential for a secondary rearrangement resulting in a V(H)-D(-D)-J(H) formation. With this finding, we propose a novel pathway, in which the V(H)-D complex is an intermediate in the formation of a functional V(H) exon.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT LAB MED,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR SANZ I, 1991, J IMMUNOL, V147, P1720
   ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118
   ALT FW, 1984, EMBO J, V3, P1209
   ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   MEEK KD, 1989, J EXP MED, V170, P39, DOI 10.1084/jem.170.1.39
   KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201
   DAVIDSON A, 1990, J CLIN INVEST, V85, P1401, DOI 10.1172/JCI114584
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   OLLIER P, 1985, EMBO J, V4, P3681
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395
   YAOITA Y, 1983, NUCLEIC ACIDS RES, V11, P7303, DOI 10.1093/nar/11.21.7303
   ZONG SQ, 1988, IMMUNOL LETT, V17, P329
NR 17
TC 14
Z9 14
U1 0
U2 0
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD SEP
PY 1993
VL 23
IS 9
BP 2365
EP 2367
DI 10.1002/eji.1830230947
PG 3
WC Immunology
SC Immunology
GA LY555
UT WOS:A1993LY55500046
PM 8370413
ER

PT J
AU HAIRE, RN
   BUELL, RD
   LITMAN, RT
   OHTA, Y
   FU, SM
   HONJO, T
   MATSUDA, F
   DELAMORENA, M
   CARRO, J
   GOOD, RA
   LITMAN, GW
AF HAIRE, RN
   BUELL, RD
   LITMAN, RT
   OHTA, Y
   FU, SM
   HONJO, T
   MATSUDA, F
   DELAMORENA, M
   CARRO, J
   GOOD, RA
   LITMAN, GW
TI DIVERSIFICATION, NOT USE, OF THE IMMUNOGLOBULIN-VH GENE REPERTOIRE IS
   RESTRICTED IN DIGEORGE-SYNDROME
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID X-LINKED AGAMMAGLOBULINEMIA; VARIABLE REGION GENES; B-CELL REPERTOIRE;
   HEAVY-CHAIN; PREFERENTIAL UTILIZATION; ANTIBODY REPERTOIRE;
   LYMPHOCYTES-B; DIVERSITY; SEGMENTS; LOCUS
AB Immunoglobulin (Ig) genes were isolated from unamplified conventional as well as polymerase chain reaction-generated cDNA libraries constructed from the peripheral blood cells of a patient with complete DiGeorge syndrome. Comparison of the sequences of 36 heavy chain clones to the recently expanded database of human V(H) genes permitted identification of the germline V(H) genes that are expressed in this patient as well as placement of 19 of these genes in a partially resolved 0.8-mb region of the human V(H) locus. The pattern of V(H) gene use does not resemble the fetal (early) repertoire. However, as in the fetal repertoire, there are a number of cDNAs derived from germline genes that previously have been identified as autoantibodies. Two Dmu sequences also were identified, as was another sequence resulting from a unique recombination event linking J(H) to an unidentified sequence containing a recombination signal sequence-like heptamer. All of the DiGeorge cDNAs are closely related to germline V(H) genes, showing little or no evidence of somatic mutation. In contrast, comparably selected IgM V(H) sequences derived from normal adult and age-matched human libraries, and from a second DiGeorge syndrome patient in whom the degree of thymic dysfunction is much less severe, exhibit considerable evidence of somatic mutation. The absence of somatic mutation is consistent with the atypical development of functional antibody responses associated with complete DiGeorge syndrome and implicates a role for T cells in the generation of diversity within the B cell repertoire.
C1 UNIV S FLORIDA,ALL CHILDRENS HOSP,DEPT PEDIAT,801 6TH ST S,ST PETERSBURG,FL 33701.
   UNIV VIRGINIA,SCH MED,CHARLOTTESVILLE,VA 22908.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR ANKER R, 1989, J EXP MED, V169, P2109, DOI 10.1084/jem.169.6.2109
   KIPPS TJ, 1989, ADV IMMUNOL, V47, P117
   BLACKWELL TK, 1989, ANNU REV GENET, V23, P605
   SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R
   SANZ I, 1991, J IMMUNOL, V147, P1720
   GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7
   SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146
   LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672
   PASCUAL V, 1991, ADV IMMUNOL, V49, P1, DOI 10.1016/S0065-2776(08)60774-9
   HERZENBERG LA, 1993, IMMUNOL TODAY, V14, P79, DOI 10.1016/0167-5699(93)90063-Q
   BERMAN JE, 1988, EMBO J, V7, P727
   BRAUN J, 1992, J CLIN INVEST, V89, P1395, DOI 10.1172/JCI115728
   GOIDL EA, 1974, J EXP MED, V140, P1285, DOI 10.1084/jem.140.5.1285
   HILLSON JL, 1992, J IMMUNOL, V149, P3741
   HUANG CC, 1992, J CLIN INVEST, V89, P1331, DOI 10.1172/JCI115719
   IBEGBU CC, 1992, ANN NY ACAD SCI, V651, P572
   Innis MA, 1990, PCR PROTOCOLS
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   MORTARI F, 1992, EUR J IMMUNOL, V22, P241, DOI 10.1002/eji.1830220135
   MORTARI F, 1991, NUCLEIC ACIDS RES, V19, P673, DOI 10.1093/nar/19.3.673
   OLEE T, 1991, J CLIN INVEST, V88, P193, DOI 10.1172/JCI115277
   RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0
   SANZ I, 1989, EMBO J, V8, P3741
   SCHROEDER HW, 1990, INT IMMUNOL, V20, P41
   SCHWARZ K, 1991, J EXP MED, V174, P1039, DOI 10.1084/jem.174.5.1039
   SHERR DH, 1978, J EXP MED, V147, P196, DOI 10.1084/jem.147.1.196
   SHIN EK, 1991, EMBO J, V10, P3641
   SZEWCZUK MR, 1978, EUR J IMMUNOL, V8, P370, DOI 10.1002/eji.1830080514
   TIMMERS E, 1991, EUR J IMMUNOL, V21, P2355, DOI 10.1002/eji.1830211010
   VANES JH, 1992, J IMMUNOL, V149, P492
   Wortis H H, 1992, Int Rev Immunol, V8, P235, DOI 10.3109/08830189209055576
   YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395
NR 36
TC 23
Z9 24
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD SEP 1
PY 1993
VL 178
IS 3
BP 825
EP 834
DI 10.1084/jem.178.3.825
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LU309
UT WOS:A1993LU30900007
PM 8350056
ER

PT J
AU SAITO, Y
   NAZAREA, M
   HONJO, T
AF SAITO, Y
   NAZAREA, M
   HONJO, T
TI PSEUDO-HIGH-AFFINITY IL-2 RECEPTOR AND GROWTH SIGNAL-TRANSDUCTION IN
   LYMPHOCYTES
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE IL-2 RECEPTOR; LIGAND RECEPTOR INTERACTION
ID TYROSINE PROTEIN-KINASE; HUMAN INTERLEUKIN-2 RECEPTOR; BETA-CHAIN P70;
   LIGAND-BINDING; 3RD COMPONENT; CELL-LINE; EXPRESSION; COMPLEX; CLONING;
   PHOSPHORYLATION
AB We examined whether the psuedo-high-affinity IL-2 receptor (IL-2R) could transduce a growth signal in lymphocytes. Since lymphocytes devoid of the I chain were not available, we employed functional depletion of the I chain from a mouse T cell line CTLL-2 transfected with cDNA for the human H chain and its defective mutants which can bind IL-2 but cannot transduce a growth signal. The numbers of human H, mouse 1, and mouse H chains expressed in these transfectants were similar to each other. When the human H chain (and mutants) -expressing CTLL-2 transfectants were incubated with 300 pM human IL-2, the majority of human H and mouse I chains together with the L chain formed the high-affinity receptor complex whereas the majority of mouse H chains remained free. When the human H chain mutant-expressing CTLL-2 transfectants were incubated with 300 pM human IL-2, the I chain was expected to be functionally depleted by the formation of the inactive high-affinity complex with the inactive human H chain mutants. However, the human H chain mutant-expressing CTLL-2 transfectants proliferated with a half maximal response to human IL-2 at 300-500 pM which agrees with the pseudo-high affinity K(d) value displayed by the mouse L and H chains. The human H chain-expressing transfectants proliferated in response the human IL-2 in a similar kinetics with CTLL-2. CTLL-2 and the human H chain/mutants-transfectants all responded to mouse IL-2 in the same kinetics. The maximal responses of each cell line to mouse and human IL-2 were similar. These results suggest that the pseudo-high-affinity IL-2R composed of the L and H chains may transduce a growth signal, and that a molecule other than the I chain may be involved in proliferative signal transduction.
RP SAITO, Y (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302
   TANAKA T, 1991, J IMMUNOL, V147, P2222
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   ARIMA N, 1992, J EXP MED, V176, P1265, DOI 10.1084/jem.176.5.1265
   TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559
   KONDO S, 1987, NATURE, V327, P64, DOI 10.1038/327064a0
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0
   HATAKEYAMA M, 1991, SCIENCE, V252, P1532
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   HATAKEYAMA M, 1987, J EXP MED, V166, P362, DOI 10.1084/jem.166.2.362
   HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7
   HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996
   KAMIO M, 1990, INT IMMUNOL, V2, P521, DOI 10.1093/intimm/2.6.521
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   LOWENTHAL JW, 1987, J EXP MED, V166, P1156, DOI 10.1084/jem.166.4.1156
   MINAMOTO S, 1990, J IMMUNOL, V145, P2177
   NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   OGURA T, 1988, MOL BIOL MED, V5, P123
   OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959
   OTANI H, 1992, P NATL ACAD SCI USA, V89, P2789, DOI 10.1073/pnas.89.7.2789
   QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8
   ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126
   SABE H, 1991, INT IMMUNOL, V3, P1137, DOI 10.1093/intimm/3.11.1137
   Sabe H, 1984, Mol Biol Med, V2, P379
   SAITO Y, 1988, J EXP MED, V168, P1563, DOI 10.1084/jem.168.5.1563
   SAITO Y, 1991, J BIOL CHEM, V266, P22186
   SAITO Y, 1990, Progress in Growth Factor Research, V2, P207, DOI 10.1016/0955-2235(90)90019-G
   SAITO Y, 1990, INT IMMUNOL, V2, P1167, DOI 10.1093/intimm/2.12.1167
   SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922
   TAKESHITA T, 1992, J IMMUNOL, V148, P2154
   TAKESHITA T, 1990, INT IMMUNOL, V2, P477, DOI 10.1093/intimm/2.5.477
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TORIGOE T, 1992, P NATL ACAD SCI USA, V89, P2674, DOI 10.1073/pnas.89.7.2674
   TSUDO M, 1990, J IMMUNOL, V145, P599
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   VOSS SD, 1990, J EXP MED, V172, P1101, DOI 10.1084/jem.172.4.1101
   WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055
   ZURAWSKI SM, 1990, EMBO J, V9, P3899
NR 43
TC 2
Z9 2
U1 0
U2 2
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD OCT
PY 1993
VL 5
IS 10
BP 1211
EP 1217
DI 10.1093/intimm/5.10.1211
PG 7
WC Immunology
SC Immunology
GA ME620
UT WOS:A1993ME62000003
PM 8268128
ER

PT J
AU NISITANI, S
   TSUBATA, T
   MURAKAMI, M
   OKAMOTO, M
   HONJO, T
AF NISITANI, S
   TSUBATA, T
   MURAKAMI, M
   OKAMOTO, M
   HONJO, T
TI THE BCL-2 GENE-PRODUCT INHIBITS CLONAL DELETION OF SELF-REACTIVE
   B-LYMPHOCYTES IN THE PERIPHERY BUT NOT IN THE BONE-MARROW
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID PROGRAMMED CELL-DEATH; TRANSGENIC MICE; AUTOIMMUNE-DISEASE;
   IMMUNOGLOBULIN; EXPRESSION; TOLERANCE; SURVIVAL; GROWTH;
   DIFFERENTIATION; PRECURSOR
AB To test whether the product of the bcl-2 proto-oncogene blocks clonal deletion of self-reactive B cells, we have generated transgenic mice carrying the bcl-2 gene and the immunoglobulin genes for the anti-erthrocyte 4C8 antibody. In these transgenic mice, clonal deletion of self-reactive immature B cells in the bone marrow was not inhibited in spite of expression of the bcl-2 gene. In contrast, self-antigen-induced clonal deletion of mature self-reactive Ly-1 B (B1) cells in the peritoneal cavity was inhibited in the transgenic mice. These results indicate that the mechanism for clonal deletion of immature self-reactive B cells in the bone marrow differs from that of mature self-reactive B cells in the periphery.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661
   GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0
   TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009
   ISHIDA Y, 1992, EMBO J, V11, P3887
   STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3
   TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430
   HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   OHNO H, 1993, IMMUNOL LETT, V35, P197, DOI 10.1016/0165-2478(93)90091-F
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2
   MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   NUNEZ G, 1990, J IMMUNOL, V144, P3602
   BORZILLO GV, 1992, ONCOGENE, V7, P869
   ERA T, 1991, EMBO J, V10, P337
   GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0
   YELLEN AJ, 1991, J IMMUNOL, V146, P1446
   YELLENSHAW AJ, 1992, J EXP MED, V176, P129, DOI 10.1084/jem.176.1.129
NR 28
TC 96
Z9 96
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD OCT 1
PY 1993
VL 178
IS 4
BP 1247
EP 1254
DI 10.1084/jem.178.4.1247
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LY323
UT WOS:A1993LY32300010
PM 8376932
ER

PT J
AU TSUBATA, T
   MURAKAMI, M
   HONJO, T
AF TSUBATA, T
   MURAKAMI, M
   HONJO, T
TI ANTIGEN-RECEPTOR CROSS-LINKING INDUCES PERITONEAL B-CELL APOPTOSIS IN
   NORMAL BUT NOT AUTOIMMUNITY-PRONE MICE
SO CURRENT BIOLOGY
LA English
DT Article
ID REACTIVE LYMPHOCYTES-B; TRANSGENIC MICE; IMMUNOGLOBULIN-D; LY-1 B;
   ANTIBODY-RESPONSES; SOMATIC MUTATION; DNA-SYNTHESIS; T-CELLS; DEATH;
   EXPRESSION
AB Background: Programmed cell death (apoptosis) is an essential process in the development of various tissues and seems to be involved in the elimination of self-reactive immature T and B lymphocytes when they interact with self antigens. Indeed, signaling through the antigen receptor of immature T cells induces their apoptotic cell death. Immature B cells have also been shown to be eliminated when they interact with antigens, although the involvement of apoptosis has yet, to be demonstrated. In contrast, little is known about the elimination of mature lymphocytes upon interaction with antigens. We have previously demonstrated that Ly1 B cells in the peritoneal cavity of transgenic mice undergo apoptotic cell death upon interaction with antigens. As Ly1 B cells constitute a B-cell lineage distinct from conventional B cells, it is important to know whether conventional B cells also undergo apoptosis upon antigen-receptor cross-linking. Results: Our experiments shaw that, in vivo, strong cross-linking of cell-surface immunoglobulins induced apoptotic death of normal, mature B cells in the peritoneal cavity, regardless of whether they were conventional or Ly1 B cells. The same treatment did not kill, but rather activated, B cells in bcl-2-transgenic, apoptosis-resistant mice. Peritoneal B cells from autoimmune-disease-prone New Zealand mouse strains were also found to be resistant to cell death induced by surface immunoglobulin cross-linking. Conclusion: Self-reactive B cells are eliminated by the binding of antigen at both mature and immature stages. B-cell activation appears to require, in addition to antigen binding, a second signal that induces expression of rescue molecules such as the bcl-2 gene product. Resistance to B-cell apoptosis induced by antigen receptor cross-linking may play a crucial role in the production of autoantibodies and in the pathogenesis of the autoimmune diseases found in the strains of mice used here.
RP TSUBATA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ALESMARTINEZ JE, 1988, P NATL ACAD SCI USA, V85, P6919, DOI 10.1073/pnas.85.18.6919
   STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661
   GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265
   GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0
   ROTHSTEIN TL, 1988, J IMMUNOL, V141, P4089
   MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367
   VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0
   ISHIDA Y, 1992, EMBO J, V11, P3887
   STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3
   TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3
   SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   ROTHSTEIN TL, 1988, J IMMUNOL, V140, P2880
   COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2
   SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0
   MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9
   SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0
   NUNEZ G, 1990, J IMMUNOL, V144, P3602
   BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   WIENANDS J, 1991, EUR J IMMUNOL, V21, P2373, DOI 10.1002/eji.1830211012
   BRETSCHE.P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042
   CUENDE E, 1993, EMBO J, V12, P1555
   DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x
   FINKELMAN FD, 1982, J IMMUNOL, V129, P629
   GERSHWIN ME, 1979, J IMMUNOL, V122, P2020
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   HIROSE S, 1993, IN PRESS EUR J IMMUN
   KLAUS GGB, 1984, IMMUNOLOGY, V53, P693
   LAMOYI E, 1983, J IMMUNOL METHODS, V56, P235, DOI 10.1016/0022-1759(83)90415-5
   MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   PARKER DC, 1980, IMMUNOL REV, V52, P115, DOI 10.1111/j.1600-065X.1980.tb00333.x
   PHILLIPS NE, 1984, J IMMUNOL, V132, P627
   REININGER L, 1992, J EXP MED, V176, P1343, DOI 10.1084/jem.176.5.1343
   RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0
   SCOTT DW, 1987, IMMUNOL TODAY, V8, P105, DOI 10.1016/0167-5699(87)90859-0
   SMITH HR, 1983, ANNU REV IMMUNOL, V1, P175, DOI 10.1146/annurev.iy.01.040183.001135
   TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914
   TSUBATA T, 1991, EUR J IMMUNOL, V21, P1359, DOI 10.1002/eji.1830210605
NR 54
TC 48
Z9 48
U1 0
U2 0
PU CURRENT BIOLOGY LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD JAN 1
PY 1994
VL 4
IS 1
BP 8
EP 17
DI 10.1016/S0960-9822(00)00003-8
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA MY541
UT WOS:A1994MY54100002
PM 7922322
ER

PT J
AU MATSUDA, F
   SHIN, EK
   NAGAOKA, H
   MATSUMURA, R
   HAINO, M
   HONJO, T
AF MATSUDA, F
   SHIN, EK
   NAGAOKA, H
   MATSUMURA, R
   HAINO, M
   HONJO, T
TI ORGANIZATION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS
SO CYTOGENETICS AND CELL GENETICS
LA English
DT Meeting Abstract
C1 KYOTO UNIV,CTR MOLEC BIOL GENET,KYOTO 606,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0171
J9 CYTOGENET CELL GENET
JI Cytogenet. Cell Genet.
PY 1994
VL 66
IS 1
BP 14
EP 14
PG 1
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA MR937
UT WOS:A1994MR93700014
ER

PT J
AU TSUBATA, T
   WU, J
   HONJO, T
AF TSUBATA, T
   WU, J
   HONJO, T
TI B-CELL APOPTOSIS INDUCED BY ANTIGEN RECEPTOR CROSS-LINKING IS BLOCKED BY
   T-CELL SIGNAL THROUGH CD40
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PY 1994
SU 18D
BP 435
EP 435
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA NE254
UT WOS:A1994NE25401495
ER

PT J
AU MATSUMURA, R
   MATSUDA, F
   NAGAOKA, H
   FUJIKURA, J
   SHIN, EK
   FUKITA, Y
   HAINO, M
   HONJO, T
AF MATSUMURA, R
   MATSUDA, F
   NAGAOKA, H
   FUJIKURA, J
   SHIN, EK
   FUKITA, Y
   HAINO, M
   HONJO, T
TI STRUCTURAL-ANALYSIS OF THE HUMAN-V(H) LOCUS USING NONREPETITIVE
   INTERGENIC PROBES AND REPETITIVE SEQUENCE PROBES - EVIDENCE FOR RECENT
   RESHUFFLING
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID IMMUNOGLOBULIN HEAVY-CHAIN; VARIABLE-REGION GENE; IG VH LOCUS; MAMMALIAN
   GENOMES; DNA-SEQUENCES; EVOLUTION; SEGMENTS; FAMILY; ORGANIZATION;
   TRANSLOCATION
AB The organization and evolution of the 0.8-Mb JH-proximal region in the human Ig V(H) locus were studied by mapping DNA fragments hybridized to non-repetitive intergenic probes and by determination of the content and distribution of repetitive sequences. Southern blot analysis of cloned DNA covering the 0.8-Mb region with intergenic probes allowed us to map two to seven cross-hybridizing fragments by each probe. Clusters of fragments detected by an identical set of probes appeared repeatedly within the 0.8-Mb J(H)-proximal region. Distantly located V(H) segments flanked by a cluster of DNA fragments hybridized by the same set of probes were highly homologous to each other, providing evidence for recent frequent duplication and translocation throughout the locus. DNA fragments detected by the same set of probes were orientated with the same 5' to 3' order within the cluster, suggesting little involvement of inversion upon recombination in the locus. The content of interspersed Alu and L1 sequences in the V(H) locus were not significantly greater than the average in the genome.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,YOSHIDA,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR ADAMS JW, 1980, NUCLEIC ACIDS RES, V8, P6113, DOI 10.1093/nar/8.24.6113
   KOFLER R, 1992, IMMUNOL REV, V128, P5, DOI 10.1111/j.1600-065X.1992.tb00830.x
   WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128
   SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067
   GRIMALDI G, 1984, EMBO J, V3, P1753
   DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9
   SHEN MR, 1991, J MOL EVOL, V33, P311
   CURRIER SJ, 1988, J IMMUNOL, V140, P1651
   BERMAN JE, 1988, EMBO J, V7, P727
   CHEN PP, 1990, SCAND J IMMUNOL, V31, P593, DOI 10.1111/j.1365-3083.1990.tb02810.x
   CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205
   DEVLIN RH, 1990, AM J HUM GENET, V46, P112
   HAINO M, 1993, IN PRESS J BIOL CHEM
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875
   HYRIEN O, 1987, EMBO J, V6, P2401
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   MATSUDA F, 1988, EMBO J, V7, P1047
   MATSUDA F, 1990, EMBO J, V9, P2501
   MIYAKE T, 1983, NUCLEIC ACIDS RES, V11, P6837, DOI 10.1093/nar/11.19.6837
   OTSU M, 1987, MOL CELL BIOL, V7, P708
   RINEHART FP, 1981, BIOCHEMISTRY-US, V20, P3003, DOI 10.1021/bi00514a003
   SASSO EH, 1992, J IMMUNOL, V149, P1230
   SHIN EK, 1991, EMBO J, V10, P3641
   SINGER MF, 1985, TRENDS BIOCHEM SCI, V10, P119, DOI 10.1016/0968-0004(85)90271-3
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   VANDIJK KW, 1989, J IMMUNOL, V142, P2547
   YANG PM, 1990, P NATL ACAD SCI USA, V87, P7907, DOI 10.1073/pnas.87.20.7907
   ZACHAU HG, 1990, BIOL CHEM H-S, V371, P1, DOI 10.1515/bchm3.1990.371.1.1
NR 33
TC 15
Z9 15
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JAN 15
PY 1994
VL 152
IS 2
BP 660
EP 666
PG 7
WC Immunology
SC Immunology
GA MR216
UT WOS:A1994MR21600030
PM 8283043
ER

PT J
AU HAINO, M
   HAYASHIDA, H
   MIYATA, T
   SHIN, EK
   MATSUDA, F
   NAGAOKA, H
   MATSUMURA, R
   TAKAISHI, S
   FUKITA, Y
   FUJIKURA, J
   HONJO, T
AF HAINO, M
   HAYASHIDA, H
   MIYATA, T
   SHIN, EK
   MATSUDA, F
   NAGAOKA, H
   MATSUMURA, R
   TAKAISHI, S
   FUKITA, Y
   FUJIKURA, J
   HONJO, T
TI COMPARISON AND EVOLUTION OF HUMAN IMMUNOGLOBULIN-V(H) SEGMENTS LOCATED
   IN THE 3' 0.8-MEGABASE REGION - EVIDENCE FOR UNIDIRECTIONAL TRANSFER OF
   SEGMENTAL GENE-SEQUENCES
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CHRONIC LYMPHOCYTIC-LEUKEMIA; HEAVY-CHAIN PROMOTER; SYSTEMIC
   LUPUS-ERYTHEMATOSUS; CELL-TYPE SPECIFICITY; ANTI-DNA ANTIBODY; 2 MOUSE
   STRAINS; VARIABLE-REGION; VH-GENES; SOMATIC MUTATION; CONSERVED SEQUENCE
AB Nucleotide sequences of 64 V(H) segments within the 3' 0.8-megabase region of the human immunoglobulin germ line V(H) locus were compared with trace evolution of human V(H) segments. Based on alignment of the deduced amino acid sequences of 37 functional germ line V(H) segments, a phylogenetic tree was generated using the neighbor-joining method. The phylogenetic tree clearly supports the previous classification of human V(H) segments into six families, which correlate roughly with mouse V(H) families with varying conservation. The human V(H-III) family is most homologous to mouse V(H) segments, suggesting that members of the V(H-III) family may be conserved by some functional constraint. The 5'-flanking region of each family has a family-specific structure. The sequenced 64 V(H) segments include 31 pseudogenes, of which 24 were highly conserved. Unidirectional transfer of segmental sequences was identified within the V(H-III) and V(H-IV) families, providing clear examples of germ line gene conversion. Such gene conversion may contribute to conserve structures of pseudo-V(H) segments. Comparison of the V(H-IV) family members indicates that recent repeated duplications and frequent gene conversions are responsible for strong conservation of this family, although functional selection is not completely excluded.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC SCI,DEPT BIOPHYS,SAKYO KU,KYOTO 606,JAPAN.
RP HAINO, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4
   BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1
   KOFLER R, 1992, IMMUNOL REV, V128, P5, DOI 10.1111/j.1600-065X.1992.tb00830.x
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795
   FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0
   BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2
   PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   KEMLER I, 1989, EMBO J, V8, P2001
   BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012
   BALLARD DW, 1986, P NATL ACAD SCI USA, V83, P9626, DOI 10.1073/pnas.83.24.9626
   BERMAN JE, 1988, EMBO J, V7, P727
   COHEN JB, 1983, EMBO J, V2, P2013
   COHEN JB, 1983, EMBO J, V2, P1795
   DAVIDSON A, 1990, J CLIN INVEST, V85, P1401, DOI 10.1172/JCI114584
   EATON S, 1987, P NATL ACAD SCI USA, V84, P7634, DOI 10.1073/pnas.84.21.7634
   FOSTER J, 1985, NATURE, V315, P423, DOI 10.1038/315423a0
   GIVOL D, 1981, NATURE, V292, P426, DOI 10.1038/292426a0
   GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6
   HARTMAN AB, 1984, EMBO J, V3, P3023
   HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671
   HOCH S, 1987, J IMMUNOL, V139, P1689
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   HUANG H, 1981, Journal of Molecular and Applied Genetics, V1, P93
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KLEINFIELD RW, 1989, J IMMUNOL, V142, P4483
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   KOFLER R, 1988, J IMMUNOL, V140, P4031
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   Logtenberg T, 1989, Int Immunol, V1, P362, DOI 10.1093/intimm/1.4.362
   LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9
   MAYER R, 1990, BLOOD, V75, P1518
   MIYATA T, 1980, P NATL ACAD SCI-BIOL, V77, P2143, DOI 10.1073/pnas.77.4.2143
   MIYATA T, 1980, P NATL ACAD SCI-BIOL, V77, P7328, DOI 10.1073/pnas.77.12.7328
   NEAR RI, 1984, P NATL ACAD SCI-BIOL, V81, P2167, DOI 10.1073/pnas.81.7.2167
   OLLO R, 1983, NUCLEIC ACIDS RES, V11, P7887, DOI 10.1093/nar/11.22.7887
   PENNELL CA, 1989, EUR J IMMUNOL, V19, P2115, DOI 10.1002/eji.1830191122
   Rathbun G.A., 1987, P85
   RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   REININGER L, 1988, EUR J IMMUNOL, V18, P1521, DOI 10.1002/eji.1830181008
   Riblet R., 1987, P53
   ROUDIER J, 1990, J IMMUNOL, V144, P1526
   SANZ I, 1989, J IMMUNOL, V142, P4054
   SCHROEDER HW, 1990, INT IMMUNOL, V20, P41
   SCHUTTE MEM, 1991, EUR J IMMUNOL, V21, P1115, DOI 10.1002/eji.1830210505
   SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563
   SHIN EK, 1991, EMBO J, V10, P3641
   SIU G, 1987, J IMMUNOL, V138, P4466
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TUTTER A, 1991, J IMMUNOL, V147, P3215
   VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461
   WINTER E, 1985, EMBO J, V4, P2861
NR 56
TC 25
Z9 25
U1 1
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 28
PY 1994
VL 269
IS 4
BP 2619
EP 2626
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA MV432
UT WOS:A1994MV43200042
PM 8300591
ER

PT J
AU IWASATO, T
   KANARI, Y
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
AF IWASATO, T
   KANARI, Y
   SHIMIZU, A
   HONJO, T
   YAMAGISHI, H
TI TRANSFORMING GROWTH-FACTOR-BETA INDUCED CLASS SWITCH RECOMBINATION MAY
   BE MODIFIED DURING THE CELL-PROLIFERATION RESTORED BY IL-2 STIMULATION
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE CIRCULAR DNA; TRANSFORMING GROWTH FACTOR-BETA; INTERLEUKIN-2; IG CLASS
   SWITCH; RECOMBINATION SITE; S REGION USAGE
ID IMMUNOGLOBULIN HEAVY-CHAIN; IGA PRODUCTION; NUCLEOTIDE-SEQUENCES;
   LYMPHOCYTES-B; CIRCULAR DNA; GENE; LIPOPOLYSACCHARIDE; REGIONS;
   MECHANISM
AB Mouse spleen cells were stimulated, first by transforming growth factor beta (TGF-beta) and then by interleukin-2 (IL-2) in the presence of bacterial lipopolysaccharide (LPS). LPS plus IL-2 stimulation restored the cell proliferation suppressed by TGF-beta and increased the number of B cells. Both TGF-beta alone or TGF-beta plus IL-2 enhanced production of surface IgA-positive (sIgA(+)) cells in LPS-stimulated B-cell cultures. We characterized extrachromosomal circular DNAs generated in TGF-beta-primed and IL-2-stimulated B cells and identified the breakpoints of S mu/S gamma 3 recombinants which were the major intermediates of S mu to S alpha switch recombination. All switch recombination sites were dispersed evenly within both S mu and S gamma 3 regions. This even distribution of S mu/S gamma 3 breakpoints is in contrast to the site preference of class switch breakpoints induced by TGF-beta alone. These results suggest that IL-2-stimulated cell proliferation may modify class switch recombination primed by TGF-beta.
C1 KYOTO UNIV,FAC SCI,DEPT BIOPHYS,MOLEC BIOL LAB,SAKYO KU,KYOTO 60601,JAPAN.
   KYOTO UNIV,FAC MED,CTR MOLEC BIOL & GENET,KYOTO 60601,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 60601,JAPAN.
CR SONODA E, 1992, CELL IMMUNOL, V140, P158, DOI 10.1016/0008-8749(92)90184-Q
   KEHRL JH, 1986, J IMMUNOL, V137, P3855
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415
   SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   LEBMAN DA, 1990, J IMMUNOL, V144, P952
   LEBMAN DA, 1990, P NATL ACAD SCI USA, V87, P3962, DOI 10.1073/pnas.87.10.3962
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437
   SHIMIZU T, 1992, EMBO J, V11, P4869
   YAMAGISHI H, 1983, GENE, V26, P317
NR 17
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD FEB
PY 1994
VL 39
IS 2
BP 173
EP 178
DI 10.1016/0165-2478(94)90104-X
PG 6
WC Immunology
SC Immunology
GA ND852
UT WOS:A1994ND85200011
PM 8013963
ER

PT J
AU SHIN, EK
   AKAMIZU, T
   MATSUDA, F
   SUGAWA, H
   FUJIKURA, J
   MORI, T
   HONJO, T
AF SHIN, EK
   AKAMIZU, T
   MATSUDA, F
   SUGAWA, H
   FUJIKURA, J
   MORI, T
   HONJO, T
TI VARIABLE REGIONS OF IG HEAVY-CHAIN GENES ENCODING ANTITHYROTROPIN
   RECEPTOR ANTIBODIES OF PATIENTS WITH GRAVES-DISEASE
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID AUTOIMMUNE THYROID-DISEASE; HUMAN THYROTROPIN RECEPTOR;
   MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; SOMATIC MUTATION; GONADOTROPIN
   RECEPTORS; NUCLEOTIDE-SEQUENCES; IMMUNE-RESPONSE; LYMPHOCYTES-B; TSH
   RECEPTOR
AB We have established EBV-transformed human B cell clones producing monoclonal antithyrotropin receptor antibodies from two patients with Graves' disease. We then isolated and characterized Ig H chain genes of 5 B cell clones with the thyrotropin-binding inhibitor Ig (TBII) activity and 4 B cell clones with the thyroid-stimulating antibody (TSAb) activity. We found that V(H) gene families used in the 5 TBII clones were all V(H-III), although those of the four TSAb clones were diverse, including V(H-II, -III, -IV), and -V. Most of V(H), segments used in TBII and TSAb are commonly used in other autoantibodies and fetal liver repertoire. The frequency of somatic mutations in TBII was higher than that in TSAb. Inasmuch as the same germline V(H) segment (V3-23) was used for both TBII and TSAb, the frequency and position of somatic mutations may be important for generation of TBII and TSAb.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT LAB MED,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR AKAMIZU T, 1990, P NATL ACAD SCI USA, V87, P5677, DOI 10.1073/pnas.87.15.5677
   BURMAN KD, 1985, ENDOCR REV, V6, P183
   SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   SANZ I, 1991, J IMMUNOL, V147, P1720
   GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0
   SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0
   PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796
   NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P145, DOI 10.1210/me.6.2.145
   CUMANO A, 1986, EMBO J, V5, P2459
   PASCUAL V, 1991, ADV IMMUNOL, V49, P1, DOI 10.1016/S0065-2776(08)60774-9
   BAKER JR, 1983, J CLIN INVEST, V72, P1487, DOI 10.1172/JCI111105
   BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0
   BULUWELA L, 1988, EMBO J, V7, P2003
   DAVIDSON A, 1990, J CLIN INVEST, V85, P1401, DOI 10.1172/JCI114584
   DEGROOT LJ, 1989, ENDOCR REV, V10, P537
   DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496
   HEIJDEN RW, 1990, J IMMUNOL, V144, P2835
   HUANG CC, 1992, J CLIN INVEST, V89, P1331, DOI 10.1172/JCI115719
   HUGHESJONES NC, 1990, BIOCHEM J, V268, P135
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KASAGI K, 1982, J CLIN ENDOCR METAB, V54, P108
   KNIGHT J, 1986, J CLIN ENDOCR METAB, V62, P342
   KOSUGI S, 1992, MOL ENDOCRINOL, V6, P169
   KOSUGI S, 1991, J BIOL CHEM, V266, P19413
   LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8
   LU C, 1991, IMMUNOL LETT, V28, P233, DOI 10.1016/0165-2478(91)90009-Y
   MARTIN T, 1992, J EXP MED, V175, P983, DOI 10.1084/jem.175.4.983
   MATSUDA F, 1993, NAT GENET, V3, P89
   MATSUDA F, 1990, EMBO J, V9, P2501
   MEEKER TC, 1988, J IMMUNOL, V141, P3994
   MORI T, 1991, BIOCHEM BIOPH RES CO, V178, P165, DOI 10.1016/0006-291X(91)91794-D
   NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7
   NAGAYAMA Y, 1991, J CLIN INVEST, V88, P336, DOI 10.1172/JCI115297
   OLEE TW, 1992, J EXP MED, V175, P831, DOI 10.1084/jem.175.3.831
   OTSU M, 1987, MOL CELL BIOL, V7, P708
   Sambrook J, 1989, MOL CLONING LABORATO
   SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5
   SANZ I, 1989, J IMMUNOL, V142, P4054
   SANZ I, 1989, J IMMUNOL, V142, P883
   SHIN EK, 1993, EUR J IMMUNOL, V23, P2365, DOI 10.1002/eji.1830230947
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   SMITH BR, 1988, ENDOCR REV, V9, P106
   SONNTAG D, 1989, NUCLEIC ACIDS RES, V17, P1267, DOI 10.1093/nar/17.3.1267
   SPATZ LA, 1990, J IMMUNOL, V144, P2821
   VALENTE WA, 1982, P NATL ACAD SCI-BIOL, V79, P6680, DOI 10.1073/pnas.79.21.6680
   VANES JH, 1992, J IMMUNOL, V149, P2234
   VICTOR KD, 1992, EUR J IMMUNOL, V22, P2231, DOI 10.1002/eji.1830220908
   VICTOR KD, 1992, MOL IMMUNOL, V29, P1501, DOI 10.1016/0161-5890(92)90224-L
   VITTI P, 1986, J CLIN ENDOCR METAB, V63, P454
   WERNER SC, 1972, NEW ENGL J MED, V287, P421, DOI 10.1056/NEJM197208312870901
   WILLIAMS RC, 1988, J CLIN INVEST, V82, P1306, DOI 10.1172/JCI113731
   WYSOCKI L, 1986, P NATL ACAD SCI USA, V83, P1847, DOI 10.1073/pnas.83.6.1847
   YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395
   YOSHIDA T, 1988, J BIOL CHEM, V263, P16341
   ZOUALI M, 1992, IMMUNOL REV, V128, P73, DOI 10.1111/j.1600-065X.1992.tb00833.x
NR 56
TC 31
Z9 32
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD FEB 1
PY 1994
VL 152
IS 3
BP 1485
EP 1492
PG 8
WC Immunology
SC Immunology
GA MV630
UT WOS:A1994MV63000059
PM 8301147
ER

PT J
AU TUN, T
   HAMAGUCHI, Y
   MATSUNAMI, N
   FURUKAWA, T
   HONJO, T
   KAWAICHI, M
AF TUN, T
   HAMAGUCHI, Y
   MATSUNAMI, N
   FURUKAWA, T
   HONJO, T
   KAWAICHI, M
TI RECOGNITION SEQUENCE OF A HIGHLY CONSERVED DNA-BINDING PROTEIN
   RBP-JKAPPA
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID RECOMBINATION SIGNAL SEQUENCE; SITE-SPECIFIC RECOMBINASES;
   DROSOPHILA-MELANOGASTER; IMMUNOGLOBULIN GENES; ENHANCER SEQUENCES; CELL
   FATES; HAIRLESS; DIVERSITY; ORGANIZATION; SIMILARITIES
AB DNA binding specificity of the RBP-J kappa protein was extensively examined. The mouse RBP-J kappa protein was originally isolated as a nuclear protein binding to the J kappa type V(D)J recombination signal sequence which consisted of the conserved heptamer (CACTGTG) and nonamer (GGTTTTTGT) sequences separated by a 23-base pair spacer. Electrophoretic mobility shift assay using DNA probes with mutations in various parts of the J kappa recombination signal sequence showed that the RBP-J kappa protein recognized the sequence outside the recombination signal in addition to the heptamer but did not recognize the nonamer sequence and the spacer length at all. Database search identified the best naturally occurring binding motif (CACTGTGGGAACGG) for the RBP-J kappa protein in the promoter region of the m8 gene in the Enhancer of split gene cluster of Drosophila. The binding assay with a series of m8 motif mutants indicated that the protein recognized mostly the GTGGGAA sequence and also interacted weakly with ACT and CG sequences flanking this heptanucleotide. Oligonucleotides binding to the RBP-J kappa protein were enriched from a pool of synthetic oligonucleotides containing 20-base random sequences by the repeated electrophoretic mobility shift assay. The enriched oligomer shared a common sequence of CGTGGGAA. All these data indicate that the RBP-J kappa protein recognizes a unique core sequence of CGTGGGAA and does not bind to the V(D)J recombination signal without the flanking sequence.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P844, DOI 10.1073/pnas.82.3.844
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325
   LITMAN GW, 1985, P NATL ACAD SCI USA, V82, P2082, DOI 10.1073/pnas.82.7.2082
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6
   KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.immunol.4.1.529
   BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8
   BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752
   BANG AG, 1991, DEVELOPMENT, V111, P89
   ISRAEL A, 1989, NUCLEIC ACIDS RES, V17, P5245, DOI 10.1093/nar/17.13.5245
   ARGOS P, 1986, EMBO J, V5, P433
   BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572
   KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K
   HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053
   ASHBURNER M, 1982, GENETICS, V101, P447
   DELACONCHA A, 1988, GENETICS, V118, P499
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   ISRAEL A, 1987, P NATL ACAD SCI USA, V84, P2653, DOI 10.1073/pnas.84.9.2653
   KAWAICHI M, 1991, J BIOL CHEM, V266, P18387
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KLAMBT C, 1989, EMBO J, V8, P203
   KNUST E, 1987, EMBO J, V6, P4113
   MIYAZAKI J, 1986, P NATL ACAD SCI USA, V83, P9537, DOI 10.1073/pnas.83.24.9537
   Plunkett CR, 1926, J EXP ZOOL, V46, P181, DOI 10.1002/jez.1400460204
   POYARTSALMERON C, 1989, EMBO J, V8, P2425
   SCHWAGER J, 1988, EMBO J, V7, P2409
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
NR 35
TC 205
Z9 209
U1 2
U2 4
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAR 25
PY 1994
VL 22
IS 6
BP 965
EP 971
DI 10.1093/nar/22.6.965
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ND770
UT WOS:A1994ND77000010
PM 8152928
ER

PT J
AU DOU, SB
   ZENG, XO
   CORTES, P
   ERDJUMENTBROMAGE, H
   TEMPST, P
   HONJO, T
   VALES, LD
AF DOU, SB
   ZENG, XO
   CORTES, P
   ERDJUMENTBROMAGE, H
   TEMPST, P
   HONJO, T
   VALES, LD
TI THE RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN RBP-2N FUNCTIONS AS A
   TRANSCRIPTIONAL REPRESSOR
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID RNA POLYMERASE-II; POLYPEPTIDE-IX; DROSOPHILA HOMOLOG; MESSENGER-RNA;
   J-KAPPA; GENE; DNA; PROMOTER; PURIFICATION; EXPRESSION
AB We have identified a cellular protein, RBP-2N, a presumed recombinase, as a repressor of transcription. Inhibition of transcription by RBP-2N was dependent on its DNA recognition site and was demonstrated in vitro and in vivo. This repression appears to be general, as transcription mediated by SP1 and Gal4/VP16 was inhibited by RBP-2N. The protein was purified to near homogeneity from human cells on the basis of its binding to a site present in the promoter of the adenovirus pIX gene. The DNA recognition sequence is 5'-TGGGAAAGAA, which is markedly different from the recombination signal sequence originally identified as the target site for this protein. The sequence of the purified protein is 97% identical with that published for the mouse RBP-2N protein. The reported homolog in Drosophila is Suppressor of Hairless. RBP-2N binding sites are present in a number of cellular and viral promoters, so RBP-2N may have a general role in transcriptional repression.
C1 UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854.
   MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,NEW YORK,NY 10021.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALESTROM P, 1980, CELL, V19, P671, DOI 10.1016/S0092-8674(80)80044-4
   WU L, 1988, GENE DEV, V2, P403, DOI 10.1101/gad.2.4.403
   CROSSLAND LD, 1983, J VIROL, V46, P737
   NIELSCH U, 1992, J VIROL, V66, P1884
   MALDONADO E, 1990, MOL CELL BIOL, V10, P6335
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180
   WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   ASHBURNER M, 1982, GENETICS, V101, P447
   Ausubel F.G., 1992, CURRENT PROTOCOLS MO
   BABISS LE, 1991, J VIROL, V65, P598
   DOU SX, UNPUB
   DRKIN R, 1993, CURR BIOL, V5, P469
   ERDJUMENTBROMAG.H, 1993, TECHNIQUES PROTEIN C, V4, P419
   FLORES O, 1992, J BIOL CHEM, V267, P2786
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1992, J BIOL CHEM, V34, P23334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HARLOW E, 1988, ANTIBODIES LABORATOR
   HERSCHBACH BM, 1993, ANNU REV CELL BIOL, V9, P479, DOI 10.1146/annurev.cb.09.110193.002403
   INOSTROZA J, 1991, J BIOL CHEM, V266, P9304
   JUPP R, 1993, J VIROL, V67, P5595
   KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   NASH D, 1965, GENET RES, V6, P175
   NASH D, 1970, GENETICS, V64, P471
   SANDHU GS, 1991, BIOTECHNIQUES, V11, P14
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   TEMPST P, 1990, ELECTROPHORESIS, V11, P537, DOI 10.1002/elps.1150110704
   TEMPST P, 1989, ANAL BIOCHEM, V183, P290, DOI 10.1016/0003-2697(89)90482-X
   TUN T, UNPUB
   VALES LD, 1989, GENE DEV, V3, P49, DOI 10.1101/gad.3.1.49
   WU J, 1993, J VIROL, V67, P7547
   WU L, 1987, Nature (London), V326, P512, DOI 10.1038/326512a0
   ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2
NR 37
TC 138
Z9 140
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD MAY
PY 1994
VL 14
IS 5
BP 3310
EP 3319
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA NG756
UT WOS:A1994NG75600046
PM 8164682
ER

PT J
AU NISITANI, S
   TSUBATA, T
   HONJO, T
AF NISITANI, S
   TSUBATA, T
   HONJO, T
TI LINEAGE MARKER-NEGATIVE LYMPHOCYTE PRECURSORS DERIVED FROM EMBRYONIC
   STEM-CELLS IN-VITRO DIFFERENTIATE INTO MATURE LYMPHOCYTES IN-VIVO
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE EMBRYONIC STEM CELLS; DIFFERENTIATION CULTURE; LYMPHOCYTE PRECURSORS;
   RECOMBINATION ACTIVATING GENES
ID IMMUNOGLOBULIN HEAVY-CHAIN; B-CELL; BONE-MARROW; PRE-B; HEMATOPOIETIC
   DEVELOPMENT; PLURIPOTENTIAL CELLS; V(D)J RECOMBINATION;
   MONOCLONAL-ANTIBODY; GENE REARRANGEMENT; RECEPTOR GENES
AB We induced differentiation of mouse embryonic stem (ES) cells into lymphoid cells by culturing in methylcellulose, followed by the co-culture with a bone marrow stromal cell line ST2 in the presence of IL-7. These lymphoid cells expressed transcripts of the recombination activating genes, RAG-1 and RAG-2, as well as the C(mu) gene, although the lymphoid cells did not express surface antigens specific to T or B lymphocytes such as T200, CD4, CD8 and B220, or transcripts of B lymphocyte-specific genes such as lambda5 and mb-1. D-J rearrangement was detectable in the lymphoid cells differentiated from ES cells in vitro and a sizeable number of both B and T lymphocytes were generated in vivo when the ES-derived lymphoid cells were transferred into RAG-2-deficient mice, which contain no B or T lymphocytes. The results indicate that in the in vitro co-culture system, ES cells give rise to immature lymphocyte precursors which have potentials to differentiate into both mature B and T lymphocytes in vivo. The ES-derived lineage marker-negative lymphocyte precursors would thus provide useful materials for studying early events of lymphopoiesis.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   OKADA S, 1991, BLOOD, V78, P1706
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257
   GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O
   RETH M, 1987, EMBO J, V6, P3299
   KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0
   SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728
   HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213
   WILES MV, 1991, DEVELOPMENT, V111, P259
   GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065
   UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951
   OGAWA M, 1988, EMBO J, V7, P1337
   SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410
   ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825
   SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125
   THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339
   ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0
   KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201
   DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
   BURKERT U, 1991, NEW BIOL, V3, P698
   CHEN U, 1992, P NATL ACAD SCI USA, V89, P2541, DOI 10.1073/pnas.89.7.2541
   DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389
   Ehrlich A, 1993, CELL, V72, P695
   FULOP GM, 1989, BLOOD, V74, P1537
   GUTIERREZRAMOS JC, 1992, P NATL ACAD SCI USA, V89, P9171, DOI 10.1073/pnas.89.19.9171
   HOLMES KL, 1986, J EXP MED, V164, P443, DOI 10.1084/jem.164.2.443
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   KINCADE PW, 1981, J IMMUNOL, V127, P2262
   KODAMA HA, 1982, J CELL PHYSIOL, V112, P89, DOI 10.1002/jcp.1041120114
   KUDO A, 1992, INT IMMUNOL, V4, P831, DOI 10.1093/intimm/4.8.831
   KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0
   MILLER BA, 1985, J IMMUNOL, V134, P3286
   NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843
   NISHI M, 1985, P NATL ACAD SCI USA, V82, P6399, DOI 10.1073/pnas.82.19.6399
   PALACIOS R, 1987, EMBO J, V6, P3687
   RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0
   SHEVACH EM, 1989, IMMUNOL TODAY, V10, P195, DOI 10.1016/0167-5699(89)90324-1
   SNODGRASS HR, 1985, NATURE, V315, P232, DOI 10.1038/315232a0
   SUDA T, 1989, BLOOD, V74, P1348
   SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333
   TASHIRO K, 1991, IMMUNOL LETT, V28, P147, DOI 10.1016/0165-2478(91)90113-O
   TROWBRIDGE IS, 1978, J EXP MED, V148, P313, DOI 10.1084/jem.148.1.313
   TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973
   VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634
   YAOITA Y, 1983, NUCLEIC ACIDS RES, V11, P7303, DOI 10.1093/nar/11.21.7303
NR 58
TC 20
Z9 21
U1 0
U2 2
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUN
PY 1994
VL 6
IS 6
BP 909
EP 916
DI 10.1093/intimm/6.6.909
PG 8
WC Immunology
SC Immunology
GA NT226
UT WOS:A1994NT22600013
PM 8086378
ER

PT J
AU NAGAOKA, H
   OZAWA, K
   MATSUDA, F
   HAYASHIDA, H
   MATSUMURA, R
   HAINO, M
   SHIN, EK
   FUKITA, Y
   IMAI, T
   ANAND, R
   YOKOYAMA, K
   EKI, T
   SOEDA, E
   HONJO, T
AF NAGAOKA, H
   OZAWA, K
   MATSUDA, F
   HAYASHIDA, H
   MATSUMURA, R
   HAINO, M
   SHIN, EK
   FUKITA, Y
   IMAI, T
   ANAND, R
   YOKOYAMA, K
   EKI, T
   SOEDA, E
   HONJO, T
TI RECENT TRANSLOCATION OF VARIABLE AND DIVERSITY SEGMENTS OF THE
   HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN FROM CHROMOSOME-14 TO CHROMOSOME-15 AND
   CHROMOSOME-16
SO GENOMICS
LA English
DT Article
ID INSITU HYBRIDIZATION; GEL-ELECTROPHORESIS; CARDIAC ACTIN; GENE FAMILIES;
   REGION GENES; PHYSICAL MAP; LOCUS; ORGANIZATION; SEQUENCES; EVOLUTION
AB We studied the organization and origin of three orphon regions, V-H-F, D-5-a, and D-5-b, of the human immuno globulin heavy-chain gene using yeast artificial chromo somes. V-H-F and two D-5 regions were mapped to chromosome bands 16p11 and 15q11-q12, respectively, by using human/rodent somatic cell hybrids and fluorescence in situ hybridization. No D-5 segments were found on chromosome 14, in contradiction to previous reports. The V-H-F region consists of 7 V-H segments and encompasses 160 kb of DNA. A cluster of V-H segments homologous to the V-H-F region orphons was found in the region 245-430 kb (V2-26 to V3-11) upstream of the J(H) cluster on chromosome 14. Comparison of V-H sequences between the V-H-F and the chromosome 14 loci indicates that the translocation of the V-H-F region took place, at the earliest, 20 x 10(6) years ago. The D-5-a and D-5-b regions were obtained in two independent contigs. The former contains only D segments in 140 kb of DNA, while the latter carries 3 V-H segments downstream of D segments in 110 kb of DNA. V-54, one of these V-H orphon segments, is about 95% homologous to V1-18, which is located within the putative ancestor of the V-H-F region on chromosome 14. Furthermore, the region detected by two DNA probes flanking the V-54 Segment was found only in the proximity of V1-18 within the 0.8-Mb V-H region on chromosome 14. These results suggest that the two orphon loci on chromosomes 15 and 16 may have been translocated simultaneously. (C) 1994 Academic Press, Inc.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN.
   NARA MED UNIV,NARA 634,JAPAN.
   ICI PHARMACEUT PLC,DEPT BIOTECHNOL,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND.
RI Matsuda, Fumihiko/B-9893-2009
CR ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425
   KOFLER R, 1992, IMMUNOL REV, V128, P5, DOI 10.1111/j.1600-065X.1992.tb00830.x
   RUSSO G, 1989, P NATL ACAD SCI USA, V86, P602, DOI 10.1073/pnas.86.2.602
   OZAWA K, 1992, GENOMICS, V12, P214, DOI 10.1016/0888-7543(92)90368-3
   ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067
   BERMAN JE, 1988, EMBO J, V7, P727
   BULUWELA L, 1988, EMBO J, V7, P2003
   CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205
   CHUNG JH, 1984, FED PROC, V43, P1486
   GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3
   GUNNING P, 1984, P NATL ACAD SCI-BIOL, V81, P1813, DOI 10.1073/pnas.81.6.1813
   HAINO M, 1994, J BIOL CHEM, V269, P2619
   HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664
   MATSUDA F, 1988, EMBO J, V7, P1047
   MATSUDA F, 1990, EMBO J, V9, P2501
   MATSUMURA R, 1994, J IMMUNOL, V152, P660
   MIYATA T, 1981, P NATL ACAD SCI-BIOL, V78, P450, DOI 10.1073/pnas.78.1.450
   MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221
   NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833
   PONTE P, 1983, MOL CELL BIOL, V3, P1783
   PURELLO M, 1987, CYTOGENET CELL GENET, V44, P32
   Sambrook J, 1989, MOL CLONING LABORATO
   SHIN EK, 1991, EMBO J, V10, P3641
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   ZONG SQ, 1988, IMMUNOL LETT, V17, P329
NR 38
TC 22
Z9 22
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD JUL 1
PY 1994
VL 22
IS 1
BP 189
EP 197
DI 10.1006/geno.1994.1360
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA NW898
UT WOS:A1994NW89800023
PM 7959766
ER

PT J
AU MURAKAMI, M
   TSUBATA, T
   SHINKURA, R
   NISITANI, S
   OKAMOTO, M
   YOSHIOKA, H
   USUI, T
   MIYAWAKI, S
   HONJO, T
AF MURAKAMI, M
   TSUBATA, T
   SHINKURA, R
   NISITANI, S
   OKAMOTO, M
   YOSHIOKA, H
   USUI, T
   MIYAWAKI, S
   HONJO, T
TI ORAL-ADMINISTRATION OF LIPOPOLYSACCHARIDES ACTIVATES B-1 CELLS IN THE
   PERITONEAL-CAVITY AND LAMINA PROPRIA OF THE GUT AND INDUCES AUTOIMMUNE
   SYMPTOMS IN AN AUTOANTIBODY TRANSGENIC MOUSE
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID REACTIVE LYMPHOCYTES-B; LY-1 B; INTRAEPITHELIAL LYMPHOCYTES; MICE;
   SUSCEPTIBILITY; EXPRESSION; POPULATION; GENERATION; ANTIBODIES;
   INTESTINE
AB About a half of the antierythrocyte autoantibody transgenic (autoAb Tg) mice, in which almost all B cells are detected in the spleen, lymph nodes, and Peyer's patches, but not in the peritoneal cavity, suffer from autoimmune hemolytic anemia. The occurrence of this disease is strongly linked to production of autoAb by activated peritoneal B-1 cells in the Tg mice. In this study, we have shown that oral administration of lipopolysaccharides (LPS) activated B-1 cells in the lamina propria of the gut as well as the peritoneal cavity in the healthy Tg mice and induced the autoimmune symptoms in all the Tg mice. The activation of peritoneal and lamina propria B-1 cells by enteric LPS is found not only in the anti-RBC autoAb Tg mice and normal mice but also in the aly mice which congenitally lack lymph nodes and Peyer's patches. These results suggest that B-1 cells in the two locations may form a common pool independent of Peyer's patches and lymph nodes, and can be activated by enteric thymus-independent antigens or polyclonal activators such as LPS. The induction of autoimmune hemolytic anemia in the Tg mice by enteric LPS through the activation of B-1 cells in the lamina propria of gut and in the peritoneal cavity suggests that B-1 cells and bacterial infection may play a pathogenic role in the onset of autoimmune diseases.
C1 KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT GERIATR MED,SAKYO KU,KYOTO 606,JAPAN.
   NIPPON SHINYAKU CO LTD,DIV RES & DEV,YAMASHIMA LABS,YAMASHIMA KU,KYOTO 607,JAPAN.
CR GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543
   HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   STALL AM, 1992, ANN NY ACAD SCI, V651, P33
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   VANDERHEIJDEN PJ, 1987, J IMMUNOL METHODS, V103, P161, DOI 10.1016/0022-1759(87)90285-7
   TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1
   HSU SM, 1981, AM J CLIN PATHOL, V75, P734
   DAVIES MDJ, 1981, GUT, V22, P481, DOI 10.1136/gut.22.6.481
   GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0
   IZUI S, 1977, J EXP MED, V145, P1115, DOI 10.1084/jem.145.5.1115
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43
   CHONG Y, 1991, INT IMMUNOL, V3, P467
   GOWERMANN J, 1993, CELL, V72, P551
   HARDY R, 1992, ANN NY ACAD SCI, V651, P99
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   HAYAKAWA K, 1984, P NATL ACAD SCI USA, V81, P2492
   HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745
   KELLY J, 1987, J IMMUNOL METHODS, V96, P127, DOI 10.1016/0022-1759(87)90376-0
   LEFRANCOIS L, 1991, IMMUNOL TODAY, V12, P436, DOI 10.1016/0167-5699(91)90015-L
   LETER FH, 1990, ROLE MICROORGANISMS
   MIYAWAKI S, 1991, IN PRESS EUR J IMMUN
   MURAKAMI K, 1992, AUTOIMMUNITY, V12, P69, DOI 10.3109/08916939209146132
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   Ottaway CA, 1990, IMMUNOLOGY IMMUNOPAT, P49
   SCHER I, 1982, IMMUNOL REV, V64, P117, DOI 10.1111/j.1600-065X.1982.tb00421.x
   SMITH HR, 1983, ANNU REV IMMUNOL, V1, P175, DOI 10.1146/annurev.iy.01.040183.001135
   STROBER W, 1990, IMMUNOLOGY IMMUNOPAT, P141
   WESTPHAL O, 1975, INT ARCH ALLER A IMM, V49, P1
NR 38
TC 134
Z9 135
U1 0
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JUL 1
PY 1994
VL 180
IS 1
BP 111
EP 121
DI 10.1084/jem.180.1.111
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA NR989
UT WOS:A1994NR98900014
PM 8006578
ER

PT J
AU CHUNG, CN
   HAMAGUCHI, Y
   HONJO, T
   KAWAICHI, M
AF CHUNG, CN
   HAMAGUCHI, Y
   HONJO, T
   KAWAICHI, M
TI SITE-DIRECTED MUTAGENESIS STUDY ON DNA-BINDING REGIONS OF THE MOUSE
   HOMOLOG OF SUPPRESSOR OF HAIRLESS, RBP-J-KAPPA
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID RECOMBINATION SIGNAL SEQUENCE; FLP RECOMBINASE; DROSOPHILA-MELANOGASTER;
   PROTEIN GENE; INITIATION
AB To map regions important for DNA binding of the mouse homologue of Suppressor of Hairless or RBP-J kappa protein, mutated mouse RBP-J kappa cDNAs were made by insertion of oligonucleotide linkers or base replacement. DNA binding assays using the mutated proteins expressed in COS cells showed that various mutations between 218 Arg and 227 Arg decreased the DNA binding activity drastically. The DNA binding activity was not affected by amino acid replacements within the integrase motif of the RBP-J kappa protein (230His-269His). Replacements between 291Arg and 323Tyr affected the DNA binding activity slightly but reproducibly. These results indicate that the region encompassing 218Arg-227Arg is critical for the DNA binding activity of RBP-J kappa. This region did not show any significant homology to motifs or domains of the previously described DNA binding proteins. Using a truncation mutant protein RBP-J kappa was shown to associate with DNA as a monomer.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   AMIN AA, 1989, MOL CELL BIOL, V9, P1987
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   BANG AG, 1991, DEVELOPMENT, V111, P89
   ARGOS P, 1986, EMBO J, V5, P433
   KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   ASHBURNER M, 1982, GENETICS, V101, P447
   FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KNUST E, 1987, EMBO J, V6, P4113
   NASH D, 1965, GENET RES, V6, P175
   NASH D, 1970, GENETICS, V64, P471
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201
   PARSONS RL, 1990, J BIOL CHEM, V265, P4527
   POYARTSALMERON C, 1989, EMBO J, V8, P2425
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7
NR 26
TC 62
Z9 62
U1 1
U2 2
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 11
PY 1994
VL 22
IS 15
BP 2938
EP 2944
DI 10.1093/nar/22.15.2938
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA PD657
UT WOS:A1994PD65700011
PM 8065905
ER

PT J
AU NAKANO, T
   KODAMA, H
   HONJO, T
AF NAKANO, T
   KODAMA, H
   HONJO, T
TI GENERATION OF LYMPHOHEMATOPOIETIC CELLS FROM EMBRYONIC STEM-CELLS IN
   CULTURE
SO SCIENCE
LA English
DT Article
ID IMMUNOGLOBULIN HEAVY-CHAIN; COLONY-STIMULATING FACTOR; HEMATOPOIETIC
   DEVELOPMENT; YOLK-SAC; INVITRO; DIFFERENTIATION; GENE; INTERLEUKIN-7;
   EXPRESSION; INVIVO
AB An efficient system was developed that induced the differentiation of embryonic stem (ES) cells into blood cells of erythroid, myeloid, and B cell lineages by coculture with the stromal cell line OP9. This cell line does not express functional macrophage colony-stimulating factor (M-CSF). The presence of M-CSF had inhibitory effects on the differentiation of ES cells to blood cells other than macrophages. Embryoid body formation or addition of exogenous growth factors was not required, and differentiation was highly reproducible even after the selection of ES cells with the antibiotic G418. Combined with the ability to genetically manipulate ES cells, this system will facilitate the study of molecular mechanisms involved in development and differentiation of hematopoietic cells.
C1 OHU UNIV,SCH DENT,DEPT ANAT,FUKUSHIMA 963,JAPAN.
RP NAKANO, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
   OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63
   SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728
   CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260
   WILES MV, 1991, DEVELOPMENT, V111, P259
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   OGAWA M, 1988, EMBO J, V7, P1337
   ROLINK A, 1991, EMBO J, V10, P327
   MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833
   KELLER G, 1993, MOL CELL BIOL, V13, P473
   KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269
   DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
   BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703
   BURKERT U, 1991, NEW BIOL, V3, P698
   CHEN U, 1992, P NATL ACAD SCI USA, V89, P2541, DOI 10.1073/pnas.89.7.2541
   Chen U, 1992, Dev Immunol, V2, P29, DOI 10.1155/1992/79518
   GUTIERREZRAMOS JC, 1992, P NATL ACAD SCI USA, V89, P9171, DOI 10.1073/pnas.89.19.9171
   HAYASHI SI, 1990, J EXP MED, V171, P1683, DOI 10.1084/jem.171.5.1683
   JACKS T, 1992, NATURE, V359, P328
   KAWAKAMI T, 1980, NUCLEIC ACIDS RES, V8, P3933, DOI 10.1093/nar/8.17.3933
   KINCADE PW, 1988, J IMMUNOL, V18, P97
   KODAMA H, 1984, J CELL PHYSIOL, V118, P233, DOI 10.1002/jcp.1041180303
   KODAMA H, IN PRESS EXP HEMATOL
   LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0
   NAKANO T, UNPUB
   Sambrook J, 1989, MOL CLONING LABORATO
   SUDA T, 1985, J CELL PHYSIOL, V124, P182, DOI 10.1002/jcp.1041240203
   SUDA T, 1989, BLOOD, V74, P1936
   SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333
NR 32
TC 541
Z9 565
U1 2
U2 12
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD AUG 19
PY 1994
VL 265
IS 5175
BP 1098
EP 1101
DI 10.1126/science.8066449
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA PC539
UT WOS:A1994PC53900038
PM 8066449
ER

PT J
AU TSUBATA, T
   MURAKAMI, M
   NISITANI, S
   HONJO, T
AF TSUBATA, T
   MURAKAMI, M
   NISITANI, S
   HONJO, T
TI MOLECULAR MECHANISMS FOR B-LYMPHOCYTE SELECTION - INDUCTION AND
   REGULATION OF ANTIGEN-RECEPTOR-MEDIATED APOPTOSIS OF MATURE B-CELLS IN
   NORMAL MICE AND THEIR DEFECT IN AUTOIMMUNITY-PRONE MICE
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES
   B-BIOLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT Royal Society Discussion Meeting on Death from Inside out: The Role of
   Apoptosis in Development, Tissue Homeostasis and Malignancy
CY FEB 23-24, 1994
CL LONDON, ENGLAND
SP ROYAL SOC LONDON
ID BCL-2 GENE; CHROMOSOMAL BREAKPOINT; FOLLICULAR LYMPHOMA;
   ANTIBODY-RESPONSES; TRANSGENIC MICE; DEATH; TOLERANCE; PROTOONCOGENE;
   ACTIVATION; EXPRESSION
AB Apoptosis (programmed cell death) has been suggested to be involved in clonal elimination of self-reactive lymphocytes for the normal function of the immune system. By crosslinking the antigen receptor (surface immunoglobulin; sIg) on the peritoneal B cells of normal mice, we found that strong crosslinking of sig induces apoptosis of mature B cells, suggesting that interaction with membrane-bound self-antigens may eliminate self-reactive mature B cells by apoptosis. Antigen-receptor-mediated B cell apoptosis is blocked when a signal is transduced via the CD40 molecule on the B cell surface. Because the ligand of CD40 (CD40) is expressed on activated T helper cells, B cells may escape from apoptosis and are activated when the immune system interacts with foreign antigens, which are normally able to activate T helper cells. Moreover, sig crosslinking fails to induce apoptosis of both bcl-2-transgenic mice and autoimmune-disease-prone New Zealand mice. In these mice, the defect in sig-mediated apoptosis of mature B cells may allow generation of self-reactive B cells, resulting in pathogenic consequences.
RP TSUBATA, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N
   STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661
   GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0
   TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430
   TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0
   HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8
   NUNEZ G, 1990, J IMMUNOL, V144, P3602
   BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2
   GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   BRETSCHE.P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042
   CHILLER JM, 1970, P NATL ACAD SCI USA, V65, P551, DOI 10.1073/pnas.65.3.551
   DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x
   FINKELMAN FD, 1982, J IMMUNOL, V129, P629
   HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810
   HIROSE S, 1993, EUR J IMMUNOL, V23, P2813, DOI 10.1002/eji.1830231114
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   PARKER DC, 1980, IMMUNOL REV, V52, P115, DOI 10.1111/j.1600-065X.1980.tb00333.x
   RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0
   SCOTT DW, 1987, J IMMUNOL, V139, P3924
NR 28
TC 11
Z9 11
U1 0
U2 2
PU ROYAL SOC LONDON
PI LONDON
PA 6 CARLTON HOUSE TERRACE, LONDON, ENGLAND SW1Y 5AG
SN 0962-8436
J9 PHILOS T ROY SOC B
JI Philos. Trans. R. Soc. Lond. Ser. B-Biol. Sci.
PD AUG 30
PY 1994
VL 345
IS 1313
BP 297
EP 301
DI 10.1098/rstb.1994.0109
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA PJ867
UT WOS:A1994PJ86700012
PM 7531346
ER

PT J
AU NAKAMURA, N
   AZUMA, C
   AKAMIZU, T
   SUGAWA, H
   MATSUDA, F
   MITSUDA, N
   HONJO, T
   MORI, T
   YAMAJI, K
AF NAKAMURA, N
   AZUMA, C
   AKAMIZU, T
   SUGAWA, H
   MATSUDA, F
   MITSUDA, N
   HONJO, T
   MORI, T
   YAMAJI, K
TI HETEROGENEITY AND DIVERSITY OF IGM AND IGG LUPUS ANTICOAGULANTS IN AN
   INDIVIDUAL WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODY;
   AUTOIMMUNE-DISEASE; FETAL LOSS; COMPLEX; ANTIGEN
AB From one patient with systemic lupus erythematosus retaining lupus anticoagulant (LAC), we established 6 Epstein-Barr virus-transformed human B cell clones secreting antibodies that affect the coagulation assay. Two and 4 of the clones secreted IgM and IgG antibodies, respectively. Although all 6 antibodies displayed anticardiolipin activity in ELISA, the increased binding activity in the presence of beta(2)-glycoprotein I was limited only to the IgG antibodies. Five antibodies (two IgM and three IgG) had LAC activity which prolonged the activated partial thromboplastin time (APTT), whereas one IgG antibody shortened the APTT. Two of the IgG producing clones had an identical Ig heavy chain gene rearrangement despite their opposite effects on the coagulation assay. These results demonstrated the heterogeneity of LACs and diversity among their physiological functions. (C) 1994 Academic Press, Inc.
C1 OSAKA UNIV,SCH MED,DEPT OBSTET & GYNECOL,SUITA,OSAKA 565,JAPAN.
   KYOTO UNIV,FAC MED,DEPT LAB MED,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   OSAKA MED CTR & RES INST MATERNAL & CHILD HLTH,DEPT OBSTET,OSAKA 59002,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RP NAKAMURA, N (reprint author), OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT NURSING,1-20 MACHIKANEYAMA CHO,TOYONAKA,OSAKA 560,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR MATSUURA E, 1990, LANCET, V336, P177, DOI 10.1016/0140-6736(90)91697-9
   MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120
   BRANCH DW, 1990, AM J OBSTET GYNECOL, V163, P210
   GLEICHER N, 1985, JAMA-J AM MED ASSOC, V253, P3278, DOI 10.1001/jama.253.22.3278
   HARRIS EN, 1986, ARCH INTERN MED, V146, P2153, DOI 10.1001/archinte.146.11.2153
   HUNT JE, 1992, LUPUS, V1, P75, DOI 10.1177/096120339200100204
   MATSUDA J, 1993, AM J HEMATOL, V43, P146, DOI 10.1002/ajh.2830430215
   PEACEMAN AM, 1992, AM J OBSTET GYNECOL, V167, P1543
   RAUCH J, 1986, J BIOL CHEM, V261, P9672
   SAMMARITANO LR, 1990, SEMIN ARTHRITIS RHEU, V20, P81, DOI 10.1016/0049-0172(90)90021-7
   SHIN EK, 1994, J IMMUNOL, V152, P1485
   TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
   VANES JH, 1992, J IMMUNOL, V149, P2234
   ZAKARIJA M, 1986, J CLIN ENDOCR METAB, V62, P368
NR 14
TC 10
Z9 10
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 30
PY 1994
VL 203
IS 3
BP 1789
EP 1794
DI 10.1006/bbrc.1994.2394
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA PJ526
UT WOS:A1994PJ52600060
PM 7945329
ER

PT J
AU SHINOHARA, T
   TANIWAKI, M
   ISHIDA, Y
   KAWAICHI, M
   HONJO, T
AF SHINOHARA, T
   TANIWAKI, M
   ISHIDA, Y
   KAWAICHI, M
   HONJO, T
TI STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN PD-1 GENE (PDCD1)
SO GENOMICS
LA English
DT Note
ID SUPERFAMILY
AB A cDNA encoding mouse PD-1, a member of the immunoglobulin superfamily was previously isolated from apoptosis-induced cells by subtractive hybridization. To determine the structure and chromosomal location of the human PD-1 gene, we screened a human T cell cDNA library by mouse PD-1 probe and isolated a cDNA coding for the human PD-1 protein. The deduced amino acid sequence of human PD-1 was 60% identical to the mouse counterpart, and a putative tyrosine kinase-association motif was well conserved. The human PD-1 gene was mapped to 2q37.3 by chromosomal in situ hybridization. (C) 1994 Academic Press, Inc.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO PREFECTURAL MED SCH,DEPT INTERNAL MED 3,SAKYO KU,KYOTO 606,JAPAN.
CR ALBER G, 1993, CURR BIOL, V3, P333, DOI 10.1016/0960-9822(93)90196-U
   ISHIDA Y, 1992, EMBO J, V11, P3887
   WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121
   KOLANUS W, 1992, EMBO J, V11, P4861
   LOCKSHIN RA, 1909, APOPTOSIS MOL BASIS, P47
   Sambrook J, 1989, MOL CLONING LABORATO
   TANIWAKI M, 1994, IN PRESS BLOOD
NR 7
TC 80
Z9 88
U1 5
U2 11
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD OCT
PY 1994
VL 23
IS 3
BP 704
EP 706
DI 10.1006/geno.1994.1562
PG 3
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA PN753
UT WOS:A1994PN75300026
PM 7851902
ER

PT J
AU ZIMBERSTROBL, U
   STROBL, LJ
   MEITINGER, C
   HINRICHS, R
   SAKAI, T
   FURUKAWA, T
   HONJO, T
   BORNKAMM, GW
AF ZIMBERSTROBL, U
   STROBL, LJ
   MEITINGER, C
   HINRICHS, R
   SAKAI, T
   FURUKAWA, T
   HONJO, T
   BORNKAMM, GW
TI EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 EXERTS ITS TRANSACTIVATING FUNCTION
   THROUGH INTERACTION WITH RECOMBINATION SIGNAL BINDING-PROTEIN
   RBP-J-KAPPA, THE HOMOLOG OF DROSOPHILA SUPPRESSOR OF HAIRLESS
SO EMBO JOURNAL
LA English
DT Article
DE DNA-PROTEIN INTERACTION; EBNA-2; EBV; RBP-J-KAPPA; TP1 PROMOTER
ID LATENT MEMBRANE-PROTEIN; B-CELL IMMORTALIZATION; BAMHI C-PROMOTER;
   TRANSCRIPTION FACTOR; GENE-EXPRESSION; LYMPHOMA-CELLS; DNA; ACTIVATION;
   SEQUENCE; ENHANCER
AB Epstein-Barr virus nuclear antigen 2 (EBNA-2) plays a crucial role in B cell immortalization by Epstein-Barr virus (EBV), most probably by its ability to transactivate several cellular and viral genes. Recently, we showed that EBNA-2 interacts with the TP1 promoter of EBV through a cellular protein. In this report we provide evidence that this protein is recombination signal binding protein (RBP)-J kappa, highly conserved in evolution, and originally isolated by its ability to bind to the J kappa-type V(D)J recombination signal sequence. To identify the cellular protein interacting with the TP1 promoter, we performed electrophoretic mobility shift assays using binding sequences of known transcription factors, that carry partial homology to the crucial sequences of the EBNA-2 responsive element (EBNA-2RE), as competitor. Competition assays revealed the RBP-J kappa recognition site as a very efficient competitor of cellular TP1 promoter binding protein. In parallel, we purified the protein to homogeneity from Raji cells by two ion-exchange columns and affinity purification using the EBNA-2RE coupled to magnetic beads. Affinity purified fractions separated on SDS-PAGE revealed a single predominant band after silver staining which was recognized by anti-RBP-J kappa monoclonal antibody. These purified fractions exhibited binding specificity for EBNA-2RE and EBNA2. In vitro-translated murine RBP-2 cDNA reacted with EBNA-2RE and EBNA-2 in the same fashion as the affinity purified protein. The interaction between RBP-J kappa and EBNA-2 is a prerequisite for EBNA-2-mediated transactivation of the TP1 promoter.
C1 GSF MUNICH,FORSCHUNGSZENTRUM UMWELT GESUNDHEIT,INST KLIN MOLEK BIOL & TUMOR GENET,D-81377 MUNICH,GERMANY.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   FAHRAEUS R, 1990, P NATL ACAD SCI USA, V87, P7390, DOI 10.1073/pnas.87.19.7390
   THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043
   HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0
   BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0
   ROONEY C, 1989, J VIROL, V63, P1531
   LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7
   ZIMBERSTROBL U, 1993, EMBO J, V12, P167
   JIN XW, 1992, J VIROL, V66, P2846
   GHOSH D, 1990, J VIROL, V64, P1855
   WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x
   WANG F, 1987, P NATL ACAD SCI USA, V84, P3452, DOI 10.1073/pnas.84.10.3452
   ZIMBERSTROBL U, 1991, J VIROL, V65, P415
   NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975
   KNUTSON JC, 1990, J VIROL, V64, P2530
   SUNG NS, 1991, J VIROL, V65, P2164
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   WANG F, 1991, J VIROL, V65, P4101
   ALLDAY MJ, 1989, J GEN VIROL, V70, P1755, DOI 10.1099/0022-1317-70-7-1755
   LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   GABRIELSEN OS, 1993, METHOD ENZYMOL, V218, P508
   ABBOT SD, 1990, J VIROL, V64, P2126
   CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060
   COHEN JI, 1991, J VIROL, V65, P2545
   CORDIER M, 1990, J VIROL, V64, P1002
   CRAWFORD DH, 1979, INT J CANCER, V24, P294, DOI 10.1002/ijc.2910240305
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594
   JAINCHIL.JL, 1969, J VIROL, V4, P549
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KIEFF E, 1990, VIROLOGY, P1889
   LAUX G, 1994, IN PRESS J VIROL, V68
   MEITINGER C, 1994, IN PRESS J VIROL, V68
   MUDRYJ M, 1990, EMBO J, V9, P2179
   PULVERTA.RJ, 1965, J CLIN PATHOL, V18, P261, DOI 10.1136/jcp.18.3.261
   REEDY ESP, 1991, ONCOGENE, V6, P2285
   RING CJA, 1994, J GEN VIROL, V75, P1, DOI 10.1099/0022-1317-75-1-1
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   TSANG SF, 1991, J VIROL, V65, P6765
NR 44
TC 160
Z9 162
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0261-4189
J9 EMBO J
JI Embo J.
PD OCT 17
PY 1994
VL 13
IS 20
BP 4973
EP 4982
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA PN994
UT WOS:A1994PN99400028
PM 7957063
ER

PT J
AU FURUKAWA, T
   KIMURA, K
   KOBAYAKAWA, Y
   TAMURA, K
   KAWAICHI, M
   TANIMURA, T
   HONJO, T
AF FURUKAWA, T
   KIMURA, K
   KOBAYAKAWA, Y
   TAMURA, K
   KAWAICHI, M
   TANIMURA, T
   HONJO, T
TI GENETIC-CHARACTERIZATION OF DROSOPHILA RBP-J-KAPPA (SUPPRESSOR OF
   HAIRLESS) AS A NEUROGENIC GENE IN ADULT PNS DEVELOPMENT
SO JAPANESE JOURNAL OF GENETICS
LA English
DT Article
ID RECOMBINATION SIGNAL SEQUENCE; PERIPHERAL NERVOUS-SYSTEM;
   BINDING-PROTEIN GENE; CELL FATES; HOMOLOG; EXPRESSION; ENCODES; NOTCH;
   MELANOGASTER; EMERGENCE
AB Drosophila RBP-J chi is a novel sequence-specific DNA binding protein encompassing the integrase motif which is highly conserved in various organisms. Its gene has been shown to be identical to Suppressor of Hairless which regulates adult peripheral nervous system (PNS) development. To elucidate the precise function of the RBP-J chi protein in adult PNS development, we analyzed transgenic flies that misexpress the RBP-J chi protein. Such studies have shown that RBP-J chi regulates PNS cell fate in at least two steps: commitment to sensory mother cell by lateral inhibition and terminal differentiation into the socket and shaft, cells. Taken together with analysis of phenotypes of Suppressor of Hairless mutants, RBP-J chi shows the synergistic activity with neurogenic genes.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   HOKKAIDO UNIV,BIOL LAB,IWAMIZAWA 068,JAPAN.
   KYUSHU UNIV,BIOL LAB,FUKUOKA 810,JAPAN.
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8
   ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752
   SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0
   GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   BANG AG, 1991, DEVELOPMENT, V111, P89
   BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M
   MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6
   SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433
   ARTAVANISTSAKON.S, 1991, TRENDS GENET, V7, P403
   ASHBURNER M, 1982, GENETICS, V101, P447
   CAMPOSORTEGA JA, 1992, ROUX ARCH DEV BIOL, V201, P1, DOI 10.1007/BF00188770
   DECELIS JF, 1991, P NATL ACAD SCI USA, V88, P632, DOI 10.1073/pnas.88.2.632
   Dietrich U, 1984, J Neurogenet, V1, P315, DOI 10.3109/01677068409107094
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1988, NUCLEIC ACIDS RES, V17, P9015
   HUANG F, 1991, DEVELOPMENT, V111, P1087
   Jan Y. N., 1993, DEV DROSOPHILA MELAN, VII, P1207
   Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019
   LINDSLEY D, 1968, CARNEGIE I WASH PUBL, V627
   LINDSLEY D, 1985, DROSOPHILA INFORM SE, V62
   NASH D, 1970, GENETICS, V64, P471
   REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   SIMPSON P, 1990, DEVELOPMENT, V109, P509
   USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054
NR 35
TC 9
Z9 9
U1 1
U2 1
PU GENETICS SOC JAPAN
PI KYOTO
PA INST FOR VIRUS RESEARCH, KYOTO UNIV, KYOTO 606, JAPAN
SN 0021-504X
J9 JPN J GENET
JI Jpn. J. Genet.
PD DEC
PY 1994
VL 69
IS 6
BP 701
EP 711
DI 10.1266/jjg.69.701
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA PZ506
UT WOS:A1994PZ50600010
PM 7857674
ER

PT J
AU ASANO, M
   ISHIDA, Y
   SABE, H
   KONDO, M
   SUGAMURA, K
   HONJO, T
AF ASANO, M
   ISHIDA, Y
   SABE, H
   KONDO, M
   SUGAMURA, K
   HONJO, T
TI IL-2 CAN SUPPORT GROWTH OF CD8(+) T-CELLS BUT NOT CD4(+) T-CELLS OF
   HUMAN IL-2 RECEPTOR BETA-CHAIN TRANSGENIC MICE
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HUMAN INTERLEUKIN-2 RECEPTOR; PROTEIN TYROSINE PHOSPHORYLATION; BLOOD
   MONONUCLEAR-CELLS; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; ALPHA-CHAIN;
   GAMMA-CHAIN; EXPRESSION; IDENTIFICATION; COMPLEX
AB We have generated transgenic mice expressing the human (h) IL-2R beta-chain on lymphoid cells under the control of the mouse H-2K(d) promoter. Spleen cells and thymocytes of the transgenic mice were cultured in the presence of 5 nM hIL-2. After a 10-day culture, the expanded populations were analyzed by flow cytometry and shown to be composed of CD8(+) T cells and gamma delta T cells. Surprisingly, CD4(+) T cells of the transgenic mice did not proliferate in response to hIL-2, although the CD4(+) T cells expressed the transgenic hIL-2R beta-chain as well as the endogenous gamma-chain on their surface and bound I-125-labeled IL-2. When CD4(+) T cells of the transgenic mice were stimulated with anti-CD3 mAb, the CD4(+) T cells proliferated in response to hIL-2. These findings suggest that CD4(+) T cells may require another triggering signal to respond to IL-2 even when IL-2Rs are expressed. By contrast, CD8(+) T cells and gamma delta T cells respond to IL-2 as long as IL-2Rs are expressed.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   TOHOKU UNIV,SCH MED,DEPT MICROBIOL,SENDAI,MIYAGI 980,JAPAN.
RI Sabe, Hisataka/A-4066-2012
CR ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455
   TANAKA T, 1991, J IMMUNOL, V147, P2222
   TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982
   TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559
   KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301
   ASAO H, 1990, J EXP MED, V171, P637, DOI 10.1084/jem.171.3.637
   CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   DESTGROTH SF, 1982, J IMMUNOL METHODS, V49, pR11, DOI 10.1016/0022-1759(82)90269-1
   GREENE WC, 1985, J EXP MED, V162, P363, DOI 10.1084/jem.162.1.363
   HARLOW E, 1988, ANTIBODIES LABORATOR
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7
   HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0
   HATTORI M, 1990, J IMMUNOL, V144, P3809
   Hogan B, 1986, MANIPULATING MOUSE E
   ISHII T, 1988, J IMMUNOL, V141, P174
   KAMIO M, 1990, INT IMMUNOL, V2, P521, DOI 10.1093/intimm/2.6.521
   KONDO M, 1994, IN PRESS EUR J IMMUN
   KONDO S, 1986, NATURE, V320, P75, DOI 10.1038/320075a0
   KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026
   KURNAKI S, 1993, BIOCHEM BIOPH RES CO, V193, P356
   LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0
   MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694
   MERIDA I, 1990, J BIOL CHEM, V265, P5690
   MILLS GB, 1990, J BIOL CHEM, V265, P3561
   NAGLER A, 1990, J EXP MED, V171, P1527, DOI 10.1084/jem.171.5.1527
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   OHASHI Y, 1989, J IMMUNOL, V143, P3548
   RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0
   ROBB RJ, 1986, P NATL ACAD SCI USA, V83, P3992, DOI 10.1073/pnas.83.11.3992
   SABE H, 1991, INT IMMUNOL, V3, P1137, DOI 10.1093/intimm/3.11.1137
   SHARON M, 1988, J EXP MED, V167, P1265, DOI 10.1084/jem.167.3.1265
   SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876
   TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223
   TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694
   WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337
   YAGITA H, 1989, J EXP MED, V170, P1445, DOI 10.1084/jem.170.4.1445
NR 41
TC 20
Z9 20
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD DEC 15
PY 1994
VL 153
IS 12
BP 5373
EP 5381
PG 9
WC Immunology
SC Immunology
GA PW703
UT WOS:A1994PW70300003
PM 7989743
ER

PT S
AU Murakami, M
   Honjo, T
AF Murakami, M
   Honjo, T
BE Casali, P
   Silberstein, LE
TI B-1 cells and autoimmunity
SO IMMUNOGLOBULIN GENE EXPRESSION IN DEVELOPMENT AND DISEASE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Immunoglobulin Gene Expression in Development and Disease
CY JUL 13-17, 1994
CL MONTREAL, CANADA
SP New York Acad Sci
ID ANTI-DNA ANTIBODY; LY-1 B-CELLS; LUPUS-ERYTHEMATOSUS PATIENTS; MICE;
   IGM; AUTOANTIBODIES; LYMPHOCYTES; STIMULATION; PRECURSORS; CD5+
RP Murakami, M (reprint author), KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Casali, Paolo/F-6579-2010
CR SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543
   ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305
   HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   HITOSHI Y, 1990, J IMMUNOL, V144, P4218
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   REAP EA, 1993, J EXP MED, V177, P69, DOI 10.1084/jem.177.1.69
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0
   GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0
   BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0
   CASALI P, 1989, J IMMUNOL, V143, P3476
   CHONG Y, 1991, INT IMMUNOL, V3, P467
   DATA SK, 1987, J EXP MED, V165, P1252
   DEFRANCE T, 1992, EUR J IMMUNOL, V22, P2831, DOI 10.1002/eji.1830221112
   FEIGO N, 1990, J EXP MED, V172, P1625
   GUYGRAND D, 1974, EUR J IMMUNOL, V4, P435, DOI 10.1002/eji.1830040610
   HARDY R, 1992, ANN NY ACAD SCI, V651, P99
   Hasegawa K, 1989, INT IMMUNOL, V1, P99, DOI 10.1093/intimm/1.1.99
   HIROSE S, 1993, EUR J IMMUNOL, V23, P2813, DOI 10.1002/eji.1830231114
   HOLZMANN B, 1989, IMMUNOL REV, V108, P45, DOI 10.1111/j.1600-065X.1989.tb00012.x
   KANNO K, 1992, ANN NY ACAD SCI, V651, P576
   MURAKAMI M, 1992, CLIN EXP IMMUNOL, V90, P245
   MURAKAMI M, 1994, J EXP MED, V180, P11
   SEKIGAWA I, 1987, J IMMUNOL, V138, P2890
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   STEINBERG BJ, 1982, J CLIN INVEST, V70, P587, DOI 10.1172/JCI110651
   TARGRAN SR, 1991, IMMUNOLOGY IMMUNOPAT
   TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761
NR 34
TC 18
Z9 18
U1 1
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021
SN 0077-8923
BN 0-89766-933-9
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1995
VL 764
BP 402
EP 409
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Cell Biology; Immunology
GA BE39E
UT WOS:A1995BE39E00058
PM 7486555
ER

PT J
AU YAMAMOTO, Y
   TAKEKOSHI, Y
   ITAMI, N
   HONJO, T
   KOJIMA, H
   YANO, S
   TAKAHASHI, H
   SAITO, I
   TAKAHASHI, K
AF YAMAMOTO, Y
   TAKEKOSHI, Y
   ITAMI, N
   HONJO, T
   KOJIMA, H
   YANO, S
   TAKAHASHI, H
   SAITO, I
   TAKAHASHI, K
TI ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR EXTRACELLULAR
   GLUTATHIONE-PEROXIDASE IN SERUM OF NORMAL INDIVIDUALS AND PATIENTS WITH
   RENAL-FAILURE ON HEMODIALYSIS
SO CLINICA CHIMICA ACTA
LA English
DT Note
DE GLUTATHIONE PEROXIDASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; RENAL
   FAILURE; EXTRACELLULAR ENZYME; SELENIUM
ID SELENIUM DEFICIENCY; PLASMA; PROTEIN
C1 HOKKAIDO UNIV,FAC PHARMACEUT SCI,DEPT HYG CHEM,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN.
   HOKKAIDO UNIV,MED CTR,DEPT PEDIAT,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN.
   MURORAN NIKKO MEM HOSP,DEPT NEPHROL,MURORAN,HOKKAIDO 051,JAPAN.
   MORINAGA INST BIOL SCI,TSURUMI KU,YOKOHAMA,KANAGAWA 230,JAPAN.
   HOKKAIDO INST PUBL HLTH,DIV PHARMACOL & TOXICOL,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN.
   TAIYO KAGAKU CO LTD,CENT RES LABS,YOKKAICHI,MIE 510,JAPAN.
CR YAMAMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V305, P541, DOI 10.1006/abbi.1993.1458
   TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2
   HATTA H, 1990, AGR BIOL CHEM TOKYO, V54, P2531
   TAKAHASHI K, 1986, BLOOD, V68, P640
   TAKAHASHI K, 1986, J CLIN INVEST, V77, P1402, DOI 10.1172/JCI112449
   MANNERVIK B, 1985, METHOD ENZYMOL, V113, P490
   BURK RF, 1993, ANNU REV NUTR, V13, P65, DOI 10.1146/annurev.nutr.13.1.65
   RICHARD MJ, 1991, NEPHRON, V57, P10, DOI 10.1159/000186208
   AVISSAR N, 1994, AM J PHYSIOL, V266, pC378
   CHE FF, 1992, BLOOD, V79, P3233
   CHE FF, 1993, J BIOL CHEM, V268, P2571
   COHEN HJ, 1985, AM J CLIN NUTR, V41, P735
   Flohe L, 1989, GLUTATHIONE CHEM BIO, P644
   HASHIDA S, 1984, Journal of Applied Biochemistry, V6, P56
   LANE HW, 1981, P SOC EXP BIOL MED, V167, P383
   SAINTGEORGES MD, 1989, KIDNEY INT, V36, P5274
   TAKAHASHI K, 1990, J BIOCHEM-TOKYO, V108, P145
   URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5
   VANRIJ AM, 1979, AM J CLIN NUTR, V32, P2076
   YOSHIMURA S, 1991, J BIOCHEM-TOKYO, V109, P918
NR 20
TC 16
Z9 16
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD APR 30
PY 1995
VL 236
IS 1
BP 93
EP 99
DI 10.1016/0009-8981(95)06041-4
PG 7
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA RB749
UT WOS:A1995RB74900010
PM 7664470
ER

PT J
AU MURAKAMI, M
   YOSHIOKA, H
   SHIRAI, T
   TSUBATA, T
   HONJO, T
AF MURAKAMI, M
   YOSHIOKA, H
   SHIRAI, T
   TSUBATA, T
   HONJO, T
TI PREVENTION OF AUTOIMMUNE SYMPTOMS IN AUTOIMMUNE-PRONE MICE BY
   ELIMINATION OF B-1 CELLS
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE AUTOIMMUNITY; B-1
ID LY-1 B-CELLS; ANTI-DNA ANTIBODY; CHRONIC LYMPHOCYTIC-LEUKEMIA;
   LUPUS-ERYTHEMATOSUS PATIENTS; X NZW)F1 MICE; RHEUMATOID-FACTOR;
   AUTOANTIBODIES; F1-MICE; GENE; CD5+
AB Our recent studies on an autoantibody-transgenic mouse line demonstrated that peritoneal B-1 cells are responsible for autoimmune symptoms, However, whether B-1 cells in the peritoneum are generally involved in the pathogenesis of autoimmune disease remains controversial. To test the possible involvement of peritoneal B-1 cells in autoimmune symptoms of autoimmune-prone NZB mice, we eliminated the peritoneal cells by hypotonic shock with repeated i.p. injection of distilled water every 7 days into neonatal or 8-week-old NZB mice. By this treatment, B-1 cells, which self-renew within the peritoneal cavity, are expected to be preferentially eliminated, while other peritoneal cells can be easily supplied from bone marrows after this treatment. Indeed, in distilled water-treated old NZB mice, the number of B-1 cells decreased in spleen as well as in lamina propria of the gut but the numbers of conventional a cells and T cells did not change, Moreover, the production of autoantibodies against erythrocytes significantly decreased and the occurrence of autoimmune hemolytic anemia was reduced in 12-month-old treated NZB mice. Similarly, the elimination of peritoneal cells of NZB/NZW (NZB/W) F-1 mice by water injection decreased anti-DNA IgG antibodies in the sera and reduced the pathological changes of the kidney, These results suggest that peritoneal B-1 cells may be a source of autoantibody-producing cells in autoimmune diseases of NZB and NZB/W F-1 mice.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT GERIATR MED,SAKYO KU,KYOTO 606,JAPAN.
   JUNTENDO UNIV,SCH MED,DEPT PATHOL,BUNKYO KU,TOKYO 113,JAPAN.
CR ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305
   HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057
   TSUI HW, 1993, NAT GENET, V4, P124
   PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   REAP EA, 1993, J EXP MED, V177, P69, DOI 10.1084/jem.177.1.69
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021
   FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414
   ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213
   PLATERZYBERK C, 1985, ARTHRITIS RHEUM, V28, P971, DOI 10.1002/art.1780280903
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   CASALI P, 1989, J IMMUNOL, V143, P3476
   CONGER JD, 1987, P NATL ACAD SCI USA, V84, P2931, DOI 10.1073/pnas.84.9.2931
   DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252
   DEFRANCE T, 1992, EUR J IMMUNOL, V22, P2831, DOI 10.1002/eji.1830221112
   HIROSE S, 1993, EUR J IMMUNOL, V23, P2813, DOI 10.1002/eji.1830231114
   HONJO T, 1992, SCIENCE, V258, P591, DOI 10.1126/science.1384132
   Howie J B, 1968, Adv Immunol, V9, P215, DOI 10.1016/S0065-2776(08)60444-7
   KANNO K, 1992, ANN NY ACAD SCI, V651, P576
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   MURAKAMI M, 1992, CLIN EXP IMMUNOL, V90, P245
   MURAKAMI M, 1994, J EXP MED, V10, P111
   SCHER I, 1982, IMMUNOL REV, V64, P117, DOI 10.1111/j.1600-065X.1982.tb00421.x
   SEKIGAWA I, 1987, J IMMUNOL, V138, P2890
   SHIRAI T, 1992, ANN NY ACAD SCI, V651, P509
   SHULTZ LD, 1984, AM J PATHOL, V116, P179
   STEINBERG BJ, 1982, J CLIN INVEST, V70, P587, DOI 10.1172/JCI110651
   TAUROG JD, 1979, J EXP MED, V150, P31, DOI 10.1084/jem.150.1.31
   TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761
   TOKADO H, 1991, ACTA PATHOL JAPON, V41, P1
   WOFSY D, 1987, EUR J IMMUNOL, V17, P809, DOI 10.1002/eji.1830170612
   YOSHIOKA H, 1989, CLIN EXP IMMUNOL, V75, P129
NR 37
TC 100
Z9 102
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD MAY
PY 1995
VL 7
IS 5
BP 877
EP 882
DI 10.1093/intimm/7.5.877
PG 6
WC Immunology
SC Immunology
GA QZ064
UT WOS:A1995QZ06400017
PM 7547714
ER

PT J
AU FURUKAWA, T
   KOBAYAKAWA, Y
   TAMURA, K
   KIMURA, KI
   KAWAICHI, M
   TANIMURA, T
   HONJO, T
AF FURUKAWA, T
   KOBAYAKAWA, Y
   TAMURA, K
   KIMURA, KI
   KAWAICHI, M
   TANIMURA, T
   HONJO, T
TI SUPPRESSOR OF HAIRLESS, THE DROSOPHILA HOMOLOG OF RBP-J-KAPPA,
   TRANSACTIVATES THE NEUROGENIC GENE E(SPL)M8
SO JAPANESE JOURNAL OF GENETICS
LA English
DT Article
ID RECOMBINATION SIGNAL SEQUENCE; PERIPHERAL NERVOUS-SYSTEM;
   BINDING-PROTEIN GENE; LOOP-HELIX PROTEINS; OF-SPLIT COMPLEX; CELL FATES;
   MELANOGASTER; ENHANCER; EXPRESSION; ENCODES
AB Suppressor of Hairless[Su(H)], the Drosophila homologue of RBP-J kappa is a novel type of sequence-specific DNA binding protein without known motifs, and highly conserved in various organisms. Su(H) regulates peripheral nervous system (PNS) development. Recently Su(H) was suggested to participate in the Notch-mediated signal transduction pathway. We show here that the Su(H) protein binds to TGTGGGAA sequence located 616 base-pairs upstream of the transcription initiation site of the Enhancer of split [E(spl)]m8 gene which is mapped to the terminus of the genetic cascade of the neurogenic genes. Su(H) transactivates the E(spl)m8 promoter not only in cultured Drosophila cells but also in vivo. The present study bridges the biochemical gap between Notch and E(spl) in the neurogenic gene cascade including Delta, Notch, deltex, Su(H), Hairless and E(spl).
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 810,JAPAN.
   HOKKAIDO UNIV,BIOL LAB,IWAMIZAWA,HOKKAIDO 068,JAPAN.
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731
   DEWET JR, 1987, MOL CELL BIOL, V7, P725
   VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325
   PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   NYE JS, 1994, DEVELOPMENT, V120, P2421
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752
   GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   SINCLAIR AJ, 1994, EMBO J, V13, P3321
   JENNINGS B, 1994, DEVELOPMENT, V120, P3537
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   KNUST E, 1992, GENETICS, V132, P505
   BANG AG, 1991, DEVELOPMENT, V111, P89
   THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   SCHRONS H, 1992, GENETICS, V132, P481
   HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0
   FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0
   MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6
   SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433
   BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491
   HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079
   BUSSEAU I, 1994, GENETICS, V136, P585
   ASHBURNER M, 1982, GENETICS, V101, P447
   ASHBURNER M, 1989, DROSOPHILA LABORATOR
   Bartel P.L., 1993, CELLULAR INTERACTION, P153
   CAMPOSORTEGA JA, 1992, ROUX ARCH DEV BIOL, V201, P1, DOI 10.1007/BF00188770
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N
   CROSS DP, 1978, J EMBRYOL EXP MORPH, V45, P161
   DELACONCHA A, 1988, GENETICS, V118, P499
   DELIDAKIS C, 1991, GENETICS, V129, P803
   Dietrich U, 1984, J Neurogenet, V1, P315, DOI 10.3109/01677068409107094
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   FURUKAWA T, 1994, JPN J GENET, V69, P701, DOI 10.1266/jjg.69.701
   GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   Jan Y. N., 1993, DEV DROSOPHILA MELAN, VII, P1207
   KLAMBT C, 1989, EMBO J, V8, P203
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   LINDSLEY D, 1985, DROSOPHILA INFORM SE, V62
   Lindsley D.L., 1968, GENETIC VARIATIONS D
   MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329
   NASH D, 1970, GENETICS, V64, P471
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   SIMPSON P, 1990, DEVELOPMENT, V109, P509
NR 62
TC 45
Z9 45
U1 0
U2 0
PU GENETICS SOC JAPAN
PI KYOTO
PA INST FOR VIRUS RESEARCH, KYOTO UNIV, KYOTO 606, JAPAN
SN 0021-504X
J9 JPN J GENET
JI Jpn. J. Genet.
PD AUG
PY 1995
VL 70
IS 4
BP 505
EP 524
DI 10.1266/jjg.70.505
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA RX859
UT WOS:A1995RX85900004
PM 7546844
ER

PT J
AU SHIROZU, M
   NAKANO, T
   INAZAWA, J
   TASHIRO, K
   TADA, H
   SHINOHARA, T
   HONJO, T
AF SHIROZU, M
   NAKANO, T
   INAZAWA, J
   TASHIRO, K
   TADA, H
   SHINOHARA, T
   HONJO, T
TI STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN STROMAL CELL-DERIVED
   FACTOR 1(SDF1) GENE
SO GENOMICS
LA English
DT Article
ID NEUROTROPHIC FACTOR; GENOMIC STRUCTURE; FACTOR FAMILY; SEQUENCE; DNA;
   MEMBER; IDENTIFICATION; HYBRIDIZATION; CYTOKINE; PROTEINS
AB Stromal cell-derived factors 1 alpha and 1 beta are small cytokines belonging to the intercrine CXC subfamily and originally isolated from a murine bone-marrow stroma cell line by the signal sequence trap method. cDNA and genomic clones of human SDF1 alpha and SDF1 beta (SDF1A and SDF1B) were isolated and characterized. cDNAs of SDF1 alpha and SDF1 beta encode proteins of 89 and 93 amino acids, respectively. SDF1 alpha and SDF1 beta sequences are more than 92% identical to those of the human counterparts. The genomic structure of the SDF1 gene revealed that human SDF1 alpha and SDF1 beta are encoded by a single gene and arise by alternative splicing. SDF1 alpha and SDF1 beta are encoded by 3 and 4 exons, respectively. Ubiquitous expression of the SDF1 gene, except in blood cells, was consistent with the presence of the GC-rich sequence in the 5'-flanking region of the SDF1 gene, as is often the case in the ''housekeeping'' genes. Although genes encoding other members of the intercrine family are localized on chromosome 49 or 17q, the human SDF1 gene was mapped to chromosome 10q by fluorescence in situ hybridization. Strong evolutionary conservation and unique chromosomal localization of the SDF1 gene suggest that SDF1 alpha and SDF1 beta may have important functions distinct from those of other members of the intercrine family. (C) 1995 Academic Press, Inc.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO PREFECTURAL UNIV MED,DEPT HYG,KAMIKYO KU,KYOTO 602,JAPAN.
CR ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351
   NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117
   LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346
   HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0
   KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   MUKAIDA N, 1989, J IMMUNOL, V143, P1366
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0
   PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245
   ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0
   MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0
   HOFER M, 1990, EMBO J, V9, P2459
   JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060
   OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617
   DEMARTIN R, 1987, EMBO J, V6, P3673
   HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0
   NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305
   BAKER NE, 1990, NUCLEIC ACIDS RES, V18, P6453, DOI 10.1093/nar/18.21.6453
   GARDNER E, 1993, HUM MOL GENET, V2, P241, DOI 10.1093/hmg/2.3.241
   HEINRICH JN, 1993, MOL CELL BIOL, V13, P2020
   INAZAWA J, 1993, GENOMICS, V17, P153, DOI 10.1006/geno.1993.1297
   JIANG W, 1994, EXP CELL RES, V215, P284, DOI 10.1006/excr.1994.1344
   KODAMA H, 1984, J CELL PHYSIOL, V118, P233, DOI 10.1002/jcp.1041180303
   KULMBURG PA, 1992, J EXP MED, V176, P1773, DOI 10.1084/jem.176.6.1773
   LUSTER AD, 1987, MOL CELL BIOL, V7, P3723
   MILLER DA, 1989, MOL ENDOCRINOL, V3, P1108
   MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136
   PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934
   ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R
   Sambrook J, 1989, MOL CLONING LABORATO
   VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
   WIDMER U, 1991, J IMMUNOL, V146, P4031
NR 34
TC 456
Z9 479
U1 1
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
J9 GENOMICS
JI Genomics
PD AUG 10
PY 1995
VL 28
IS 3
BP 495
EP 500
DI 10.1006/geno.1995.1180
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA RQ989
UT WOS:A1995RQ98900018
PM 7490086
ER

PT J
AU SAKAI, T
   FURUKAWA, T
   IWANARI, H
   OKA, C
   NAKANO, T
   KAWAICHI, M
   HONJO, T
AF SAKAI, T
   FURUKAWA, T
   IWANARI, H
   OKA, C
   NAKANO, T
   KAWAICHI, M
   HONJO, T
TI LOSS OF IMMUNOSTAINING OF THE RBP-J(KAPPA) TRANSCRIPTION FACTOR UPON F9
   CELL-DIFFERENTIATION INDUCED BY RETINOIC ACID
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE DIFFERENTIATION; EMBRYONIC STEM CELL; F9; RBP-J-KAPPA; RETINOIC ACID
ID RECOMBINATION SIGNAL SEQUENCE; DROSOPHILA HOMOLOG; MESSENGER-RNA;
   J-KAPPA; PROTEIN; BINDING; ANTIGEN; GENES; LINE; DNA
AB RBP-J(kappa) is a novel type of transcriptional regulatory protein that does not contain any known DNA-binding motif, We raised anti-RBP-J(kappa) monoclonal antibodies (K0043 and T6709) to investigate the roles of RBP-J(kappa) in cell differentiation, These antibodies stained nuclei of undifferentiated embryonic stem cells and F9 cells but not those of the other differentiated cell lines tested so far although the RBP-J(kappa) protein is expressed at similar levels, Interestingly, differentiated F9 cells lost the immunostaining reaction with the anti-RBP-J(kappa) monoclonal antibodies, Biochemical subcellular fractionation study showed that the majority of REP-J(kappa) was localized in nuclei of F9 cells and that there are at least two forms of the RBP-J(kappa) protein in the nuclei of undifferentiated F9 cells, a free form and a chromatin-bound form, Upon induction of F9 cell differentiation, free nuclear RBP-J(kappa) disappeared concomitantly with the loss of immunostaining, suggesting that the anti-RBPJ(kappa) antibodies cannot recognize chromatin-bound RBP-J(kappa). Since there is no evidence to indicate covalent modification of RBP-J(kappa), we assume that chromatin-bound RBP-J(kappa) interacts with a large number of proteins which block the exposure of RBP-J kappa epitopes to the monoclonal antibodies.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   INST IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN.
CR ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9
   WALTZER L, 1994, EMBO J, V13, P5633
   LAUX G, 1994, EMBO J, V13, P5624
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0
   SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433
   BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491
   PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2
   ARTZT K, 1973, P NATL ACAD SCI USA, V70, P2988, DOI 10.1073/pnas.70.10.2988
   BERNSTIN.EG, 1973, P NATL ACAD SCI USA, V70, P3899, DOI 10.1073/pnas.70.12.3899
   BUSCH H, 1967, METHOD ENZYMOL, V12, P448
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   Earle WR, 1943, J NATL CANCER I, V4, P165
   ELIZABETH M, 1982, J CELL BIOL, V94, P253
   FLASWINKEL H, 1994, EMBO J, V13, P83
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1994, JPN J GENET, V69, P701, DOI 10.1266/jjg.69.701
   FURUKAWA T, IN PRESS
   GOLDIN I, 1991, NATURE, V352, P807
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   JAINCHIL.JL, 1969, J VIROL, V4, P549
   LANIER LL, 1981, J IMMUNOL, V126, P626
   OKA C, 1995, IN PRESS DEVELOPMENT
   RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0
   RICKLES RJ, 1988, J BIOL CHEM, V263, P1563
   Sambrook J., 1989, MOL CLONING
   SAMELSON LE, 1983, J IMMUNOL, V131, P2645
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
NR 41
TC 27
Z9 27
U1 0
U2 1
PU JAPAN BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem.(Tokyo)
PD SEP
PY 1995
VL 118
IS 3
BP 621
EP 628
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA RT916
UT WOS:A1995RT91600025
PM 8690727
ER

PT J
AU OKA, C
   NAKANO, T
   WAKEHAM, A
   DELAPOMPA, JL
   MORI, C
   SAKAI, T
   OKAZAKI, S
   KAWAICHI, M
   SHIOTA, K
   MAK, TW
   HONJO, T
AF OKA, C
   NAKANO, T
   WAKEHAM, A
   DELAPOMPA, JL
   MORI, C
   SAKAI, T
   OKAZAKI, S
   KAWAICHI, M
   SHIOTA, K
   MAK, TW
   HONJO, T
TI DISRUPTION OF THE MOUSE RBP-J-KAPPA GENE RESULTS IN EARLY EMBRYONIC
   DEATH
SO DEVELOPMENT
LA English
DT Article
DE RBP-J-KAPPA; SOMITE DEFECT; NEURAL TUBE DEFECT; IN SITU HYBRIDIZATION;
   HOMOLOGOUS RECOMBINATION; MOUSE
ID RECOMBINATION SIGNAL SEQUENCE; BINDING-PROTEIN GENE; STEM-CELLS;
   HOMOLOGOUS RECOMBINATION; DROSOPHILA HOMOLOG; NOTCH-GENE
AB The RBP-JK protein is a transcription factor that recognizes the sequence C(T)GTGGGGA, The RBP-J kappa gene is highly conserved in a wide variety of species and the Drosophila homologue has been shown to be identical to Suppressor of Hairless [Su(H)] which plays important roles in the development of the peripheral nervous system, To explore the function of the RBP-J kappa gene in mouse embryogenesis, a mutation was introduced into the functional RBP-J kappa gene in embryonic stem (ES) cells by homologous recombination, Null mutant ES cells survived but null mutant mice showed embryonic lethality before 10.5 days of gestation, The mutant mice showed severe growth retardation as early as 8.5 days of gestation, Developmental abnormalities, including incomplete turning of the body axis, microencephaly, abnormal placental development, anterior neuropore opening and defective somitogenesis, were observed in the mutant mice at 9.5 days of gestation, RBP-J kappa mutant embryos expressed a posterior mesodermal marker FGFR1. Their irregularly shaped somites expressed a somite marker gene Mox I but failed to express myogenin. The RBP-J kappa gene was revealed to be essential for postimplantation development of mice.
C1 KYOTO UNIV,FAC MED,DEPT ANAT,KYOTO 606,JAPAN.
   AMGEN INST,ONTARIO CANC INST,TORONTO,ON M4X 1K9,CANADA.
RP OKA, C (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
RI De La Pompa Minguez, Jose Luis/F-9719-2014
OI De La Pompa Minguez, Jose Luis/0000-0001-6761-7265
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918
   ROBBINS J, 1992, J VIROL, V66, P2594
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0
   SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032
   JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433
   CANDIA AF, 1992, DEVELOPMENT, V116, P1123
   Bradley A, 1987, TERATOCARCINOMAS EMB, P113
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   CONLON RA, 1993, METHOD ENZYMOL, V225, P373
   DELACONCHA A, 1988, GENETICS, V118, P499
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   FURUKAWA T, 1994, JPN J GENET, V69, P701, DOI 10.1266/jjg.69.701
   GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   HANAOKA K, 1991, DIFFERENTIATION, V48, P183, DOI 10.1111/j.1432-0436.1991.tb00256.x
   Kaufman MH, 1992, ATLAS MOUSE DEV
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KWE L, 1995, DEVELOPMENT, V121, P489
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   NASH D, 1970, GENETICS, V64, P471
   OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92
   STEVEN DH, 1975, COMP PLACENTATION, P56
   VICKERS TH, 1985, TERATOLOGY, V31, P19, DOI 10.1002/tera.1420310104
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
   WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184
   WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361
NR 44
TC 369
Z9 376
U1 1
U2 4
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD OCT
PY 1995
VL 121
IS 10
BP 3291
EP 3301
PG 11
WC Developmental Biology
SC Developmental Biology
GA RZ756
UT WOS:A1995RZ75600016
PM 7588063
ER

PT J
AU NISITANI, S
   TSUBATA, T
   MURAKAMI, M
   HONJO, T
AF NISITANI, S
   TSUBATA, T
   MURAKAMI, M
   HONJO, T
TI ADMINISTRATION OF INTERLEUKIN-5 OR INTERLEUKIN-10 ACTIVATES PERITONEAL
   B-1 CELLS AND INDUCES AUTOIMMUNE HEMOLYTIC-ANEMIA IN ANTIERYTHROCYTE
   AUTOANTIBODY-TRANSGENIC MICE
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE AUTOIMMUNITY; B-1 CELLS; TRANSGENIC MOUSE; INTERLEUKIN-5; INTERLEUKIN-10
ID LY-1 B-CELLS; GROWTH-FACTOR; CYTOKINE PRODUCTION; IFN-GAMMA; T-CELLS;
   EOSINOPHILIA; ANTIBODIES; EXPRESSION; LINEAGES; CLONING
AB Activation mechanisms of B-l (Ly-l B) cells have been suggested to be different from those of conventional B cells. To assess the role of various interleukins (IL) in the activation of B-l cells, we injected IL-4, IL-5 or IL-10 into nonanemic anti-red blood cells (RBC) autoantibody-transgenic mice, in which conventional B cells are clonally deleted but peritoneal B-l cells persist without secreting Ig. Intraperitoneal or intramuscular injection of IL-5 or IL-10, but not IL-4, increased the number of antibody-producing peritoneal B-l cells by four- to five-fold, resulting in increased anti-RBC serum autoantibody and induction of hemolytic anemia. These results suggest that IL-5 or IL-10 may play an important role in the terminal differentiation of B-l cells into antibody-producing cells in vivo.
C1 KYOTO UNIV, FAC MED, DEPT MED CHEM, SAKYO KU, KYOTO 606, JAPAN.
CR OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314
   FINKELMAN FD, 1993, J IMMUNOL, V151, P1235
   MEGA J, 1992, J IMMUNOL, V148, P2030
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501
   DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   TAGUCHI T, 1990, J IMMUNOL, V145, P68
   HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213
   FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414
   SU SD, 1991, J IMMUNOL, V146, P327
   HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149
   ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213
   FIORENTINO DF, 1991, J IMMUNOL, V146, P3444
   HITOSHI Y, 1991, INT IMMUNOL, V3, P135, DOI 10.1093/intimm/3.2.135
   HUSTON DP, 1993, J IMMUNOL S, V175, pA182
   KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0
   KROESE FGM, 1993, MUSCOSAL IMMUNOLOGY, V1, P217
   KROESE FGM, 1992, ANN NY ACAD SCI, V651, P44
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   O'Garra A, 1992, Int Rev Immunol, V8, P219, DOI 10.3109/08830189209055575
   OGARRA A, 1988, IMMUNOL TODAY, V9, P45, DOI 10.1016/0167-5699(88)91259-5
   TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429
   UMLAND SP, 1988, J IMMUNOL, V142, P1528
NR 29
TC 59
Z9 59
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD NOV
PY 1995
VL 25
IS 11
BP 3047
EP 3052
DI 10.1002/eji.1830251110
PG 6
WC Immunology
SC Immunology
GA TE647
UT WOS:A1995TE64700009
PM 7489742
ER

PT J
AU MURAKAMI, M
   HONJO, T
AF MURAKAMI, M
   HONJO, T
TI INVOLVEMENT OF B-1 CELLS IN MUCOSAL IMMUNITY AND AUTOIMMUNITY
SO IMMUNOLOGY TODAY
LA English
DT Review
ID LY-1 B-CELLS; LUPUS-ERYTHEMATOSUS PATIENTS; ANTI-DNA ANTIBODIES;
   TRANSGENIC MICE; LYMPHOCYTES; IGM; DIFFERENTIATION; AUTOANTIBODIES;
   PROLIFERATION; STIMULATION
AB B-1 cells are distinguished from conventional B cells by their anatomical localization, surface phenotypes and functional characteristics. The physiological functions and pathological roles of these cells remain controversial. In this review, Masao Murakami and Tasuku Honjo summarize recent evidence for the involvement of B-1 cells in mucosal immunity and autoimmunity, and discuss the relationship between these phenomena.
RP MURAKAMI, M (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALLISON AC, 1992, ANN NY ACAD SCI, V651, P200
   SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543
   ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305
   CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.immunol.7.1.513
   KEARNEY JF, 1985, J IMMUNOL, V135, P3468
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   REAP EA, 1993, J EXP MED, V177, P69, DOI 10.1084/jem.177.1.69
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   MERCOLINO TJ, 1988, J EXP MED, V168, P687, DOI 10.1084/jem.168.2.687
   KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021
   ARNOLD LW, 1992, ANN NY ACAD SCI, V651, P143
   CASALI P, 1989, J IMMUNOL, V143, P3476
   CONGER JD, 1987, P NATL ACAD SCI USA, V84, P2931, DOI 10.1073/pnas.84.9.2931
   DATA SK, 1987, J EXP MED, V165, P1252
   DEFRANCE T, 1992, EUR J IMMUNOL, V22, P2831, DOI 10.1002/eji.1830221112
   GORDIN IE, 1993, NATURE, V364, P67
   HARDY KK, 1986, IMMUNOL REV, V93, P81
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P53
   HIROSE S, 1993, EUR J IMMUNOL, V23, P2813, DOI 10.1002/eji.1830231114
   KROESE GGM, 1989, INT IMMUNOL, V1, P45
   MEGA J, 1991, INT IMMUNOL, V3, P793, DOI 10.1093/intimm/3.8.793
   MURAKAMI M, 1992, CLIN EXP IMMUNOL, V90, P245
   MURAKAMI M, 1994, INT IMMUNOL, V6, P909
   MURAKAMI M, 1994, ADV DIGESTIVE DIS, P75
   NISHITANI S, IN PRESS EUR J IMMUN
   Ottaway CA, 1990, IMMUNOLOGY IMMUNOPAT, P49
   PASQUIER LD, 1989, FUNDAMENTAL IMMUNOLO, P139
   SCHER I, 1982, IMMUNOL REV, V64, P117, DOI 10.1111/j.1600-065X.1982.tb00421.x
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   STEINBERG BJ, 1982, J CLIN INVEST, V70, P587, DOI 10.1172/JCI110651
   STROBER W, 1990, IMMUNOLOGY IMMUNOPAT, P141
   TAUROG JD, 1979, J EXP MED, V150, P31, DOI 10.1084/jem.150.1.31
   TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761
   WHITMORE AC, 1992, ANN NY ACAD SCI, V651, P143
NR 38
TC 86
Z9 87
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0167-5699
J9 IMMUNOL TODAY
JI Immunol. Today
PD NOV
PY 1995
VL 16
IS 11
BP 534
EP 539
DI 10.1016/0167-5699(95)80047-6
PG 6
WC Immunology
SC Immunology
GA TC721
UT WOS:A1995TC72100008
PM 7495491
ER

PT J
AU NAKAMURA, T
   TASHIRO, K
   NAZAREA, M
   NAKANO, T
   SASAYAMA, S
   HONJO, T
AF NAKAMURA, T
   TASHIRO, K
   NAZAREA, M
   NAKANO, T
   SASAYAMA, S
   HONJO, T
TI THE MURINE LYMPHOTOXIN-BETA RECEPTOR CDNA - ISOLATION BY THE SIGNAL
   SEQUENCE TRAP AND CHROMOSOMAL MAPPING
SO GENOMICS
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR RECEPTOR; T-CELL HYBRIDOMA; B-CELL;
   HETEROMERIC COMPLEX; 33-KDA GLYCOPROTEIN; MOLECULAR-CLONING; FAS
   ANTIGEN; EXPRESSION; GENE
AB To isolate novel molecules involved in intercellular signaling during mouse embryogenesis, we employed the signal sequence trap (SST) method, a newly developed strategy for cloning secreted proteins and type I membrane proteins. We constructed an SST cDNA library of mouse embryonic heart mRNA, screened 2000 clones, and acquired 1 positive clone that appeared to contain the signal sequence. Homology searches revealed that this clone encodes the mouse lymphotoxin-beta receptor (LT beta-R). The deduced amino acid sequence of the mouse LT beta-R was 66% identical to that of the human LT beta-R. Northern analysis of various organs in adult mice showed that expression levels of LT beta-R mRNA were strong in lung, liver, and kidney, moderate in heart and testis, but weak in brain, thymus, spleen, and lymph nodes. Since the mouse LT beta-R was already expressed in 7-day-postcoitus embryo, the LT beta/LT beta-R system might have some functions in early embryogenesis. We performed chromosomal mapping of the murine LT beta-R gene by linkage analysis with recombinant inbred mouse strains and found that its locus is very close to the tumor necrosis factor receptor 1 gene on chromosome 6. 1995 Academic Press, Inc.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT MED,DIV 3,SAKYO KU,KYOTO 606,JAPAN.
CR ANDROLEWICZ MJ, 1992, J BIOL CHEM, V267, P2542
   BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A
   SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731
   PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C
   INAZAWA J, 1992, GENOMICS, V14, P821, DOI 10.1016/S0888-7543(05)80200-9
   ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   PETERS K, 1994, EMBO J, V13, P3296
   LATZA U, 1994, EUR J IMMUNOL, V24, P677, DOI 10.1002/eji.1830240329
   DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323
   BROWNING JL, 1991, J IMMUNOL, V147, P1230
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   ECK MJ, 1992, J BIOL CHEM, V267, P2119
   OGAWA M, 1988, EMBO J, V7, P1337
   MILATOVICH A, 1991, SOMAT CELL MOLEC GEN, V17, P519, DOI 10.1007/BF01233176
   ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0
   FONATSCH C, 1992, GENOMICS, V14, P825, DOI 10.1016/S0888-7543(05)80203-4
   WARE CF, 1992, J IMMUNOL, V149, P3881
   NEDWIN GE, 1985, J IMMUNOL, V135, P2492
   BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881
   LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V
   LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S
   BAKER E, 1991, CYTOGENET CELL GENET, V57, P117, DOI 10.1159/000133127
   BARRETT K, 1991, EUR J IMMUNOL, V21, P1649, DOI 10.1002/eji.1830210710
   BEANS M, 1993, GENOMICS, V16, P214
   BENTLEY KL, 1993, GENOMICS, V18, P43, DOI 10.1006/geno.1993.1425
   BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316
   BROWNELL E, 1992, J EXP ZOOL, V262, P340, DOI 10.1002/jez.1402620314
   CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
   EARDLEY DD, 1980, J IMMUNOL, V124, P1199
   ENGLISH BK, 1991, J BIOL CHEM, V266, P7108
   FUCHS P, 1992, GENOMICS, V13, P219, DOI 10.1016/0888-7543(92)90226-I
   Gilbert SF, 1994, DEV BIOL, P575
   GOLSTEIN P, 1995, CELL, V81, P185, DOI 10.1016/0092-8674(95)90327-5
   GOODWIN RG, 1991, MOL CELL BIOL, V11, P3020
   GRIMALDI JC, 1992, J IMMUNOL, V149, P3921
   HELLER RA, 1990, P NATL ACAD SCI USA, V87, P6151, DOI 10.1073/pnas.87.16.6151
   HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P1403, DOI 10.1073/pnas.83.5.1403
   KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714
   KOLLS J, 1994, P NATL ACAD SCI USA, V91, P215, DOI 10.1073/pnas.91.1.215
   KURAMOTO T, 1994, INT IMMUNOL, V6, P991, DOI 10.1093/intimm/6.7.991
   LOENEN WAM, 1992, J IMMUNOL, V149, P3937
   MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089
   MARSTERS SA, 1992, J BIOL CHEM, V267, P5747
   NOGAWA H, 1991, DEVELOPMENT, V112, P855
   PEPPEL K, 1993, J IMMUNOL, V151, P5699
   POKHOLOK DK, 1995, P NATL ACAD SCI USA, V92, P674, DOI 10.1073/pnas.92.3.674
   RAMESH N, 1993, SOMAT CELL MOLEC GEN, V19, P295, DOI 10.1007/BF01233077
   RETTIG WJ, 1986, SOMAT CELL MOLEC GEN, V12, P441, DOI 10.1007/BF01539915
   TAKAO S, 1993, IMMUNOGENETICS, V37, P199
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
   WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274
   WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4
NR 57
TC 17
Z9 18
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD NOV 20
PY 1995
VL 30
IS 2
BP 312
EP 319
DI 10.1006/geno.1995.9872
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA TG447
UT WOS:A1995TG44700022
PM 8586432
ER

PT J
AU Tamura, K
   Taniguchi, Y
   Minoguchi, S
   Sakai, T
   Tun, T
   Furukawa, T
   Honjo, T
AF Tamura, K
   Taniguchi, Y
   Minoguchi, S
   Sakai, T
   Tun, T
   Furukawa, T
   Honjo, T
TI Physical interaction between a novel domain of the receptor Notch and
   the transcription factor RBP-J kappa/Su(H)
SO CURRENT BIOLOGY
LA English
DT Article
ID RECOMBINATION SIGNAL SEQUENCE; BINDING-PROTEIN GENE; RBP-J-KAPPA;
   DROSOPHILA-NOTCH; MOUSE HOMOLOG; DNA
AB Background: The mammalian transcription factor RBP-J kappa binds to the DNA sequence motif CGTGGGAA and is involved in the regulation of gene expression; for example, it plays a part in the transactivation of viral and cellular genes by Epstein-Barr virus nuclear antigen-2. The Drosophila homologue of RBP-J kappa is the product of the Suppressor of Hairless (Su(H)) gene. Su(H) is a neurogenic gene that acts downstream of Notch, which encodes a cell-surface receptor. Furthermore, in the mouse, the phenotypes of homozygous mutant Notch1 embryos are very similar to those of homozygous mutant RBP-J kappa embryos. Recent studies, using the yeast two-hybrid system, have led to the suggestion that the CDC10/ankyrin-like repeats of the Drosophila Notch protein interact with the Su(H) protein.
   Results: We searched for proteins that interact with mouse RBP-J kappa using the yeast two-hybrid system, and in this way identified a short intracellular region (mRAM23) of the mouse Notch1 protein that lacks any known sequence motif. In vitro interaction studies, using proteins fused to glutathione-S-transferase, showed that RBP-J kappa and Su(H) bind directly to the RAM23 regions of mouse Notch1 and Drosophila Notch, respectively. Immunoprecipitation analysis showed that RBP-J kappa and the mRAM23 region of mouse Notch1 also interact in vivo. Further studies, including site-directed mutagenesis experiments, narrowed down the region of mouse Notch1 that interacts with RBP-J kappa. The results indicate that this region is less than 50 amino-acid residues in length, and lies immediately downstream of the transmembrane region.
   Conclusions: We show that the transcription factor RBP-J kappa/Su(H) interacts directly with a novel intracellular domain of the cell-surface receptor Notch. RBP-J kappa/Su(H) does not appear to interact with Notch via the CDC10/ankyrin repeats implicated in previous studies.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Taniguchi, Yoshihito/L-5746-2013
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   ROBBINS J, 1992, J VIROL, V66, P2594
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610
   KIDD S, 1986, MOL CELL BIOL, V6, P3094
   VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C
   WALTZER L, 1994, EMBO J, V13, P5633
   LAUX G, 1994, EMBO J, V13, P5624
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   OKA C, 1995, DEVELOPMENT, V121, P3291
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   WEINMASTER G, 1991, DEVELOPMENT, V113, P199
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   Greenwald Iva, 1994, Current Opinion in Genetics and Development, V4, P556, DOI 10.1016/0959-437X(94)90072-B
   ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Ausubel FM, 1987, CURRENT PROTOCOLS MO
   BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U
   BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639
   CONLON RA, 1995, DEVELOPMENT, V121, P1553
   DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   Nolan G P, 1992, Curr Opin Genet Dev, V2, P211, DOI 10.1016/S0959-437X(05)80276-X
   SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
NR 44
TC 342
Z9 344
U1 0
U2 6
PU CURRENT BIOLOGY LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD DEC 1
PY 1995
VL 5
IS 12
BP 1416
EP 1423
DI 10.1016/S0960-9822(95)00279-X
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA TL102
UT WOS:A1995TL10200019
PM 8749394
ER

PT J
AU Shibahara, K
   Asano, M
   Ishida, Y
   Aoki, T
   Koike, T
   Honjo, T
AF Shibahara, K
   Asano, M
   Ishida, Y
   Aoki, T
   Koike, T
   Honjo, T
TI Isolation of a novel mouse gene MA-3 that is induced upon programmed
   cell death
SO GENE
LA English
DT Article
DE apoptosis; differential display; sequence; evolutionary conservation;
   mRNA expression
ID NERVE GROWTH-FACTOR; ACTIVATION; REQUIREMENTS; EXPRESSION; APOPTOSIS;
   ANTIGEN; CULTURE; CLONES; LINE
AB Typical programmed cell death requires de novo macromolecular synthesis and shares common morphological changes referred to as apoptosis. To elucidate the molecular mechanism of apoptosis, we isolated cDNA clones that are induced in various types of apoptosis by the differential display method. Among such clones, the MA-3 mRNA was induced in all apoptosis-inducible cell lines tested so far, including thymocytes, T cells, B cells and pheochromocytoma, The nucleotide sequence of the MA-3 cDNA predicted an amino acid (aa) sequence of 469 aa, which did not reveal significant similarity to any known proteins and functional aa motifs in databases. The MA-3 mRNA was strongly expressed in the thymus although small amounts of the MA-3 mRNA were ubiquitously expressed in mouse adult tissues. The MA-3 gene was highly conserved during evolution and cross-hybridization bands were found not only in vertebrates but also in Drosophila melanogaster.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   HOKKAIDO UNIV,GRAD PROGRAM BIOL SCI,SAPPORO,HOKKAIDO 060,JAPAN.
CR ADAMS SE, 1988, MOL CELL BIOL, V8, P2989
   WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0
   ISHIDA Y, 1992, EMBO J, V11, P3887
   LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0
   MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   KOIKE T, 1992, PROG NEURO-PSYCHOPH, V16, P95
   LANIER LL, 1981, J IMMUNOL, V126, P626
   PALACIOS R, 1987, EMBO J, V6, P3687
   Sambrook J, 1989, MOL CLONING LABORATO
   SCHWARTZ LM, 1990, P NATL ACAD SCI USA, V87, P6594, DOI 10.1073/pnas.87.17.6594
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   UCKER DS, 1989, J IMMUNOL, V143, P3461
   WARDEN CH, 1993, GENOMICS, V18, P295, DOI 10.1006/geno.1993.1469
   ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037
NR 21
TC 141
Z9 157
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD DEC 12
PY 1995
VL 166
IS 2
BP 297
EP 301
DI 10.1016/0378-1119(95)00607-9
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA TL600
UT WOS:A1995TL60000019
PM 8543179
ER

PT J
AU Matsuda, F
   Honjo, T
AF Matsuda, F
   Honjo, T
TI Organization of the human immunoglobulin heavy-chain locus
SO ADVANCES IN IMMUNOLOGY, VOL 62
SE ADVANCES IN IMMUNOLOGY
LA English
DT Review
ID VARIABLE REGION SEGMENT; GENE SEGMENTS; PHYSICAL MAP; VH GENE;
   PREFERENTIAL UTILIZATION; HYPERVARIABLE LOOPS; MULTIPLE-SCLEROSIS; V(H)
   LOCUS; IG HEAVY; DIVERSITY
RP Matsuda, F (reprint author), KYOTO UNIV,CTR MOL BIOL & GENET,KYOTO 60601,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4
   GRIFFITHS AD, 1994, EMBO J, V13, P3245
   VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410
   SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465
   JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795
   BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825
   WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128
   AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312
   CUISINIER AM, 1989, SCAND J IMMUNOL, V30, P493, DOI 10.1111/j.1365-3083.1989.tb02455.x
   SHIN EK, 1993, IMMUNOGENETICS, V38, P304
   SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7
   FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M
   RETH MG, 1986, EMBO J, V5, P2131
   CUISINIER AM, 1993, EUR J IMMUNOL, V23, P110, DOI 10.1002/eji.1830230118
   SHEN MR, 1991, J MOL EVOL, V33, P311
   KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
   KEMLER I, 1989, EMBO J, V8, P2001
   SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146
   BALLARD DW, 1986, P NATL ACAD SCI USA, V83, P9626, DOI 10.1073/pnas.83.24.9626
   BERMAN JE, 1988, EMBO J, V7, P727
   BULUWELA L, 1988, EMBO J, V7, P2003
   BULUWELA L, 1988, EUR J IMMUNOL, V18, P1843, DOI 10.1002/eji.1830181130
   CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205
   CHUNG JH, 1984, FED PROC, V43, P1486
   COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162
   DEVLIN RH, 1990, AM J HUM GENET, V46, P112
   EATON S, 1987, P NATL ACAD SCI USA, V84, P7634, DOI 10.1073/pnas.84.21.7634
   GIVOL D, 1981, NATURE, V292, P426, DOI 10.1038/292426a0
   GREEN LL, 1994, NAT GENET, V7, P13, DOI 10.1038/ng0594-13
   HAINO M, 1994, J BIOL CHEM, V269, P2619
   HASHIMOTO LL, 1993, J NEUROIMMUNOL, V44, P77, DOI 10.1016/0165-5728(93)90270-9
   HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671
   HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567
   HONJO T, 1985, ANN REV BIOCH, V152, P803
   HYRIEN O, 1987, EMBO J, V6, P2401
   ICHIHARA Y, 1988, EUR J IMMUNOL, V18, P649, DOI 10.1002/eji.1830180426
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   Kirkham P M, 1994, Semin Immunol, V6, P347, DOI 10.1006/smim.1994.1045
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667
   LOTSCHER E, 1986, NATURE, V320, P456, DOI 10.1038/320456a0
   LOTSCHER E, 1988, GENE, V69, P215, DOI 10.1016/0378-1119(88)90432-5
   MATSUDA F, 1988, EMBO J, V7, P1047
   MATSUDA F, 1990, EMBO J, V9, P2501
   MATSUDA F, 1993, METH MOL G, V2, P226
   MATSUMURA R, 1994, J IMMUNOL, V152, P660
   MIYATA T, 1980, P NATL ACAD SCI-BIOL, V77, P7328, DOI 10.1073/pnas.77.12.7328
   NAGAOKA H, 1994, GENOMICS, V22, P189, DOI 10.1006/geno.1994.1360
   RAYNAUD CA, 1987, CELL, V48, P379
   RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405
   SASSO EH, 1993, P NATL ACAD SCI USA, V89, P10430
   SATO T, 1988, BIOCHEM BIOPH RES CO, V154, P265, DOI 10.1016/0006-291X(88)90679-1
   SCHROEDER HW, 1988, P NATL ACAD SCI USA, V85, P8196, DOI 10.1073/pnas.85.21.8196
   SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563
   SHIN EK, 1994, J IMMUNOL, V152, P1485
   SHIN EK, 1991, EMBO J, V10, P3641
   SHIN EK, 1993, EUR J IMMUNOL, V23, P2365, DOI 10.1002/eji.1830230947
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   SIU G, 1987, J IMMUNOL, V138, P4466
   STRAUBINGER B, 1988, J MOL BIOL, V199, P23, DOI 10.1016/0022-2836(88)90376-2
   TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579
   TOMLINSON IM, 1994, HUM MOL GENET, V3, P856
   TOMPSON CB, 1987, CELL, V48, P369
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   Tuaillon N., 1995, P501
   TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037
   WALTER G, 1993, NUCLEIC ACIDS RES, V21, P4524, DOI 10.1093/nar/21.19.4524
   WALTER MA, 1990, EMBO J, V9, P3303
   WALTER MA, 1991, J EXP MED, V174, P335, DOI 10.1084/jem.174.2.335
   YANG PH, 1990, P NATL ACAD SCI USA, V88, P7907
   ZONG SQ, 1988, IMMUNOL LETT, V17, P329
NR 79
TC 34
Z9 35
U1 0
U2 4
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495
SN 0065-2776
J9 ADV IMMUNOL
JI Adv.Immunol.
PY 1996
VL 62
BP 1
EP 29
DI 10.1016/S0065-2776(08)60426-5
PG 29
WC Immunology
SC Immunology
GA BG02G
UT WOS:A1996BG02G00001
PM 8781265
ER

PT J
AU Oka, C
   Nakano, T
   Wakeham, A
   delaPompa, JL
   Mori, C
   Sakai, T
   Okazaki, S
   Kawaichi, M
   Shiota, K
   Mak, TW
   Honjo, T
AF Oka, C
   Nakano, T
   Wakeham, A
   delaPompa, JL
   Mori, C
   Sakai, T
   Okazaki, S
   Kawaichi, M
   Shiota, K
   Mak, TW
   Honjo, T
TI Disruption of the mouse RBP-J(kappa) gene results in early embryonic
   death (vol 121, pg 3291, 1995)
SO DEVELOPMENT
LA English
DT Correction, Addition
DE RBP-J(kappa); somite defect; neural tube defect; in situ hybridization;
   homologous recombination; mouse
AB The RBP-J kappa protein is a transcription factor that recognizes the sequence C(T)GTGGGGA, The RBP-J kappa gene is highly conserved in a wide variety of species and the Drosophila homologue has been shown to be identical to Suppressor of Hairless [Su(H)] which plays important roles in the development of the peripheral nervous system. To explore the function of the RBP-J kappa gene in mouse embryogenesis, a mutation was introduced into the functional RBP-J kappa gene in embryonic stem (ES) cells by homologous recombination. Null mutant ES cells survived but null mutant mice showed embryonic lethality before 10.5 days of gestation, The mutant mice showed severe growth retardation as early as 8.5 days of gestation, Developmental abnormalities, including incomplete turning of the body axis, microencephaly, abnormal placental development, anterior neuropore opening and defective somitogenesis, were observed in the mutant mice at 9.5 days of gestation. RBP-J kappa mutant embryos expressed a posterior mesodermal marker FGFR1, Their irregularly shaped somites expressed a somite marker gene Mox 1 but failed to express myogenin. The RBP-J kappa gene was revealed to be essential for postimplantation development of mice.
C1 KYOTO UNIV,FAC MED,DEPT ANAT,KYOTO 606,JAPAN.
   AMGEN INST,ONTARIO CANC INST,TORONTO,ON M5G 2M9,CANADA.
RP Oka, C (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
CR OKA C, 1995, DEVELOPMENT, V121, P3291
NR 1
TC 1
Z9 1
U1 0
U2 0
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD JAN
PY 1996
VL 122
IS 1
BP 405
EP 407
PG 3
WC Developmental Biology
SC Developmental Biology
GA TY516
UT WOS:A1996TY51600039
ER

PT J
AU Honjo, T
AF Honjo, T
TI The shortest path from the surface to the nucleus: RBP-J kappa/Su(H)
   transcription factor
SO GENES TO CELLS
LA English
DT Review
ID RBP-J-KAPPA; SIGNAL-BINDING-PROTEIN; BARR-VIRUS EBNA2; PERIPHERAL
   NERVOUS-SYSTEM; ALTERNATIVE CELL FATES; DROSOPHILA HOMOLOG; NEUROGENIC
   GENE; NOTCH PROTEINS; MOUSE HOMOLOG; HAIRLESS
AB Communication between cell surface receptors and nuclear transcription factors is of primary importance to multicellular organisms. Since there are numerous molecules involved in this process, their mutual interaction forms complex networks of informational regulation, which is still under extensive investigation. The RBP-JK transcription factor interacts directly with the Notch receptor involved in cell. lineage commitment, implicating the presence of a uniquely simple communication strategy between the surface receptor and the nucleus.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   ROBBINS J, 1992, J VIROL, V66, P2594
   POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   ZIMBERSTROBL U, 1993, EMBO J, V12, P167
   WALTZER L, 1994, EMBO J, V13, P5633
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752
   GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   OKA C, 1995, DEVELOPMENT, V121, P3291
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   BANG AG, 1991, DEVELOPMENT, V111, P89
   LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237
   FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   Greenwald Iva, 1994, Current Opinion in Genetics and Development, V4, P556, DOI 10.1016/0959-437X(94)90072-B
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6
   SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433
   BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   ASHBURNER M, 1982, GENETICS, V101, P447
   CAMPOSORTEGA JA, 1992, ROUX ARCH DEV BIOL, V201, P1, DOI 10.1007/BF00188770
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   FURUKAWA T, 1994, JPN J GENET, V69, P701, DOI 10.1266/jjg.69.701
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   Jan Y. N., 1993, DEV DROSOPHILA MELAN, VII, P1207
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KIEFF E, 1990, VIROLOGY, P1889
   LARDELLI M, 1994, MECH DEVELOP, V46, P1233
   Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   Lindsey D.L., 1968, GENETIC VARIATIONS D
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   NASH D, 1970, GENETICS, V64, P471
   SAKAI T, 1995, J BIOCH, V118, P6210
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   SIMPSON P, 1990, DEVELOPMENT, V109, P509
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
NR 49
TC 157
Z9 158
U1 2
U2 2
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 1356-9597
J9 GENES CELLS
JI Genes Cells
PD JAN
PY 1996
VL 1
IS 1
BP 1
EP 9
DI 10.1046/j.1365-2443.1996.10010.x
PG 9
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA VC842
UT WOS:A1996VC84200002
PM 9078362
ER

PT J
AU Nakamura, M
   Kondo, S
   Sugai, M
   Nazarea, M
   Imamura, S
   Honjo, T
AF Nakamura, M
   Kondo, S
   Sugai, M
   Nazarea, M
   Imamura, S
   Honjo, T
TI High frequency class switching of an IgM(+) B lymphoma clone CH12F3 to
   IgA(+) cells
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE CH12; germline transcript; Ig; isotype switching; methylation
ID X-LINKED IMMUNODEFICIENCY; HEAVY-CHAIN TRANSCRIPTS; GROWTH FACTOR-BETA;
   MOUSE H19 GENE; CD40 LIGAND; HYPER-IGM; LYMPHOCYTES-B; CIRCULAR DNA;
   T-CELLS; EXPRESSION
AB We have developed an efficient in vitro class switching system using a subclone (CH12F3) of the IgM(+) CH12.LX lymphoma cell line. CH12F3 cells switched from surface IgM(+) cells to surface IgA(+) cells at a high frequency (similar to 50%) after 72 h stimulation with IL-4, transforming growth factor (TGF)-beta and CD40L. No other class isotype-producing cells were detected, indicating that the CH12F3 clone is exclusively committed to IgA isotype switching. To understand the molecular basis of the isotype commitment, we studied the methylation profiles of I region promoters and I region transcription of CH12F3 cells. No germline transcripts other than those from the I-alpha region were detected and only the I-alpha promoter was demethylated in uninduced CH12F3 cells. TGF-beta, CD40L and IL-4 synergistically induced efficient switch recombination in CH12F3 cells, suggesting that the three stimulations up-regulate different steps of switch recombination in isotype-committed a cells such as CH12F3 cells. Stimulation of CH12F3 cells by IL-4 or TGF-beta, but not by CD40L, induced transient but complete methylation of the I-alpha region. TGF-beta and CD40L, but not IL-4, increased the amounts of germline alpha transcripts. We found that the extents of methylation and the amounts of germline transcripts do not necessarily correlate with the efficiency of recombination in induced CH12F3 cells. These results led to the proposal that switch recombination can be separated into at least two phases, i.e. commitment and recombination. The roles of IL-4, TGF-beta and CD40L in the two phases are discussed.
C1 KYOTO UNIV,FAC MED,CTR MOLEC BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT DERMATOL,SAKYO KU,KYOTO 606,JAPAN.
CR FINKELMAN FD, 1988, J IMMUNOL, V140, P1022
   FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0
   ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0
   ESSER C, 1989, EMBO J, V8, P483
   DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0
   COFFMAN RL, 1986, J IMMUNOL, V136, P4538
   COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64
   ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801
   KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0
   ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   JARRETT EEE, 1982, PROG ALLERGY, V31, P178
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672
   ARAKAWA H, 1993, J BIOL CHEM, V268, P4661
   ARNOLD LW, 1988, J IMMUNOL, V140, P4355
   BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   COUTELIER JP, 1988, J EXP MED, V168, P2373, DOI 10.1084/jem.168.6.2373
   GERONDAKIS S, 1990, P NATL ACAD SCI USA, V87, P1581, DOI 10.1073/pnas.87.4.1581
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049
   KUNIMOTO DY, 1993, J IMMUNOL, V150, P1338
   KUNIMOTO DY, 1988, J IMMUNOL, V141, P713
   LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209
   LEBMAN DA, 1990, J IMMUNOL, V144, P952
   LEDERMAN S, 1992, J IMMUNOL, V149, P3817
   LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061
   LUTZKER S, 1988, MOL CELL BIOL, V8, P1849
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550
   RADCLIFFE G, 1990, MOL CELL BIOL, V10, P382
   Sambrook J., 1989, MOL CLONING
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   SNAPPER CM, 1988, J IMMUNOL, V140, P2121
   STAVNEZER J, 1985, J EXP MED, V161, P577, DOI 10.1084/jem.161.3.577
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   WAKATSUKI Y, 1993, J EXP MED, V178, P129, DOI 10.1084/jem.178.1.129
   Xu M, 1990, Dev Immunol, V1, P11, DOI 10.1155/1990/47659
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 46
TC 89
Z9 90
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD FEB
PY 1996
VL 8
IS 2
BP 193
EP 201
DI 10.1093/intimm/8.2.193
PG 9
WC Immunology
SC Immunology
GA TW657
UT WOS:A1996TW65700005
PM 8671604
ER

PT J
AU Shinohara, T
   Honjo, T
AF Shinohara, T
   Honjo, T
TI Epidermal growth factor can replace thymic mesenchyme in induction of
   embryonic thymus morphogenesis in vitro
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE fetal thymus; matrigel; epidermal growth factor; lobule formation
ID MOUSE SALIVARY EPITHELIUM; MEMBRANE-LIKE SUBSTRATUM; NEURAL CREST;
   FACTOR-ALPHA; BRANCHING MORPHOGENESIS; CELL-DIFFERENTIATION;
   GENE-EXPRESSION; MAMMARY-GLAND; MICE; MICROENVIRONMENT
AB The thymus is surrounded by a thin layer of mesenchyme and the epithelial-mesenchymal interaction is known to be essential for the thymus development. To clarify the roles of mesenchyme in the thymus lobule formation that occurs around embryonic days 14-15 in vivo, we set up a three-dimensional organ culture system. The epithelium of embryonic day 13 thymic primordium was separated from the mesenchyme and cultured in Matrigel (reconstituted basement membrane). Addition of the mesenchyme to a chamber separated by a membrane filler induced the lobule formation of the thymic epithelium in vitro. We found that epidermal growth factor (EGF) can replace the mesenchyme for lobulation of the embryonic thymus in vitro. Among other growth factors tested. only transforming growth factor (TGF)-alpha was as effective as EGF, in agreement with the fact that EGF and TGF-alpha bind to the same receptor. These results suggest that EGF or its family members may be involved in morphogenesis and differentiation of the thymus gland epithelium. although we cannot exclude the possibility that other unknown factors are required in vivo.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3
   BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J
   JOWETT AK, 1993, DEVELOPMENT, V117, P461
   GOLDIN GV, 1980, J EMBRYOL EXP MORPH, V60, P235
   HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0
   TAUB M, 1990, P NATL ACAD SCI USA, V87, P4002, DOI 10.1073/pnas.87.10.4002
   DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0
   SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611
   BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851
   CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0
   SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711
   ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0
   SANVITO F, 1994, DEVELOPMENT, V120, P3451
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   COLEMAN S, 1988, DEV BIOL, V127, P304, DOI 10.1016/0012-1606(88)90317-X
   LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17
   CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303
   OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431
   VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591
   PESCARMONA E, 1993, HISTOPATHOLOGY, V23, P39, DOI 10.1111/j.1365-2559.1993.tb01181.x
   AUERBACH R, 1960, DEV BIOL, V2, P271, DOI 10.1016/0012-1606(60)90009-9
   AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599
   BOCKMAN DE, 1989, ANAT REC, V225, P209, DOI 10.1002/ar.1092250306
   DEKOSSODO S, 1992, J EXP MED, V176, P1259, DOI 10.1084/jem.176.5.1259
   EKBLOM P, 1994, DEVELOPMENT, V120, P2003
   HOFF MHB, 1989, DEVELOPMENT, V105, P223
   KURATANI S, 1990, ANAT REC, V228, P185, DOI 10.1002/ar.1092280210
   Le Lièvre C S, 1975, J Embryol Exp Morphol, V34, P125
   LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147
   MCKUSICK VA, 1990, MENDELIAN INHERITANC, P916
   MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424
   NOGAWA H, 1991, DEVELOPMENT, V112, P855
   Partanen A M, 1990, Curr Top Dev Biol, V24, P31, DOI 10.1016/S0070-2153(08)60083-6
   PARTANEN AM, 1985, DEV BIOL, V111, P84, DOI 10.1016/0012-1606(85)90437-3
   SCHUGER L, 1990, DEVELOPMENT, V110, P1091
   SHEN MM, 1994, EMBO J, V13, P1375
   SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393
   TAKAHASHI Y, 1991, DEVELOPMENT, V111, P327
   TOYODA H, 1995, J BIOL CHEM, V270, P7495
   VONDERHAAR BK, 1987, J CELL PHYSIOL, V132, P581, DOI 10.1002/jcp.1041320324
NR 42
TC 27
Z9 28
U1 0
U2 0
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD APR
PY 1996
VL 26
IS 4
BP 747
EP 752
DI 10.1002/eji.1830260404
PG 6
WC Immunology
SC Immunology
GA UJ769
UT WOS:A1996UJ76900003
PM 8625963
ER

PT J
AU Agata, Y
   Kawasaki, A
   Nishimura, H
   Ishida, Y
   Tsubata, T
   Yagita, H
   Honjo, T
AF Agata, Y
   Kawasaki, A
   Nishimura, H
   Ishida, Y
   Tsubata, T
   Yagita, H
   Honjo, T
TI Expression of the PD-1 antigen on the surface of stimulated mouse T and
   B lymphocytes
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE anti-CD3 antibody; anti-IgM antibody; immunoprecipitation; induced
   expression
ID CELL ACTIVATION; MONOCLONAL-ANTIBODIES; RECEPTOR COMPLEX; IL-2 RECEPTOR;
   INVIVO; DIFFERENTIATION; PROLIFERATION; INDUCTION; PATHWAY; INVITRO
AB A mAb J43 has been produced against the product of the mouse PD-1 gene, a member of the Ig gene superfamily, which was previously isolated from an apoptosis-induced T cell hybridoma (2B4.11) by using subtractive hybridization, Analyses by flow cytometry and immunoprecipitation using the J43 mAb revealed that the PD-1 gene product is a 50-55 kDa membrane protein expressed on the cell surface of several PD-1 cDNA transfectants and 2B4.11 cells, Since the molecular weight calculated from the amino acid sequence is 29,310, the PD-1 protein appears to be heavily glycosylated, Normal murine lymphoid tissues such as thymus, spleen, lymph node and bone marrow contained very small numbers of PD-1(+) cells, However, a significant PD-1(+) population appeared in the thymocytes as well as T cells in spleen and lymph nodes by the in vivo anti-CD3 mAb treatment, Furthermore, the PD-1 antigen expression was strongly induced in distinct subsets of thymocytes and spleen T cells by in vitro stimulation with either anti-CD3 mAb or concanavalin A (Con A) which could lead T cells to both activation and cell death, Similarly, PD-1 expression was induced on spleen B cells by in vitro stimulation with anti-IgM antibody, By contrast, PD-1 was not significantly expressed on lymphocytes by treatment with growth factor deprivation, dexamethasone or lipopolysaccharide, These results suggest that the expression of the PD-1 antigen is tightly regulated and induced by signal transduction through the antigen receptor and do not exclude the possibility that the PD-1 antigen may play a role in clonal selection of lymphocytes although PD-1 expression is not required for the common pathway of apoptosis.
C1 KYOTO UNIV,CTR MOLEC BIOL & GENET,FAC MED,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,DEPT MED CHEM,FAC MED,SAKYO KU,KYOTO 606,JAPAN.
   JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN.
CR PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709
   COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0
   DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
   ISHIDA Y, 1992, EMBO J, V11, P3887
   PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280
   TADAKUMA T, 1990, EUR J IMMUNOL, V20, P779, DOI 10.1002/eji.1830200411
   HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326
   HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988
   UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580
   MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445
   SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497
   ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173
   BLOMGREN H, 1971, CELL IMMUNOL, V1, P545
   CEBRIAN M, 1988, J EXP MED, V168, P1621, DOI 10.1084/jem.168.5.1621
   Coffman R L, 1982, Immunol Rev, V69, P5
   Coligan JE, 1991, CURRENT PROTOCOLS IM
   GUNTER KC, 1984, J EXP MED, V159, P716, DOI 10.1084/jem.159.3.716
   HARA T, 1985, J EXP MED, V161, P1513, DOI 10.1084/jem.161.6.1513
   HIRSCH R, 1989, J IMMUNOL, V142, P737
   KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473
   MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0
   MALEK TR, 1986, J EXP MED, V164, P709, DOI 10.1084/jem.164.3.709
   Marrack P, 1986, Adv Immunol, V38, P1, DOI 10.1016/S0065-2776(08)60005-X
   MERCEP M, 1988, J IMMUNOL, V140, P324
   MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4
   MORTTA A, 1985, J EXP MED, V162, P823
   NAKAMURA S, 1989, J EXP MED, V169, P677, DOI 10.1084/jem.169.3.677
   ORTEGA G, 1984, J IMMUNOL, V133, P1970
   PALACIOS R, 1987, EMBO J, V6, P3687
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314
   SCREPANTI I, 1989, J IMMUNOL, V142, P3378
   SHI YF, 1991, J IMMUNOL, V146, P3340
   SUSSMAN JJ, 1988, J IMMUNOL, V140, P2520
   UCKER DS, 1989, J IMMUNOL, V143, P3461
   ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421
   YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3
   YOKOYAMA WM, 1988, J IMMUNOL, V141, P369
NR 44
TC 455
Z9 480
U1 2
U2 9
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD MAY
PY 1996
VL 8
IS 5
BP 765
EP 772
DI 10.1093/intimm/8.5.765
PG 8
WC Immunology
SC Immunology
GA UN188
UT WOS:A1996UN18800016
PM 8671665
ER

PT J
AU Nishimura, H
   Agata, Y
   Kawasaki, A
   Sato, M
   Imamura, S
   Minato, N
   Yagita, H
   Nakano, T
   Honjo, T
AF Nishimura, H
   Agata, Y
   Kawasaki, A
   Sato, M
   Imamura, S
   Minato, N
   Yagita, H
   Nakano, T
   Honjo, T
TI Developmentally regulated expression of the PD-1 protein on the surface
   of double-negative (CD4(-)CD8(-)) thymocytes
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE anti-CD3 stimulation; double-negative thymocytes; PD-1; RAG 2(-/-) mice;
   T cell development
ID T-CELL DEVELOPMENT; MONOCLONAL-ANTIBODIES; RECEPTOR; MICE; ONTOGENY;
   DEATH; CD4
AB PD-1, a member of the Ig superfamily, was previously isolated from an apoptosis-induced T cell hybridoma 2B4.11 by subtractive hybridization, Expression of the PD-1 mRNA is restricted to thymus in adult mice, Using an anti-PD-1 mAb (J43), we examined expression of the PD-1 protein during differentiation of thymocytes in normal adult, fetal and RAG-2(-/-) mice with or without anti-CD3 mAb stimulation, While PD-1 was expressed only on 3-5% of total normal thymocytes, similar to 34% of the CD4(-)CD8(-) double-negative (DN) fraction are PD-1(+) cells with two distinct expression levels (low and high), PD-1(high) thymocytes belonged to TCR gamma delta lineage cells, In the UN compartment of the TCR alpha beta lineage, PD-1 expression started at the low level from the CD44(+)CD25(+) stage and the majority of thymocytes expressed PD-1 at the CD44(-)CD25(-) stage in which thymocytes express TCR beta chains, The anti-CD3 epsilon antibody administration augmented the PD-1 expression as well as the differentiation of the CD44(-)CD25(+) DN cells into the CD44(-)CD25(-) UN stage, not only in normal mice but also in RAG-2-deficient mice, The fraction of the PD-1(low) cells in the CD4(+)CD8(+) double-positive (DP) compartment was very small (<5%) but increased by stimulation with the anti-CD3 antibody, although the total number of Up cells was drastically reduced, The results show that PD-1 expression is specifically induced at the stages preceding clonal selection.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT DERMATOL,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT IMMUNOL,SAKYO KU,KYOTO 606,JAPAN.
   JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN.
CR ADKINS B, 1987, ANNU REV IMMUNOL, V5, P325, DOI 10.1146/annurev.immunol.5.1.325
   MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B
   HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0
   SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336
   GODFREY DI, 1994, J IMMUNOL, V152, P4783
   NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X
   GODFREY DI, 1993, J IMMUNOL, V150, P4244
   LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374
   VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531
   KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301
   BALLAS ZK, 1990, J IMMUNOL, V145, P1039
   CARDING SR, 1991, IMMUNOL TODAY, V12, P239, DOI 10.1016/0167-5699(91)90037-T
   FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0
   GODFREY DI, 1992, J IMMUNOL, V149, P2281
   GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U
   HUGO P, 1990, INT IMMUNOL, V2, P209, DOI 10.1093/intimm/2.3.209
   ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094
   PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614
   ROTHENBERG EV, 1993, J IMMUNOL, V151, P3530
   SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703
   SHI YF, 1991, J IMMUNOL, V146, P3340
   SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995
   TAKAHAMA Y, 1991, J IMMUNOL, V146, P1134
   VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1
NR 29
TC 88
Z9 96
U1 2
U2 7
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD MAY
PY 1996
VL 8
IS 5
BP 773
EP 780
DI 10.1093/intimm/8.5.773
PG 8
WC Immunology
SC Immunology
GA UN188
UT WOS:A1996UN18800017
PM 8671666
ER

PT J
AU Nakano, T
   Kodama, H
   Honjo, T
AF Nakano, T
   Kodama, H
   Honjo, T
TI In vitro development of primitive and definitive erythrocytes from
   different precursors
SO SCIENCE
LA English
DT Article
ID HEMATOPOIETIC PROGENITOR CELLS; C-KIT; DEVELOPING MOUSE; STEM-CELLS;
   YOLK-SAC; EXPRESSION; INVITRO; BLOOD; CULTURE; EMBRYO
AB During mouse embryogenesis the production of ''primitive'' erythrocytes (EryP) precedes the production of ''definitive'' erythrocytes (EryD) in parallel with the transition of the hematopoietic site from the yolk sac to the fetal liver. On a macrophage colony-stimulating factor-deficient stromal cell line OP9, mouse embryonic stem cells were shown to give rise to EryP and EryD sequentially with a time course similar to that seen in murine ontogeny. Studies of the different growth factor requirements and limiting dilution analysis of precursor frequencies indicate that most EryP and EryD probably developed from different precursors by way of distinct differentiation pathways.
C1 KYOTO UNIV,FAC ENGN,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   OHU UNIV,SCH DENT,DEPT ANAT,KORIYAMA,FUKUSHIMA 963,JAPAN.
CR OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63
   MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   KODAMA H, 1994, EXP HEMATOL, V22, P979
   NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816
   MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7
   WONG PMC, 1986, BLOOD, V67, P716
   KELLER G, 1993, MOL CELL BIOL, V13, P473
   MIWA Y, 1991, DEVELOPMENT, V111, P543
   WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1
   DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
   BREIVIK H, 1971, J CELL PHYSIOL, V78, P73, DOI 10.1002/jcp.1040780111
   COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677
   CRAIG ML, 1964, DEV BIOL, V10, P191, DOI 10.1016/0012-1606(64)90040-5
   DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6
   INGRAM VM, 1972, NATURE, V235, P338, DOI 10.1038/235338a0
   JOYNER AL, 1993, GENE TARGETING
   LEDER A, 1992, DEVELOPMENT, V116, P1041
   LINDENBAUM MH, 1990, GENE DEV, V4, P2075, DOI 10.1101/gad.4.12a.2075
   MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x
   Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0
   NAKANO T, UNPUB
   OGAWA M, 1993, DEVELOPMENT, V117, P1089
   PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0
   RUGH R, 1968, MOUSE
   Sambrook J., 1989, MOL CLONING LAB MANU
   STAMATOYANNOPOU.G, 1994, MOL BASIS BLOOD DIS
   SUDA T, 1985, J CELL PHYSIOL, V124, P182, DOI 10.1002/jcp.1041240203
   WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184
   WONG PMC, 1983, BLOOD, V62, P1280
NR 30
TC 168
Z9 173
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD MAY 3
PY 1996
VL 272
IS 5262
BP 722
EP 724
DI 10.1126/science.272.5262.722
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA UJ051
UT WOS:A1996UJ05100051
PM 8614833
ER

PT J
AU Nomura, T
   Han, H
   Howard, MC
   Yagita, H
   Yakura, H
   Honjo, T
   Tsubata, T
AF Nomura, T
   Han, H
   Howard, MC
   Yagita, H
   Yakura, H
   Honjo, T
   Tsubata, T
TI Antigen receptor-mediated B cell death is blocked by signaling via CD72
   or treatment with dextran sulfate and is defective in autoimmunity-prone
   mice
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE B lymphocytes; CD72; dextran sulfate; mouse; programmed cell death
ID 4 CONSTANT DOMAINS; LYMPHOCYTES-B; DNA ANTIBODIES; CROSS-LINKING;
   INCREASED EXPRESSION; HEMOLYTIC-ANEMIA; TRANSGENIC MICE; CLONAL
   DELETION; MURINE IGM; IMMUNOGLOBULIN
AB Mature B cells undergo programmed cell death when surface (s) Ig is extensively multimerized. A signal that blocks death of B cells is thus required for activation of B cells in response to antigen stimulation, Here we show that only a few diverse transmembrane signals capable of inducing activation and proliferation of B cells blocked sig-mediated death of normal mature a cells, and that there is no correlation between mitogenic activity and the ability to rescue B cells from death, The results suggest that a specific signal is required for abrogating B cell death induced by sig cross-linking, Signaling via IL-4 receptor and CD40, both of which are derived from activated T cells, blocked sig-mediated death, as described previously, Signaling through a B cell antigen CD72, a counter-receptor of the pan-T antigen CD5, also blocked death of anti-Ig-treated mouse spleen B cells, CD72 signal may play a role in survival of B cells at the initial step of T-B interaction, where resting T cells recognize antigens presented by B cells, Moreover, a cell death by anti-Ig was blocked by T cell-independent antigens such as lipopolysaccharide and dextran sulfate, and spleen B cells from New Zealand mice, which are prone to autoantibody-dependent autoimmune diseases, were resistant to sig-mediated death, Mechanisms for blocking sig-mediated death may therefore be required in antibody response to foreign antigens regardless of T independence or T dependence and in autoantibody production.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   DNAX RES INST MOLEC & CELLULAR BIOL INC,PALO ALTO,CA 94304.
   JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN.
   TOKYO METROPOLITAN INST NEUROSCI,TOKYO 183,JAPAN.
CR STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661
   GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0
   TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0
   HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3
   CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457
   SANTOSARGUMEDO L, 1993, J IMMUNOL, V151, P3119
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   FANG W, 1995, J IMMUNOL, V155, P66
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.immunol.10.1.97
   MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217
   THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9
   BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881
   TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8
   MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   BAIXERAS E, 1993, IMMUNOL REV, V132, P5, DOI 10.1111/j.1600-065X.1993.tb00836.x
   BOYD AW, 1981, J IMMUNOL, V126, P2466
   BRETSCHE.P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042
   CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0
   CHOI MSK, 1995, EUR J IMMUNOL, V25, P1352, DOI 10.1002/eji.1830250533
   FINKELMAN FD, 1995, J EXP MED, V181, P515, DOI 10.1084/jem.181.2.515
   GENARO AM, 1994, EUR J IMMUNOL, V24, P2515, DOI 10.1002/eji.1830241038
   GILBERT KM, 1994, J EXP MED, V179, P249, DOI 10.1084/jem.179.1.249
   GOROFF DK, 1991, J IMMUNOL, V146, P18
   HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816
   HIROSE S, 1993, EUR J IMMUNOL, V23, P2813, DOI 10.1002/eji.1830231114
   KAMESAKI H, 1994, J IMMUNOL, V152, P3294
   LEDERMAN S, 1994, J IMMUNOL, V152, P2163
   LEPTIN M, 1985, EUR J IMMUNOL, V15, P131, DOI 10.1002/eji.1830150206
   LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610
   MOND JJ, 1981, J IMMUNOL, V127, P881
   NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   PARRY SL, 1994, EUR J IMMUNOL, V24, P974, DOI 10.1002/eji.1830240429
   PARRY SL, 1994, J IMMUNOL, V152, P2821
   PAUL E, 1990, International Reviews of Immunology, V5, P295, DOI 10.3109/08830189009056736
   RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0
   SANTOSARGUMEDO L, 1994, CELL IMMUNOL, V156, P272, DOI 10.1006/cimm.1994.1174
   SARMIENTO M, 1980, J IMMUNOL, V125, P2665
   SCOTT DW, 1987, IMMUNOL REV, V99, P153, DOI 10.1111/j.1600-065X.1987.tb01176.x
   Subbarao B, 1982, Immunol Rev, V69, P81
   SUBBARAO B, 1983, J IMMUNOL, V130, P2033
   THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P90, DOI 10.1016/0167-5699(95)80095-6
   THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2
   TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761
   VALENTINE MA, 1992, EUR J IMMUNOL, V22, P3141, DOI 10.1002/eji.1830221217
   VANDEVELDE H, 1991, NATURE, V351, P662
   WEBER RJ, 1987, CELL IMMUNOL, V104, P400, DOI 10.1016/0008-8749(87)90041-4
   YAKURA H, 1986, J IMMUNOL, V137, P1475
   YAKURA H, 1981, J EXP MED, V153, P129, DOI 10.1084/jem.153.1.129
   YAKURA H, 1982, J EXP MED, V155, P1309, DOI 10.1084/jem.155.5.1309
   YAMASHITA Y, 1995, IMMUNOLOGY, V85, P248
   YELTON DE, 1981, HYBRIDOMA, V1, P5, DOI 10.1089/hyb.1.1981.1.5
   ZOUALI M, 1988, IMMUNOL REV, V105, P137, DOI 10.1111/j.1600-065X.1988.tb00770.x
NR 58
TC 44
Z9 47
U1 0
U2 2
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUN
PY 1996
VL 8
IS 6
BP 867
EP 875
DI 10.1093/intimm/8.6.867
PG 9
WC Immunology
SC Immunology
GA UU915
UT WOS:A1996UU91500007
PM 8671676
ER

PT J
AU Kurooka, H
   Segre, JA
   Hirano, Y
   Nemhauser, JL
   Nishimura, H
   Yoneda, K
   Lander, ES
   Honjo, T
AF Kurooka, H
   Segre, JA
   Hirano, Y
   Nemhauser, JL
   Nishimura, H
   Yoneda, K
   Lander, ES
   Honjo, T
TI Rescue of the hairless phenotype in nude mice by transgenic insertion of
   the wild-type Hfh11 genomic locus
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE hair growth; Hfh11; nude; thymic development; transgenic mouse
ID GENE; MOUSE; CLONING; EXPRESSION; MUTATION; RAT
AB Mice and rats homozygous for mutations at the nude (nu) locus exhibit the pleiotropic phenotypes of hairlessness and athymia. A recent positional cloning study identified, as a nude gene, a novel fork head transcription factor, Hfh11 (also called whn), that is expressed in skin and thymus, and is mutated in nude rodents, To obtain the direct biological proof that this gene is responsible for the nude phenotype, we microinjected a cosmid clone containing the wild-type Hfh11 genomic locus into fertilized nude eggs, Two independent founder lines of transgenic mice were generated that corrected the hairless phenotype, but not the thymic defect. This partial rescue demonstrates that Hfh11 is the gene responsible for the hairless defect in the nude mouse, Taken together with previous genetic studies, this complementation result indicates that Hfh11 is indeed the nude gene and the Hfh11 locus is likely to be subject to complicated regulation.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142.
   MIT,DEPT BIOL,CAMBRIDGE,MA 02139.
CR NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0
   CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7
   SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187
   VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D
   MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454
   READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0
   HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0
   BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4
   KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   FLANAGAN SP, 1966, GENET RES, V8, P295
   FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776
   CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303
   CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778
   BERRIDGE M, 1979, TRANSPLANTATION, V27, P419
   COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3
   HAMMER RE, 1984, NATURE, V311, P65, DOI 10.1038/311065a0
   Hogan B, 1986, MANIPULATING MOUSE E
   JENKINS NA, 1994, GENOMICS, V19, P402, DOI 10.1006/geno.1994.1085
   JONES SN, 1990, J BIOL CHEM, V265, P14684
   KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J
   KRUMLAUF R, 1985, MOL CELL BIOL, V5, P1639
   KURAMOTO T, 1993, CYTOGENET CELL GENET, V63, P107, DOI 10.1159/000133511
   KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591
   LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0
   LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57
   MANIATIS T, 1982, MOL CLONING LAB MANU, P9
   NEHIS M, 1994, EUR J IMMUNOL, V24, P1721
   Pantelouris E M, 1973, Differentiation, V1, P437, DOI 10.1111/j.1432-0436.1973.tb00143.x
   SCULTZ LD, 1978, ANIMAL MODELS COMP D, P211
   TAKAHASHI Y, 1992, J EXP MED, V175, P873, DOI 10.1084/jem.175.3.873
   WU JG, 1994, P NATL ACAD SCI USA, V91, P2344, DOI 10.1073/pnas.91.6.2344
   ZHA H, 1995, MAMM GENOME, V6, P137, DOI 10.1007/BF00303260
NR 35
TC 13
Z9 13
U1 0
U2 4
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUN
PY 1996
VL 8
IS 6
BP 961
EP 966
DI 10.1093/intimm/8.6.961
PG 6
WC Immunology
SC Immunology
GA UU915
UT WOS:A1996UU91500016
PM 8671685
ER

PT J
AU Shinkura, R
   Matsuda, F
   Sakiyama, T
   Tsubata, T
   Hiai, H
   Paumen, M
   Miyawaki, S
   Honjo, T
AF Shinkura, R
   Matsuda, F
   Sakiyama, T
   Tsubata, T
   Hiai, H
   Paumen, M
   Miyawaki, S
   Honjo, T
TI Defects of somatic hypermutation and class switching in alymphoplasia
   (aly) mutant mice
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE aly/aly mice; immune response; somatic hypermutation
ID GERMINAL CENTER FORMATION; PRIMARY IMMUNE-RESPONSE; B-CELLS; AFFINITY
   MATURATION; ANTIBODY MUTANTS; LYMPH-NODES; CD40 LIGAND; MEMORY;
   RECRUITMENT; GENERATION
AB The alymphoplasia (aly) mutation of mice causes the systemic absence of lymph nodes, Peyer's patches and well-defined lymphoid follicles in the spleen. We found that antibody responses are elicited, albeit weakly, to either T cell-dependent or T cell-independent antigen by aly/aly mutants. However, isotype switching was defective. The T cell-dependent immune response was not elicited in splenectomized aly/aly mice. Neither hypermutation nor germinal center formation was observed in aly/aly mice. These results suggest that T-B collaboration requires either lymph nodes or spleen, and that hypermutation and affinity maturation depend on germinal center formation.
C1 KYOTO UNIV,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,CTR MOL BIOL & GENET,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,DEPT PATHOL,SAKYO KU,KYOTO 606,JAPAN.
   NIPPON SHINYAKU CO LTD,RES LABS,DEPT MOL BIOL,MINAMI KU,KYOTO 601,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR AMLOT PL, 1985, EUR J IMMUNOL, V15, P508, DOI 10.1002/eji.1830150516
   WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681
   JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679
   ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45
   CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F
   YELAMOS J, 1995, NATURE, V376, P225
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q
   KLAUS GGB, 1977, IMMUNOLOGY, V33, P31
   BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B
   XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6
   CUMANO A, 1986, EMBO J, V5, P2459
   JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0
   KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.immunol.7.1.537
   ALLEN D, 1988, EMBO J, V7, P1995
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012
   BANKS TA, 1995, J IMMUNOL, V155, P1685
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   BEREK C, 1992, IMMUNOL REV, V126, P5, DOI 10.1111/j.1600-065X.1992.tb00628.x
   BLIER PR, 1987, J IMMUNOL, V139, P3996
   EERTWEGH AJM, 1993, J EXP MED, V178, P1555
   JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KUSAKABE M, 1984, STAIN TECHNOL, V59, P127
   LANE PJL, 1986, EUR J IMMUNOL, V16, P1569, DOI 10.1002/eji.1830161216
   LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7
   NANNO M, 1994, J IMMUNOL, V153, P2014
   NIEUWENHUIS P, 1992, IMMUNOL REV, V126, P77, DOI 10.1111/j.1600-065X.1992.tb00632.x
   ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0
   SCHITTEK B, 1992, J EXP MED, V176, P427, DOI 10.1084/jem.176.2.427
   Togni PD, 1994, SCIENCE, V264, P703
   TSIAGBE VK, 1992, IMMUNOL REV, V126, P113, DOI 10.1111/j.1600-065X.1992.tb00634.x
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
NR 36
TC 42
Z9 42
U1 1
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUL
PY 1996
VL 8
IS 7
BP 1067
EP 1075
DI 10.1093/intimm/8.7.1067
PG 9
WC Immunology
SC Immunology
GA UZ993
UT WOS:A1996UZ99300010
PM 8757952
ER

PT J
AU Nakano, T
   Kodama, H
   Honjo, T
AF Nakano, T
   Kodama, H
   Honjo, T
TI Differential development of primitive and definitive erythrocytes
   culture.
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
C1 OSAKA UNIV,MICROBIAL DIS RES INST,DEPT MOL CELL BIOL,SUITA,OSAKA 565,JAPAN.
   OHU UNIV,FAC DENT,KORIYAMA,FUKUSHIMA,JAPAN.
   KYOTO UNIV,FAC MED,KYOTO,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CARDEN JENNINGS PUBL CO LTD
PI CHARLOTTESVILLE
PA BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD AUG
PY 1996
VL 24
IS 9
BP 216
EP 216
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA VC092
UT WOS:A1996VC09200215
ER

PT J
AU Han, H
   Nomura, T
   Honjo, T
   Tsubata, T
AF Han, H
   Nomura, T
   Honjo, T
   Tsubata, T
TI Differential modulation of cyclin-dependent kinase inhibitor p27(Kip1)
   by negative signaling via the antigen receptor of B cells and positive
   signaling via CD40
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE CD40; p27(Kip1); surface immunoglobulin; cell cycle; B cell
ID ANTIBODIES INDUCE APOPTOSIS; INDUCED GROWTH ARREST; LYMPHOMA-CELLS;
   CROSS-LINKING; CD40-DEFICIENT MICE; IMMUNE-RESPONSES; CDK INHIBITORS;
   T-LYMPHOCYTES; G1 PHASE; TGF-BETA
AB The cross-linking of surface immunoglobulins (sIg) of B cells can transmit a negative signal, resulting in cell cycle arrest, apoptosis or both. Signaling via the B cell antigen CD40 reverses the sIg-mediated negative signaling and induces activation and proliferation of B cells. We investigated the molecular mechanisms for cell cycle regulation by negative and positive signaling via sig and CD40, respectively, by using the B cell line WEHI-231. Cross-linking of sig almost completely reduced the activity of cyclin-dependent kinase (Cdk) 2, essential for cell cycle progression in the late G1 phase, although the level of Cdk2 was not reduced. Among the factors that regulate Cdk2 activation, the activity of the Cdk-activating kinase (CAK) appeared intact and cyclin E was reduced only partially in sig-cross-linked WEHI-231. In contrast, sig crosslinking induced a significant Cdk inhibitor (CKI) activity. Since a 27-kDa protein was co-precipitated with Cdk2 in anti-Ig-treated, but not untreated WEHI-231, and the CKI activity in anti-Ig-treated WEHI-231 was neutralized by anti-p27(Kip1) antibodies, it is most likely that p27(Kip1) is responsible for the CKI activity induced by sig cross-linking. p27(Kip1) may thus play a role in growth inhibition of B cells by negative signaling via sig. In contrast, CD40 signaling enhanced Cdk2 activity and reduced the p27(Kip1) level in anti-Ig-treated WEHI-231, suggesting that the reduction of p27(Kip1) plays an important role in the abrogation of sIg-mediated growth arrest by CD40 signaling. Taken together, p27(Kip1) likely to be a crucial target molecule of the negative signaling via sig and the positive signaling via CD40 essential for T cell-dependent immune responses.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO,JAPAN.
CR NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0
   FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889
   TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0
   MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4
   DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4
   CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457
   SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5
   HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6
   CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q
   LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673
   TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   FANG W, 1995, J IMMUNOL, V155, P66
   NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341
   XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6
   RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.immunol.10.1.97
   MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066
   BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881
   TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8
   KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7
   GU Y, 1992, EMBO J, V11, P3995
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135
   RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889
   LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x
   CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494
   POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   CHOI MSK, 1995, EUR J IMMUNOL, V25, P1352, DOI 10.1002/eji.1830250533
   COTTER TG, 1992, ANTICANCER RES, V12, P773
   DEFRANCO AL, 1987, IMMUNOL REV, V95, P161, DOI 10.1111/j.1600-065X.1987.tb00504.x
   FINKELMAN FD, 1995, J EXP MED, V181, P515, DOI 10.1084/jem.181.2.515
   HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810
   HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816
   KAMESAKI H, 1994, J IMMUNOL, V152, P3294
   KUNG AL, 1990, CANCER RES, V50, P7307
   LEDERMAN S, 1994, J IMMUNOL, V152, P2163
   LEONARDO AD, 1994, GENE DEV, V8, P2540
   Nomura T, 1996, INT IMMUNOL, V8, P867, DOI 10.1093/intimm/8.6.867
   PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075
   PARKER DC, 1980, IMMUNOL REV, V52, P115, DOI 10.1111/j.1600-065X.1980.tb00333.x
   PARRY SL, 1994, EUR J IMMUNOL, V24, P974, DOI 10.1002/eji.1830240429
   PARRY SL, 1994, J IMMUNOL, V152, P2821
   POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9
   REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831
   SANTOSARGUMEDO L, 1994, CELL IMMUNOL, V156, P272, DOI 10.1006/cimm.1994.1174
   SCOTT DW, 1985, CELL IMMUNOL, V93, P124, DOI 10.1016/0008-8749(85)90393-4
   SCOTT DW, 1986, J EXP MED, V164, P156, DOI 10.1084/jem.164.1.156
   SOLOMON MJ, 1994, TRENDS BIOCHEM SCI, V19, P496, DOI 10.1016/0968-0004(94)90137-6
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   VALENTINE MA, 1992, EUR J IMMUNOL, V22, P3141, DOI 10.1002/eji.1830221217
NR 54
TC 23
Z9 24
U1 0
U2 1
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 1996
VL 26
IS 10
BP 2425
EP 2432
DI 10.1002/eji.1830261024
PG 8
WC Immunology
SC Immunology
GA VM200
UT WOS:A1996VM20000023
PM 8898956
ER

PT J
AU Akamizu, T
   Matsuda, F
   Okuda, J
   Li, H
   Kanda, H
   Watanabe, T
   Honjo, T
   Mori, T
AF Akamizu, T
   Matsuda, F
   Okuda, J
   Li, H
   Kanda, H
   Watanabe, T
   Honjo, T
   Mori, T
TI Molecular analysis of stimulatory anti-thyrotropin receptor antibodies
   (TSAbs) involved in Graves' disease - Isolation and reconstruction of
   antibody genes, and production of monoclonal TSAbs
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HEAVY-CHAIN; TSH RECEPTOR; LOCUS; REGION; EXPRESSION; AUTOANTIBODIES;
   ORGANIZATION; SEGMENTS
AB Anti-thyrotropin (TSH) receptor autoantibodies (TRAbs) have been known to be involved in Graves' disease, To understand the molecular mechanism for pathogenesis of TSAbs in Graves' disease, we isolated and reconstituted the Ig genes of EBV-transformed B cell clones producing monoclonal thyroid stimulating Ab (TSAb) obtained from patients with Graves' disease, The V region genes of Ig heavy (H) and light (L) chains of two TSAb clones, Ige clone B6B7 and IgM clone 101-2, were isolated by the PCR, Nucleotide sequencing analysis revealed that germ-line V-H and V-kappa segments widely used for autoantibodies including the previously isolated TRAbs were utilized in the two clones, A significant number of somatic mutations were found in V regions of both clones, indicating the involvement of somatic mutations for the TSAb specificity, Reconstituted Ig H and L chain genes of the two clones were stably introduced into myeloma cells for IgG1 production, IgGs purified from cultured supernatants of both transfectants exhibited significant TSAb activities, while they did not inhibit TSH binding to the receptor, The successful expression of recombinant TSAbs in eukaryotic cells will provide opportunities to apply them to various pathophysiologic, diagnostic and therapeutic investigations in autoimmune thyroid diseases.
C1 KYOTO UNIV,SCH MED,DEPT LAB MED,KYOTO 60601,JAPAN.
   KYOTO UNIV,SCH MED,DEPT MED CHEM,KYOTO 60601,JAPAN.
   KYOTO UNIV,CTR MOL BIOL & GENET,KYOTO 60601,JAPAN.
   EIKEN CHEM CO LTD,IMMUNOCHEM RES LAB,TOCHIGI,JAPAN.
   KYUSHU UNIV,MED INST BIOREGULAT,FAC MED,DEPT MOL IMMUNOL,FUKUOKA 812,JAPAN.
RI Matsuda, Fumihiko/B-9893-2009
CR AKAMIZU T, 1990, P NATL ACAD SCI USA, V87, P5677, DOI 10.1073/pnas.87.15.5677
   BURMAN KD, 1985, ENDOCR REV, V6, P183
   AKAMIZU T, 1995, ENDOCR J, V42, P617, DOI 10.1507/endocrj.42.617
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   SILBERSTEIN LE, 1991, BLOOD, V78, P2372
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   BULUWELA L, 1988, EMBO J, V7, P2003
   HIETER PA, 1982, J BIOL CHEM, V257, P1516
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   KANDA H, 1994, HYBRIDOMA, V13, P359, DOI 10.1089/hyb.1994.13.359
   KIPPS TJ, 1989, J IMMUNOL, V142, P4261
   KOHN LD, 1992, INT REV IMMUNOL, V9, P1135
   LI H, 1995, BIOCHEM BIOPH RES CO, V207, P985, DOI 10.1006/bbrc.1995.1282
   MORI T, 1994, ENDOCR J, V41, P1, DOI 10.1507/endocrj.41.1
   NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P146
   OKUDA J, 1994, J CLIN ENDOCR METAB, V79, P1600, DOI 10.1210/jc.79.6.1600
   PARGENT W, 1991, EUR J IMMUNOL, V21, P1821, DOI 10.1002/eji.1830210807
   RADOUX V, 1986, J EXP MED, V164, P2119, DOI 10.1084/jem.164.6.2119
   Rees Smith B, 1988, Endocr Rev, V9, P106
   SHIA EK, 1994, J IMMUNOL, V152, P1485
   STRAUBINGER B, 1988, J MOL BIOL, V199, P23, DOI 10.1016/0022-2836(88)90376-2
   SUGAWA H, 1993, EXCERPTA MED, P491
   WEETMAN AP, 1990, J CLIN INVEST, V86, P723, DOI 10.1172/JCI114768
   WEETMAN AP, 1994, ENDOCR REV, V15, P78
NR 25
TC 30
Z9 30
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD OCT 1
PY 1996
VL 157
IS 7
BP 3148
EP 3152
PG 5
WC Immunology
SC Immunology
GA VL106
UT WOS:A1996VL10600053
PM 8816426
ER

PT J
AU Nakamura, T
   Yabe, D
   Shioi, T
   Furukawa, Y
   Nakano, T
   Honjo, T
AF Nakamura, T
   Yabe, D
   Shioi, T
   Furukawa, Y
   Nakano, T
   Honjo, T
TI Molecular cloning and expression of a novel FK506-binding protein in
   murine embryonic heart by the signal sequence trap method
SO CIRCULATION
LA English
DT Meeting Abstract
C1 KYOTO UNIV,KYOTO,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT 15
PY 1996
VL 94
IS 8
SU S
BP 2064
EP 2064
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA VN119
UT WOS:A1996VN11902059
ER

PT J
AU Hamada, T
   Tashiro, K
   Tada, H
   Inazawa, J
   Shirozu, M
   Shibahara, K
   Nakamura, T
   Martina, N
   Nakano, T
   Honjo, T
AF Hamada, T
   Tashiro, K
   Tada, H
   Inazawa, J
   Shirozu, M
   Shibahara, K
   Nakamura, T
   Martina, N
   Nakano, T
   Honjo, T
TI Isolation and characterization of a novel secretory protein, stromal
   cell-derived factor-2 (SDF-2) using the signal sequence trap method
SO GENE
LA English
DT Article
DE mouse cDNA; human homologue; chromosome mapping; yeast
   mannosyltransferase
ID O-GLYCOSYLATION; GENE; HYBRIDIZATION; CLONING
AB With use of the signal sequence trap method, we isolated a cDNA encoding a novel secretory protein, SDF-2, from the mouse stromal cell line, ST2. The human homologue of SDF-2 was also isolated. The amino acid (aa) sequences deduced from both the clones were conserved more than 92%. The chromosomal localization of the human SDF-2 gene was mapped to 17q11.2. The aa sequence of SDF-2 shows similarity to those of yeast dolichyl phosphate-D-mannose:protein mannosyltransferases, Pmt1p [Strahl-Bolsinger et al. (1993) Proc. Natl. Acad. Sci. USA 90, 8164-8168] and Pmt2p [Lussier et al. (1995) J. Biol. Chem. 270, 2770-2775], whose activities have not been detected in higher eukaryotes.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO PREFECTURAL UNIV MED,DEPT HYG,KAMIGYO KU,KYOTO 602,JAPAN.
CR STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107
   STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   OGAWA M, 1988, EMBO J, V7, P1337
   Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23
   IKEDA T, 1991, J BONE MINER RES, V6, P1013
   INAZAWA J, 1993, GENOMICS, V17, P153, DOI 10.1006/geno.1993.1297
   LUSSIER M, 1995, J BIOL CHEM, V270, P2770
   PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934
   ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738
   SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1
   Sambrook J., 1989, MOL CLONING LAB MANU
   TASHIRO K, 1996, IN PRESS METHODS MOL
   VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X
   VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17
NR 15
TC 39
Z9 41
U1 4
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD OCT 17
PY 1996
VL 176
IS 1-2
BP 211
EP 214
DI 10.1016/0378-1119(96)00251-X
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA VR399
UT WOS:A1996VR39900033
PM 8918255
ER

PT J
AU Tsubata, R
   Tsubata, T
   Hiai, H
   Shinkura, R
   Matsumura, R
   Sumida, T
   Miyawaki, S
   Ishida, H
   Kumagai, S
   Nakao, K
   Honjo, T
AF Tsubata, R
   Tsubata, T
   Hiai, H
   Shinkura, R
   Matsumura, R
   Sumida, T
   Miyawaki, S
   Ishida, H
   Kumagai, S
   Nakao, K
   Honjo, T
TI Autoimmune disease of exocrine organs in immunodeficient alymphoplasia
   mice: A spontaneous model for Sjogren's syndrome
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE autoimmune disease; exocrine organs; Sjogren's syndrome
ID LYMPHOCYTES; ANTIBODIES; DEFICIENT; MUTATION; LESIONS
AB Mice homozygous for an autosomal recessive mutation aly (alymphoplasia) lack both lymph nodes and Peyer's patches, and show defect in both humoral and cellular immunity. Histopathological analysis revealed chronic inflammatory changes in exocrine organs such as the salivary gland, lacrimal gland, and pancreas of the homozygotes (aly/aly), but not the heterozygotes (aly/+). In these exocrine organs. mononuclear cells consisting mainly of CD4(+) T cells infiltrate periductal areas, and, in some cases, the cell infiltration extended to lobules. The inflammatory changes in exocrine organs were transferred by a T cell-enriched fraction of spleen cells from homozygous animals. These results suggest that autoimmune mechanisms mediated by self-reactive T cells may be involved in the inflammatory lesions of various exocrine organs in the homozygous mice, although these mice show immunodeficiency. Inflammatory changes were also observed in the lung of the homozygotes. Since Sjogren's syndrome is characterized by diffuse lymphocyte infiltration in the periductal areas of the lacrimal and salivary glands and is occasionally associated with pulmonary disease, aly/aly mice may serve as a unique spontaneous model of Sjogren's syndrome.
C1 KYOTO UNIV,POSTGRAD MED SCH,DEPT MED CHEM,KYOTO,JAPAN.
   KYOTO UNIV,POSTGRAD MED SCH,DEPT MED & CLIN SCI,KYOTO,JAPAN.
   KYOTO UNIV,POSTGRAD MED SCH,DEPT PATHOL & BIOL DIS,KYOTO,JAPAN.
   NATL UTANO HOSP,DIV INTERNAL MED,KYOTO,JAPAN.
   TOHO UNIV,SCH MED,DEPT INTERNAL MED,SAKURA,JAPAN.
   ST MARIANNA UNIV,SCH MED,INST MED SCI,DIV RHEUMATOL & MOL IMMUNOL,KAWASAKI,KANAGAWA,JAPAN.
   NIPPON SHINYAKU CO LTD,KYOTO,JAPAN.
CR ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   ADAMSON TC, 1983, J IMMUNOL, V130, P203
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322
   BLOCH KJ, 1965, MEDICINE, V44, P187, DOI 10.1097/00005792-196505000-00001
   HANEJI N, 1994, J IMMUNOL, V153, P2769
   TAN EM, 1989, ADV IMMUNOL, V44, P93
   KESSLER HS, 1968, AM J PATHOL, V52, P671
   KOJIMA A, 1976, LAB INVEST, V34, P550
   KESSLER HS, 1971, ARCH OPHTHALMOL-CHIC, V85, P211
   CARLSOO B, 1979, ARCH OTO-RHINO-LARYN, V225, P57, DOI 10.1007/BF00455876
   FOX RI, 1985, J IMMUNOL, V135, P207
   HAYASHI Y, 1994, PATHOL INT, V44, P559, DOI 10.1111/j.1440-1827.1994.tb01716.x
   HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120
   HAYASHI Y, 1988, AM J PATHOL, V132, P173
   HOFFMAN RW, 1984, ARTHRITIS RHEUM, V27, P157, DOI 10.1002/art.1780270206
   Kasturi K N, 1994, Int Rev Immunol, V11, P253, DOI 10.3109/08830189409061731
   KURAMOTO T, 1994, INT IMMUNOL, V6, P991, DOI 10.1093/intimm/6.7.991
   NISHIZUK.Y, 1971, ENDOCRINOLOGY, V89, P886
   PARKES WF, 1945, BRIT J OPHTHALMOL, V29, P299
   Sjogren H., 1933, ACTA OPHTHALMOL    S, V2, P1
   SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635
   THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2
NR 24
TC 54
Z9 54
U1 0
U2 2
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD NOV
PY 1996
VL 26
IS 11
BP 2742
EP 2748
DI 10.1002/eji.1830261129
PG 7
WC Immunology
SC Immunology
GA VT775
UT WOS:A1996VT77500028
PM 8921964
ER

PT J
AU Shirozu, M
   Tada, H
   Tashiro, K
   Nakamura, T
   Lopez, ND
   Nazarea, M
   Hamada, T
   Sato, T
   Nakano, T
   Honjo, T
AF Shirozu, M
   Tada, H
   Tashiro, K
   Nakamura, T
   Lopez, ND
   Nazarea, M
   Hamada, T
   Sato, T
   Nakano, T
   Honjo, T
TI Characterization of novel secreted and membrane proteins isolated by the
   signal sequence trap method
SO GENOMICS
LA English
DT Article
ID EPITHELIUM-DERIVED FACTOR; TRANSMEMBRANE DOMAINS; GENE; EXPRESSION;
   CLONING; CELLS; CDNA; DIFFERENTIATION; TRANSCRIPT
AB We recently described a method, called the signal sequence trap (SST) method, to clone cDNAs of secreted proteins and/or type I transmembrane proteins containing N-terminal signal sequences by using an epitope-tagging expression plasmid vector, In this paper we describe the summary of a large-scale screening of approximately 5900 clones of an SST cDNA library constructed from mouse bone marrow stromal cell line ST-2 cells. Of 26 positive clones obtained and sequenced, 11 clones appeared to contain authentic signal sequences, Five of the clones corresponded to the 5' ends of the cDNA of known genes containing N-terminal signal sequences, The full-length cDNA clones of the 6 other unknown clones were isolated and sequenced. One clone, termed SDF3, encoded a mouse counterpart of human pigment epithelium-derived factor. Another clone, termed SDR1, had considerable homology with basigin, a member of the immunoglobulin superfamily, A third clone, termed SDF5, had partial homology with a Drosophila tissue polarity gene frizzled (fi) and its rat homologues, fz-1 and fz-2. The other three clones had no significant homology with sequences in the databases. These results indicate that the SST method is effective and useful for the isolation of secreted and membrane proteins without knowledge of their functions. (C) 1996 Academic Press, Inc.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR TOMBRANTINK J, 1994, GENOMICS, V19, P266, DOI 10.1006/geno.1994.1057
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117
   VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0
   MIYAUCHI T, 1991, J BIOCHEM-TOKYO, V110, P770
   ALTRUDA F, 1989, GENE, V85, P445, DOI 10.1016/0378-1119(89)90438-1
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   BECERRA SP, 1993, J BIOL CHEM, V268, P23148
   METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0
   BEHAL A, 1990, J BIOL CHEM, V265, P8252
   CHAN SDH, 1992, J BIOL CHEM, V267, P25202
   EIPPER BA, 1992, J BIOL CHEM, V267, P4008
   GONG QH, 1988, NUCLEIC ACIDS RES, V16, P1203, DOI 10.1093/nar/16.3.1203
   HAMADA T, 1996, IN PRESS GENE
   HOWE CC, 1988, DIFFERENTIATION, V37, P20, DOI 10.1111/j.1432-0436.1988.tb00792.x
   IKEDA T, 1991, J BONE MINER RES, V6, P1013
   NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872
   KRETSING.RH, 1973, J BIOL CHEM, V248, P3313
   PAUL SR, 1991, BLOOD, V77, P1723
   ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHWARZBAUER JE, 1987, EMBO J, V6, P2573
   STEELE FR, 1992, P NATL ACAD SCI USA, V90, P1526
   TASHIRO K, 1996, IN PRESS METHODS MOL
NR 27
TC 65
Z9 72
U1 1
U2 3
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD NOV 1
PY 1996
VL 37
IS 3
BP 273
EP 280
DI 10.1006/geno.1996.0560
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA VU075
UT WOS:A1996VU07500001
PM 8938438
ER

PT S
AU Nisitani, S
   Murakami, M
   Honjo, T
AF Nisitani, S
   Murakami, M
   Honjo, T
BE Chiorazzi, N
   Lahita, RG
   Pavelka, K
   Ferrarini, M
TI Anti-red blood cell immunoglobulin transgenic mice - An experimental
   model of autoimmune hemolytic anemia
SO B LYMPHOCYTES AND AUTOIMMUNITY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on B Lymphocytes and Autoimmunity
CY MAY 21-25, 1996
CL PRAGUE, CZECH REPUBLIC
SP Inst Rheumatol Prague, New York Acad Sci, Minist Hlth Czech Republic, Harry Winston Fdn Inc, Mucos Pharma, Baxter Biotech, Hyland Div, Commiss European Communities, Czech Rheumatol Inst, Leo Pharm Prod, Rockfeller Univ, Sandoz Pharma Ltd, Sanofi Winthrop, Zeneca Pharm
ID REACTIVE LYMPHOCYTES-B; B-1 CELLS; CLONAL DELETION; TOLERANCE;
   AUTOANTIBODY; EXPRESSION; INDUCTION; DIFFERENTIATION; MOUSE; CHAIN
C1 KYOTO UNIV, FAC MED, DEPT MED CHEM, KYOTO 606, JAPAN.
CR GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043
   ROSE LM, 1994, AUTOIMMUNITY, V17, P271, DOI 10.3109/08916939409010667
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   TSAO BP, 1992, J IMMUNOL, V149, P350
   BROMBACHER F, 1991, J EXP MED, V174, P1335, DOI 10.1084/jem.174.6.1335
   DUSTIN LB, 1995, J IMMUNOL, V154, P4936
   GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999
   HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0
   METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   OFFEN D, 1992, P NATL ACAD SCI USA, V89, P8332, DOI 10.1073/pnas.89.17.8332
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   TIGHE H, 1993, J EXP MED, V177, P109, DOI 10.1084/jem.177.1.109
NR 21
TC 2
Z9 2
U1 0
U2 3
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-076-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1997
VL 815
BP 246
EP 252
DI 10.1111/j.1749-6632.1997.tb52066.x
PG 7
WC Immunology; Multidisciplinary Sciences; Rheumatology
SC Immunology; Science & Technology - Other Topics; Rheumatology
GA BH93X
UT WOS:A1997BH93X00027
PM 9186661
ER

PT J
AU Aoki, T
   Koike, T
   Nakano, T
   Shibahara, K
   Kondo, S
   Kikuchi, H
   Honjo, T
AF Aoki, T
   Koike, T
   Nakano, T
   Shibahara, K
   Kondo, S
   Kikuchi, H
   Honjo, T
TI Induction of Bip mRNA upon programmed cell death of differentiated PC12
   cells as well as rat sympathetic neurons
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE apoptosis; Bip; calcium homeostasis; heat shock protein; PC12
ID NERVE GROWTH-FACTOR; GLUCOSE-REGULATED PROTEIN; ENDOPLASMIC-RETICULUM;
   FACTOR DEPRIVATION; FACTOR DEPENDENCE; STRESS PROTEINS; MAMMALIAN-CELLS;
   EVENTS; CA2+; DEPOLARIZATION
AB We have found that expression of the Bip (immunoglobulin heavy chain binding protein)/ GRP78 (glucose regulated protein 78) gene is markedly enhanced specifically among the heat shock protein (HSP) 70 gene family during the neuronal cell death of PC12 (22a) cells, that is induced by removal of nerve growth factor (NGF) and blocked by a transcription inhibitor, actinomycin D. The Bip mRNA induction is suppressed when the NGF-deprivation-dependent cell death of PC12 (22a) cells is inhibited by cAMP, cycloheximide or high K+. The Ca2+ ionophore, A23181, caused neuronal cell death accompanied by up-regulation of Bip, HSP90, and HSP70 mRNAs. In addition, a chelator of intracellular Ca2+ (BAPTA) elevated Bip mRNA and induced cell death in a low Ca2+ medium. Alterations of intracellular calcium homeostasis thus appear to induce Bip mRNA expression as well as apoptosis in PC12 (22a) cells. However, release of Ca2+ from intracellular stores by thapsigargin induced Bip mRNA expression but not fell death, indicating that Bip mRNA induction is not sufficient for neuronal death. Induction of Bip mRNA in association with apoptosis was also observed for NGF-deprived sympathetic ganglion cells in primary culture. These lines of evidence suggest that selective induction of Bip mRNA may play an important role in the programmed cell death of neurons deprived of neurotrophic factors and could be a landmark of the neuronal programmed cell death.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,FAC MED,DEPT NEUROSURG,SAKYO KU,KYOTO 606,JAPAN.
   HOKKAIDO UNIV,GRAD PROGRAM BIOL SCI,SAPPORO,HOKKAIDO 060,JAPAN.
CR PITTMAN RN, 1993, J NEUROSCI, V13, P3669
   KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0
   COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175
   EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537
   LI WWF, 1993, J BIOL CHEM, V268, P12003
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207
   FRANKLIN JL, 1995, J NEUROSCI, V15, P643
   KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421
   SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840
   HIGASHI T, 1994, BRAIN RES, V650, P239, DOI 10.1016/0006-8993(94)91787-6
   KOIKE T, 1992, PROG NEURO-PSYCHOPH, V16, P95
   KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892
   LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9
   LI X, 1991, MOL CELL BIOL, V11, P3446
   MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829
   MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875
   MIZZEN LA, 1991, CELL REGUL, V2, P165
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145
   Sambrook J., 1989, MOL CLONING LAB MANU
   TANAKA S, 1992, BIOCHIM BIOPHYS ACTA, V1175, P114, DOI 10.1016/0167-4889(92)90017-6
NR 22
TC 21
Z9 21
U1 0
U2 0
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD JAN
PY 1997
VL 121
IS 1
BP 122
EP 127
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA WC977
UT WOS:A1997WC97700021
PM 9058202
ER

PT J
AU Chen, NN
   Kerr, D
   Chang, CF
   Honjo, T
   Khalili, K
AF Chen, NN
   Kerr, D
   Chang, CF
   Honjo, T
   Khalili, K
TI Evidence for regulation of transcription and replication of the human
   neurotropic virus JCV genome by the human S mu bp-2 protein in glial
   cells
SO GENE
LA English
DT Article
DE human polyoma virus; PML; DNA binding protein
ID DNA-BINDING PROTEIN; HUMAN POLYOMAVIRUS-JC; HUMAN-BRAIN CELLS;
   STIMULATES TRANSCRIPTION; TRANSGENIC MICE; PROMOTER; REGION; EXPRESSION;
   ENHANCER; ORIGIN
AB Glial factor 1 (GF-1) is a partial cDNA isolated from a human brain cDNA library which encodes a truncated protein with binding ability to the B-regulatory domain of the human neurotropic virus, JCV. GF-1 exhibits sequence homology to the central region of the newly identified human DNA-binding protein S mu bp-2. GF-1 appears to be a partial cDNA for human S mu bp-2 based on its sequence homology to S mu bp-2 and their chromosomal co-localization. In this report, we have employed transfection assay and have compared the ability of GF-1 and its full-length form, S mu bp-2, on regulating the activity of JCV promoters in glial cells. Our results demonstrate that, unlike GF-1 which stimulates JCV early promoter in glial cells, overexpression of S mu bp-2 exhibits no drastic effect on the transcription of the viral early promoter. The activity of the viral late promoter was noticeably increased by both GF-1 and S mu bp-2, although the level of induction by GF-1 was consistently higher than that detected by S mu bp-2. Use of deletion constructs in co-transfection assay revealed that the B-domain of the JCV promoter is required for transcriptional activation by GF-1 and S mu bp-2. Expression of GF-1 and S mu bp-2 in glial cells increased the induced level of JCV late gene transcription by the viral early protein, T-antigen. Examination of the viral DNA replication by DpnI assay indicated that, unlike GF-1, S mu bp-2 has the ability to decrease the level df JCV DNA replication in glial cells. These observations suggest that the N-terminal portion of S mu bp-2 which encompasses several helicase motifs and/or its C-terminus, both of which are missing in GF-1, may confer differential effects on viral gene transcription and replication. The biological importance of our findings in regulation of the JCV lytic cycle in glial cells is discussed.
C1 THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOL BIOL,MOL NEUROVIROL SECT,JEFFERSON INST MOL MED,PHILADELPHIA,PA 19107.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 60601,JAPAN.
RI KERR, Douglas /B-9270-2008
CR AHMED S, 1990, J BIOL CHEM, V265, P13899
   AMEMIYA K, 1992, J BIOL CHEM, V267, P14204
   AMEMIYA K, 1989, J BIOL CHEM, V264, P7025
   LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413
   FUKITA Y, 1993, J BIOL CHEM, V268, P17463
   JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8
   BERGER JR, 1995, J NEUROVIROL, V1, P5, DOI 10.3109/13550289509111006
   FEIGENBAUM L, 1987, P NATL ACAD SCI USA, V84, P3695, DOI 10.1073/pnas.84.11.3695
   Frisque R.J., 1992, MOL NEUROVIROLOGY, P25
   FROMENTHAL C, 1989, CELL, V54, P943
   GRAHAM FL, 1973, VIROLOGY, V52, P56
   GUO ZS, 1992, MOL CELL BIOL, V12, P2514
   HAAS S, 1994, VIROLOGY, V202, P89, DOI 10.1006/viro.1994.1325
   HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5
   HOANG AT, 1992, MOL CELL BIOL, V12, P3087
   HODGMAN TC, 1988, NATURE, V333, P578
   HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0
   KENNEY S, 1984, SCIENCE, V226, P1337, DOI 10.1126/science.6095453
   KERR D, 1991, J BIOL CHEM, V266, P15876
   KERR D, 1994, J VIROL, V68, P7637
   KHALILI K, 1988, EMBO J, V7, P1205
   MAJOR EO, 1992, NEUROPATHOGENIC VIRU, P207
   MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761
   NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177
   RAJ GV, 1995, VIROLOGY, V213, P283, DOI 10.1006/viro.1995.0001
   SMALL JA, 1986, CELL, V46, P13, DOI 10.1016/0092-8674(86)90855-X
   SOCK E, 1991, VIROLOGY, V182, P298, DOI 10.1016/0042-6822(91)90673-Y
   TADA H, 1991, VIROLOGY, V180, P327, DOI 10.1016/0042-6822(91)90037-C
   TADA H, 1989, J VIROL, V63, P463
   TAMURA T, 1990, J GEN VIROL, V71, P1829, DOI 10.1099/0022-1317-71-8-1829
NR 32
TC 16
Z9 17
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD JAN 31
PY 1997
VL 185
IS 1
BP 55
EP 62
DI 10.1016/S0378-1119(96)00630-0
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA WG854
UT WOS:A1997WG85400009
PM 9034313
ER

PT J
AU Shinohara, T
   Honjo, T
AF Shinohara, T
   Honjo, T
TI Studies in vitro on the mechanism of the epithelial/mesenchymal
   interaction in the early fetal thymus
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE thymus; epithelium; mesenchyme; major histocompatibility complex; growth
   factor
ID GROWTH FACTOR-I; MOUSE THYMUS; CELL-DIFFERENTIATION; EPITHELIAL-CELLS;
   FACTOR RECEPTOR; NUDE-MICE; EXPRESSION; MICROENVIRONMENT; MORPHOGENESIS;
   INTERLEUKIN-7
AB The effect of the mesenchyme on early thymus development was investigated in vitro by culturing tissue recombinants of the epithelium and mesenchyme derived from the earliest fetal thymus primordium. The thymus mesenchyme promoted the development of the epithelium as assessed by expression of epithelial surface molecules such as major histocompatibility complex (MHC) class I and class II antigens; mesenchymes of other organs were similarly effective. We looked for the culture conditions in which the epithelium could normally express the MHC class II antigen without the mesenchyme and found that the insulin-like growth factors - I and - II were able to support epithelial development under serum-free conditions. When we cultured the prospective thymus region of a day 9 embryo which had not initiated lymphoid precursor migration, MHC class IT antigen was expressed on the epithelium, indicating that lymphoid precursors are not required for early epithelial differentiation. This system provides a means to dissect the complex tissue interactions during the earliest stages of thymus development.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ALEMANY J, 1989, J BIOL CHEM, V264, P17559
   NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0
   BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J
   WADA J, 1993, P NATL ACAD SCI USA, V90, P10360, DOI 10.1073/pnas.90.21.10360
   JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280
   HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0
   ROGERS SA, 1991, J CELL BIOL, V113, P1447, DOI 10.1083/jcb.113.6.1447
   BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851
   MUEGGE K, 1993, SCIENCE, V261, P93, DOI 10.1126/science.7686307
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4
   MANLEY NR, 1995, DEVELOPMENT, V121, P1989
   SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711
   BAKER J, 1993, CELL, V75, P73, DOI 10.1016/S0092-8674(05)80085-6
   ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17
   CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303
   OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431
   VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591
   HAN VKM, 1987, SCIENCE, V236, P193, DOI 10.1126/science.3563497
   AUERBACH R, 1960, DEV BIOL, V2, P271, DOI 10.1016/0012-1606(60)90009-9
   Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198
   BRAXTON LP, 1993, GENE DEV, V7, P2609
   FURLANETTO RW, 1987, J CLIN ENDOCR METAB, V64, P1142
   GOOD MF, 1983, P NATL ACAD SCI-BIOL, V80, P3045, DOI 10.1073/pnas.80.10.3045
   Le Lièvre C S, 1975, J Embryol Exp Morphol, V34, P125
   LO D, 1986, J IMMUNOL, V137, P1772
   METCAF D, 1971, HEMATOPOETIC CELLS
   MOTTOLA C, 1984, J BIOL CHEM, V259, P2705
   NOGAWA H, 1991, DEVELOPMENT, V112, P855
   PARTANEN AM, 1985, DEV BIOL, V111, P84, DOI 10.1016/0012-1606(85)90437-3
   PENIT C, 1989, J IMMUNOL, V142, P3369
   PERUS JCF, 1981, J IMMUNOL, V126, P2310
   RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425
   ROPKE C, 1995, DEV IMMUNOL, V4, P149, DOI 10.1155/1995/23168
   Sambrook J., 1989, MOL CLONING LAB MANU
   Shinohara T, 1996, EUR J IMMUNOL, V26, P747, DOI 10.1002/eji.1830260404
   VANVLIET E, 1985, EUR J IMMUNOL, V15, P675, DOI 10.1002/eji.1830150707
   WASSARMAN PM, 1993, METHOD ENZYMOL, V225, P502
   WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424
NR 40
TC 24
Z9 25
U1 0
U2 0
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD FEB
PY 1997
VL 27
IS 2
BP 522
EP 529
DI 10.1002/eji.1830270225
PG 8
WC Immunology
SC Immunology
GA WJ737
UT WOS:A1997WJ73700024
PM 9045926
ER

PT J
AU Kurooka, H
   Kato, K
   Minoguchi, S
   Takahashi, Y
   Ikeda, J
   Habu, S
   Osawa, N
   Buchberg, AM
   Moriwaki, K
   Shisa, H
   Honjo, T
AF Kurooka, H
   Kato, K
   Minoguchi, S
   Takahashi, Y
   Ikeda, J
   Habu, S
   Osawa, N
   Buchberg, AM
   Moriwaki, K
   Shisa, H
   Honjo, T
TI Cloning and characterization of the nucleoredoxin gene that encodes a
   novel nuclear protein related to thioredoxin
SO GENOMICS
LA English
DT Article
ID NF-KAPPA-B; ESCHERICHIA-COLI THIOREDOXIN; DNA-BINDING; REDOX REGULATION;
   MOUSE; EXPRESSION; ACTIVATION; REDUCTION; SEQUENCE; INVITRO
AB In a yeast artificial chromosome contig close to the nude locus on mouse chromosome 11, we identified a novel gene, nucleoredoxin, that encodes a protein with similarity to the active site of thioredoxins. Nucleoredoxin is conserved between mammalian species, and two homologous genes mere found in Caenorhabditis elegans. The nucleoredoxin transcripts are expressed in all adult tissues examined, but restricted to the nervous system and the limb buds in Day 10.5-11.5 embryos, The nucleoredoxin protein is predominantly localized in the nucleus of cells transfected with the nucleoredoxin expression construct, Since the bacterially expressed protein of nucleoredoxin showed oxido-reductase activity of the insulin disulfide bonds with kinetics similar to that of thioredoxin, it may be a redox regulator of the nuclear proteins, such as transcription factors. (C) 1997 Academic Press.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   TOKAI UNIV,INST MED SCI,DEPT MOL & MED GENET,ISEHARA,KANAGAWA 25911,JAPAN.
   TOKAI UNIV,SCH MED,DEPT IMMUNOL,ISEHARA,KANAGAWA 25911,JAPAN.
   KITASATO UNIV,SCH MED,DEPT MICROBIOL,SAGAMIHARA,KANAGAWA 228,JAPAN.
   THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19107.
   GRAD UNIV ADV STUDIES,HAYAMA,KANAGAWA 24001,JAPAN.
   SAITAMA CANC SITE RES INST,DEPT PATHOL,INA,SAITAMA 362,JAPAN.
OI Buchberg, Arthur/0000-0002-0543-5631
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20
   LAURENT TC, 1964, J BIOL CHEM, V239, P3436
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187
   HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237
   SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672
   TAGAYA Y, 1989, EMBO J, V8, P757
   CONLON RA, 1992, DEVELOPMENT, V116, P357
   MULLER EGD, 1991, J BIOL CHEM, V266, P9194
   BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0
   WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506
   ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   MEYER M, 1993, EMBO J, V12, P2005
   ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527
   GRIPPO JF, 1985, J BIOL CHEM, V260, P93
   BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005
   EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857
   RUSSEL M, 1986, J BIOL CHEM, V261, P4997
   CSEKE C, 1986, BIOCHIM BIOPHYS ACTA, V853, P43, DOI 10.1016/0304-4173(86)90004-2
   DYSON HJ, 1988, FEBS LETT, V228, P254, DOI 10.1016/0014-5793(88)80010-3
   FALKENSTEIN E, 1994, BBA-BIOENERGETICS, V1185, P252, DOI 10.1016/0005-2728(94)90218-6
   GALANG CK, 1993, MOL CELL BIOL, V13, P4609
   GLEASON FK, 1992, PROTEIN SCI, V1, P609
   GUEHMANN S, 1992, NUCLEIC ACIDS RES, V20, P2279, DOI 10.1093/nar/20.9.2279
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Kurooka H, 1996, INT IMMUNOL, V8, P961, DOI 10.1093/intimm/8.6.961
   KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591
   LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57
   MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780
   MORGAN BA, 1994, DEVELOPMENT, P181
   RIVIERAMADRID R, 1995, P NATL ACAD SCI USA, V92, P5620
   RUSSEL M, 1985, P NATL ACAD SCI USA, V82, P29, DOI 10.1073/pnas.82.1.29
   TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328
   vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3
   WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0
NR 40
TC 73
Z9 77
U1 0
U2 5
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0888-7543
J9 GENOMICS
JI Genomics
PD FEB 1
PY 1997
VL 39
IS 3
BP 331
EP 339
DI 10.1006/geno.1996.4493
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA WH109
UT WOS:A1997WH10900011
PM 9119370
ER

PT J
AU Paumen, MB
   Ishida, Y
   Muramatsu, M
   Yamamoto, M
   Honjo, T
AF Paumen, MB
   Ishida, Y
   Muramatsu, M
   Yamamoto, M
   Honjo, T
TI Inhibition of carnitine palmitoyltransferase I augments sphingolipid
   synthesis and palmitate-induced apoptosis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; ACYL-COA SYNTHETASE;
   SPHINGOMYELIN PATHWAY; FLOW-CYTOMETRY; FACTOR-ALPHA; RAT-HEART;
   CERAMIDE; EXPRESSION; PROTEIN
AB To identify cell death-induced genes, we employed a subtractive hybridization approach and isolated a cDNA encoding a mouse homolog of carnitine palmitoyltransferase I (CPT I), an enzyme that resides at the outer mitochondrial membrane and facilitates passage of long-chain fatty acids into mitochondria for beta-oxidation. Induced expression of CPT I mRNA was observed upon programmed cell death in the murine hematopoietic cell lines LyD9 and WEHI-231. To elucidate the role of CPT I in programmed cell death, we examined the effects of long-chain fatty acids and found that the addition of palmitate or stearate to cultured cells led to activation of a death program with a morphology resembling that of apoptosis. Other naturally occurring fatty acids, including myristate and palmitoleate, had no effect, Since both palmitate and stearate are sphingolipid precursors, the effect of these fatty acids on sphingolipid metabolism was tested, Our results indicate that apoptosis induced by palmitate or stearate is correlated with de novo synthesis of ceramide, Inhibition of CPT I by etomoxir enhanced palmitate-induced cell death and led to a further increase in ceramide synthesis.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR WANG E, 1991, J BIOL CHEM, V266, P14486
   ISHIDA Y, 1992, EMBO J, V11, P3887
   HANADA K, 1992, J BIOL CHEM, V267, P23527
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   KIM MY, 1991, J BIOL CHEM, V266, P484
   HANNUN YA, 1994, J BIOL CHEM, V269, P3125
   OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305
   MCGARRY JD, 1989, DIABETES METAB REV, V5, P271
   MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3
   LOZANO J, 1994, J BIOL CHEM, V269, P19200
   SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604
   WEIS BC, 1994, J BIOL CHEM, V269, P18712
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73
   Wyllie A H, 1980, Int Rev Cytol, V68, P251
   GOTTSCHALK AR, 1995, EUR J IMMUNOL, V25, P1032, DOI 10.1002/eji.1830250426
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   PUSHKAREVA M, 1995, IMMUNOL TODAY, V16, P294, DOI 10.1016/0167-5699(95)80184-7
   Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0
   TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3
   MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827
   BARTLETT K, 1984, BIOCHEM SOC T, V12, P688
   Britten R J, 1974, Methods Enzymol, V29, P363
   BROWN NF, 1995, J BIOL CHEM, V270, P8952
   ESSER V, 1993, J BIOL CHEM, V268, P5817
   GOLSTEIN P, 1995, CELL, V81, P185, DOI 10.1016/0092-8674(95)90327-5
   HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311
   KUBOTA M, 1989, JPN J EXP MED, V59, P59
   LANIER LL, 1981, J IMMUNOL, V126, P626
   MURTHY MSR, 1994, BIOCHEM J, V304, P31
   MURTHY MSR, 1994, J BIOL CHEM, V269, P18283
   Nakamura S, 1996, J BIOL CHEM, V271, P1255
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   PALACIOS R, 1987, EMBO J, V6, P3687
   RATHEISER K, 1991, METABOLISM, V40, P1185, DOI 10.1016/0026-0495(91)90214-H
   Sambrook J., 1989, MOL CLONING LAB MANU
   STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463
   SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4
   TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595
   TOMODA H, 1991, J BIOL CHEM, V266, P4214
   VANVELDHOVEN PP, 1995, BIOCHEM MOL BIOL INT, V36, P21
   White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1
NR 48
TC 259
Z9 262
U1 1
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 7
PY 1997
VL 272
IS 6
BP 3324
EP 3329
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA WG192
UT WOS:A1997WG19200032
PM 9013572
ER

PT J
AU Murakami, M
   Nakajima, K
   Yamazaki, K
   Muraguchi, T
   Serikawa, T
   Honjo, T
AF Murakami, M
   Nakajima, K
   Yamazaki, K
   Muraguchi, T
   Serikawa, T
   Honjo, T
TI Effects of breeding environments on generation and activation of
   autoreactive B-1 cells in anti-red blood cell autoantibody transgenic
   mice
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID AUTOIMMUNE HEMOLYTIC-ANEMIA; LY-1 B-CELLS; LIPOPOLYSACCHARIDES; DISEASE;
   LINEAGE
AB In anti-red blood cell autoantibody transgenic (autoAb Tg) mice almost all B cells are deleted except for B-l cells in the peritoneal cavity and the gut. About one-half of the auto Ab Tg mice suffer from autoimmune hemolytic anemia (AIHA) in the conventional condition. Oral administration of lipopolysaccharides activates B-l cells and induces autoimmune symptoms in the Tg mice, suggesting that the autoimmune disease in anti-RBC autoAb Tg mice is triggered by infections. To examine the association of bacterial infections with the generation of B-l cells and the occurrence of the autoimmune disease, we analyzed anti-RBC autoAb Tg mice bred in germ-free and specfic pathogen-free conditions. In germ-free conditions, few peritoneal B-l cells were detected, while a significant number of peritoneal B-l cells existed in specfic pathogen-free conditions. In both conditions, no mice suffered from AIHA. However, when these Tg mice were transferred to the conventional condition or injected with lipopolysaccharide, peritoneal B-l cells expanded and some of these mice suffered from AIHA. These results clearly showed that bacterial infections are responsible for both the expansion of B-l cells and the onset of the autoimmune disease in these Tg mice.
C1 KYOTO UNIV,DEPT MED CHEM,FAC MED,SAKYO KU,KYOTO 606,JAPAN.
   KYOTO UNIV,INST LAB ANIM,FAC MED,SAKYO KU,KYOTO 606,JAPAN.
CR HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1
   IZUI S, 1977, J EXP MED, V145, P1115, DOI 10.1084/jem.145.5.1115
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021
   FORSTER I, 1991, EUR J IMMUNOL, V21, P1779, DOI 10.1002/eji.1830210732
   GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z
   HARDY R, 1992, ANN NY ACAD SCI, V651, P99
   HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745
   LETER EH, 1990, ROLE MICROORGANISMS
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   MURAKAMI K, 1992, AUTOIMMUNITY, V12, P69, DOI 10.3109/08916939209146132
   MURAKAMI M, 1995, IMMUNOL TODAY, V16, P534, DOI 10.1016/0167-5699(95)80047-6
NR 17
TC 69
Z9 70
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD FEB 17
PY 1997
VL 185
IS 4
BP 791
EP 794
DI 10.1084/jem.185.4.791
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA WK038
UT WOS:A1997WK03800020
PM 9034157
ER

PT J
AU Paumen, MB
   Ishida, Y
   Han, H
   Muramatsu, M
   Eguchi, Y
   Tsujimoto, Y
   Honjo, T
AF Paumen, MB
   Ishida, Y
   Han, H
   Muramatsu, M
   Eguchi, Y
   Tsujimoto, Y
   Honjo, T
TI Direct interaction of the mitochondrial membrane protein carnitine
   palmitoyltransferase I with Bcl-2
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID PROGRAMMED CELL-DEATH; SPHINGOMYELIN PATHWAY; RAT-HEART; ACTIVATION;
   ISOFORM; SYSTEM
AB To demonstrate interaction between the mitochondrial membrane proteins CPT I and Bcl-2 the yeast two-hybrid system was used. Full-length CPT I was required for binding to Bcl-2. Direct protein interaction was confirmed in a GST binding assay and in coimmunoprecipitations using two different kinds of anti-Eel-2 antibodies. (C) 1997 Academic Press.
C1 OSAKA UNIV,SCH MED,BIOMED RES CTR,SUITA,OSAKA 565,JAPAN.
RP Paumen, MB (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5
   COHEN JJ, 1991, ADV IMMUNOL, V50, P55, DOI 10.1016/S0065-2776(08)60822-6
   OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305
   MCGARRY JD, 1989, DIABETES METAB REV, V5, P271
   KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3
   LOZANO J, 1994, J BIOL CHEM, V269, P19200
   KRAJEWSKI S, 1993, CANCER RES, V53, P4701
   WEIS BC, 1994, J BIOL CHEM, V269, P18712
   JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1
   Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0
   KAMADA S, 1995, CANCER RES, V55, P354
   BROWN NF, 1995, J BIOL CHEM, V270, P8952
   FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311
   KORSMEYER SJ, 1992, IMMUNOL TODAY, V13, P285, DOI 10.1016/0167-5699(92)90037-8
   MURTHY MSR, 1994, BIOCHEM J, V304, P31
   MURTHY MSR, 1994, J BIOL CHEM, V269, P18283
   Nunez Gabriel, 1994, Trends in Cell Biology, V4, P399, DOI 10.1016/0962-8924(94)90053-1
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   PALACIOS R, 1987, EMBO J, V6, P3687
   PAUMEN MB, 1997, IN PRESS J BIOL CHEM
NR 23
TC 58
Z9 59
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 24
PY 1997
VL 231
IS 3
BP 523
EP 525
DI 10.1006/bbrc.1997.6089
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA WK484
UT WOS:A1997WK48400001
PM 9070836
ER

PT J
AU delaPompa, J
   Wakeham, A
   Correia, KM
   Samper, E
   Brown, S
   Aguilera, RJ
   Nakano, T
   Honjo, T
   Mak, TW
   Rossant, J
   Conlon, RA
AF delaPompa, J
   Wakeham, A
   Correia, KM
   Samper, E
   Brown, S
   Aguilera, RJ
   Nakano, T
   Honjo, T
   Mak, TW
   Rossant, J
   Conlon, RA
TI Conservation of the Notch signalling pathway in mammalian neurogenesis
SO DEVELOPMENT
LA English
DT Article
DE mouse; neurogenesis; Notch pathway
ID DEVELOPING NERVOUS-SYSTEM; RBP-J-KAPPA; LOOP-HELIX PROTEIN; EGF-LIKE
   REPEATS; BINDING-PROTEIN; SPINAL-CORD; DROSOPHILA HOMOLOG; GENE-DELTA;
   CELL FATE; MOLECULAR CHARACTERIZATION
AB The Notch pathway functions in multiple cell fate determination processes in invertebrate embryos, including the decision between the neuroblast and epidermoblast lineages in Drosophila, In the mouse, targeted mutation of the Notch pathway genes Notch1 and RBP-Jk has demonstrated a role for these genes in somite segmentation, but a function in neurogenesis and in cell fate decisions has not been shown. Here we show that these mutations lead to altered expression of the Notch signalling pathway homologues Hes-5, Mash-1 and Dll1, resulting in enhanced neurogenesis, Precocious neuronal differentiation is indicated by the expanded expression domains of Math4A, neuroD and NSCL-1. The RBP-Jk mutation has stronger effects on expression of these genes than does the Notch1 mutation, consistent with functional redundancy of Notch genes in neurogenesis. Our results demonstrate conservation of the Notch pathway and its regulatory mechanisms from fly to mouse, and support a role for the murine Notch signalling pathway in the regulation of neural stem cell differentiation.
C1 UNIV TORONTO,ONTARIO CANC INST,TORONTO,ON M5G 2C1,CANADA.
   UNIV TORONTO,DEPT MED BIOPHYS,TORONTO,ON M5G 2C1,CANADA.
   UNIV TORONTO,DEPT IMMUNOL,TORONTO,ON M5G 2C1,CANADA.
   CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106.
   UNIV CALIF LOS ANGELES,DEPT MOL CELL & DEV BIOL,LOS ANGELES,CA.
   KYOTO UNIV,FAC MED,DEPT MED CHEM,KYOTO 606,JAPAN.
   MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA.
   UNIV TORONTO,DEPT MOL & MED GENET,TORONTO,ON,CANADA.
   UNIV TORONTO,DEPT OBSTET & GYNECOL,TORONTO,ON,CANADA.
RP delaPompa, J (reprint author), AMGEN INST,620 UNIV AVE,TORONTO,ON M5G 2C1,CANADA.
RI De La Pompa Minguez, Jose Luis/F-9719-2014
OI De La Pompa Minguez, Jose Luis/0000-0001-6761-7265
CR SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620
   BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38
   AUSTIN CP, 1995, DEVELOPMENT, V121, P3637
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6
   NYE JS, 1994, DEVELOPMENT, V120, P2421
   VASSIN H, 1987, EMBO J, V6, P3431
   Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136
   MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y
   Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5
   AKAZAWA C, 1992, J BIOL CHEM, V267, P21879
   FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188
   HARTENSTEIN V, 1989, NEURON, V3, P399, DOI 10.1016/0896-6273(89)90200-6
   GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W
   HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   OKA C, 1995, DEVELOPMENT, V121, P3291
   WEINMASTER G, 1991, DEVELOPMENT, V113, P199
   REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S
   HARTENSTEIN V, 1993, J COMP NEUROL, V328, P213, DOI 10.1002/cne.903280205
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930
   Heitzler P, 1996, DEVELOPMENT, V122, P161
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0
   CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0
   Greenwald Iva, 1994, Current Opinion in Genetics and Development, V4, P556, DOI 10.1016/0959-437X(94)90072-B
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609
   LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368
   Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069
   Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   SKEATH JB, 1992, DEVELOPMENT, V114, P939
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   MAIER CE, 1995, DEV NEUROSCI-BASEL, V17, P149, DOI 10.1159/000111283
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Campos-Ortega Jose A., 1993, P1091
   CONLON RA, 1993, METHOD ENZYMOL, V225, P373
   DELAMO FF, 1992, DEVELOPMENT, V115, P737
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   Gho M, 1996, DEVELOPMENT, V122, P1673
   GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J
   HALL R, 1984, NATURE, V311, P379, DOI 10.1038/311379a0
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   JENNINGS B, 1995, DEVELOPMENT, V121, P3745
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KLAEMBT C, 1989, EMBO J, V8, P203
   KOOP KE, 1996, IN PRESS MECH DEV
   KUNISCH M, 1994, P NATL ACAD SCI USA, V91, P10139, DOI 10.1073/pnas.91.21.10139
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   LECOURTOIS M, 1995, GENE DEV, V9, P2698
   LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4
   LEHMANN R, 1981, Wilhelm Roux's Archives of Developmental Biology, V190, P226, DOI 10.1007/BF00848307
   MCCONNELL JA, 1981, J COMP NEUROL, V200, P273, DOI 10.1002/cne.902000207
   MIRANDA GA, 1995, EXP CELL RES, V217, P294, DOI 10.1006/excr.1995.1090
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6
   TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342
   TECHNAU GM, 1986, ROUX ARCH DEV BIOL, V195, P445, DOI 10.1007/BF00375748
   TRUMPP A, 1992, GENE DEV, V6, P14, DOI 10.1101/gad.6.1.14
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
   WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8
NR 69
TC 430
Z9 435
U1 0
U2 5
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD MAR
PY 1997
VL 124
IS 6
BP 1139
EP 1148
PG 10
WC Developmental Biology
SC Developmental Biology
GA WR186
UT WOS:A1997WR18600005
PM 9102301
ER

PT J
AU Minoguchi, S
   Taniguchi, Y
   Kato, H
   Okazaki, T
   Strobl, LJ
   ZimberStrobl, U
   Bornkamm, GW
   Honjo, T
AF Minoguchi, S
   Taniguchi, Y
   Kato, H
   Okazaki, T
   Strobl, LJ
   ZimberStrobl, U
   Bornkamm, GW
   Honjo, T
TI RBP-L, a transcription factor related to RBP-J kappa
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID EPSTEIN-BARR-VIRUS; SIGNAL-BINDING-PROTEIN; SPLIT COMPLEX GENES; NUCLEAR
   ANTIGEN-2; DROSOPHILA HOMOLOG; MOUSE HOMOLOG; NOTCH GENE; NEUROGENIC
   GENE; MAMMALIAN NOTCH; CIS-ELEMENT
AB RBP-J kappa is a sequence-specific DNA binding protein which plays a central role in signalling downstream of the Notch receptor by physically interacting with its intracellular region. Although at least four Notch genes exist in mammals, it is unknown whether each Notch requires a specific downstream signalling molecule. Here we report isolation and characterization of a mouse RBP-J kappa-related gene named RBP-L that is expressed almost exclusively in lung, in contrast to the ubiquitous expression of RBP-J kappa. For simplicity, we propose to call RBP-J kappa RBP-J. The RBP-L protein bound to a DNA sequence almost identical to that of RBP-J. Surprisingly, RBP-L did not interact with any of the known four mouse Notch proteins. Although we found that RBP-L and EBNA-2 cooperated in transcriptional activation, they did not show significantly strong protein-protein interaction that can be detected by several in vivo and in vitro assays. This is again in contrast to physical association of RBP-J with EBNA-2. Several models to explain functional interaction between RBP-L and EBNA-2 are discussed.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
   GSF FORSCHUNGSZENTRUM UMWELT & GESUNDHEIT,INST MOL BIOL & TUMORGENET,D-81377 MUNICH,GERMANY.
RI Taniguchi, Yoshihito/L-5746-2013
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407
   Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0
   SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517
   COHEN JI, 1989, P NATL ACAD SCI USA, V86, P9558, DOI 10.1073/pnas.86.23.9558
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   ZIMBERSTROBL U, 1993, EMBO J, V12, P167
   WALTZER L, 1994, EMBO J, V13, P5633
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197
   LAUX G, 1994, J VIROL, V68, P6947
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   OKA C, 1995, DEVELOPMENT, V121, P3291
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   WEINMASTER G, 1991, DEVELOPMENT, V113, P199
   LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777
   WOISETSCHLAEGER M, 1991, P NATL ACAD SCI USA, V88, P3942, DOI 10.1073/pnas.88.9.3942
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Christensen S, 1996, DEVELOPMENT, V122, P1373
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1994, JPN J GENET, V69, P701, DOI 10.1266/jjg.69.701
   FURUKAWA T, 1991, J BIOL CHEM, V266, P2334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   HSIEH L, 1996, MOL CELL BIOL, V16, P952
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KANG T, 1993, J BIOL CHEM, V268, P9629
   LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   SAKAI T, 1995, J BIOCH, V118, P6210
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
   YALAMANCHILI R, 1994, VIROLOGY, V204, P634, DOI 10.1006/viro.1994.1578
NR 61
TC 92
Z9 93
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD MAY
PY 1997
VL 17
IS 5
BP 2679
EP 2687
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA WV199
UT WOS:A1997WV19900035
PM 9111338
ER

PT J
AU Aoki, T
   Koike, T
   Nakano, T
   Shibahara, K
   Nishimura, H
   Kikuchi, H
   Honjo, T
AF Aoki, T
   Koike, T
   Nakano, T
   Shibahara, K
   Nishimura, H
   Kikuchi, H
   Honjo, T
TI Rat TAFII(31) gene is induced upon programmed cell death in
   differentiated PC12 cells deprived of NGF
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID GROWTH-FACTOR DEPRIVATION; TRANSCRIPTIONAL ACTIVATION; MESSENGER-RNA;
   P53 PROTEIN; COMPLEX; MDM-2; BAX
AB Typical programmed cell death (PCD) requires de novo macromolecular synthesis and shares common morphological changes referred to as apoptosis, To elucidate the molecular mechanism of apoptosis, we isolated cDNA clones that are induced in differentiated PC12 cells deprived of NGF by differential display method. Among such clones, homology searches revealed that the one clone encodes the rat TATA-binding-protein-associated factor TAFII(31), a component of TFIID, and a transcriptional coactivator of the p53 protein. Northern analysis of various organs in human showed one band in heart, brain, skeletal muscle and pancreas, whose size is similar to 1.1 kb which identical to that of human TAFII(31) mRNA, although the size of rat human TAPII(31) mRNAs similar to 2.7 kb. The deduced amino acid sequence of the rat TAFII(31) was 77% identical to that of the human TAFII(31). Northern analysis of various organs in adult mice showed that expression levels of TAFII(31) mRNA were strong in heart but weak in spleen, although this gene is ubiquitously expressed. (C) 1997 Academic Press.
C1 KYOTO UNIV,FAC MED,DEPT NEUROSURG,SAKYO KU,KYOTO 606,JAPAN.
   HOKKAIDO UNIV,GRAD PROGRAM BIOL SCI,SAPPORO,HOKKAIDO 060,JAPAN.
RP Aoki, T (reprint author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235
   COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175
   TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5
   THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597
   MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R
   MIYASHITA T, 1995, CELL, V80, P293
   LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   HARPER JW, 1993, CELL, V75, P805
   KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421
   SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727
   Aoki T, 1997, J BIOCHEM-TOKYO, V121, P122
   KOIKE T, 1992, PROG NEURO-PSYCHOPH, V16, P95
   MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Sambrook J., 1989, MOL CLONING LAB MANU
   Goodrich James A., 1994, Current Opinion in Cell Biology, V6, P403, DOI 10.1016/0955-0674(94)90033-7
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
NR 20
TC 7
Z9 8
U1 2
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 8
PY 1997
VL 234
IS 1
BP 230
EP 234
DI 10.1006/bbrc.1997.6610
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA WZ565
UT WOS:A1997WZ56500046
PM 9168994
ER

PT J
AU Yabe, D
   Nakamura, T
   Kanazawa, N
   Tashiro, K
   Honjo, T
AF Yabe, D
   Nakamura, T
   Kanazawa, N
   Tashiro, K
   Honjo, T
TI Calumenin, a Ca2+-binding protein retained in the endoplasmic reticulum
   with a novel carboxyl-terminal sequence, HDEF
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CALCIUM-BINDING PROTEIN; GLUCOSE-REGULATED PROTEIN; LUMINAL ER PROTEINS;
   SARCOPLASMIC-RETICULUM; MOLECULAR-CLONING; RECEPTOR; CALRETICULIN;
   RETENTION; MEMBRANE; SIGNAL
AB We have identified and characterized a cDNA encoding a novel Ca2+-binding protein named calumenin from mouse heart by the signal sequence trap method, The deduced amino acid sequence (315 residues) of calumenin contains an amino-terminal signal sequence and sis Ca2+-binding (EF-hand) motifs and shows homology with reticulocalbin, Erc-55, and Cab45. These proteins seem to form a new subset of the EF-hand protein family expressed in the lumen of the endoplasmic reticulum (ER) and Golgi apparatus. Purified calumenin had Ca2+-binding ability. The carboxyl-terminal tetrapeptide His-Asp-Glu-Phe was shown to be responsible far retention of calumenin in ER by the retention assay, immunostaining with a confocal laser microscope, and the deglycosylation assay, This is the first report indicating that the Phe residue is included in the ER retention signal, Calumenin is expressed most strongly in heart of adult and 18.5-day embryos. The calumenin gene (Calu) was mapped at the proximal portion of mouse chromosome 7.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Yabe, Daisuke/J-6682-2014; 
OI Yabe, Daisuke/0000-0002-5334-7687; Kanazawa, Nobuo/0000-0003-3000-9711
CR AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315
   ANDRES DA, 1990, J BIOL CHEM, V265, P5952
   ANDRES DA, 1991, J BIOL CHEM, V266, P14277
   ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015
   WADA I, 1995, J BIOL CHEM, V270, P20298
   BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6
   Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257
   BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558
   LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8
   CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774
   MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511
   OZAWA M, 1993, J BIOL CHEM, V268, P699
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847
   OBRIG TG, 1971, J BIOL CHEM, V246, P174
   LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F
   KOCH GLE, 1990, BIOESSAYS, V12, P527, DOI 10.1002/bies.950121105
   NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741
   EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0
   VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   PELHAM HRB, 1988, EMBO J, V7, P1757
   IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033
   DANG CV, 1985, J BIOL CHEM, V260, P9713
   FLIEGEL L, 1989, J BIOL CHEM, V264, P21522
   SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189
   BRILLIANT MH, 1994, MAMM GENOME, V5, pS104
   BRINK PA, 1995, CIRCULATION, V91, P1633
   CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5
   CHIESI M, 1981, J CELL BIOL, V91, P728, DOI 10.1083/jcb.91.3.728
   Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
   DODDS D, 1995, J NEUROCHEM, V64, P2339
   FREEDMAN RB, 1989, BIOCHEM SOC SYMP, V55, P167
   GANIM JR, 1992, CIRC RES, V71, P1021
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   JACOBS K, 1996, Patent No. 5536637
   KAUFAMN MH, 1992, ATLAS MOUSE DEV, P47
   KAWASAKI T, 1994, BIOCHEM BIOPH RES CO, V199, P1120, DOI 10.1006/bbrc.1994.1347
   Kretsinger R H, 1980, Ann N Y Acad Sci, V356, P14, DOI 10.1111/j.1749-6632.1980.tb29594.x
   LODISH HF, 1990, J BIOL CHEM, V265, P10893
   MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089
   MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875
   MELNICK J, 1992, J BIOL CHEM, V267, P21303
   MOORMAN AFM, 1995, CIRC RES, V76, P616
   MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9
   NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872
   OHTA T, 1995, J BIOL CHEM, V270, P15571
   SEMENZA JC, 1992, J MOL BIOL, V224, P1, DOI 10.1016/0022-2836(92)90571-Z
   SORGER PK, 1987, J MOL BIOL, V194, P341, DOI 10.1016/0022-2836(87)90380-9
   TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325
   WEIS K, 1994, J BIOL CHEM, V269, P19142
   WIKSTROM L, 1993, J BIOL CHEM, V268, P14412
   WILEMAN T, 1991, J BIOL CHEM, V266, P4500
NR 54
TC 78
Z9 80
U1 1
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 18
PY 1997
VL 272
IS 29
BP 18232
EP 18239
DI 10.1074/jbc.272.29.18232
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA XL735
UT WOS:A1997XL73500050
PM 9218460
ER

PT J
AU Kato, H
   Taniguchi, Y
   Kurooka, H
   Minoguchi, S
   Sakai, T
   NomuraOkazaki, S
   Tamura, K
   Honjo, T
AF Kato, H
   Taniguchi, Y
   Kurooka, H
   Minoguchi, S
   Sakai, T
   NomuraOkazaki, S
   Tamura, K
   Honjo, T
TI Involvement of RBP-J in biological functions of mouse Notch1 and its
   derivatives
SO DEVELOPMENT
LA English
DT Article
DE RBP-J; RAM domain; transactivation; differentiation suppression; mouse;
   Notch
ID J-KAPPA; TRANSCRIPTION FACTOR; CELL FATE; SUPPRESSOR; HAIRLESS;
   RECEPTOR; GENE; HOMOLOG; MYOGENESIS; NEOPLASMS
AB Notch is involved in the cell fate determination of many cell lineages, The intracellular region (RAMIC) of Notch1 transactivates genes by interaction with a DNA binding protein RBP-J. We have compared the activities of mouse RAMIC and its derivatives in transactivation and differentiation suppression of myogenic precursor cells, RAMIC comprises two separate domains, IC for transactivation and RAM for RBP-J binding. Although the physical interaction of IC with RBP-J was much weaker than with RAM, transactivation activity of IC was shown to involve RBP-J by using an RBP-J null mutant cell line. IC showed differentiation suppression activity that was generally comparable to its transactivation activity, The RBP-J-VP16 fusion protein, which has strong transactivation activity, also suppressed myogenesis of C2C12. The RAM domain, which has no other activities than binding to RBP-J, synergistically stimulated transactivation activity of IC to the level of RAMIC, The RAM domain was proposed to compete with a putative co-repressor for binding to RBP-J because the RAM domain can also stimulate the activity of RBP-J-VP16, These results taken together, indicate that differentiation suppression of myogenic precursor cells by Notch signalling is due to transactivation of genes carrying RBP-J binding motifs.
C1 KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.
RI Taniguchi, Yoshihito/L-5746-2013
CR Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283
   JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096
   Wettstein DA, 1997, DEVELOPMENT, V124, P693
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0
   NYE JS, 1994, DEVELOPMENT, V120, P2421
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   OKA C, 1995, DEVELOPMENT, V121, P3291
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Shawber C, 1996, DEVELOPMENT, V122, P3765
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KANG T, 1993, J BIOL CHEM, V268, P9629
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   MONOGUCHI S, 1997, IN PRESS MOL CELL BI
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621
   STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O
   Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939
NR 33
TC 220
Z9 222
U1 0
U2 0
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD OCT
PY 1997
VL 124
IS 20
BP 4133
EP 4141
PG 9
WC Developmental Biology
SC Developmental Biology
GA YE934
UT WOS:A1997YE93400020
PM 9374409
ER

PT J
AU Nakamura, T
   Yabe, D
   Honjo, T
AF Nakamura, T
   Yabe, D
   Honjo, T
TI Molecular cloning and characterization of a novel cytokine obtained from
   the murine embryonic heart
SO CIRCULATION
LA English
DT Meeting Abstract
C1 KYOTO UNIV,KYOTO 606,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT 21
PY 1997
VL 96
IS 8
SU S
BP 2368
EP 2368
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA YC880
UT WOS:A1997YC88002356
ER

PT J
AU Murakami, M
   Honjo, T
AF Murakami, M
   Honjo, T
TI Transgenic mouse models for B-cell dominant autoimmune diseases
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID MYASTHENIA-GRAVIS; HEMOLYTIC-ANEMIA; LY-1 B; ACETYLCHOLINE-RECEPTOR; DNA
   ANTIBODY; B-1 CELLS; MICE; AUTOANTIBODY; TOLERANCE; ENCEPHALOMYELITIS
AB To study the molecular mechanism for the development of B-cell dominant autoimmune diseases, several autoantibody transgenic mouse models were established. These studies have revealed that the escape of autoreactive B cells from clonal deletion or functional inactivation (clonal anergy) alone is not enough to develop autoimmune disease. Indeed, additional factors such as infections, cytokines and the costimulatory help of T cells are required for the activation of autoreactive B cells. The requirement for activation of autoreactive clones is also shown for the development of T-cell dominant autoimmune diseases in a T-cell receptor transgenic model. These findings will clarify the two-step mechanism of autoimmune disease: appearance and activation of autoreactive lymphocytes.
C1 Kyoto Univ, Fac Med, Dept Internal Med 2, Sakou Ku, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakou Ku, Kyoto 606, Japan.
RP Murakami, M (reprint author), Kyoto Univ, Fac Med, Dept Internal Med 2, Sakou Ku, 54 Kawahara Cho, Kyoto 606, Japan.
EM mmurakam@kuhp.kyoto-u.ac.jp
CR TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5
   LINDSTROM JM, 1976, NEUROLOGY, V26, P1054
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3
   LINDSTROM J, 1988, ADV IMMUNOL, V42, P233, DOI 10.1016/S0065-2776(08)60847-0
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   Zhang GX, 1996, J EXP MED, V184, P349, DOI 10.1084/jem.184.2.349
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791
   FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7
   LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   TSAO BP, 1992, J IMMUNOL, V149, P350
   CROSS AH, 1995, J CLIN INVEST, V95, P2783, DOI 10.1172/JCI117982
   Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264
   Balasa B, 1997, J EXP MED, V186, P385, DOI 10.1084/jem.186.3.385
   CHEN C, 1994, J IMMUNOL, V152, P1970
   COMALL RJ, 1995, CURR OPIN IMMUNOL, V7, P804
   GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999
   GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z
   GU DL, 1995, J EXP MED, V181, P547, DOI 10.1084/jem.181.2.547
   HE XW, 1993, ARTHRITIS RHEUM, V36, P1061, DOI 10.1002/art.1780360806
   HIROHATA S, 1991, CELL IMMUNOL, V138, P445, DOI 10.1016/0008-8749(91)90168-B
   ISENBERG D, 1990, J AUTOIMMUN, V3, P393, DOI 10.1016/S0896-8411(05)80008-3
   IZUI S, 1994, CURR OPIN IMMUNOL, V6, P926, DOI 10.1016/0952-7915(94)90015-9
   KOPF M, 1996, IMMUNITY, V4, P501
   LININGTON C, 1993, J AUTOIMMUN, V3, P501
   Link J, 1994, Acta Neurol Scand Suppl, V158, P1
   Ma J, 1996, J IMMUNOL, V157, P417
   OFFEN D, 1992, P NATL ACAD SCI USA, V89, P8332, DOI 10.1073/pnas.89.17.8332
   PISETSKY DS, 1990, J CLIN INVEST, V85, P899, DOI 10.1172/JCI114517
   Velupillai P, 1996, INFECT IMMUN, V64, P4557
   VINCENT A, 1980, J NEUROL NEUROSUR PS, V43, P590, DOI 10.1136/jnnp.43.7.590
   WILLCOX N, 1993, CURR OPIN IMMUNOL, V5, P910, DOI 10.1016/0952-7915(93)90105-2
NR 38
TC 17
Z9 18
U1 1
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON W1P 6LB, ENGLAND
SN 0952-7915
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD DEC
PY 1997
VL 9
IS 6
BP 846
EP 850
DI 10.1016/S0952-7915(97)80188-4
PG 5
WC Immunology
SC Immunology
GA YW017
UT WOS:000071887300013
PM 9492988
ER

PT J
AU Nisitani, S
   Murakami, M
   Akamizu, T
   Okino, T
   Ohmori, K
   Mori, T
   Imamura, M
   Honjo, T
AF Nisitani, S
   Murakami, M
   Akamizu, T
   Okino, T
   Ohmori, K
   Mori, T
   Imamura, M
   Honjo, T
TI Preferential localization of human CD5(+) B cells in the peritoneal
   cavity
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID AUTOIMMUNE HEMOLYTIC-ANEMIA; PERIPHERAL-BLOOD; T-LYMPHOCYTES; B-1 CELLS;
   LY-1 B; LINEAGES; CD5+; MICE; ANTIBODIES; EXPRESSION
AB In a transgenic mouse model of autoimmune haemolytic anaemia, CD5(+) B lymphocytes localized in the peritoneal cavity are shown to play an important role in the onset of autoimmune disease. The authors have examined whether CD5(+) B cells are present in the peritoneal cavity of 12 human individuals with noninvasive gastrointestinal tumours and found that in humans CD5(+) B cells preferentially lodge in the peritoneal cavity as compared to the peripheral blood and spleen while the numbers of the peritoneal B lymphocytes in humans are much lower than in mice and vary widely between individuals.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Lab Med, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Med & Clin Sci, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Surg & Surg Basic Sci, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
CR BOFILL M, 1985, J IMMUNOL, V134, P1531
   HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057
   CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.immunol.7.1.513
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   Casali P, 1996, CURR TOP MICROBIOL, V210, P167
   WELLS SM, 1994, J IMMUNOL, V153, P5503
   KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   KROESE FGM, 1992, ANN NY ACAD SCI, V651, P44
   HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213
   TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8
   SOLVASON N, 1992, J EXP MED, V175, P397, DOI 10.1084/jem.175.2.397
   DUTRA WO, 1994, INT IMMUNOL, V6, P499, DOI 10.1093/intimm/6.4.499
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243
   Calvert J E, 1988, Autoimmunity, V1, P223, DOI 10.3109/08916938808997167
   GADOL N, 1986, IMMUNOL REV, V93, P25
   HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x
   HARTMANN J, 1995, EUR J IMMUNOL, V25, P2626, DOI 10.1002/eji.1830250933
   Ishida Y, 1989, Int Immunol, V1, P113, DOI 10.1093/intimm/1.2.113
   KIPPS TJ, 1989, ADV IMMUNOL, V47, P115
   KROEMER G, 1993, ADV IMMUNOL, V53, P157, DOI 10.1016/S0065-2776(08)60500-3
   MORIKAWA K, 1993, INT IMMUNOL, V5, P809, DOI 10.1093/intimm/5.8.809
   PLATERZYBERK C, 1992, ANN NY ACAD SCI, V651, P540
   REIJNHART RM, 1994, IMMUNOBIOLOGY, V191, P1
   SPIRA TJ, 1992, ANN NY ACAD SCI, V651, P591
   TALAL N, 1992, ANN NY ACAD SCI, V651, P551
NR 31
TC 26
Z9 26
U1 0
U2 1
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0300-9475
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD DEC
PY 1997
VL 46
IS 6
BP 541
EP 545
DI 10.1046/j.1365-3083.1997.d01-166.x
PG 5
WC Immunology
SC Immunology
GA YN864
UT WOS:000071216000002
PM 9420615
ER

PT J
AU Taniguchi, Y
   Furukawa, T
   Tun, T
   Han, H
   Honjo, T
AF Taniguchi, Y
   Furukawa, T
   Tun, T
   Han, H
   Honjo, T
TI LIM protein KyoT2 negatively regulates transcription by association with
   the RBP-J DNA-binding protein
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID RECOMBINATION SIGNAL SEQUENCE; BARR-VIRUS EBNA2; ALTERNATIVE CELL FATES;
   J-KAPPA; DROSOPHILA HOMOLOG; SOLUBLE FORMS; MOUSE HOMOLOG; HAIRLESS;
   GENE; SUPPRESSOR
AB The RBP-J/Su(H) DNA-binding protein plays a key role in transcriptional regulation by targeting Epstein-Barr virus nuclear antigen 2 (EBNA2) and the intracellular portions of Notch receptors to specific promoters, Using the yeast two-hybrid system, we isolated a LIM-only protein, KyoT, which physically interacts with RBP-J, Differential splicing gave rise to two transcripts of the KyoT gene, KyoT1 and KyoT2, that encoded proteins with four and two LIM domains, respectively, With differential splicing resulting in deletion of an exon, KyoT2 lacked two LIM domains from the C terminus and had a frameshift in the last exon, creating the RBP-J-binding region in the C terminus, KyoT1 had a negligible level of interaction with RBP-J, Strong expression of KyoT mRNAs was detected in skeletal muscle and lung, with a predominance of KyoT1 mRNA, When expressed in F9 embryonal carcinoma cells, KyoT1 and KyoT2 were localized in the cytoplasm and the nucleus, respectively, The binding site of KyoT2 on RBP-J overlaps those of EBNA2 and Notch1 but is distinct from that of Hairless, the negative regulator of RBP-J-mediated transcription in Drosophila. KyoT2 but not KyoT1 repressed the RBP-J-mediated transcriptional activation by EBNA2 and Notch1 by competing with them for binding to RBP-J and by dislocating RBP-J from DNA, KyoT2 is a novel negative regulatory molecule for RBP-J-mediated transcription in mammalian systems.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RI Taniguchi, Yoshihito/L-5746-2013
CR ABRAMOVICH C, 1994, FEBS LETT, V338, P295, DOI 10.1016/0014-5793(94)80287-4
   AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   WADMAN I, 1994, EMBO J, V13, P4831
   SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F
   WALTZER L, 1994, EMBO J, V13, P5633
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   LING PD, 1995, J VIROL, V69, P1944
   BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   CASCINO I, 1995, J IMMUNOL, V154, P2706
   OKA C, 1995, DEVELOPMENT, V121, P3291
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598
   WANG F, 1991, J VIROL, V65, P4101
   CHUA AO, 1995, J IMMUNOL, V155, P4286
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   BACH MA, 1990, MOL ENDOCRINOL, V4, P899
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433
   BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491
   ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G
   BAFLEY AM, 1995, GENE DEV, V9, P2609
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4
   DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FENG LL, 1994, J BIOL CHEM, V269, P2342
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   GARCIA IS, 1995, ONCOGENE, V10, P1301
   GARCIA LS, 1994, TRENDS GENET, V10, P315
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   Morgan MJ, 1996, BIOCHEM BIOPH RES CO, V225, P632, DOI 10.1006/bbrc.1996.1222
   ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q
   ROSE WH, 1996, TRENDS GENET, V12, P229
   SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621
   SAKAI T, UNPUB
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   Tsakonas SA, 1995, SCIENCE, V268, P225
   TSANG SF, 1991, J VIROL, V65, P6765
   ZHOU W, 1994, DNA CELL BIOL, V13, P605, DOI 10.1089/dna.1994.13.605
   Zimber Strobl U, 1993, EMBO J, V12, P167
NR 56
TC 126
Z9 135
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JAN
PY 1998
VL 18
IS 1
BP 644
EP 654
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA YN687
UT WOS:000071195700064
PM 9418910
ER

PT J
AU Winkler, C
   Modi, W
   Smith, MW
   Nelson, GW
   Wu, XY
   Carrington, M
   Dean, M
   Honjo, T
   Tashiro, K
   Yabe, D
   Buchbinder, S
   Vittinghoff, E
   Goedert, JJ
   O'Brien, TR
   Jacobson, LP
   Detels, R
   Donfield, S
   Willoughby, A
   Gomperts, E
   Vlahov, D
   Phair, J
   O'Brien, SJ
AF Winkler, C
   Modi, W
   Smith, MW
   Nelson, GW
   Wu, XY
   Carrington, M
   Dean, M
   Honjo, T
   Tashiro, K
   Yabe, D
   Buchbinder, S
   Vittinghoff, E
   Goedert, JJ
   O'Brien, TR
   Jacobson, LP
   Detels, R
   Donfield, S
   Willoughby, A
   Gomperts, E
   Vlahov, D
   Phair, J
   O'Brien, SJ
CA ALIVE Study
   Hemophilia Growth Dev Study
   Multicenter AIDS Cohort Study
   Multicenter Hemophilia Cohort Study
   San Francisco City Cohort
TI Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene
   variant
SO SCIENCE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 INFECTION; TYPE-1 INFECTION;
   PROGRESSION; RECEPTORS; RESISTANCE; INDIVIDUALS; COFACTOR; DISEASE;
   ENTRY
AB Stromal-derived factor (SDF-1) is the principal ligand for CXCR4, a coreceptor with CD4 for T lymphocyte cell line-tropic human immunodeficiency virus-type 1 (HIV-1). A common polymorphism, SDF1-3'A, was identified in an evolutionarily conserved segment of the 3' untranslated region of the SDF-1 structural gene transcript. In the homozygous state, SDF1-3'A/3'A delays the onset of acquired immunodeficiency syndrome (AIDS), according to a genetic association analysis of 2857 patients enrolled in five AIDS cohort studies. The recessive protective effect of SDF1-3'A was increasingly pronounced in individuals infected with HIV-1 for longer periods, was twice as strong as the dominant genetic restriction of AIDS conferred by CCR5 and CCR2 chemokine receptor variants in these populations, and was complementary with these mutations in delaying the onset of AIDS.
C1 NCI, Lab Genom Divers, Frederick, MD 21702 USA.
   NCI, Sci Applicat Int Corp, Frederick, MD 21702 USA.
   Kyoto Univ, Dept Med Chem, Kyoto 606, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 606, Japan.
   Dept Publ Hlth, AIDS Off, San Francisco, CA 94102 USA.
   NCI, Viral Epidemiol Branch, Bethesda, MD 20892 USA.
   Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, CAMACS, Baltimore, MD 21205 USA.
   Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Ctr Hlth Sci, Los Angeles, CA 90095 USA.
   Rho Inc, Chapel Hill, NC 27514 USA.
   NICHHD, Ctr Res Mothers & Children, Bethesda, MD 20892 USA.
   Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.
   Northwestern Univ, Sch Med, Comprehens AIDS Ctr, Chicago, IL 60611 USA.
RP O'Brien, SJ (reprint author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.
RI Smith, Michael/B-5341-2012; Dean, Michael/G-8172-2012; Yabe,
   Daisuke/J-6682-2014
OI Dean, Michael/0000-0003-2234-0631; Yabe, Daisuke/0000-0002-5334-7687
CR ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453
   WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8
   Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959
   Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338
   KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0
   BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014
   OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1
   Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240
   Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412
   COX DR, 1972, J R STAT SOC B, V34, P187
   Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8
   SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180
   Michael NL, 1997, NAT MED, V3, P1160, DOI 10.1038/nm1097-1160
   Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856
   Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621
   ROOS MTL, 1992, J INFECT DIS, V165, P427
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   DSouza MP, 1996, NAT MED, V2, P1293, DOI 10.1038/nm1296-1293
   Theodorou I, 1997, LANCET, V349, P1219
   Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
   Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139
   Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6
   SCHUITEMAKER H, 1992, J VIROL, V66, P1354
   Zimmerman PA, 1997, MOL MED, V3, P23
   ASJO B, 1986, LANCET, V2, P660
   Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252
   BLUEL CC, 1996, NATURE, V382, P829
   BLUEL CC, 1996, J EXP MED, V184, P1101
   Cohen OJ, 1997, J CLIN INVEST, V100, P1581, DOI 10.1172/JCI119682
   CONNOR RI, 1993, J VIROL, V67, P1772
   COX DR, 1984, ANAL SURVIVAL DATA, P36
   Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0
   Detels R, 1996, AIDS, V10, P102, DOI 10.1097/00002030-199601000-00016
   DETELS R, 1994, J ACQ IMMUN DEF SYND, V7, P1263
   Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
   GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701
   HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208
   KUBE D, 1995, CYTOKINE, V7, P107
   LEDERMAN MM, 1995, J INFECT DIS, V172, P228
   LUI KJ, 1988, SCIENCE, V240, P1333, DOI 10.1126/science.3163848
   MARUBINI E, 1995, ANAL SURVIVAL DATA C, P160
   McNicholl JM, 1997, EMERG INFECT DIS, V3, P261
   MOGOWAN KM, 1997, J BIOL CHEM, V272, P1331
   PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490
   PRMACK BA, 1996, NAT MED, V2, P1174
   RAVNIKGLAVAC M, 1994, HUM MOL GENET, V3, P801, DOI 10.1093/hmg/3.5.801
   Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0
   Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1
   SCHUITEMAKER H, 1991, J VIROL, V65, P356
   Smith MW, 1997, NAT MED, V3, P1052, DOI 10.1038/nm1097-1052c
   Tsai KC, 1997, J NEUROSCI, V17, P1950
   *US CDC, 1987, MORB MORTAL WKLY S1, V36
   *US CDC, 1992, MORB MORTAL WKLY S1, V41
   VLAHOV D, 1991, NIDA RES MONOGRAPH S, V103
   Weiss RA, 1996, SCIENCE, V272, P1885, DOI 10.1126/science.272.5270.1885
NR 62
TC 557
Z9 582
U1 2
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD JAN 16
PY 1998
VL 279
IS 5349
BP 389
EP 393
DI 10.1126/science.279.5349.389
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA YT158
UT WOS:000071570800048
PM 9430590
ER

PT J
AU Mohan, WS
   Chen, ZQ
   Zhang, X
   Khalili, K
   Honjo, T
   Deeley, RG
   Tam, SP
AF Mohan, WS
   Chen, ZQ
   Zhang, X
   Khalili, K
   Honjo, T
   Deeley, RG
   Tam, SP
TI Human S mu binding protein-2 binds to the drug response element and
   transactivates the human apoA-I promoter: role of gemfibrozil
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE apolipoprotein A-I; gemfibrozil; gene expression; regulatory sequence;
   transcription factor
ID APOLIPOPROTEIN-A-I; PROLIFERATOR-ACTIVATED RECEPTOR; HIGH-DENSITY
   LIPOPROTEIN; CYTOCHROME P-450C GENE; HEPATOMA-CELL LINES;
   SACCHAROMYCES-CEREVISIAE; REGULATORY ELEMENTS; TRANSGENIC MICE; RETINOIC
   ACID; CDNA CLONING
AB Previously, we demonstrated that protein-DNA interactions at the drug response element (DRE) in the human apoA-I promoter were important for the induction of apoA-I gene expression by gemfibrozil. We now report the cloning and characterization of a DRE transactivating factor. The cloned protein is identical to the putative helicase and potential transcription factor human S mu binding protein-2 (HS mu BP2). It is also related to glial factor-1 (GF1), an incomplete version of HS mu BP2 lacking the first 494 and the last 128 amino acids. Gel mobility shift assays demonstrated that HS mu BP2 binds apoA-I DRE oligomers and forms a specific protein-DNA complex. Northern blot analysis showed that HS mu BP2 mRNA is expressed at various levels in a wide range of human tissues. Transient cotransfection experiments performed in HepG2 cells demonstrated that overexpression of HS mu BP2 or GF1 induced apoA-I proximal promoter activity by 3-fold and that the apoA-I DRE was necessary for transactivation. Additionally, we demonstrated that transactivation was increased a further 2- to 3-fold by exposing the cells to gemfibrozil. Together these observations indicate that HS mu BP2 acts as a transcription factor that regulates apoA-I gene expression in hepatoma cells and whose activity may be stimulated by gemfibrozil treatment.
C1 Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.
   Thomas Jefferson Univ, Jefferson Med Coll, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA.
   Kyoto Univ, Fac Med, Ctr Mol Biol & Genet, Dept Med Chem, Kyoto 60601, Japan.
RP Tam, SP (reprint author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.
RI Zhang, Xia/B-8152-2008
OI Zhang, Xia/0000-0002-9040-1486
CR FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001
   WILSON GM, 1995, PLASMID, V33, P198, DOI 10.1006/plas.1995.1021
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   BARDOT O, 1993, BIOCHEM BIOPH RES CO, V192, P37, DOI 10.1006/bbrc.1993.1378
   TUGWOOD JD, 1992, EMBO J, V11, P433
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   GOTTO AM, 1986, METHOD ENZYMOL, V128, P3
   TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485
   MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044
   KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0
   MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051
   GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128
   PALMER CNA, 1994, J BIOL CHEM, V269, P18083
   LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293
   HIGUCHI K, 1988, J BIOL CHEM, V263, P18530
   WALSH A, 1989, J BIOL CHEM, V264, P6488
   FUKITA Y, 1993, J BIOL CHEM, V268, P17463
   ZHU YJ, 1993, J BIOL CHEM, V268, P26817
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179
   RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0
   TAM SP, 1992, ALCOHOL CLIN EXP RES, V16, P1021, DOI 10.1111/j.1530-0277.1992.tb00693.x
   Plump AS, 1996, J CLIN INVEST, V97, P2660, DOI 10.1172/JCI118716
   CHAN J, 1993, NUCLEIC ACIDS RES, V21, P1205, DOI 10.1093/nar/21.5.1205
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DAVIS JL, 1992, MOL CELL BIOL, V12, P1879
   DELAIGLESIA FA, 1982, ATHEROSCLEROSIS, V43, P19, DOI 10.1016/0021-9150(82)90096-X
   Glomset J A, 1980, Adv Intern Med, V25, P91
   GROGER RK, 1989, GENE, V81, P285, DOI 10.1016/0378-1119(89)90189-3
   HARNISH DC, 1994, J BIOL CHEM, V269, P28220
   KERR D, 1991, J BIOL CHEM, V266, P15876
   Kockx M, 1996, ANN NY ACAD SCI, V804, P711, DOI 10.1111/j.1749-6632.1996.tb18676.x
   LAURENT BC, 1992, MOL CELL BIOL, V12, P1893
   LI Y, 1992, J BIOL CHEM, V267, P15097
   MCBRIDE K, 1993, MOL CELL BIOL, V13, P600
   MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761
   PAPAZAFIRI P, 1991, J BIOL CHEM, V266, P5790
   ROBERTS EA, 1994, HEPATOLOGY, V19, P1390, DOI 10.1016/0270-9139(94)90233-X
   ROTTMAN JN, 1991, MOL CELL BIOL, V11, P3814
   SAMBROOK J, 1991, MOL CLONING LAB MANU
   SASTRY KN, 1988, MOL CELL BIOL, V8, P605
   SEBASTIANI G, 1995, MAMM GENOME, V6, P147, DOI 10.1007/BF00303264
   SHIEH SY, 1995, J BIOL CHEM, V270, P21503
   SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5
   SNIDERMAN AD, 1988, CAN J CARDIOL, V4, pA24
   SOGAWA K, 1986, P NATL ACAD SCI USA, V83, P8044, DOI 10.1073/pnas.83.21.8044
   SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015
   TAM SP, 1991, ATHEROSCLEROSIS, V91, P51, DOI 10.1016/0021-9150(91)90186-7
   Tzameli I, 1996, J BIOL CHEM, V271, P8402
   VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801
   VUDAC N, 1994, J BIOL CHEM, V269, P31012
   WIDOM RL, 1992, MOL CELL BIOL, V12, P3380
   WIDOM RL, 1991, MOL CELL BIOL, V11, P677
   ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541
   Zhang X, 1996, J BIOL CHEM, V271, P27152
NR 56
TC 15
Z9 16
U1 1
U2 2
PU LIPID RESEARCH INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0022-2275
J9 J LIPID RES
JI J. Lipid Res.
PD FEB
PY 1998
VL 39
IS 2
BP 255
EP 267
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA YX524
UT WOS:000072049200003
PM 9507986
ER

PT J
AU Lee, CG
   Kondo, S
   Honjo, T
AF Lee, CG
   Kondo, S
   Honjo, T
TI Frequent but biased class switch recombination in the S mu flanking
   regions
SO CURRENT BIOLOGY
LA English
DT Article
ID CIRCULAR DNA; TRANSCRIPTION; CELLS
AB Immunoglobulin (Ig) heavy chain class switch recombination occurs mainly by joining two switch (S) regions, segments of tandemly repeated DNA sequences that lie upstream of heavy chain constant region genes, The products of this recombination event are a chromosomal DNA joint and a 'looped-out" circular DNA joint, Although a previous study showed that 40% of chromosomal joints in the mu gene switch region (S mu) are found in the flanking regions of S mu, which do not contain typical S mu region repeats ill, other studies revealed that almost all recombination sites on looped-out circular DNA are found within S regions [2-4]. To resolve this discrepancy, we have isolated and sequenced 164 DNA fragments containing recombination joints from both chromosomal and looped-out DNA of a single cell line, the murine B lymphoma line CH12F3, which switches from IgM to IgA production with a high frequency upon cytokine stimulation [5], The recombination sites were distributed almost evenly in the S mu region and its flanking regions, suggesting that the final joining of DNA ends may not necessarily take place in S regions, In contrast, there were few joining sites in the exon located 5' of the switch region (the I mu exon), suggesting that the 3' end of the I mu exon might be the upstream border of the recombination joint. (C) Current Biology Ltd.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
CR Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   COFFMAN RL, 1986, J IMMUNOL, V136, P949
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   BOTTARO A, 1994, EMBO J, V13, P665
   REABAN ME, 1994, J BIOL CHEM, V269, P21850
   CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
NR 11
TC 48
Z9 48
U1 1
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON W1P 6LB, ENGLAND
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD FEB 12
PY 1998
VL 8
IS 4
BP 227
EP 230
DI 10.1016/S0960-9822(98)70087-9
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA YX724
UT WOS:000072070900018
PM 9501985
ER

PT J
AU Sugai, M
   Kondo, S
   Shimizu, A
   Honjo, T
AF Sugai, M
   Kondo, S
   Shimizu, A
   Honjo, T
TI Isolation of differentially expressed genes upon immunoglobulin class
   switching by a subtractive hybridization method using uracil DNA
   glycosylase
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID IL-4 RESPONSIVE ELEMENT; GROWTH-FACTOR-BETA; CDNA CLONING; PROMOTER;
   REGION; RECOMBINATION; IDENTIFICATION; TRANSCRIPTION; ENHANCER; MICE
AB Immunoglobulin class switch recombination enables B lymphocytes to sequentially express antibodies that have identical specificities but that differ in class and effector function, Although several cis elements required for class switch recombination have been identified, few trans-acting factors which are directly related to class switching have been found, Previously we have developed an efficient in vitro class switching system using a cell line, CH12F3-2. To clarify the molecular mechanism of class switching, we intended to isolate genes induced with interleukin (IL)-4, transforming growth factor (TGF)-beta and CD40L using the in vitro class switching system, For that purpose, an improved method for making subtracted cDNA libraries, using uracil DNA glycosylase, has been developed, This method can overcome a general problem of subtraction, that rare cDNAs are easily lost, This new subtraction method was applied to the CH12F3-2 switching system to isolate genes induced by stimulations with IL-4, TGF-beta and CD40L, and cDNAs encoding deiodinase 1 and SS32, an alternatively spliced form of the muscle LIM protein, were obtained, Their expression patterns in response to various combinations of stimuli and the time courses of the induction supported the usefulness of this method.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
CR GROSSNIKLAUS U, 1989, DEVELOPMENT, V107, P189
   COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4
   Chung KY, 1996, J BIOL CHEM, V271, P3272
   LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152
   ICHIKI T, 1993, J IMMUNOL, V150, P5408
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   ZHANG J, 1993, EMBO J, V12, P3529
   LI JM, 1995, J BIOL CHEM, V270, P26750
   COFFMAN RL, 1986, J IMMUNOL, V136, P949
   DUGUID JR, 1990, NUCLEIC ACIDS RES, V18, P2789, DOI 10.1093/nar/18.9.2789
   COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4
   OKA C, 1995, DEVELOPMENT, V121, P3291
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H
   ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9
   HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640
   BERRY MJ, 1993, J CLIN INVEST, V92, P1517, DOI 10.1172/JCI116730
   BRITTEN RJ, 1970, SCI AM, V222, P24
   DUNCAN BK, 1984, GENE, V28, P211, DOI 10.1016/0378-1119(84)90258-0
   ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.immunol.8.1.717
   GREENWEL P, 1995, MOL CELL BIOL, V15, P6813
   HARA E, 1993, ANAL BIOCHEM, V214, P58, DOI 10.1006/abio.1993.1456
   Harriman GR, 1996, J CLIN INVEST, V97, P477, DOI 10.1172/JCI118438
   ILLGES H, 1992, MOL IMMUNOL, V29, P1265, DOI 10.1016/0161-5890(92)90063-4
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   KOHNE DE, 1977, BIOCHEMISTRY-US, V16, P5329, DOI 10.1021/bi00643a026
   KRETSOVALI A, 1995, NUCLEIC ACIDS RES, V23, P2919, DOI 10.1093/nar/23.15.2919
   LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x
   LIN YCA, 1992, J IMMUNOL, V149, P2914
   Lorenz M, 1996, CURR TOP MICROBIOL, V217, P151
   MAIA AL, 1995, MOL ENDOCRINOL, V9, P969, DOI 10.1210/me.9.8.969
   NAKAYAMA E, 1989, P NATL ACAD SCI USA, V86, P1352, DOI 10.1073/pnas.86.4.1352
   NILSSON L, 1995, INT IMMUNOL, V7, P1191, DOI 10.1093/intimm/7.8.1191
   NORDGRENJS, 1986, EMBO J, V5, P95
   ROTHMAN P, 1991, MOL CELL BIOL, V11, P5551
   Sambrook J., 1989, MOL CLONING LAB MANU
   SARGENT T D, 1983, Science (Washington D C), V222, P135, DOI 10.1126/science.6688681
   Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631
   TAKAHASHI N, 1980, GENE, V11, P117
   TAKESHITA A, 1995, J IMMUNOL, V155, P419
   Tsubata R, 1996, EUR J IMMUNOL, V26, P2742, DOI 10.1002/eji.1830261129
   WANG Z, 1991, P NATL ACAD SCI USA, V88, P11505, DOI 10.1073/pnas.88.24.11505
   XU MZ, 1992, EMBO J, V11, P145
   ZENG J, 1994, NUCLEIC ACIDS RES, V22, P4381, DOI 10.1093/nar/22.21.4381
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
NR 50
TC 11
Z9 12
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB 15
PY 1998
VL 26
IS 4
BP 911
EP 918
DI 10.1093/nar/26.4.911
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA YZ260
UT WOS:000072236300006
PM 9461447
ER

PT J
AU Moriya, C
   Shioda, T
   Tashiro, K
   Nagasawa, T
   Ikegawa, M
   Ohnishi, Y
   Kato, A
   Hu, HL
   Xin, XM
   Hasan, MK
   Maekawa, M
   Takebe, Y
   Sakai, Y
   Honjo, T
   Nagai, Y
AF Moriya, C
   Shioda, T
   Tashiro, K
   Nagasawa, T
   Ikegawa, M
   Ohnishi, Y
   Kato, A
   Hu, HL
   Xin, XM
   Hasan, MK
   Maekawa, M
   Takebe, Y
   Sakai, Y
   Honjo, T
   Nagai, Y
TI Large quantity production with extreme convenience of human SDF-1 alpha
   and SDF-1 beta by a Sendai virus vector
SO FEBS LETTERS
LA English
DT Article
DE HIV-1; chemokine; stromal cell-derived factor 1; Sendai virus; virus
   vector; mammalian expression system
ID RECOMBINANT VACCINIA VIRUS; GROWTH-STIMULATING FACTOR;
   AMINO-ACID-SEQUENCES; HIV-1 ENTRY; NUCLEOTIDE-SEQUENCE;
   MOLECULAR-CLONING; GENOME RNA; P-PROTEIN; RECEPTOR; FUSION
AB We describe a robust expression of human stromal cell-derived factor-1 alpha (SDF-1 alpha) and SDF-1 beta, the members of CXC-chemokine family, with a novel vector system based upon Sendai virus, a non-segmented negative strand RNA virus, Recombinant SDF-1 alpha and SDF-1 beta were detected as a major protein species in culture supernatants, reached as high as 10 mu g/ml. This remarkable enrichment of the products allowed us to use even the crude supernatants as the source for biological and antiviral assays without further concentration nor purification and will thus greatly facilitate to screen their genetically engineered derivatives. (C) 1998 Federation of European Biochemical Societies.
C1 Univ Tokyo, Inst Med Sci, Dept Viral Infect, Minato Ku, Tokyo 108, Japan.
   Univ Tokyo, Inst Med Sci, Dept Infect Dis, Tokyo 108, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 606, Japan.
   Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Immunol, Osaka, Japan.
   Kyoto Univ, Dept Med Chem, Kyoto 606, Japan.
   Kyoto Univ, Dept Social Med, Kyoto 606, Japan.
   Kyoto Univ, Dept Pharmacol, Kyoto 606, Japan.
   Natl Ctr Infect Dis, Ctr AIDS Res, Dept Mol Virol & Epidemiol, Tokyo, Japan.
RP Nagai, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Viral Infect, Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.
EM ynagai@ims.u-tokyo.ac.jp
CR TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409
   Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x
   SHIODA T, 1986, NUCLEIC ACIDS RES, V14, P1545, DOI 10.1093/nar/14.4.1545
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405
   Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8
   HAMAGUCHI M, 1983, VIROLOGY, V128, P105, DOI 10.1016/0042-6822(83)90322-7
   Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Oravecz T, 1996, J IMMUNOL, V157, P1329
   Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726
   NAIDU YM, 1988, J VIROL, V62, P4691
   Hasan MK, 1997, J GEN VIROL, V78, P2813
   Rollins BJ, 1997, BLOOD, V90, P909
   NUSSBAUM O, 1994, J VIROL, V68, P5411
   Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0
   Berson JF, 1996, J VIROL, V70, P6288
   Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111
   ADACHI A, 1986, J VIROL, V59, P284
   SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180
   Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0
   Deng HK, 1997, NATURE, V388, P296
   Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0
   SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0
   Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139
   NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305
   Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6
   Marcon L, 1997, J VIROL, V71, P2522
   ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0
   BLUEL CC, 1996, J EXP MED, V184, P1101
   Chen ZW, 1997, J VIROL, V71, P2705
   Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0
   Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
   Edinger AL, 1997, P NATL ACAD SCI USA, V94, P4005, DOI 10.1073/pnas.94.8.4005
   GRAHAM GJ, 1994, J BIOL CHEM, V269, P4974
   HANAFUSA H, 1969, P NATL ACAD SCI USA, V63, P318, DOI 10.1073/pnas.63.2.318
   HIDAKA Y, 1984, NUCLEIC ACIDS RES, V12, P7965, DOI 10.1093/nar/12.21.7965
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamb RA, 1996, FIELDS VIROLOGY, P1177
   MURAKAMI T, 1997, IN PRESS J EXP MED
   OKA S, 1994, AIDS RES HUM RETROV, V10, P271, DOI 10.1089/aid.1994.10.271
   Shioda T, 1997, J VIROL, V71, P4871
   SHIODA T, 1983, NUCLEIC ACIDS RES, V11, P7317, DOI 10.1093/nar/11.21.7317
   Tachibana K, 1997, J EXP MED, V185, P1865, DOI 10.1084/jem.185.10.1865
   XIN X, IN PRESS ARCH VIROL
   YORKHIGGINS D, 1990, J VIROL, V64, P4016
   Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x
NR 51
TC 14
Z9 15
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD MAR 20
PY 1998
VL 425
IS 1
BP 105
EP 111
DI 10.1016/S0014-5793(98)00207-5
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA ZE342
UT WOS:000072783000021
PM 9541016
ER

PT J
AU Nishimura, H
   Hiai, H
   Minato, N
   Honjo, T
AF Nishimura, H
   Hiai, H
   Minato, N
   Honjo, T
TI PD-1 regulates self-tolerance to prevent tissue destruction.
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
C1 Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Pathol & Biol Dis, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Immunol, Kyoto 606, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 1998
VL 110
IS 4
BP 477
EP 477
PG 1
WC Dermatology
SC Dermatology
GA ZD914
UT WOS:000072738200056
ER

PT J
AU Kanazawa, N
   Nakamura, T
   Tashiro, K
   Morita, K
   Yoneda, K
   Inaba, K
   Imamura, S
   Honjo, T
AF Kanazawa, N
   Nakamura, T
   Tashiro, K
   Morita, K
   Yoneda, K
   Inaba, K
   Imamura, S
   Honjo, T
TI Identification of a new class of chemokine expressed in murine dendritic
   cells by the signal sequence trap method.
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
C1 Kyoto Univ, Fac Med, Dept Dermatol, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
   Kyoto Univ, Fac Sci, Ctr Mol Biol & Genet, Kyoto, Japan.
   Kyoto Univ, Fac Sci, Dept Zool, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 1998
VL 110
IS 4
BP 561
EP 561
PG 1
WC Dermatology
SC Dermatology
GA ZD914
UT WOS:000072738200564
ER

PT J
AU Yabe, D
   Taniwaki, M
   Nakamura, T
   Kanazawa, N
   Tashiro, K
   Honjo, T
AF Yabe, D
   Taniwaki, M
   Nakamura, T
   Kanazawa, N
   Tashiro, K
   Honjo, T
TI Human calumenin gene (CALU): cDNA isolation and chromosomal mapping to
   7q32
SO GENOMICS
LA English
DT Article
ID CA2+-BINDING PROTEIN; CELL
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Prefectural Univ Med, Dept Internal Med 3, Kamigyo Ku, Kyoto 602, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.
RI Yabe, Daisuke/J-6682-2014; 
OI Yabe, Daisuke/0000-0002-5334-7687; Kanazawa, Nobuo/0000-0003-3000-9711
CR Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257
   SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   BRINK PA, 1995, CIRCULATION, V91, P1633
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   NEI M, 1987, MOL EVOLUTIONARY GEN, P293
   OHTA T, 1995, J BIOL CHEM, V270, P15571
   OZAWA M, 1993, J BIOL CHEM, V268, P669
   TANIWAKI M, 1994, BLOOD, V83, P2962
   WEIS K, 1994, J BIOL CHEM, V269, P19142
   WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0
NR 11
TC 22
Z9 24
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
J9 GENOMICS
JI Genomics
PD APR 15
PY 1998
VL 49
IS 2
BP 331
EP 333
DI 10.1006/geno.1998.5245
PG 3
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA ZN543
UT WOS:000073656400023
PM 9598325
ER

PT J
AU Shioda, T
   Kato, H
   Ohnishi, Y
   Tashiro, K
   Ikegawa, M
   Nakayama, EE
   Hu, HL
   Kato, A
   Sakai, Y
   Liu, HL
   Honjo, T
   Nomoto, A
   Iwamoto, A
   Morimoto, C
   Nagai, Y
AF Shioda, T
   Kato, H
   Ohnishi, Y
   Tashiro, K
   Ikegawa, M
   Nakayama, EE
   Hu, HL
   Kato, A
   Sakai, Y
   Liu, HL
   Honjo, T
   Nomoto, A
   Iwamoto, A
   Morimoto, C
   Nagai, Y
TI Anti-HIV-1 and chemotactic activities of human stromal cell-derived
   factor 1 alpha (SDF-1 alpha) and SDF-1 beta are abolished by
   CD26/dipeptidyl peptidase IV-mediated cleavage
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; HIV-1 ENTRY; CD26; INFECTION;
   ACTIVATION; RECEPTOR; CLONING; SURFACE; ANTIGEN
AB CD26 is a leukocyte-activation antigen that is expressed on T lymphocytes and macrophages and possesses dipeptidyl peptidase IV (DPPIV) activity, whose natural substrates have not been identified yet. CXC chemokines, stromal cell-derived factor 1 alpha (SDF-1 alpha) and 1 beta (SDF-1 beta), sharing the receptor CXCR-4, are highly efficacious chemoattractants for resting lymphocytes and CD34(+) progenitor cells, and they efficiently block the CXCR-4-mediated entry into cells of T cell line tropic strains of HIV type 1 (HIV-1). Here we show that both the chemotactic and antiviral activities of these chemokines are abrogated by DPPIV-mediated specific removal of the N-terminal dipeptide, not only when the chemokines are produced in transformed mouse L cell line to express human CD26 but also when they were exposed to a human T cell line (H9) physiologically expressing CD26. Mutagenesis of SDF-1 alpha confirmed the critical requirement of the N-terminal dipeptide for its chemotactic and antiviral activities. These data suggest that CD26-mediated cleavage of SDF-1 alpha and SDF-1 beta likely occurs in human bodies and promotes HIV-1 replication and disease progression. They may also explain why memory function of CD4(+) cells is preferentially lost in HIV-1 infection. Furthermore, CD26 would modulate various other biological processes in which SDF-1 alpha and SDF-1 beta are involved.
C1 Univ Tokyo, Dept Infect Dis, Inst Med Sci, Minato Ku, Tokyo 108, Japan.
   Univ Tokyo, Dept Viral Infect, Inst Med Sci, Tokyo 108, Japan.
   Univ Tokyo, Dept Microbiol, Inst Med Sci, Tokyo 108, Japan.
   Univ Tokyo, Dept Clin Immunol, Inst Med Sci, Tokyo 108, Japan.
   Univ Tokyo, Ctr AIDS Res, Inst Med Sci, Tokyo 108, Japan.
   Nippon Roche Res Ctr, Kanagawa, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 606, Japan.
   Kyoto Univ, Dept Social Med, Kyoto 606, Japan.
   Kyoto Univ, Dept Med Chem, Kyoto 606, Japan.
RP Shioda, T (reprint author), Univ Tokyo, Dept Infect Dis, Inst Med Sci, Minato Ku, 4-6-1 Shiroganedai, Tokyo 108, Japan.
EM shioda@ims.u-tokyo.ac.jp
OI Liu, Huanliang/0000-0002-1006-6666
CR TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409
   WALTER R, 1980, MOL CELL BIOCHEM, V30, P111
   Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x
   TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391
   Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8
   Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996
   Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   Pal R, 1997, SCIENCE, V278, P695, DOI 10.1126/science.278.5338.695
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0
   SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058
   Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389
   Oravecz T, 1996, J IMMUNOL, V157, P1329
   TORIMOTO Y, 1991, J IMMUNOL, V147, P2514
   Hasan MK, 1997, J GEN VIROL, V78, P2813
   Rollins BJ, 1997, BLOOD, V90, P909
   Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0
   DukeCohan JS, 1996, J IMMUNOL, V156, P1714
   SUGDEN B, 1985, MOL CELL BIOL, V5, P410
   Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111
   ADACHI A, 1986, J VIROL, V59, P284
   SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180
   Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139
   NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305
   Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6
   ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0
   ASJO B, 1986, LANCET, V2, P660
   BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073
   BLUEL CC, 1996, NATURE, V382, P829
   BLUEL CC, 1996, J EXP MED, V184, P1101
   CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945
   Chun TW, 1997, J VIROL, V71, P4436
   DANG NH, 1990, J IMMUNOL, V144, P4092
   Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0
   Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
   FLEISCHER B, 1994, IMMUNOL TODAY, V15, P180, DOI 10.1016/0167-5699(94)90316-6
   Hori T, 1998, J IMMUNOL, V160, P180
   HU H, IN PRESS ARCH VIROL
   LAZARO I, 1994, J VIROL, V68, P6535
   MORIMOTO C, 1989, J IMMUNOL, V143, P3430
   NOESEL CJM, 1990, J CLIN INVEST, V86, P293
   OVARECZ T, 1997, J EXP MED, V186, P1865
   TERSMETTE M, 1989, LANCET, V1, P983
   Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x
NR 48
TC 128
Z9 129
U1 1
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 26
PY 1998
VL 95
IS 11
BP 6331
EP 6336
DI 10.1073/pnas.95.11.6331
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ZQ352
UT WOS:000073852600086
PM 9600965
ER

PT J
AU Sakai, T
   Taniguchi, Y
   Tamura, K
   Minoguchi, S
   Fukuhara, T
   Strobl, LJ
   Zimber-Strobl, U
   Bornkamm, GW
   Honjo, T
AF Sakai, T
   Taniguchi, Y
   Tamura, K
   Minoguchi, S
   Fukuhara, T
   Strobl, LJ
   Zimber-Strobl, U
   Bornkamm, GW
   Honjo, T
TI Functional replacement of the intracellular region of the Notch1
   receptor by Epstein-Barr virus nuclear antigen 2
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID SIGNAL-BINDING-PROTEIN; RBP-J-KAPPA; MOUSE NOTCH; SEQUENCE; EBNA2; DNA;
   ELEMENTS; HOMOLOG; DOMAIN; GENE
AB The intracellular region (RAMIC) of the mouse Notch1 receptor interacts with RBP-J/CBF-1, which binds to the DNA sequence CGTGGGAA and suppresses differentiation by transcriptional activation of genes regulated by RBP-J. Epstein-Barr virus nuclear antigen 2 (EBNA2) is essential for immortalization of human B cells by the virus. EBNA2 is a pleiotropic activator of viral and cellular genes and is targeted to DNA at least in part by interacting with RBP-J, We found that EBNA2 and the Notch1 RAMIC compete for binding to RBP-J, indicating that their interaction sites on RBP-J overlap at least partially, EBNA2 and Notch1 RAMIC transactivated the same set of viral and host promoters, i.e., the EBNA2 response element of the Epstein-Barr virus TP1 and the HES-1 promoter. Furthermore, EBNA2 functionally replaced the Notch1 RAMIC by suppressing differentiation of C2C12 myoblast progenitor cells.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   GSF Forschungszentrum Umwelt & Gesundheit GMBH, Inst Klin Mol Biol & Tumorgenet, D-81377 Munich, Germany.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RI Taniguchi, Yoshihito/L-5746-2013
CR ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0
   Kato H, 1997, DEVELOPMENT, V124, P4133
   COHEN JI, 1989, P NATL ACAD SCI USA, V86, P9558, DOI 10.1073/pnas.86.23.9558
   ZIMBERSTROBL U, 1993, EMBO J, V12, P167
   VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C
   WALTZER L, 1994, EMBO J, V13, P5633
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015
   Hsieh JJD, 1997, J VIROL, V71, P1938
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1
   YALAMANCHILI R, 1994, VIROLOGY, V204, P634, DOI 10.1006/viro.1994.1578
NR 29
TC 54
Z9 55
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD JUL
PY 1998
VL 72
IS 7
BP 6034
EP 6039
PG 6
WC Virology
SC Virology
GA ZU089
UT WOS:000074160500082
PM 9621066
ER

PT J
AU Nisitani, S
   Sakiyama, T
   Honjo, T
AF Nisitani, S
   Sakiyama, T
   Honjo, T
TI Involvement of IL-10 in induction of autoimmune hemolytic anemia in
   anti-erythrocyte Ig transgenic mice
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE autoimmunity; B lymphocytes; cytokines; T lymphocytes;
   transgenic/knockout
ID LY-1 B-CELLS; NECROSIS-FACTOR-ALPHA; B-1 CELLS; LYMPHOCYTES-B; VH GENE;
   T-CELLS; PERITONEAL-CAVITY; RHEUMATOID-FACTOR; INTERLEUKIN-10;
   EXPRESSION
AB Activation of peritoneal B-1 cells triggers autoimmune anemia in anti-erythrocyte Ig transgenic mice (HL mice). Numbers of peritoneal B-1 cells and Ig-producing cells were negligible in the T cell-deficient HL mice generated by the cross with RAG-2(-/-) mice (RAG-2(-/-) x HL mice). Proliferation and activation of B-1 cells in RAG-2(-/-) x HL mice were recovered by fetal thymus transfer, indicating involvement of T cells in B-l cell-mediated autoimmune hemolytic anemia. involvement of T cells in proliferation and activation of B-1 cells could be by-passed by administration of lipopolysaccharide (LPS), IL-5 or IL-10 to RAG-2(-/-) x HL mice. Administration of LPS elevated the serum IL-10 level in HL, RAG-2(-/-) x HL and normal mice. Proliferation and activation of B-1 cells were blocked by an anti-IL-10 antibody in conventionally bred as well as LPS-treated HL mice. Taken together, IL-10 plays a pivotal role in activation of peritoneal B-1 cells.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
CR ANDRADE L, 1989, EUR J IMMUNOL, V19, P1117, DOI 10.1002/eji.1830190623
   SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543
   HARDY RR, 1989, J IMMUNOL, V142, P3643
   ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305
   HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314
   KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9
   PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554
   CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   HITOSHI Y, 1990, J IMMUNOL, V144, P4218
   BARSIG J, 1995, EUR J IMMUNOL, V25, P2888, DOI 10.1002/eji.1830251027
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   MERCOLINO TJ, 1988, J EXP MED, V168, P687, DOI 10.1084/jem.168.2.687
   XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309
   KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317
   GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0
   FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414
   ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213
   PLATERZYBERK C, 1985, ARTHRITIS RHEUM, V28, P971, DOI 10.1002/art.1780280903
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   FLUCKIGER AC, 1993, J EXP MED, V178, P1473, DOI 10.1084/jem.178.5.1473
   FUJIHASHI K, 1992, J EXP MED, V175, P695, DOI 10.1084/jem.175.3.695
   ISHIDA Y, 1989, J EXP MED, V170, P1103, DOI 10.1084/jem.170.4.1103
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   Nomura T, 1996, INT IMMUNOL, V8, P867, DOI 10.1093/intimm/8.6.867
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   PARRY SL, 1994, J IMMUNOL, V152, P2821
   PECQUET SS, 1992, INFECT IMMUN, V60, P503
   PLATZER C, 1995, INT IMMUNOL, V7, P517, DOI 10.1093/intimm/7.4.517
   REININGER L, 1988, EUR J IMMUNOL, V18, P1521, DOI 10.1002/eji.1830181008
   ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9
   WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
   WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926
NR 48
TC 20
Z9 20
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD AUG
PY 1998
VL 10
IS 8
BP 1039
EP 1047
DI 10.1093/intimm/10.8.1039
PG 9
WC Immunology
SC Immunology
GA 111GY
UT WOS:000075430000003
PM 9723689
ER

PT J
AU Nishimura, H
   Minato, N
   Nakano, T
   Honjo, T
AF Nishimura, H
   Minato, N
   Nakano, T
   Honjo, T
TI Immunological studies on PD-1-deficient mice: implication of PD-1 as a
   negative regulator for B cell responses
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE IgG3; knockout mice; ITIM; PD-1; peritoneal B cells; T-independent
   antigen
ID PROTEIN-TYROSINE-PHOSPHATASE; ANTIGEN RECEPTOR; GENOMIC ORGANIZATION;
   LUPUS MOUSE; SH2 DOMAIN; EXPRESSION; GENE; SURFACE; LOCALIZATION;
   LYMPHOCYTES
AB PD-1, an Ig superfamily member, contains an immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic tail, It is expressed in a minor fraction of CD4(-)CD8(-) normal thymocytes and induced in peripheral lymphocytes following activation. To assess the possible roles of PD-1 in the immune responses, PD-1-deficient (PD-1(-/-)) mice were generated by a gene-targeting strategy. PD-1(-/-) mice developed and grew normally. Although the thymus was apparently normal, PD-1(-/-) mice showed moderate but consistent splenomegaly, which reflected the increased cellularity of both lymphoid and myeloid cells. The proliferative response of a cells by anti-IgM antibodies, but not of T cells by an anti-CD3 (145-2C11) mAb in vitro, was augmented in PD-1(-/-) mice as compared with control littermates. PD-1(-/-) mice showed increased serum levels of IgG2b, IgA and most strikingly IgG3, while those of IgM and IgG1 were comparable with control mice. Furthermore, PD-1(-/-) mice exhibited significantly augmented IgG3 anti-DNP antibody response to a type 2 T-independent antigen, DNP-Ficoll, with comparable IgM and IgG1 antibody responses with littermate controls. In the peritoneal cavity, the B-1 cell population in PD-1(-/-) mice exhibited significantly reduced expression of CD5, a negative regulator of B-1 cell activation, despite a marginal increase in the number of B-1 cells. Thus, PD-1 was suggested to be involved in the negative regulation for particular aspects of a cell proliferation and differentiation including class switching.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Immunol, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Yoshida Konce, Kyoto 606, Japan.
CR ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6
   STALL AM, 1992, ANN NY ACAD SCI, V651, P33
   SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O
   PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077
   Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4
   CONG YZ, 1991, INT IMMUNOL, V3, P467
   Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0
   PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123
   MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6
   DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087
   YI TL, 1992, MOL CELL BIOL, V12, P836
   Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906
   MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655
   SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7
   HARDY RR, 1992, CURR OPIN IMMUNOL, V4, P181, DOI 10.1016/0952-7915(92)90010-C
   ITOH J, 1993, AM J PATHOL, V143, P1436
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   TAKAHASHI S, 1993, MOL IMMUNOL, V30, P177
   TAKAHASHI S, 1991, J IMMUNOL, V147, P515
   THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953
   Vyse TJ, 1996, CURR OPIN IMMUNOL, V8, P843, DOI 10.1016/S0952-7915(96)80014-8
   Whitmore AC, 1996, INT IMMUNOL, V8, P533, DOI 10.1093/intimm/8.4.533
NR 29
TC 187
Z9 201
U1 2
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD OCT
PY 1998
VL 10
IS 10
BP 1563
EP 1572
DI 10.1093/intimm/10.10.1563
PG 10
WC Immunology
SC Immunology
GA 129JL
UT WOS:000076460000018
PM 9796923
ER

PT J
AU Nakamura, T
   Yabe, D
   Kanazawa, N
   Tashiro, K
   Sasayama, S
   Honjo, T
AF Nakamura, T
   Yabe, D
   Kanazawa, N
   Tashiro, K
   Sasayama, S
   Honjo, T
TI Molecular cloning, characterization, and chromosomal localization of
   FKBP23, a novel FK506-binding protein with Ca2+-binding ability
SO GENOMICS
LA English
DT Article
ID GLUCOSE-REGULATED PROTEIN; CALCIUM-RELEASE CHANNEL; FK506
   BINDING-PROTEIN; MUSCLE SARCOPLASMIC-RETICULUM; SIGNAL SEQUENCE TRAP;
   HEAT-SHOCK PROTEIN; ENDOPLASMIC-RETICULUM; ASIALOGLYCOPROTEIN RECEPTOR;
   RYANODINE RECEPTOR; FK-506-BINDING PROTEIN
AB We have identified and characterized a cDNA encoding a novel FK506-binding protein (FKBP), named FKBP23, from mouse heart by the signal sequence trap method. The deduced amino acid sequence has significant homology to other FKBP family members around the peptidylprolyl cis-trans-isomerase motifs. FKBP23 also has two Ca2+-binding (EF-hand) motifs, and purified FKBP23 protein was shown to have Ca2+-binding ability. This is the first report of a Ca2+-binding FKBP. FKBP23 is a glycoprotein retained in the endoplasmic reticulum by its carboxyl-terminal tetrapeptide His-Asp-Glu-Leu, as demonstrated by immunostaining, retention, and deglycosylation assays. FKBP23 mRNA is expressed most strongly in heart, lung, and testis, beginning at day 8.5 of embryonic development. The FKBP23 gene was mapped to mouse chromosome 2. (C) 1998 Academic Press.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.
RI Yabe, Daisuke/J-6682-2014; 
OI Yabe, Daisuke/0000-0002-5334-7687; Kanazawa, Nobuo/0000-0003-3000-9711
CR AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315
   BAUGHMAN G, 1995, MOL CELL BIOL, V15, P4395
   CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784
   Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713
   COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   JIN YJ, 1993, P NATL ACAD SCI USA, V90, P7769, DOI 10.1073/pnas.90.16.7769
   KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125
   BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6
   BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9
   LAM E, 1995, J BIOL CHEM, V270, P26511
   Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257
   NIGAM SK, 1993, BIOCHEM J, V294, P511
   BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558
   MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511
   OZAWA M, 1993, J BIOL CHEM, V268, P699
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x
   LODISH HF, 1992, J BIOL CHEM, V267, P12753
   KOCH GLE, 1990, BIOESSAYS, V12, P527, DOI 10.1002/bies.950121105
   FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6
   EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0
   VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992
   PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8
   SMITH T, 1995, J BIOL CHEM, V270, P18323
   FRANKEL WN, 1990, GENETICS, V124, P221
   NIGAM SK, 1994, J BIOL CHEM, V269, P1744
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   FLIEGEL L, 1989, J BIOL CHEM, V264, P21522
   SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189
   JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474
   MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094
   BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3
   BUSH KT, 1994, BIOCHEM J, V303, P705
   COSS MC, 1995, J BIOL CHEM, V270, P29336
   Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295
   ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0
   FERREIRA LR, 1994, J CELL BIOCHEM, V56, P518, DOI 10.1002/jcb.240560412
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   KRESTINGER RH, 1980, ANN NY ACAD SCI, V356, P14
   KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990
   LEFORT A, 1989, EMBO J, V8, P111
   LODISH HF, 1990, J BIOL CHEM, V265, P10893
   MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2
   MALTAIS LJ, 1984, J HERED, V75, P468
   MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089
   MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875
   NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872
   NEMOTO Y, 1993, J CELL BIOL, V123, P963, DOI 10.1083/jcb.123.4.963
   Okadome T, 1996, J BIOL CHEM, V271, P21687
   PARTALEDIS JA, 1993, P NATL ACAD SCI USA, V90, P5450, DOI 10.1073/pnas.90.12.5450
   PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974
   RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579
   ROY B, 1995, MOL CELL BIOL, V15, P2263
   SEWELL TJ, 1994, J BIOL CHEM, V269, P21094
   Taylor P, 1997, ENANTIOMER, V2, P249
   Vogt TF, 1996, DEV GENET, V19, P33
   WEIS K, 1994, J BIOL CHEM, V269, P19142
   WIKSTROM L, 1993, J BIOL CHEM, V268, P14412
   WILEMAN T, 1991, J BIOL CHEM, V266, P4500
   WOODEN SK, 1991, MOL CELL BIOL, V11, P5612
   Yabe D, 1998, GENOMICS, V49, P331, DOI 10.1006/geno.1998.5245
NR 68
TC 28
Z9 31
U1 0
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
J9 GENOMICS
JI Genomics
PD NOV 15
PY 1998
VL 54
IS 1
BP 89
EP 98
DI 10.1006/geno.1998.5571
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 139YE
UT WOS:000077058200011
PM 9806833
ER

PT J
AU Kinoshita, K
   Tashiro, J
   Tomita, S
   Lee, CG
   Honjo, T
AF Kinoshita, K
   Tashiro, J
   Tomita, S
   Lee, CG
   Honjo, T
TI Target specificity of immunoglobulin class switch recombination is not
   determined by nucleotide sequences of S regions
SO IMMUNITY
LA English
DT Article
ID HEAVY-CHAIN SWITCH; CIRCULAR DNA; B-CELLS; GENE; TRANSCRIPTS;
   EXPRESSION; ISOTYPE; DELETION; REARRANGEMENT; ORGANIZATION
AB We describe a model system for class switch recombination (CSR) using CH12F3-2 cells transfected with a DNA construct containing two S sequences transcribed by different promoters and separated by a viral thymidine kinase (TK) gene. Recombination observed using this system shares key properties with physiological CSR: deletion of DNA between two S regions, requirement for cytokine stimulation, and nonhomologous and no consensus breakpoint sequences. Studies on transfectants with variants of this construct led us to the following conclusions: (1) two S sequences are required for CSR; (2) isotype specificity of recombination is not determined by nucleotide sequences of S regions; (3) S sequences are not strand-specific; and (4) induction of recombination activity requires cytokine stimulation.
C1 Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0
   ARAKAWA H, 1993, J BIOL CHEM, V268, P4651
   Snapper CM, 1996, J IMMUNOL, V156, P183
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   BOTTARO A, 1994, EMBO J, V13, P665
   REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0
   Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   Ballantyne J, 1998, J IMMUNOL, V161, P1336
   Ballantyne J, 1997, INT IMMUNOL, V9, P963, DOI 10.1093/intimm/9.7.963
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   Du J, 1997, NUCLEIC ACIDS RES, V25, P3066, DOI 10.1093/nar/25.15.3066
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Harriman GR, 1996, J CLIN INVEST, V97, P477, DOI 10.1172/JCI118438
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151
   LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154
   Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   OTT DE, 1987, EMBO J, V6, P557
   PURKERSON JM, 1992, J EXP MED, V175, P973, DOI 10.1084/jem.175.4.973
   QIU G, 1999, IN PRESS INT IMMUNOL
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   SEVERINSON E, 1990, EUR J IMMUNOL, V20, P1079, DOI 10.1002/eji.1830200520
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   WAKATSUKI Y, 1993, J EXP MED, V178, P129, DOI 10.1084/jem.178.1.129
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   ZELAZOWSKI P, 1995, J IMMUNOL, V154, P1223
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
NR 52
TC 55
Z9 55
U1 1
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD DEC
PY 1998
VL 9
IS 6
BP 849
EP 858
DI 10.1016/S1074-7613(00)80650-0
PG 10
WC Immunology
SC Immunology
GA 153MJ
UT WOS:000077836600010
PM 9881975
ER

PT J
AU Hoshiyama, D
   Suga, H
   Iwabe, N
   Koyanagi, M
   Nikoh, N
   Kuma, K
   Matsuda, F
   Honjo, T
   Miyata, T
AF Hoshiyama, D
   Suga, H
   Iwabe, N
   Koyanagi, M
   Nikoh, N
   Kuma, K
   Matsuda, F
   Honjo, T
   Miyata, T
TI Sponge Pax cDNA related to Pax-2/5/8 and ancient gene duplications in
   the Pax family
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Article
DE Pax-2/5/8; sponge; gene duplication; Pax family; Cambrian explosion;
   evolution
ID TISSUE-SPECIFIC GENES; FUNCTIONAL CONSTRAINTS; MOLECULAR EVOLUTION;
   DIVERGENCE; DIFFERENTIATION; SEQUENCES; PROTEINS; METAZOA; KINASE
AB Members of the Pax gene family encode transcription factors containing a DNA-binding paired domain which is involved in developmental control and the formation of the central nervous system (CNS). The family members are classified into six classes or subfamilies, depending on the presence or absence of paired-type homeobox and octapeptide. To obtain rough estimates of times when the different classes of the Pax family diverged by gene duplication, we cloned and sequenced a Pax-related cDNA, sPax-2/5/8, from Ephydatia fluviatilis, a freshwater sponge, which encodes a paired-type homeobox and an octapeptide, in addition to a paired domain. A phylogenetic tree based on the paired domain sequences suggest that sPax-2/5/8 is a homologue of vertebrate Pax-2/5/8. It was also suggested that the majority of gene duplications that gave rise to distinct classes has been completed in the very early evolution of animals before the parazoan-eumetazoan split. Long after the ancient gene duplications, further gene duplications that gave rise to members in each subfamily occurred on the chordate lineages and completed before the fish-tetrapod split. This suggests that the major classes of the Pax genes involved in the formation of CNS characteristic of triploblasts had already existed long before the Cambrian explosion of triploblasts, and there is no direct link between the creation of new genes with novel functions and the Cambrian explosion. The pattern of gene diversification found in the Pax family is similar to those in five gene families involved in the signal transduction analyzed by us. Furthermore, the evolutionary rates of the Pax proteins have been shown to decrease with increasing organismal complexity during animal evolution.
C1 Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068507, Japan.
RP Miyata, T (reprint author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.
RI Matsuda, Fumihiko/B-9893-2009
CR Adachi J, 1992, COMPUTER SCI MONOGRA, V27
   SEIMIYA M, 1994, EUR J BIOCHEM, V221, P219, DOI 10.1111/j.1432-1033.1994.tb18732.x
   KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K
   NEEDLEMA.SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678
   Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1
   FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998
   Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568
   MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0
   MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067
   Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479
   BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y
   DAYHOFF MO, 1978, ATLAS PROTEIN SEQUEN, V5, P1
   HENDRIKS W, 1987, P NATL ACAD SCI USA, V84, P5320, DOI 10.1073/pnas.84.15.5320
   Iwabe N, 1996, MOL BIOL EVOL, V13, P483
   KUMA K, 1995, MOL BIOL EVOL, V12, P123
   Margulis L., 1988, 5 KINGDOMS
   MIYATA T, 1994, JPN J GENET, V69, P473, DOI 10.1266/jjg.69.473
   Nikoh N, 1997, J MOL EVOL, V45, P97, DOI 10.1007/PL00006208
   Sambrook J., 1989, MOL CLONING LAB MANU
   StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0
   Strachan Tom, 1994, Current Opinion in Genetics and Development, V4, P427, DOI 10.1016/0959-437X(94)90032-9
   Suga H, 1997, FEBS LETT, V412, P540, DOI 10.1016/S0014-5793(97)00639-X
   Sun HM, 1997, P NATL ACAD SCI USA, V94, P5156, DOI 10.1073/pnas.94.10.5156
NR 28
TC 81
Z9 84
U1 1
U2 4
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0022-2844
J9 J MOL EVOL
JI J. Mol. Evol.
PD DEC
PY 1998
VL 47
IS 6
BP 640
EP 648
DI 10.1007/PL00006421
PG 9
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA 143WR
UT WOS:000077280900002
PM 9847404
ER

PT J
AU Kurooka, H
   Kuroda, K
   Honjo, T
AF Kurooka, H
   Kuroda, K
   Honjo, T
TI Roles of the ankyrin repeats and C-terminal region of the mouse Notch1
   intracellular region
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID RBP-J-KAPPA; BARR-VIRUS EBNA2; SIGNAL-BINDING-PROTEIN; SPLIT COMPLEX
   GENES; TRANSCRIPTION FACTOR; DROSOPHILA-NOTCH; MAMMALIAN NOTCH;
   CELL-INTERACTIONS; HOMOLOG; SUPPRESSOR
AB The Notch intracellular region (RAMIC) interacts with a DNA binding protein RBP-J to activate transcription of genes that inhibit cell differentiation. The RAM domain and ankyrin (ANK) repeats of mouse Notch1 RAMIC were shown to be responsible for RBP-J binding and necessary for transactivation. The C-terminal portion of Notch1 RAMIC has also been suggested to be important for transactivation. Using GAL4 fusion constructs, we identified a novel transactivation domain (TAD) between the ANK repeats and the PEST sequence of mouse Notch1. The C-terminal half of mouse Notch2 RAMIC also exhibited TAD activity. Unexpectedly, the RBP-J chimeric protein with the Notch1 TAD failed to activate transcription but the activity was recovered by addition of either the RAM domain or ANK repeats. The results suggest that the activity of Notch1 TAD is repressed by fusion with RBP-J because of the presence of a RBP-J-associated co-repressor(s), which could be displaced by either the RAM domain or ANK repeats. Taken together, mouse Notch1 RAMIC can experimentally be separated into three functional domains: the RAM domain and ANK repeats for RBP-J binding and co-repressor displacement and the C-terminal TAD.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Wettstein DA, 1997, DEVELOPMENT, V124, P693
   Schroeter EH, 1998, NATURE, V393, P382
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6
   NYE JS, 1994, DEVELOPMENT, V120, P2421
   WALTZER L, 1994, EMBO J, V13, P5633
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   WEINMASTER G, 1991, DEVELOPMENT, V113, P199
   MATSUNO K, 1995, DEVELOPMENT, V121, P2633
   LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930
   Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663
   SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4
   BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609
   Luo B, 1997, MOL CELL BIOL, V17, P6057
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   COHEN JI, 1992, P NATL ACAD SCI USA, V89, P8030, DOI 10.1073/pnas.89.17.8030
   LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E
   Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0
   Taniguchi Y, 1998, MOL CELL BIOL, V18, P644
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   AUSTIN J, 1989, CELL, V58, P565, DOI 10.1016/0092-8674(89)90437-6
   DELAMO FF, 1992, DEVELOPMENT, V115, P737
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Hsieh JJD, 1997, J VIROL, V71, P1938
   Hubbard EJA, 1996, SCIENCE, V273, P112, DOI 10.1126/science.273.5271.112
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KANG T, 1993, J BIOL CHEM, V268, P9629
   KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0
   LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   Matsuno K, 1997, DEVELOPMENT, V124, P4265
   OLAVE L, 1998, GENE DEV, V12, P1621
   REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N
   Roehl H, 1996, EMBO J, V15, P7002
   Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
NR 55
TC 147
Z9 148
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD DEC 1
PY 1998
VL 26
IS 23
BP 5448
EP 5455
DI 10.1093/nar/26.23.5448
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 147WE
UT WOS:000077487400029
PM 9826771
ER

PT J
AU Matsuda, F
   Ishii, K
   Bourvagnet, P
   Kuma, K
   Hayashida, H
   Miyata, T
   Honjo, T
AF Matsuda, F
   Ishii, K
   Bourvagnet, P
   Kuma, K
   Hayashida, H
   Miyata, T
   Honjo, T
TI The complete nucleotide sequence of the human immunoglobulin heavy chain
   variable region locus
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE immunoglobulin gene; physical map; antibody repertoire; phylogenetic
   tree; DNA duplication
ID DNA-SEQUENCE; CHROMOSOMAL LOCATION; IMPRINTED GENES; D-SEGMENT;
   DIVERSITY; ORGANIZATION; EVOLUTION; ELEMENTS; RECOMBINATION;
   HYBRIDIZATION
AB The complete nucleotide sequence of the 957-kb DNA of the human immunoglobulin heavy chain variable (V-H) legion locus was determined and 43 novel V-H segments were identified. The region contains 123 V-H segments classifiable into seven different families, of which 79 are pseudogenes. Of the 44 V-H segments with an open reading frame, 39 are expressed as heavy chain proteins and 1 as mRNA, while the remaining 4 are not found in immunoglobulin cDNAs. Combinatorial diversity of V-H region was calculated to be similar to 6,000. Conservation of the promoter and recombination signal sequences was observed to be higher in functional VH segments than in pseudogenes. Phylogenetic analysis of 114 V-H segments clearly showed clustering of the V-H segments of each family. However, an independent branch in the tree contained a single V-H, V4-44.1P, sharing similar levels of homology to human V-H families and to those of other vertebrates. Comparison between different copies of homologous units that appear repeatedly across the locus clearly demonstrates that dynamic DNA reorganization of the locus took place at least eight times between 133 and 10 million years ago. One nonimmunoglobulin gene of unknown function was identified in the intergenic region.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 60601, Japan.
   CNRS, INSERM, F-34033 Montpellier, France.
   Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 60601, Japan.
   Nara Med Univ, Kashihara, Nara 634, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 60601, Japan.
RI Matsuda, Fumihiko/B-9893-2009
CR MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622
   Ramsden DA, 1996, EMBO J, V15, P3197
   SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980
   FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0
   MCBRIDE OW, 1982, J EXP MED, V155, P1480, DOI 10.1084/jem.155.5.1480
   TOMLINSON IM, 1994, HUM MOL GENET, V3, P853
   NEEDLEMA.SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146
   Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1
   RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6
   Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250
   HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258
   OHARA B, 1990, CELL GROWTH DIFFER, V1, P119
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0
   BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N
   O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985
   Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167
   BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479
   COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162
   Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141
   COUMO CA, 1996, MOL CELL BIOL, V16, P5683
   DAVIES B, 1993, GENOMICS, V15, P68, DOI 10.1006/geno.1993.1011
   DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475
   DAYHOFF MO, 1976, ATLAS PROTEIN SEQ S2, V5, P1
   EATON S, 1987, P NATL ACAD SCI USA, V84, P7634, DOI 10.1073/pnas.84.21.7634
   Efstratiadis Argiris, 1994, Current Opinion in Genetics and Development, V4, P265, DOI 10.1016/S0959-437X(05)80054-1
   Erlich R, 1996, J BIOL CHEM, V271, P8328
   FRIPPIAT JP, 1995, HUM MOL GENET, V4, P983
   HAINO M, 1994, J BIOL CHEM, V269, P2619
   Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301
   HOLMQUIST GP, 1989, J MOL EVOL, V28, P469, DOI 10.1007/BF02602928
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   IOANNOU PA, 1994, NAT GENET, V6, P84
   Jukes T. H., 1969, MAMMALIAN PROTEIN ME, V3, P21
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   MALCOLM S, 1982, P NATL ACAD SCI-BIOL, V79, P4957, DOI 10.1073/pnas.79.16.4957
   MATSUDA F, 1993, METH MOL G, V2, P226
   Matsuda F, 1996, ADV IMMUNOL, V62, P1, DOI 10.1016/S0065-2776(08)60426-5
   MATSUMURA R, 1994, J IMMUNOL, V152, P660
   NAGAOKA H, 1994, GENOMICS, V22, P189, DOI 10.1006/geno.1994.1360
   NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12
   PERRY ACF, 1995, BIOCHEM J, V312, P239
   RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   Tenzen T, 1997, MOL CELL BIOL, V17, P4043
   TONEGAWA S, 1983, NATURE, V302, P505
   Zachau H. G., 1995, IMMUNOGLOBULIN GENES, P173, DOI 10.1016/B978-012053640-5/50011-2
NR 57
TC 222
Z9 228
U1 2
U2 10
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD DEC 7
PY 1998
VL 188
IS 11
BP 2151
EP 2162
DI 10.1084/jem.188.11.2151
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 147JA
UT WOS:000077484700018
PM 9841928
ER

PT J
AU Tashiro, K
   Nakamura, T
   Honjo, T
AF Tashiro, K
   Nakamura, T
   Honjo, T
TI The signal sequence trap method
SO CDNA PREPARATION AND CHARACTERIZATION
SE METHODS IN ENZYMOLOGY
LA English
DT Review
ID ENCODING SECRETED PROTEINS; MOLECULAR-CLONING; ENDOPLASMIC-RETICULUM;
   MEMBRANE-PROTEINS; CHEMOKINE SDF-1; CELLS; CDNA; CHEMOATTRACTANT;
   LESTR/FUSIN; SELECTION
C1 Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Tashiro, K (reprint author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Mori K, 1997, FEBS LETT, V401, P218, DOI 10.1016/S0014-5793(96)01473-1
   UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
   YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O
   Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101
   NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0
   Imai T, 1996, J BIOL CHEM, V271, P21514
   NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305
   NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9
   Ausubel F. M., 1987, CURRENT PROTOCOL MOL
   GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8
   Grosse F, 1993, Methods Mol Biol, V16, P95, DOI 10.1385/0-89603-234-5:95
   HAMADA T, 1996, GENE, V30, P112
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229
   LOPEZ ND, IN PRESS BIOMED RES
   LUDWIG T, 1995, TRENDS CELL BIOL, V5, P202, DOI 10.1016/S0962-8924(00)89000-5
   NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872
   NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0
   PERSON WR, 1988, P NATL ACAD SCI USA, V85, P2444
   SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHUSTER DM, 1992, FOCUS, V14, P46
   Shirozu M, 1996, GENOMICS, V37, P273, DOI 10.1006/geno.1996.0560
   Tashiro K, 1997, Methods Mol Biol, V69, P203
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
   YOKOYAMAKOBAYASHI M, 1995, GENE, V163, P193, DOI 10.1016/0378-1119(95)00322-W
NR 36
TC 15
Z9 19
U1 1
U2 1
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 1999
VL 303
BP 479
EP 495
PG 17
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BN43D
UT WOS:000081913000027
PM 10349661
ER

PT J
AU Kinoshita, K
   Lee, CG
   Tashiro, J
   Muramatsu, M
   Chen, XC
   Yoshikawa, K
   Honjo, T
AF Kinoshita, K
   Lee, CG
   Tashiro, J
   Muramatsu, M
   Chen, XC
   Yoshikawa, K
   Honjo, T
TI Molecular mechanism of immunoglobulin class switch recombination
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article; Proceedings Paper
CT 64th Symposia: Signaling and Gene Expression in the Immune System
CY JUN 02-07, 1999
CL NEW YORK, NEW YORK
SP Alafi Capital Co, Amgen Inc, BASF Biores Corp, Bayer Corp, Bristol Myers Squibb Co, Chiron Corp, Chugai Res Inst Molec Med, Diagnost Prod Corp, Du Pont Pharmaceut Co, Forest Labs, Genentech Inc, Genet Inst, Glaxo Wellcome Inc, Hoechst Marion Roussel, Hoffmann La Roche Inc, Johnson & Johnson, Eli Lilly & Co, Merck Res Labs, New England BioLabs Inc, Novartis Pharma Res, OSI Pharmaceut Inc, Pall Corp, Parke Davis Pharmaceut Res, PE Biosyst, Pfizer Inc, Pharmacia & Upjohn Inc, Res Genet Inc, Schering Plough Corp, SmithKline Beecham Pharmaceut, Wyeth Ayerst Res, Zeneca Grp PLC
ID HEAVY-CHAIN SWITCH; CIRCULAR DNA; B-CELLS; NUCLEOTIDE-SEQUENCES; GENE;
   DELETION; SPECIFICITY; ISOTYPE; REGIONS; TRANSCRIPTS
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Kinoshita, K (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0
   BOTTARO A, 1994, EMBO J, V13, P665
   Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   ARNOLD LW, 1988, J IMMUNOL, V140, P4355
   Ballantyne J, 1997, INT IMMUNOL, V9, P963, DOI 10.1093/intimm/9.7.963
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   Du J, 1997, NUCLEIC ACIDS RES, V25, P3066, DOI 10.1093/nar/25.15.3066
   DUNNICK W, 1980, NATURE, V286, P669, DOI 10.1038/286669a0
   DUNNICK W, 1989, MOL CELL BIOL, V9, P1850
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151
   LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154
   Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X
   LUPTON SD, 1991, MOL CELL BIOL, V11, P3374
   MAKI R, 1980, P NATL ACAD SCI-BIOL, V77, P2138, DOI 10.1073/pnas.77.4.2138
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2
   NAKAMURA M, 1996, INT IMMUNOL, V8, P196
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   OTT DE, 1987, EMBO J, V6, P557
   Petry Katja, 1999, International Immunology, V11, P753, DOI 10.1093/intimm/11.5.753
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 47
TC 14
Z9 14
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1999
VL 64
BP 217
EP 226
DI 10.1101/sqb.1999.64.217
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 317KW
UT WOS:000087225400027
PM 11232289
ER

PT J
AU Tani, S
   Taniwaki, M
   Taniguchi, Y
   Minoguchi, S
   Kuroda, K
   Han, H
   Aoki, T
   Miyatake, S
   Hashimoto, N
   Honjo, T
AF Tani, S
   Taniwaki, M
   Taniguchi, Y
   Minoguchi, S
   Kuroda, K
   Han, H
   Aoki, T
   Miyatake, S
   Hashimoto, N
   Honjo, T
TI Chromosomal mapping of two RBP-J-related genes: Kyo-T and RBP-L
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE chromosomal mapping; Kyo-T; RBP-L; RBP-J
ID TRANSCRIPTION FACTOR; J-KAPPA; MUTATIONS; RBP-J-KAPPA/SU(H); NOTCH1
AB We have recently isolated two genes encoding proteins which have either homology or affinity to RBP-J, a transcription factor involved in Notch signaling. Kyo-T interacts with RBP-J and possibly regulates the function of RBP-J. RBP-L has a highly homologous region with REP J but the function of RBP-L is unknown. Fluorescence in situ hybridization analysis of human metaphase chromosomes localized Kyo-T and RBP-L to Xq26 and 20q12-13.1, respectively.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Neurosurg, Kyoto 606, Japan.
   Kyoto Prefectural Med Sch, Dept Internal Med 3, Kyoto, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RI Taniguchi, Yoshihito/L-5746-2013
CR Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   OKA C, 1995, DEVELOPMENT, V121, P3291
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0
   Taniguchi Y, 1998, MOL CELL BIOL, V18, P644
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   TANIWAKI M, 1994, BLOOD, V83, P2962
NR 13
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113, JAPAN
SN 1434-5161
J9 J HUM GENET
JI J. Hum. Genet.
PY 1999
VL 44
IS 1
BP 73
EP 75
DI 10.1007/s100380050112
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA 159TV
UT WOS:000078191400017
PM 9929984
ER

PT J
AU Lopez, ND
   Kinoshita, A
   Taniwaki, M
   Tada, H
   Shirozu, M
   Nakano, T
   Tashiro, K
   Honjo, T
AF Lopez, ND
   Kinoshita, A
   Taniwaki, M
   Tada, H
   Shirozu, M
   Nakano, T
   Tashiro, K
   Honjo, T
TI Isoform specific expression of the SDR-1 protein, alpha and beta in
   subregions of adult rodent brain
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
ID SIGNAL SEQUENCE TRAP; IMMUNOGLOBULIN SUPERFAMILY; MEMBRANE-PROTEINS;
   SECRETED PROTEINS; NERVOUS-SYSTEM; GENE; GP65; GP55; LOCALIZATION;
   MEMBERS
AB Stromal cell-derived receptor-1 (SDR-1) alpha and beta, also called gp55 and gp65, belong to the immunoglobulin (Ig) superfamily. Rabbit antisera specific to SDR-1 beta and those recognizing both alpha and beta forms of SDR-1 were raised to study regional distributions of SDR-1 alpha and beta in the adult rodent brain. Immunohistochemical studies of adult rat brains with either antibodies revealed a granular pattern of staining distributed within neuropils. SDR-1 beta form like immunoreactivity (beta-LI) was detected in limited regions, namely the glomerulus of the olfactory bulb and the superficial layers (layers II: III) of the cerebral cortex, whereas alpha beta-LI was found in the olfactory tubercle, cerebral center, hippocampus, thalamus, midbrain, and molecular layer in the cerebellum, suggesting wider distribution of SDR-1 alpha. The SDR1 gene is highly conserved from Xenopus to human. The human SDR-1 cDNA was isolated and the human SDR1 gene was mapped to chromosome 15q22 by fluorescence in situ hybridization.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068507, Japan.
   Kyoto Univ, Fac Med, Dept Morphol Brain Sci, Kyoto 6068507, Japan.
   Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 6020841, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068507, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068507, Japan.
CR Kinoshita A, 1996, NEUROSCI LETT, V207, P199, DOI 10.1016/0304-3940(96)12519-2
   WILLMOTT T, 1992, J NEUROCHEM, V58, P2037, DOI 10.1111/j.1471-4159.1992.tb10944.x
   Sharp JD, 1997, HUM MOL GENET, V6, P591, DOI 10.1093/hmg/6.4.591
   HILL IE, 1988, BRAIN RES, V461, P27, DOI 10.1016/0006-8993(88)90722-6
   Langnaese K, 1997, J BIOL CHEM, V272, P821
   Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346
   Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   Langnaese K, 1998, FEBS LETT, V429, P284, DOI 10.1016/S0014-5793(98)00616-4
   Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613
   Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H
   Naruhashi K, 1997, BIOCHEM BIOPH RES CO, V236, P733, DOI 10.1006/bbrc.1997.6993
   Shirozu M, 1996, GENOMICS, V37, P273, DOI 10.1006/geno.1996.0560
   TANIWAKI M, 1994, BLOOD, V83, P2962
   Tashiro K, 1997, Methods Mol Biol, V69, P203
   Uyemura K, 1996, Essays Biochem, V31, P37
   Volenec A, 1997, NEUROREPORT, V8, P2913, DOI 10.1097/00001756-199709080-00022
   YAZAKI T, 1994, NEUROSCI LETT, V176, P13, DOI 10.1016/0304-3940(94)90859-1
NR 20
TC 1
Z9 4
U1 1
U2 1
PU BIOMEDICAL RESEARCH PRESS LTD
PI TOKYO
PA 5F KYOWA BLDG, 2-1-3 KYOBASHI, CHUO-KU, TOKYO, 104-0031, JAPAN
SN 0388-6107
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PD FEB
PY 1999
VL 20
IS 1
BP 43
EP 49
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 206UR
UT WOS:000080898100006
ER

PT J
AU Saito, S
   Nishimura, H
   Brumeanu, TD
   Casares, S
   Stan, AC
   Honjo, T
   Bona, CA
AF Saito, S
   Nishimura, H
   Brumeanu, TD
   Casares, S
   Stan, AC
   Honjo, T
   Bona, CA
TI Characterization of mutated protein encoded by partially duplicated
   fibrillin-1 gene in tight skin (TSK) mice
SO MOLECULAR IMMUNOLOGY
LA English
DT Article
ID MARFAN-SYNDROME; DERMAL FIBROBLASTS; N-GLYCOSYLATION; MOUSE;
   MICROFIBRILS; EXPRESSION; MUTATIONS; COLLAGEN; GROWTH; FBN1
AB Fibrillin-1 (Fbn-1) is a ubiquitous protein present in the extracellular matrix of various organs and it is a major component of microfibrils embedded in the core of elastic fibers. In humans, mutations or deletions of the Fbn-1 gene are associated with several genetic diseases. In addition, several microsatellite alleles near Fbn-1 gene were found associated with diffuse scleroderma. In TSK/+mice, which develop a scleroderma-like syndrome, the Fbn-1 gene exhibits an inframe duplication of exons 17-40. In this study, we report that the synthesis and secretion of wild-type Fbn-1 in TSK/+ is higher than that of the mutated Fbn-1 protein excluding the possibility that TSK genetic defect is due to a loss of the wild allele. We also demonstrate for the first time that TGF-beta, which plays a crucial role in skin fibrosis, binds to both wild-type and mutated Fbn-1. The amount of bound TGF-beta was higher in mutated than wild-type Fbn-1 and appears related to the number of TGF-beta binding motifs. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Hannover Med Sch, Inst Neuropathol, D-30625 Hannover, Germany.
RP Bona, CA (reprint author), CUNY Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.
CR INAGAKI Y, 1994, J BIOL CHEM, V269, P14828
   Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300
   HAYWARD C, 1994, MOL CELL PROBE, V8, P325, DOI 10.1006/mcpr.1994.1045
   SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499
   Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1362, DOI 10.1002/art.1780390814
   VARGA J, 1987, BIOCHEM J, V247, P597
   DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349
   LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110
   GREEN MC, 1976, AM J PATHOL, V82, P493
   MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589
   BONA C, 1994, CURR OPIN IMMUNOL, V6, P831
   Bona C A, 1997, DNA Res, V4, P267, DOI 10.1093/dnares/4.4.267
   DIETZ HC, 1995, HUM MOL GENET, V4, P1799
   HANFORD P, 1995, J BIOL CHEM, V270, P6751
   HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205
   JIMENEZ SA, 1986, J BIOL CHEM, V261, P657
   Kasturi KN, 1997, J AUTOIMMUN, V10, P505, DOI 10.1006/jaut.1997.0158
   Kielty CM, 1998, J CELL BIOL, V140, P1159, DOI 10.1083/jcb.140.5.1159
   Lonnqvist L, 1996, GENOMICS, V36, P468, DOI 10.1006/geno.1996.0492
   Murai C, 1998, AUTOIMMUNITY, V28, P151, DOI 10.3109/08916939808996283
   NIJIEROEK G, 1995, AM J HUM GENET, V57, P8
   OSBORN TG, 1983, J RHEUMATOL, V10, P793
   Raghunath M, 1996, J INVEST DERMATOL, V106, P1090, DOI 10.1111/1523-1747.ep12339373
   RAGHUNATH M, 1995, J MOL BIOL, V248, P901, DOI 10.1006/jmbi.1995.0270
   Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4
   Tan FK, 1998, ARTHRITIS RHEUM, V41, P1729
   YIN WS, 1995, J BIOL CHEM, V270, P1798
NR 27
TC 29
Z9 29
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD FEB
PY 1999
VL 36
IS 3
BP 169
EP 176
DI 10.1016/S0161-5890(99)00035-8
PG 8
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 208XD
UT WOS:000081016400002
PM 10403482
ER

PT J
AU Kuroda, K
   Tani, S
   Tamura, K
   Minoguchi, S
   Kurooka, H
   Honjo, T
AF Kuroda, K
   Tani, S
   Tamura, K
   Minoguchi, S
   Kurooka, H
   Honjo, T
TI Delta-induced notch signaling mediated by RBP-J inhibits MyoD expression
   and myogenesis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID LOOP-HELIX FACTORS; BARR-VIRUS EBNA2; J-KAPPA; TRANSCRIPTION FACTOR;
   DROSOPHILA HOMOLOG; NERVOUS-SYSTEM; BINDING-SITE; MOUSE NOTCH; CELL
   FATE; GENE
AB Signaling induced by interaction between the receptor Notch and its ligand Delta plays an important role in cell fate determination in vertebrates as well as invertebrates. Vertebrate Notch signaling has been investigated using its constitutively active form, i.e. the truncated intracellular region which is believed to mimic Notch-Delta signaling by interaction with a DNA-binding protein RBP-J. However, the molecular mechanism for Notch signaling triggered by ligand binding, which leads to inhibition of differentiation, is not clear. We have established a myeloma cell line expressing mouse Deltal on its cell surface which can block muscle differentiation by co-culture with C2C12 muscle progenitor cells. We showed that Delta-induced Notch signaling stimulated transcriptional activation of RBP-J binding motif, containing promoters including the HES1 promoter. Furthermore, ligand-induced Notch signaling up-regulated HES1 mRNA expression within 1 h and subsequently reduced expression of MyoD mRNA, Since cycloheximide treatment did not inhibit induction of HES1 mRNA, the HES1 promoter appears to be a primary target of activated Notch. In addition, a transcriptionally active form of RBP-J, i.e. VP16-RBP-J, inhibited muscle differentiation of C2C12 cells by blocking the expression of MyoD protein. These results suggest that HES1 induction by the Deltal/Notch signaling is mediated by RBP-J and blocks myogenic differentiation of C2C12 cells by subsequent inhibition of MyoD expression.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8
   SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407
   SPEICHER SA, 1994, DEVELOPMENT, V120, P535
   WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3
   Kato H, 1997, DEVELOPMENT, V124, P4133
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   Schroeter EH, 1998, NATURE, V393, P382
   BRAUN T, 1989, EMBO J, V8, P701
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   NYE JS, 1994, DEVELOPMENT, V120, P2421
   Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136
   YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Couso JP, 1995, CURR BIOL, V5, P1437, DOI 10.1016/S0960-9822(95)00281-8
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Yoshida N, 1998, J CELL SCI, V111, P769
   GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W
   HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X
   REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X
   DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X
   OKA C, 1995, DEVELOPMENT, V121, P3291
   BRAUN T, 1989, EMBO J, V8, P3617
   Shawber C, 1996, DEVELOPMENT, V122, P3765
   THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   Sakai T, 1998, J VIROL, V72, P6034
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   Luo B, 1997, MOL CELL BIOL, V17, P6057
   deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y
   FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505
   GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831
   WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104
   ASAKURA A, 1993, MOL CELL BIOL, V13, P7153
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037
   DELAMO FF, 1993, GENOMICS, V15, P289
   EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628
   FUJISAWASEHARA A, 1990, J BIOL CHEM, V265, P15219
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   GU Y, 1995, DEVELOPMENT, V121, P855
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Hsieh JJD, 1997, J VIROL, V71, P1938
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Matsuno K, 1997, DEVELOPMENT, V124, P4265
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411
   Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9
   SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P921
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   Tsakonas SA, 1995, SCIENCE, V268, P225
   Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939
   Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612
NR 69
TC 178
Z9 182
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 12
PY 1999
VL 274
IS 11
BP 7238
EP 7244
DI 10.1074/jbc.274.11.7238
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 175DV
UT WOS:000079078400057
PM 10066785
ER

PT J
AU Kanazawa, N
   Yoneda, K
   Tashiro, K
   Inaba, K
   Miyachi, Y
   Honjo, T
AF Kanazawa, N
   Yoneda, K
   Tashiro, K
   Inaba, K
   Miyachi, Y
   Honjo, T
TI Constitutive expression of CX3C chemokine fractalkine in mouse skin
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
C1 Kyoto Univ, Fac Med, Dept Dermatol, Kyoto 606, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
   Kyoto Univ, Fac Sci, Dept Zool, Kyoto, Japan.
   Kyoto Univ, Fac Sci, Ctr Mol Biol & Genet, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 1999
VL 112
IS 4
MA 754
BP 648
EP 648
PG 1
WC Dermatology
SC Dermatology
GA 182JL
UT WOS:000079495800774
ER

PT J
AU Shinkura, R
   Kitada, K
   Matsuda, F
   Tashiro, K
   Ikuta, K
   Suzuki, M
   Kogishi, K
   Serikawa, T
   Honjo, T
AF Shinkura, R
   Kitada, K
   Matsuda, F
   Tashiro, K
   Ikuta, K
   Suzuki, M
   Kogishi, K
   Serikawa, T
   Honjo, T
TI Alymphoplasia is caused by a point mutation in the mouse gene encoding
   Nf-kappa b-inducing kinase
SO NATURE GENETICS
LA English
DT Article
ID LYMPHOTOXIN-BETA-RECEPTOR; TUMOR-NECROSIS-FACTOR; PERIPHERAL LYMPHOID
   ORGANS; ALY MUTANT MICE; DEFICIENT MICE; CELL-DEATH; ALPHA;
   ORGANOGENESIS; ORGANIZATION; EXPRESSION
AB The alymphoplasia (aly) mutation of mouse is autosomal recessive and characterized by the systemic absence of lymph nodes (LN) and Peyer's patches (PP) and disorganized splenic and thymic structures with immunodeficiency(1-3). Although recent reports have shown that the interaction between lymphotoxin (LT) and the LT beta-receptor (Lt beta r, encoded by Ltbr) provides a critical signal for LN genesis in mice(4-10), the aly locus on chromosome 11 (ref, 11) is distinct from those for LT and its receptor. We found that the aly allele carries a point mutation causing an amino acid substitution in the carboxy-terminal interaction domain of Nf-kappa b-inducing kinase(12,13) (Nik, encoded by the gene Nik). Transgenic complementation with wild-type Nik restored the normal structures of LN, PP, spleen and thymus, and the normal immune response in aly/aly mice. In addition, the aly mutation in a kinase domain-truncated Nik abolished its dominant-negative effect on Nf-kappa b activation induced by an excess of Lt beta r. Our observations agree with previous reports that Lt beta r-deficient mice showed defects in LN genesis(4) and that Nik is a common mediator of Nf-kappa b activation by the tumour necrosis factor (TNF) receptor family(12,13). Nik is able to interact with members of the TRAF family (Traf1, 2, 3, 5 and 6; ref. 13), suggesting it acts downstream of TRAF-associating receptor signalling pathways, including Tnfr (ref. 12), Cd40 (refs 14,15), Cd30 (refs 16,17) and Lt beta r (refs 18-21). The phenotypes of aly/aly mice are more severe than those of Ltbr(-/-) mice, however, indicating involvement of Nik in signal transduction mediated by other receptors.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan.
   Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Matsuda, Fumihiko/B-9893-2009
CR Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792
   Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699
   Nakano H, 1996, J BIOL CHEM, V271, P14661
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322
   Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9
   Lin X, 1998, MOL CELL BIOL, V18, P5899
   BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437
   Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437
   KOSCO MH, 1992, J IMMUNOL, V148, P2331
   Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0
   VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460
   Koike R, 1996, EUR J IMMUNOL, V26, P669, DOI 10.1002/eji.1830260324
   SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419
   Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7
   Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999
   CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327
   BANKS TA, 1995, J IMMUNOL, V155, P1685
   Duckett CS, 1997, MOL CELL BIOL, V17, P1535
   Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627
   Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835
   Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23
   Krajewska M, 1998, AM J PATHOL, V152, P1549
   KURAMOTO T, 1994, INT IMMUNOL, V6, P991, DOI 10.1093/intimm/6.7.991
   KVIST S, 1983, EMBO J, V2, P245
   NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872
   NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0
   Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067
NR 28
TC 328
Z9 333
U1 0
U2 2
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1061-4036
J9 NAT GENET
JI Nature Genet.
PD MAY
PY 1999
VL 22
IS 1
BP 74
EP 77
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 192TU
UT WOS:000080096300026
PM 10319865
ER

PT J
AU Kanazawa, N
   Nakamura, T
   Tashiro, K
   Muramatsu, M
   Morita, K
   Yoneda, K
   Inaba, K
   Imamura, S
   Honjo, T
AF Kanazawa, N
   Nakamura, T
   Tashiro, K
   Muramatsu, M
   Morita, K
   Yoneda, K
   Inaba, K
   Imamura, S
   Honjo, T
TI Fractalkine and macrophage-derived chemokine: T cell-attracting
   chemokines expressed in T cell area dendritic cells
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE chemokine; T cell recruitment; T cell area dendritic cell
ID SIGNAL SEQUENCE TRAP; CC-CHEMOKINE; MOLECULAR-CLONING; SECRETED
   PROTEINS; LYMPHOCYTES; RECEPTORS; CX(3)CR1; ACTS; MDC; CHEMOATTRACTANT
AB Dendritic cells (DC) are a system of antigen-presenting cells specialized in interaction with T cells. Recently it has been reported that DC can produce CC (beta) chemokines that attract T cells. In this study we isolated mouse fractalkine and macrophage-derived chemokine (MDC) belonging to CX3C (delta) and CC chemokine families, respectively, from bone marrow-derived mature DC. While expression of fractalkine, which has so Car been only examined in the brain and in vitro endothelial cells so far, was rather ubiquitous, MDC, which has been reported to be synthesized by macrophages and DC, was expressed specifically in the thymus and lymph node. This is the first report that indicates fractalkine expression by DC. Expression of fractalkine and MDC mRNA increased with maturation of DG during in vitro culture of bone marrow cells. Spleen- and epidermis-derived mature DC in culture also expressed these chemokines. Furthermore, their expression was detected selectively by Northern hybridization in CD11c(+) B220(-) DC freshly purified from lymph nodes, and in large stellate cells in the lymph node T cell areas by in situ hybridization. Conditioned media of 293T cells transfected with these chemokine cDNA were chemotactic to Con A-activated splenic T cells as well as the mouse T cell line EL4. In conclusion, while fractalkine and MDC belong to different families of chemokines, both may be involved in recruitment of T cells for interaction with mature DC in the immune response.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068315, Japan.
   Kyoto Univ, Fac Med, Dept Dermatol, Kyoto 6068315, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068315, Japan.
   Kyoto Univ, Fac Sci, Dept Zool, Kyoto 6068315, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068315, Japan.
OI Kanazawa, Nobuo/0000-0003-3000-9711
CR Chang MS, 1997, J BIOL CHEM, V272, P25229, DOI 10.1074/jbc.272.40.25229
   D'Ambrosio D, 1998, J IMMUNOL, V161, P5111
   Nomiyama H, 1998, CYTOGENET CELL GENET, V81, P10, DOI 10.1159/000015000
   Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2
   Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x
   Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101
   Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595
   Ward SG, 1998, IMMUNITY, V9, P1, DOI 10.1016/S1074-7613(00)80583-X
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896
   Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451
   Rossi DL, 1998, GENOMICS, V47, P163, DOI 10.1006/geno.1997.5058
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451
   Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413
   Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716
   Andrew DP, 1998, J IMMUNOL, V161, P5027
   NUMA F, 1995, CANCER RES, V55, P4676
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Rollins BJ, 1997, BLOOD, V90, P909
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665
   Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3
   Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9
   UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y
   Imai T, 1996, J BIOL CHEM, V271, P21514
   Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491
   Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037
   Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0
   GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6
   NGO NV, 1998, J EXP MED, V188, P181
   Ortner U, 1996, J IMMUNOL METHODS, V193, P71, DOI 10.1016/0022-1759(96)00058-0
   Sambrook J., 1989, MOL CLONING LAB MANU
   Yoneda K, 1998, BRIT J DERMATOL, V138, P37
NR 36
TC 77
Z9 81
U1 2
U2 3
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JUN
PY 1999
VL 29
IS 6
BP 1925
EP 1932
DI 10.1002/(SICI)1521-4141(199906)29:06<1925::AID-IMMU1925>3.0.CO;2-U
PG 8
WC Immunology
SC Immunology
GA 205NV
UT WOS:000080828200019
PM 10382755
ER

PT J
AU Sakiyama, T
   Ikuta, K
   Nisitani, S
   Takatsu, K
   Honjo, T
AF Sakiyama, T
   Ikuta, K
   Nisitani, S
   Takatsu, K
   Honjo, T
TI Requirement of IL-5 for induction of autoimmune hemolytic anemia in
   anti-red blood cell autoantibody transgenic mice
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE autoimmune hemolytic anemia; IL-5
ID LY-1 B-CELLS; B-1 CELLS; INTERLEUKIN-5
AB IL-5, IL-10 and lipopolysaccharide (LPS) are known to activate B-1 cells in vivo in normal mice and anti-red blood cell autoantibody transgenic mice (HL mice). To assess the exact role of IL-5 in proliferation and activation of peritoneal B-1 cells, we analyzed IL-5 receptor a chain-deficient HL (IL-5Ra(-/-) x HL) mice generated by the cross between IL-5R alpha(-/-) and HL mice. In IL-5R alpha(-/-) x HL mice, Ig-producing B-1 cells in the peritoneal cavity were negligible, although the total number of B-1 cells in the peritoneal cavity were as many as 30% of that in HL mice. Moreover, LPS- or IL-10-induced differentiation of B-l cells into antibody-producing cells was severely impaired in IL-5R alpha(-/-) x HL mice. We also used in vivo 5-bromo-2'-deoxyuridine labeling to estimate the proliferation of B-1 cells in IL-5R alpha(-/-) mice. The absence of IL-5R alpha did not affect spontaneous proliferation of peritoneal B-1 cells. However, induced proliferation of peritoreal B-1 cells by oral administration of LPS was markedly impaired in IL-5R alpha(-/-) mice. These results suggest that IL-5 is required for activation-associated proliferation of B-1 cells but not for their spontaneous proliferation and support the idea that IL-5 plays an important role on the induction of autoantibody production from B-l cells.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Univ Tokyo, Inst Med Sci, Dept Immunol, Tokyo 108, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR DEENEN GJ, 1993, EUR J IMMUNOL, V23, P12, DOI 10.1002/eji.1830230104
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   HITOSHI Y, 1990, J IMMUNOL, V144, P4218
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317
   ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   CARAYON P, 1992, J IMMUNOL METHODS, V147, P225
   FOSTER I, 1989, INT IMMUNOL, V1, P321
   Nisitani S, 1998, INT IMMUNOL, V10, P1039, DOI 10.1093/intimm/10.8.1039
   TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429
NR 19
TC 18
Z9 18
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUN
PY 1999
VL 11
IS 6
BP 995
EP 1000
DI 10.1093/intimm/11.6.995
PG 6
WC Immunology
SC Immunology
GA 210FL
UT WOS:000081094400016
PM 10360974
ER

PT J
AU Lee, JS
   Haruna, T
   Ishimoto, A
   Honjo, T
   Yanagawa, SI
AF Lee, JS
   Haruna, T
   Ishimoto, A
   Honjo, T
   Yanagawa, SI
TI Intracisternal type A particle-mediated activation of the Notch4/int3
   gene in a mouse mammary tumor: Generation of truncated Notch4/int3 mRNAs
   by retroviral splicing events
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID NOTCH-GENE; NEOPLASTIC TRANSFORMATION; FAMILY; INT-3; VIRUS; LEUKEMIA;
   REPEATS; HOMOLOG; MEMBER; CELLS
AB The int3 oncogene was discovered as a frequent target in mouse mammary tumor virus-induced mammary tumors and encodes the intracellular domain of a Notch-4/int3 protein. In one spontaneous mammary tumor, no. 9, that developed in a BALB/c mouse, we have found an insertion of a 1.2-kb sequence, consisting of a 5' long terminal repeat and gag sequences of an intracisternal type A particle (IAP) as well as an extra copy of the Notch4/int3 genomic sequences containing exons 23 and 24, into the intron between exons 24 and 25 of the Notch4/int3 gene. In this tumor, unique splicing events between the IAP and the Notch4/int3 sequences generated two types of IAP-Notch4/int3 fusion transcripts encoding two different portions of the intracellular domain of Notch4/int3 proteins: one with a RAM domain and the other without. Interestingly, these two proteins showed different subcellular localizations in a mouse mammary epithelial cell line, HC-11.
C1 Kyoto Univ, Inst Virus Res, Dept Viral Onocl, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068507, Japan.
RP Yanagawa, SI (reprint author), Kyoto Univ, Inst Virus Res, Dept Viral Onocl, Sakyo Ku, Kyoto 6068507, Japan.
CR Gallahan D, 1987, J Virol, V61, P218
   Yanagawa SI, 1997, J BIOL CHEM, V272, P25243, DOI 10.1074/jbc.272.40.25243
   ROBBINS J, 1992, J VIROL, V66, P2594
   Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7
   MIETZ JA, 1987, J VIROL, V61, P3020
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930
   Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   CHRISTY RJ, 1988, MOL CELL BIOL, V8, P1093
   DUNN TB, 1955, PHYSIOPATHOLOGY CANC, P38
   HOROWITZ M, 1984, EMBO J, V3, P2937
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345
   KORDON EC, 1995, J VIROL, V69, P8066
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   LESLIE KB, 1991, MOL CELL BIOL, V11, P5562
   Rohn JL, 1996, J VIROL, V70, P8071
   UYTTENDAELE H, 1996, DEVELOPMENT, V122, P199
   WEINMASTER G, 1992, DEVELOPMENT, V116, P2251
NR 23
TC 15
Z9 16
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD JUN
PY 1999
VL 73
IS 6
BP 5166
EP 5171
PG 6
WC Virology
SC Virology
GA 195UW
UT WOS:000080271400073
PM 10233982
ER

PT J
AU Muramatsu, M
   Sankaranand, VS
   Anant, S
   Sugai, M
   Kinoshita, K
   Davidson, NO
   Honjo, T
AF Muramatsu, M
   Sankaranand, VS
   Anant, S
   Sugai, M
   Kinoshita, K
   Davidson, NO
   Honjo, T
TI Specific expression of activation-induced cytidine deaminase (AID), a
   novel member of the RNA-editing deaminase family in germinal center B
   cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CLASS SWITCH RECOMBINATION; PRIMARY IMMUNE-RESPONSE; CATALYTIC SUBUNIT;
   CHROMOSOMAL LOCALIZATION; SOMATIC HYPERMUTATION; MOLECULAR-CLONING;
   PROTEIN; ENZYME; MATURATION; BINDING
AB We have identified a novel gene referred to as activation-induced deaminase (AID) by subtraction of cDNAs derived from switch-induced and uninduced murine B lymphoma CH12F3-2 cells, more than 80% of which switch exclusively to IgA upon stimulation. The amino acid sequence encoded by ALD cDNA is homologous to that of apolipoprotein B (apoB) mRNA-editing enzyme, catalytic polypeptide 1 (APOBEC-1), a type of cytidine deaminase that constitutes a catalytic subunit for the apoB mRNA-editing complex. In vitro experiments using a glutathione S-transferase AID fusion protein revealed significant cytidine deaminase activity that is blocked by tetrahydrouridine and by zinc chelation. However, AID alone did neither demonstrate activity in C to U editing of apoB mRNA nor bind to AU-rich RNA targets, AID mRNA expression is induced in splenic B cells that were activated in vitro or by immunizations with sheep red blood cells. In situ hybridization of immunized spleen sections revealed the restricted expression of AID mRNA in developing germinal centers in which modulation of immunoglobulin gene information through somatic hypermutation and class switch recombination takes place. Taken together, these findings suggest that AID is a new member of the RNA-editing deaminase family and may play a role in genetic events in the germinal center B cell.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan.
   Washington Univ, Sch Med, Dept Internal Med, Div Gastroenterol, St Louis, MO 63110 USA.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ANANT S, 1995, J BIOL CHEM, V270, P14762
   TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409
   NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3
   BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451
   JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011
   BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996
   KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206
   Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506
   BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013
   George J, 1992, Semin Immunol, V4, P11
   Innerarity TL, 1996, J BIOL CHEM, V271, P2353
   JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165
   KINOSHITA K, 1998, IMMUNITY, V9, P349
   KRAAL G, 1985, ADV EXP MED BIOL, V186, P145
   LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   Lorenz M, 1996, CURR TOP MICROBIOL, V217, P151
   MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768
   Nakamura T, 1998, GENOMICS, V54, P89, DOI 10.1006/geno.1998.5571
   NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709
   REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307
   SABLITZKY F, 1985, EMBO J, V4, P345
   SIMPSON L, 1995, CELL, V81, P837, DOI 10.1016/0092-8674(95)90003-9
   Smith HC, 1996, TRENDS GENET, V12, P418, DOI 10.1016/0168-9525(96)10042-1
   Sugai M, 1998, NUCLEIC ACIDS RES, V26, P911, DOI 10.1093/nar/26.4.911
   YAMANAKA S, 1994, J BIOL CHEM, V269, P21725
NR 34
TC 686
Z9 699
U1 4
U2 29
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 25
PY 1999
VL 274
IS 26
BP 18470
EP 18476
DI 10.1074/jbc.274.26.18470
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 209PJ
UT WOS:000081056700047
PM 10373455
ER

PT J
AU Hagiyama, H
   Adachi, T
   Yoshida, T
   Nomura, T
   Miyasaka, N
   Honjo, T
   Tsubata, T
AF Hagiyama, H
   Adachi, T
   Yoshida, T
   Nomura, T
   Miyasaka, N
   Honjo, T
   Tsubata, T
TI Signaling through the antigen receptor of B lymphocytes activates a
   p53-independent pathway of c-Myc-induced apoptosis
SO ONCOGENE
LA English
DT Article
DE apoptosis; B lymphocyte; c-Myc; p53
ID CELL-CYCLE ARREST; DNA-BINDING SITE; TRANSGENIC MICE; LYMPHOMA-CELLS;
   MEDIATED APOPTOSIS; GROWTH ARREST; P53; EXPRESSION; INDUCTION; PROTEIN
AB Deregulated expression of c-Myc has been shown to induce or enhance apoptosis in various different cell types, c-Myc requires p53 for apoptosis in some but not all the cell types, indicating heterogeneous mechanisms for c-Myc-induced apoptosis, In B lymphoma line WEHI-231, stable expression of c-Myc has been demonstrated to protect cells from BCR-mediated apoptosis. However, stable expression of c-Myc carrying pro-apoptotic functions may generate variant cells resistant to apoptosis. By utilizing an inducible system for c-Myc, me demonstrated here that deregulated expression of c-Myc induced apoptosis of WEHI-231 by itself, indicating that c-Myc induces apoptosis in WEHI-231 as is the case for other cell types. When transactivation of p53 was inactivated, WEHI-231 cells overexpressing c-Myc no longer underwent apoptosis in the absence of other stimuli, but showed markedly enhanced apoptosis in the presence of BCR ligation. These results indicate that deregulated c-Myc expression enhances apoptosis by a p53-independent pathway in the presence of BCR signaling but requires p53 for apoptosis in the absece of BCR crosslinking in WEHI-231, BCR ligation may thus activate a p53-independent pathway of Myc-induced apoptosis.
C1 Tokyo Med & Dent Univ, Inst Med Res, Dept Immunol, Bunkyo Ku, Tokyo 1138510, Japan.
   Tokyo Med & Dent Univ, Fac Med, Dept Internal Med 1, Bunkyo Ku, Tokyo 1138519, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Tsubata, T (reprint author), Tokyo Med & Dent Univ, Inst Med Res, Dept Immunol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
RI Yoshida, Tsutomu/A-7486-2012; Yoshida, Tsutomu/H-9046-2013
CR KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0
   ASKEW DS, 1991, ONCOGENE, V6, P1915
   HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232
   GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489
   WU C, 1984, NATURE, V311, P81, DOI 10.1038/311081a0
   HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170
   STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0
   Klefstrom J, 1997, EMBO J, V16, P7382, DOI 10.1093/emboj/16.24.7382
   FUNK WD, 1992, MOL CELL BIOL, V12, P2866
   WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817
   KLEFSTROM J, 1994, EMBO J, V13, P5442
   REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57
   Wu M, 1996, EMBO J, V15, P4682
   EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T
   CHEN CH, 1994, RADIAT RES, V139, P307, DOI 10.2307/3578828
   EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0
   WANG Y, 1995, MOL CELL BIOL, V15, P2157
   ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0
   SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581
   BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630
   DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824
   Dong JA, 1997, ONCOGENE, V15, P639, DOI 10.1038/sj.onc.1201237
   ELIYAHU D, 1988, ONCOGENE, V3, P313
   Evan G I, 1993, Curr Opin Genet Dev, V3, P44, DOI 10.1016/S0959-437X(05)80339-9
   FISCHER G, 1994, J EXP MED, V179, P221, DOI 10.1084/jem.179.1.221
   Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0
   HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810
   Lenahan MK, 1996, ONCOGENE, V12, P1847
   MCCORMACK JE, 1984, P NATL ACAD SCI-BIOL, V81, P5546, DOI 10.1073/pnas.81.17.5546
   Sakamuro D, 1995, ONCOGENE, V11, P2411
   Scott DW, 1996, INT IMMUNOL, V8, P1375, DOI 10.1093/intimm/8.9.1375
   Trudel M, 1997, J EXP MED, V186, P1873, DOI 10.1084/jem.186.11.1873
   Wang KS, 1996, EXPERT SYST APPL, V10, P1, DOI 10.1016/0957-4174(95)00029-1
   WARNER GL, 1992, CELL GROWTH DIFFER, V3, P175
   Wu M, 1996, MOL CELL BIOL, V16, P5015
   Yi AK, 1996, J IMMUNOL, V157, P4918
NR 37
TC 19
Z9 19
U1 1
U2 4
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND
SN 0950-9232
J9 ONCOGENE
JI Oncogene
PD JUL 15
PY 1999
VL 18
IS 28
BP 4091
EP 4098
DI 10.1038/sj.onc.1202772
PG 8
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 216FP
UT WOS:000081431000006
PM 10435590
ER

PT J
AU Lee, JS
   Ishimoto, A
   Honjo, T
   Yanagawa, S
AF Lee, JS
   Ishimoto, A
   Honjo, T
   Yanagawa, S
TI Murine leukemia provirus-mediated activation of the Notch1 gene leads to
   induction of HES-1 in a mouse T lymphoma cell line, DL-3
SO FEBS LETTERS
LA English
DT Article
DE Notch1; HES-1; insertional mutagenesis; murine leukemia virus; lymphoma
ID SIGNAL-TRANSDUCTION; DROSOPHILA NOTCH; RBP-J; HOMOLOG; VIRUS; MICE;
   NEOPLASMS; DOMAIN; KAPPA; CD4
AB Constitutive activation of Notch signaling is known to be associated with tumorigenesis, In a mouse T lymphoma cell line, DL-3, we found that a murine leukemia provirus was inserted in the Notch1 locus, which led to marked expression of a virus-Notch1 fusion mRNA encoding an intracellular portion of the Notch1 protein, Furthermore, expression and nuclear localization of this constitutively active form of Notch1 protein were confirmed. Corresponding to this finding, the transcription of the hairylenhancer of split (HES-1) gene, a known target of Notch1 signaling, mas elevated in this cell line. A potential role for overexpressed HES-1 in the development of the lymphoma was discussed. (C) 1999 Federation of European Biochemical Societies.
C1 Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068507, Japan.
RP Yanagawa, S (reprint author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan.
CR SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620
   Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283
   Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Schroeter EH, 1998, NATURE, V393, P382
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   Jarriault S, 1998, MOL CELL BIOL, V18, P7423
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930
   Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   Oswald F, 1998, MOL CELL BIOL, V18, P2077
   YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4
   DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G
   Kim HK, 1998, MOL CELL BIOL, V18, P7166
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014
   RASSART E, 1986, J VIROL, V58, P96
   Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9
   Rohn JL, 1996, J VIROL, V70, P8071
   YANAGAWA SI, 1993, J VIROL, V67, P112
   YANAGAWA SI, 1990, J VIROL, V64, P2474
NR 28
TC 16
Z9 17
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUL 23
PY 1999
VL 455
IS 3
BP 276
EP 280
DI 10.1016/S0014-5793(99)00901-1
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 221XU
UT WOS:000081753500017
PM 10437788
ER

PT J
AU Nishimura, H
   Nose, M
   Hiai, H
   Minato, N
   Honjo, T
AF Nishimura, H
   Nose, M
   Hiai, H
   Minato, N
   Honjo, T
TI Development of lupus-like autoimmune diseases by disruption of the PD-1
   gene encoding an ITIM motif-carrying immunoreceptor
SO IMMUNITY
LA English
DT Article
ID PROTEIN-TYROSINE-PHOSPHATASE; LYMPHOCYTE IMMUNE DEFECT; CELL ANTIGEN
   RECEPTOR; VERSUS-HOST DISEASE; LYN-DEFICIENT MICE; NEGATIVE SELECTION;
   TRANSGENIC MICE; B-CELLS; REGULATED EXPRESSION; CD22-DEFICIENT MICE
AB PD-1, a 55 kDa transmembrane protein containing an immunoreceptor tyrosine-based inhibitory motif, is induced in lymphocytes and monocytic cells following activation. Aged C57BL/6(B6)-PD-1(-/-) congenic mice spontaneously developed characteristic lupus-like proliferative arthritis and glomerulonephritis with predominant IgG3 deposition, which were markedly accelerated by introduction of a Fas mutation (lpr). Introduction of a PD-1 null mutation into the 2C-TCR (anti-H-2L(d)) transgenic mice of the H-2(b/d) background resulted in the chronic and systemic graft-versus-host-like disease. Furthermore, CD8(+)2C-TCR+PD-1(-/-) cells exhibited markedly augmented proliferation in vitro in response to H-2(d) allogenic cells. Collectively, it is suggested that PD-1 is involved in the maintenance of peripheral self-tolerance by serving as a negative regulator of immune responses.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Fac Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Fac Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Ehime Univ, Sch Med, Dept Pathol, Shigenobu, Ehime 7910295, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661
   STEINBERG EB, 1983, J IMMUNOL, V131, P2789
   OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307
   Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6
   Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3
   PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077
   HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X
   Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0
   IZUI S, 1995, IMMUNOL REV, V144, P137, DOI 10.1111/j.1600-065X.1995.tb00068.x
   KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X
   ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951
   Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4
   GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1
   NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4
   Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8
   Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0
   SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0
   NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X
   ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961
   MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396
   IZUI S, 1984, J IMMUNOL, V133, P227
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326
   MILLER JFAP, 1992, ANNU REV IMMUNOL, V10, P51, DOI 10.1146/annurev.immunol.10.1.51
   DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087
   SCHER I, 1975, J EXP MED, V142, P637, DOI 10.1084/jem.142.3.637
   VOLCPLATZER B, 1988, J INVEST DERMATOL, V91, P162, DOI 10.1111/1523-1747.ep12464407
   YI TL, 1992, MOL CELL BIOL, V12, P836
   Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261
   THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9
   Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0
   ASANO T, 1988, CLIN EXP IMMUNOL, V74, P36
   Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7
   DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252
   DRAKE CG, 1995, IMMUNOL REV, V144, P51, DOI 10.1111/j.1600-065X.1995.tb00065.x
   KARIYONE A, 1988, CELL IMMUNOL, V115, P112, DOI 10.1016/0008-8749(88)90166-9
   KAWAI K, 1991, CLIN EXP IMMUNOL, V84, P359
   Ma J, 1996, J IMMUNOL, V157, P417
   MILLER JFAP, 1994, CURR OPIN IMMUNOL, V6, P892, DOI 10.1016/0952-7915(94)90010-8
   Mondino A, 1996, P NATL ACAD SCI USA, V93, P2245, DOI 10.1073/pnas.93.6.2245
   MURPHY GF, 1991, AM J PATHOL, V138, P983
   PERLMUTTER RM, 1979, J EXP MED, V149, P993, DOI 10.1084/jem.149.4.993
   PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1126
   ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157
   SCHER I, 1975, J EXP MED, V141, P788
   SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   SLACK JH, 1984, J IMMUNOL, V132, P1271
   TAKAHASHI S, 1993, MOL IMMUNOL, V30, P177
   TAKAHASHI S, 1991, J IMMUNOL, V147, P515
   THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953
   VONBOEHMER H, 1991, CURR OPIN IMMUNOL, V3, P210, DOI 10.1016/0952-7915(91)90052-3
NR 58
TC 879
Z9 937
U1 6
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD AUG
PY 1999
VL 11
IS 2
BP 141
EP 151
DI 10.1016/S1074-7613(00)80089-8
PG 11
WC Immunology
SC Immunology
GA 232RH
UT WOS:000082383400003
PM 10485649
ER

PT J
AU Ye, SK
   Maki, K
   Kitamura, T
   Sunaga, S
   Akashi, K
   Domen, J
   Weissman, IL
   Honjo, T
   Ikuta, K
AF Ye, SK
   Maki, K
   Kitamura, T
   Sunaga, S
   Akashi, K
   Domen, J
   Weissman, IL
   Honjo, T
   Ikuta, K
TI Induction of germline transcription in the TCR gamma locus by Stat5:
   Implications for accessibility control by the IL-7 receptor
SO IMMUNITY
LA English
DT Article
ID T-CELL RECEPTOR; V-J RECOMBINATION; INTERLEUKIN-7 RECEPTOR; DEFICIENT
   MICE; GENE REARRANGEMENT; TARGETED DELETION; ALPHA-CHAIN; BCL-2;
   EXPRESSION; LYMPHOPOIESIS
AB IL-7 receptor (IL-7R) plays critical roles in lymphocyte development by promoting survival and proliferation and by inducing V(D)J recombination in TCR and Ig loci. Here, we demonstrate that IL-7R-activated Stat5 binds to consensus motifs in the 5' regions of J gamma segments and induces germline transcripts. We also show that a constitutively active form of Stat5 restores V-J recombination of TCR gamma genes and partially rescues T cell development from IL-7R(-/-) T cell precursors, especially in favor of gamma delta T cells. Therefore, this study reveals a potential role of Stat5 in T cell development and also implies that IL-7R may control the accessibility of the TCR gamma locus through Stat5-induced germline transcription.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan.
   Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo 1080071, Japan.
   Tokyo Univ Hosp, Dept Hematol & Oncol, Tokyo 1138655, Japan.
   Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.
   Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.
RP Ikuta, K (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan.
RI Ye, Sang Kyu/J-2768-2012
CR Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630
   Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5
   Corcoran AE, 1998, NATURE, V391, P904
   Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0
   Domen J, 1998, BLOOD, V91, P2272
   Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172
   Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4
   LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8
   Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X
   Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4
   Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3
   Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293
   Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233
   ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825
   Sunaga S, 1997, J IMMUNOL, V158, P4223
   Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222
   Mui ALF, 1996, EMBO J, V15, P2425
   PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955
   Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6
   Candeias S, 1997, IMMUNOL LETT, V57, P9, DOI 10.1016/S0165-2478(97)00062-X
   Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X
   He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289
   Hempel WM, 1998, ADV IMMUNOL, V69, P309
   IKUTA K, 1986, J EXP MED, V164, P428, DOI 10.1084/jem.164.2.428
   Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423
   Onishi M, 1998, MOL CELL BIOL, V18, P3871
   Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5
   Utley RT, 1998, NATURE, V394, P498
   vanderPlas DC, 1996, LEUKEMIA, V10, P1317
   VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935
   Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9
   vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8
   WAKAO H, 1992, J BIOL CHEM, V267, P16365
   WEINSTEIN Y, 1995, EUR CYTOKINE NETW, V6, P97
   WEINSTEIN Y, 1989, J EXP MED, V169, P2059, DOI 10.1084/jem.169.6.2059
   Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X
NR 38
TC 96
Z9 96
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD AUG
PY 1999
VL 11
IS 2
BP 213
EP 223
DI 10.1016/S1074-7613(00)80096-5
PG 11
WC Immunology
SC Immunology
GA 232RH
UT WOS:000082383400010
PM 10485656
ER

PT J
AU Nakamura, T
   Ruiz-Lozano, P
   Lindner, V
   Yabe, D
   Taniwaki, M
   Furukawa, Y
   Kobuke, K
   Tashiro, K
   Lu, ZJ
   Andon, NL
   Schaub, R
   Matsumori, A
   Sasayama, S
   Chien, KR
   Honjo, T
AF Nakamura, T
   Ruiz-Lozano, P
   Lindner, V
   Yabe, D
   Taniwaki, M
   Furukawa, Y
   Kobuke, K
   Tashiro, K
   Lu, ZJ
   Andon, NL
   Schaub, R
   Matsumori, A
   Sasayama, S
   Chien, KR
   Honjo, T
TI DANCE, a novel secreted RGD protein expressed in developing,
   atherosclerotic, and balloon-injured arteries
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SIGNAL SEQUENCE TRAP; SMOOTH-MUSCLE CELLS; GROWTH-FACTOR;
   EXTRACELLULAR-MATRIX; CALCIUM-BINDING; GENE; RECEPTOR; DOMAIN;
   LOCALIZATION; FIBULIN-1
AB We have identified and characterized mouse, rat, and human cDNAs that encode a novel secreted protein of 448 amino acids named DANCE (developmental arteries and neural crest epidermal growth factor (EGF)-like). DANCE contains six calcium-binding EGF-like domains, one of which includes an RGD motif. Overexpression studies of recombinant DANCE protein document that DANCE is a secreted 66-kDa protein. DANCE and recently described protein S1-5 comprise a new EGF-like protein family. The human DANCE gene was mapped at chromosome 14q32.1. DANCE mRNA is mainly expressed in heart, ovary, and colon in adult human tissues. Expression profile analysis by in situ hybridization revealed prominent DANCE expression in developing arteries. DANCE is also expressed in neural crest cell derivatives, endocardial cushion tissue, and several other mesenchymal tissues. In adult vessels, DANCE expression is largely diminished but is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells that lose their ability to proliferate in late stage of injury. DANCE protein was shown to promote adhesion of endothelial cells through interaction of integrins and the RGD motif of DANCE. DANCE is thus a novel vascular ligand for integrin receptors and may play a role in vascular development and remodeling.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 606, Japan.
   Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA.
   Maine Med Ctr, Res Inst, S Portland, ME 04106 USA.
   Kyoto Prefectural Univ Med, Dept Internal Med 3, Kamigyo Ku, Kyoto 602, Japan.
   Genet Inst Inc, Cambridge, MA 02140 USA.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.
RI Yabe, Daisuke/J-6682-2014
OI Yabe, Daisuke/0000-0002-5334-7687
CR Adam S, 1997, J MOL BIOL, V272, P226, DOI 10.1006/jmbi.1997.1244
   GIDDENS DP, 1993, J BIOMECH ENG-T ASME, V115, P588, DOI 10.1115/1.2895545
   Shattil SJ, 1997, J CLIN INVEST, V100, pS91
   RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4
   PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269
   KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125
   GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431
   KUROO M, 1991, J BIOL CHEM, V266, P3768
   CLOWES AW, 1983, LAB INVEST, V49, P208
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6
   LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120
   CORNHILL JF, 1976, ATHEROSCLEROSIS, V23, P489
   Landry DB, 1997, AM J PATHOL, V151, P1085
   HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0
   ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179
   ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155
   DOOLITTLE RF, 1984, NATURE, V307, P558, DOI 10.1038/307558a0
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ikegawa S, 1996, GENOMICS, V35, P590, DOI 10.1006/geno.1996.0402
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   LINDNER V, 1993, CIRC RES, V73, P589
   MATTEI MG, 1994, GENOMICS, V22, P437, DOI 10.1006/geno.1994.1406
   NAKAMURA T, 1995, GENOMICS, V30, P312, DOI 10.1006/geno.1995.9872
   Ruoslahti E, 1997, J CLIN INVEST, V99, P1149, DOI 10.1172/JCI119269
   SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642
   TANIWAKI M, 1994, BLOOD, V83, P2962
   Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4
   VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4
   ZHANG RZ, 1994, GENOMICS, V22, P425, DOI 10.1006/geno.1994.1404
NR 32
TC 116
Z9 124
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 6
PY 1999
VL 274
IS 32
BP 22476
EP 22483
DI 10.1074/jbc.274.32.22476
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 223YD
UT WOS:000081868400053
PM 10428823
ER

PT J
AU Watanabe, N
   Nisitani, S
   Ikuta, K
   Suzuki, M
   Chiba, T
   Honjo, T
AF Watanabe, N
   Nisitani, S
   Ikuta, K
   Suzuki, M
   Chiba, T
   Honjo, T
TI Expression levels of B cell surface immunoglobulin regulate efficiency
   of allelic exclusion and size of autoreactive B-1 cell compartment
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE transgenic lines; homozygosity; flow cytometry; anti-RBC antibody
ID AUTOIMMUNE HEMOLYTIC-ANEMIA; AUTOANTIBODY-TRANSGENIC MICE; ENDOGENOUS
   IMMUNOGLOBULIN; BONE-MARROW; IG-BETA; PHOSPHATIDYL CHOLINE; CYTOPLASMIC
   DOMAINS; GENE REARRANGEMENT; CLONAL SELECTION; IMMUNE-RESPONSE
AB Surface-expressed immunoglobulin (Ig) has been shown to have a critical role in allelic exclusion of Ig heavy (H) and light (L) chains. Although various degrees of suppression of endogenous Ig expression are observed in Ig transgenic (Tg) mice, it was not clear whether this difference is due to different onsets of Tg expression or to different levels of Tg expression, which are obviously affected by integration sites of the transgene. In this study we generated antierythrocyte antibody Tg mice that carry tandem joined H and L chain transgenes (H+L) and confirmed that homozygosity of the transgene loci enhances the level of transgene expression as compared with heterozygosity. Suppression of endogenous H and L chain gene expression was stronger in homozygous than in heterozygous Tg mice. Similar results were obtained in control Tg mice carrying the H chain only. These results suggest that there is a threshold of the B cell receptor expression level that induces allelic exclusion. In addition, despite the same B cell receptor specificity, the size of Tg autoreactive B-1 cell compartment in the peritoneal cavity is larger in homozygous than in heterozygous mice, although the number of the Tg B-2 cell subset decreased in the spleen and bone marrow of homozygous Tg mice as compared with heterozygous Tg mice. By contrast, homozygosity of the H chain alone Tg line, which does not recognize self-antigens, did not increase the size of the peritoneal B-1 subset. These results suggest that the size of the B-1 cell subset in the Tg mice may depend on strength of signals through B cell receptors triggered by self-antigens.
C1 Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Dept Gastroenterol, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kumamoto Univ, Ctr Anim Resources & Dev, Sakyo Ku, Kumamoto 8620976, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
CR GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0
   Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009
   Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788
   TSUI HW, 1993, NAT GENET, V4, P124
   LALOR PA, 1990, EUR J IMMUNOL, V20, P485, DOI 10.1002/eji.1830200305
   Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5
   PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077
   KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L
   HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554
   NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267
   Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   CONG YZ, 1991, INT IMMUNOL, V3, P467
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0
   MERCOLINO TJ, 1986, J EXP MED, V163, P155, DOI 10.1084/jem.163.1.155
   Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791
   Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6
   Berland R, 1998, J IMMUNOL, V161, P277
   Shaffer AL, 1997, J IMMUNOL, V159, P1265
   KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021
   FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414
   ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585
   SU SD, 1991, J IMMUNOL, V146, P327
   Huang CA, 1996, EUR J IMMUNOL, V26, P2537, DOI 10.1002/eji.1830261039
   TORNBERG UC, 1995, EMBO J, V14, P1680
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   CARMACK CE, 1991, J IMMUNOL, V147, P2024
   FORNI L, 1990, EUR J IMMUNOL, V20, P983, DOI 10.1002/eji.1830200506
   GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999
   GRANDIEN A, 1990, EUR J IMMUNOL, V20, P991, DOI 10.1002/eji.1830200507
   IACOMINI J, 1991, INT IMMUNOL, V3, P185
   KENNY JJ, 1989, J IMMUNOL, V142, P4466
   LAM KP, 1993, INT IMMUNOL, V5, P1011, DOI 10.1093/intimm/5.9.1011
   Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0
   MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   MULLER W, 1989, EUR J IMMUNOL, V19, P923, DOI 10.1002/eji.1830190520
   Nisitani S, 1998, INT IMMUNOL, V10, P1039, DOI 10.1093/intimm/10.8.1039
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969
   PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544
   PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389
   RATH S, 1989, J IMMUNOL, V143, P2074
   RITCHIE KA, 1984, NATURE, V312, P517, DOI 10.1038/312517a0
   RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   STALL AM, 1988, P NATL ACAD SCI USA, V85, P3546, DOI 10.1073/pnas.85.10.3546
   STORB U, 1995, IMMUNOGLOBULIN GENES, P345, DOI 10.1016/B978-012053640-5/50018-5
   Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753
   ten Boekel E, 1998, IMMUNITY, V8, P199
   WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305
NR 63
TC 62
Z9 62
U1 1
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD AUG 16
PY 1999
VL 190
IS 4
BP 461
EP 469
DI 10.1084/jem.190.4.461
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 228VR
UT WOS:000082156800003
PM 10449517
ER

PT J
AU Apelqvist, A
   Li, H
   Sommer, L
   Beatus, P
   Anderson, DJ
   Honjo, T
   de Angelis, MH
   Lendahl, U
   Edlund, H
AF Apelqvist, A
   Li, H
   Sommer, L
   Beatus, P
   Anderson, DJ
   Honjo, T
   de Angelis, MH
   Lendahl, U
   Edlund, H
TI Notch signalling controls pancreatic cell differentiation
SO NATURE
LA English
DT Article
ID LOOP-HELIX PROTEIN; TRANSCRIPTION FACTOR; INSULIN GENE; EXPRESSION;
   PROGENITOR; NEURONS; NEUROGENESIS; ORIGIN; MICE
AB The pancreas contains both exocrine and endocrine cells, but the molecular mechanisms controlling the differentiation of these cell types are largely unknown. Despite their endodermal origin, pancreatic endocrine cells share several molecular characteristics with neurons(1-5), and, like neurons in the central nervous system(6,7) differentiating endocrine cells in the pancreas appear in a scattered fashion within a field of progenitor coils(8,9). This indicates that they may be generated by lateral specification through Notch signalling(6,7). Here, to test this idea, we analysed pancreas development in mice genetically altered at several steps in the Notch signalling pathway, Mice deficient for Delta-like gene 1 (Dll1)(10) or the intracellular mediator RBP-JK(11) showed accelerated differentiation of pancreatic endocrine cells. A similar phenotype was observed in mice over-expressing neurogenin 3 (ngn 3)(12) or the intracellular form of Notch3 (ref. 13) (a repressor of Notch signalling). These data provide evidence that ngn3 acts as pro-endocrine gene and that Notch signalling is critical for the decision between the endocrine and progenitor/exocrine fates in the developing pancreas.
C1 Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.
   ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland.
   CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   GSF, Inst Mammalian Genet, D-85764 Neuherberg, Germany.
   Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.
RP Edlund, H (reprint author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.
RI Hrabe de Angelis, Martin/F-5531-2012
CR Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5
   Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0
   OHLSSON H, 1993, EMBO J, V12, P4251
   UPCHURCH BH, 1994, DEVELOPMENT, V120, P245
   Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5
   Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X
   Krapp A, 1996, EMBO J, V15, P4317
   NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817
   FONTAINE J, 1977, J EMBRYOL EXP MORPH, V41, P209
   SLACK JMW, 1995, DEVELOPMENT, V121, P1569
   LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368
   Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7
   Mitsiadis TA, 1998, DEV BIOL, V204, P420, DOI 10.1006/dbio.1998.9092
   deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0
   Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473
   Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8
   PICTET RL, 1976, SCIENCE, V191, P191, DOI 10.1126/science.1108195
   THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V
   Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752
   Beatus P, 1998, J NEUROSCI RES, V54, P125, DOI 10.1002/(SICI)1097-4547(19981015)54:2<125::AID-JNR1>3.0.CO;2-G
   Beatus P, 1999, DEVELOPMENT, V126, P3925
   Hogan B, 1994, MANIPULATING MOUSE E
   LEDOUARIN NM, 1988, CELL, V53, P169, DOI 10.1016/0092-8674(88)90375-3
   Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X
   MISHIBASHI M, 1995, GENE DEV, V15, P3136
   Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323
   Pictet R., 1972, HDB PHYSL, P25
   Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060
NR 30
TC 743
Z9 756
U1 10
U2 33
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD AUG 26
PY 1999
VL 400
IS 6747
BP 877
EP 881
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 230CA
UT WOS:000082233200047
PM 10476967
ER

PT J
AU Minoguchi, S
   Ikeda, T
   Itohara, S
   Kaneko, T
   Okaichi, H
   Honjo, T
AF Minoguchi, S
   Ikeda, T
   Itohara, S
   Kaneko, T
   Okaichi, H
   Honjo, T
TI Studies on the cell-type specific expression of RBP-L, a RBP-J family
   member, by replacement insertion of beta-galactosidase
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE DNA binding protein; gene targeting; tissue-specific expression
ID SIGNAL-BINDING-PROTEIN; BARR-VIRUS EBNA2; J-KAPPA; TRANSCRIPTION FACTOR;
   MONOCLONAL-ANTIBODIES; DROSOPHILA SUPPRESSOR; RAT-BRAIN; ADULT-RAT;
   NOTCH; SEQUENCE
AB The RBP-L gene encodes a DNA binding protein that is structurally related to RBP-J, the mammalian homolog of Drosophila Suppressor of Hairless, Although the RBP-L protein binds the same DNA sequence as RBP-J, the in vivo function of this protein remains largely unknown, In order to investigate the role of this protein, we generated RBP-L mutant mice by targeted disruption involving replacement of the protein-coding sequence in the first exon with an in-frame fusion of the nlacZ cDNA, The homozygous mutant mice appeared morphologically normal and fertile. Unexpectedly, we found the possible existence of additional promoter(s) downstream of the first exon whose activity was not fully disrupted in the mutant mice. The promoter upstream of the first exon is regulated in a cell type-specific manner so that transcription is active in neurons but almost inactive in lung where the downstream promoter is active. The specific expression of the beta-galactosidase fusion protein was detected in layer VT of the cerebral cortex, in the pyramidal cell layer of the hippocampus, and in the granule cell layer of the dentate gyrus. Furthermore, we found that the upstream promoter activity in neurons might be regulated by some neuronal activity.
C1 Kyoto Univ, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN, Brain Res Inst, Adv Technol Dev Ctr, Wako, Saitama 3510198, Japan.
   Doshisha Univ, Dept Psychol, Kamigyo Ku, Kyoto 6020198, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Itohara, Shigeyoshi/I-8769-2012
CR AMAKAWA R, 1993, GENOMICS, V17, P306, DOI 10.1006/geno.1993.1326
   KANEKO T, 1994, NEUROSCIENCE, V61, P839, DOI 10.1016/0306-4522(94)90407-3
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Wettstein DA, 1997, DEVELOPMENT, V124, P693
   Schroeter EH, 1998, NATURE, V393, P382
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   WALTZER L, 1994, EMBO J, V13, P5633
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   Christensen S, 1996, DEVELOPMENT, V122, P1373
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   FURUKAWA T, 1991, J BIOL CHEM, V266, P23334
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KANEKO T, 1989, NEUROSCIENCE, V32, P79, DOI 10.1016/0306-4522(89)90109-7
   KANEKO T, 1987, J NEUROSCI, V7, P302
   KANEKO T, 1992, J COMP NEUROL, V322, P181, DOI 10.1002/cne.903220204
   KANEKO T, 1988, J HISTOCHEM CYTOCHEM, V36, P997
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KIMURA S, 1994, DEV GROWTH DIFFER, V36, P521
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   SAMBROOK J, 1989, MOL CLONING LAB MANU, P1339
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   TANI S, 1998, J HUM GEN, V44, P73
NR 39
TC 8
Z9 8
U1 1
U2 1
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD OCT
PY 1999
VL 126
IS 4
BP 738
EP 747
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 245CR
UT WOS:000083089100016
PM 10502683
ER

PT J
AU Matsuda, F
   Honjo, T
AF Matsuda, F
   Honjo, T
TI The human immunoglobulin V-H locus
SO IMMUNOLOGIST
LA English
DT Review
ID CHAIN VARIABLE REGION; HEAVY-CHAIN; MULTIPLE-SCLEROSIS; DNA-SEQUENCE;
   PHYSICAL MAP; SEGMENTS; ORGANIZATION; DIVERSITY; GENES; SUSCEPTIBILITY
AB Since the first demonstration of somatic DNA recombination in the genome of mammals, attempts to elucidate all of the molecular events underlying the generation of antibody diversity continue, Here, Fumihiko Matsuda and Tasuku Honjo summarize their contribution to this with the completion of the nucleotide sequence of the entire human V-H locus, and discuss its implications in the immune response.
C1 Ctr Natl Genotypage, F-91057 Evry, France.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 60601, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 60601, Japan.
RP Matsuda, F (reprint author), Ctr Natl Genotypage, 2 Rue Gaston Cremieux, F-91057 Evry, France.
RI Matsuda, Fumihiko/B-9893-2009
CR Ramsden DA, 1996, EMBO J, V15, P3197
   WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128
   SHIN EK, 1993, IMMUNOGENETICS, V38, P304
   SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41
   CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416
   Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146
   Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151
   MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88
   Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250
   Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167
   BERMAN JE, 1988, EMBO J, V7, P727
   COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162
   Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141
   COUMO CA, 1996, MOL CELL BIOL, V16, P5683
   du Pasquier L., 1999, FUNDAMENTAL IMMUNOLO, P605
   EATON S, 1987, P NATL ACAD SCI USA, V84, P7634, DOI 10.1073/pnas.84.21.7634
   FRIPPIAT JP, 1995, HUM MOL GENET, V4, P983
   HAINO M, 1994, J BIOL CHEM, V269, P2619
   HASHIMOTO LL, 1993, J NEUROIMMUNOL, V44, P77, DOI 10.1016/0165-5728(93)90270-9
   HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.biochem.54.1.803
   ICHIHARA Y, 1988, EMBO J, V7, P4141
   Kabat E.A., 1991, SEQUENCES PROTEINS I
   KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1
   LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7
   MATSUDA F, 1990, EMBO J, V9, P2501
   NAGAOKA H, 1994, GENOMICS, V22, P189, DOI 10.1006/geno.1994.1360
   NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12
   RAST JP, 1995, IMMUNOGLOBULIN GENES, P316
   RONEGAWA S, 1983, NATURE, V302, P505
   SASSO EH, 1993, P NATL ACAD SCI USA, V89, P10430
   SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563
   SHIN EK, 1991, EMBO J, V10, P3641
   SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0
   SIU G, 1987, J IMMUNOL, V138, P4466
   TOMLINSON IM, 1994, HUM MOL GENET, V3, P856
   YANG PM, 1991, P NATL ACAD SCI USA, V88, P7907
   Zachau H. G., 1995, IMMUNOGLOBULIN GENES, P173, DOI 10.1016/B978-012053640-5/50011-2
NR 37
TC 3
Z9 3
U1 0
U2 2
PU HOGREFE & HUBER PUBLISHERS
PI KIRKLAND
PA PO BOX 2487, KIRKLAND, WA 98083-2487 USA
SN 1192-5612
J9 IMMUNOLOGIST
JI Immunologist
PD NOV-DEC
PY 1999
VL 7
IS 6
BP 171
EP 176
PG 6
WC Immunology
SC Immunology
GA 306TJ
UT WOS:000086612300002
ER

PT J
AU Heissig, B
   Hattori, K
   Dias, S
   Tashiro, K
   Honjo, T
   Rafii, S
   Crystal, RG
   Moore, MAS
AF Heissig, B
   Hattori, K
   Dias, S
   Tashiro, K
   Honjo, T
   Rafii, S
   Crystal, RG
   Moore, MAS
TI Stormal-derived factor-1 (SDF1) induces TNF-alpha mediated progenitor
   cell apoptosis of CD34+cells derived from chronic myeloid leukemia
   (CML).
SO BLOOD
LA English
DT Meeting Abstract
C1 Sloan Kettering Inst, New York, NY USA.
   Cornell Univ, New York, NY USA.
   Kyoto Univ, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1999
VL 94
IS 10
SU 1
MA 437
BP 100A
EP 100A
PN 1
PG 1
WC Hematology
SC Hematology
GA 257PH
UT WOS:000083790300486
ER

PT J
AU Ochi, H
   Takeshita, H
   Suda, T
   Nisitani, S
   Honjo, T
   Watanabe, T
AF Ochi, H
   Takeshita, H
   Suda, T
   Nisitani, S
   Honjo, T
   Watanabe, T
TI Regulation of B-1 cell activation and its autoantibody production by Lyn
   kinase-regulated signallings
SO IMMUNOLOGY
LA English
DT Article
ID LY-1 B-CELLS; DEFICIENT MICE; AUTOIMMUNE-DISEASE; T-CELL; RECEPTOR;
   PROLIFERATION; LYMPHOCYTES; LACKING; MOUSE; SYK
AB The src-family protein tyrosine kinase, Lyn, has been reported to play a crucial role in the regulation of B-cell antigen receptor (BCR)-mediated signalling. To elucidate the role of Lyn in the maintenance of immunological tolerance and the prevention of B-1 cell activation and its autoantibody production, Lyn-deficient mice were crossed with transgenic mice carrying the immunoglobulin heavy and light chain genes encoding an autoantibody against mouse red blood cells. In the transgenic mice, most peripheral B cells expressed the B-1 cell phenotype. When the transgenic mice were bred in specific pathogen-free (SPF) conditions, B-1 cells were anergic and did not produce any autoantibody. In contrast, Lyn-deficient transgenic mice kept in the same SPF conditions revealed markedly increased numbers of activated B-1 cells and developed severe autoimmune haemolytic anaemia. Moreover, the mice had a huge splenomegaly containing a remarkable accumulation of erythroblasts, resulted from extramedullary erythropoiesis, in addition to the increased numbers of lymphoblast-like cells of the B-1 cell lineages. The present study demonstrates a crucial role of Lyn kinase in the regulation of B-1 cell activation and maintenance of tolerance.
C1 Kyushu Univ, Med Inst Bioregulat, Dept Mol Immunol, Higashi Ku, Fukuoka 8128582, Japan.
   Kumamoto Univ, Sch Med, Dept Mol Mol Embryol & Genet, Kumamoto 860, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
RP Watanabe, T (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Mol Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
RI Suda, Toshio/H-6761-2013
OI Suda, Toshio/0000-0001-7540-1771
CR ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0
   CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0
   MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857
   HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R
   HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0
   HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X
   KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0
   Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4
   MORRIS DL, 1994, INT IMMUNOL, V6, P1011, DOI 10.1093/intimm/6.7.1011
   TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4
   Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906
   HERZENBERG LA, 1993, IMMUNOL TODAY, V14, P79, DOI 10.1016/0167-5699(93)90063-Q
   Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355
   Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7
   HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x
   MURAKAMI M, 1997, J EXP MED, V185, P79
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831
   YING-ZI C, 1991, International Immunology, V3, P467, DOI 10.1093/intimm/3.5.467
NR 28
TC 16
Z9 16
U1 0
U2 0
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 1999
VL 98
IS 4
BP 595
EP 603
DI 10.1046/j.1365-2567.1999.00899.x
PG 9
WC Immunology
SC Immunology
GA 268UQ
UT WOS:000084434400017
PM 10594694
ER

PT J
AU Fossati-Jimack, L
   Reininger, L
   Chicheportiche, Y
   Clynes, R
   Ravetch, JV
   Honjo, T
   Izui, S
AF Fossati-Jimack, L
   Reininger, L
   Chicheportiche, Y
   Clynes, R
   Ravetch, JV
   Honjo, T
   Izui, S
TI High pathogenic potential of low-affinity autoantibodies in experimental
   autoimmune hemolytic anemia
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE autoantibody; autoimmune hemolytic anemia; Fc receptor; Kupffer cell;
   knockout mouse
ID ANTI-DNA ANTIBODIES; NZB MICE; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING;
   RHEUMATOID-FACTOR; SOMATIC MUTATION; CELL DEFECTS; FC RECEPTOR; MOUSE;
   IGG
AB To assess the potency of low-affinity anti-red blood cell (RBC) autoantibodies in the induction of anemia, we generated an immunoglobulin (Ig)G2a class-switch variant of a 4C8 IgM anti-mouse RBC autoantibody, and compared its pathogenic potential with that of its IgM isotype and a high-affinity 34-3C IgG2a autoantibody. The RBC-binding activity of the 4C8 IgG2a variant was barely detectable, at least 1,000 times lower than that of its IgM isotype, having a high-binding avidity, and that of the 34-3C IgG2a monoclonal antibody (mAb). This low-affinity feature of the 4C8 mAb was consistent with the lack of detection of opsonized RBCs in the circulating blood from the 4C8 IgG2a-injected mice. However, the 4C8 IgG2a variant was highly pathogenic, as potent as its IgM isotype and the 34-3C IgG2a mAb, due to its capacity to interact with Fc receptors involved in erythrophagocytosis. In addition, our results indicated that the pentameric form of the low-affinity ISM isotype, by promoting the binding and agglutination of RBCs, is critical for its pathogenic activity. Demonstration of the remarkably high pathogenic potency of low-affinity autoantibodies, if combined with appropriate heavy chain effector functions, highlights the critical role of the Ig heavy chain constant regions, but the relatively minor role of autoantigen-binding affinities, in autoimmune hemolytic anemia.
C1 Univ Geneva, Ctr Med Univ, Dept Pathol, CH-1211 Geneva 4, Switzerland.
   INSERM U399, F-13385 Marseille, France.
   Rockefeller Univ, New York, NY 10021 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Izui, S (reprint author), Univ Geneva, Ctr Med Univ, Dept Pathol, CH-1211 Geneva 4, Switzerland.
CR SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5
   SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F
   FULPIUS T, 1993, P NATL ACAD SCI USA, V90, P2345, DOI 10.1073/pnas.90.6.2345
   Oliveira GGD, 1996, CLIN EXP IMMUNOL, V105, P313
   SEARS DW, 1990, J IMMUNOL, V144, P371
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SHIBATA T, 1990, INT IMMUNOL, V2, P1133, DOI 10.1093/intimm/2.12.1133
   TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8
   CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8
   Meyer D, 1998, BLOOD, V92, P3997
   BERNEY T, 1992, INT IMMUNOL, V4, P93, DOI 10.1093/intimm/4.1.93
   CAULFIELD MJ, 1989, IMMUNOLOGY, V66, P233
   COOKE LA, 1982, IMMUNOLOGY, V47, P569
   DALE GL, 1991, BLOOD, V77, P1096
   GARCIAGONZALEZ M, 1988, J IMMUNOL METHODS, V111, P17, DOI 10.1016/0022-1759(88)90054-3
   HIROSE S, 1993, EUR J IMMUNOL, V23, P2813, DOI 10.1002/eji.1830231114
   JACOBSON BA, 1994, J IMMUNOL, V152, P4489
   LABIT C, 1984, HYBRIDOMA, V3, P163, DOI 10.1089/hyb.1984.3.163
   NEUBERGER MS, 1983, EMBO J, V2, P1373
   OKAMOTO M, 1990, NUCLEIC ACIDS RES, V18, P1895, DOI 10.1093/nar/18.7.1895
   OZAKI S, 1984, IMMUNOL LETT, V8, P115, DOI 10.1016/0165-2478(84)90062-2
   Reininger L, 1996, J EXP MED, V184, P853, DOI 10.1084/jem.184.3.853
   REININGER L, 1992, J EXP MED, V176, P1343, DOI 10.1084/jem.176.5.1343
   SCOTT BB, 1993, IMMUNOLOGY, V79, P568
   SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0
   SIMON T, 1988, NUCLEIC ACIDS RES, V16, P354, DOI 10.1093/nar/16.1.354
   TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761
   WEINSHANK RL, 1988, J EXP MED, V167, P1909, DOI 10.1084/jem.167.6.1909
   WOFSY D, 1985, J EXP MED, V161, P378, DOI 10.1084/jem.161.2.378
NR 34
TC 59
Z9 61
U1 1
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD DEC 6
PY 1999
VL 190
IS 11
BP 1689
EP 1696
DI 10.1084/jem.190.11.1689
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 263QY
UT WOS:000084137800014
PM 10587359
ER

PT S
AU Fagarasan, S
   Shinkura, R
   Kamata, T
   Nogaki, F
   Ikuta, K
   Honjo, T
AF Fagarasan, S
   Shinkura, R
   Kamata, T
   Nogaki, F
   Ikuta, K
   Honjo, T
BE Potter, M
   Melchers, F
TI Mechanism of B1 cell differentiation and migration in GALT
SO B 1 LYMPHOCYTES IN B CELL NEOPLASIA
SE CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article; Proceedings Paper
CT 16th Workshop on the Mechanisms of B Cell Neoplasia
CY OCT 28-29, 1999
CL NIH, NATL LIB MED, BETHESDA, MARYLAND
SP NCI, Lab Genet, Div Basic Sci
HO NIH, NATL LIB MED
ID GUT LAMINA PROPRIA; IGA PLASMA-CELLS; LYMPHOID ORGANS; PEYER PATCHES;
   CHEMOKINE; LYMPHOCYTES; MICE; ALYMPHOPLASIA; RECEPTOR; ATTRACTS
C1 Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
RP Fagarasan, S (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR Bos NA, 1996, INFECT IMMUN, V64, P616
   KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55
   HARDY RR, 1994, ADV IMMUNOL, V55, P297
   Gunn MD, 1998, NATURE, V391, P799
   Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554
   Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634
   HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146
   Hromas R, 1997, J IMMUNOL, V159, P2554
   Hedrick JA, 1997, J IMMUNOL, V159, P1589
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5
   Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518
   Yoshida R, 1998, INT IMMUNOL, V10, P901, DOI 10.1093/intimm/10.7.901
   Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258
   Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   CRAIG SW, 1975, J IMMUNOL, V114, P492
   Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   TSENG J, 1984, J IMMUNOL, V132, P2730
   TSENG J, 1981, J IMMUNOL, V127, P2039
   Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175
NR 28
TC 13
Z9 13
U1 1
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
BN 3-540-67567-1
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2000
VL 252
BP 221
EP 229
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA BR65E
UT WOS:000167097400023
PM 11125479
ER

PT J
AU Garceau, N
   Kosaka, Y
   Masters, S
   Hambor, J
   Shinkura, R
   Honjo, T
   Noelle, RJ
AF Garceau, N
   Kosaka, Y
   Masters, S
   Hambor, J
   Shinkura, R
   Honjo, T
   Noelle, RJ
TI Lineage-restricted function of nuclear factor kappa B-inducing kinase
   (NIK) in transducing signals via CD40
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE CD40 signaling; nuclear factor kappa B-inducing kinase; dendritic cell;
   nuclear factor kappa B activation; alymphoplasia mice
ID NECROSIS-FACTOR RECEPTOR; HYPER-IGM SYNDROME; DENDRITIC CELLS;
   CYTOPLASMIC DOMAIN; IMMUNE-RESPONSES; MICE DEFICIENT; CROSS-LINKING;
   T-CELLS; ACTIVATION; PROTEIN
AB CD40 signaling in B cells and dendritic cells (DCs) is critical for the development of humoral and cell-mediated immunity, respectively. Nuclear factor kappa B (NF-kappa B)-inducing kinase (NIK) has been implicated as a central transducing kinase in CD40-dependent activation. Here, we show that although NIK is essential for B cell activation, it is dispensable for activation of DCs. Such data provide compelling evidence that different intermediary kinases are used by different cellular lineages to trigger NF-kappa B activation via CD40.
C1 Dartmouth Med Sch, Dept Microbiol, Lebanon, NH 03756 USA.
   Pfizer Inc, Cent Res, Dept Mol Sci, Groton, CT 06340 USA.
   Kyoto Univ, Dept Med Chem, Kyoto 6068501, Japan.
RP Noelle, RJ (reprint author), Dartmouth Med Sch, Dept Microbiol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.
CR Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792
   HU HM, 1994, J BIOL CHEM, V269, P30069
   ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0
   Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747
   BERBERICH I, 1994, J IMMUNOL, V153, P4357
   Zandi E, 1999, MOL CELL BIOL, V19, P4547
   Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337
   DiDonato J, 1996, MOL CELL BIOL, V16, P1295
   REGNIER CH, 1995, J BIOL CHEM, V270, P25715
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322
   Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3
   Banchereau J, 1995, ADV EXP MED BIOL, V378, P79
   Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8
   ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G
   Mackey MF, 1998, J LEUKOCYTE BIOL, V63, P418
   Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437
   Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0
   ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915
   Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953
   XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6
   Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319
   May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3
   Ishida T, 1996, J BIOL CHEM, V271, P28745
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567
   Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5
   Buhlmann JE, 1999, J IMMUNOL, V162, P4373
   CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263
   CONLEY ME, 1994, J CLIN INVEST, V94, P1404, DOI 10.1172/JCI117476
   Durandy A, 1997, J IMMUNOL, V158, P2576
   FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923
   Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057
   Noelle RJ, 1998, AGENT ACTION SUPPL, V49, P17
   Revy P, 1998, EUR J IMMUNOL, V28, P3648, DOI 10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.3.CO;2-L
   ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243
   Sakata N, 1995, J BIOL CHEM, V270, P30823
NR 37
TC 59
Z9 59
U1 1
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JAN 17
PY 2000
VL 191
IS 2
BP 381
EP 385
DI 10.1084/jem.191.2.381
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 276ZJ
UT WOS:000084908000018
PM 10637282
ER

PT J
AU Ono, SJ
   Zhou, G
   Tai, AKF
   Inaba, M
   Kinoshita, K
   Honjo, T
AF Ono, SJ
   Zhou, G
   Tai, AKF
   Inaba, M
   Kinoshita, K
   Honjo, T
TI Identification of a stimulus-dependent DNase I hypersensitive site
   between the I alpha and C alpha exons during immunoglobulin heavy chain
   class switch recombination
SO FEBS LETTERS
LA English
DT Article
DE immunoglobulin gene; class switching; hypersensitive site; IgA
ID V(D)J RECOMBINATION; CIRCULAR DNA; TGF-BETA; REGION; GENES; SPECIFICITY;
   TRANSCRIPTS; SEQUENCES; LYMPHOMA; SMAD3
AB The complete humoral response to foreign antigen depends upon tno distinct recombination events within the heavy chain locus of immunoglobulin. The First recombination event takes place in what will become the antigen combining site of the antibody molecule, encoded by V, D and J segments. The second recombination event involves the looping-out of large spans of DNA which separate the various dusters of heavy chain exons which define the different immunoglobulin isotypes. or classes, While a great deal has been learned about the nature of the VDJ recombinase, very little is known about the nature of the class-switch recombinase, Using a cell, system where class-switch recombination occurs primarily to the IgA locus, ne have looked for stimulus-dependent changes in the chromatin structure of the IgA locus which might result from interactions between components of the recombinase and cis-elements within the region. We present evidence that strongly suggests that the class-switch recombinase interacts between the I alpha and C alpha exons of IgA, just upstream of the highly reiterated DR1 and DR2 elements, However, although multiple potential SMAD-4 sites are located precisely within the DNase I hypersensitive site and 160 bp upstream of that site, ne failed to detect any evidence of DNA/protein interactions near the hypersensitive site, Moreover, recombinant SMAD-3/4 proteins fail to interact with these sites with appreciable affinity in vitro. These data suggest that same other structural alteration at this site (e.g. RNA/DNA hybrid) mag mediate the nuclease sensitivity. (C) 2000 Federation of European Biochemical Societies.
C1 Harvard Univ, Schepens Eye Res Inst, Lab Mol Immunol, Boston, MA 02114 USA.
   Harvard Univ, Comm Immunol, Boston, MA 02114 USA.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RP Ono, SJ (reprint author), Harvard Univ, Schepens Eye Res Inst, Lab Mol Immunol, 20 Staniford St, Boston, MA 02114 USA.
CR Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091
   Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6
   SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F
   FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.immunol.8.1.303
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4
   Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6
   Sawchuk DJ, 1997, J EXP MED, V185, P2025, DOI 10.1084/jem.185.11.2025
   Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   ARNOLD LW, 1988, J IMMUNOL, V140, P4355
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   LYCKE N, 1989, J IMMUNOL, V142, P3781
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MCINTYRE TM, 1995, J IMMUNOL, V154, P1177
   Osipovich O, 1997, J BIOL CHEM, V272, P27259, DOI 10.1074/jbc.272.43.27259
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   STAVNEZER J, 1995, J IMMUNOL, V155, P1647
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
NR 24
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD FEB 11
PY 2000
VL 467
IS 2-3
BP 268
EP 272
DI 10.1016/S0014-5793(00)01151-0
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 285ZF
UT WOS:000085417700028
PM 10675552
ER

PT J
AU Nishimura, H
   Honjo, T
   Minato, N
AF Nishimura, H
   Honjo, T
   Minato, N
TI Facilitation of beta selection and modification of positive selection in
   the thymus of PD-1-deficient mice
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE immunoreceptor tyrosine-based inhibitory motif knock-out mice; positive
   selection; T cell receptor transgenic mice; RAG-2-deficient mice
ID RECEPTOR TRANSGENIC MICE; T-CELL DEVELOPMENT; ALPHA-BETA; NEGATIVE
   SELECTION; SURFACE EXPRESSION; ALLELIC EXCLUSION; ANTIGEN RECEPTOR;
   GENE; LYMPHOCYTES; CHAIN
AB PD-1 is an immunoglobulin superfamily member bearing an immunoreceptor tyrosine-based inhibitory motif, and disruption of the PD-1 gene results in the development of lupus-like autoimmune diseases. In this study, we examined effects of the PD-1 deficiency on the thymocyte differentiation at the clonal level using T cell receptor (TCR)-beta (V beta 8) and TCR-alpha/beta (H-Y and 2C) transgenic mice. In these TCR transgenic lines, PD-1 expression in the thymus was variably augmented, bur: as in the normal mice, confined largely to the CD4(-)CD8(-) thymocytes. The transgenic mice crossed with PD-1(-/-) mice in the neutral genetic backgrounds exhibited selective increase in the CD4(+)CD8(+) (DP) population with little effect on other thymocytes subsets. Similarly, the absence of PD-1 facilitated expansion of DP thymocytes in recombination activating gene (RAG)-2(-/-) mice by anti-CDSE antibody injection. On the other hand, H-Y or 2C transgenic PD-1(-/-) mice with the positively selecting background showed significantly reduced efficiency for the generation of CD8(+) single positive cells bearing the transgenic TCR-alpha/beta in spits of the increased DP population. These results collectively indicate that PD-1 negatively regulates the beta selection and modulates the positive selection, and suggest that PD-1 deficiency may lead to the significant alteration of mature T cell repertoire.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR ADKINS B, 1987, ANNU REV IMMUNOL, V5, P325, DOI 10.1146/annurev.immunol.5.1.325
   MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0
   GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4
   KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0
   KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3
   TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0
   von Boehmer H, 1998, IMMUNOL REV, V165, P111
   MALISSEN M, 1995, EMBO J, V14, P4641
   SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0
   NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541
   CROOKS MEC, 1994, IMMUNITY, V1, P277
   FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0
   KISHI H, 1991, EMBO J, V10, P93
   KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573
   Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767
   Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6
   NISHI S, 1919, ARBEIT ANAT I U SEND, V3, P1
   ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L
   SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703
   SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995
   VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1
   VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729
NR 30
TC 75
Z9 82
U1 1
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAR 6
PY 2000
VL 191
IS 5
BP 891
EP 897
DI 10.1084/jem.191.5.891
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 292RZ
UT WOS:000085810000015
PM 10704469
ER

PT J
AU Kinoshita, K
   Honjo, T
AF Kinoshita, K
   Honjo, T
TI Unique and unprecedented recombination mechanisms in class switching -
   Commentary
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Editorial Material
ID HEAVY-CHAIN LOCUS; B-CELLS; BINDING-PROTEIN; TANDEM REPEATS; CONTROL
   REGION; IMMUNOGLOBULIN; DNA; SEQUENCES; SPECIFICITY; GENES
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Kinoshita, K (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212
   Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025
   COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4
   BOTTARO A, 1994, EMBO J, V13, P665
   Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000
   Wuerffel RA, 1997, J IMMUNOL, V159, P4139
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Ballantyne J, 1997, INT IMMUNOL, V9, P963, DOI 10.1093/intimm/9.7.963
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   KINOSHITA K, 1999, IN PRESS COLD SPRING, V64
   Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151
   LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154
   Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X
   Lyon CJ, 1996, MOL IMMUNOL, V33, P157, DOI 10.1016/0161-5890(95)00125-5
   MIRANDA GA, 1995, EXP CELL RES, V217, P294, DOI 10.1006/excr.1995.1090
   MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761
   Murray HL, 1999, CELL, V96, P599, DOI 10.1016/S0092-8674(00)80568-1
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   OTT DE, 1987, EMBO J, V6, P557
   SCHRADER MR, 1999, J EXP MED, V190, P323
   SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1
   Stavnezer J, 1999, J IMMUNOL, V163, P2028
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   WATERS SH, 1989, MOL CELL BIOL, V9, P5594
   WUERFFEL RA, 1990, MOL CELL BIOL, V10, P1714
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 45
TC 41
Z9 43
U1 0
U2 0
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD APR
PY 2000
VL 12
IS 2
BP 195
EP 198
DI 10.1016/S0952-7915(99)00072-2
PG 4
WC Immunology
SC Immunology
GA 292GQ
UT WOS:000085786300010
PM 10712941
ER

PT J
AU Fossati-Jimack, L
   Ioan-Facsinay, A
   Reininger, L
   Chicheportiche, Y
   Watanabe, N
   Saito, T
   Hofhuis, FMA
   Gessner, JE
   Schiller, C
   Schmidt, RE
   Honjo, T
   Verbeek, JS
   Izui, S
AF Fossati-Jimack, L
   Ioan-Facsinay, A
   Reininger, L
   Chicheportiche, Y
   Watanabe, N
   Saito, T
   Hofhuis, FMA
   Gessner, JE
   Schiller, C
   Schmidt, RE
   Honjo, T
   Verbeek, JS
   Izui, S
TI Markedly different pathogenicity of four immunoglobulin G isotype-switch
   variants of an antierythrocyte autoantibody is based on their capacity
   to interact in vivo with the low-affinity Fc gamma receptor III
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE autoantibody; autoimmune hemolytic anemia; Fc receptor; IgG isotype;
   knockout mouse
ID AUTOIMMUNE HEMOLYTIC-ANEMIA; CYTOPLASMIC DOMAIN HETEROGENEITY; DEFICIENT
   MICE; IN-VIVO; FUNCTIONAL DOMAINS; RHEUMATOID-FACTOR; RIII CD16; IGG;
   MOUSE; GLOMERULONEPHRITIS
AB Using three different Fc gamma receptor (Fc gamma R)-deficient mouse strains, we examined the induction of autoimmune hemolytic anemia by each of the four immunoglobulin (Ig)G isotype-switch variants of a 4C8 IgM antierythrocyte autoantibody and its relation to the contributions of the two Fc gamma R, Fc gamma RI, and Fc gamma RIII, operative in the phagocytosis of opsonized particles. We found that the four IgG isotypes of this antibody displayed striking differences in pathogenicity, which were related to their respective capacity to interact in vivo with the two phagocytic Fc gamma Rs, defined as follows: IgG2a > IgG2b > IgG3/IgG1 for Fc gamma RI, and IgG2a > IgG1 > IgG2b > IgG3 for Fc gamma RIII. Accordingly, the IgG2a autoantibody exhibited the highest pathogenicity, similar to 20-100-fold more potent than its IgG1 and IgG2b variants, respectively, while the IgG3 variant, which displays little interaction with these Fc gamma Rs, was not pathogenic at all. An unexpected critical role of the low-affinity Fc gamma RIII was revealed by the use of two different IgG2a anti-red blood cell autoantibodies, which displayed a striking preferential utilization of Fc gamma RIII, compared with the high-affinity Fc gamma RI. This demonstration of the respective roles in vivo of four different IgG isotypes, and of two phagocytic Fc gamma Rs, in autoimmune hemolytic anemia highlights the major importance of the regulation of IgG isotype responses in autoantibody-mediated pathology and humoral immunity.
C1 Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland.
   Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2300 RA Leiden, Netherlands.
   INSERM, U399, F-13385 Marseille, France.
   Chiba Univ, Grad Sch Med, Dept Mol Genet, Chiba 260, Japan.
   Univ Utrecht Hosp, Dept Immunol, NL-3508 GA Utrecht, Netherlands.
   Hannover Med Sch, Dept Clin Immunol, D-30625 Hannover, Germany.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Izui, S (reprint author), Ctr Med Univ Geneva, Dept Pathol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.
RI Saito, Takashi/C-9684-2009
OI Saito, Takashi/0000-0001-9495-3547
CR MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5
   Schiller C, 2000, EUR J IMMUNOL, V30, P481
   Hazenbos WLW, 1998, J IMMUNOL, V161, P3026
   TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5
   AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455
   FULPIUS T, 1993, P NATL ACAD SCI USA, V90, P2345, DOI 10.1073/pnas.90.6.2345
   HULETT MD, 1991, J IMMUNOL, V147, P1863
   SEARS DW, 1990, J IMMUNOL, V144, P371
   ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023
   Watanabe N, 1999, BLOOD, V94, P3855
   Fossati-Jimack L, 1999, J EXP MED, V190, P1689, DOI 10.1084/jem.190.11.1689
   ALLEN JM, 1989, SCIENCE, V243, P378, DOI 10.1126/science.2911749
   Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256
   Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179
   Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573
   RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5
   UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078
   HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9
   AHEARN JM, 1989, ADV IMMUNOL, V46, P183
   Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584
   RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457
   Gavin AL, 1998, J IMMUNOL, V160, P20
   Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7
   Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750
   SHIBATA T, 1990, INT IMMUNOL, V2, P1133, DOI 10.1093/intimm/2.12.1133
   Haas C, 1997, J IMMUNOL, V158, P5484
   Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052
   Miller KL, 1996, J EXP MED, V183, P2227, DOI 10.1084/jem.183.5.2227
   CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8
   Meyer D, 1998, BLOOD, V92, P3997
   HEUSSER CH, 1977, J EXP MED, V145, P1316, DOI 10.1084/jem.145.5.1316
   Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0
   Yuan RR, 1998, J EXP MED, V187, P641, DOI 10.1084/jem.187.4.641
   BERNEY T, 1992, BLOOD, V79, P2960
   BERNEY T, 1992, INT IMMUNOL, V4, P93, DOI 10.1093/intimm/4.1.93
   Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X
   HELYER BJ, 1963, BRIT J HAEMATOL, V9, P119, DOI 10.1111/j.1365-2141.1963.tb05450.x
   ITOH J, 1993, AM J PATHOL, V143, P1436
   LUZUY S, 1986, J IMMUNOL, V136, P4420
   NEUBERGER MS, 1983, EMBO J, V2, P1373
   OKAMOTO M, 1990, NUCLEIC ACIDS RES, V18, P1895, DOI 10.1093/nar/18.7.1895
   REININGER L, 1990, P NATL ACAD SCI USA, V87, P10038, DOI 10.1073/pnas.87.24.10038
   Santiago ML, 1997, J EXP MED, V185, P65, DOI 10.1084/jem.185.1.65
   SCHREIBE.AD, 1972, J CLIN INVEST, V51, P575, DOI 10.1172/JCI106846
   SIMON T, 1988, NUCLEIC ACIDS RES, V16, P354, DOI 10.1093/nar/16.1.354
   Takahashi T, 1997, J IMMUNOL, V159, P2532
   WEINSHANK RL, 1988, J EXP MED, V167, P1909, DOI 10.1084/jem.167.6.1909
   WELS JA, 1984, EMBO J, V3, P2041
   YAMAWAKIKATAOKA Y, 1980, NATURE, V283, P786, DOI 10.1038/283786a0
NR 53
TC 124
Z9 125
U1 2
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD APR 17
PY 2000
VL 191
IS 8
BP 1293
EP 1302
DI 10.1084/jem.191.8.1293
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 307JU
UT WOS:000086650800005
PM 10770797
ER

PT J
AU Fagarasan, S
   Shinkura, R
   Kamata, T
   Nogaki, F
   Ikuta, K
   Honjo, T
AF Fagarasan, S
   Shinkura, R
   Kamata, T
   Nogaki, F
   Ikuta, K
   Honjo, T
TI Differentiation and migration of B1 cells in GALT
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Kyoto Univ, Fac Med, Dept Med Chem, Kyoto, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 20
PY 2000
VL 14
IS 6
SU S
BP A1189
EP A1189
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 307FQ
UT WOS:000086643101631
ER

PT J
AU Freeman, GJ
   Long, AJ
   Iwai, Y
   Bourque, K
   Chernova, T
   Nishimura, H
   Fitz, L
   Malenkovich, N
   Okazaki, T
   Byrne, M
   Horton, H
   Fouser, L
   Carter, L
   Carreno, B
   Collins, M
   Wood, CR
   Honjo, T
AF Freeman, GJ
   Long, AJ
   Iwai, Y
   Bourque, K
   Chernova, T
   Nishimura, H
   Fitz, L
   Malenkovich, N
   Okazaki, T
   Byrne, M
   Horton, H
   Fouser, L
   Carter, L
   Carreno, B
   Collins, M
   Wood, CR
   Honjo, T
TI The B7-homologue, PD-L, is the ligand of the PD-1 immunoinhibitory
   receptor
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.
   Genet Inst, Cambridge, MA 02140 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6063501, Japan.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 20
PY 2000
VL 14
IS 6
SU S
BP A1170
EP A1170
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 307FQ
UT WOS:000086643101520
ER

PT J
AU Muramatsu, M
   Kinoshita, K
   Davidson, NO
   Shinkai, Y
   Honjo, T
AF Muramatsu, M
   Kinoshita, K
   Davidson, NO
   Shinkai, Y
   Honjo, T
TI A germinal center specific gene, AID promotes isotype switching in a
   mouse B cell lymphoma cells.
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Kyoto Univ, Fac Med, Dept Med Chem, Kyoto, Japan.
   Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto, Japan.
   Washington Univ, Sch Med, St Louis, MO 63130 USA.
RI Shinkai, Yoichi/N-3909-2014; Muramatsu, Masamichi/C-4339-2015
OI Shinkai, Yoichi/0000-0002-6051-2484; Muramatsu,
   Masamichi/0000-0002-0153-3533
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 20
PY 2000
VL 14
IS 6
SU S
BP A1046
EP A1046
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 307FQ
UT WOS:000086643100789
ER

PT J
AU Fagarasan, S
   Shinkura, R
   Kamata, T
   Nogaki, F
   Ikuta, K
   Tashiro, K
   Honjo, T
AF Fagarasan, S
   Shinkura, R
   Kamata, T
   Nogaki, F
   Ikuta, K
   Tashiro, K
   Honjo, T
TI Alymphoplasia (aly)-type nuclear factor kappa B-inducing kinase (NIK)
   causes defects in secondary lymphoid tissue chemokine receptor signaling
   and homing of peritoneal cells to the gut-associated lymphatic tissue
   system
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE RAG-2(-/-) mice; peritoneal cavity cell transfer; lamina propria; IgA
   plasma cells; chemotaxis assay
ID PROTEIN-COUPLED RECEPTOR; TUMOR-NECROSIS-FACTOR; ALPHA-DEFICIENT MICE;
   IGA PLASMA-CELLS; ALY MUTANT MICE; LYMPHOTOXIN-ALPHA; PEYERS-PATCHES;
   ORGAN DEVELOPMENT; GERMINAL-CENTERS; IMMUNE-RESPONSE
AB Alymphoplasia (aly) mice, which carry a point mutation in the nuclear factor kappa B-inducing kinase (NIK) gene, are characterized by the systemic absence of lymph nodes and Peyer's patches, disorganized splenic and thymic architectures, and immunodeficiency. Another unique feature of aly/aly mice is that their peritoneal cavity contains more B1 cells than normal and aly/+ mice. Transfer experiments of peritoneal lymphocytes from aly/aly mice into recombination activating gene (RAG)-2(-/-) mice revealed that B and T cells fail to migrate to other lymphoid tissues, particularly to the gut-associated lymphatic tissue system. In vivo homing defects of aly/aly peritoneal cells correlated with reduction of their in vitro chemotactic responses to secondary lymphoid tissue chemokine (SLC) and B lymphocyte chemoattractant (BLC). The migration defect of aly/aly lymphocytes was not due to a lack of expression of chemokines and their receptors, but rather to impaired signal transduction downstream of the receptors for SLC, indicating that NIK is involved in the chemokine signaling pathway known to couple only with G proteins. The results showed that the reduced serum levels of immunoglobulins (Igs) and the absence of class switch to IgA in aly/aly mice are due, at least in part, to a migration defect of lymphocytes to the proper microenvironment where B cells proliferate and differentiate into Ig-producing cells.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR Bos NA, 1996, INFECT IMMUN, V64, P616
   SCHWEICKART VL, 1994, GENOMICS, V23, P643, DOI 10.1006/geno.1994.1553
   Yang RB, 1998, NATURE, V395, P284
   Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289
   Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997
   Gunn MD, 1998, NATURE, V391, P799
   Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0
   HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146
   Hromas R, 1997, J IMMUNOL, V159, P2554
   DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107
   MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418
   Hedrick JA, 1997, J IMMUNOL, V159, P1589
   Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322
   CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323
   Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7
   Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319
   Medzhitov R, 1997, NATURE, V388, P394
   Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102
   Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   BURGSTAHLER R, 1995, BIOCHEM BIOPH RES CO, V215, P737, DOI 10.1006/bbrc.1995.2525
   Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437
   Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0
   Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7
   Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999
   Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5
   Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397
   Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518
   Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111
   Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009
   BANKS TA, 1995, J IMMUNOL, V155, P1685
   Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258
   Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8
   Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403
   CHEN JJR, 1995, COMPUT SYST SCI ENG, V10, P67
   CRAIG SW, 1975, J IMMUNOL, V114, P492
   KAISER E, 1993, EUR J IMMUNOL, V23, P2532, DOI 10.1002/eji.1830231023
   KLEINSCHNEEGANS AS, 1989, J IMMUNOL METHODS, V119, P117, DOI 10.1016/0022-1759(89)90388-8
   Koike R, 1997, CELL IMMUNOL, V180, P62, DOI 10.1006/cimm.1997.1177
   MARIATHASAN S, 1995, J INFLAMM, V45, P72
   NANNO M, 1994, J IMMUNOL, V153, P2014
   Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067
   TSENG J, 1984, J IMMUNOL, V132, P2730
   TSENG J, 1981, J IMMUNOL, V127, P2039
   Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175
NR 50
TC 100
Z9 105
U1 1
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 1
PY 2000
VL 191
IS 9
BP 1477
EP 1486
DI 10.1084/jem.191.9.1477
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 311LC
UT WOS:000086884900005
PM 10790423
ER

PT J
AU Kurooka, K
   Honjo, T
AF Kurooka, K
   Honjo, T
TI Functional interaction between the mouse Notch1 intracellular region and
   histone acetyltransferases PCAF and GCN5
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RBP-J-KAPPA; NUCLEAR RECEPTOR COACTIVATOR; ADENOVIRAL ONCOPROTEIN E1A;
   SPLIT COMPLEX GENES; BARR-VIRUS EBNA2; TRANSCRIPTION FACTOR;
   SIGNAL-TRANSDUCTION; REPRESS TRANSCRIPTION; ACETYLASE PCAF; BINDING
AB The Notch receptor that plays an important role in cell fate determination is intracellularly cleaved by interaction with the ligand. The cleaved intracellular region (RAMIC) of Notch is translocated into the nucleus and interacts with a DNA-binding protein RBP-J to activate transcription of genes that regulate cell differentiation. Although RAMIC has been shown to facilitate the RBP-J-mediated transactivation by displacing the histone deacetylase corepressor complex from RBP-J, there is no evidence demonstrating the involvement of histone acetyltransferases (HATs) in the transactivation. Here we show that mouse Notch1 RAMIC interacts with two conserved HATs, mouse PCAF and GCN5, and recruits each of the HATs to RBP-J. The ankyrin repeats and the transactivation domain of RAMIC and the N-terminal regions of PCAF and GCN5, respectively, are required for the interaction. We also show that not only mouse Notch1 but also Drosophila Notch RAMIC interacts with mouse PCAF and GCN5 in mammalian cells. Furthermore, the RBP-J-mediated transactivation activity of RAMIC is repressed by two HAT inhibitor proteins, E1A and Twist. These results suggest that HATs including PCAF and GCN5 play an important role in the RBP-J-mediated transactivation by RAMIC.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703
   Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23
   Schroeter EH, 1998, NATURE, V393, P382
   Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X
   Xu WT, 1998, MOL CELL BIOL, V18, P5659
   Dhalluin C, 1999, NATURE, V399, P491
   Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0
   Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9
   Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4
   Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2
   Jarriault S, 1998, MOL CELL BIOL, V18, P7423
   Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0
   Candau R, 1996, MOL CELL BIOL, V16, P593
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   YOSHIDA M, 1990, J BIOL CHEM, V265, P17174
   LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598
   Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1
   Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728
   Cho H, 1998, MOL CELL BIOL, V18, P5355
   Radkov SA, 1999, J VIROL, V73, P5688
   Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   Sakai T, 1998, J VIROL, V72, P6034
   Spencer TE, 1997, NATURE, V389, P194
   Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3
   Wang L, 2000, P NATL ACAD SCI USA, V97, P430, DOI 10.1073/pnas.97.1.430
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609
   Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5
   Luo B, 1997, MOL CELL BIOL, V17, P6057
   Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5
   COHEN JI, 1992, P NATL ACAD SCI USA, V89, P8030, DOI 10.1073/pnas.89.17.8030
   Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8
   Masumi A, 1999, MOL CELL BIOL, V19, P1810
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638
   Ciana P, 1998, EMBO J, V17, P7382, DOI 10.1093/emboj/17.24.7382
   Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Jayachandra S, 1999, P NATL ACAD SCI USA, V96, P11566, DOI 10.1073/pnas.96.20.11566
   Jiang H, 1999, MOL CELL BIOL, V19, P8136
   Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700
   LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949
   LINT CV, 1996, EMBO J, V15, P1112
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   OTSUKA T, 1999, EMBO J, V18, P2196
   Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469
   Roehl H, 1996, EMBO J, V15, P7002
   Smith ER, 1998, NUCLEIC ACIDS RES, V26, P2948, DOI 10.1093/nar/26.12.2948
   Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9
   Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939
NR 67
TC 26
Z9 26
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 2
PY 2000
VL 275
IS 22
BP 17211
EP 17220
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 320FY
UT WOS:000087392200114
ER

PT J
AU Kato, K
   Morrison, AM
   Nakano, T
   Tashiro, K
   Honjo, T
AF Kato, K
   Morrison, AM
   Nakano, T
   Tashiro, K
   Honjo, T
TI ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and
   reproductive systems of embryonic and adult mice
SO BLOOD
LA English
DT Article
ID RECEPTOR TYROSINE KINASES; TOLL-LIKE RECEPTOR-4; C-KIT;
   LYMPHOHEMATOPOIETIC CELLS; STEM-CELLS; GENE; MOUSE; LIPOPOLYSACCHARIDE;
   DROSOPHILA; GENERATION
AB To isolate soluble factors expressed in early phases of hematopoietic differentiation, we applied the signal sequence trap method to the in vitro murine hematopoietic differentiation system, in which ES cells are cocultured with OP-9 stroma cells. This strategy allowed us to isolate cDNA for a secreted protein, ESOP-1, of 160 amino acids, the sequence of which shows 64% identity with human ESOP-1/MD-2. ESOP-1 mRNA was highly expressed in the mouse embryos at 7.5 days after coitus. Expression of the ESOP-1 mRNA and protein was shown in the embryonic and adult hematopoietic system. In addition, the ESOP-1 protein was found in the yolk sec-blood islands, the developing nervous system, and the adult reproductive system. These results suggest that ESOP-1 may play some roles in the development or maintenance of hematopoietic, nervous, and reproductive systems. (Blood. 2000;96:362-364) (C) 2000 by The American Society of Hematology.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kanoe Cho, Kyoto 6068507, Japan.
CR SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2
   Shen MM, 1997, DEVELOPMENT, V124, P429
   HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777
   Choi K, 1998, BIOCHEM CELL BIOL, V76, P947, DOI 10.1139/bcb-76-6-947
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6
   HIRATA T, 1993, DEVELOPMENT, V119, P49
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   Yoshida H, 1998, DEV COMP IMMUNOL, V22, P321, DOI 10.1016/S0145-305X(98)00008-1
   Nishikawa S, 1998, DEVELOPMENT, V125, P1747
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   ORRURTREGER A, 1990, DEVELOPMENT, V109, P911
   CHOI KH, 1994, ONCOGENE, V9, P1261
   GUIMARAES MJ, 1995, DEVELOPMENT, V121, P3335
   HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134
   HONJO T, 1999, Patent No. 18205
   QUI P, 1998, DEVELOPMENT, V125, P1909
   Tashiro K, 1999, METHOD ENZYMOL, V303, P479
   Vincent S, 1998, DEVELOPMENT, V125, P4585
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
   Yoshida H, 1997, DEV BIOL, V184, P122, DOI 10.1006/dbio.1997.8503
NR 25
TC 14
Z9 16
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD JUL 1
PY 2000
VL 96
IS 1
BP 362
EP +
PG 4
WC Hematology
SC Hematology
GA 327UX
UT WOS:000087813200054
PM 10891475
ER

PT J
AU Fagarasan, S
   Watanabe, N
   Honjo, T
AF Fagarasan, S
   Watanabe, N
   Honjo, T
TI Generation, expansion, migration and activation of mouse B1 cells
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review
ID AUTOIMMUNE HEMOLYTIC-ANEMIA; AUTOANTIBODY-TRANSGENIC MICE; IGA
   PLASMA-CELLS; PHORBOL ESTER RESPONSIVENESS; REGION GENE-EXPRESSION; GUT
   LAMINA PROPRIA; B-1 CELLS; T-CELL; PHOSPHOINOSITIDE 3-KINASE;
   PHOSPHATIDYL CHOLINE
AB We have studied the expansion, activation, homing and antibody production of B1 cells in two different mouse models. One is the Hi transgenic mouse, which carries Ig genes encoding the anti-red blood cell autoantibody (4C8) and develops autoimmune hemolytic anemia by the activation of autoreactive B1 cells that escape from clonal deletion and expand in the peritoneal cavity (PEC). The other model is represented by alymphoplasia (aly) mice, which carry a point mutation in the gene encoding NF-kappa B-inducing kinase (NIK) and have drastically reduced immunoglobulin serum levels, in spite of their peritoneal cavity containing a large number of B1 cells. We have found that a) expression levels of the B-cell antigen receptor (BCR) influence the size of the B1-cell compartment and efficiency of allelic exclusion and BZ-cell deletion; b) antibody production of B1 cells is closely related with their migration from PEC to other lymphoid organs and is dependent on NIK; and c) infection, lipopolysaccharide stimulation, cytokine administration or T-cell activation by noncanonical antigens induces migration and differentiation of peritoneal B1 cells into antibody-producing cells. We describe a scenario where most of B1 and BZ differences are due to a distinct activation threshold of BCR and antigen repertoire.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Fac Med, Dept Gastroenterol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR KROESE FGM, 1989, IMMUNOL INVEST, V18, P47, DOI 10.3109/08820138909112226
   Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543
   ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0
   HARDY RR, 1989, J IMMUNOL, V142, P3643
   Watanabe N, 1999, J EXP MED, V190, P461, DOI 10.1084/jem.190.4.461
   Bos NA, 1996, INFECT IMMUN, V64, P616
   Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788
   MURPHY TP, 1990, EUR J IMMUNOL, V20, P1137, DOI 10.1002/eji.1830200529
   KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55
   Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707
   KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9
   MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857
   PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721
   LALOR PA, 1990, EUR J IMMUNOL, V20, P485, DOI 10.1002/eji.1830200305
   Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390
   Tarakhovsky A, 1997, J EXP MED, V185, P981, DOI 10.1084/jem.185.6.981
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   Tanguay DA, 1999, J EXP MED, V189, P1685, DOI 10.1084/jem.189.11.1685
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423
   HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x
   TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0
   HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4
   ROTHSTEIN TL, 1988, J IMMUNOL, V140, P2880
   HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554
   CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056
   Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1
   HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0
   FORSTER I, 1991, CURR TOP MICROBIOL, V173, P247
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2
   TARLINTON D, 1988, EMBO J, V7, P3705
   Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   CONG YZ, 1991, INT IMMUNOL, V3, P467
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801
   MERCOLINO TJ, 1986, J EXP MED, V163, P155, DOI 10.1084/jem.163.1.155
   Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393
   Humbert PO, 1997, J IMMUNOL, V159, P5273
   Berland R, 1998, J IMMUNOL, V161, P277
   HAYAKAWA K, 1990, J EXP MED, V172, P869, DOI 10.1084/jem.172.3.869
   FORSTER I, 1988, EMBO J, V7, P3693
   Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804
   TSUBATA T, 1994, CURR BIOL, V4, P8, DOI 10.1016/S0960-9822(00)00003-8
   Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906
   Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471
   FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414
   ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585
   SU SD, 1991, J IMMUNOL, V146, P327
   CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3
   Huang CA, 1996, EUR J IMMUNOL, V26, P2537, DOI 10.1002/eji.1830261039
   TORNBERG UC, 1995, EMBO J, V14, P1680
   PENNELL CA, 1988, J IMMUNOL, V141, P2788
   Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   Sakiyama T, 1999, INT IMMUNOL, V11, P995, DOI 10.1093/intimm/11.6.995
   BONNEVILLE M, 1990, NATURE, V344, P163, DOI 10.1038/344163a0
   BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979
   CRAIG SW, 1975, J IMMUNOL, V114, P492
   Hardy R R, 1992, Int Rev Immunol, V8, P189, DOI 10.3109/08830189209055573
   HARDY RR, 1992, CURR OPIN IMMUNOL, V4, P181, DOI 10.1016/0952-7915(92)90010-C
   Histoshi Y., 1990, J IMMUNOL, V144, P4218
   ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B
   KEARNEY JF, 1993, CURR OPIN IMMUNOL, V5, P223, DOI 10.1016/0952-7915(93)90008-G
   KOLBER DL, 1991, EUR J IMMUNOL, V21, P721, DOI 10.1002/eji.1830210327
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   Nisitani S, 1998, INT IMMUNOL, V10, P1039, DOI 10.1093/intimm/10.8.1039
   NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   ROTHSTEIN TL, 1991, J IMMUNOL, V147, P3728
   SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115
   SPANER D, 1993, P NATL ACAD SCI USA, V90, P8419
   TSENG J, 1984, J IMMUNOL, V132, P2730
   TSENG J, 1981, J IMMUNOL, V127, P2039
NR 85
TC 71
Z9 73
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0105-2896
J9 IMMUNOL REV
JI Immunol. Rev.
PD AUG
PY 2000
VL 176
BP 205
EP 215
PG 11
WC Immunology
SC Immunology
GA 355FV
UT WOS:000089376400017
PM 11043779
ER

PT J
AU Kamata, T
   Nogaki, F
   Fagarasan, S
   Sakiyama, T
   Kobayashi, N
   Miyawaki, S
   Ikuta, K
   Muso, E
   Yoshida, H
   Sasayama, S
   Honjo, T
AF Kamata, T
   Nogaki, F
   Fagarasan, S
   Sakiyama, T
   Kobayashi, N
   Miyawaki, S
   Ikuta, K
   Muso, E
   Yoshida, H
   Sasayama, S
   Honjo, T
TI Increased frequency of surface IgA-positive plasma cells in the
   intestinal lamina propria and decreased IgA excretion in hyper IgA,
   (HIGA) mice, a murine model of IgA nephropathy with hyperserum IgA
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID GLOMERULAR EXTRACELLULAR-MATRIX; LY-1 B-CELLS; DDY MICE;
   IMMUNOGLOBULIN-A; TRANSGENIC MICE; SERUM IGA; PERITONEAL-CAVITY;
   DEFICIENT MICE; LYMPHOCYTES-B; J-CHAIN
AB Because abnormalities of mucosal immunity have been suggested in human IgA nephropathy, we examined the involvement of mucosal immunity in IgA deposition to the kidney in hyper IgA (HIGA) mice, which was established as a mouse model for human IgA nephropathy with hyperserum IgA, The number of surface IgA(+)B220(-) lymphocytes in the intestinal lamina propria (LP) of HIGA mice increased 2.7-fold at 30 wk of age as compared with those at 10 wk of age, whereas normal mice did not show such increase. The surface IgA(+)B220(-) LP lymphocytes spontaneously secreted IgA in culture, Morphological studies showed that the surface IgA(+)B220(-) lymphocytes of murine intestinal LP are identical with plasma cells (PCs), About 20% of IgA(+)B220(-) PC in LP expressed both Mac-1 and CD19, suggesting that they may derive from peritoneal B-l cells, Cell cycle study on intestinal IgA-PCs using bromodeoxyuridine revealed no difference between HIGA mice and normal mice, suggesting that the high frequency of IgA-producing PCs in HIGA mice is not due to enhanced proliferation or prolonged survival of IgA-producing PCs in LP, In addition, IgA secretion into the gut lumen of HIGA mice decreased drastically (to one forth) with aging. These data suggest that the increased number of intestinal IgA-producing PCs and the down-regulation of IgA excretion into the intestinal lumen might synergistically contribute to the hyperserum IgA in HIGA mice and resultant IgA deposition to the kidney.
C1 Kyoto Univ, Fac Med,Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Dept Internal Med, Div 3, Kyoto, Japan.
   Nippon Shinyaku Co Ltd, Res Labs, Kyoto 601, Japan.
   Kitano Hosp, Med Res Inst, Div Nephrol, Osaka, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med,Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517
   GOMEZGUERRERO C, 1993, J IMMUNOL, V151, P7172
   TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   IMAI H, 1985, KIDNEY INT, V27, P756, DOI 10.1038/ki.1985.76
   Miyawaki S, 1997, NEPHRON, V76, P201
   Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915
   Bao S, 1998, IMMUNOLOGY, V94, P181, DOI 10.1046/j.1365-2567.1998.00512.x
   SANDERSON RD, 1989, CELL REGUL, V1, P27
   KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317
   NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I
   NADLER LM, 1983, J IMMUNOL, V131, P244
   WILLIAMS RC, 1972, SCIENCE, V177, P697, DOI 10.1126/science.177.4050.697
   MATTIOLI CA, 1973, J EXP MED, V138, P452, DOI 10.1084/jem.138.2.452
   BEAGLEY KW, 1995, IMMUNOL CELL BIOL, V73, P425, DOI 10.1038/icb.1995.66
   Berger J, 1968, J Urol Nephrol (Paris), V74, P694
   BRANDTZAEG P, 1981, CLIN EXP IMMUNOL, V44, P221
   BUTCHER EC, 1982, J IMMUNOL, V129, P2698
   CAGNOLI L, 1985, KIDNEY INT, V28, P646, DOI 10.1038/ki.1985.178
   CARAYON P, 1992, J IMMUNOL METHODS, V147, P225
   COPPO R, 1986, CLIN NEPHROL, V26, P72
   DEVOS T, 1991, J IMMUNOL METHODS, V141, P285, DOI 10.1016/0022-1759(91)90155-9
   FERRARINI M, 1976, EUR J IMMUNOL, V6, P562, DOI 10.1002/eji.1830060807
   HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817
   HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905
   Hendrickson BA, 1996, J IMMUNOL, V157, P750
   Hiroi T, 1999, J IMMUNOL, V162, P821
   Kamata T, 1999, KIDNEY INT, V55, P864, DOI 10.1046/j.1523-1755.1999.055003864.x
   KUMAGAI K, 1975, J IMMUNOL, V115, P982
   LAYWARD L, 1993, CLIN IMMUNOL IMMUNOP, V69, P306, DOI 10.1006/clin.1993.1185
   Oliver AM, 1997, J IMMUNOL, V158, P1108
   PISKURICH JF, 1995, J IMMUNOL, V154, P1735
   RAMASAMY R, 1974, IMMUNOLOGY, V26, P563
   Saparov A, 1997, EUR J IMMUNOL, V27, P1774, DOI 10.1002/eji.1830270727
   Suzuki S, 1996, CLIN NEPHROL, V46, P287
   Takahashi I, 1996, J INFECT DIS, V173, P627
   TAKEUCHI E, 1989, KIDNEY INT, V35, P638, DOI 10.1038/ki.1989.33
   TSENG J, 1984, J IMMUNOL, V132, P2730
   VAERMAN JP, 1973, EUR J IMMUNOL, V3, P580, DOI 10.1002/eji.1830030911
   WOODROFFE AJ, 1980, KIDNEY INT, V18, P366, DOI 10.1038/ki.1980.147
NR 44
TC 44
Z9 44
U1 1
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD AUG 1
PY 2000
VL 165
IS 3
BP 1387
EP 1394
PG 8
WC Immunology
SC Immunology
GA 337CV
UT WOS:000088340600030
PM 10903742
ER

PT J
AU Muto, T
   Muramatsu, M
   Taniwaki, M
   Kinoshita, K
   Honjo, T
AF Muto, T
   Muramatsu, M
   Taniwaki, M
   Kinoshita, K
   Honjo, T
TI Isolation, tissue distribution, and chromosomal localization of the
   human activation-induced cytidine deaminase (AID) gene
SO GENOMICS
LA English
DT Article
ID RNA-EDITING PROTEIN; SEQUENCES; SEARCH; MEMBER; FAMILY
AB The gene encoding activation-induced cytidine deaminase (AID), a member of the cytidine deaminase family, was isolated from a murine B cell lymphoma line, CH12F3-2, induced by combined stimulation of TGF-beta, IL-4, and CD40L, We have isolated the human orthologue of mouse AID cDNA, which has an open reading frame of 198 residues containing a conserved cytidine deaminase motif, The amino acid sequence of human AID is 92% identical to that of mouse AID. RT-PCR analysis of 15 human tissues showed that AID mRNA is expressed strongly in lymph nodes and tonsils. The complete human AID gene consisting of five exons was isolated and mapped to chromosome 12p13 by fluorescence in situ hybridization. (C) 2000 Academic Press.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Prefectural Univ Med, Dept Internal Med 3, Kamigyo Ku, Kyoto 6020841, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925
   Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   INA Y, 1994, COMPUT APPL BIOSCI, V10, P11
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522
   MIYATA T, 1993, BUNSHI SHINKA KIKKEN, P357
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   SACCONE S, 1994, GENOMICS, V22, P661, DOI 10.1006/geno.1994.1448
NR 10
TC 100
Z9 103
U1 3
U2 9
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
J9 GENOMICS
JI Genomics
PD AUG 15
PY 2000
VL 68
IS 1
BP 85
EP 88
DI 10.1006/geno.2000.6268
PG 4
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 349EM
UT WOS:000089030700010
PM 10950930
ER

PT J
AU Muramatsu, M
   Kinoshita, K
   Fagarasan, S
   Yamada, S
   Shinkai, Y
   Honjo, T
AF Muramatsu, M
   Kinoshita, K
   Fagarasan, S
   Yamada, S
   Shinkai, Y
   Honjo, T
TI Class switch recombination and hypermutation require activation-induced
   cytidine deaminase (AID), a potential RNA editing enzyme
SO CELL
LA English
DT Article
ID HEAVY-CHAIN LOCUS; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME;
   SOMATIC HYPERMUTATION; CD40 LIGAND; IMMUNOGLOBULIN GENES; CIRCULAR DNA;
   B-CELLS; SACCHAROMYCES-CEREVISIAE; REGION RECOMBINATION
AB Induced overexpression of AID in CH12F3-2 B lymphoma cells augmented class switching from IgM to IgA without cytokine stimulation. AID deficiency caused a complete defect in class switching and showed a hyper-IgM phenotype with enlarged germinal centers containing strongly activated B cells before or after immunization. AID(-/-) spleen cells stimulated in vitro with LPS and cytokines failed to undergo class switch recombination although they expressed germline transcripts. Immunization of AID(-/-) chimera with 4-hydroxy-3-nitrophenylacetyl (NP) chicken gamma-globulin induced neither accumulation of mutations in the NP-specific variable region gene nor class switching. These results suggest that AID may be involved in regulation or catalysis of the DNA modification step of both class switching and somatic hypermutation.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RI Shinkai, Yoichi/N-3909-2014; Muramatsu, Masamichi/C-4339-2015;
   Fagarasan, Sidonia/A-5258-2016
OI Shinkai, Yoichi/0000-0002-6051-2484; Muramatsu,
   Masamichi/0000-0002-0153-3533; Fagarasan, Sidonia/0000-0003-2086-6402
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Sonoda E, 1999, MOL CELL BIOL, V19, P5166
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3
   Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0
   MANTOVANI L, 1993, J IMMUNOL, V151, P473
   Wabl M, 1999, CURR OPIN IMMUNOL, V11, P186, DOI 10.1016/S0952-7915(99)80031-4
   Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441
   ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801
   COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4
   KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0
   ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G
   KELLY BS, 1979, IMMUNOLOGY, V37, P45
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0
   YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458
   ALLEN D, 1988, EMBO J, V7, P1995
   Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9
   Holbeck SL, 1997, GENETICS, V147, P1017
   Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Ballantyne J, 1998, J IMMUNOL, V161, P1336
   BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950
   CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528
   CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397
   Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X
   Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2
   Kinoshita K, 1999, COLD SPRING HARB SYM, V64, P217, DOI 10.1101/sqb.1999.64.217
   KINOSHITA K, 1998, IMMUNITY, V9, P349
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   MUTO T, 2000, IN PRESS GENOMICS
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1
   Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6
   SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0
   Smith HC, 1996, TRENDS GENET, V12, P418, DOI 10.1016/0168-9525(96)10042-1
   SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Wilson P, 1998, IMMUNOL REV, V162, P143, DOI 10.1111/j.1600-065X.1998.tb01437.x
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   ZHANG T, 1995, IMMUNOGLOBULIN GENES, P235
NR 62
TC 1835
Z9 1863
U1 25
U2 129
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD SEP 1
PY 2000
VL 102
IS 5
BP 553
EP 563
DI 10.1016/S0092-8674(00)00078-7
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 350ML
UT WOS:000089105200004
PM 11007474
ER

PT J
AU Revy, P
   Muto, T
   Levy, Y
   Geissmann, F
   Plebani, A
   Sanal, O
   Catalan, N
   Forveille, M
   Dufourcq-Lagelouse, R
   Gennery, A
   Tezcan, I
   Ersoy, F
   Kayserili, H
   Ugazio, AG
   Brousse, N
   Muramatsu, M
   Notarangelo, LD
   Kinoshita, K
   Honjo, T
   Fischer, A
   Durandy, A
AF Revy, P
   Muto, T
   Levy, Y
   Geissmann, F
   Plebani, A
   Sanal, O
   Catalan, N
   Forveille, M
   Dufourcq-Lagelouse, R
   Gennery, A
   Tezcan, I
   Ersoy, F
   Kayserili, H
   Ugazio, AG
   Brousse, N
   Muramatsu, M
   Notarangelo, LD
   Kinoshita, K
   Honjo, T
   Fischer, A
   Durandy, A
TI Activation-induced cytidine deaminase (AID) deficiency causes the
   autosomal recessive form of the hyper-IgM syndrome (HIGM2)
SO CELL
LA English
DT Article
ID CLASS SWITCH RECOMBINATION; X-LINKED IMMUNODEFICIENCY; FACTOR-KAPPA-B;
   CD40 LIGAND; SOMATIC HYPERMUTATION; GERMINAL-CENTERS; DEFECTIVE
   EXPRESSION; IMMUNOGLOBULIN GENES; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR
AB The activation-induced cytidine deaminase (AID) gene, specifically expressed in germinal center B cells in mice, is a member of the cytidine deaminase family. We herein report mutations in the human counterpart of AID in patients with the autosomal recessive form of hyper-IgM syndrome (HIGM2). Three major abnormalities characterize AID deficiency: (1) the absence of immunoglobulin class switch recombination, (2) the lack of immunoglobulin somatic hypermutations, and (3) lymph node hyperplasia caused by the presence of giant germinal centers. The phenotype observed in HIGM2 patients (and in AID(-/-) mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses.
C1 Hop Necker Enfants Malad, INSERM, U429, Paris, France.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
   Hop Cochin, INSERM, U474, F-75674 Paris, France.
   Hop Necker Enfants Malad, Serv Anatomopathol, Paris, France.
   Univ Brescia, Pediat Clin, Brescia, Italy.
   Univ Brescia, Ist Med Mol Angelo Novicelli, Brescia, Italy.
   Hacettepe Univ, Div Immunol, Ihsan Dogramaci Childrens Hosp, Ankara, Turkey.
   Univ Istanbul, Inst Child Hlth, Istanbul, Turkey.
   Hop Necker Enfants Malad, Unite Immunol Hematol, Paris, France.
RP Durandy, A (reprint author), Hop Necker Enfants Malad, INSERM, U429, Paris, France.
RI Plebani, Alessandro/C-8593-2011; Muramatsu, Masamichi/C-4339-2015;
   Karabulut, Erman/G-6679-2011
OI Muramatsu, Masamichi/0000-0002-0153-3533; 
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792
   ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705
   STEWART AK, 1993, J EXP MED, V177, P409, DOI 10.1084/jem.177.2.409
   JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679
   SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543
   HU HM, 1994, J BIOL CHEM, V269, P30069
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219
   BERBERICH I, 1994, J IMMUNOL, V153, P4357
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X
   FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170
   ZHANG J, 1993, EMBO J, V12, P3529
   Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2
   Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241
   SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q
   KUPPERS R, 1993, EMBO J, V12, P4955
   LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0
   DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0
   COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
   ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801
   Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731
   Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9
   KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0
   ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G
   REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673
   Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B
   BOTTARO A, 1994, EMBO J, V13, P665
   Lagresle C, 1996, J EXP MED, V183, P1377, DOI 10.1084/jem.183.4.1377
   GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265
   Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421
   Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437
   Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0
   Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963
   Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563
   Zan H, 1999, J IMMUNOL, V162, P3437
   CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327
   Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5
   Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325
   Ishida T, 1996, J BIOL CHEM, V271, P28745
   Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   CALLARD RE, 1994, J IMMUNOL, V153, P3295
   CONLEY ME, 1994, J CLIN INVEST, V94, P1404, DOI 10.1172/JCI117476
   DURANDY A, 1990, J IMMUNOL, V144, P60
   Durandy A, 1997, J IMMUNOL, V158, P2576
   DURANDY A, 1993, EUR J IMMUNOL, V23, P2294, DOI 10.1002/eji.1830230936
   FACCHETTI F, 1995, J IMMUNOL, V154, P6624
   Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697
   KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0
   Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2
   Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679
   KRAUTER K, 1995, NATURE, V377, P321
   KRUGLYAK L, 1995, AM J HUM GENET, V56, P519
   LEDERMAN S, 1992, J IMMUNOL, V149, P3817
   MUTO T, 2000, IN PRESS GENOMICS
   NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709
   NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101
   Revy P, 1998, EUR J IMMUNOL, V28, P3648, DOI 10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.3.CO;2-L
   SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0
   SIMPSON L, 1995, CELL, V81, P837, DOI 10.1016/0092-8674(95)90003-9
   Tracy RB, 2000, SCIENCE, V288, P1058, DOI 10.1126/science.288.5468.1058
   Wiesendanger M, 1998, CELL, V94, P415, DOI 10.1016/S0092-8674(00)81581-0
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
NR 76
TC 966
Z9 981
U1 11
U2 32
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD SEP 1
PY 2000
VL 102
IS 5
BP 565
EP 575
DI 10.1016/S0092-8674(00)00079-9
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 350ML
UT WOS:000089105200005
PM 11007475
ER

PT J
AU Nakashiba, T
   Ikeda, T
   Nishimura, S
   Tashiro, K
   Honjo, T
   Culotti, JG
   Itohara, S
AF Nakashiba, T
   Ikeda, T
   Nishimura, S
   Tashiro, K
   Honjo, T
   Culotti, JG
   Itohara, S
TI Netrin-G1: a novel glycosyl phosphatidylinositol-linked mammalian netrin
   that is functionally divergent from classical netrins
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE netrin; GPI-linkage; glycosyl phosphatidylinositol; axon guidance;
   receptor; signal sequence trap; UNC-6; mouse; isoform; alternative
   splicing; CNS
ID C-ELEGANS; AXON GUIDANCE; EPH RECEPTORS; COLORECTAL-CANCER;
   MEMBRANE-PROTEINS; SECRETED PROTEINS; COMMISSURAL AXONS; DIRECTED
   GROWTH; SUGGESTS ROLES; MOTOR AXONS
AB UNC-6/netrins compose a small phylogenetically conserved family of proteins that act as axon guidance cues. With a signal sequence trap method, we isolated a cDNA encoding a novel member of the UNC-6/netrin family, which we named netrin-G1. Unlike classical netrins, netrin-G1 consists of at least six isoforms of which five were predominantly anchored to the plasma membrane via glycosyl phosphatidyl-inositol linkages. Netrin-G1 transcripts were first detected in midbrain and hindbrain regions by embryonic day 12 and reached highest levels at perinatal stages in various brain regions, including olfactory bulb mitral cells, thalamus, and deep cerebellar nuclei. Its expression was primarily restricted to the CNS. Interestingly, netrin-G1 proteins did not show appreciable affinity to any netrin receptor examined. Unlike netrin-1, a secreted form of netrin-G1 consistently failed to attract circumferentially growing axons from the cerebellar plate. Our findings suggest that netrin-G1 and its putative receptors have coevolved independently from the classical netrins. The expression pattern of netrin-G1 and its predicted neuronal membrane localization suggest it may also have novel signaling functions in nervous system development.
C1 RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Fac Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
   Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.
RP Itohara, S (reprint author), RIKEN, Brain Sci Inst, Lab Behav Genet, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
RI Itohara, Shigeyoshi/I-8769-2012; Culotti, Joseph/G-6467-2013; 
OI Culotti, Joseph/0000-0001-6325-4612
CR ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P66
   Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5
   HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K
   Metin C, 1997, DEVELOPMENT, V124, P5063
   SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0
   Wang H, 1999, J NEUROSCI, V19, P4938
   Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5
   TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9
   Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1
   Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626
   Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0
   de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4
   DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265
   ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E
   CONLON RA, 1992, DEVELOPMENT, V116, P357
   KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7
   KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7
   Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X
   VanRaay TJ, 1997, GENOMICS, V41, P279, DOI 10.1006/geno.1997.4659
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8
   Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598
   BECK K, 1990, FASEB J, V4, P148
   Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0
   GERBER LD, 1992, J BIOL CHEM, V267, P12168
   Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309
   Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640
   Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0
   Richards LJ, 1997, J NEUROSCI, V17, P2445
   Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1
   Araujo M, 1998, DEVELOPMENT, V125, P4195
   BROWN D, 1993, CURR OPIN IMMUNOL, V5, P349, DOI 10.1016/0952-7915(93)90052-T
   Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125
   DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7
   Engvall E, 1996, J CELL BIOCHEM, V61, P493
   Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3
   Holder N, 1999, DEVELOPMENT, V126, P2033
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   Leonardo ED, 1997, COLD SPRING HARB SYM, V62, P467
   Lierheimer R, 1997, EUR J BIOCHEM, V243, P502, DOI 10.1111/j.1432-1033.1997.0502a.x
   Nagase T, 1999, DNA Res, V6, P63, DOI 10.1093/dnares/6.1.63
   Puschel AW, 1999, MECH DEVELOP, V83, P65, DOI 10.1016/S0925-4773(99)00035-0
   SASAKI M, 1988, J BIOL CHEM, V263, P16536
   VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683
   WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7
NR 51
TC 82
Z9 85
U1 1
U2 4
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD SEP 1
PY 2000
VL 20
IS 17
BP 6540
EP 6550
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 348VJ
UT WOS:000089006900026
PM 10964959
ER

PT J
AU Yanagawa, S
   Lee, JS
   Kakimi, K
   Matsuda, Y
   Honjo, T
   Ishimoto, A
AF Yanagawa, S
   Lee, JS
   Kakimi, K
   Matsuda, Y
   Honjo, T
   Ishimoto, A
TI Identification of Notch1 as a frequent target for provirus insertional
   mutagenesis in T-cell lymphomas induced by leukemogenic mutants of mouse
   mammary tumor virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID LONG TERMINAL REPEAT; INTRACELLULAR DOMAIN; MEDIATED ACTIVATION;
   DROSOPHILA NOTCH; TRANSGENIC MICE; B RETROVIRUS; GENE; LEUKEMIA;
   NEOPLASMS; HOMOLOG
AB In contrast to wild-type mouse mammary tumor virus (MMTV), the MMTV mutants with specific deletions in the U3 region of their long terminal repeats cause T-cell lymphomas. In 30% of T-cell lymphomas arising in BALB/c mice infected with MLA-MMTV, a Leukemogenic MMTV mutant, we have found that MMTV proviruses were integrated into a short region of the Notch1 genome, so that truncated Notch1 transcripts encoding the transmembrane and the cytoplasmic domains of Notch1 protein could be expressed. Thus, Notch1 is a major target of provirus insertional mutagenesis in these T-cell lymphomas.
C1 Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068507, Japan.
RP Yanagawa, S (reprint author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan.
CR De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083
   Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283
   Schroeter EH, 1998, NATURE, V393, P382
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930
   Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035
   MAJORS JE, 1983, J VIROL, V47, P495
   ARTAVANISTSAKON.S, 1999, SCIENCE, V284, P70
   BALL JK, 1988, J VIROL, V62, P2985
   BALL JK, 1987, VIROLOGY, V161, P357, DOI 10.1016/0042-6822(87)90128-0
   Callahan R, 1996, BREAST CANCER RES TR, V39, P33, DOI 10.1007/BF01806076
   Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4
   DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055
   Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991
   DUDLEY J, 1984, J VIROL, V49, P92
   Girard L, 1998, ONCOGENE, V16, P517, DOI 10.1038/sj.onc.1201562
   HSU CLL, 1988, J VIROL, V62, P4644
   Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G
   KORDON EC, 1995, J VIROL, V69, P8066
   Lee JS, 1999, FEBS LETT, V455, P276, DOI 10.1016/S0014-5793(99)00901-1
   Lee JS, 1999, J VIROL, V73, P5166
   LEE WTL, 1987, VIROLOGY, V159, P39, DOI 10.1016/0042-6822(87)90345-X
   MICHALIDES R, 1986, VIROLOGY, V154, P76, DOI 10.1016/0042-6822(86)90431-9
   MICHALIDES R, 1982, J VIROL, V43, P819
   MUELLER RE, 1992, VIROLOGY, V191, P628, DOI 10.1016/0042-6822(92)90238-K
   Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5
   PANQUETTE Y, 1992, MOL CELL BIOL, V12, P3522
   Rajan L, 1997, MAMM GENOME, V8, P295, DOI 10.1007/s003359900420
   Rajan L, 2000, J VIROL, V74, P2466, DOI 10.1128/JVI.74.5.2466-2471.2000
   Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9
   SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655
   Sorensen AB, 2000, J VIROL, V74, P2161, DOI 10.1128/JVI.74.5.2161-2168.2000
   VANLEEUWEN F, 1995, SEMIN CANCER BIOL, V6, P127, DOI 10.1006/scbi.1995.0018
   YANAGAWA SI, 1993, J VIROL, V67, P112
   YANAGAWA SI, 1990, J VIROL, V64, P2474
NR 37
TC 29
Z9 31
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD OCT
PY 2000
VL 74
IS 20
BP 9786
EP 9791
DI 10.1128/JVI.74.20.9786-9791.2000
PG 6
WC Virology
SC Virology
GA 357LP
UT WOS:000089503400055
PM 11000255
ER

PT J
AU Saito, S
   Nishimura, H
   Phelps, RG
   Wolf, I
   Suzuki, M
   Honjo, T
   Bona, C
AF Saito, S
   Nishimura, H
   Phelps, RG
   Wolf, I
   Suzuki, M
   Honjo, T
   Bona, C
TI Induction of skin fibrosis in mice expressing a mutated fibrillin-1 gene
SO MOLECULAR MEDICINE
LA English
DT Article
ID TIGHT-SKIN; CONNECTIVE-TISSUE; MOUSE CHROMOSOME-2; AUTOANTIBODIES;
   SCLERODERMA; CELLS; ASSOCIATION; PROTEIN
AB Background: Tight skin mice (TSK) bear a mutated Fibrillin-1 (Fbn-1) gene. Genetic studies show that the TSR mutation is closely associated with the Fbn-1 locus (0-0.7 cM). A previous study showed two recombinants between the Fbn-1 locus and the TSK mutation. TSK mutation and mutated Fbn-1 gene cosegregate in F1 mice. Materials and
   Methods: To elucidate the role of the mutated Fbn-1 gene in occurrence of TSK syndrome, we generated transgenic (Tg) mice expressing mutated Fbn-1 gene. In another set of experiments, we injected normal mice after birth with a plasmid bearing mutated Fbn-1 gene (pdFbn-1).
   Results: Our results demonstrate that the pdFbn-1 Tg mice developed permanent cutaneous hyperplasia that was permanent. In mice injected as newborns with a plasmid bearing the sense pdFbn-1 gene, cutaneous hyperplasia was transient. In contrast to TSK mice, neither Tg nor mice injected with plasmid developed lung emphysema. The pdFbn-1 Tg and TSK mice spontaneously produced anti-topoisomerase I and anti-Fbn-1 antibodies, as do humans afflicted by scleroderma; whereas, those injected with a plasmid containing the pdFbn-1 gene produced only anti-Fbn-1 autoantibodies.
   Conclusions: The results suggest that, although cutaneous hyperplasia is due to mutated Fbn-1 gene, the TSK syndrome may be multifactorial.
C1 CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.
   CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA.
   CUNY Mt Sinai Sch Med, Dept Biochem, New York, NY 10029 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
   Kumamoto Univ, Ctr Anim Resources, Kumamoto, Japan.
RP Bona, C (reprint author), CUNY Mt Sinai Sch Med, Dept Microbiol, Annenberg Bld 16-60,Box 1124,1 Gustave Levy Pl, New York, NY 10029 USA.
CR Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300
   MURYOI T, 1992, J EXP MED, V175, P1103, DOI 10.1084/jem.175.4.1103
   Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1362, DOI 10.1002/art.1780390814
   Arnett FC, 1999, ARTHRITIS RHEUM, V42, P2656, DOI 10.1002/1529-0131(199912)42:12<2656::AID-ANR22>3.0.CO;2-N
   FIOCCO U, 1993, ANN RHEUM DIS, V52, P272, DOI 10.1136/ard.52.4.272
   GREEN MC, 1976, AM J PATHOL, V82, P493
   Hatakeyama A, 1996, CELL IMMUNOL, V167, P135, DOI 10.1006/cimm.1996.0017
   Tan FK, 1999, J IMMUNOL, V163, P1066
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Bona C A, 1999, Curr Dir Autoimmun, V1, P194
   BONA C, 1994, CURR OPIN IMMUNOL, V6, P931, DOI 10.1016/0952-7915(94)90016-7
   Bona C A, 1997, DNA Res, V4, P267, DOI 10.1093/dnares/4.4.267
   Bot A, 1998, Dev Immunol, V5, P197, DOI 10.1155/1998/50472
   Casares S, 1997, J EXP MED, V186, P1481, DOI 10.1084/jem.186.9.1481
   COSTAGLIOLA S, 1998, J IMMUNOL, V160, P1485
   DOUTE RC, 1994, GENOMICS, V22, P223, DOI 10.1006/geno.1994.1368
   JABLONSKA S, 1989, J AM ACAD DERMATOL, V21, P943, DOI 10.1016/S0190-9622(89)70280-2
   JIMENEZ SA, 1986, J BIOL CHEM, V261, P657
   Kasturi KN, 1997, J AUTOIMMUN, V10, P505, DOI 10.1006/jaut.1997.0158
   KIELTY JM, 1998, J CELL BIOL, V140, P1156
   KOVACS EJ, 1994, FASEB J, V8, P854
   LI X, 1993, GENOMICS, V18, P667, DOI 10.1016/S0888-7543(05)80371-4
   Murai C, 1998, AUTOIMMUNITY, V28, P151, DOI 10.3109/08916939808996283
   NEDELMAN BW, 1992, ARTHRITIS RHEUM, V35, P67
   OSBORN TG, 1987, J MOL CELL CARDIOL, V19, P581, DOI 10.1016/S0022-2828(87)80363-2
   OSBORN TG, 1983, J RHEUMATOL, V10, P793
   PHELPS RG, 1993, J AUTOIMMUN, V6, P701, DOI 10.1006/jaut.1993.1059
   ROSS SC, 1983, ARTHRITIS RHEUM, V26, P653, DOI 10.1002/art.1780260512
   ROSSI GA, 1984, AM REV RESPIR DIS, V123, P680
   Saito S, 1999, MOL IMMUNOL, V36, P169, DOI 10.1016/S0161-5890(99)00035-8
   SHERO JH, 1986, SCIENCE, V231, P727
   Tan FK, 1998, ARTHRITIS RHEUM, V41, P1729
   TIGE RA, 1998, IMMUNOL TODAY, V19, P89
   UNEMORI E N, 1991, Current Opinion in Rheumatology, V3, P953, DOI 10.1097/00002281-199112000-00010
NR 34
TC 26
Z9 26
U1 1
U2 1
PU JOHNS HOPKINS UNIV PRESS
PI BALTIMORE
PA JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD
   21218-4319 USA
SN 1076-1551
J9 MOL MED
JI Mol. Med.
PD OCT
PY 2000
VL 6
IS 10
BP 825
EP 836
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 368AF
UT WOS:000090094600002
PM 11126198
ER

PT J
AU Freeman, GJ
   Long, AJ
   Iwai, Y
   Bourque, K
   Chernova, T
   Nishimura, H
   Fitz, LJ
   Malenkovich, N
   Okazaki, T
   Byrne, MC
   Horton, HF
   Fouser, L
   Carter, L
   Ling, V
   Bowman, MR
   Carreno, BM
   Collins, M
   Wood, CR
   Honjo, T
AF Freeman, GJ
   Long, AJ
   Iwai, Y
   Bourque, K
   Chernova, T
   Nishimura, H
   Fitz, LJ
   Malenkovich, N
   Okazaki, T
   Byrne, MC
   Horton, HF
   Fouser, L
   Carter, L
   Ling, V
   Bowman, MR
   Carreno, BM
   Collins, M
   Wood, CR
   Honjo, T
TI Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family
   member leads to negative regulation of lymphocyte activation
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE binding; proliferation inhibition; cytokine secretion inhibition; tissue
   expression; peripheral tolerance
ID CELL CO-STIMULATION; T-CELLS; EXPRESSION; CTLA-4; CD28; INDUCTION;
   IMMUNORECEPTOR; SECRETION; SURFACE; LIGAND
AB PD-1 is an immunoinhibitory receptor expressed by activated T cells, B cells, and myeloid cells. Mice deficient in PD-1 exhibit a breakdown of peripheral tolerance and demonstrate multiple autoimmune features. We report here that the ligand of PD-1 (PD-LI) is a member of the B7 gene family. Engagement of PD-1 by PD-L1 leads to the inhibition of T cell rcceptor-mediated lymphocyte proliferation and cytokine secretion. In addition, PD-1 signaling can inhibit at least suboptimal levels of CD28-mediated costimulation. PD-L1 is expressed by antigen-presenting cells, including human peripheral blood monocytes stimulated with interferon gamma, and activated human and murine dendritic cells. In addition, PD-L1 is expressed in nonlymphoid tissues such as heart and lung. The relative levels of inhibitory PD-L1 and costimulatory B7-1/B7-2 signals on antigen-presenting cells may determine the extent of T cell activation and consequently the threshold between tolerance and autoimmunity. PD-L1 expression on nonlymphoid tissues and its potential interaction with PD-1 may subsequently determine the extent of immune responses at sites of inflammation.
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
   Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.
   Wyeth Ayerst Res, Inst Genet, Cambridge, MA 02140 USA.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
CR ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Vibhakar R, 1997, EXP CELL RES, V232, P25, DOI 10.1006/excr.1997.3493
   Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582
   Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4
   Dong HD, 1999, NAT MED, V5, P1365
   SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   HARPER K, 1991, J IMMUNOL, V147, P1037
   Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X
   Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0
   Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2
   FREEMAN GJ, 1992, J IMMUNOL, V149, P3795
   Henry J, 1999, IMMUNOL TODAY, V20, P285, DOI 10.1016/S0167-5699(98)01418-2
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Blair PJ, 1998, J IMMUNOL, V160, P12
   Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x
   BYRNE MC, 2000, CURRENT PROTOCOLS MO, V49
   Fitz LJ, 1997, ONCOGENE, V15, P613, DOI 10.1038/sj.onc.1201191
   FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O
   Freeman GJ, 1998, J IMMUNOL, V161, P2708
   Ling V, 2000, J IMMUNOL, V164, P1653
   NICKOLOFF BJ, 1993, AM J PATHOL, V142, P1029
   Reeves RH, 1997, MAMM GENOME, V8, P581, DOI 10.1007/s003359900508
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x
NR 28
TC 1260
Z9 1360
U1 31
U2 86
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD OCT 2
PY 2000
VL 192
IS 7
BP 1027
EP 1034
DI 10.1084/jem.192.7.1027
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 361QD
UT WOS:000089733000010
PM 11015443
ER

PT J
AU Fagarasan, S
   Honjo, T
AF Fagarasan, S
   Honjo, T
TI T-independent immune response: New aspects of B cell biology
SO SCIENCE
LA English
DT Editorial Material
ID MEMBER; MICE; PD-1
AB Recent results emphasize the roles of T-independent antibody response in humoral defenses, for which B1 cells and marginal zone B cells are mostly responsible. We discuss how these cells are activated, migrate, and differentiate into antibody-producing cells in various Lymphoid tissues. Based on recent findings in each of these areas of B cell biology, we propose a possible mechanism for peripheral tolerance of autoreactive B cells at target organs.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   Bos NA, 1996, INFECT IMMUN, V64, P616
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0
   Yan MH, 2000, NAT IMMUNOL, V1, P37
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501
   Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84
   Kamata T, 2000, J IMMUNOL, V165, P1387
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348
   Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697
   Fagarasan S, 2000, IMMUNOL REV, V176, P205
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Guinamard R, 2000, NAT IMMUNOL, V1, P31
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   FREEMAN GJ, IN PRESS J EXP MED
   KASAIAN MT, 1993, AUTOIMMUNITY, V15, P315, DOI 10.3109/08916939309115755
   NISHIMURA H, UNPUB
   OKAZAKI T, UNPUB
   Watanabe N., UNPUB
NR 28
TC 244
Z9 251
U1 4
U2 11
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD OCT 6
PY 2000
VL 290
IS 5489
BP 89
EP 92
DI 10.1126/science.290.5489.89
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 361LP
UT WOS:000089724800038
PM 11021805
ER

PT J
AU Schroeder, T
   Fraser, S
   Oka, C
   Bornkamm, G
   Nishikawa, SI
   Honjo, T
   Just, U
AF Schroeder, T
   Fraser, S
   Oka, C
   Bornkamm, G
   Nishikawa, SI
   Honjo, T
   Just, U
TI Disruption of the mouse RBP-J gene alters differentiation of cell
   lineages derived from mesoderm.
SO BLOOD
LA English
DT Meeting Abstract
C1 GSF, Natl Res Ctr Environm & Hlth, Inst Clin Mol Biol, Munich, Germany.
   Kyoto Univ, Dept Mol Genet, Kyoto, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2000
VL 96
IS 11
MA 1234
BP 287A
EP 287A
PN 1
PG 1
WC Hematology
SC Hematology
GA 372WB
UT WOS:000165256101235
ER

PT J
AU Freeman, GJ
   Long, AJ
   Iwai, Y
   Latchman, Y
   Bourque, K
   Brown, JA
   Boussiotis, VA
   Dorfman, DM
   Chernova, T
   Nishimura, H
   Fitz, L
   Malenkovich, N
   Okazaki, T
   Byrne, M
   Horton, H
   Fouser, L
   Carter, L
   Sharpe, AH
   Carreno, B
   Collins, M
   Wood, CR
   Honjo, T
AF Freeman, GJ
   Long, AJ
   Iwai, Y
   Latchman, Y
   Bourque, K
   Brown, JA
   Boussiotis, VA
   Dorfman, DM
   Chernova, T
   Nishimura, H
   Fitz, L
   Malenkovich, N
   Okazaki, T
   Byrne, M
   Horton, H
   Fouser, L
   Carter, L
   Sharpe, AH
   Carreno, B
   Collins, M
   Wood, CR
   Honjo, T
TI Engagement of the PD-1 immunoinhibitory receptor by a novel B7-family
   member leads to negative regulation of lymphocyte activation.
SO BLOOD
LA English
DT Meeting Abstract
C1 Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA USA.
   Genet Inst Inc, Cambridge, MA USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
   Kyoto Univ, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 11
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2000
VL 96
IS 11
MA 3502
BP 810A
EP 811A
PN 1
PG 2
WC Hematology
SC Hematology
GA 372WB
UT WOS:000165256103501
ER

PT J
AU Schroeder, T
   Fraser, S
   Oka, C
   Bornkamm, G
   Nishikawa, SI
   Honjo, T
   Just, U
AF Schroeder, T
   Fraser, S
   Oka, C
   Bornkamm, G
   Nishikawa, SI
   Honjo, T
   Just, U
TI Disruption of the mouse RBP-J gene alters differentiation of cell
   lineages derived from mesoderm
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
C1 GSF, Inst Clin Mol Biol, Munich, Germany.
   Kyoto Univ, Dept Mol Genet, Kyoto, Japan.
   Kyoto Univ, Dept Med Chem, Kyoto 606, Japan.
NR 0
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD DEC
PY 2000
VL 28
IS 12
MA 918
BP 1496
EP 1496
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 385XB
UT WOS:000166029500042
ER

PT J
AU Watanabe, N
   Ikuta, K
   Fagarasan, S
   Yazumi, S
   Chiba, T
   Honjo, T
AF Watanabe, N
   Ikuta, K
   Fagarasan, S
   Yazumi, S
   Chiba, T
   Honjo, T
TI Migration and differentiation of autoreactive B-1 cells induced by
   activated gamma/delta T cells in antierythrocyte immunoglobulin
   transgenic mice
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE RAG2 deficient; gamma/delta TCR transgenic; germinal center; peritoneal
   cavity; hemolytic anemia
ID AUTOIMMUNE HEMOLYTIC-ANEMIA; LY-1 B-CELLS; RHEUMATOID-FACTOR;
   LYMPHOCYTES-T; ANTIGEN; MOUSE; EXPRESSION; RECOGNITION; REPERTOIRE;
   CHEMOKINES
AB Using normal and transgenic (Tg) mice, we have shown that peritoneal B-1 cells are activated by administration of cytokines or lipopolysaccharide and migrate to other lymphoid organs where they differentiate into antibody-secreting cells. However, little is known about the process of B-1 cell migration and differentiation in vivo. We developed a mouse line by crossing the antierythrocyte antibody Tg mice (HL mice) with TCR-gamma/delta Tg mice specific for a self-thymus leukemia (TL) antigen in the recombination activating gene (RAG)2(-/-) background. In the presence of the self-antigen, Tg gamma/delta T cells increased in number and manifested activated phenotypes. Peritoneal B-1 cells in these mice migrated into mesenteric lymph nodes and differentiated into autoantibody-secreting cells, resulting in strong autoimmune hemolytic anemia. Furthermore, transfer of RAG2(-/-) X HL bone marrow or peritoneal cells into the peritoneal cavity of RAG2(-/-) X TCR-gamma/delta Tg mice gave rise to donor-derived B-1 cells in mesenteric lymph nodes, and these cells produced the autoantibody. Thus, this study demonstrates that the migration of B-1 cells and differentiation into the antibody-secreting cells can be induced by noncognate T cell help and implies the possibility that gamma/delta T cells may induce B-1 cell differentiation in vivo.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR KROESE FGM, 1989, IMMUNOL INVEST, V18, P47, DOI 10.3109/08820138909112226
   TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0
   Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   Watanabe N, 1999, J EXP MED, V190, P461, DOI 10.1084/jem.190.4.461
   Bos NA, 1996, INFECT IMMUN, V64, P616
   HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   HARDY RR, 1994, ADV IMMUNOL, V55, P297
   LALOR PA, 1990, EUR J IMMUNOL, V20, P485, DOI 10.1002/eji.1830200305
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423
   CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056
   Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2
   HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146
   MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111
   MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494
   ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637
   Kamata T, 2000, J IMMUNOL, V165, P1387
   Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791
   Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H
   Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3
   ZIEGLER SF, 1994, STEM CELLS, V12, P456
   Boismenu R, 1996, J IMMUNOL, V157, P985
   HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202
   BONNEVILLE M, 1990, NATURE, V344, P163, DOI 10.1038/344163a0
   BORN W, 1990, SCIENCE, V249, P67, DOI 10.1126/science.1695022
   BUDD RC, 1987, J IMMUNOL, V138, P3120
   Cipriani B, 2000, BLOOD, V95, P39
   IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759
   ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B
   KRONENBERG M, 1994, CURR OPIN IMMUNOL, V6, P64, DOI 10.1016/0952-7915(94)90035-3
   MARCOS MAR, 1989, EUR J IMMUNOL, V19, P2031, DOI 10.1002/eji.1830191110
   Nisitani S, 1998, INT IMMUNOL, V10, P1039, DOI 10.1093/intimm/10.8.1039
   Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925
   Stall A M, 1996, Semin Immunol, V8, P45, DOI 10.1006/smim.1996.0007
   YOKOYAMA WM, 1989, IMMUNOL REV, V109, P153, DOI 10.1111/j.1600-065X.1989.tb00024.x
NR 42
TC 34
Z9 35
U1 1
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD DEC 4
PY 2000
VL 192
IS 11
BP 1577
EP 1586
DI 10.1084/jem.192.11.1577
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 382QE
UT WOS:000165833100007
PM 11104800
ER

PT J
AU Tanigaki, K
   Nogaki, F
   Takahashi, J
   Tashiro, K
   Kurooka, H
   Honjo, T
AF Tanigaki, K
   Nogaki, F
   Takahashi, J
   Tashiro, K
   Kurooka, H
   Honjo, T
TI Notch1 and Notch3 instructively restrict bFGF-responsive multipotent
   neural progenitor cells to an astroglial fate
SO NEURON
LA English
DT Article
ID LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS;
   INTRACELLULAR DOMAIN; TRANSCRIPTION FACTOR; SUBVENTRICULAR ZONE; LINEAGE
   COMMITMENT; CEREBRAL-CORTEX; ADULT BRAIN; RBP-J
AB Notch1 has been shown to induce glia in the peripheral nervous system. However, it has not been known whether Notch can direct commitment to glia from multipotent progenitors of the central nervous system. Here we present evidence that activated Notch1 and Notch3 promotes the differentiation of astroglia from the rat adult hippocampus-derived multipotent progenitors (AHPs). Quantitative clonal analysis indicates that the action of Notch is likely to be instructive. Transient activation of Notch can direct commitment of AHPs irreversibly to astroglia. Astroglial induction by Notch signaling was shown to be independent of STAT3, which is a key regulatory transcriptional factor when ciliary neurotrophic factor (CNTF) induces astroglia. These data suggest that Notch provides a CNTF-independent instructive signal of astroglia differentiation in CNS multipotent progenitor cells.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Yoshida Konoe Sakyo, Kyoto 6068501, Japan.
CR Taga T, 1996, J NEUROCHEM, V67, P1
   METCALF D, 1991, P NATL ACAD SCI USA, V88, P11310, DOI 10.1073/pnas.88.24.11310
   GRAY GE, 1992, DEVELOPMENT, V114, P271
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X
   Hojo M, 2000, DEVELOPMENT, V127, P2515
   Apelqvist A, 1999, NATURE, V400, P877
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Schroeter EH, 1998, NATURE, V393, P382
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7
   Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x
   GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879
   Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196
   Nakashima K, 1999, J NEUROSCI, V19, P5429
   Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2
   Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558
   Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477
   Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.0.CO;2-Q
   Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1
   Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595
   Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797
   RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602
   Sakurada K, 1999, DEVELOPMENT, V126, P4017
   Barres BA, 1999, CELL, V97, P667, DOI 10.1016/S0092-8674(00)80777-1
   RAEDLER E, 1980, ANAT EMBRYOL, V158, P253, DOI 10.1007/BF00301816
   KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653
   FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0
   Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479
   Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0
   Greenwald Iva, 1994, Current Opinion in Genetics and Development, V4, P556, DOI 10.1016/0959-437X(94)90072-B
   REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7
   Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2
   Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337
   KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Beatus P, 1999, DEVELOPMENT, V126, P3925
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Jacobson M., 1991, DEV NEUROBIOLOGY
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   METCALF D, 1980, P NATL ACAD SCI-BIOL, V77, P5327, DOI 10.1073/pnas.77.9.5327
   MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326
   Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463
   REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N
   Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090
   Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721
   Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1
   WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1
NR 58
TC 264
Z9 289
U1 2
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD JAN
PY 2001
VL 29
IS 1
BP 45
EP 55
DI 10.1016/S0896-6273(01)00179-9
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 397NX
UT WOS:000166702700008
PM 11182080
ER

PT J
AU Nishimura, H
   Okazaki, T
   Tanaka, Y
   Nakatani, K
   Hara, M
   Matsumori, A
   Sasayama, S
   Mizoguchi, A
   Hiai, H
   Minato, N
   Honjo, T
AF Nishimura, H
   Okazaki, T
   Tanaka, Y
   Nakatani, K
   Hara, M
   Matsumori, A
   Sasayama, S
   Mizoguchi, A
   Hiai, H
   Minato, N
   Honjo, T
TI Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
SO SCIENCE
LA English
DT Article
ID ANTIBODIES; DISEASES
AB Dilated cardiomyopathy is a severe pathology of the heart with poorly understood etiology. Disruption of the gene encoding the negative immunoregulatory receptor PD-1 in BALB/c mice, but not in BALB/c RAG-2(-/-) mice, caused dilated cardiomyopathy with severely impaired contraction and sudden death by congestive heart failure. Affected hearts showed diffuse deposition of immunoglobulin G (IgG) on the surface of cardiomyocytes. ALL of the affected PD-1(-/-) mice exhibited high-titer circulating IgG autoantibodies reactive to a 33-kilodalton protein expressed specifically on the surface of cardiomyocytes. These results indicate that PD-1 may be an important factor contributing to the prevention of autoimmune diseases.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Osaka City Univ, Sch Med, Dept Anat 2, Osaka 5458585, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
CR Matsumori A, 1997, JPN CIRC J, V61, P275, DOI 10.1253/jcj.61.275
   KLEIN R, 1984, CLIN EXP IMMUNOL, V58, P283
   Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297
   Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89
   MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Richardson P, 1996, CIRCULATION, V93, P841
   CAFORIO ALP, 1994, LANCET, V344, P773, DOI 10.1016/S0140-6736(94)92339-6
   HOSENPUD JD, 2000, CONGESTIVE HEART FAI, P281
   NISHIMURA H, UNPUB
   SABN DJ, 1978, CIRCULATION, V58, P1072
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHULZE K, 1989, CIRC RES, V64, P179
   Sedarat F, 2000, AM J PHYSIOL-HEART C, V279, pH202
NR 16
TC 645
Z9 683
U1 8
U2 22
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD JAN 12
PY 2001
VL 291
IS 5502
BP 319
EP 322
DI 10.1126/science.291.5502.319
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 391JM
UT WOS:000166352900050
PM 11209085
ER

PT J
AU Muramatsu, M
   Honjo, T
AF Muramatsu, M
   Honjo, T
TI Complex layers of genetic alteration in the generation of antibody
   diversity
SO TRENDS IN IMMUNOLOGY
LA English
DT Editorial Material
ID CYTIDINE DEAMINASE AID; HYPER-IGM SYNDROME; SOMATIC HYPERMUTATION;
   IMMUNOGLOBULIN GENES; CLASS SWITCH; B-CELLS; RNA; DELETIONS
AB The diversity of the immune system is known to be somatically amplified by various genetic alteration mechanisms including V(D)J recombination, somatic hypermutation (SH) and class switch recombination (CSR). Recent findings that both CSR and SH are abolished by mutations of mouse and human AID, a member of the RNA-editing cytidine deaminase family, suggest that at least dual layers of genetic alteration mechanisms are involved in the generation of immune diversity.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Muramatsu, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Konoe Cho, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6
   Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59
   Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X
   CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   MANTOVANI L, 1993, J IMMUNOL, V151, P473
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   ALLEN D, 1988, EMBO J, V7, P1995
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Kenter AL, 1999, J EXP MED, V190, P307, DOI 10.1084/jem.190.3.307
   SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0
NR 15
TC 6
Z9 6
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD FEB
PY 2001
VL 22
IS 2
BP 66
EP 68
DI 10.1016/S1471-4906(00)01818-4
PG 3
WC Immunology
SC Immunology
GA 453UW
UT WOS:000169935700003
PM 11286696
ER

PT J
AU Latchman, Y
   Wood, CR
   Chernova, T
   Chaudhary, D
   Borde, M
   Chernova, I
   Iwai, Y
   Long, AJ
   Brown, JA
   Nunes, R
   Greenfield, EA
   Bourque, K
   Boussiotis, VA
   Carter, LL
   Carreno, BM
   Malenkovich, N
   Nishimura, H
   Okazaki, T
   Honjo, T
   Sharpe, AH
   Freeman, GJ
AF Latchman, Y
   Wood, CR
   Chernova, T
   Chaudhary, D
   Borde, M
   Chernova, I
   Iwai, Y
   Long, AJ
   Brown, JA
   Nunes, R
   Greenfield, EA
   Bourque, K
   Boussiotis, VA
   Carter, LL
   Carreno, BM
   Malenkovich, N
   Nishimura, H
   Okazaki, T
   Honjo, T
   Sharpe, AH
   Freeman, GJ
TI PD-L2 is a second ligand for PD-I and inhibits T cell activation
SO NATURE IMMUNOLOGY
LA English
DT Article
ID INTERFERON-GAMMA; PD-1-DEFICIENT MICE; B7 FAMILY; CTLA-4; EXPRESSION;
   CD4(+); MEMBER; LEADS; LYMPHOPROLIFERATION; DIFFERENTIATION
AB Programmed death I (PD-1)-deficient mice develop a variety of autoimmune-like diseases, which suggests that this immunoinhibitory receptor plays an important role in tolerance. We identify here PD-1 ligand 2 (PD-L2) as a second ligand for PD-1 and compare the function and expression of PD-L1 and PD-L2. Engagement of PD-1 by PD-L2 dramatically inhibits T cell receptor (TCR)-mediated proliferation and cytokine production by CD4(+) T cells,At low antigen concentrations, PD-L2-PD-1 interactions inhibit strong B7-CD28 signals, In contrast, at high antigen concentrations, PD-L2-PD-1 interactions reduce cytokine production but do not inhibit T cell proliferation. PD-L-PD-1 interactions lead to cell cycle arrest in G(0)/G(1) but do not increase cell death. In addition, ligation of PD-1 + TCR leads to rapid phosphorylation of SHP-2, as compared to TCR ligation alone, PD-L expression was up-regulated on antigen-presenting cells by interferon gamma treatment and was also present on some normal tissues and tumor cell lines,Taken together, these studies show overlapping functions of PD-L1 and PD-L2 and indicate a key role for the PD-L-PD-1 pathway in regulating T cell responses.
C1 Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Adult Oncol, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Wyeth Ayerst Res, Genet Inst, Cambridge, MA 02140 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Freeman, GJ (reprint author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.
CR Konieczny BT, 1998, J IMMUNOL, V160, P2059
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   McAdam AJ, 1998, IMMUNOL REV, V165, P231
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Chuang E, 1999, J IMMUNOL, V162, P1270
   Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533
   Dong HD, 1999, NAT MED, V5, P1365
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   MORGAN A, 1995, IMMUNOLOGY, V86, P319
   Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541
   Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9
   DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0
   Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   McAdam AJ, 2000, J IMMUNOL, V165, P5035
   Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354
   Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123
   FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   OKAZAKI T, 2001, UNPUB J EXP MED
NR 24
TC 876
Z9 954
U1 29
U2 68
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD MAR
PY 2001
VL 2
IS 3
BP 261
EP 268
DI 10.1038/85330
PG 8
WC Immunology
SC Immunology
GA 409YT
UT WOS:000167413800020
PM 11224527
ER

PT J
AU Brown, JA
   Dorfman, DM
   Butler, M
   Nunes, R
   Latchman, Y
   Long, AJ
   Iwai, Y
   Bourque, K
   Boussiotis, VA
   Chernova, T
   Nishimura, H
   Fitz, L
   Malenkovich, N
   Honjo, T
   Wood, CR
   Nadler, LM
   Sharpe, AH
   Freeman, GJ
AF Brown, JA
   Dorfman, DM
   Butler, M
   Nunes, R
   Latchman, Y
   Long, AJ
   Iwai, Y
   Bourque, K
   Boussiotis, VA
   Chernova, T
   Nishimura, H
   Fitz, L
   Malenkovich, N
   Honjo, T
   Wood, CR
   Nadler, LM
   Sharpe, AH
   Freeman, GJ
TI Expression and functional consequences of PD-1 ligands on natural APCS
   and tumors
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Dana Farber Canc Inst, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
   Genet Inst, Cambridge, MA 02140 USA.
   Kyoto Univ, Kyoto 6068501, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 7
PY 2001
VL 15
IS 4
BP A345
EP A345
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 410KA
UT WOS:000167438101972
ER

PT J
AU Latchman, Y
   Wood, C
   Chemova, T
   Iwai, Y
   Malenkovich, N
   Long, A
   Bourque, K
   Boussiotis, V
   Nishimura, H
   Honjo, T
   Sharpe, A
   Freeman, G
AF Latchman, Y
   Wood, C
   Chemova, T
   Iwai, Y
   Malenkovich, N
   Long, A
   Bourque, K
   Boussiotis, V
   Nishimura, H
   Honjo, T
   Sharpe, A
   Freeman, G
TI PD-L2, a novel B7 homologue, is a second ligand for PD-1 and inhibits T
   cell activation.
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Brigham & Womens Hosp, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Genet Inst, Cambridge, MA 02140 USA.
   Dana Farber Canc Inst, Boston, MA 02115 USA.
   Kyoto Univ, Kyoto 6068501, Japan.
NR 0
TC 0
Z9 0
U1 3
U2 7
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 7
PY 2001
VL 15
IS 4
BP A345
EP A345
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 410KA
UT WOS:000167438101975
ER

PT J
AU Tani, S
   Kurooka, H
   Aoki, T
   Hashimoto, N
   Honjo, T
AF Tani, S
   Kurooka, H
   Aoki, T
   Hashimoto, N
   Honjo, T
TI The N- and C-terminal regions of RBP-J interact with the ankyrin repeats
   of Notch1 RAMIC to activate transcription
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BARR-VIRUS EBNA2; DNA-BINDING PROTEIN; J-KAPPA; INTRACELLULAR REGION;
   MOUSE NOTCH1; DROSOPHILA HOMOLOG; NUCLEAR ANTIGEN-2; SUPPRESSOR;
   HAIRLESS; DOMAIN
AB The evolutionarily-conserved DNA-binding protein RBP-J directly interacts with the RAM domain and the ankyrin (ANK) repeats of the Notch intracellular region (RAMIC), and activates transcription of downstream target genes that regulate cell differentiation. In vitro binding assays demonstrate that the truncated N- and C-terminal regions of RBP-J bind to the ANK repeats but not to the RAM domain, Using an OT11 mouse cell line, in which the RBP-J locus is disrupted, we showed that RBP-J constructs mutated in the N- and C-terminal regions were defective in their transcriptional activation induced by either RAMIC or IC (the Notch intracellular region without the RAM domain) although they had normal levels of binding activity to DNA and the RAM domain. The studies using chimeric molecules between RBP-J and its homolog RBP-L showed that the N- and C-terminal regions of RBP-J conferred the IC- as well as RAMIC-induced transactivation potential on RBP-L, which binds to the same DNA sequence as RBP-J but fails to interact with RAMIC, Taken together, these results indicate that the interactions between the N- and C-terminal regions of RBP-J and the ANK repeats of RAMIC are important for transactivation of RBP-J by RAMIC.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621
   Apelqvist A, 1999, NATURE, V400, P877
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23
   Schroeter EH, 1998, NATURE, V393, P382
   NYE JS, 1994, DEVELOPMENT, V120, P2421
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   LING PD, 1994, J VIROL, V68, P5375
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   OKA C, 1995, DEVELOPMENT, V121, P3291
   HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657
   Hsieh JJD, 1996, MOL CELL BIOL, V16, P952
   Sakai T, 1998, J VIROL, V72, P6034
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y
   Taniguchi Y, 1998, MOL CELL BIOL, V18, P644
   Aster JC, 1997, J BIOL CHEM, V272, P11336
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   DOU SB, 1994, MOL CELL BIOL, V14, P3310
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Kurooka Hisanori, 2000, Journal of Biological Chemistry, V275, P17211, DOI 10.1074/jbc.M000909200
   Minoguchi S, 1999, J BIOCHEM-TOKYO, V126, P738
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   WALTER C, 1995, DENDROME, V2, P1
NR 35
TC 38
Z9 39
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAR 15
PY 2001
VL 29
IS 6
BP 1373
EP 1380
DI 10.1093/nar/29.6.1373
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 411ZH
UT WOS:000167529200014
PM 11239004
ER

PT J
AU Tashiro, J
   Kinoshita, K
   Honjo, T
AF Tashiro, J
   Kinoshita, K
   Honjo, T
TI Palindromic but not G-rich sequences are targets of class switch
   recombination
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE artificial switch constructs; B lymphoma cells; breakpoint sequence; S
   sequence; secondary structure
ID CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; HEAVY-CHAIN LOCUS; SOMATIC
   HYPERMUTATION; IMMUNOGLOBULIN GENES; REPETITIVE SEQUENCES; EXPRESSION
   VECTOR; STEM-LOOP; REGION; DNA
AB In order to understand the specificity of sequences or structures recognized by a recombinase involved in class switch recombination (CSR), we examined the relative CSR efficiency of various switch sequences in artificial CSR constructs that undergo CSR in CH12F3-2 murine B lymphoma line. Since CSR recombination is not specific to switch regions of different isotypes or orientation of S sequences, we examined the efficiency of S sequences of non-mammalian species and artificial sequences which lack several characters of mammal switch sequences: chicken S-mu, Xenopus S-mu telomere, multiple cloning site (MCS) and unrelated negative control sequence. CSR occurred in chicken S-mu and MCS with significantly higher efficiency than the negative control. A common character of these two sequences is that they are rich in palindrome and stem-loop structures. However, telomeres, which are G-rich and repetitive but not palindromic, could not serve as switch sequences at all. The AT-rich Xenopus S-mu sequence was inefficient but capable of CSR. CSR breakpoint distribution suggests that the cleavage may take place preferentially in the proximity of the junctions (neck) between the loop and stem in the secondary structure of the single-stranded S sequence, which can be formed by palindromic sequences. The results suggest that the secondary structure of S-region sequences which is transiently formed during transcription may be necessary for recognition by class switch recombinase.
C1 Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
CR Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0
   Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   ARAKAWA H, 1993, J BIOL CHEM, V268, P4651
   Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441
   Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   BLACKBURN EH, 1984, CELL, V37, P7, DOI 10.1016/0092-8674(84)90295-2
   CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P2285, DOI 10.1093/nar/21.9.2285
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2
   Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8
   Kitao H, 2000, INT IMMUNOL, V12, P959, DOI 10.1093/intimm/12.7.959
   LUPTON SD, 1991, MOL CELL BIOL, V11, P3374
   Mendez MJ, 1997, NAT GENET, V16, P410
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1
   Richardson N, 1998, J BIOL CHEM, V273, P31707, DOI 10.1074/jbc.273.48.31707
   SNAPPER CM, 1999, IMMUNOGLOBULIN CLASS, P831
   Storb U, 1998, INT J DEV BIOL, V42, P977
   TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579
   Yen CH, 1997, MAMM GENOME, V8, P775, DOI 10.1007/s003359900565
   YOUN HJ, 1988, IMMUNOGENETICS, V28, P345, DOI 10.1007/BF00364233
NR 42
TC 60
Z9 62
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD APR
PY 2001
VL 13
IS 4
BP 495
EP 505
DI 10.1093/intimm/13.4.495
PG 11
WC Immunology
SC Immunology
GA 421KA
UT WOS:000168062500011
PM 11282989
ER

PT J
AU Agata, Y
   Katakai, T
   Ye, SK
   Sugai, M
   Gonda, H
   Honjo, T
   Ikuta, K
   Shimizu, A
AF Agata, Y
   Katakai, T
   Ye, SK
   Sugai, M
   Gonda, H
   Honjo, T
   Ikuta, K
   Shimizu, A
TI Histone acetylation determines the developmentally regulated
   accessibility for T cell receptor gamma gene recombination
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE V(D)J recombination; germline transcript; ligation-mediated PCR;
   chromatin immunoprecipitation; histone deacetylase
ID V(D)J RECOMBINATION; NUCLEOSOME STRUCTURE; CHROMATIN STRUCTURE;
   REARRANGEMENT; EXPRESSION; CLEAVAGE; LOCUS; DNA; TRANSCRIPTION;
   DIVERSITY
AB Variable/diversity/joining (V[D]J) recombination of the T cell receptor (TCR) and immunoglobulin (Ig) genes is regulated by chromatin accessibility of the target locus to the recombinase in a lineage- and stage-specific manner. Histone acetylation has recently been proposed as a molecular mechanism underlying the accessibility control. Here, we investigate the role for histone acetylation in the developmentally regulated rearrangements of the mouse TCR-gamma gene, wherein predominant rearrangement is switched from V gamma3 to V gamma2 gene during the fetal to adult thymocyte development. Our results indicate that histone acetylation correlates with accessibility, as histone acetylation at the fetal-type V gamma3 gene in accord with germline transcription is relatively high in fetal thymocytes, but specifically becomes low in adult thymocytes within the entirely hyperacetylated locus. Furthermore, inhibition of histone deacetylation during the development of adult bone marrow-derived thymocytes by a specific histone deacetylase inhibitor, trichostatin A, leads to elevated histone acetylation, germline transcription, cleavage, and rearrangement of the V gamma3 gene. These data demonstrate that histone acetylation functionally determines the chromatin accessibility for V(D)J recombination in vivo and that an epigenetic modification of chromatin plays a direct role in executing a developmental switch in cell fate determination.
C1 Kyoto Univ, Dept Mol Biol & Genet, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Agata, Y (reprint author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.
RI Ye, Sang Kyu/J-2768-2012
CR ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788
   BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592
   VanLint C, 1996, GENE EXPRESSION, V5, P245
   Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407
   YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510
   SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520
   McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X
   ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4
   Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625
   HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0
   Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712
   Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599
   Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459
   Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545
   Ausubel FM, 1987, CURRENT PROTOCOLS MO
   Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289
   Baker JE, 1998, IMMUNITY, V9, P159, DOI 10.1016/S1074-7613(00)80598-1
   GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7
   Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X
   GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729
   Hempel WM, 1998, ADV IMMUNOL, V69, P309
   Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7
   McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8
   RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.immunol.7.1.175
   RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x
   Schatz D G, 1997, Semin Immunol, V9, P149, DOI 10.1006/smim.1997.0068
   Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066
   Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5
NR 30
TC 76
Z9 76
U1 1
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD APR 2
PY 2001
VL 193
IS 7
BP 873
EP 879
DI 10.1084/jem.193.7.873
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 420WN
UT WOS:000168028400011
PM 11283160
ER

PT J
AU Jalil, MA
   Fujinami, S
   Honjo, T
   Nishikawa, H
AF Jalil, MA
   Fujinami, S
   Honjo, T
   Nishikawa, H
TI A new tripod PPN bridging ligand and its copper, silver and palladium
   complexes: syntheses, characterizations and X-ray structures
SO POLYHEDRON
LA English
DT Article
DE tripod ligand; PPN bridging ligand; face-to-face type molecules; copper;
   silver; palladium
ID 2-<BIS(DIPHENYLPHOSPHINO)METHYL>PYRIDINE PNP LIGANDS;
   MOLECULAR-STRUCTURES; CRYSTAL-STRUCTURES; CHEMISTRY;
   2-(DIPHENYLPHOSPHINO)PYRIDINE; BIS(DIPHENYLPHOSPHINO)METHANE; RHODIUM;
   DPPY
AB A new tripod bridging ligand 2-{bis(diisopropylphosphino)methyl}-1-methylimidazole, MeImCH(Pi-Pr-2)(2) (PPN) was synthesized conveniently by reacting 2-{bis(trimethylsilyl)methyl}-1-methylimidazole and chlorodiisopropylphosphine. The dicationic dinuclear complex [Cu-2(PPN)(2)][ClO4](2) (1) was prepared by the reaction of the ligand with [Cu(MeCN)(4)]ClO4 in acetonitrile. The reaction of the ligand with AgNO3 in propane-2-ol followed by addition of NH4PF6 led to the formation of a similar type complex [Ag-2(PPN)(2)][PF6](2) (2). The X-ray diffraction studies of 1 and 2 revealed a mu (2) - eta (1): eta (2) tripod-like bonding of the PPN ligand, with one P and one N atom chelating to one metal ion and the remaining one P atom binds to another metal ion, affording a face-to-face type molecule. An eight-membered M2P4C2 and a 10-membered M2P2N2C4 ring are thus formed with this new functional diphosphine ligand. In both complexes the two metal ions are held in very close proximity [2.6707 Angstrom for 1 and 2.859(3) Angstrom for 2]. Complex 1 underwent a rapid ligand exchange process in solution. Besides these dinuclear complexes the ligand also afforded a mononuclear palladium complex. [PdCl2(PPN)] (3). when it was treated with an equimolar amount of [PdCl2(PhCN)(2)] in benzene. In 3 the ligand acts as a bidentate chelate through its two phosphorus atoms, leaving the imidazole donor dangling. On the other hand, a P,P-bridged dinuclear Pd(I) complex [Pd2Cl2(PPN)(2)] (4) was achieved by reacting two moles of the ligand with one mole of [PdCl3(PhCN)(2)], followed by the addition of one mole of Pd(dba)(2) [dba = dibenzylideneacetone]. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Kanazawa Univ, Fac Sci, Dept Chem, Kanazawa, Ishikawa 9201192, Japan.
RP Nishikawa, H (reprint author), Kanazawa Univ, Fac Sci, Dept Chem, Kanazawa, Ishikawa 9201192, Japan.
CR ABEL EW, 1982, COMPREHENSIVE ORGANI
   ANDERSON MP, 1983, INORG CHEM, V22, P3267, DOI 10.1021/ic00164a020
   ANDERSON MP, 1983, ORGANOMETALLICS, V2, P1246, DOI 10.1021/om50003a030
   ANDERSON MP, 1983, INORG CHEM, V22, P2644, DOI 10.1021/ic00160a037
   Andrieu J, 1996, INORG CHEM, V35, P5975, DOI 10.1021/ic951412p
   Zhang ZZ, 1996, COORDIN CHEM REV, V147, P1, DOI 10.1016/0010-8545(94)01112-5
   HEMMERICH P, 1963, EXPERIENTIA, V19, P488, DOI 10.1007/BF02150666
   [Anonymous], 1992, TEXSAN CRYST STRUCT
   BADER A, 1991, COORDIN CHEM REV, V108, P27, DOI 10.1016/0010-8545(91)80013-4
   Espinet P, 1999, COORDIN CHEM REV, V193-5, P499, DOI 10.1016/S0010-8545(99)00140-X
   STEFFEN WL, 1976, INORG CHEM, V15, P2432, DOI 10.1021/ic50164a025
   PUDDEPHATT RJ, 1983, CHEM SOC REV, V12, P99, DOI 10.1039/cs9831200099
   DOYLE JR, 1960, INORG SYN, V6, P216, DOI 10.1002/9780470132371.ch69
   NEWKOME GR, 1993, CHEM REV, V93, P2067, DOI 10.1021/cr00022a006
   BALCH AL, 1994, PROG INORG CHEM, V41, P239, DOI 10.1002/9780470166420.ch4
   Beurskens P.T., 1994, DIRDIF 94 PROGRAM SY
   Braunstein P, 2000, J CHEM SOC DALTON, P1067, DOI 10.1039/b000148l
   Cotton F. A., 1992, PROG INORG CHEM, V40, P179, DOI 10.1002/9780470166413.ch3
   Del Zotto A, 1998, INORG CHIM ACTA, V277, P111, DOI 10.1016/S0020-1693(98)00028-0
   DIEZ J, 1987, J CHEM SOC DALTON, P1275, DOI 10.1039/dt9870001275
   HO DM, 1983, INORG CHEM, V22, P4079, DOI 10.1021/ic00168a051
   Jalil MA, 1999, J CHEM SOC DALTON, P1655, DOI 10.1039/a900450e
   Jalil MA, 1999, J CHEM SOC DALTON, P3499, DOI 10.1039/a905186d
   Johnson C. K., 1976, ORNL5138 ORTEP
   LANFREDI AMM, 1985, INORG CHIM A-ART LET, V99, P111, DOI 10.1016/S0020-1693(00)86058-2
   LASTRA E, 1989, J CHEM SOC DALTON, P1499, DOI 10.1039/dt9890001499
   LIU HF, 1992, XIAMEN DAXUE XUEBAO, V31, P57
   Mague JT, 1997, J CHEM CRYSTALLOGR, V27, P603
   MCNAIR RJ, 1985, INORG CHEM, V24, P1935, DOI 10.1021/ic00206a048
   NELSON SM, 1976, J CHEM SOC PERK T, P1204
   Rettig M. F., 1977, INORG SYNTH, V17, P134, DOI 10.1002/9780470132487.ch37
   Sheldrick G.M., 1985, CRYSTALLOGRAPHIC COM, V3, P175
   teXsan, 1985, TEXSAN CRYST STRUCT
   TIEKINK ERT, 1990, ACTA CRYSTALLOGR C, V46, P235, DOI 10.1107/S0108270189006426
NR 34
TC 3
Z9 3
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-5387
J9 POLYHEDRON
JI Polyhedron
PD APR 30
PY 2001
VL 20
IS 9-10
BP 1071
EP 1078
PG 8
WC Chemistry, Inorganic & Nuclear; Crystallography
SC Chemistry; Crystallography
GA 440HM
UT WOS:000169169900039
ER

PT J
AU Ikegawa, M
   Yuan, JL
   Matsumoto, K
   Herrmann, S
   Iwamoto, A
   Nakamura, T
   Matsushita, S
   Kimura, T
   Honjo, T
   Tashiro, K
AF Ikegawa, M
   Yuan, JL
   Matsumoto, K
   Herrmann, S
   Iwamoto, A
   Nakamura, T
   Matsushita, S
   Kimura, T
   Honjo, T
   Tashiro, K
TI Elevated plasma stromal cell-derived factor 1 protein level in the
   progression of HIV type I infection/AIDS
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CXCR4; CD4(+) T-CELLS;
   DOWN-REGULATION; AIDS; GENE; CCR5; REPLICATION; INHIBITION; CLONING
AB Stromal cell-derived factor 1 (SDF-1) is a unique chemokine involved in multiple organogenesis as well as in the regulation of HIV infection. Here we determined the plasma SDF-1 concentrations of 193 HIV-1-infected individuals and 154 normal Japanese volunteers by developing a highly sensitive measurement system based on time-resolved fluoroimmunoassay (SDF-1 TR-FIA), This system is also valid for the mouse model to quantitate circulating SDF-1 concentration in vivo and thereby its correlation with CXCR4 expression level on CD4(+) T cells. Interestingly, plasma SDF-1 concentrations in HIV-1-infected individuals were three times higher than those in a normal control group and plasma SDF-1 protein levels showed an inverse correlation with CD4(+) T cell count and a positive correlation with plasma HIV-1 RNA load. Notably, individuals with later stage HIV-1 infection, who maintained fewer than 200 CD4(+) T cells per cubic milliliter and more than 10,000 copies of HIV-1 RNA per milliliter, showed the highest plasma SDF-1 level among individuals at any stage of HIV-1 infection, These results suggest that endogenous SDF-1 is upregulated by HIV-1 infection, particularly in late-stage HIV-1 infection/AIDS.
C1 Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068507, Japan.
   Waseda Univ, Dept Chem, Shinjuku Ku, Tokyo 1698555, Japan.
   Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan.
   Genet Inst, Cambridge, MA 02140 USA.
   Univ Tokyo, Inst Med Sci, Dept Infect Dis, Tokyo 1088639, Japan.
   Kumamoto Univ, Ctr AIDS Res, Div Clin Retrovirol & Infect Dis, Kumamoto 8600811, Japan.
RP Tashiro, K (reprint author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
RI Matsushita, Shuzo/F-5782-2013; Kumamoto University, CAIDS/G-8446-2013
CR FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305
   Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
   Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442
   Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381
   Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996
   Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261
   Hendel H, 1998, J ACQ IMMUN DEF SYND, V19, P381
   Poznansky MC, 2000, NAT MED, V6, P543
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Yuan JL, 1998, ANAL CHEM, V70, P596, DOI 10.1021/ac970936z
   Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0
   Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389
   Gougeon ML, 1999, ANN NY ACAD SCI, V887, P199
   NEOTE K, 1994, BLOOD, V84, P44
   Yuan JL, 1997, ANAL BIOCHEM, V254, P283, DOI 10.1006/abio.1997.2444
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180
   Burger JA, 1999, BLOOD, V94, P3658
   HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0
   Magierowska M, 1999, BLOOD, V93, P936
   DSouza MP, 1996, NAT MED, V2, P1293, DOI 10.1038/nm1296-1293
   Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026
   Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139
   Hesselgesser J, 1998, J IMMUNOL, V160, P877
   Rabkin CS, 1999, BLOOD, V93, P1838
   NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305
   Balotta C, 1999, J INFECT DIS, V180, P285, DOI 10.1086/314864
   Berndt C, 1998, P NATL ACAD SCI USA, V95, P12556, DOI 10.1073/pnas.95.21.12556
   BLEUL CC, 1996, NATURE, V382, P635
   Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650
   Cairns JS, 1998, NAT MED, V4, P563, DOI 10.1038/nm0598-563
   DEZZUTTI CS, 2000, AIDS, V14, P821
   GIOVANETTI A, 1995, CLIN EXP IMMUNOL, V118, P87
   Kim S, 2000, AIDS RES HUM RETROV, V16, P645, DOI 10.1089/088922200308873
   Lacey SF, 1997, P NATL ACAD SCI USA, V94, P9842, DOI 10.1073/pnas.94.18.9842
   Leonard Edward J., 1996, Methods (Orlando), V10, P150, DOI 10.1006/meth.1996.0089
   Marechal V, 1999, J VIROL, V73, P3608
   OBERLIN E, 1996, NATURE, V382, P829
   Ohashi T, 1998, VIROLOGY, V244, P467, DOI 10.1006/viro.1998.9151
   Ostrowski MA, 1998, J IMMUNOL, V161, P3195
   SAKSELA K, 1995, ANN INTERN MED, V123, P641
   Secchiero P, 1998, BLOOD, V92, P4521
   WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0
   Yang OO, 1999, J VIROL, V73, P4582
NR 49
TC 24
Z9 24
U1 1
U2 4
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD MAY 1
PY 2001
VL 17
IS 7
BP 587
EP 595
DI 10.1089/088922201300119680
PG 9
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 432PE
UT WOS:000168700800002
PM 11375054
ER

PT J
AU Kamioka, H
   Honjo, T
   Takano-Yamamoto, T
AF Kamioka, H
   Honjo, T
   Takano-Yamamoto, T
TI Do the osteocytes in bone attach to their surrounding canaliculi and
   lacuna?
SO BONE
LA English
DT Meeting Abstract
C1 Okayama Univ, Sch Dent, Okayama 700, Japan.
NR 0
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY
PY 2001
VL 28
IS 5
SU S
BP S107
EP S107
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 434PL
UT WOS:000168825000172
ER

PT J
AU Nishimura, H
   Honjo, T
AF Nishimura, H
   Honjo, T
TI PD-1: an inhibitory immunoreceptor involved in peripheral tolerance
SO TRENDS IN IMMUNOLOGY
LA English
DT Article
ID DEVELOPMENTALLY-REGULATED EXPRESSION; T-LYMPHOCYTE ACTIVATION; CELL
   CO-STIMULATION; PD-1-DEFICIENT MICE; AUTOIMMUNE-DISEASE; NEGATIVE
   REGULATOR; GENE; FAMILY; MEMBER; CTLA-4
AB PD-1 deficiency causes a variety of autoimmune diseases. Inhibitory signaling through the PD-1 receptor might therefore be involved in the regulation of peripheral tolerance. The constitutive expression of PD-1 ligands (PD-L1 and PD-LP) on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Konoe, Kyoto 6068501, Japan.
CR Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6
   Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115
   McAdam AJ, 1998, IMMUNOL REV, V165, P231
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8
   Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582
   Waterhouse P, 1996, IMMUNOL REV, V153, P183, DOI 10.1111/j.1600-065X.1996.tb00925.x
   Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89
   Marelli-Berg FM, 1999, IMMUNOL REV, V172, P297
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   Hutloff A, 1999, NATURE, V397, P263
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Kinoshita K, 2000, J IMMUNOL, V164, P6046
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2
   Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260
   Heath WR, 1999, CURR OPIN IMMUNOL, V11, P314, DOI 10.1016/S0952-7915(99)80050-8
   Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   Reeves RH, 1997, MAMM GENOME, V8, P581, DOI 10.1007/s003359900508
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x
NR 33
TC 235
Z9 254
U1 6
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD MAY
PY 2001
VL 22
IS 5
BP 265
EP 268
DI 10.1016/S1471-4906(01)01888-9
PG 4
WC Immunology
SC Immunology
GA 453VD
UT WOS:000169936400014
PM 11323285
ER

PT J
AU Hattori, K
   Heissig, B
   Tashiro, K
   Honjo, T
   Tateno, M
   Shieh, JH
   Hackett, NR
   Quitoriano, MS
   Crystal, RG
   Rafii, S
   Moore, MAS
AF Hattori, K
   Heissig, B
   Tashiro, K
   Honjo, T
   Tateno, M
   Shieh, JH
   Hackett, NR
   Quitoriano, MS
   Crystal, RG
   Rafii, S
   Moore, MAS
TI Plasma elevation of stromal cell-derived factor-1 induces mobilization
   of mature and immature hematopoietic progenitor and stem cells
SO BLOOD
LA English
DT Article
ID CHEMOKINE RECEPTOR CXCR4; BONE-MARROW; TRANSENDOTHELIAL MIGRATION;
   ADHESION MOLECULE-1; FACTOR-I; ENDOTHELIAL SELECTINS; NOD/SCID MICE;
   EXPRESSION; SDF-1; LYMPHOPOIESIS
AB The chemokine, stromal cell-derived factor-1 (SDF1), is produced in the hone marrow and has been shown to modulate the homing of stem cells to this site by mediating chemokinesis and chemotaxis. Therefore, it was hypothesized that elevation of SDF1 level in the peripheral circulation would result in mobilization of primitive hematopoietic stem and progenitor cells. SDF1 plasma level was increased by intravenous injection of an adenoviral vector expressing SDF1 alpha (AdSDF1) into severe combined immunodeficient mice. This resulted in a 10-fold increase in leukocyte count, a 3-fold increase in platelets, and mobilization of progenitors, including colony-forming units-granulocyte-macrophage to the peripheral circulation. In addition, AdSDF1 induced mobilization of cells with stem cell potential, including colony-forming units in spleen and long-term reconstituting cells. These data demonstrate that overexpression of SDF1 in the peripheral circulation results in the mobilization of hematopoietic cells with repopulating capacity, progenitor cells, and precursor cells, These studies lay the foundation for using SDF1 to induce mobilization of hematopoietic stem and progenitor cells in in vivo studies. (Blood. 2001;97:3354-3360) (C) 2001 by The American Society of Hematology.
C1 Sloan Kettering Inst Canc Res, James Ewing Lab Dev Hematopoiesis, New York, NY 10021 USA.
   Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY USA.
   New York Med Coll, Cornell Med Ctr, Div Pulm & Crit Care Med, New York, NY USA.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto, Japan.
   Sapporo City Gen Hosp, Dept Pathol, Sapporo, Hokkaido, Japan.
RP Moore, MAS (reprint author), Sloan Kettering Inst Canc Res, James Ewing Lab Dev Hematopoiesis, 1275 York Ave,Mailbox 101,Rm 717,RRL, New York, NY 10021 USA.
CR Imai K, 1999, BLOOD, V93, P149
   Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Verlinden SFF, 1998, EXP HEMATOL, V26, P627
   Wang JF, 1998, BLOOD, V92, P756
   Schweitzer KM, 1996, AM J PATHOL, V148, P165
   RAFII S, 1994, BLOOD, V84, P10
   Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423
   Kim CH, 1998, BLOOD, V91, P100
   Verfaillie CM, 1998, BLOOD, V92, P2609
   Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111
   Mohle R, 1998, BLOOD, V91, P4523
   Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954
   Papayannopoulou T, 1998, BLOOD, V91, P2231
   Vermeulen M, 1998, BLOOD, V92, P894
   Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539
   PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647
   Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448
   Lataillade JJ, 2000, BLOOD, V95, P756
   BUTCHER EC, 1996, SCIENCE, V272, P90
   Frey BM, 1998, J IMMUNOL, V160, P691
   Frey BM, 1998, BLOOD, V91, P2781
   HERTZ J, 1993, P NATL ACAD SCI USA, V90, P2812
   Lapidot T, 1998, BLOOD, V92, p717A
   Liu FL, 1997, BLOOD, V90, P2522
   Naiyer AJ, 1999, BLOOD, V94, P4011
   Papayannopoulou T, 1997, ACTA HAEMATOL-BASEL, V97, P97
   Riviere C, 1999, BLOOD, V93, P1511
   STORCH MJ, 1993, J IMMUNOL METHODS, V157, P197, DOI 10.1016/0022-1759(93)90087-N
   TAVASSOLI M, 1990, BLOOD, V76, P1059
   ZANJANI ED, 1993, BLOOD, V81, P399
NR 34
TC 359
Z9 383
U1 1
U2 11
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD JUN 1
PY 2001
VL 97
IS 11
BP 3354
EP 3360
DI 10.1182/blood.V97.11.3354
PG 7
WC Hematology
SC Hematology
GA 436GJ
UT WOS:000168927900007
PM 11369624
ER

PT J
AU Lee, HC
   Ye, SK
   Honjo, T
   Ikuta, K
AF Lee, HC
   Ye, SK
   Honjo, T
   Ikuta, K
TI Induction of germline transcription in the human TCR gamma locus by
   STAT5
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID RECEPTOR-DEFICIENT MICE; T-CELL DEVELOPMENT; INTERLEUKIN-7 RECEPTOR;
   ACCESSIBILITY CONTROL; GENE REARRANGEMENT; IL-7 RECEPTOR; V(D)J
   RECOMBINATION; BETA LOCUS; ALPHA; DIFFERENTIATION
AB TCR and Ig genes are assembled by V(D)J recombination during lymphocyte development. The enhancer and the germline promoter control the accessibility of each locus for the common recombinase activity. In the mouse TCR gamma locus, STAT5 proteins activated by the IL-7R interact with consensus motifs in 5 ' regions of J gamma segments and induce germline transcription. To evaluate the role of STAT5 in controlling the accessibility of the TCR gamma locus, we characterized the germline transcription of human TCR gamma genes and compared it with mouse. We first demonstrated that J gamma -C gamma germline transcripts are induced in a cytokine-dependent human erythroleukemia cell line. STAT consensus motifs are present in 5 ' regions of J-gamma1.1 and J gamma2.1 gene segments, and activated STAT5 binds to these motifs. By using a reporter assay, we showed that the J gamma1.1 germline promoter is transactivated by STAT5 and that mutations in any of the two STAT motifs abrogate this activity. Thus, this study demonstrates that STAT5 induces germline transcription in the TCR gamma locus of both mouse and human and suggests the possibility that this mechanism may play an essential role in controlling the TCR gamma locus accessibility. In addition, STAT motifs are conserved among 5 ' J gamma germline promoters, 3 ' enhancers, and a locus control region-like element, HsA, in both mouse and human TCR gamma loci, indicating the possibility that IL-7R/STAT5 signaling probably controls the locus-wide accessibility through these elements.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Ikuta, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Ye, Sang Kyu/J-2768-2012
CR Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5
   Corcoran AE, 1998, NATURE, V391, P904
   Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7
   Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172
   Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045
   Blom B, 1999, BLOOD, V93, P3033
   Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4
   McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495
   Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3
   Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625
   KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219
   Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293
   Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233
   ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825
   Corcoran AE, 1996, EMBO J, V15, P1924
   PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955
   Baker JE, 1999, J EXP MED, V190, P669, DOI 10.1084/jem.190.5.669
   Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6
   Candeias S, 1997, IMMUNOL LETT, V57, P9, DOI 10.1016/S0165-2478(97)00062-X
   He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289
   Hempel WM, 1998, ADV IMMUNOL, V69, P309
   HETTMANN T, 1994, MOL IMMUNOL, V31, P315, DOI 10.1016/0161-5890(94)90129-5
   Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423
   QUERTERMOUS T, 1987, J IMMUNOL, V138, P2687
   Sleckman BP, 1998, IMMUNOL REV, V165, P121, DOI 10.1111/j.1600-065X.1998.tb01235.x
   STRAUSS WM, 1987, SCIENCE, V237, P1217, DOI 10.1126/science.3498213
   UPPENKAMP M, 1987, J IMMUNOL, V138, P1618
   Utley RT, 1998, NATURE, V394, P498
   Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9
   vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8
   Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X
   Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5
NR 32
TC 15
Z9 15
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JUL 1
PY 2001
VL 167
IS 1
BP 320
EP 326
PG 7
WC Immunology
SC Immunology
GA 471VJ
UT WOS:000170949100044
PM 11418666
ER

PT J
AU Kinoshita, K
   Honjo, T
AF Kinoshita, K
   Honjo, T
TI Linking class-switch recombination with somatic hypermutation
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID IMMUNOGLOBULIN HEAVY-CHAIN; HYPER-IGM SYNDROME; B MESSENGER-RNA;
   NUCLEOTIDE EXCISION-REPAIR; X-LINKED IMMUNODEFICIENCY; CYTIDINE
   DEAMINASE AID; DOUBLE-STRAND BREAKS; CD40 LIGAND; MICE DEFICIENT;
   CIRCULAR DNA
AB The recent discovery of a molecular link between two apparently different genetic alteration events - class-switch recombination and somatic hypermutation - has led to the idea that the recognition and cleavage of target DNA in these two events might be mediated by similar or identical molecules to those involved in RNA editing. This could mean that the complexity of mammalian genetic information may be enriched by an interplay between RNA editing and DNA modification.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579
   Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59
   Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   YELAMOS J, 1995, NATURE, V376, P225
   AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121
   Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4
   Klotz EL, 1998, J IMMUNOL, V161, P782
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   Seidl KJ, 1998, INT IMMUNOL, V10, P1683, DOI 10.1093/intimm/10.11.1683
   BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0
   THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7
   FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   ZHANG J, 1993, EMBO J, V12, P3529
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0
   MANTOVANI L, 1993, J IMMUNOL, V151, P473
   Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323
   ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801
   Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765
   Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Storb U, 1998, IMMUNOL REV, V162, P153
   Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207
   Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0
   BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6
   REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9
   Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745
   Rueter SM, 1999, NATURE, V399, P75
   Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509
   Bertocci B, 1998, IMMUNITY, V9, P257, DOI 10.1016/S1074-7613(00)80608-1
   Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564
   CASEY JL, 1995, J VIROL, V69, P7593
   Christine R, 1999, CYTOMETRY, V37, P205, DOI 10.1002/(SICI)1097-0320(19991101)37:3<205::AID-CYTO7>3.0.CO;2-9
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735
   Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   Kim N, 1997, J EXP MED, V186, P413, DOI 10.1084/jem.186.3.413
   Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2
   Kong QZ, 2001, GENETICS, V158, P369
   KONOSHITA K, 1999, COLD SPRING HARB SYM, P217
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151
   LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154
   Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159
   Ma JY, 1997, J BIOL CHEM, V272, P672
   MAKI R, 1980, P NATL ACAD SCI-BIOL, V77, P2138, DOI 10.1073/pnas.77.4.2138
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Muramatsu M, 2001, TRENDS IMMUNOL, V22, P66, DOI 10.1016/S1471-4906(00)01818-4
   MURAMATSU M, 2000, CELL, V102, P653
   Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1
   OTT DE, 1987, EMBO J, V6, P557
   Ott D E, 1989, Int Immunol, V1, P582, DOI 10.1093/intimm/1.6.582
   RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0
   Revy P, 1998, EUR J IMMUNOL, V28, P3648, DOI 10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.3.CO;2-L
   SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460
   SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493
   Stavnezer J, 1999, J IMMUNOL, V163, P2028
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 105
TC 95
Z9 96
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD JUL
PY 2001
VL 2
IS 7
BP 493
EP 503
DI 10.1038/35080033
PG 11
WC Cell Biology
SC Cell Biology
GA 451EX
UT WOS:000169789100012
PM 11433363
ER

PT J
AU Honjo, T
   Lim, EM
AF Honjo, T
   Lim, EM
TI Visualization of landscape by VRML system
SO LANDSCAPE AND URBAN PLANNING
LA English
DT Article
DE computer graphics; landscape design; visualization; virtual reality;
   VRML
ID TREE
AB Virtual reality modeling language (VRML) is a high performance language for three-dimensional (3-D) visualization on the World Wide Web (WWW). Three-dimensional information can be easily transferred through the Internet by this technology. In this study, we made a landscape visualization system that enables virtual experience in a planned landscape by using VRML and the applicability of the system to the landscape design was shown. To perform real-time rendering of landscape, a tree was expressed by using two textured planes instead of thousands of polygons. Trees were placed automatically on a textured terrain based on the plant database by the system developed in this study. With the system, we made models of real gardens based on measured data and walk-through simulations in the gardens were tested. The system showed good performance and it also indicated the potential of VRML systems. The information on the virtual landscape can be placed on WWW. This method can be utilized both for the design of and for the public discussion on landscape planning. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chiba Univ, Grad Sch Sci & Technol, Inage Ku, Chiba 263, Japan.
RP Honjo, T (reprint author), Chiba Univ, Fac Hort, 648 Matsudo, Matsudo, Chiba 2718510, Japan.
CR AONO M, 1984, IEEE COMPUT GRAPH, V4, P10, DOI 10.1109/MCG.1984.276141
   Bloomenthal J., 1985, Computer Graphics, V19
   de Reffye P., 1988, Computer Graphics, V22
   Greene N., 1989, Computer Graphics, V23
   HONDA H, 1971, J THEOR BIOL, V31, P331, DOI 10.1016/0022-5193(71)90191-3
   HONJO T, 1999, J JPN I LANDSCAPE AR, V62, P665
   HONJO T, 1995, B SCH HIGH TECH TOKA, V5, P177
   HONJO T, 1992, J JPN I LANDSCAPE AR, V55, P301
   HONJO T, 1997, J JPN I LANDSCAPE AR, V60, P611
   HONJO T, 1998, J JPN I LANDSCAPE AR, V61, P605
   LIM E, 2000, J JPN I LANDSCAPE AR, V63, P799
   MORIMOTO Y, 1993, J JPN I LANDSCAPE AR, V57, P113
   Oppenheimer P. E., 1986, Computer Graphics, V20
   PRUSINKIEWICZ P, 1988, COMP GRAPH, V22, P146
   Saito K., 1993, NICONGRAPH PAPER CON, V9, P226
   *TOKY METR GOV KOR, 1986, REP ENV BIOL INV KOI
   Viennot X. G., 1989, Computer Graphics, V23
NR 17
TC 25
Z9 30
U1 3
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2046
J9 LANDSCAPE URBAN PLAN
JI Landsc. Urban Plan.
PD JUL 30
PY 2001
VL 55
IS 3
BP 175
EP 183
DI 10.1016/S0169-2046(01)00152-9
PG 9
WC Ecology; Environmental Studies; Geography; Geography, Physical; Urban
   Studies
SC Environmental Sciences & Ecology; Geography; Physical Geography; Urban
   Studies
GA 453JW
UT WOS:000169913600003
ER

PT J
AU Mizutani, T
   Taniguchi, Y
   Aoki, T
   Hashimoto, N
   Honjo, T
AF Mizutani, T
   Taniguchi, Y
   Aoki, T
   Hashimoto, N
   Honjo, T
TI Conservation of the biochemical mechanisms of signal transduction among
   mammalian Notch family members
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; RBP-J; BETA-SECRETASE;
   INTRACELLULAR DOMAIN; DROSOPHILA NOTCH; NUCLEAR ACCESS; MOUSE NOTCH1;
   CELL BIOLOGY; IN-VIVO
AB Mouse Notch1, which plays an important rote in cell fate determination in development, is proteolytically processed within its transmembrane domain by unidentified gamma -secretase-like activity that depends on presenilin. To study this proteolytic event, we established a cell-free Notch cleavage assay system using the membrane fraction of fibroblast transfectants of various Notch constructs with deletion of the extracellular portion (Notch Ey. The cytoplasmic portion of Notch1 DeltaE was released from the membrane upon incubation at 37 degreesC, which was inhibited by the specific gamma -secretase inhibitor, MW167, or by overexpression of dominant negative presenilin1. Likewise, other members of mouse Notch family were proteolytically cleaved in a presenilin-dependent, MW167-sensitive mariner is vivo as well as in the cell-free Notch DeltaE cleavage assay system. All four members of the mouse Notch family migrated to the nucleus and activated the transcription from the promoter carrying the RBP-J consensus sequences after they were released from the membrane. These results demonstrate the conserved biochemical mechanism of signal transduction among mammalian Notch family members.
C1 Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Fac Med, Dept Neurosurg, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Yoshida, Kyoto 6068501, Japan.
RI Taniguchi, Yoshihito/L-5746-2013
CR De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083
   Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091
   Schroeter EH, 1998, NATURE, V393, P382
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4
   Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801
   Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7
   Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0
   De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Jarriault S, 1998, MOL CELL BIOL, V18, P7423
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811
   Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107
   Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   OKA C, 1995, DEVELOPMENT, V121, P3291
   SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290
   Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1
   WEINMASTER G, 1991, DEVELOPMENT, V113, P199
   Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456
   Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872
   Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108
   CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174
   Ye YH, 1999, NATURE, V398, P525
   GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847
   Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2
   Luo B, 1997, MOL CELL BIOL, V17, P6057
   Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055
   Haass C, 1997, NEURON, V18, P687, DOI 10.1016/S0896-6273(00)80309-8
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   MAMM JS, 2000, MOL CELL, V5, P197
   MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V179, P1670, DOI 10.1016/0006-291X(91)91767-7
   Selkoe DJ, 1999, NATURE, V399, pA23
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
NR 48
TC 95
Z9 102
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 31
PY 2001
VL 98
IS 16
BP 9026
EP 9031
DI 10.1073/pnas.161269998
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 458VV
UT WOS:000170216900022
PM 11459941
ER

PT J
AU Yamamoto, M
   Honjo, T
AF Yamamoto, M
   Honjo, T
TI Separation of chromium (VI) and chromium (III) with crown ether by means
   of ion-pair extraction
SO BUNSEKI KAGAKU
LA Japanese
DT Article
DE chromium(VI); chromium(III); dicyclohexyl-18-crown-6; ion-pair
   extraction; separation
AB A new method for the separation of chromium(VI) and chromium(III) with dicyclohexyl 18-crown-6 (DC18C6) in 1,2-dichloroethane was developed by means of solvent extraction. In this process, Cr-VI as HCrO4- was extracted as an ion-pair complex with the potassium-crown ether complex cation in the organic phase within 1 min. The extracted species was ascertained to be [K(DC18C6)]+. [HCrO4](-). When mixtures of Cr-VI and Cr-III were extracted under the optimum condition, Cr-VI alone was extracted quantatively, whereas Cr-III remained in the aqueous phase. After extraction, Cr-VI in the organic phase was quantatively back-extracted by a 0.1 M NH3 solution. Then, each of the concentrations of Cr-VI and Cr-III could.be determined by means of inductively coupled plasma atomic emission spectrometry (ICP-AES). Cations, such as iron(III), zinc(II) and cadmium(II), interfered with this extraction. The present method was applied to recover Cr-VI trace in the presence of Cr-III in real samples, and clarified to be applicable to Cr-VI determination in natural water samples.
C1 Kanazawa Univ, Fac Sci, Dept Chem, Kanazawa, Ishikawa 9201192, Japan.
RP Yamamoto, M (reprint author), Kanazawa Univ, Fac Sci, Dept Chem, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.
CR SHENYANG T, 1986, TALANTA, V33, P775, DOI 10.1016/0039-9140(86)80187-4
   *JIS, 1957, K0101 JIS, P61
   KOSHIMA H, 1993, ANAL SCI, V9, P141, DOI 10.2116/analsci.9.141
   UPOR E, 1985, COMPREHENSIVE ANAL C, V20, P180
   Yakshin VV, 1998, J ANAL CHEM+, V53, P409
   YAKSHIN VV, 1996, RUSS J INORG CHEM, V43, P791
NR 6
TC 2
Z9 2
U1 1
U2 8
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0525-1931
J9 BUNSEKI KAGAKU
JI Bunseki Kagaku
PD AUG
PY 2001
VL 50
IS 8
BP 567
EP 570
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 464EG
UT WOS:000170519800008
ER

PT J
AU Lee, CG
   Kinoshita, K
   Arudchandran, A
   Cerritelli, SM
   Crouch, RJ
   Honjo, T
AF Lee, CG
   Kinoshita, K
   Arudchandran, A
   Cerritelli, SM
   Crouch, RJ
   Honjo, T
TI Quantitative regulation of class switch recombination by switch region
   transcription
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE secondary structures; recombinase; artificial constructs; tet inducible
   promoter; B lymphoma line
ID CYTIDINE DEAMINASE AID; HEAVY-CHAIN SWITCH; SOMATIC HYPERMUTATION;
   DNA-SEQUENCES; B-CELLS; IMMUNOGLOBULIN; GENE; EXPRESSION; MUTATION;
   PROMOTER
AB The isotype specificity of immunoglobulin (Ig) class switching is regulated by a cytokine which induces transcription of a specific switch (S) region, giving rise to so-called germline transcripts. Although previous studies have demonstrated that germline transcription of an S region is required for class switch recombination (CSR) of that particular S region, it has not been shown whether the level of S region transcription affects the efficiency of CSR. We addressed this question by using an artificial DNA construct containing a constitutively transcribed mu switch (S mu) region and an alpha switch (S alpha) region driven by a tetracycline-responsive promoter. The construct was introduced into a switch-inducible B lymphoma line and the quantitative correlation between Sot region transcription and class switching efficiency was evaluated. The level of Su transcription was linearly correlated with CSR efficiency, reaching a plateau at saturation. On the other hand, we failed to obtain the evidence to support involvement of either RNA-DNA heteroduplex or trans germline transcripts in CSR Taken together, it is likely that S region transcription and/or transcript processing in situ may be required for CSR. We propose that because of the unusual properties of S region DNA, transcription induces the DNA to transiently be single stranded, permitting secondary structure(s) to form. Such structures may be recognition targets of a putative class switch recombinase.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4
   GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   ZHANG J, 1993, EMBO J, V12, P3529
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689
   Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DUNNICK W, 1980, NATURE, V286, P669, DOI 10.1038/286669a0
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Han LY, 1997, BIOTECHNIQUES, V23, P920
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   Sambrook J., 1989, MOL CLONING LAB MANU
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   ZHANG T, 1995, IMMUNOGLOBULIN GENES
NR 44
TC 47
Z9 47
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD AUG 6
PY 2001
VL 194
IS 3
BP 365
EP 373
DI 10.1084/jem.194.3.365
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 461UQ
UT WOS:000170382200015
PM 11489955
ER

PT J
AU Ye, SK
   Maki, K
   Lee, HC
   Ito, A
   Kawai, K
   Suzuki, H
   Mak, TW
   Chien, YH
   Honjo, T
   Ikuta, K
AF Ye, SK
   Maki, K
   Lee, HC
   Ito, A
   Kawai, K
   Suzuki, H
   Mak, TW
   Chien, YH
   Honjo, T
   Ikuta, K
TI Differential roles of cytokine receptors in the development of epidermal
   gamma delta T cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID THYMIC STROMAL LYMPHOPOIETIN; NATURAL-KILLER-CELLS; INTERLEUKIN-7
   RECEPTOR; DEFICIENT MICE; IL-7 RECEPTOR; ALPHA-CHAIN; BETA-CHAIN;
   LYMPHOCYTE DEVELOPMENT; GENE REARRANGEMENT; MUTANT MICE
AB IL-7 and IL-15 play important roles in gamma delta T cell development. These receptors transmit proliferation and/or survival signals in,gamma delta T cells. In addition, the IL-7R promotes recombination and transcription in the TCR gamma locus. To clarify the role of the cytokine receptors in the development of epidermal gamma delta T cells, we introduced a V gamma3/V delta1 TCR transgene, derived from Thy-1(+) dendritic epidermal T cells (DETC), into IL-7R alpha -deficient mice, and we found that they partly rescued gamma delta T cells in the adult thymus but not in the spleen. Introduction of an additional Bcl-2 transgene had a minimal effect on gamma delta T cells in the adult thymus of these mice. In contrast to the adult thymus, the introduction of the V gamma3/V delta1 TCR transgene into IL-7R alpha (-/-) mice completely restored V gamma3(+) T cells in the fetal thymus and DETC in the adult skin. On the contrary, the same V gamma3/V delta1 TCR transgene failed to rescue DETC in the skin of IL-2R beta -deficient mice, even with the additional Bcl-2 transgene. These results suggest that the IL-2/IL-15R, rather than the IL-7R, plays an essential role in proliferation and survival of DETC in the fetal thymus and the skin. In contrast, the IL-7R is probably essential in the induction of V-J recombination of TCR gamma genes. Thus, this study proves that IL-7R and IL-2/IL-15R serve differential functions in epidermal gamma delta T cell development.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Niigata Univ, Sch Med, Dept Dermatol, Niigata 951, Japan.
   Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan.
   Amgen Inst, Toronto, ON, Canada.
   Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
RP Ikuta, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
EM ikuta@mfour.med.kyoto-u.ac.jp
RI Kawai, Kazuhiro/D-4998-2011; Ye, Sang Kyu/J-2768-2012
OI Kawai, Kazuhiro/0000-0001-9375-0713; 
CR DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377
   Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5
   Nakajima H, 1999, J IMMUNOL, V162, P782
   Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449
   Corcoran AE, 1998, NATURE, V391, P904
   GIRI JG, 1995, EMBO J, V14, P3654
   Maraskovsky E, 1996, J IMMUNOL, V157, P5315
   Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499
   Kang J, 1999, J EXP MED, V190, P973, DOI 10.1084/jem.190.7.973
   Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7
   Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659
   Domen J, 1998, BLOOD, V91, P2272
   Di Santo JP, 1999, J EXP MED, V189, P563, DOI 10.1084/jem.189.3.563
   Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172
   HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0
   Kawai K, 1998, J INVEST DERMATOL, V110, P961, DOI 10.1046/j.1523-1747.1998.00214.x
   Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X
   Pandey A, 2000, NAT IMMUNOL, V1, P59
   Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3
   Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0
   HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4
   Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293
   BHATIA SK, 1995, J EXP MED, V181, P1399, DOI 10.1084/jem.181.4.1399
   Porter BO, 1999, J IMMUNOL, V163, P5906
   Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275
   SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125
   Corcoran AE, 1996, EMBO J, V15, P1924
   SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771
   PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955
   Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771
   Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6
   Candeias S, 1997, IMMUNOL LETT, V57, P9, DOI 10.1016/S0165-2478(97)00062-X
   CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0
   Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975
   He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289
   IKUTA K, 1991, J EXP MED, V174, P1279, DOI 10.1084/jem.174.5.1279
   IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759
   IWASHIMA M, 1991, INT IMMUNOL, V3, P385, DOI 10.1093/intimm/3.4.385
   Jacobs H, 1999, J EXP MED, V190, P1059, DOI 10.1084/jem.190.8.1059
   KAWAI K, 1995, J EXP MED, V181, P345, DOI 10.1084/jem.181.1.345
   LECLERCQ G, 1993, J EXP MED, V178, P309, DOI 10.1084/jem.178.1.309
   Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423
   Malissen M, 1997, J EXP MED, V186, P1277, DOI 10.1084/jem.186.8.1277
   Porter BO, 2001, J IMMUNOL, V166, P262
   TANAKA T, 1992, INT IMMUNOL, V4, P487, DOI 10.1093/intimm/4.4.487
   VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519
   vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8
   Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5
NR 50
TC 18
Z9 18
U1 2
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD AUG 15
PY 2001
VL 167
IS 4
BP 1929
EP 1934
PG 6
WC Immunology
SC Immunology
GA 471VP
UT WOS:000170949600014
PM 11489972
ER

PT J
AU Kobuke, K
   Furukawa, Y
   Sugai, M
   Tanigaki, K
   Ohashi, N
   Matsumori, A
   Sasayama, S
   Honjo, T
   Tashiro, K
AF Kobuke, K
   Furukawa, Y
   Sugai, M
   Tanigaki, K
   Ohashi, N
   Matsumori, A
   Sasayama, S
   Honjo, T
   Tashiro, K
TI ESDN, a novel neuropilin-like membrane protein cloned from vascular
   cells with the longest secretory signal sequence among eukaryotes, is
   up-regulated after vascular injury
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SMOOTH-MUSCLE CELLS; ENDOTHELIAL GROWTH-FACTOR;
   DICTYOSTELIUM-DISCOIDEUM; CORONARY ANGIOPLASTY; GENETIC SELECTION;
   SEMAPHORIN-III; LIGAND-BINDING; ANGIOTENSIN-II; HIGH-AFFINITY; FACTOR-C
AB A novel cDNA has been isolated from primary culture of human coronary arterial cells by a signal sequence trap method, and designated ESDN ((e) under bar ndothelial and (s) under bar mooth muscle cell-(d) under bar erived (n) under bar europilin-like molecule). ESDN is a type-I transmembrane protein with the longest cleavable secretory signal sequence among eukaryotes. ESDN contains a CUB domain and a coagulation factor V/VIII homology domain, which reminds us of the structure of neuropilins. ESDN also harbors an LCCL domain, which is shared by Limulus factor C and Coch. Mouse and rat counterparts were also identified revealing > 84% amino acid identity with human ESDN. The human ESDN gene was mapped between D3S1552 and D3S1271. Northern blot analysis showed that ESDN mRNA was expressed in various tissues; particularly highly expressed in cultured vascular smooth muscle cells. The ESDN expression was up-regulated in platelet-derived growth factor-BB-stimulated vascular smooth muscle cells in vitro and neointima of the balloon-injured carotid artery in vivo. Overexpression of ESDN in 293T cells suppressed their bromodeoxyuridine uptake. In addition, ESDN protein was strongly expressed in nerve bundles in rodents. Thus, ESDN is considered to play a role in regulation of vascular cell growth and may have a wide variety of functions in other tissues including the nervous system, like neuropilins.
C1 Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet,Dept Med Chem, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
RP Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet,Dept Med Chem, Sakyo Ku, 53 Kawahara Cho1, Kyoto 6068507, Japan.
EM ktashiro@mfour.med.kyoto-u.ac.jp
CR Bagnard D, 1998, DEVELOPMENT, V125, P5043
   Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X
   Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6
   Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149
   SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195
   Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6
   FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454
   NIWA H, 1991, GENE, V108, P193
   Todaka T, 1999, STROKE, V30, P419
   JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613
   Kaplan F, 1999, AM J PHYSIOL-LUNG C, V276, pL1027
   LINDNER V, 1991, CIRC RES, V68, P106
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391
   SCHWARTZ SM, 1995, CIRC RES, V77, P445
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0
   KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125
   ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207
   OGATA RT, 1993, J IMMUNOL, V150, P2273
   NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616
   Fuh G, 2000, J BIOL CHEM, V275, P26690
   Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476
   Lambert-Buisine C, 1998, MOL MICROBIOL, V28, P1283, DOI 10.1046/j.1365-2958.1998.00892.x
   Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283
   Mi S, 2000, NATURE, V403, P785
   Vogel W, 1999, FASEB J, V13, pS77
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   Touyz RM, 2000, PHARMACOL REV, V52, P639
   Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830
   Robertson NG, 1998, NAT GENET, V20, P299
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   MUTA T, 1991, J BIOL CHEM, V266, P6554
   Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0
   Baumgartner S, 1998, PROTEIN SCI, V7, P1626
   [Anonymous], 1989, ANN NY ACAD SCI
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2
   TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5
   Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221
   HAMPTON JR, 1993, LANCET, V341, P573
   Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8
   BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6
   Hughes AD, 1996, GEN PHARMACOL, V27, P1079, DOI 10.1016/S0306-3623(96)00060-2
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   de Kok YJM, 1999, HUM MOL GENET, V8, P361, DOI 10.1093/hmg/8.2.361
   Ohashi N, 2000, ARTERIOSCL THROM VAS, V20, P2521
   Trexler M, 2000, EUR J BIOCHEM, V267, P5751, DOI 10.1046/j.1432-1327.2000.01641.x
   POOLE S, 1981, J MOL BIOL, V153, P273, DOI 10.1016/0022-2836(81)90278-3
   Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309
   HAUDENSCHILD CC, 1979, LAB INVEST, V41, P407
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Polleux F, 2000, NATURE, V404, P567
   Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476
   McCaffrey TA, 2000, CYTOKINE GROWTH F R, V11, P103, DOI 10.1016/S1359-6101(99)00034-9
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X
   Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1
   Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   BROWN J, 1995, HUM MOL GENET, V4, P1625, DOI 10.1093/hmg/4.9.1625
   CASTELLOT JJ, 1981, J CELL BIOL, V90, P372, DOI 10.1083/jcb.90.2.372
   Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744
   FISHMAN JA, 1975, LAB INVEST, V32, P339
   Furukawa Y, 1999, CIRC RES, V84, P306
   HANSSON GK, 1991, CIRCULATION, V84, P1266
   Jacobs KA, 1999, METHOD ENZYMOL, V303, P468
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   Janero DR, 2000, FREE RADICAL BIO MED, V29, P1199, DOI 10.1016/S0891-5849(00)00434-2
   KANE WH, 1988, BLOOD, V71, P539
   Kato K, 2000, BLOOD, V96, P362
   LEIMGRUBER PP, 1986, CIRCULATION, V73, P710
   Nadadur SS, 1999, BBA-GENE STRUCT EXPR, V1489, P433, DOI 10.1016/S0167-4781(99)00189-X
   Nakamura T, 1998, GENOMICS, V54, P89, DOI 10.1006/geno.1998.5571
   NAKAMURA T, 1988, J BIOCHEM-TOKYO, V103, P370
   Naylor SL, 1996, CYTOGENET CELL GENET, V72, P90, DOI 10.1159/000134170
   ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457
   [Anonymous], 1989, MOL CLONING LAB MANU
   SPRINGER WR, 1984, CELL, V39, P557, DOI 10.1016/0092-8674(84)90462-8
   STEPHENS EB, 1992, VIROLOGY, V190, P569, DOI 10.1016/0042-6822(92)90894-U
   Tashiro K, 1999, METHOD ENZYMOL, V303, P479
   WEBER H, 1994, J CLIN INVEST, V93, P788, DOI 10.1172/JCI117033
NR 90
TC 32
Z9 36
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 7
PY 2001
VL 276
IS 36
BP 34105
EP 34114
DI 10.1074/jbc.M105293200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 471CP
UT WOS:000170910200109
PM 11447234
ER

PT J
AU Durandy, A
   Honjo, T
AF Durandy, A
   Honjo, T
TI Human genetic defects in class-switch recombination (hyper-IgM
   syndromes)
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID CYTIDINE DEAMINASE AID; B MESSENGER-RNA; NF-KAPPA-B; X-LINKED
   IMMUNODEFICIENCY; DOUBLE-STRAND BREAKS; CD40 LIGAND; SOMATIC
   HYPERMUTATION; MISMATCH REPAIR; IMMUNOGLOBULIN GENES; CATALYTIC SUBUNIT
AB Several genetic defects in class-switch recombination, leading to hyper-IgM syndromes, have been recently described in humans. Besides the well-known role of interaction between CD40-ligand and CD40, these pathological conditions definitively demonstrate the requirement of CD40-mediated NF-kappaB activation and the essential role of a newly described molecule, activation-induced cytidine deaminase (AID), in B cell terminal differentiation.
C1 Hop Necker Enfants Malad, INSERM, U429, Paris 15, France.
   Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
RP Durandy, A (reprint author), Hop Necker Enfants Malad, INSERM, U429, 149 Rue Sevres, Paris 15, France.
CR Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   BERBERICH I, 1994, J IMMUNOL, V153, P4357
   Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170
   Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505
   Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89
   Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166
   DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
   Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323
   Wabl M, 1999, CURR OPIN IMMUNOL, V11, P186, DOI 10.1016/S0952-7915(99)80031-4
   ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801
   Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Storb U, 1998, IMMUNOL REV, V162, P153
   Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914
   Evans E, 2000, MOL CELL BIOL, V20, P7839, DOI 10.1128/MCB.20.21.7839-7844.2000
   Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563
   Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200
   Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X
   Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732
   Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509
   CALLARD RE, 1994, J IMMUNOL, V153, P3295
   Durandy A, 1997, J IMMUNOL, V158, P2576
   Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5
   Kenter AL, 1999, J EXP MED, V190, P307, DOI 10.1084/jem.190.3.307
   KINOSHITA K, 2001, IN PRESS NAT REV MOL
   KROCZEK RA, 1994, IMMUNOL REV, V138, P39, DOI 10.1111/j.1600-065X.1994.tb00846.x
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   Li J, 1996, NUCLEIC ACIDS RES, V24, P2104, DOI 10.1093/nar/24.11.2104
   NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709
   NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101
   Tabone MD, 1999, EUR J IMMUNOL, V29, P367
   Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259
   Wiesendanger M, 1998, CELL, V94, P415, DOI 10.1016/S0092-8674(00)81581-0
NR 53
TC 47
Z9 48
U1 1
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD OCT
PY 2001
VL 13
IS 5
BP 543
EP 548
DI 10.1016/S0952-7915(00)00256-9
PG 6
WC Immunology
SC Immunology
GA 469BC
UT WOS:000170791800006
PM 11544001
ER

PT J
AU Fagarasan, S
   Kinoshita, K
   Muramatsu, M
   Ikuta, K
   Honjo, T
AF Fagarasan, S
   Kinoshita, K
   Muramatsu, M
   Ikuta, K
   Honjo, T
TI In situ class switching and differentiation to IgA-producing cells in
   the gut lamina propria
SO NATURE
LA English
DT Article
ID CYTIDINE DEAMINASE AID; B-CELLS; SURFACE-RECEPTORS; MARGINAL ZONE;
   PLASMA-CELLS; CD40 LIGAND; FC RECEPTOR; MICE; ACTIVATION; EXPRESSION
AB One of the front lines of the immune defence is the gut mucosa, where immunoglobulin-alpha (IgA) is continuously produced to react with commensal bacteria and dietary antigens. It is generally accepted that, after antigenic stimulation in the Peyer's patches, IgA(+) lymphoblasts (B220(+)IgA(+)) migrate through the lymph and blood circulation, and eventually home to the lamina propria of the intestine(1,2). Mice that lack activation-induced cytidine deaminase (AID) are defective in class switch recombination (CSR) and somatic hypermutation(3). CSR changes the immunoglobulin heavy chain constant region (CH) gene being expressed from C mu to other CH genes, resulting in a switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA. AID(-/-) mice also secrete large amounts of immunoglobulin-m (IgM) into faeces, and accumulate B220(-)IgM(+) plasma cells as well as B220(+)IgM(+) cells in the gut. Here we show that lamina propria B220(+)IgA(+) cells have just completed CSR, as they still express both AID and transcripts from circular DNA that has been 'looped-out' during CSR. Lamina propria IgM(+) B cells seem to be pre-committed to switching to IgA(+) in vitro as well as in vivo. Culturing lamina propria IgM(+) B cells together with lamina propria stromal cells enhances preferential switching and differentiation of B cells to IgA(+) plasma cells. We conclude that IgA(+) cells in the gut lamina propria are generated in situ from B220(+)IgM(+) lymphocytes.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016
OI Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan,
   Sidonia/0000-0003-2086-6402
CR Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89
   Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206
   Kamata T, 2000, J IMMUNOL, V165, P1387
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6
   Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373
   Fagarasan S, 2000, IMMUNOL REV, V176, P205
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415
   RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012
   RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   KINOSHITA K, IN PRESS P NATL ACAD
   LEBMAN DA, 1987, J EXP MED, V166, P1405, DOI 10.1084/jem.166.5.1405
   Martin F, 1999, CURR TOP MICROBIOL, V246, P45
   Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TSENG J, 1981, J IMMUNOL, V127, P2039
   WALDSCHMIDT TJ, 1988, J IMMUNOL, V140, P2148
   WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305
   Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5
NR 31
TC 265
Z9 273
U1 3
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD OCT 11
PY 2001
VL 413
IS 6856
BP 639
EP 643
DI 10.1038/35098100
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 480WE
UT WOS:000171485700051
PM 11675788
ER

PT J
AU Kinoshita, K
   Harigai, M
   Fagarasan, S
   Muramatsu, M
   Honjo, T
AF Kinoshita, K
   Harigai, M
   Fagarasan, S
   Muramatsu, M
   Honjo, T
TI A hallmark of active class switch recombination: Transcripts directed by
   I promoters on looped-out circular DNAs
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CYTIDINE DEAMINASE AID; GERMINAL-CENTERS; B-CELLS; IMMUNOGLOBULIN;
   ACTIVATION; HYPERMUTATION; DELETION; GENE
AB To specify when and where Ig class switch recombination (CSR) takes place, a good molecular marker closely associated with active CSR is required. CSR is accompanied by deletion of circular DNA from the Ig heavy chain locus. The circular DNA contains a DNA segment between S mu and a target S region including its I promoter, which is driven by specific cytokine stimulation before CSR. We found that the specific I promoter is still active in looped-out circular DNA and directs production of I-C mu transcripts termed "circle transcripts." Reverse transcription-PCR demonstrated transient induction of specific circle transcripts upon CSR in a murine lymphoma cell line, CH12F3-2A, as well as spleen B cells. Production of the circle transcripts appeared to depend on expression of activation-induced cytidine deaminase (AID), an essential factor for CSR. A comparison of kinetics between circle transcripts and circular DNA showed more rapid disappearance of circle transcripts. Thus, circle transcripts may serve as a hallmark for active CSR in vitro and in vivo.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016
OI Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan,
   Sidonia/0000-0003-2086-6402
CR Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X
   MANTOVANI L, 1993, J IMMUNOL, V151, P473
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303
   JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0
   Sunaga S, 1997, J IMMUNOL, V158, P4223
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   BACHMANN MF, 1994, J IMMUNOL, V153, P3386
   Collins JT, 1999, J IMMUNOL, V163, P5758
   Elenich LA, 1996, J IMMUNOL, V157, P176
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561
   SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493
NR 20
TC 113
Z9 115
U1 2
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 23
PY 2001
VL 98
IS 22
BP 12620
EP 12623
DI 10.1073/pnas.221454398
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 486EU
UT WOS:000171806100060
PM 11606740
ER

PT J
AU Ye, SK
   Agata, Y
   Lee, HC
   Kurooka, H
   Kitamura, T
   Shimizu, A
   Honjo, T
   Ikuta, K
AF Ye, SK
   Agata, Y
   Lee, HC
   Kurooka, H
   Kitamura, T
   Shimizu, A
   Honjo, T
   Ikuta, K
TI The IL-7 receptor controls the accessibility of the TCR gamma locus by
   Stat5 and histone acetylation
SO IMMUNITY
LA English
DT Article
ID T-CELL DEVELOPMENT; INTERLEUKIN-7 RECEPTOR; V(D)J RECOMBINATION; GENE
   REARRANGEMENT; ALPHA; TRANSCRIPTION; ENHANCER; PROTEIN; REGION; P300
AB The IL-7 receptor (IL-7R) plays critical roles in expansion and V(D)J recombination during lymphocyte development. Here we demonstrate that cytokine stimulation rapidly recruits Stat5 and transcriptional coactivators to the Jy germline promoter and induces histone acetylation, germline transcription, and accessibility in Ba/F3 cells. We also show that histone acetylation of the TCR gamma locus is significantly reduced in IL-7R-deficient thymocytes and that the introduction of active Stat5 restores the histone acetylation and accessibility of the locus. Furthermore, treatment with histone deacetylase inhibitor recovers the histone acetylation and accessibility in IL-7R-deficient thymocytes. Therefore, these results suggest that Stat5 may recruit the transcriptional coactivators to the Jy germline promoter and control the accessibility of the TCR gamma locus by histone acetylation.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068507, Japan.
   Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo 1080071, Japan.
RP Ikuta, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RI Ye, Sang Kyu/J-2768-2012
CR Corcoran AE, 1998, NATURE, V391, P904
   Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7
   Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0
   Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X
   Domen J, 1998, BLOOD, V91, P2272
   Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327
   Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045
   CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0
   SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520
   Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4
   McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495
   MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500
   Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4
   ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869
   Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092
   Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0
   Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625
   Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293
   Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233
   Corcoran AE, 1996, EMBO J, V15, P1924
   Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8
   Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873
   Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289
   Baker JE, 1999, J EXP MED, V190, P669, DOI 10.1084/jem.190.5.669
   Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609
   He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289
   Hempel WM, 1998, ADV IMMUNOL, V69, P309
   Kurooka K, 2000, J BIOL CHEM, V275, P17211
   Lee HC, 2001, J IMMUNOL, V167, P320
   Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423
   Makino K, 1996, COLLOID SURFACE B, V8, P93, DOI 10.1016/S0927-7765(96)01313-6
   Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1
   Sleckman BP, 1998, IMMUNOL REV, V165, P121, DOI 10.1111/j.1600-065X.1998.tb01235.x
   Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9
   Whitelaw CBA, 1999, CYTOTECHNOLOGY, V31, P3, DOI 10.1023/A:1008044517150
   Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5
NR 36
TC 118
Z9 118
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD NOV
PY 2001
VL 15
IS 5
BP 813
EP 823
DI 10.1016/S1074-7613(01)00230-8
PG 11
WC Immunology
SC Immunology
GA 498UE
UT WOS:000172528200013
PM 11728342
ER

PT J
AU Chen, XC
   Kinoshita, K
   Honjo, T
AF Chen, XC
   Kinoshita, K
   Honjo, T
TI Variable deletion and duplication at recombination junction ends:
   Implication for staggered double-strand cleavage in class-switch
   recombination
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID HEAVY-CHAIN GENES; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION;
   IMMUNOGLOBULIN GENES; B-CELLS; NUCLEOTIDE-SEQUENCES; CIRCULAR DNA;
   REPETITIVE SEQUENCES; RGYW MOTIFS; REGION
AB Immunoglobulin class-switch recombination (CSR) gives rise to looped-out circular DNA of a cleaved S segment, which is lost eventually after cell divisions. To understand the molecular mechanism of S region cleavage during CSR, we constructed artificial CSR substrates in which inversion-type CSR takes place to retain the cleaved S segment. Sequencing analyses of recombinant clones of these substrates revealed that varying degrees of deletions and duplications exist at CSR breakpoints, suggesting the involvement of staggered cleavage of the S region in CSR. In addition, mutations frequently found near junctions showed a similar profile of base replacement to Ig somatic hypermutation. These findings suggest that single-strand tails of staggered cleavage may be repaired by error-prone DNA synthesis.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
CR Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4
   Dorner T, 1998, EUR J IMMUNOL, V28, P3384
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Foster SJ, 1999, EUR J IMMUNOL, V29, P4011, DOI 10.1002/(SICI)1521-4141(199912)29:12<4011::AID-IMMU4011>3.0.CO;2-W
   Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x
   Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745
   TAKEBE Y, 1988, MOL CELL BIOL, V8, P466
   Fiedler U, 2001, NUCLEIC ACIDS RES, V29, P2706, DOI 10.1093/nar/29.13.2706
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   BASHL J, 2001, J IMMUNOL, V166, P5051
   COLECLOUGH C, 1980, P NATL ACAD SCI-BIOL, V77, P1422, DOI 10.1073/pnas.77.3.1422
   CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0
   DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415
   DUNNICK W, 1980, NATURE, V286, P669, DOI 10.1038/286669a0
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735
   KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2
   Kinoshita K, 1999, COLD SPRING HARB SYM, V64, P217, DOI 10.1101/sqb.1999.64.217
   Kong QZ, 2001, GENETICS, V158, P369
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TAKAHASHI N, 1980, GENE, V11, P117
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0
   YOUN HJ, 1988, IMMUNOGENETICS, V28, P345, DOI 10.1007/BF00364233
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
NR 60
TC 58
Z9 58
U1 1
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 20
PY 2001
VL 98
IS 24
BP 13860
EP 13865
DI 10.1073/pnas.241524898
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 495EW
UT WOS:000172328100071
PM 11717442
ER

PT J
AU Okazaki, T
   Maeda, A
   Nishimura, H
   Kurosaki, T
   Honjo, T
AF Okazaki, T
   Maeda, A
   Nishimura, H
   Kurosaki, T
   Honjo, T
TI PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by
   recruiting src homology 2-domain-containing tyrosine phosphatase 2 to
   phosphotyrosine
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID ANTIGEN-RECEPTOR; EXPRESSION; ACTIVATION; MICE; PROTEIN; MEMBER; FAMILY;
   SHP-1; LYMPHOCYTES; P62(DOK)
AB PD-1 is an immunoreceptor that belongs to the immunoglobulin (Ig) superfamily and contains two tyrosine residues in the cytoplasmic region. Studies on PD-1-deficient mice have shown that PD-1 plays critical roles in establishment and/or maintenance of peripheral tolerance, but the mode of action is totally unknown. To study the molecular mechanism for negative regulation of lymphocytes through the PD-1 receptor, we generated chimeric molecules composed of the IgG Fc receptor type IIB (Fc gamma RIIB) extracellular region and the PD-1 cytoplasmic region and expressed them in a B lymphoma cell line, IIA1.6. Coligation of the cytoplasmic region of PD-1 with the B cell receptor(BCR) in IIA1.6 transformants inhibited BCR-mediated growth retardation, Ca2+ mobilization, and tyrosine phosphorylation of effector molecules, including Ig beta, Syk, phospholipase C-gamma2 (PLC gamma2), and ERK1/2, whereas phosphorylation of Lyn and Dok was not affected. Mutagenesis studies indicated that these inhibitory effects do not require the N-terminal tyrosine in the immunoreceptor tyrosine-based inhibitory motif-like sequence, but do require the other tyrosine residue in the C-terminal tail. This tyrosine was phosphorylated and recruited src homology 2-domain-containing tyrosine phosphatase 2 (SHP-2) on coligation of PD-1 with BCR. These results show that PD-1 can inhibit BCR signaling by recruiting SHP-2 to its phosphotyrosine and dephosphorylating key signal transducers of BCR signaling.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Mol Immunol & Allergy, Sakyo Ku, Kyoto 6068501, Japan.
   Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.
RI Kurosaki, Tomohiro/D-1306-2009
OI Kurosaki, Tomohiro/0000-0002-6352-304X
CR Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552
   OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798
   Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9
   Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5
   Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0
   Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3
   Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809
   Dong HD, 1999, NAT MED, V5, P1365
   Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Hippen KL, 1997, IMMUNITY, V7, P49, DOI 10.1016/S1074-7613(00)80509-9
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855
   BOLEN JB, 1995, CURR OPIN IMMUNOL, V7, P306, DOI 10.1016/0952-7915(95)80103-0
   Boll S, 1999, DISTRIB PARALLEL DAT, V7, P149, DOI 10.1023/A:1008754511383
   Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066
   Kitamura T, 1998, INT J HEMATOL, V67, P351
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9
NR 29
TC 265
Z9 291
U1 2
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 20
PY 2001
VL 98
IS 24
BP 13866
EP 13871
DI 10.1073/pnas.231486598
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 495EW
UT WOS:000172328100072
PM 11698646
ER

PT J
AU Petersen, S
   Casellas, R
   Reina-San-Martin, B
   Chen, HT
   Difilippantonio, MJ
   Wilson, PC
   Hanitsch, L
   Celeste, A
   Muramatsu, M
   Pilch, DR
   Redon, C
   Ried, T
   Bonner, WM
   Honjo, T
   Nussenzweig, MC
   Nussenzweig, A
AF Petersen, S
   Casellas, R
   Reina-San-Martin, B
   Chen, HT
   Difilippantonio, MJ
   Wilson, PC
   Hanitsch, L
   Celeste, A
   Muramatsu, M
   Pilch, DR
   Redon, C
   Ried, T
   Bonner, WM
   Honjo, T
   Nussenzweig, MC
   Nussenzweig, A
TI AID is required to initiate Nbs1/gamma-H2AX focus formation and
   mutations at sites of class switching
SO NATURE
LA English
DT Article
ID DOUBLE-STRAND BREAKS; CYTIDINE DEAMINASE AID; HEAVY-CHAIN SWITCH;
   SOMATIC HYPERMUTATION; B-CELLS; IMMUNOGLOBULIN GENES; DNA-DAMAGE;
   RECOMBINATION; REPAIR; SEQUENCES
AB Class switch recombination (CSR) is a region-specific DNA recombination reaction that replaces one immunoglobulin heavy-chain constant region (CH) gene with another. This enables a single variable (V) region gene to be used in conjunction with different downstream CH genes, each having a unique biological activity. The molecular mechanisms that mediate CSR have not been defined, but activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme, is required for this reaction(1). Here we report that the Nijmegen breakage syndrome protein (Nbs1) and phosphorylated H2A histone family member X (gamma -H2AX, also known as gamma -H2afx), which facilitate DNA double-strand break (DSB) repair(2-4), form nuclear foci at the CH region in the G1 phase of the cell cycle in cells undergoing CSR, and that switching is impaired in H2AX(-/-) mice. Localization of Nbs1 and gamma -H2AX to the IgH locus during CSR is dependent on AID. In addition, AID is required for induction of switch region (S mu)-specific DNA lesions that precede CSR. These results place AID function upstream of the DNA modifications that initiate CSR.
C1 NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.
   NCI, Genet Branch, NIH, Bethesda, MD 20892 USA.
   NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA.
   Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.
   Howard Hughes Med Inst, New York, NY 10021 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Nussenzweig, A (reprint author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7
   Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905
   Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   Downs JA, 2000, NATURE, V408, P1001
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Zhu XD, 2000, NAT GENET, V25, P347
   Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600
   Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2
   Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509
   DUNNICK W, 1989, MOL CELL BIOL, V9, P1850
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Li MJ, 1996, P NATL ACAD SCI USA, V93, P10222, DOI 10.1073/pnas.93.19.10222
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   WINTER E, 1987, EMBO J, V6, P1663
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 30
TC 360
Z9 369
U1 1
U2 9
PU MACMILLAN PUBLISHERS LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD DEC 6
PY 2001
VL 414
IS 6864
BP 660
EP 665
DI 10.1038/414660a
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 498WB
UT WOS:000172535600053
PM 11740565
ER

PT J
AU Honjo, T
   Kinoshita, K
   Muramatsu, M
AF Honjo, T
   Kinoshita, K
   Muramatsu, M
TI Molecular mechanism of class switch recombination: Linkage with somatic
   hypermutation
SO ANNUAL REVIEW OF IMMUNOLOGY
LA English
DT Review
DE AID; RNA editing; transcription; stem-loop structure; nick endonuclease
ID IMMUNOGLOBULIN HEAVY-CHAIN; INDUCED CYTIDINE DEAMINASE;
   DNA-POLYMERASE-ETA; B-CELL LINE; ANTIBODY CLASS SWITCH; GERMINAL CENTER
   FORMATION; MISMATCH REPAIR PROTEIN; ALPHA-DEFICIENT MICE; DOUBLE-STRAND
   BREAKS; HYPER-IGM SYNDROME
AB Class switch recombination (CSR) and somatic hypermutation (SHM) have been considered to be mediated by different molecular mechanisms because both target DNAs and DNA modification products are quite distinct. However, involvement of activation-induced cytidine deaminase (AID) in both CSR and SHM has revealed that the two genetic alteration mechanisms are surprisingly similar. Accumulating data led us to propose the following scenario: AID is likely to be an RNA editing enzyme that modifies an unknown pre-mRNA to generate mRNA encoding a nicking endonuclease specific to the stem-loop structure. Transcription of the S and V regions, which contain palindromic sequences, leads to transient denaturation, forming the stem-loop structure that is cleaved by the AID-regulated endonuclease. Cleaved single-strand tails will be processed by error-prone DNA polymerase-mediated gap-filling or exonuclease-mediated resection. Mismatched bases will be corrected or fixed by mismatch repair enzymes. CSR ends are then ligated by the NHEJ system while SHM nicks are repaired by another ligation system.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp; kkinoshi@mfour.med.kyoto-u.ac.jp;
   muramatu@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR KROESE FGM, 1989, IMMUNOL INVEST, V18, P47, DOI 10.3109/08820138909112226
   GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775
   Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   Bos NA, 1996, INFECT IMMUN, V64, P616
   Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579
   Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5
   Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788
   Phung QH, 1999, J IMMUNOL, V162, P3121
   Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59
   Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   YELAMOS J, 1995, NATURE, V376, P225
   AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121
   Kingzette M, 1998, P NATL ACAD SCI USA, V95, P11840, DOI 10.1073/pnas.95.20.11840
   MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7
   van der Stoep N, 1998, IMMUNITY, V8, P743, DOI 10.1016/S1074-7613(00)80579-8
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717
   Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4
   Dorner T, 1998, EUR J IMMUNOL, V28, P3384
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   Klotz EL, 1998, J IMMUNOL, V161, P782
   Qiu G, 1999, INT IMMUNOL, V11, P37, DOI 10.1093/intimm/11.1.37
   Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   Seidl KJ, 1998, INT IMMUNOL, V10, P1683, DOI 10.1093/intimm/10.11.1683
   Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0
   Carrasco D, 1998, J EXP MED, V187, P973, DOI 10.1084/jem.187.7.973
   Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X
   CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q
   Lin SC, 1998, MOL CELL BIOL, V18, P5523
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   ZHANG J, 1993, EMBO J, V12, P3529
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166
   ARAKAWA H, 1993, J BIOL CHEM, V268, P4651
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
   Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323
   Sun JS, 1997, IMMUNOGENETICS, V46, P452, DOI 10.1007/s002510050305
   BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385
   Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497
   Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025
   COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Linehan LA, 1998, J IMMUNOL, V161, P302
   Kamata T, 2000, J IMMUNOL, V165, P1387
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   Peakman MC, 1998, J IMMUNOL, V161, P4008
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B
   Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x
   BOTTARO A, 1994, EMBO J, V13, P665
   Zan H, 1998, J IMMUNOL, V161, P5217
   Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421
   Matsuda T, 2000, NATURE, V404, P1011
   LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367
   Kong QZ, 1999, MOL IMMUNOL, V36, P83, DOI 10.1016/S0161-5890(99)00027-9
   REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Storb U, 1998, IMMUNOL REV, V162, P153
   Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100
   Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207
   Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447
   Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Foster SJ, 1999, EUR J IMMUNOL, V29, P4011, DOI 10.1002/(SICI)1521-4141(199912)29:12<4011::AID-IMMU4011>3.0.CO;2-W
   Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x
   Iciek LA, 1997, J IMMUNOL, V158, P4769
   BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6
   Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303
   Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689
   XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6
   Zan H, 1999, J IMMUNOL, V162, P3437
   Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000
   Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0
   JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0
   Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540
   Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833
   Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Dorner T, 1997, J IMMUNOL, V158, P2779
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   Wuerffel RA, 1997, J IMMUNOL, V159, P4139
   KROESE FGM, 1995, ADV EXP MED BIOL, V371, P435
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0
   Guinamard R, 2000, NAT IMMUNOL, V1, P31
   Nguyen VK, 1999, MOL IMMUNOL, V36, P515
   Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X
   Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4
   Bachl J, 1996, EUR J IMMUNOL, V26, P870, DOI 10.1002/eji.1830260422
   Bachl J, 1997, EUR J IMMUNOL, V27, P3398, DOI 10.1002/eji.1830271239
   Bachl J, 1998, P NATL ACAD SCI USA, V95, P2396, DOI 10.1073/pnas.95.5.2396
   Ballantyne J, 1998, J IMMUNOL, V161, P1336
   Ballantyne J, 1997, INT IMMUNOL, V9, P963, DOI 10.1093/intimm/9.7.963
   Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509
   Bergthorsdottir S, 2001, J IMMUNOL, V166, P2228
   Bertocci B, 1998, IMMUNITY, V9, P257, DOI 10.1016/S1074-7613(00)80608-1
   Borggrefe T, 1999, EUR J IMMUNOL, V29, P1812, DOI 10.1002/(SICI)1521-4141(199906)29:06<1812::AID-IMMU1812>3.0.CO;2-J
   Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799
   CHEN X, 2001, IN PRESS P NATL ACAD
   CHUNG IK, 1992, NUCLEIC ACIDS RES, V20, P1973, DOI 10.1093/nar/20.8.1973
   Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2
   Dahlenborg K, 2000, IMMUNOLOGY, V101, P210, DOI 10.1046/j.1365-2567.2000.00091.x
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224
   de Waard R, 1998, Dev Immunol, V6, P81, DOI 10.1155/1998/37576
   Diaz M, 2001, J IMMUNOL, V167, P327
   Du J, 1997, NUCLEIC ACIDS RES, V25, P3066, DOI 10.1093/nar/25.15.3066
   DUNNICK W, 1989, MOL CELL BIOL, V9, P1850
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23
   Ezernieks J, 1996, EUR J BIOCHEM, V240, P667, DOI 10.1111/j.1432-1033.1996.0667h.x
   Ferlin WG, 1996, EUR J IMMUNOL, V26, P2911, DOI 10.1002/eji.1830261216
   Ford GS, 1998, J IMMUNOL, V160, P595
   Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397
   Fujieda S, 1996, MOL IMMUNOL, V33, P1335, DOI 10.1016/S0161-5890(96)00092-2
   Goldfarb AN, 1996, MOL IMMUNOL, V33, P947, DOI 10.1016/S0161-5890(96)00047-8
   Goyenechea B, 1996, P NATL ACAD SCI USA, V93, P13979, DOI 10.1073/pnas.93.24.13979
   Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987
   GUATT AL, 2001, SCIENCE, V292, P1876
   Hanakahi LA, 2000, NUCLEIC ACIDS RES, V28, P2651, DOI 10.1093/nar/28.14.2651
   Harriman GR, 1996, J CLIN INVEST, V97, P477, DOI 10.1172/JCI118438
   ISHIGURO H, 1989, FEBS LETT, V247, P317, DOI 10.1016/0014-5793(89)81360-2
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735
   Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5
   Jumper MD, 1996, MOL IMMUNOL, V33, P965, DOI 10.1016/S0161-5890(96)00045-4
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   Kato J, 1998, J IMMUNOL, V160, P4788
   KENTER AL, 1991, MOL CELL BIOL, V11, P4398
   KENTER AL, 1993, J IMMUNOL, V151, P4718
   Kim N, 1997, J EXP MED, V186, P413, DOI 10.1084/jem.186.3.413
   Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21
   KINOSHITA K, 1991, IMMUNOL LETT, V27, P151, DOI 10.1016/0165-2478(91)90143-X
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2
   Kinoshita K, 1999, COLD SPRING HARB SYM, V64, P217, DOI 10.1101/sqb.1999.64.217
   Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8
   Kitao H, 2000, INT IMMUNOL, V12, P959, DOI 10.1093/intimm/12.7.959
   Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01<317::AID-IMMU317>3.0.CO;2-S
   KNIGHT KL, 1987, VET IMMUNOL IMMUNOP, V17, P17, DOI 10.1016/0165-2427(87)90123-1
   KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2
   Kong QZ, 2001, GENETICS, V158, P369
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200
   LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151
   LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154
   Li J, 1996, NUCLEIC ACIDS RES, V24, P2104, DOI 10.1093/nar/24.11.2104
   Li MJ, 1996, P NATL ACAD SCI USA, V93, P10222, DOI 10.1073/pnas.93.19.10222
   Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X
   Li MJ, 1997, EXP CELL RES, V237, P93, DOI 10.1006/excr.1997.3761
   Lin SC, 1996, MOL CELL BIOL, V16, P4591
   Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159
   LUNDGREN M, 1995, EUR J IMMUNOL, V25, P2042, DOI 10.1002/eji.1830250736
   Lyon CJ, 1997, MOL IMMUNOL, V34, P209, DOI 10.1016/S0161-5890(97)00030-8
   Lyon CJ, 1996, MOL IMMUNOL, V33, P157, DOI 10.1016/0161-5890(95)00125-5
   Ma LM, 1997, INT IMMUNOL, V9, P1021, DOI 10.1093/intimm/9.7.1021
   MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117
   Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Messner B, 1997, J IMMUNOL, V159, P3330
   Miao M, 2000, EUR J BIOCHEM, V267, P7237, DOI 10.1046/j.1432-1327.2000.01836.x
   MIRANDA GA, 1995, EXP CELL RES, V217, P294, DOI 10.1006/excr.1995.1090
   Mizoguchi C, 1999, J IMMUNOL, V162, P2812
   MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761
   Monson NL, 2000, EUR J IMMUNOL, V30, P1597, DOI 10.1002/1521-4141(200006)30:6<1597::AID-IMMU1597>3.0.CO;2-R
   Muller JR, 1998, J IMMUNOL, V160, P3337
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   Oprea M, 2001, J IMMUNOL, V166, P892
   OTT DE, 1987, EMBO J, V6, P557
   Ott D E, 1989, Int Immunol, V1, P582, DOI 10.1093/intimm/1.6.582
   Pan Q, 1999, EUR J IMMUNOL, V29, P2779
   Pan Q, 2000, EUR J IMMUNOL, V30, P1019, DOI 10.1002/(SICI)1521-4141(200004)30:4<1019::AID-IMMU1019>3.0.CO;2-W
   Pan Q, 2000, EUR J IMMUNOL, V30, P2388, DOI 10.1002/1521-4141(2000)30:8<2388::AID-IMMU2388>3.0.CO;2-C
   PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329
   Petry Katja, 1999, International Immunology, V11, P753, DOI 10.1093/intimm/11.5.753
   Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307
   RABBITTS TH, 1983, NATURE, V306, P806, DOI 10.1038/306806a0
   Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206
   RADCLIFFE G, 1990, MOL CELL BIOL, V10, P382
   RUDIKOFF S, 1984, P NATL ACAD SCI-BIOL, V81, P2162, DOI 10.1073/pnas.81.7.2162
   Ryffel B, 1997, J IMMUNOL, V158, P2126
   Sakai E, 1999, INT IMMUNOL, V11, P1709, DOI 10.1093/intimm/11.10.1709
   SCHULTE PA, 1991, CANCER EPIDEM BIOMAR, V1, P3
   SEBASTIANI G, 1995, MAMM GENOME, V6, P147, DOI 10.1007/BF00303264
   Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365
   Shen HN, 1997, MOL IMMUNOL, V34, P527, DOI 10.1016/S0161-5890(97)00064-3
   Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067
   Stavnezer J, 1999, J IMMUNOL, V163, P2028
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Strom L, 1999, SCAND J IMMUNOL, V49, P523
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7
   Tokuyama H, 1997, CELL IMMUNOL, V176, P14, DOI 10.1006/cimm.1996.1069
   Venter J.C., 2001, SCIENCE, V291, P1301
   Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471
   Warren WD, 1999, MOL IMMUNOL, V36, P31, DOI 10.1016/S0161-5890(98)00114-X
   WATERS SH, 1989, MOL CELL BIOL, V9, P5594
   Willers J, 1999, IMMUNOBIOLOGY, V200, P150
   WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353
   Winter DB, 1997, MOL IMMUNOL, V34, P359, DOI 10.1016/S0161-5890(97)00073-4
   Wu HY, 1995, EUR J IMMUNOL, V25, P3263, DOI 10.1002/eji.1830251210
   WU TT, 1979, P NATL ACAD SCI USA, V76, P4617, DOI 10.1073/pnas.76.9.4617
   WUERFFEL R, 1992, J EXP MED, V176, P339, DOI 10.1084/jem.176.2.339
   Xie XQ, 1999, EUR J IMMUNOL, V29, P488, DOI 10.1002/(SICI)1521-4141(199902)29:02<488::AID-IMMU488>3.0.CO;2-N
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   XU LZ, 1992, INT IMMUNOL, V4, P875, DOI 10.1093/intimm/4.8.875
   Yanagihara Y, 1997, CELL IMMUNOL, V176, P66, DOI 10.1006/cimm.1996.1071
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   Zelazowski P, 1997, J IMMUNOL, V159, P3133
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
   Zhang Q, 1999, VIROLOGY, V255, P160, DOI 10.1006/viro.1998.9588
NR 256
TC 392
Z9 399
U1 2
U2 17
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0732-0582
J9 ANNU REV IMMUNOL
JI Annu. Rev. Immunol.
PY 2002
VL 20
BP 165
EP 196
DI 10.1146/annurev.immunol.20.090501.112049
PG 34
WC Immunology
SC Immunology
GA 541XV
UT WOS:000175012600008
PM 11861601
ER

PT J
AU Higuchi, T
   Aiba, Y
   Nomura, T
   Matsuda, J
   Mochida, K
   Suzuki, M
   Kikutani, H
   Honjo, T
   Nishioka, K
   Tsubata, T
AF Higuchi, T
   Aiba, Y
   Nomura, T
   Matsuda, J
   Mochida, K
   Suzuki, M
   Kikutani, H
   Honjo, T
   Nishioka, K
   Tsubata, T
TI Cutting edge: Ectopic expression of CD40 ligand on B cells induces
   lupus-like autoimmune disease
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID LYN-DEFICIENT MICE; TRANSGENIC MICE; ERYTHEMATOSUS; RESPONSES; NEPHRITIS
AB CD40 ligand (CD40L) is ectopically expressed on B cells in patients with systemic lupus erythematosus (SLE) and lupus-prone BXSB mice. To assess the role of the ectopic CD40L expression in development of SLE, we have established transgenic mice expressing CD40L on B cells. Some of the 12- to 14-mo-old CD40L-transgenic mice spontaneously produced autoantibodies such as antinuclear Abs, anti-DNA Abs, and antihistone Abs. Moreover, approximately half of the transgenic mice developed glomerulonephritis with immune-complex deposition, whereas the kidneys of the normal littermates showed either no pathological findings or only mild histological changes. These results indicate that CD40L on B cells causes lupus-like disease in the presence of yet unknown environmental factors that by themselves do not induce the disease. Thus, ectopic CD40L expression on B cells may play a crucial role in development of SLE.
C1 Tokyo Med & Dent Univ, Inst Med Res, Dept Immunol, Bunkyo Ku, Tokyo 1138510, Japan.
   Tokyo Med & Dent Univ, Fac Med, Dept Dermatol, Tokyo 1138510, Japan.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 606, Japan.
   Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan.
   Kumamoto Univ, Ctr Anim Resources & Dev, Div Transgen Technol, Kumamoto, Japan.
   Osaka Univ, Res Inst Microbial Dis, Dept Mol Immunol, Osaka, Japan.
RP Tsubata, T (reprint author), Tokyo Med & Dent Univ, Inst Med Res, Dept Immunol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
RI Kikutani, Hitoshi/C-9525-2009
CR Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3
   Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115
   Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4
   Foster MH, 1999, SEMIN NEPHROL, V19, P173
   HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X
   Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953
   Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3
   NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4
   Napirei M, 2000, NAT GENET, V25, P177
   Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56
   SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2
   BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881
   Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697
   vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330
   Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735
   DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643
   Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697
   Cheema GS, 2001, ARTHRITIS RHEUM, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S
   Zhang J, 2001, J IMMUNOL, V166, P6
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   TERBORG EJ, 1990, ARTHRITIS RHEUM, V33, P634, DOI 10.1002/art.1780330505
   Esdaile JM, 1996, ARTHRITIS RHEUM, V39, P370, DOI 10.1002/art.1780390304
   Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111
   Early GS, 1996, J IMMUNOL, V157, P3159
   Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855
   Blossom S, 1997, J IMMUNOL, V159, P4580
   Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7
   KNIGHT JG, 1977, CLIN EXP IMMUNOL, V28, P352
   MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608
   STEINBERG AD, 1991, ANN INTERN MED, V115, P548
   YELLIN MJ, 1994, J IMMUNOL, V152, P598
NR 31
TC 87
Z9 95
U1 1
U2 3
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JAN 1
PY 2002
VL 168
IS 1
BP 9
EP 12
PG 4
WC Immunology
SC Immunology
GA 505UM
UT WOS:000172934000003
PM 11751940
ER

PT J
AU Nakamura, T
   Lozano, PR
   Ikeda, Y
   Iwanaga, Y
   Hinek, A
   Minamisawa, S
   Cheng, CF
   Kobuke, K
   Dalton, N
   Takada, Y
   Tashiro, K
   Ross, J
   Honjo, T
   Chien, KR
AF Nakamura, T
   Lozano, PR
   Ikeda, Y
   Iwanaga, Y
   Hinek, A
   Minamisawa, S
   Cheng, CF
   Kobuke, K
   Dalton, N
   Takada, Y
   Tashiro, K
   Ross, J
   Honjo, T
   Chien, KR
TI Fibulin-5/DANCE is essential for elastogenesis in vivo
SO NATURE
LA English
DT Article
ID EXTRACELLULAR-MATRIX; ELASTIN; ARTERIES
AB The elastic fibre system has a principal role in the structure and function of various types of organs that require elasticity, such as large arteries, lung and skin(1,2). Although elastic fibres are known to be composed of microfibril proteins (for example, fibrillins and latent transforming growth factor (TGF)-beta -binding proteins) and polymerized elastin, the mechanism of their assembly and development is not well understood. Here we report that fibulin-5 (also known as DANCE), a recently discovered integrin ligand(3), is an essential determinant of elastic fibre organization. fibulin-5(-/-) mice generated by gene targeting exhibit a severely disorganized elastic fibre system throughout the body. fibulin-5(-/-) mice survive to adulthood, but have a tortuous aorta with loss of compliance, severe emphysema, and loose skin (cutis laxa). These tissues contain fragmented elastin without an increase of elastase activity, indicating defective development of elastic fibres. Fibulin-5 interacts directly with elastic fibres in vitro, and serves as a ligand for cell surface integrins alphav beta3, alphav beta5 and alpha9 beta1 through its aminoterminal domain. Thus, fibulin-5 may provide anchorage of elastic fibres to cells, thereby acting to stabilize and organize elastic fibres in the skin, lung and vasculature.
C1 Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA.
   Univ Calif San Diego, UCSD Inst Mol Med, La Jolla, CA 92093 USA.
   Scripps Res Inst, La Jolla, CA 92037 USA.
   Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068501, Japan.
RP Chien, KR (reprint author), Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA.
CR Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920
   Shattil SJ, 1997, J CLIN INVEST, V100, pS91
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1
   Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Robert L, 1998, GERONTOLOGY, V44, P307, DOI 10.1159/000022034
   DOBRIN PB, 1990, J SURG RES, V48, P116, DOI 10.1016/0022-4804(90)90202-D
   Dietz HC, 2000, MATRIX BIOL, V19, P481, DOI 10.1016/S0945-053X(00)00101-3
   Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8
   Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476
   Eto B, 2000, J BIOL CHEM, V275, P34922
   FAZIO MJ, 1989, CUTIS, V43, P437
   FEIGENBAUM H, 1995, ECOCARDIOGRAPHY
   LABATROBERT J, 1988, EXP GERONTOL, V23, P5, DOI 10.1016/0531-5565(88)90015-0
   Piquette CA, 2000, TXB RESP MED, P1187
   RAPAPORT E, 2000, TXB RESP MED, P1631
   Robb BW, 1999, MOL BIOL CELL, V10, P3595
   ROSENBLOOM J, 1993, FASEB J, V7, P1208
   SENIOR RM, 1998, PULMONARY DIS DISORD, P659
   Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413
   YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691
   Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345
NR 23
TC 337
Z9 358
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD JAN 10
PY 2002
VL 415
IS 6868
BP 171
EP 175
DI 10.1038/415171a
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 509PR
UT WOS:000173159300042
PM 11805835
ER

PT J
AU Kanatsu-Shinohara, M
   Ogura, A
   Ikegawa, M
   Inoue, K
   Ogonuki, N
   Tashiro, K
   Toyokuni, S
   Honjo, T
   Shinohara, T
AF Kanatsu-Shinohara, M
   Ogura, A
   Ikegawa, M
   Inoue, K
   Ogonuki, N
   Tashiro, K
   Toyokuni, S
   Honjo, T
   Shinohara, T
TI Adenovirus-mediated gene delivery and in vitro microinsemination produce
   offspring from infertile male mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID MOUSE SPERMATOGENIC CELLS; TYROSINE KINASE RECEPTOR; LINE STEM-CELLS;
   C-KIT; RECOMBINANT ADENOVIRUS; SEMINIFEROUS TUBULES; PROTO-ONCOGENE;
   SERTOLI-CELL; IN-VIVO; W-LOCUS
AB Sertoli cells play a pivotal role in spermatogenesis through their interactions with germ cells. To set up a strategy for treating male infertility caused by Sertoli cell dysf unction, we developed a Sertoli cell gene transfer system by using an adenovirus vector, which maintained long-term transgene expression in the testes of infertile mice. Introduction of an adenovirus carrying the mouse Steel (Sl) gene into Sertoli cells restored partial spermatogenesis in infertile Steel/Steel(dickie) (Sl/Sl(d)) mutant mouse testes. Although these males remained infertile, round spermatids and spermatozoa from the testes produced normal fertile offspring after intracytoplasmic injection into oocytes. None of the offspring showed evidence of germ line transmission of adenoviral DNA. Thus, we demonstrate a successful treatment for infertility by using a gene therapy vector. Therefore, adenovirus-mediated gene delivery into Sertoli cells not only provides an efficient and convenient means for studying germ cell-Sertoli cell interactions through manipulation of the germ cell microenvironment in vivo, but also is a useful method to treat male infertility resulting from a Sertoli cell defect.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Kyoto 6068507, Japan.
   Natl Inst Infect Dis, Dept Vet Sci, Tokyo 1628640, Japan.
RP Shinohara, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RI Toyokuni, Shinya/C-1358-2010; Ogura, Atsuo/J-3916-2014
OI Toyokuni, Shinya/0000-0002-5757-1109; Ogura, Atsuo/0000-0003-0447-1988
CR Silber SJ, 2000, FERTIL STERIL, V73, P897, DOI 10.1016/S0015-0282(00)00488-X
   Blanchard KT, 1997, BIOL REPROD, V56, P495, DOI 10.1095/biolreprod56.2.495
   NIWA H, 1991, GENE, V108, P193
   Ogawa T, 2000, NAT MED, V6, P29
   Ogawa T, 1997, INT J DEV BIOL, V41, P111
   SILBER SJ, 1995, HUM REPROD, V10, P1031
   ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U
   BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298
   GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7
   Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0
   Ohta H, 2000, DEVELOPMENT, V127, P2125
   Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655
   BELLVE AR, 1993, METHOD ENZYMOL, V225, P84
   BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832
   BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0
   YOSHINAGA K, 1991, DEVELOPMENT, V113, P689
   Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927
   DELCASTILLO EB, 1947, J CLIN ENDOCRINOL, V7, P493
   FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T
   KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816
   Escalier D, 2001, HUM REPROD UPDATE, V7, P191, DOI 10.1093/humupd/7.2.191
   Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144
   BARKER CF, 1977, ADV IMMUNOL, V25, P1
   BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1
   Silber SJ, 1998, HUM REPROD, V13, P509, DOI 10.1093/humrep/13.3.509
   PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F
   KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709
   CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0
   Nagano M, 2000, FEBS LETT, V475, P7, DOI 10.1016/S0014-5793(00)01606-9
   SELAWRY HP, 1993, CELL TRANSPLANT, V2, P123
   YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759
   Hall SJ, 2000, HUM GENE THER, V11, P1705, DOI 10.1089/10430340050111359
   HULL MGR, 1985, BRIT MED J, V291, P1693
   Kim JH, 1997, MOL REPROD DEV, V46, P515, DOI 10.1002/(SICI)1098-2795(199704)46:4<515::AID-MRD10>3.0.CO;2-V
   Kuroda-Kawaguchi Tomoko, 2001, Nature Genetics, V29, P279, DOI 10.1038/ng757
   MENG X, 2002, IN PRESS BIOL REPROD
   Menke DB, 1997, AM J HUM GENET, V60, P237
   NAKAYAMA H, 1988, DEVELOPMENT, V102, P117
   Ogura A, 1999, HUM REPROD, V14, P1294, DOI 10.1093/humrep/14.5.1294
   Ogura A, 1996, THERIOGENOLOGY, V45, P1141, DOI 10.1016/0093-691X(96)00070-2
   Russell LD, 1990, HISTOLOGICAL HISTOPA, P1
   SANBERG PR, 1999, TISSUE, V31, P461
   Silber SJ, 1997, HUM REPROD, V12, P2422, DOI 10.1093/humrep/12.11.2422
   Silber SJ, 2000, CLIN OBSTET GYNECOL, V43, P854, DOI 10.1097/00003081-200012000-00017
   SILVERS WK, 1979, COAT COLORS MICE MOD, P242
   Vincent S, 1998, DEVELOPMENT, V125, P4585
   WIVEL NA, 1999, DEV HUMAN GENE THERA, P87
   Yamazaki Y, 1998, BIOL REPROD, V59, P1439, DOI 10.1095/biolreprod59.6.1439
   Ye XH, 1998, HUM GENE THER, V9, P2135, DOI 10.1089/hum.1998.9.14-2135
NR 49
TC 45
Z9 48
U1 1
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 5
PY 2002
VL 99
IS 3
BP 1383
EP 1388
DI 10.1073/pnas.022646399
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 519YF
UT WOS:000173752500053
PM 11818536
ER

PT J
AU Nagaoka, H
   Muramatsu, M
   Yamamura, N
   Kinoshita, K
   Honjo, T
AF Nagaoka, H
   Muramatsu, M
   Yamamura, N
   Kinoshita, K
   Honjo, T
TI Activation-induced deaminase (AID)-directed hypermutation in the
   immunoglobulin S mu region: Implication of AID involvement in a common
   step of class switch recombination and somatic hypermutation
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE B lymphocyte; immunoglobulin gene; heavy chain; DNA cleavage;
   error-prone repair
ID DOUBLE-STRAND BREAKS; MEMORY B-CELLS; GENE; SEQUENCES; DIFFERENTIATION;
   MUTATION; SITES; IG
AB Somatic hypermutation (SHM) and class switch recombination (CSR) cause distinct genetic alterations at different regions of immunoglobulin genes in B lymphocytes: point mutations in variable regions and large deletions in S regions, respectively. Yet both depend on activation-induced deaminase (AID), the function of which in the two reactions has been an enigma. Here we report that B cell stimulation which induces CSR but not SHM, leads to AID-dependent accumulation of SHM-like point mutations in the switch mu region, uncoupled with CSR. These findings strongly suggest that AID itself or a single molecule generated by RNA editing function of AID may mediate a common step of SHM and CSR, which is likely to be involved in DNA cleavage.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0
   Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732
   Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509
   Bergthorsdottir S, 2001, J IMMUNOL, V166, P2228
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   KINSOHITA K, 2001, NAT REV MOL CELL BIO, V2, P493
   Kong QZ, 2001, GENETICS, V158, P369
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159
   MANSER T, 1987, J IMMUNOL, V139, P234
   MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   Ramsden DA, 1997, CURR OPIN IMMUNOL, V9, P114, DOI 10.1016/S0952-7915(97)80167-7
   RUDIKOFF S, 1984, P NATL ACAD SCI-BIOL, V81, P2162, DOI 10.1073/pnas.81.7.2162
   SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   WINTER E, 1987, EMBO J, V6, P1663
NR 34
TC 131
Z9 132
U1 1
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD FEB 18
PY 2002
VL 195
IS 4
BP 529
EP 534
DI 10.1084/jem.20012144
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 560ZA
UT WOS:000176110200014
PM 11854365
ER

PT J
AU Carter, LL
   Fouser, LA
   Jussif, J
   Fitz, L
   Deng, B
   Wood, CR
   Collins, M
   Honjo, T
   Freeman, GJ
   Carreno, BM
AF Carter, LL
   Fouser, LA
   Jussif, J
   Fitz, L
   Deng, B
   Wood, CR
   Collins, M
   Honjo, T
   Freeman, GJ
   Carreno, BM
TI PD-1 : PD-L inhibitory pathway affects both CD4(+)and CD8(+) T cells and
   is overcome by IL-2
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE PD-1; PD-L1; inhibitory receptor
ID IN-VIVO; LYMPHOCYTE RESPONSE; ANTIGEN RECEPTOR; TRANSGENIC MICE; CUTTING
   EDGE; B7 FAMILY; CTLA-4; ACTIVATION; PROLIFERATION; ANERGY
AB Programmed death-1 (PD-1) is an immunoreceptor tyrosine-based inhibitory motif (ITIM)containing receptor expressed upon T cell activation. PD-1(-/-) animals develop autoimmune diseases, suggesting an inhibitory role for PD-1 in immune responses. Members of the B7 family, PD-L1 and PD-L2, are ligands for PD-1. This study examines the functional consequences of PD-1:PD-L engagement on murine CD4 and CD8 T cells and shows that these interactions result in inhibition of proliferation and cytokine production. T cells stimulated with anti-CD3/PD-L1. Fc-coated beads display dramatically decreased proliferation and IL-2 production, while CSFE analysis shows fewer cells cycling and a slower division rate. Costimulation with soluble anti-CD28 mAb can overcome PD-1-mediated inhibition by augmenting IL-2 production. However, PD-1:PD-L interactions inhibit IL-2 production even in the presence of costimulation and, thus, after prolonged activation, the PD-1:PD-L inhibitory pathway dominates. Exogenous IL-2 is able to overcome PD-L1-mediated inhibition at all times, indicating that cells maintain IL-2 responsiveness. Experiments using TCR transgenic CD4(+) or CD8(+) T cells stimulated with antigen-presenting cells expressing PD-L1 show that both T cell subsets are susceptible to this inhibitory pathway. However, CD8(+) T cells may be more sensitive to modulation by the PD-1:PD-L pathway because of their intrinsic inability to produce significant levels of IL-2.
C1 Wyeth Genet Inst Inc, Cambridge, MA 02140 USA.
   Kyoto Univ, Grad Sch Med, Kyoto, Japan.
   Harvard Med Sch, Dana Farber Canc Res Inst, Boston, MA USA.
RP Carter, LL (reprint author), Wyeth Genet Inst Inc, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.
CR Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144
   KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459
   Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7
   Whitmire JK, 1996, J VIROL, V70, P8375
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Chambers CA, 1998, EUR J IMMUNOL, V28, P3137, DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.3.CO;2-O
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809
   Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533
   Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47
   Ugolini S, 2001, NAT IMMUNOL, V2, P430
   Dong HD, 1999, NAT MED, V5, P1365
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1
   Brunner MC, 1999, J IMMUNOL, V162, P5813
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9
   SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   JENKINS MK, 1991, J IMMUNOL, V147, P2461
   Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0
   Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.3.CO;2-O
   Bachmann MF, 1998, J IMMUNOL, V160, P95
   BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661
   Blair PJ, 1998, J IMMUNOL, V160, P12
   Chambers CA, 1999, P NATL ACAD SCI USA, V96, P8603, DOI 10.1073/pnas.96.15.8603
   Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO;2-X
   Cook JR, 1997, IMMUNITY, V7, P233, DOI 10.1016/S1074-7613(00)80526-9
   Dubois PM, 1998, J IMMUNOL, V161, P5260
   Hayashi RJ, 1998, J IMMUNOL, V160, P33
   Maier CC, 1998, IMMUNOL RES, V17, P133, DOI 10.1007/BF02786438
   Peacock CD, 2000, J VIROL, V74, P7032, DOI 10.1128/JVI.74.15.7032-7038.2000
   Ranganath S, 1998, J IMMUNOL, V161, P3822
   Siegel RM, 1999, J ALLERGY CLIN IMMUN, V103, P729, DOI 10.1016/S0091-6749(99)70412-4
NR 41
TC 310
Z9 352
U1 2
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD MAR
PY 2002
VL 32
IS 3
BP 634
EP 643
DI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
PG 10
WC Immunology
SC Immunology
GA 531VY
UT WOS:000174439000005
PM 11857337
ER

PT J
AU Taniguchi, Y
   Karlstrom, H
   Lundkvist, J
   Mizutani, T
   Otaka, A
   Vestling, M
   Bernstein, A
   Donoviel, D
   Lendahl, U
   Honjo, T
AF Taniguchi, Y
   Karlstrom, H
   Lundkvist, J
   Mizutani, T
   Otaka, A
   Vestling, M
   Bernstein, A
   Donoviel, D
   Lendahl, U
   Honjo, T
TI Notch receptor cleavage depends on but is not directly executed by
   presenilins
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID GAMMA-SECRETASE INHIBITORS; AMYLOID PRECURSOR PROTEIN; INTRACELLULAR
   DOMAIN; PROTEOLYTIC RELEASE; ALZHEIMERS-DISEASE; NUCLEAR ACCESS;
   DROSOPHILA; ACTIVATION; EMBRYOS
AB Notch receptors undergo three distinct proteolytic cleavages during maturation and activation. The third cleavage occurs within the plasma membrane and results in the release and translocation of the intracellular domain into the nucleus to execute Notch signaling. This so-called gamma-secretase cleavage is under the control of presenilins, but it is not known whether presenilins themselves carry out the cleavage or whether they act by means of yet unidentified gamma-secretase(s). In this article, we show that Notch intracellular cleavage in intact cells completely depends on presenilins. In contrast, partial purification of the Notch cleavage activity reveals an activity, which is present only in protein extracts from presenilin-containing cells, and which does not comigrate With presenilin. This finding provides evidence for the existence of a specific Notch-processing activity, which is physically distinct from presenilins. We conclude from these experiments that presenilins are critically required for Notch intracellular cleavage but are not themselves directly mediating the cleavage.
C1 Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.
   Kyoto Univ, Dept Med Chem, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Pharmaceut Sci, Fac Med, Sakyo Ku, Kyoto 6068501, Japan.
   Karolinska Inst, Neurotec, Novum, Kliniskt Forsknings Ctr,Med Nobel Inst, SE-17177 Stockholm, Sweden.
   Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.
RP Lendahl, U (reprint author), Karolinska Inst, Dept Cell & Mol Biol, Von Eulers Vag 3, SE-17177 Stockholm, Sweden.
RI Taniguchi, Yoshihito/L-5746-2013; 
OI Karlstrom, Helena/0000-0002-0498-2473; Lendahl,
   Urban/0000-0001-9543-8141
CR De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083
   Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900
   Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091
   Schroeter EH, 1998, NATURE, V393, P382
   Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683
   Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801
   Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7
   Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200
   Li YM, 2000, NATURE, V405, P689
   Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959
   Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581
   Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9
   Huppert SS, 2000, NATURE, V405, P966
   Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728
   Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872
   Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5
   Ye YH, 1999, NATURE, V398, P525
   Zhang ZH, 2000, NAT CELL BIOL, V2, P463
   Capell A, 2000, NAT CELL BIOL, V2, P205
   Esler WP, 2000, NAT CELL BIOL, V2, P428
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Beatus P, 1999, DEVELOPMENT, V126, P3925
   Berechid BE, 1999, CURR BIOL, V9, P1493, DOI 10.1016/S0960-9822(00)80121-9
   Frisen J, 2001, BIOESSAYS, V23, P3, DOI 10.1002/1521-1878(200101)23:1<3::AID-BIES1001>3.0.CO;2-F
   LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0
   Selkoe D. J., 1999, NATURE S, V399, P23
NR 28
TC 43
Z9 45
U1 1
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 19
PY 2002
VL 99
IS 6
BP 4014
EP 4019
DI 10.1073/pnas.052017699
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 533CC
UT WOS:000174511000116
PM 11891288
ER

PT J
AU Alaverdi, N
   Iwai, Y
   Honjo, T
AF Alaverdi, N
   Iwai, Y
   Honjo, T
TI Mouse PD-1 expression and function
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Kyoto Univ, Kyoto 6068502, Japan.
   eBioscience, San Diego, CA 92121 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 20
PY 2002
VL 16
IS 4
BP A710
EP A710
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 533MG
UT WOS:000174533603942
ER

PT J
AU Okazaki, IM
   Kinoshita, K
   Muramatsu, M
   Yoshikawa, K
   Honjo, T
AF Okazaki, IM
   Kinoshita, K
   Muramatsu, M
   Yoshikawa, K
   Honjo, T
TI The AID enzyme induces class switch recombination in fibroblasts
SO NATURE
LA English
DT Article
ID CYTIDINE DEAMINASE AID; B-CELLS; S-REGIONS; GENE; HYPERMUTATION;
   SPECIFICITY; EXPRESSION; SEQUENCES; SITES
AB The switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA is mediated by class switch recombination (CSR). CSR changes the immunoglobulin heavy chain constant region (C-H) gene from Cmu to one of the other C-H genes(1,2). Somatic hypermutation introduces massive numbers of point mutations in the immunoglobulin variable (V) region gene, giving rise to immunoglobulin with higher affinity(3). Activation-induced cytidine deaminase (AID), a putative RNA-editing cytidine deaminase, is expressed strictly in activated B cells and is indispensable in both CSR and somatic hypermutation(4,5). But the exact function of AID is unknown. Here we show that ectopic expression of AID induces CSR in an artificial switch construct in fibroblasts at a level comparable to that in stimulated B cells. Sequences around recombination junctions in the artificial substrate have features similar to endogenous CSR junctions. Furthermore, AID-induced CSR in fibroblasts is dependent on transcription of the target S region, as shown in endogenous CSR in B cells. The results show that AID is the only B-cell-specific factor required for initiation of the CSR reaction in the activated locus.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   ZHANG J, 1993, EMBO J, V12, P3529
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   Kitamura T, 1998, INT J HEMATOL, V67, P351
   Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   LUPTON SD, 1991, MOL CELL BIOL, V11, P3374
   OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   WINTER E, 1987, EMBO J, V6, P1663
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 30
TC 186
Z9 189
U1 2
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD MAR 21
PY 2002
VL 416
IS 6878
BP 340
EP 345
DI 10.1038/nature727
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 532NP
UT WOS:000174482200048
PM 11875397
ER

PT J
AU Watanabe, N
   Ikuta, K
   Okazaki, K
   Nakase, H
   Tabata, Y
   Matsuura, M
   Tamaki, H
   Honjo, T
   Chiba, T
AF Watanabe, N
   Ikuta, K
   Okazaki, K
   Nakase, H
   Tabata, Y
   Matsuura, M
   Tamaki, H
   Honjo, T
   Chiba, T
TI Elimination of local macrophages in the intestine prevents chronic
   colitis in interleukin-10 deficient mice
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD APR
PY 2002
VL 122
IS 4
SU 1
MA M1081
BP A266
EP A266
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 548AW
UT WOS:000175366601361
ER

PT J
AU Tanigakik, K
   Han, H
   Yamamoto, N
   Tashiro, K
   Ikegawa, M
   Kuroda, K
   Suzuki, A
   Nakano, T
   Honjo, T
AF Tanigakik, K
   Han, H
   Yamamoto, N
   Tashiro, K
   Ikegawa, M
   Kuroda, K
   Suzuki, A
   Nakano, T
   Honjo, T
TI Notch-RBP-J signaling is involved in cell fate determination of marginal
   zone B cells
SO NATURE IMMUNOLOGY
LA English
DT Article
ID TRANSCRIPTION FACTOR; NUCLEAR ANTIGEN-2; GENE-EXPRESSION; KAPPA-B; MICE;
   DIFFERENTIATION; ACTIVATION; RECOMBINATION; PATHWAY; CONSERVATION
AB RBP-J is a key mediator of Notch signaling that regulates cell fate determination in various lineages. To investigate the function of Notch-RBP-J in mature B cell differentiation, we generated mice that selectively lacked B cell RBP-J expression using conditional mutagenesis. Absence of RBP-J led to the loss of marginal zone B (MZB) cells with a concomitant increase in follicular B cells; in contrast, B I cells in the peritoneal cavity were unaffected. Lack of RBP-J caused no defects in B cells maintenance, survival, plasma cell differentiation or activation. It is therefore likely that Notch-RBP-J signaling regulates the lineage commitment of mature B cells into follicular versus MZB cells. In addition, in mice with RBP-J-deficient B cells, had no obvious changes in immunoglobulin production in response to Ficoll, lipopolysaccharide or chicken gammaglobulin. In contrast, these mice exhibited increased mortality rates after blood-borne bacterial infection, which indicates that MZB cells play pivotal roles in the clearance of these bacteria.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan.
   Akita Univ, Sch Med, Dept Biochem, Akita 0108543, Japan.
   Osaka Univ, Microbial Dis Res Inst, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
OI , Norio/0000-0001-8924-0710
CR Strobl LJ, 2000, J VIROL, V74, P1727, DOI 10.1128/JVI.74.4.1727-1735.2000
   Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   NAKANE A, 1995, INFECT IMMUN, V63, P1165
   Schroeter EH, 1998, NATURE, V393, P382
   Sato S, 1997, J IMMUNOL, V158, P4662
   Radkov SA, 1997, J VIROL, V71, P8552
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4
   Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175
   Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317
   Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75
   Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Roark JH, 1998, J IMMUNOL, V160, P3121
   Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2
   Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   OKA C, 1995, DEVELOPMENT, V121, P3291
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365
   Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3
   Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855
   KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816
   Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3
   Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8
   Weih DS, 2001, J IMMUNOL, V167, P1909
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000
   DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559
   Guinamard R, 2000, NAT IMMUNOL, V1, P31
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033
   DEVOS T, 1991, J IMMUNOL METHODS, V141, P285, DOI 10.1016/0022-1759(91)90155-9
   HUA H, 2002, IN PRESS INT IMMUNOL
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   KURODA K, 1999, J BIOL CHEM, V274, P72138
   Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.0.CO;2-P
   Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200
   Morimura T, 2001, J IMMUNOL, V166, P3277
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621
   WON WJ, 2000, FASEB J, V14, P1191
NR 51
TC 278
Z9 282
U1 1
U2 11
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD MAY
PY 2002
VL 3
IS 5
BP 443
EP 450
DI 10.1038/ni793
PG 8
WC Immunology
SC Immunology
GA 548VU
UT WOS:000175411200012
PM 11967543
ER

PT J
AU Bross, L
   Muramatsu, M
   Kinoshita, K
   Honjo, T
   Jacobs, H
AF Bross, L
   Muramatsu, M
   Kinoshita, K
   Honjo, T
   Jacobs, H
TI DNA double-strand breaks: Prior to but not sufficient in targeting
   hypermutation
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE AID; class-switch recombination; DSB; Ig lambda; somatic hypermutation
ID CYTIDINE DEAMINASE AID; RNA EDITING ENZYME; B MESSENGER-RNA; SOMATIC
   HYPERMUTATION; IMMUNOGLOBULIN GENES; MOLECULAR-CLONING; IN-VIVO;
   TRANSCRIPTION; CHAINS; MUTATIONS
AB The activation-induced cytidine deaminase (AID) is required for somatic hypermutation (SHM) and class-switch recombination (CSR) of immunoglobulin (Ig) genes, both of which are associated with DNA double-strand breaks (DSBs). As AID is capable of deaminating deoxy-cytidine (dC) to deoxy-uracil (dU), it might induce nicks (single strand DNA breaks) and also DNA DSBs via a U-DNA glycosylase-mediated base excision repair pathway ('DNA-substrate model'). Alternatively, AID functions like its closest homologue Apobec1 as a catalytic subunit of a RNA editing holoenzyme ('RNA-substrate model'). Although rearranged Vlambda genes are preferred targets of SHM we found that germinal center (GC) B cells of AID-proficient and -deficient Vlambda1-expressing GC B cells display a similar frequency, distribution, and sequence preference of DSBs in rearranged and also in germline Vlambda1 genes. The possible roles of DSBs in relation to AID function and SHM are discussed.
C1 Univ Maastricht, Res Inst Growth & Dev, Dept Immunol, NL-6200 MD Maastricht, Netherlands.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Basel Inst Immunol, CH-4005 Basel, Switzerland.
RP Jacobs, H (reprint author), Univ Maastricht, Res Inst Growth & Dev, Dept Immunol, Univ Singel 50, NL-6200 MD Maastricht, Netherlands.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   YELAMOS J, 1995, NATURE, V376, P225
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   Storm G, 1998, PHARM SCI TECHNOL TO, V1, P19, DOI 10.1016/S1461-5347(98)00007-8
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
   WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Azuma T, 1998, IMMUNOL REV, V162, P97, DOI 10.1111/j.1600-065X.1998.tb01433.x
   Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O
   Friedberg EC, 1995, DNA REPAIR MUTAGENES
   Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735
   Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5
   Kong QZ, 2001, GENETICS, V158, P369
   Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200
   Lo AKF, 1997, ANN NY ACAD SCI, V815, P432, DOI 10.1111/j.1749-6632.1997.tb52095.x
   Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27
   Reynaud CA, 2001, PHILOS T ROY SOC B, V356, P91
   WEISS S, 1987, EMBO J, V6, P927
   Winter DB, 1998, IMMUNOL REV, V162, P89, DOI 10.1111/j.1600-065X.1998.tb01432.x
   ZOU YR, 1993, SCIENCE, V262, P1271, DOI 10.1126/science.8235658
NR 32
TC 59
Z9 59
U1 1
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 6
PY 2002
VL 195
IS 9
BP 1187
EP 1192
DI 10.1084/jem.20011749
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 560ZF
UT WOS:000176110700010
PM 11994423
ER

PT J
AU Han, H
   Tanigaki, K
   Yamamoto, N
   Kuroda, K
   Yoshimoto, M
   Nakahata, T
   Ikuta, K
   Honjo, T
AF Han, H
   Tanigaki, K
   Yamamoto, N
   Kuroda, K
   Yoshimoto, M
   Nakahata, T
   Ikuta, K
   Honjo, T
TI Inducible gene knockout of transcription factor recombination signal
   binding protein-J reveals its essential role in T versus B lineage
   decision
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE gene targeting; Notch; RBP-J; T-lymphocyte
ID MOUSE BONE-MARROW; CELL FATE SPECIFICATION; RBP-J-KAPPA; THYMOCYTE
   DEVELOPMENT; CUTTING EDGE; ALPHA-BETA; NOTCH; THYMUS; MICE; CD4
AB The transcription factor recombination signal binding protein-J (RBP-J) functions immediately downstream of the cell surface receptor Notch and mediates transcriptional activation by the intracellular domain of all four kinds of Notch receptors. To investigate the function of RBP-J, we introduced loxP sites on both sides of the RBP-J exons encoding its DNA binding domain. Mice bearing the loxP-flanked RBP-J alleles, RBP-J(f/f), were mated with Mx-Cre transgenic mice and deletional mutation of the RBP-J gene in adult mice was induced by injection of the IFN-alpha inducer poly(I)-poly(C). Here we show that inactivation of RBP-J in bone marrow resulted in a block of T cell development at the earliest stage and increase of B cell development in the thymus. Lymphoid progenitors deficient in RBP-J differentiate into B but not T cells when cultured in 2'-deoxyguanosine-treated fetal thymic lobes by hanging-drop fetal thymus organ culture. Competitive repopulation assay also revealed cell autonomous deficiency of T cell development from bone marrow of RBP-J knockout mouse. Myeloid and B lineage differentiation appears normal in the bone marrow of RBP-J-inactivated mice. These results suggest that RBP-J, probably by mediating Notch signaling, controls T versus B cell fate decision in lymphoid progenitors.
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
   Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
RI Yoshimoto, Momoko/N-4238-2014; 
OI Yoshimoto, Momoko/0000-0002-7272-6682; , Norio/0000-0001-8924-0710
CR Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3
   Jehn BM, 1999, J IMMUNOL, V162, P635
   Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283
   Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664
   Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2
   Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3
   Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017
   Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213
   Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   Ordentlich P, 1998, MOL CELL BIOL, V18, P2230
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3
   Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29
   Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X
   Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5
   Milner LA, 1999, BLOOD, V93, P2431
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498
   Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X
   Haks MC, 1999, SEMIN IMMUNOL, V11, P23, DOI 10.1006/smim.1998.0153
   HANDLAND BK, 2001, P NATL ACAD SCI USA, V98, P7487
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Jimenez E, 2001, J IMMUNOL, V166, P5898
   Kaneta M, 2000, J IMMUNOL, V164, P256
   KAWAICHI M, 1992, J BIOL CHEM, V267, P4016
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   MacDonald HR, 2001, CURR OPIN IMMUNOL, V13, P219, DOI 10.1016/S0952-7915(00)00207-7
   MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155
   Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5
   PEAULT B, 1994, EUR J IMMUNOL, V24, P781, DOI 10.1002/eji.1830240345
   PUI JC, 1999, IMMUNITY, V11, P199
   Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9
   Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203
   Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7
   Wilson A, 2000, J IMMUNOL, V165, P5397
   WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617
NR 48
TC 322
Z9 331
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUN
PY 2002
VL 14
IS 6
BP 637
EP 645
DI 10.1093/intimm/dxf030
PG 9
WC Immunology
SC Immunology
GA 557MJ
UT WOS:000175912100011
PM 12039915
ER

PT J
AU Yoshikawa, K
   Okazaki, IM
   Eto, T
   Kinoshita, K
   Muramatsu, M
   Nagaoka, H
   Honjo, T
AF Yoshikawa, K
   Okazaki, IM
   Eto, T
   Kinoshita, K
   Muramatsu, M
   Nagaoka, H
   Honjo, T
TI AID enzyme-induced hypermutation in an actively transcribed gene in
   fibroblasts
SO SCIENCE
LA English
DT Article
ID CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; B-CELL LINE; SOMATIC
   HYPERMUTATION; SEQUENCES; MUTATION; MUTAGENESIS; TARGETS
AB Activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme, is indispensable for somatic hypermutation (SHM), class switch recombination, and gene conversion of immunoglobulin genes, which indicates a common molecular mechanism for these phenomena. Here we show that ectopic expression of AID alone can induce hypermutation in an artificial GFP substrate in NIH 3T3 murine fibroblast cells. The frequency of mutations was closely correlated with the level of transcription of the target gene, and the distribution of mutations in NIH 3T3 cells was similar to those of SHM in B lymphocytes. These results indicate that AID is sufficient for the generation of SHIM in an actively transcribed gene in fibroblasts, as well as B cells, and that any of the required cofactors must be present in these fibroblasts.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Martin A, 2002, NATURE, V415, P802
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9
   Spencer J, 1999, J IMMUNOL, V162, P6596
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Smith DS, 1996, J IMMUNOL, V156, P2642
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851
   FUGGMAN SD, 2002, SCIENCE, V295, P1244
   Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009
   KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   YOSHIKAWA K, UNPUB
NR 28
TC 273
Z9 277
U1 1
U2 6
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD JUN 14
PY 2002
VL 296
IS 5575
BP 2033
EP 2036
DI 10.1126/science.1071556
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563UD
UT WOS:000176273300055
PM 12065838
ER

PT J
AU Watanabe, N
   Ikuta, K
   Nisitani, S
   Chiba, T
   Honjo, T
AF Watanabe, N
   Ikuta, K
   Nisitani, S
   Chiba, T
   Honjo, T
TI Activation and differentiation of autoreactive B-1 cells by interleukin
   10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte
   immunoglobulin transgenic mice
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE autoantigen; autoantibody; B cell tolerance; autoimmune
   lymphoproliferative syndrome; peritoneal cavity
ID LYMPHOPROLIFERATIVE SYNDROME; B-CELLS; T-CELLS; DISEASE; EXPRESSION;
   APOPTOSIS; IL-10; LPR
AB The Fas (CD95) gene is among critical genetic factors in some autoimmune diseases, which are characterized by autoantibody (autoAb) productions. In mice, mutations in the Fas gene cause lymphoproliferation (lpr) which predominantly develops glomerulonephritis, whereas the mutations in human cause autoimmune lymphoproliferative syndrome (ALPS) characterized by autoimmune hemolytic anemia (AIHA) and thrombocytopenia. Although the mechanism of antinuclear Ab in Fas-deficient background has been well characterized, that of antierythrocyte Ab production in ALPS has been still unclear. To investigate this mechanism, we developed a mouse line by crossing the antierythrocyte antibody transgenic mice (H+L6 mice) and Fas-deficient mice. Although Fas deficiency did not break tolerance of autoreactive B-2 cells in H+L6 mice, autoreactive B-1 cells in Fas-deficient H+L6 homozygous mice became activated and differentiated into autoAb-producing cells in mesenteric lymph nodes and lamina propria of intestine, resulting in severe anemia. In addition, serum levels of interleukin (IL)-10 significantly increased in Fas(-/-) X H+L6 homozygous mice and administration of anti-IL-10 Ab prevented exacerbation of autoAb production and AIHA. These results suggest that activation of B-1 cells is responsible for induction of AIHA in Fas-deficient condition and that IL-10 plays a critical role in terminal differentiation of B-1 cells in these mice.
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Sakyo Ku, Kyoto 6068507, Japan.
RP Ikuta, K (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Yoshida, Kyoto 6068501, Japan.
CR ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Watanabe N, 1999, J EXP MED, V190, P461, DOI 10.1084/jem.190.4.461
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577
   OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314
   Balabanian K, 2002, BLOOD, V99, P427, DOI 10.1182/blood.V99.2.427
   OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821
   Straus SE, 1999, ANN INTERN MED, V130, P591
   Rieux-Laucat F, 1999, BLOOD, V94, P2575
   NISITANI S, 1995, EUR J IMMUNOL, V25, P3047, DOI 10.1002/eji.1830251110
   Lim MS, 1998, AM J PATHOL, V153, P1541, DOI 10.1016/S0002-9440(10)65742-2
   Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501
   Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817
   Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7
   Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639
   Komano H, 1999, INT IMMUNOL, V11, P1035, DOI 10.1093/intimm/11.7.1035
   Velupillai P, 1997, J IMMUNOL, V158, P338
   Elkon KB, 1996, CURR OPIN IMMUNOL, V8, P852, DOI 10.1016/S0952-7915(96)80015-X
   FAGARASAN S, 2002, MOL PATHOLOGY AUTOIM, P522
   Fukuyama H, 1998, J IMMUNOL, V160, P3805
   Kench JA, 1998, J EXP MED, V188, P909, DOI 10.1084/jem.188.5.909
   Lernmark A, 2001, J CLIN INVEST, V108, P1091, DOI 10.1172/JCI200114234
   Lopatin U, 2001, BLOOD, V97, P3161, DOI 10.1182/blood.V97.10.3161
   MARRACK P, 2001, NAT MED, V7, P889
   Nisitani S, 1998, INT IMMUNOL, V10, P1039, DOI 10.1093/intimm/10.8.1039
   Qin XF, 1999, NATURE, V397, P355
   Ramachandra S, 1996, J CLIN INVEST, V98, P1788, DOI 10.1172/JCI118978
   Santulli-Marotto S, 2001, J IMMUNOL, V166, P5292
   Velupillai P, 1996, INFECT IMMUN, V64, P4557
NR 30
TC 29
Z9 29
U1 1
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JUL 1
PY 2002
VL 196
IS 1
BP 141
EP 146
DI 10.1084/jem.20011519
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 569TJ
UT WOS:000176618100014
PM 12093879
ER

PT J
AU Honjo, T
AF Honjo, T
TI Does AID need another aid?
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
ID CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC
   HYPERMUTATION
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
CR Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Martin A, 2002, NATURE, V415, P802
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni0902-826
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   BROSS L, 2000, J EXP MED, V195, P1187
NR 13
TC 17
Z9 19
U1 1
U2 2
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2002
VL 3
IS 9
BP 800
EP 801
DI 10.1038/ni0902-800
PG 3
WC Immunology
SC Immunology
GA 588GZ
UT WOS:000177694900005
PM 12205466
ER

PT J
AU Iwai, Y
   Ishida, M
   Tanaka, Y
   Okazaki, T
   Honjo, T
   Minato, N
AF Iwai, Y
   Ishida, M
   Tanaka, Y
   Okazaki, T
   Honjo, T
   Minato, N
TI Involvement of PD-L1 on tumor cells in the escape from host immune
   system and tumor immunotherapy by PD-L1 blockade
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID T-LYMPHOCYTES; ANTIGENS; MICE; CTLA-4; GENE; IMMUNORECEPTOR; ACTIVATION;
   REJECTION; RESPONSES; DEFICIENT
AB PD-1 is a receptor of the Ig superfamily that negatively regulates T cell antigen receptor signaling by interacting with the specific ligands (PD-L) and is suggested to play a role in the maintenance of self-tolerance. In the present study, we examined possible roles of the PD-1/PD-L system in tumor immunity. Transgenic expression of PD-L1, one of the PD-L, in P815 tumor cells rendered them less susceptible to the specific T cell antigen receptor-mediated lysis by cytotoxic T cells in vitro, and markedly enhanced their tumorigenesis and invasiveness in vivo in the syngeneic hosts as compared with the parental tumor cells that lacked endogenous PD-L. Both effects could be reversed by anti-PD-L1 Ab. Survey of murine tumor lines revealed that all of the myeloma cell lines examined naturally expressed PID-L1. Growth of the myeloma cells in normal syngeneic mice was inhibited significantly albeit transiently by the administration of anti-PD-L1 Ab in vivo and was suppressed completely in the syngeneic PD-1-deficient mice. These results suggest that the expression of PD-L1 can serve as a potent mechanism for potentially immunogenic tumors to escape from host immune responses and that blockade of interaction between PD-1 and PD-L may provide a promising strategy for specific tumor immunotherapy.
C1 Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan.
   Japan Sci & Technol Corp, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Japan Sci & Technol Corp, PRESTO, Kyoto 6068501, Japan.
RP Minato, N (reprint author), Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan.
CR RAMARATHINAM L, 1995, J IMMUNOL, V155, P5323
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Tureci O, 1997, MOL MED TODAY, V3, P342, DOI 10.1016/S1357-4310(97)01081-2
   HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904
   Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6
   Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113
   Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0
   BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337
   Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Kato Y, 2001, J IMMUNOL, V167, P5092
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Brandle D, 1998, EUR J IMMUNOL, V28, P4010, DOI 10.1002/(SICI)1521-4141(199812)28:12<4010::AID-IMMU4010>3.0.CO;2-5
   Kimura K, 2000, CANCER IMMUNOL IMMUN, V49, P71, DOI 10.1007/s002620050604
   Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x
   Udaka K, 1996, J IMMUNOL, V157, P670
   VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373
NR 24
TC 603
Z9 647
U1 16
U2 64
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 17
PY 2002
VL 99
IS 19
BP 12293
EP 12297
DI 10.1073/pnas.192461099
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 596VK
UT WOS:000178187000055
PM 12218188
ER

PT J
AU Iwaia, Y
   Okazaki, T
   Nishimura, H
   Kawasaki, A
   Yagita, H
   Honjo, T
AF Iwaia, Y
   Okazaki, T
   Nishimura, H
   Kawasaki, A
   Yagita, H
   Honjo, T
TI Microanatomical localization of PD-1 in human tonsils
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE immunohistochemistry; CD28/B7 family; costimulatory molecule
ID T-CELL ACTIVATION; IMMUNE-RESPONSES; B7 FAMILY; RECEPTOR; CTLA-4; GENE;
   IMMUNORECEPTOR; PROLIFERATION; EXPRESSION; LIGAND
AB PD-1 is an immunoinhibitory receptor, which belongs structurally to the CD28 family. PD-1-deficient mice show breakdown of peripheral tolerance and manifest multiple autoimmune symptoms. We previously described expression of PD-1 on activated T and B lymphocytes and myeloid cells. However, little is known about the microanatomical distribution of PD-1 in lymphoid organs. In this study, we performed immunohistochemistry using monoclonal antibodies against human PD-1. In human tonsils, PD-1 was expressed on most of T cells and a small subset of centrocytes in the light zone of germinal centers (GCs), where clonal selection of centrocytes takes place. These results suggest that PD-1 may play an important role in GC reaction. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Kyoto Univ, Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6
   SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139
   Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582
   Dong HD, 1999, NAT MED, V5, P1365
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X
   Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X
   LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557
   Hutloff A, 1999, NATURE, V397, P263
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x
   FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363
   KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3
   Castan J, 1997, IMMUNOLOGY, V90, P265, DOI 10.1046/j.1365-2567.1997.00162.x
   FREEDMAN AS, 1987, J IMMUNOL, V139, P3260
   Mueller DL, 2000, CURR BIOL, V10, pR227, DOI 10.1016/S0960-9822(00)00400-0
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
NR 28
TC 31
Z9 36
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD OCT 1
PY 2002
VL 83
IS 3
BP 215
EP 220
AR PII S0165-2478(02)00088-3
DI 10.1016/S0165-2478(02)00088-3
PG 6
WC Immunology
SC Immunology
GA 600CF
UT WOS:000178372500010
PM 12095712
ER

PT J
AU Ishida, M
   Iwai, Y
   Tanaka, Y
   Okazaki, T
   Freeman, GJ
   Minato, N
   Honjo, T
AF Ishida, M
   Iwai, Y
   Tanaka, Y
   Okazaki, T
   Freeman, GJ
   Minato, N
   Honjo, T
TI Differential expression of PD-L1 and PD-L2, ligands for an inhibitory
   receptor PD-1, in the cells of lymphohematopoietic tissues
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE PD-1; PD-L1; PD-L2; T-cell; inhibitory receptor; negative signal
ID CTLA-4; MICE; IMMUNORECEPTOR; ACTIVATION; MOTIF; ENGAGEMENT; DEFICIENT;
   SURFACE; ABSENCE
AB PD-1 is a member of the immunoglobulin superfamily expressed on immune cells, including T and B cells, and is involved in the delivery of inhibitory signal upon engagement of its ligands, PD-L1 and PD-L2. While the expression profile of PD-1 has been well documented, the analysis of PD-L1 and PD-L2 distributions on a protein basis has not been carried out because of the lack of available monoclonal antibodies specific for the molecules. In this study, we established two monoclonal antibodies, 1-111A and 122, specific for marine PD-L1 and PD-L2, respectively, and examined their expression profiles. Based on flow cytometric analyses, the expression of PD-L1 was detected in a variety of lymphohematopoietic cell types, including a minor proportion of T and B cells in the spleen, majority of pre-B cells and myeloid cells in bone marrow and subsets of thymocytes, while the expression of PD-L2 was not observed in the lymphohematopoietic cells at all. Notably, a significant proportion of the most immature lineage-marker-negative and c-Kit-positive bone marrow cells containing stem cells did express PD-L1. Following mitogenic stimulation, essentially all lymphocytes expressed PD-L1. Furthermore, a variety of leukemic lines also expressed PD-L1, while none of them did PD-L2. Thus, present results demonstrate the distinct expression patterns of PD-L1 and PD-L2 with the cells of lymphohematopoietic tissues exclusively expressing the former. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Kyoto 6068501, Japan.
   Harvard Univ, Sch Med, Dept Adult Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.
CR Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Chuang E, 1999, J IMMUNOL, V162, P1270
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8
   Nakaseko C, 1999, J EXP MED, V190, P765, DOI 10.1084/jem.190.6.765
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   Schneider H, 2000, BIOCHEM BIOPH RES CO, V269, P279, DOI 10.1006/bbrc.2000.2234
NR 17
TC 112
Z9 132
U1 3
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD OCT 21
PY 2002
VL 84
IS 1
BP 57
EP 62
AR PII S0165-2478(02)00142-6
DI 10.1016/S0165-2478(02)00142-6
PG 6
WC Immunology
SC Immunology
GA 608MR
UT WOS:000178850500008
PM 12161284
ER

PT J
AU Fagarasan, S
   Muramatsu, M
   Suzuki, K
   Nagaoka, H
   Hiai, H
   Honjo, T
AF Fagarasan, S
   Muramatsu, M
   Suzuki, K
   Nagaoka, H
   Hiai, H
   Honjo, T
TI Critical roles of activation-induced cytidine deaminase in the
   homeostasis of gut flora
SO SCIENCE
LA English
DT Article
ID IMMUNE-SYSTEM; AID; HYPERMUTATION; DEFICIENCY; EXPRESSION; CELLS; MICE
AB Activation-induced cytidine deaminase (AID) plays an essential role in class switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes. We report here that deficiency in AID results in the development of hyperplasia of isolated lymphoid follicles (ILFs) associated with a 100-fold expansion of anaerobic. ora in the small intestine. Reduction of bacterial. ora by antibiotic treatment of AID(-/-) mice abolished ILF hyperplasia as well as the germinal center enlargement seen in secondary lymphoid tissues. Because an inability to switch to immunoglobulin A on its own does not lead to a similar phenotype, these results suggest that SHM of ILF B cells plays a critical role in regulating intestinal microflora.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016
OI Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan,
   Sidonia/0000-0003-2086-6402
CR Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3
   BASTLEIN C, 1988, ENDOSCOPY, V20, P272, DOI 10.1055/s-2007-1018192
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Harriman GR, 1999, J IMMUNOL, V162, P2521
   Moghaddami M, 1998, GASTROENTEROLOGY, V115, P1414, DOI 10.1016/S0016-5085(98)70020-4
   Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Hamada H, 2002, J IMMUNOL, V168, P57
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Burt R., 1999, TXB GASTROENTEROLOGY, VII, P1995
   Cebra J. J., 1994, HDB MUCOSAL IMMUNOLO, P151
   Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S
   FAGARASAN S, UNPUB
   LeMaoult J, 1997, J IMMUNOL, V159, P3866
   METZGER D, COMMUNICATION
NR 17
TC 279
Z9 290
U1 3
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD NOV 15
PY 2002
VL 298
IS 5597
BP 1424
EP 1427
DI 10.1126/science.1077336
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 615AF
UT WOS:000179223100053
PM 12434060
ER

PT J
AU Okazaki, T
   Iwai, Y
   Honjo, T
AF Okazaki, T
   Iwai, Y
   Honjo, T
TI New regulatory co-receptors: inducible co-stimulator and PD-1
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID T-CELL ACTIVATION; COSTIMULATORY MOLECULE; PERIPHERAL TOLERANCE; CUTTING
   EDGE; B7 FAMILY; ICOS; RESPONSES; EXPRESSION; IMMUNORECEPTOR; LIGAND
AB Autoreactive lymphocytes are suppressed in healthy individuals by so-called peripheral tolerance. Accumulating evidence indicates that co-receptor signaling plays a pivotal role in the regulation of autoreactive lymphocytes. The positive regulatory co-receptors CD28 and inducible co-stimulator (ICOS) transduce stimulatory cosignals, whereas the negative regulatory co-stimulators CTLA-4 and PD-1 are critical for the regulation of peripheral tolerance and autoimmunity. PD-1 deficient mice develop lupus-like glomerulonephritis and arthritis on a C57Bl/6 background and autoimmune-dilated cardiomyopathy on a BALB/c background.
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Okazaki, T (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
CR Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Dong C, 2001, J IMMUNOL, V166, P3659
   Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582
   Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111
   Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339
   Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750
   Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Marelli-Berg FM, 1999, IMMUNOL REV, V172, P297
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107
   Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113
   Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X
   Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733
   Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X
   Wang SD, 2000, BLOOD, V96, P2808
   Hutloff A, 1999, NATURE, V397, P263
   Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Aicher A, 2000, J IMMUNOL, V164, P4689
   Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   McAdam AJ, 2000, J IMMUNOL, V165, P5035
   Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3
   Ling V, 2000, J IMMUNOL, V164, P1653
   Tezuka K, 2000, BIOCHEM BIOPH RES CO, V276, P335, DOI 10.1006/bbrc.2000.3466
   Wallin JJ, 2001, J IMMUNOL, V167, P132
NR 38
TC 144
Z9 153
U1 3
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD DEC
PY 2002
VL 14
IS 6
BP 779
EP 782
DI 10.1016/S0952-7915(02)00398-9
PG 4
WC Immunology
SC Immunology
GA 607VZ
UT WOS:000178812600015
PM 12413529
ER

PT J
AU Shinohara, T
   Inoue, K
   Ogonuki, N
   Kanatsu-Shinohara, M
   Miki, H
   Nakata, K
   Kurome, M
   Nagashima, H
   Toyokuni, S
   Kogishi, K
   Honjo, T
   Ogura, A
AF Shinohara, T
   Inoue, K
   Ogonuki, N
   Kanatsu-Shinohara, M
   Miki, H
   Nakata, K
   Kurome, M
   Nagashima, H
   Toyokuni, S
   Kogishi, K
   Honjo, T
   Ogura, A
TI Birth of offspring following transplantation of cryopreserved immature
   testicular pieces and in-vitro microinsemination
SO HUMAN REPRODUCTION
LA English
DT Article
DE cancer; infertility; in-vitro microinsemination; testis; transplantation
ID SPERMATOGONIAL STEM-CELLS; ROUND SPERMATIDS; INTRACYTOPLASMIC INJECTION;
   TISSUE CRYOPRESERVATION; CANCER-PATIENTS; MOUSE TESTES; GERM-CELLS;
   SPERMATOGENESIS; FERTILITY; CHEMOTHERAPY
AB Background: Fertility protection is an urgent clinical problem for prepubertal male oncology patients who undergo either chemotherapy or radiotherapy. As these patients do not have mature sperm to be frozen, there is as yet no effective method to preserve their fertility. Methods and Results: Single pieces of immature mouse (1.5x1.5x1.5 mm) or rabbit (2.0x2.0xsimilar to3.0 mm) testis were cryopreserved, thawed and transplanted into mouse testes. Histological techniques were used to determine the presence of spermatogenesis, which was restored in both mouse and rabbit testicular pieces, and led to the production of mature sperm after both cryopreservation and syngeneic or xenogeneic transplantation into mouse testes. Using sperm developed in the frozen-thawed transplants, mouse offspring were born after in-vitro microinsemination. Furthermore, rabbit offspring were obtained using rabbit sperm that developed in fresh transplants in a xenogeneic surrogate mouse. Conclusions: This approach of 'testicular tissue banking' is a promising technique for the preservation of fertility in prepubertal male oncology patients. Xenogeneic transplantation into immunodeficient mice may provide a system for studying spermatogenic failure in infertile men.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   RIKEN, Bioresource Ctr, Ibaraki, Japan.
   6 Meiji Univ, Lab Reprod Engn, Kawasaki, Kanagawa, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan.
RP Shinohara, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RI Toyokuni, Shinya/C-1358-2010; Ogura, Atsuo/J-3916-2014
OI Toyokuni, Shinya/0000-0002-5757-1109; Ogura, Atsuo/0000-0003-0447-1988
CR Jahnukainen K, 2001, CANCER RES, V61, P706
   Glenister PH, 2000, MAMM GENOME, V11, P565, DOI 10.1007/s003350010108
   Ogawa T, 2000, NAT MED, V6, P29
   Nugent D, 1997, HUM REPROD UPDATE, V3, P267, DOI 10.1093/humupd/3.3.267
   Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X
   Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370
   KIMURA Y, 1995, DEVELOPMENT, V121, P2397
   TSUTSUMI O, 1986, SCIENCE, V233, P975, DOI 10.1126/science.3090686
   Wang X, 2002, NATURE, V415, P385, DOI 10.1038/415385a
   BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298
   Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0
   Hovatta O, 1996, HUM REPROD, V11, P2472
   Aslam I, 2000, HUM REPROD, V15, P2154, DOI 10.1093/humrep/15.10.2154
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   PARROTT DMV, 1960, J REPROD FERTIL, V1, P230
   Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693
   Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409
   Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282
   Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55
   Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144
   BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1
   GOSDEN RG, 1994, HUM REPROD, V9, P597
   PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F
   Hovatta O, 2001, HUM REPROD UPDATE, V7, P378, DOI 10.1093/humupd/7.4.378
   Oktay K, 2001, HUM REPROD UPDATE, V7, P526, DOI 10.1093/humupd/7.6.526
   Royere D, 1996, HUM REPROD UPDATE, V2, P553, DOI 10.1093/humupd/2.6.553
   Bahadur G, 2000, HUM REPROD, V15, P1416, DOI 10.1093/humrep/15.6.1416
   DEANESLY R, 1954, J ENDOCRINOL, V11, P201, DOI 10.1677/joe.0.0110201
   Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331
   FOSSA SD, 1989, BRIT J UROL, V64, P524, DOI 10.1111/j.1464-410X.1989.tb05292.x
   Hafez E. S. E., 1993, P94
   Hafez E. S. E., 1993, P503
   Howell SJ, 2001, HUM REPROD UPDATE, V7, P363, DOI 10.1093/humupd/7.4.363
   Kim SS, 2001, HUM REPROD, V16, P2056, DOI 10.1093/humrep/16.10.2056
   Meistrich ML, 1998, APMIS, V106, P37
   Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060
   Ogura A, 1996, J ASSIST REPROD GEN, V13, P431, DOI 10.1007/BF02066177
   Ogura A, 1996, THERIOGENOLOGY, V45, P1141, DOI 10.1016/0093-691X(96)00070-2
   Orth J.M., 1993, CELL MOL BIOL TESTIS, P3
   PALMERO S, 1989, J ENDOCRINOL, V123, P105, DOI 10.1677/joe.0.1230105
   Russell LD, 1990, MAMMALIAN SPERMATOGE, P1
   Salzbrunn A, 1996, HUM REPROD, V11, P752
   SILBER SJ, 1995, HUM REPROD, V10, P503
   Yanagimachi R, 1994, PHYSL REPROD, V2, P189
NR 44
TC 105
Z9 118
U1 4
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
J9 HUM REPROD
JI Hum. Reprod.
PD DEC
PY 2002
VL 17
IS 12
BP 3039
EP 3045
DI 10.1093/humrep/17.12.3039
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 625XA
UT WOS:000179839800006
PM 12456600
ER

PT J
AU Kanatsu-Shinohara, M
   Ogonuki, N
   Inoue, K
   Ogura, A
   Toyokuni, S
   Honjo, T
   Shinohara, T
AF Kanatsu-Shinohara, M
   Ogonuki, N
   Inoue, K
   Ogura, A
   Toyokuni, S
   Honjo, T
   Shinohara, T
TI Allogeneic offspring produced by male germ line stem cell
   transplantation into infertile mouse testis
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE immunology; in vitro fertilization; Sertoli cells; spermatogenesis;
   testis
ID SPERMATOGONIAL TRANSPLANTATION; IMMUNE PRIVILEGE; SERTOLI CELLS; MICE;
   SPERMATOGENESIS; OOCYTES; RAT; TOLERANCE; INJECTION; LIGAND
AB The testis is one of several immune-privileged organs and is known for its unique ability to support allogeneic or xenogeneic tissue transplants. We investigated the possibility of deriving offspring from mice that underwent transplantation with allogeneic male germ line stem cells in the testis. Although mature adult mice rejected allogeneic germ cells and were infertile, offspring were obtained by intracytoplasmic germ cell injection using partially differentiated donor cells. In contrast, complete spermatogenesis occurred when allogeneic germ cells were transplanted into immature pup testes. Tolerance induction by monoclonal antibody administration allowed the pup transplant recipients to produce allogeneic offspring by natural mating, whereas no spermatozoa were found in the epididymis of untreated recipients. Thus, these results, indicate that a histoincompatible recipient can serve as a "surrogate father" to propagate the genetic information of heterologous male donors.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Dept Pathol & Biol Dis,Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan.
RP Shinohara, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Dept Pathol & Biol Dis,Sakyo Ku, Kyoto 6068501, Japan.
RI Toyokuni, Shinya/C-1358-2010; Ogura, Atsuo/J-3916-2014
OI Toyokuni, Shinya/0000-0002-5757-1109; Ogura, Atsuo/0000-0003-0447-1988
CR Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429
   Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498
   Ogawa T, 2000, NAT MED, V6, P29
   Ogawa T, 1997, INT J DEV BIOL, V41, P111
   GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189
   Sanberg PR, 1997, NAT MED, V3, P1129, DOI 10.1038/nm1097-1129
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251
   D'Alessio A, 2001, P NATL ACAD SCI USA, V98, P3316, DOI 10.1073/pnas.051566098
   BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298
   GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7
   Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0
   HEAD JR, 1983, TRANSPLANTATION, V36, P423, DOI 10.1097/00007890-198310000-00014
   Kimura Y, 1998, BIOL REPROD, V59, P871, DOI 10.1095/biolreprod59.4.871
   Cobbold SP, 1996, IMMUNOL REV, V149, P5, DOI 10.1111/j.1600-065X.1996.tb00897.x
   BENJAMIN RJ, 1986, NATURE, V320, P449, DOI 10.1038/320449a0
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256
   Sanberg PR, 1996, NAT BIOTECHNOL, V14, P1692, DOI 10.1038/nbt1296-1692
   BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0
   Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198
   Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693
   BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303
   Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611
   Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144
   BARKER CF, 1977, ADV IMMUNOL, V25, P1
   PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F
   KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709
   SELAWRY HP, 1993, CELL TRANSPLANT, V2, P123
   BRENT L, 1997, HIST TRANSPLANTATION, P182, DOI 10.1016/B978-012131770-6/50025-0
   CAPEL B, 1989, EXP HEMATOL, V17, P872
   Jiang FX, 1995, INT J ANDROL, V18, P326, DOI 10.1111/j.1365-2605.1995.tb00570.x
   KLEIN J, 1982, IMMUNOLOGY SCI SELF, P284
   Meng XJ, 2002, BIOL REPROD, V66, P726, DOI 10.1095/biolreprod66.3.726
   NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95
   Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060
   Ogura A, 1999, HUM REPROD, V14, P1294, DOI 10.1093/humrep/14.5.1294
   Ogura A, 1996, THERIOGENOLOGY, V45, P1141, DOI 10.1016/0093-691X(96)00070-2
   Orth J.M., 1993, CELL MOL BIOL TESTIS, P3
   POTTEN CS, 1992, OXFORD TXB PATHOLOGY, V1, P43
   Russell LD, 1990, HISTOLOGICAL HISTOPA, P1
   SILVERS WK, 1979, COAT COLORS MICE MOD, P206
   Tung K. S. K., 1993, CELL MOL BIOL TESTIS, P474
   Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789
NR 44
TC 63
Z9 69
U1 1
U2 1
PU SOC STUDY REPRODUCTION
PI MADISON
PA 1603 MONROE ST, MADISON, WI 53711-2021 USA
SN 0006-3363
J9 BIOL REPROD
JI Biol. Reprod.
PD JAN
PY 2003
VL 68
IS 1
BP 167
EP 173
DI 10.1095/biolreprod.102.008516
PG 7
WC Reproductive Biology
SC Reproductive Biology
GA 630MJ
UT WOS:000180111500022
PM 12493709
ER

PT S
AU Okazaki, I
   Yoshikawa, K
   Kinoshitaa, K
   Muramatsu, M
   Nagaoka, H
   Honjo, T
AF Okazaki, I
   Yoshikawa, K
   Kinoshitaa, K
   Muramatsu, M
   Nagaoka, H
   Honjo, T
BE Chiorazzi, N
   Lahita, RG
   Capra, JD
   Ferrarini, M
   Zabriskie, JB
TI Activation-induced cytidine deaminase links class switch recombination
   and somatic hypermutation
SO IMMUNE MECHANISMS AND DISEASE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Immune Mechanisms and Disease
CY APR 14-17, 2002
CL ST GEORGES, W IND ASSOC ST
SP Henry Kunkel Soc, NY Acad Sci
DE activation-induced cytidine deaminase; class switch recombination;
   somatic hypermutation; gene conversion; S regions
ID GENE CONVERSION; CELL-LINE; B-CELLS; AID; SEQUENCES; TRANSCRIPTION;
   SPECIFICITY; MECHANISM; REGION; ENZYME
AB Activation-induced cytidine deaminase (AID), a putative RNA-editing cytidine deaminase that is expressed strictly in activated B cells, is indispensable in three apparently distinct genetic alterations of inummoglobulin genes-namely, class switch recombination, somatic hypermutation, and gene conversion. Recent findings led us to propose a common DNA cleaving mechanism, in which the transient secondary structure of the S and V region DNA is recognized by a nicking enzyme regulated by the putative RNA-editing activity of AID.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konie Cho, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 29
TC 20
Z9 21
U1 1
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-434-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2003
VL 987
BP 1
EP 8
PG 8
WC Cell Biology; Immunology; Multidisciplinary Sciences
SC Cell Biology; Immunology; Science & Technology - Other Topics
GA BW84D
UT WOS:000183319000001
PM 12727618
ER

PT J
AU Fagarasan, S
   Honjo, T
AF Fagarasan, S
   Honjo, T
TI Intestinal IgA synthesis: Regulation of front-line body defences
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Review
ID CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; MUCOSAL
   IMMUNE-SYSTEM; GUT LAMINA PROPRIA; THYMUS-EXPRESSED CHEMOKINE; B-CELL
   DIFFERENTIATION; PLASMA-CELLS; SOMATIC HYPERMUTATION; DENDRITIC CELLS;
   PEYERS-PATCHES
AB Immunoglobulin A is the most abundant immunoglobulin isotype in mucosal secretions. In this review, we summarize recent advances in our understanding of the sites, mechanisms and functions of intestinal IgA synthesis in mice. On the basis of these recent findings, we propose an updated model for the induction and regulation of IgA responses in the gut. In addition, we discuss new insights into the role of IgA in the maintenance of gut homeostasis and into the reciprocal interactions between gut B cells and the bacterial flora.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775
   Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881
   van Ginkel FW, 1999, J IMMUNOL, V163, P1951
   Bos NA, 1996, INFECT IMMUN, V64, P616
   BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133
   VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41
   Lycke N, 1999, J IMMUNOL, V163, P913
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Matsunaga T, 1998, IMMUNOL REV, V166, P177, DOI 10.1111/j.1600-065X.1998.tb01262.x
   Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0
   Yamamoto M, 2000, J IMMUNOL, V164, P5184
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0
   HARRIMAN GR, 1988, J IMMUNOL, V140, P3033
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201
   Newberry RD, 2002, J IMMUNOL, V168, P4988
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761
   Maric I, 1996, J IMMUNOL, V156, P1408
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89
   Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3
   BASTLEIN C, 1988, ENDOSCOPY, V20, P272, DOI 10.1055/s-2007-1018192
   Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6
   WEINSTEIN PD, 1991, J IMMUNOL, V147, P4126
   MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63
   TOMASI TB, 1965, J EXP MED, V121, P101, DOI 10.1084/jem.121.1.101
   Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Harriman GR, 1999, J IMMUNOL, V162, P2521
   Moghaddami M, 1998, GASTROENTEROLOGY, V115, P1414, DOI 10.1016/S0016-5085(98)70020-4
   Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909
   Kamata T, 2000, J IMMUNOL, V165, P1387
   BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A
   Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B
   Hamada H, 2002, J IMMUNOL, V168, P57
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   Papadakis KA, 2000, J IMMUNOL, V165, P5069
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1039/ni829
   FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375
   Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6
   Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   CRABBE PA, 1970, LAB INVEST, V22, P448
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7
   Chaplin DD, 1998, CURR OPIN IMMUNOL, V10, P289, DOI 10.1016/S0952-7915(98)80167-2
   SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415
   RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   ROSNER AJ, 1984, J LEUKOCYTE BIOL, V35, P397
   Boursier L, 2002, EUR J IMMUNOL, V32, P2427, DOI 10.1002/1521-4141(200209)32:9<2427::AID-IMMU2427>3.0.CO;2-P
   Boursier L, 2000, EUR J IMMUNOL, V30, P2908, DOI 10.1002/1521-4141(200010)30:10<2908::AID-IMMU2908>3.0.CO;2-E
   BOWMAN EP, 2002, J EXP MED, V195, P268
   BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0
   Burt JR RW, 1999, TXB GASTROENTEROLOGY, P1995
   BUTCHER EC, 1982, J IMMUNOL, V129, P2698
   Cebra J. J., 1994, HDB MUCOSAL IMMUNOLO, P151
   Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S
   COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039
   CRAIG SW, 1975, J IMMUNOL, V114, P492
   Fischer M, 1998, EUR J IMMUNOL, V28, P2971, DOI 10.1002/(SICI)1521-4141(199809)28:09<2971::AID-IMMU2971>3.0.CO;2-3
   GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862
   GUYGRAND D, 1974, EUR J IMMUNOL, V4, P435, DOI 10.1002/eji.1830040610
   HANSON LA, 1961, INT ARCH ALLER A IMM, V18, P241
   HOTZMANN B, 1989, CELL, V56, P37
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Kelsall B, 1999, MUCOSAL IMMUNOLOGY, V2nd, P293
   Koike R, 1997, CELL IMMUNOL, V180, P62, DOI 10.1006/cimm.1997.1177
   LEBMAN DA, 1987, J EXP MED, V166, P1405, DOI 10.1084/jem.166.5.1405
   LYCKE N, 1998, MUCOSAL T CELLS, P209
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   McIntyre T., 1999, MUCOSAL IMMUNOLOGY, P319
   MCWILLIAMS M, 1977, J EXP MED, V145, P866, DOI 10.1084/jem.145.4.866
   Mestecky J, 1999, MUCOSAL IMMUNOLOGY, P133
   MESTECKY J, 1999, MUCOSAL IMMUNOLOGY, P23
   Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259
   Russell MW, 1999, MUCOSAL IMMUNOLOGY, P225
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   TSENG J, 1984, J IMMUNOL, V132, P2730
   TSENG J, 1981, J IMMUNOL, V127, P2039
   Umesaki Y, 2000, MICROBES INFECT, V2, P1343, DOI 10.1016/S1286-4579(00)01288-0
   Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0
NR 99
TC 237
Z9 246
U1 3
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD JAN
PY 2003
VL 3
IS 1
BP 63
EP 72
DI 10.1038/nri982
PG 10
WC Immunology
SC Immunology
GA 637HG
UT WOS:000180505200022
PM 12511876
ER

PT J
AU Watanabe, N
   Ikuta, K
   Okazaki, K
   Nakase, H
   Tabata, Y
   Matsuura, M
   Tamaki, H
   Kawanami, C
   Honjo, T
   Chiba, T
AF Watanabe, N
   Ikuta, K
   Okazaki, K
   Nakase, H
   Tabata, Y
   Matsuura, M
   Tamaki, H
   Kawanami, C
   Honjo, T
   Chiba, T
TI Elimination of local macrophages in intestine prevents chronic colitis
   in interleukin-10-deficient mice
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article
DE inflammatory bowel disease; macrophage; drug delivery system;
   microsphere; dichloromethylene diphosphonate; interleukin 10
ID INFLAMMATORY-BOWEL-DISEASE; CD4(+) T-CELLS; ESTABLISHED EXPERIMENTAL
   COLITIS; IMMUNE-REGULATING CELLS; CROHNS-DISEASE; BIODEGRADABLE
   MICROSPHERES; CHRONIC ENTEROCOLITIS; MUCOSAL INFLAMMATION; B-CELLS;
   SYSTEM
AB Uncontrolled activation of T cells and macrophages is involved in the development of inflammatory bowel disease (IBD). However, the precise role of intestinal macrophages for development of IBD is till unclear. To investigate the role of local macrophages for development of IBD, we developed poly-D, L-lactic acid microspheres containing dichloromethylene diphosphonate, which was specifically taken up by macrophages and depleted them, and then the animal model for human IBD was treated with this reagent. We have shown that rectal administration of the microspheres reduced the numbers of resident macrophages in the intestinal lymphoid follicles of interleukin-10-deficient mice. Importantly, depletion of intestinal macrophages was associated with suppression of development of chronic colitis. These results suggest that local macrophages in the intestine play a critical role in the development of chronic colitis in an animal model for IBD. Our study implies that elimination of resident macrophages in the intestine may become a therapeutic approach to IBD.
C1 Kyoto Univ, Dept Gastroenterol, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068507, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
RP Chiba, T (reprint author), Kyoto Univ, Dept Gastroenterol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawara Cho, Kyoto 6068507, Japan.
CR ALLISON MC, 1988, GUT, V29, P1531, DOI 10.1136/gut.29.11.1531
   DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387
   Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1
   Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107
   Sellon RK, 1998, INFECT IMMUN, V66, P5224
   Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577
   Nakase H, 2000, J PHARMACOL EXP THER, V292, P15
   GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291
   Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241
   Tran EH, 1998, J IMMUNOL, V161, P3767
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861
   Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998
   Tabata Y, 1996, VACCINE, V14, P1677, DOI 10.1016/S0264-410X(96)00149-1
   MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237
   Underhill DM, 1999, NATURE, V401, P811
   NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281
   Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7
   Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205
   Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   MACATONIA SE, 1995, J IMMUNOL, V154, P5071
   Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6
   Nakase H, 2002, J PHARMACOL EXP THER, V301, P59, DOI 10.1124/jpet.301.1.59
   Naito M, 1996, J LEUKOCYTE BIOL, V60, P337
   Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9
   Davidson NJ, 1998, J IMMUNOL, V161, P3143
   Jun HS, 1999, J EXP MED, V189, P347, DOI 10.1084/jem.189.2.347
   Nakase H, 2001, J PHARMACOL EXP THER, V297, P1122
   GRIMM MC, 1995, J GASTROEN HEPATOL, V10, P387, DOI 10.1111/j.1440-1746.1995.tb01589.x
   MACDERMOTT RP, 1988, ADV IMMUNOL, V42, P285, DOI 10.1016/S0065-2776(08)60848-2
   PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306
   POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461
   Sartor RB, 1997, AM J GASTROENTEROL, V92, p5S
   Strober W, 1998, ANN INTERN MED, V128, P848
   Watanabe N, 1998, SCAND J IMMUNOL, V47, P541
   Whithead R, 1980, INFLAMM BOWEL DIS, P296
NR 40
TC 63
Z9 65
U1 1
U2 3
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0163-2116
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD FEB
PY 2003
VL 48
IS 2
BP 408
EP 414
DI 10.1023/A:1021960401290
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 634MR
UT WOS:000180344300026
PM 12643623
ER

PT J
AU Kuroda, K
   Han, H
   Tani, S
   Tanigaki, K
   Tun, T
   Furukawa, T
   Taniguchi, Y
   Kurooka, H
   Hamada, Y
   Toyokuni, S
   Honjo, T
AF Kuroda, K
   Han, H
   Tani, S
   Tanigaki, K
   Tun, T
   Furukawa, T
   Taniguchi, Y
   Kurooka, H
   Hamada, Y
   Toyokuni, S
   Honjo, T
TI Regulation of marginal zone B cell development by MINT, a suppressor of
   Notch/RBP-J signaling pathway
SO IMMUNITY
LA English
DT Article
ID DNA-BINDING PROTEIN; RBP-J-KAPPA; MAMMALIAN NOTCH; MOUSE NOTCH;
   INTRACELLULAR DOMAIN; COREPRESSOR COMPLEX; DROSOPHILA HOMOLOG; ANKYRIN
   REPEATS; DENDRITIC CELLS; FAMILY MEMBERS
AB We found that Msx2-interacting nuclear target protein (MINT) competed with the intracellular region of Notch for binding to a DNA binding protein RBP-J and suppressed the transactivation activity of Notch signaling. Although MINT null mutant mice were embryonic lethal, MINT-deficient splenic B cells differentiated about three times more efficiently into marginal zone B cells with a concomitant reduction of follicular B cells. MINT is expressed in a cell-specific manner: high in follicular B cells and low in marginal zone B cells. Since Notch signaling directs differentiation of marginal zone B lymphocytes and suppresses that of follicular B lymphocytes in mouse spleen, the results indicate that high levels of MINT negatively regulate Notch signaling and block differentiation of precursor B cells into marginal zone B cells. MINT may serve as a functional homolog of Drosophila Hairless.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
   Natl Inst Basic Biol, Aichi 4448585, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.
RI Toyokuni, Shinya/C-1358-2010; Taniguchi, Yoshihito/L-5746-2013
OI Toyokuni, Shinya/0000-0002-5757-1109; 
CR Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   Apelqvist A, 1999, NATURE, V400, P877
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23
   Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X
   Kuang B, 2000, DEVELOPMENT, V127, P1517
   Schroeter EH, 1998, NATURE, V393, P382
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x
   Hamada Y, 1999, DEVELOPMENT, V126, P3415
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752
   Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75
   Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Rebay I, 2000, GENETICS, V154, P695
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Kamata T, 2000, J IMMUNOL, V165, P1387
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1
   Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549
   Wiellette EL, 1999, DEVELOPMENT, V126, P5373
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5
   Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201
   McCright B, 2001, DEVELOPMENT, V128, P491
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491
   Taniguchi Y, 1998, MOL CELL BIOL, V18, P644
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033
   Beatus P, 1998, J NEUROSCI RES, V54, P125, DOI 10.1002/(SICI)1097-4547(19981015)54:2<125::AID-JNR1>3.0.CO;2-G
   FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X
   HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314
   Izon DJ, 2002, CURR OPIN IMMUNOL, V14, P192, DOI 10.1016/S0952-7915(02)00321-7
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Kurooka Hisanori, 2000, Journal of Biological Chemistry, V275, P17211, DOI 10.1074/jbc.M000909200
   LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   Minoguchi S, 1997, MOL CELL BIOL, V17, P2679
   Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998
   Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j
   Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085
   SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Zhou SF, 2001, MOL CELL BIOL, V21, P6222, DOI 10.1128/MCB.21.18.6222-6232.2001
NR 54
TC 147
Z9 155
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD FEB
PY 2003
VL 18
IS 2
BP 301
EP 312
DI 10.1016/S1074-7613(03)00029-3
PG 12
WC Immunology
SC Immunology
GA 648FC
UT WOS:000181138100013
PM 12594956
ER

PT J
AU Yamamoto, N
   Tanigaki, K
   Han, H
   Hiai, H
   Honjo, T
AF Yamamoto, N
   Tanigaki, K
   Han, H
   Hiai, H
   Honjo, T
TI Notch/RBP-J signaling regulates epidermis/hair fate determination of
   hair follicular stem cells
SO CURRENT BIOLOGY
LA English
DT Article
ID RBP-J-KAPPA; MAMMALIAN NOTCH; TRANSCRIPTION FACTOR; DIFFERENTIATION;
   MICE; GENE; EXPRESSION; FOLLICLES; HOMOLOG; PATHWAY
AB Notch signaling is involved in the cell fate determination of various cell lineages [1-9]. Notch interaction with its ligand induces the cleavage of its intracellular domain (IC) [10], and the Notch IC translocates to the nucleus and binds to RBP-J [11] to transactivate transcription of target genes [10, 12]. All four Notches in mammals [13-17] bind to RBP-J to exert their transactivation activities. Notch is expressed in developing or differentiating epidermis and hairs [13-15, 18-20], inhibits the terminal differentiation of the epidermis [21], and regulates hair differentiation [22]. The common stem cells that reside in the upper portion of hair follicles (the bulge) contribute to epidermal and hair cell formation [23, 24]. However, it is unknown what determines whether hair follicular stem cells will become hairs or epidermis. Here we report that conditionally disrupting the mouse RBP-J gene in a mosaic pattern to avoid embryonic lethality of RBP-J-deficiency [25] caused hair loss, epidermal hyperkeratinization, and epidermal cyst formation. Cyst formation is probably due to a combination of the aberrant fate determination of RBP-J-deficient stem cells to epidermal progenitors and their accelerated differentiation into epidermis. These results suggest that Notch/RBP-J signaling regulates the cell fate determination of hair follicular stem cells at the bulge region.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Konoe Cho,Yoshida, Kyoto 6068501, Japan.
OI , Norio/0000-0001-8924-0710
CR Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   Favier B, 2000, DEV DYNAM, V218, P426, DOI 10.1002/1097-0177(200007)218:3<426::AID-DVDY1004>3.0.CO;2-4
   Apelqvist A, 1999, NATURE, V400, P877
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Panteleyev AA, 1998, J INVEST DERMATOL, V110, P902, DOI 10.1046/j.1523-1747.1998.00219.x
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   Niemann C, 2002, DEVELOPMENT, V129, P95
   Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310
   Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1
   Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324
   Li M, 2001, DEVELOPMENT, V128, P675
   Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Neumann CJ, 1996, DEVELOPMENT, V122, P3477
   Panteleyev AA, 2001, J CELL SCI, V114, P3419
   WEINMASTER G, 1991, DEVELOPMENT, V113, P199
   Powell BC, 1998, MECH DEVELOP, V78, P189, DOI 10.1016/S0925-4773(98)00177-4
   LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593
   Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3
   Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0
   McCright B, 2001, DEVELOPMENT, V128, P491
   MANN SJ, 1971, ANAT REC, V170, P485, DOI 10.1002/ar.1091700409
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   IBRAHIM L, 1975, J EMBRYOL EXP MORPH, V33, P831
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   Lin MH, 2000, DEVELOPMENT, V127, P2421
   MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   WEINMASTER G, 1992, DEVELOPMENT, V116, P931
   Wu YY, 2000, BRIT J DERMATOL, V142, P694, DOI 10.1046/j.1365-2133.2000.03414.x
NR 42
TC 79
Z9 88
U1 1
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD FEB 18
PY 2003
VL 13
IS 4
BP 333
EP 338
AR PII S0960-9822(03)00081-2
DI 10.1016/S0960-9822(03)00081-2
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 647CT
UT WOS:000181075300025
PM 12593800
ER

PT J
AU Doi, T
   Kinoshita, K
   Ikegawa, M
   Muramatsu, M
   Honjo, T
AF Doi, T
   Kinoshita, K
   Ikegawa, M
   Muramatsu, M
   Honjo, T
TI De novo protein synthesis is required for the activation-induced
   cytidine deaminase function in class-switch recombination
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID RNA EDITING ENZYME; SOMATIC HYPERMUTATION; B-CELLS; AID; GENE;
   EXPRESSION; MICE; DIFFERENTIATION; SPECIFICITY; FIBROBLASTS
AB Activation-induced cytidine deaminase (AID) is required for class-switch recombination (CSR), somatic hypermutation, and gene conversion of Ig genes. Although AID has sequence similarity to an RNA-editing enzyme Apobec-1, how AID functions in CSR and somatic hypermutation is unknown. Because involvement of RNA-editing but not DNA-editing in CSR requires de novo protein synthesis after AID expression, we examined whether protein synthesis inhibitors could block CSR in the presence of the AID activity. For this purpose we constructed AID fused with the hormone-binding domain of the estrogen receptor (AID-ER), which was introduced into AID-deficient spleen B cells. When such transfectants were treated with an estrogen analogue, 4-hydroxytamoxifen (OHT), CSR was induced within 1 h. Cycloheximide or puromycin drastically suppressed OHT-induced CSR in AID-ER expressing AID-/- B cells when added 1 h before OHT but not after OHT, suggesting that de novo protein synthesis is required for an event downstream to AID expression in CSR. The results lend the weight to RNA-editing hypothesis for the function of AID.
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323
   Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558
   Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206
   Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322
   Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Sunaga S, 1997, J IMMUNOL, V158, P4223
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978
   Ono SJ, 2000, FEBS LETT, V467, P268, DOI 10.1016/S0014-5793(00)01151-0
   SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
NR 33
TC 82
Z9 83
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 4
PY 2003
VL 100
IS 5
BP 2634
EP 2638
DI 10.1073/pnas.0437710100
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 652DR
UT WOS:000181365000084
PM 12591955
ER

PT J
AU Schroeder, T
   Fraser, ST
   Ogawa, M
   Nishikawa, S
   Oka, C
   Bornkamm, GW
   Nishikawa, SI
   Honjo, T
   Just, U
AF Schroeder, T
   Fraser, ST
   Ogawa, M
   Nishikawa, S
   Oka, C
   Bornkamm, GW
   Nishikawa, SI
   Honjo, T
   Just, U
TI Recombination signal sequence-binding protein J kappa alters mesodermal
   cell fate decisions by suppressing card cardiomyogenesis
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; NOTCH GENE; MOUSE
   DEVELOPMENT; DROSOPHILA-NOTCH; DIFFERENTIATION; EXPRESSION; HOMOLOG;
   MICE; PATHWAY
AB The transcription factor recombination signal sequence-binding protein Jkappa (RBP-J) is a key downstream element in the signaling pathway of all four mammalian Notch receptors that are critically involved in the control of embryonic and adult development. RBP-J-deficient mice display complex defects and die around day 9.5 postcoitum. Here, we investigate the function of RBP-J in the development of mesodermal cell lineages by using the OP9 stroma coculture system. RBP-J-deficient embryonic stem (ES) cells gave rise to cardiomyocytes, endothelial cells, and primitive and definitive hematopoietic cells. Thus, RBP-J-mediated signals are not required for generation of these cell types. However, when compared with parental RBP-J-expressing ES cells, cardiomyogenesis derived from RBP-J-deficient ES cells was increased. Repression over the cardiogenic pathway was restored by expressing RBP-J in RBP-J-deficient ES cells. Our data indicate that Notch signaling via RBP-J plays an important role for the correct specification of myocardial cell fates.
C1 Inst Clin Mol Biol & Tumor Genet, GSF Natl Res Ctr Environm & Hlth, D-81377 Munich, Germany.
   Kyoto Univ, Dept Mol Genet, Sakyo Ku, Kyoto 606, Japan.
   Kyoto Univ, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
   RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kyoto 6500047, Japan.
RP Just, U (reprint author), Univ Hamburg, Dept Dermatol, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.
RI Just, Ursula/E-6992-2010; Schroeder,  Timm/F-8448-2010
OI Schroeder,  Timm/0000-0001-9320-0252
CR Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002
   Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235
   Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261
   WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3
   KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145
   Krebs LT, 2000, GENE DEV, V14, P1343
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206
   Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853
   Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558
   Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723
   OKA C, 1995, DEVELOPMENT, V121, P3291
   REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S
   KODAMA H, 1994, EXP HEMATOL, V22, P979
   Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091
   ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B
   Shawber C, 1996, DEVELOPMENT, V122, P3765
   Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299
   Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   Rones MS, 2000, DEVELOPMENT, V127, P3865
   deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0
   Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7
   DELAMO FF, 1992, DEVELOPMENT, V115, P737
   Hirashima M, 1999, BLOOD, V93, P1253
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Kadesch T, 2000, EXP CELL RES, V260, P1, DOI 10.1006/excr.2000.4921
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243
   LINTS TJ, 1993, DEVELOPMENT CAMBRIDG, V119, P415
   McIvor ZJ, 2000, BRIT J HAEMATOL, V110, P674, DOI 10.1046/j.1365-2141.2000.02214.x
   Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722
   Nofziger D, 1999, DEVELOPMENT, V126, P1689
   Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5
   SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
NR 42
TC 82
Z9 83
U1 1
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 1
PY 2003
VL 100
IS 7
BP 4018
EP 4023
DI 10.1073/pnas.0438008100
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 664JR
UT WOS:000182058400088
PM 12655061
ER

PT J
AU Tanigaki, K
   Kuroda, K
   Han, H
   Honjo, T
AF Tanigaki, K
   Kuroda, K
   Han, H
   Honjo, T
TI Regulation of B cell development by Notch/RBP-J signaling
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE conditional knockout; Fo B cells; MZ B cells; staphylococcal infection
ID HEMATOPOIETIC PROGENITOR CELLS; MARGINAL ZONE; NUCLEAR ANTIGEN-2;
   GENE-EXPRESSION; KAPPA-B; RESPONSES; PATHWAY; SPLEEN; FATE; LINEAGE
AB RBP-J is an essential signal mediator of all four Notches in nuclei. Loss-of-function analyses clearly show the crucial roles of RBP-J in commitment of T cells versus B cells as well as MZ B cells versus Fo B cells. Such Notch/RBP-J regulation of dichotomic differentiation steps in lymphocyte is reminiscent of the development of sensory organ precursors (SOPs) in Drosophila. Studies on RBP-J conditional knockout mice that have lost MZ B cells without affecting Fo B cell functions have shown that MZ B cells play pivotal roles in immune responses to blood-borne bacteria. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
CR AMLOT PL, 1985, EUR J IMMUNOL, V15, P508, DOI 10.1002/eji.1830150516
   Strobl LJ, 2000, J VIROL, V74, P1727, DOI 10.1128/JVI.74.4.1727-1735.2000
   Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   ZIMBERSTROBL U, 1994, EMBO J, V13, P4973
   Sato S, 1997, J IMMUNOL, V158, P4662
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175
   Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196
   Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6
   OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71
   Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3
   Cheng PY, 2001, J IMMUNOL, V167, P4458
   Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855
   Ordentlich P, 1998, MOL CELL BIOL, V18, P2230
   KRAAL G, 1992, INT REV CYTOL, V132, P31
   Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8
   Weih DS, 2001, J IMMUNOL, V167, P1909
   DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559
   Guinamard R, 2000, NAT IMMUNOL, V1, P31
   Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7
   Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8
   Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   BACHMANN MF, 1994, J IMMUNOL, V153, P3386
   Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033
   Buiting AMJ, 1996, SCAND J IMMUNOL, V43, P398, DOI 10.1046/j.1365-3083.1996.d01-54.x
   Cyster JG, 2000, NAT IMMUNOL, V1, P9, DOI 10.1038/76859
   Jones P, 1998, BLOOD, V92, P1505
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Kurooka Hisanori, 2000, Journal of Biological Chemistry, V275, P17211, DOI 10.1074/jbc.M000909200
   LANE PJL, 1986, EUR J IMMUNOL, V16, P1569, DOI 10.1002/eji.1830161216
   Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.0.CO;2-P
   McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6
   Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200
   Morimura T, 2001, J IMMUNOL, V166, P3277
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203
   YIJIN L, 2002, J EXP MED, V194, P1691
NR 49
TC 25
Z9 26
U1 1
U2 4
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD APR
PY 2003
VL 15
IS 2
BP 113
EP 119
DI 10.1016/S1044-5323(03)00008-3
PG 7
WC Immunology
SC Immunology
GA 672CV
UT WOS:000182504200007
PM 12681948
ER

PT J
AU Lim, EM
   Honjo, T
AF Lim, EM
   Honjo, T
TI Three-dimensional visualization forest of landscapes by VRML
SO LANDSCAPE AND URBAN PLANNING
LA English
DT Article
DE forest landscape visualization; forest landscape simulation;
   walk-through simulation; VRML; computer graphics
ID GEOGRAPHIC INFORMATION; SIMULATION
AB Computer technology has been used to develop three-dimensional (3D) forest landscape visualization systems that include the function of three-dimensional digital plant modeling. While the earlier systems accurately simulated forest landscapes, they lacked sufficient speed and could not adequately perform walk-through simulations.
   The objective of this study is to describe the forest landscape visualization procedure capable of walk-through simulations and its application. We developed a forest landscape visualization system using virtual reality modeling language (VRML). This visualization system works with data of forest stands rather than individual trees. To confirm the feasibility of the system, we visualized an actual forest landscape with thousands to tens of thousands of trees. We also simulated a variety of forest landscapes and showed how this system can be used to simulate the changes of forest landscapes that occur as a result of natural processes or man-made disturbances such as planting, thinning, and harvesting.
   This visualization system was capable of walk-through simulation and the three-dimensional images rendered by the system enabled us to effectively visualize the forest landscape resources. The visualization by computer graphics also made it possible to confirm the accuracy of forest data. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chiba Univ, Fac Hort, Matsudo, Chiba 2718510, Japan.
   Chiba Univ, Grad Sch Sci & Technol, Inage Ku, Chiba 2638522, Japan.
RP Lim, EM (reprint author), Chiba Univ, Fac Hort, 648 Matsudo, Matsudo, Chiba 2718510, Japan.
CR Honjo T, 2001, LANDSCAPE URBAN PLAN, V55, P175, DOI 10.1016/S0169-2046(01)00152-9
   Perrin L, 2001, LANDSCAPE URBAN PLAN, V54, P33, DOI 10.1016/S0169-2046(01)00124-4
   LANGE E, 1994, LANDSCAPE URBAN PLAN, V30, P99, DOI 10.1016/0169-2046(94)90070-1
   Bergen SD, 1998, LANDSCAPE URBAN PLAN, V40, P283, DOI 10.1016/S0169-2046(97)00091-1
   Bishop ID, 2001, LANDSCAPE URBAN PLAN, V56, P97, DOI 10.1016/S0169-2046(01)00177-3
   de Reffye P., 1988, Computer Graphics, V22
   DEREFFYE P, 1991, ACTA BIOTHEOR, V39, P325
   Ervin SM, 1999, LANDSCAPE ARCHIT, V89, P54
   FRIDLEY JL, 1991, P ASAE ANN INT M PRE
   HONJO T, 1992, J JPN I LANDSCAPE AR, V55, P301
   HONJO T, 1995, B SCH HIGH TECH TOKA, P177
   McGaughey RJ, 1998, J FOREST, V96, P9
   MORIMOTO Y, 1993, J JPN I LANDSCAPE AR, V57, P113
   Muhar A, 2001, LANDSCAPE URBAN PLAN, V54, P5, DOI 10.1016/S0169-2046(01)00122-0
   Oppenheimer P. E., 1986, Computer Graphics, V20
   ORLAND B, 1994, P 5 FOR SERV REM SEN, P283
   ORLAND B, 1994, LANDSCAPE URBAN PLAN, V30, P83, DOI 10.1016/0169-2046(94)90069-8
   ORLAND B, 1997, SMART FOREST, V2, P30
   PRUSINKIEWICZ P, 1988, COMP GRAPH, V22, P146
   Saito K., 1993, NICONGRAPH PAPER CON, V9, P226
NR 20
TC 24
Z9 33
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2046
J9 LANDSCAPE URBAN PLAN
JI Landsc. Urban Plan.
PD APR 30
PY 2003
VL 63
IS 3
BP 175
EP 186
AR PII S0169-2046(02)00189-5
DI 10.1016/S0169-2046(02)00189-5
PG 12
WC Ecology; Environmental Studies; Geography; Geography, Physical; Urban
   Studies
SC Environmental Sciences & Ecology; Geography; Physical Geography; Urban
   Studies
GA 671AE
UT WOS:000182441800005
ER

PT J
AU Kanatsu-Shinohara, M
   Toyokuni, S
   Morimoto, T
   Matsui, S
   Honjo, T
   Shinohara, T
AF Kanatsu-Shinohara, M
   Toyokuni, S
   Morimoto, T
   Matsui, S
   Honjo, T
   Shinohara, T
TI Functional assessment of self-renewal activity of male germline stem
   cells following cytotoxic damage and serial transplantation
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE developmental biology; gametogenesis; Sertoli cells; spermatogenesis;
   testis
ID FISSION NEUTRON-IRRADIATION; MOUSE TESTIS; MICE; SPERMATOGENESIS;
   COLONIES
AB Spermatogenesis is dependent on a small population of stem cells. Although stem cells are believed to expand infinitely, there is little functional evidence regarding whether spermatogonial stem cells can increase in their number. Using the spermatogonial transplantation technique, we evaluated the proliferative potential of spermatogonial stem cells in two models of regeneration. After busulfan injection to deplete stem cells, the surviving stem cells were able to expand by at least 15.8-fold within 2 mo. On the other hand, a serial transplantation study indicated that one transplanted stem cell was able to expand by 3.8-and 12-fold within 2 and 4 mo, respectively. These results provide direct functional evidence for the expansion of stem cells and establish the basis for further characterization of the stem cell self-renewal process.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Clin Epidemiol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan.
RP Shinohara, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Toyokuni, Shinya/C-1358-2010
OI Toyokuni, Shinya/0000-0002-5757-1109
CR Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429
   Ogawa T, 2000, NAT MED, V6, P29
   TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193
   Ogawa T, 1997, INT J DEV BIOL, V41, P111
   SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313
   De Rooij DG, 2000, J ANDROL, V21, P776
   Bartell JG, 2000, BIOL REPROD, V63, P409, DOI 10.1095/biolreprod63.2.409
   BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298
   GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7
   Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   BELLVE AR, 1993, METHOD ENZYMOL, V225, P84
   BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1
   de Rooij D G, 1970, Virchows Arch B Cell Pathol, V4, P267
   HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431
   HEMSWORTH BN, 1963, J REPROD FERTIL, V5, P187
   KOSHIMIZU U, 1992, DEVELOPMENT, V114, P861
   KRAMER M F, 1970, Virchows Archiv B Cell Pathology, V4, P276
   Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266
   MEITRICH ML, 1978, RADIAT RES, V74, P349
   Noll M, 2002, EXP HEMATOL, V30, P679, DOI 10.1016/S0301-472X(02)00838-X
   Parreira GG, 1999, TISSUE CELL, V31, P242, DOI 10.1054/tice.1999.0006
   Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360
   POTTEN CS, 1992, OXFORD TXB PATHOLOGY, V1, P43
   SILVERS WK, 1979, COAT COLORS MICE MOD, P206
   VANKEULE.CJ, 1973, CELL TISSUE KINET, V6, P337
   VANKEULE.CJ, 1974, CELL TISSUE KINET, V7, P549
   VANBEEK MEAB, 1990, CELL TISSUE KINET, V23, P1
   VANBEEK MEAB, 1986, RADIAT RES, V107, P11, DOI 10.2307/3576846
   VANDENAARDWEG GJMJ, 1983, RADIAT RES, V94, P447, DOI 10.2307/3575904
   VANDENAARDWEG GJMJ, 1982, RADIAT RES, V89, P150, DOI 10.2307/3575692
   VANKEULEN CJG, 1975, CELL TISSUE KINET, V8, P543
   WITHERS HR, 1974, RADIAT RES, V57, P88, DOI 10.2307/3573759
   Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789
NR 34
TC 42
Z9 48
U1 1
U2 4
PU SOC STUDY REPRODUCTION
PI MADISON
PA 1603 MONROE ST, MADISON, WI 53711-2021 USA
SN 0006-3363
J9 BIOL REPROD
JI Biol. Reprod.
PD MAY
PY 2003
VL 68
IS 5
BP 1801
EP 1807
DI 10.1095/biolreprod.102.012575
PG 7
WC Reproductive Biology
SC Reproductive Biology
GA 673PQ
UT WOS:000182589700042
PM 12606387
ER

PT J
AU Sugawara, Y
   Kamioka, H
   Honjo, T
   Takano-Yamamoto, T
AF Sugawara, Y
   Kamioka, H
   Honjo, T
   Takano-Yamamoto, T
TI Three-dimensional quantitative evaluation of osteocytes in bone
SO BONE
LA English
DT Meeting Abstract
CT 1ST Joint meeting of the
   International-Bone-and-Mineral-Society/Japanese-Society-for-Bone-and-Min
   eral-Research
CY JUN 03-07, 2003
CL OSAKA, JAPAN
SP Int Bone & Mineral Soc, Japanese Soc bone & Mineral Res
C1 Okayama Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Okayama 7008530, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY
PY 2003
VL 32
IS 5
SU S
BP S142
EP S142
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 683AB
UT WOS:000183123300307
ER

PT J
AU Wang, SD
   Bajorath, J
   Flies, DB
   Dong, HD
   Honjo, T
   Chen, LP
AF Wang, SD
   Bajorath, J
   Flies, DB
   Dong, HD
   Honjo, T
   Chen, LP
TI Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple
   costimulatory function from PD-1 interaction
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE PD-1 ligands; mutagenesis; costimulation; T cell activation
ID T-CELL ACTIVATION; CO-STIMULATION; B7 FAMILY; CTLA-4; EXPRESSION;
   RECEPTOR; MEMBER; ENGAGEMENT; RESPONSES; CRITERIA
AB B7-H1 and B7-DC are ligands for PD-1, a receptor implicated in negative regulation of T and B cell functions. These ligands, however, also costimulate T cell responses. It remains elusive whether or not costimulation is mediated through PD-1. By comparative molecular modeling and site-directed mutagenesis, we found that nonconserved residues between these ligands on the A'GFCC'C" face mediate interaction with PD-1. This indicates significant structural heterogeneity of the interactions between PD-1 and its ligands. Importantly, ligand mutants with abolished PD-1 binding capacity could still costimulate proliferation and cytokine production of T cells from normal and PD-1-deficient mice. Our results reveal unique binding characteristics of B7-H1 and B7-DC and provide direct evidence for an independent costimulatory receptor other than PD-1.
C1 Mayo Clin, Mayo Grad Sch, Dept Immunol, Rochester, MN 55905 USA.
   Mayo Clin, Mayo Med Sch, Rochester, MN 55905 USA.
   Albany Mol Res Inc, Bothell Res Ctr, Bothell, WA 98011 USA.
   Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.
   Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Chen, LP (reprint author), Mayo Clin, Mayo Grad Sch, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.
CR Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L
   Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618
   Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582
   FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540
   Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339
   Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809
   Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533
   Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541
   WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X
   Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Wang SD, 2000, BLOOD, V96, P2808
   CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985
   Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112
   Bajorath J, 1997, J MOL GRAPH MODEL, V15, P135, DOI 10.1016/S1093-3263(97)00020-X
   Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527
   Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781
   Wang SD, 2002, J EXP MED, V195, P1033, DOI 10.1084/jem.20011607
NR 36
TC 168
Z9 198
U1 4
U2 8
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 5
PY 2003
VL 197
IS 9
BP 1083
EP 1091
DI 10.1084/jem.20021752
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 676KW
UT WOS:000182752000003
PM 12719480
ER

PT J
AU Okazaki, I
   Hiai, H
   Kakazu, N
   Yamada, S
   Muramatsu, M
   Kinoshita, K
   Honjo, T
AF Okazaki, I
   Hiai, H
   Kakazu, N
   Yamada, S
   Muramatsu, M
   Kinoshita, K
   Honjo, T
TI Constitutive expression of AID leads to tumorigenesis
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE class switch recombination; somatic hypermutation; genomic instability;
   lymphoma; T cell receptor gene
ID CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; RNA-EDITING ENZYME;
   SOMATIC HYPERMUTATION; MESSENGER-RNA; BURKITT-LYMPHOMA; DEFICIENT MICE;
   CELL LYMPHOMAS; B-CELLS; C-MYC
AB Genome stability is regulated by the balance between efficiencies of the repair machinery and genetic alterations such as mutations and chromosomal rearrangements. It has been postulated that deregulation of class switch recombination (CSR) and somatic hypermutation (SHM), which modify the immunoglobulin (Ig) genes in activated B cells, may be responsible for aberrant chromosomal translocations and mutations of non-Ig genes that lead to lymphocyte malignancy. However, the molecular basis for these genetic instabilities is not clearly understood. Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce both CSR and SHM in artificial substrates in fibroblasts as well as B cells. Here we show that constitutive and ubiquitous expression of AID in transgenic mice caused both T cell lymphomas and dysgenetic lesions of epithelium of respiratory bronchioles (micro-adenomas) in all individual mice. Point mutations, but not translocations, were massively introduced in expressed T cell receptor (TCR) and c-myc genes in T lymphoma cells. The results indicate that AID can mutate non-Ig genes including oncogenes, implying that aberrant AID expression could be a cause of human malignancy.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Prefectural Univ Med, Dept Hyg, Kyoto 6028566, Japan.
   Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   NIWA H, 1991, GENE, V108, P193
   Martin A, 2002, NATURE, V415, P802
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312
   DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4
   Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Storb U, 1998, IMMUNOL REV, V162, P153
   Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640
   YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423
   Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977
   IKUTA K, 1986, J EXP MED, V164, P428, DOI 10.1084/jem.164.2.428
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   Raffeld M, 1995, Curr Top Microbiol Immunol, V194, P265
NR 32
TC 283
Z9 288
U1 1
U2 10
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 5
PY 2003
VL 197
IS 9
BP 1173
EP 1181
DI 10.1084/jem.20030275
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 676KW
UT WOS:000182752000011
PM 12732658
ER

PT J
AU Harada, Y
   Muramatsu, M
   Shibata, T
   Honjo, T
   Kuroda, K
AF Harada, Y
   Muramatsu, M
   Shibata, T
   Honjo, T
   Kuroda, K
TI Unmutated immunoglobulin M can protect mice from death by influenza
   virus infection
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE AID; class-switch recombination; somatic hypermutation; antiviral
   immunity; antibody
ID CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; HETEROSUBTYPIC
   IMMUNITY; SOMATIC HYPERMUTATION; A VIRUS; T-CELLS; ANTIBODY;
   NEUTRALIZATION; RESPONSES; ENZYME
AB To elucidate the role of class switch recombination (CSR,) and somatic hypermutation (SHM) in virus infection, we have investigated the influence of the primary and secondary infections of influenza virus on mice deficient of activation-induced cytidine deaminase (AID), which is absolutely required for CSR and SHM. In the primary infection, AID deficiency caused no significant difference in mortality but did cause difference in morbidity. In the secondary infection with a lethal dose of influenza virus, both AID(-/-) and AID(+/-) mice survived completely. However, AID(-/-) mice could not completely block replication of the virus and their body weights decreased severely whereas AID(+/-) mice showed almost complete prevention from the reinfection. Depletion of CD8(+) T cells by administration of an anti-CD8 monoclonal antibody caused slightly severer body weight loss but did not alter the survival rate of AID(-/-) mice in secondary infection. These results indicate that unmutated immunoglobulin (Ig)M alone is capable of protecting mice from death upon primary and secondary infections. Because the titers of virus-neutralizing antibodies were comparable between AID(-/-) and AID(+/-) mice at the time of the secondary infection, a defect of AID(-/-) mice in protection of morbidity might be due to the absence of either other Ig classes such as IgG, high affinity antibodies with SHM, or both.
C1 Nihon Univ, Sch Med, Dept Immunol & Microbiol, Itabashi Ku, Tokyo 1738610, Japan.
   Osaka Univ Pharmaceut Sci, Dept Virol & Immunol, Takatsuki, Osaka 5691094, Japan.
   Kyoto Univ, Dept Med Chem, Grad Sch med, Kyoto 606, Japan.
RP Kuroda, K (reprint author), Nihon Univ, Sch Med, Dept Immunol & Microbiol, Itabashi Ku, Oyaguchi Kamicho, Tokyo 1738610, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250
   Nguyen HH, 1999, VIROLOGY, V254, P50, DOI 10.1006/viro.1998.9521
   Zinkernagel RM, 2001, ADV IMMUNOL, V79, P1, DOI 10.1016/S0065-2776(01)79001-3
   Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   DIMMOCK NJ, 1993, CURR TOP MICROBIOL, V183, P1
   Huber VC, 2001, J IMMUNOL, V166, P7381
   Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271
   Ugolini S, 1997, J EXP MED, V186, P1287, DOI 10.1084/jem.186.8.1287
   Benton KA, 2001, J IMMUNOL, V166, P7437
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   BEEBE DP, 1981, J IMMUNOL, V126, P1562
   CLARKE SH, 1990, J IMMUNOL, V144, P2795
   DIETZSCHOLD B, 1987, VIROLOGY, V161, P29, DOI 10.1016/0042-6822(87)90167-X
   Frazers J, 1999, FUNDAMENTAL IMMUNOLO, P37
   HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417
   LU S, 1992, J VIROL, V66, P2547
   PALLADINO G, 1995, J VIROL, V69, P2075
   Szomolanyi-Tsuda Eva, 2002, P247
   Takada A, 1999, J VIROL, V73, P8303
   WELSH RM, 1992, NATURAL KILLER CELL, P107
NR 26
TC 38
Z9 42
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JUN 16
PY 2003
VL 197
IS 12
BP 1779
EP 1785
DI 10.1084/jem.20021457
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 691RJ
UT WOS:000183619000017
PM 12796467
ER

PT J
AU Schroeder, T
   Bornkamm, G
   Nishikawa, S
   Honjo, T
   Just, U
AF Schroeder, T
   Bornkamm, G
   Nishikawa, S
   Honjo, T
   Just, U
TI Activated Notch1 impairs the development of ES cell-derived cardiac
   muscle and hematopoietic cells
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
CT 32nd Annual Scientific Meeting of the
   International-Society-for-Experimental-Hematology
CY JUL 05-08, 2003
CL PARIS, FRANCE
SP Int Soc Exptl Hematol
C1 Riken Ctr Dev, Kobe, Hyogo, Japan.
   GSF Inst Clin Mol Biol, Munich, Germany.
   Kyoto Univ, Dept Med Chem, Kyoto, Japan.
   Inst Med Biochem, Rostock, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD JUL
PY 2003
VL 31
IS 7
SU 1
MA 331
BP 171
EP 171
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 701HR
UT WOS:000184162600321
ER

PT J
AU Michishita, M
   Ikeda, T
   Nakashiba, T
   Ogawa, M
   Tashiro, K
   Honjo, T
   Doi, K
   Itohara, S
   Endo, S
AF Michishita, M
   Ikeda, T
   Nakashiba, T
   Ogawa, M
   Tashiro, K
   Honjo, T
   Doi, K
   Itohara, S
   Endo, S
TI A novel gene, Btcl1, encoding CUB and LDLa domains is expressed in
   restricted areas of mouse brain
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE axon guidance; Btcl1; CUB; LDLa; neuropilin; signal sequence trap
ID DENSITY-LIPOPROTEIN RECEPTOR; PUTATIVE TRANSMEMBRANE PROTEIN;
   CHEMOREPELLENT SEMAPHORIN-III; AXON GUIDANCE; SPECIFICITY; SEQUENCE;
   CLONING; NEUROPILIN; MECHANISMS; MODULE
AB A variety of secreted and membrane proteins play key roles in the formation of neuronal circuits in the central nervous system. Using the signal sequence trap method, we isolated and characterized a novel gene, Btcl1 (brain-specific transmembrane protein containing two CUB and an LDLa domains). BTCL1 has significant homology with neuropilin-1 and -2 in their CUB domains. Domain structure of BTCL1 indicates that BTCL1 belongs to a new class of brain-specific CUB domain-containing protein. On Northern blot analysis, Btcl1 mRNA was observed as a single transcript of 3.7 kb specifically in the brain. In situ hybridization analysis revealed that Btcl1 mRNA was highly expressed in the hippocampal CA3 region, olfactory bulb, and neocortex in the adult brain. Expression pattern of mRNA and structural similarity with neuropilin suggest that BTCL1 plays a role in the development and/or maintenance of neuronal circuitry. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 RIKEN, Brain Sci Inst, Neuronal Circuit Mech Res Grp, Wako, Saitama 3510198, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Kyoto 6068501, Japan.
   RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan.
   RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan.
   Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo 1138657, Japan.
RP Endo, S (reprint author), RIKEN, Brain Sci Inst, Neuronal Circuit Mech Res Grp, Wako, Saitama 3510198, Japan.
RI Itohara, Shigeyoshi/I-8769-2012
CR Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X
   Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8
   He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6
   Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M
   TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252
   Takahara K, 1996, GENOMICS, V34, P157, DOI 10.1006/geno.1996.0260
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305
   Qing J, 1999, ONCOGENE, V18, P335, DOI 10.1038/sj.onc.1202290
   Nakashiba T, 2000, J NEUROSCI, V20, P6540
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9
   Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1
   Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3
   Ishii H, 1998, GENOMICS, V51, P132, DOI 10.1006/geno.1998.5339
   Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k
   LECAIN E, 1991, J NEUROCHEM, V56, P2133, DOI 10.1111/j.1471-4159.1991.tb03476.x
   OBSTPERNBERG K, 1999, J NEUROSCI RES, V58, P130
   SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1
   Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s
NR 24
TC 16
Z9 18
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 4
PY 2003
VL 306
IS 3
BP 680
EP 686
DI 10.1016/S0006-291X(03)01035-0
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 695EV
UT WOS:000183818900009
PM 12810072
ER

PT J
AU Iwai, YH
   Terawaki, S
   Ikegawa, M
   Okazaki, T
   Honjo, T
AF Iwai, YH
   Terawaki, S
   Ikegawa, M
   Okazaki, T
   Honjo, T
TI PD-1 inhibits antiviral immunity at the effector phase in the liver
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE T cell; virus; peripheral tolerance; endothelial cell; immuno-inhibition
ID T-CELL PROLIFERATION; ENDOTHELIAL-CELLS; LYMPHOCYTE-ACTIVATION; B7
   FAMILY; EXPRESSION; ANTIGEN; RECEPTOR; IMMUNORECEPTOR; TOLERANCE; MEMBER
AB Unlike naive T cells, effector T cells can be activated by either T cell receptor signal or costimulatory signal alone and therefore the absence of costimulatory molecules on tissue cells cannot explain the tolerance mechanism at the effector phase. Here we report that PD-L1, the ligand for the immunoinhibitory receptor PD-1, was expressed on vascular endothelium in peripheral tissues. Liver nonparenchymal cells including sinusoidal endothelial cells and Kupffer cells constitutively expressed PD-L1 and inhibited proliferation and cell division of activated T cells expressing PD-1. The absence of PD-1 induced proliferation of effector T cells in the adenovirus-infected liver and resulted in rapid clearance of the virus. These results indicate that PD-1 plays an important role in T cell tolerance at the effector phase and the blockade of the PD-1 pathway can augment antiviral immunity.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida, Kyoto 6068501, Japan.
CR CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0
   Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123
   Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225
   Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618
   Dong HD, 1999, NAT MED, V5, P1365
   CANTOR HM, 1967, NATURE, V215, P744, DOI 10.1038/215744a0
   Knolle PA, 2001, TRENDS IMMUNOL, V22, P432, DOI 10.1016/S1471-4906(01)01957-3
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   KAMADA N, 1980, TRANSPLANTATION, V29, P429, DOI 10.1097/00007890-198005000-00021
   Rulifson IC, 1997, J IMMUNOL, V158, P658
   RUBINSTEIN D, 1986, J IMMUNOL, V137, P1803
   Limmer A, 2000, NAT MED, V6, P1348
   FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625
   Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4
   Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   Mazanet MM, 2002, J IMMUNOL, V169, P3581
   KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816
   Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1
   Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Ozkaynak E, 2002, J IMMUNOL, V169, P6546
   Shlapatska LM, 2001, J IMMUNOL, V166, P5480
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   CARAYON P, 1992, J IMMUNOL METHODS, V147, P225
   Chen YL, 2002, IMMUNOL LETT, V81, P1, DOI 10.1016/S0165-2478(01)00322-4
   Dubey C, 1996, J IMMUNOL, V157, P3280
   Flynn K, 1997, EUR J IMMUNOL, V27, P456, DOI 10.1002/eji.1830270216
   Iwaia Y, 2002, IMMUNOL LETT, V83, P215, DOI 10.1016/S0165-2478(02)00088-3
   KAWASHIMA H, 1994, CURR EYE RES, V13, P575, DOI 10.3109/02713689408999891
   KAWASHIMA H, 1994, J IMMUNOL, V153, P1982
   Marelli-Berg FM, 2000, J IMMUNOL, V165, P4182
   Mullbacher A, 1996, IMMUNOL REV, V150, P113, DOI 10.1111/j.1600-065X.1996.tb00698.x
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   Swain SL, 1996, IMMUNOL REV, V150, P143, DOI 10.1111/j.1600-065X.1996.tb00700.x
   WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G
   Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k
NR 48
TC 207
Z9 231
U1 3
U2 11
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD JUL 7
PY 2003
VL 198
IS 1
BP 39
EP 50
DI 10.1084/jem.20022235
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 700VP
UT WOS:000184132100005
PM 12847136
ER

PT J
AU Costa, RM
   Honjo, T
   Silva, AJ
AF Costa, RM
   Honjo, T
   Silva, AJ
TI Learning and memory deficits in Notch mutant mice
SO CURRENT BIOLOGY
LA English
DT Article
ID MORRIS WATER MAZE; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; PRESENILIN;
   HIPPOCAMPUS; CONTEXT; ADULT; NEUROGENESIS; PERFORMANCE; DROSOPHILA
AB Notch is a critical component of evolutionarily conserved signaling mechanisms that regulate development [1] and may contribute to plasticity-related processes, including changes in neurite structure [2] and maintenance of neural stem cells [3]. Deficits in the Notch pathway are responsible for Alagille [4] and Cadasil syndromes [5], which are associated with mental retardation and dementia. Additionally, in postmitotic neurons, Notch proteins interact with presenilins [6-9] and with beta-amyloid precursor protein [10] and could therefore have a role in the memory deficits associated with familial and sporadic Alzheimer's disease. To test if alterations in Notch signaling can lead to learning and memory deficits, we studied mice with mutations in this pathway. Here, we show that null heterozygous mutations in Notch1 result in deficits in spatial learning and memory without affecting other forms of learning, motor control, or exploratory activity. We also show that null heterozygous mutations in the downstream cofactor RBP-J result in similarly specific spatial learning and memory deficits. These data indicate that a constitutive decrease in Notch signaling can result in specific learning and memory deficits and suggest that abnormalities in Notch-dependent transcription may contribute to the cognitive deficits associated with Alzheimer's disease and Alagille and Cadasil syndromes.
C1 Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Silva, AJ (reprint author), Univ Calif Los Angeles, Dept Neurobiol, 695 Young Dr S,Room 2554,Box 951761, Los Angeles, CA 90095 USA.
OI Costa, Rui/0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494
CR Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58
   De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083
   Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263
   Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128
   Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091
   Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638
   Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599
   Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382
   Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783
   Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799
   Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6
   Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506
   Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202
   Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2001.4004
   Cho YH, 1999, BEHAV BRAIN RES, V98, P77
   Presente A, 2001, NEUROREPORT, V12, P3321, DOI 10.1097/00001756-200110290-00035
   Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898
   Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584
   Berezovska O, 1998, J NEUROPATH EXP NEUR, V57, P738, DOI 10.1097/00005072-199808000-00003
   Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910
   Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189
   GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618
   Ye YH, 1999, NATURE, V398, P525
   Berezovska O, 1999, MOL BRAIN RES, V69, P273, DOI 10.1016/S0169-328X(99)00119-9
   CONLON RA, 1995, DEVELOPMENT, V121, P1533
   Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5
   Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037//0735-7044.112.4.863
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x
   BRANDEIS R, 1989, INT J NEUROSCI, V48, P29
   Cestari V, 1999, PSYCHOPHARMACOLOGY, V146, P144, DOI 10.1007/s002130051100
   Chan SL, 2002, NEUROMOL MED, V1, P55
   Figueroa DJ, 2002, NEUROBIOL DIS, V9, P49, DOI 10.1006/nbdi.2001.0447
   Harris JG, 2001, J INT NEUROPSYCH SOC, V7, P768, DOI 10.1017/S135561770176612X
   Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243
   Micchelli Craig A., 2003, FASEB Journal, V17, P79
   Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998
   Nofziger D, 1999, DEVELOPMENT, V126, P1689
   Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26
NR 43
TC 116
Z9 123
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD AUG 5
PY 2003
VL 13
IS 15
BP 1348
EP 1354
DI 10.1016/S0960-9822(03)00492-5
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 709PJ
UT WOS:000184633300033
PM 12906797
ER

PT J
AU Ta, VT
   Nagaoka, H
   Catalan, N
   Durandy, A
   Fischer, A
   Imai, K
   Nonoyama, S
   Tashiro, J
   Ikegawa, M
   Ito, S
   Kinoshita, K
   Muramatsu, M
   Honjo, T
AF Ta, VT
   Nagaoka, H
   Catalan, N
   Durandy, A
   Fischer, A
   Imai, K
   Nonoyama, S
   Tashiro, J
   Ikegawa, M
   Ito, S
   Kinoshita, K
   Muramatsu, M
   Honjo, T
TI AID mutant analyses indicate requirement for class-switch-specific
   cofactors
SO NATURE IMMUNOLOGY
LA English
DT Article
ID INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; APOBEC-1
   COMPLEMENTATION FACTOR; RNA EDITING ENZYME; HYPER-IGM SYNDROME; SOMATIC
   HYPERMUTATION; ANTIBODY DIVERSIFICATION; GENE CONVERSION; MESSENGER-RNA;
   CELL-LINE
AB Activation-induced cytidine deaminase (AID) is the essential and sole B cell-specific factor required for class-switch recombination (CSR) and somatic hypermutation (SHM). However, it is not known how AID differentially regulates these two independent events. Involvement of several cofactors interacting with AID has been indicated by scattered distribution of loss-of-function point mutations and evolutionary conservation of the entire 198-amino-acid protein. Here, we report that human AID mutant proteins with insertions, replacements or truncations in the C-terminal region retained strong SHM activity but almost completely lost CSR activity. These results indicate that AID requires interaction with a cofactor(s) specific to CSR.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Hop Necker Enfants Malad, INSERM, U429, Paris, France.
   Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3598513, Japan.
   Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138519, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015; Imai, Kohsuke/Q-2602-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533; Imai,
   Kohsuke/0000-0003-2132-8403
CR Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Martin A, 2002, NATURE, V415, P802
   Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   YELAMOS J, 1995, NATURE, V376, P225
   AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200
   Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni0902-826
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889
   REABAN ME, 1994, J BIOL CHEM, V269, P21850
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   MUSSMANN R, 1997, EUR J IMMUNOL, V27, P1610
   Sowden MP, 2002, J CELL SCI, V115, P1027
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41
NR 47
TC 218
Z9 220
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2003
VL 4
IS 9
BP 843
EP 848
DI 10.1038/ni964
PG 6
WC Immunology
SC Immunology
GA 715YN
UT WOS:000185002200010
PM 12910268
ER

PT J
AU Toda, H
   Tsuji, M
   Nakano, I
   Kobuke, K
   Hayashi, T
   Kasahara, H
   Takahashi, J
   Mizoguchi, A
   Houtani, T
   Sugimoto, T
   Hashimoto, N
   Palmer, TD
   Honjo, T
   Tashiro, K
AF Toda, H
   Tsuji, M
   Nakano, I
   Kobuke, K
   Hayashi, T
   Kasahara, H
   Takahashi, J
   Mizoguchi, A
   Houtani, T
   Sugimoto, T
   Hashimoto, N
   Palmer, TD
   Honjo, T
   Tashiro, K
TI Stem cell-derived neural stem/progenitor cell supporting factor is an
   autocrine/paracrine survival factor for adult neural stem/progenitor
   cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; SIGNAL SEQUENCE TRAP; CAENORHABDITIS-ELEGANS;
   SECRETED PROTEINS; PROGENITOR CELLS; NERVOUS-SYSTEM; DENTATE GYRUS;
   BRAIN; PROLIFERATION; RAT
AB Recent evidence suggests that adult neural stem/progenitor cells (ANSCs) secrete autocrine/paracrine factors and that these intrinsic factors are involved in the maintenance of adult neurogenesis. We identified a novel secretory molecule, stem cell-derived neural stem/ progenitor cell supporting factor (SDNSF), from adult hippocampal neural stem/ progenitor cells by using the signal sequence trap method. The expression of SDNSF in adult central nervous system was localized to hippocampus including dentate gyrus, where the neurogenesis persists throughout life. In induced neurogenesis status seen in ischemically treated hippocampus, the expression of SDNSF was up-regulated. As functional aspects, SDNSF protein provided a dose-dependent survival effect for ANSC following basic fibroblast growth factor 2 (FGF-2) withdrawal. ANSCs treated by SDNSF also retain self-renewal potential and multipotency in the absence of FGF-2. However, SDNSF did not have mitogenic activity, nor was it a cofactor that promoted the mitogenic effects of FGF-2. These data suggested an important role of SDNSF as an autocrine/paracrine factor in maintaining stem cell potential and lifelong neurogenesis in adult central nervous system.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, Kyoto 6068507, Japan.
   Mie Univ, Sch Med, Dept Anat, Tsu, Mie 5148507, Japan.
   Kansai Med Univ, Dept Anat & Brain Sci, Osaka 5708506, Japan.
   Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan.
RP Tashiro, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
CR LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Arsenijevic Y, 2001, J NEUROSCI, V21, P7194
   Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z
   Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7
   Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192
   Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0
   SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385
   Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257
   Gritti A, 1996, J NEUROSCI, V16, P1091
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063
   Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401
   MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511
   Terami H, 1999, J CELL BIOL, V146, P193, DOI 10.1083/jcb.146.1.193
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879
   Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033
   BAYER SA, 1982, EXP BRAIN RES, V46, P315
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Ciccolini F, 1998, J NEUROSCI, V18, P7869
   Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.0.CO;2-Q
   Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595
   Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3
   ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   Nakashiba T, 2000, J NEUROSCI, V20, P6540
   MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557
   BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370
   NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424
   Palmer TD, 1999, J NEUROSCI, V19, P8487
   PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035
   KAPLAN MS, 1984, J NEUROSCI, V4, P1429
   AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Liu JL, 1998, J NEUROSCI, V18, P7768
   Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476
   LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U
   BLOCHBERGER TC, 1989, J BIOL CHEM, V264, P20718
   BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97
   DERIDDER LI, 1987, ACTA NEUROPATHOL, V72, P207
   Houtani T, 2000, J COMP NEUROL, V424, P489
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   Kato K, 2000, BLOOD, V96, P362
   Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200
   Martens DJ, 2000, J NEUROSCI, V20, P1085
   Nakamura T, 1998, GENOMICS, V54, P89, DOI 10.1006/geno.1998.5571
   NAKAYAMA H, 1992, NUCLEIC ACIDS RES, V20, P4939, DOI 10.1093/nar/20.18.4939
   Sambrook J., 1989, MOL CLONING LAB MANU
   Tashiro K, 1999, METHOD ENZYMOL, V303, P479
NR 50
TC 35
Z9 37
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 12
PY 2003
VL 278
IS 37
BP 35491
EP 35500
DI 10.1074/jbc.M305342200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 718UG
UT WOS:000185164400091
PM 12832409
ER

PT J
AU Eto, T
   Kinoshita, K
   Yoshikawa, K
   Muramatsu, M
   Honjo, T
AF Eto, T
   Kinoshita, K
   Yoshikawa, K
   Muramatsu, M
   Honjo, T
TI RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic
   hypermutation in mammalian cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; IMMUNOGLOBULIN
   HYPERMUTATION; ANTIBODY DIVERSIFICATION; GENE CONVERSION; B-CELLS; AID;
   EXPRESSION; ENZYME; MECHANISM
AB Antibody diversification by somatic hypermutation, gene conversion, and class switch recombination is completely dependent on activation-induced cytidine deaminase (AID). A recent report showing induction of DNA mutations in Escherichia coli by overexpression of AID, Apobec-1, and related members of the RNA-editing cytidine deaminase family suggested that they may directly modify deoxycytidine in DNA in mammalian cells (DNA-editing model). We therefore examined whether Apobec-1 bona fide RNA-editing enzyme could show somatic hypermutation and class switching activities in murine B lymphocytes and fibroblasts. Unlike AID, Apobec-1 was unable to induce somatic hypermutation or class switching. The results force a reevaluation of the physiological significance of the DNA deaminase activities of AID and Apobec-1 in E. coli and in vitro.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni0902-826
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Yang Y, 1997, P NATL ACAD SCI USA, V94, P13075, DOI 10.1073/pnas.94.24.13075
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Diaz M, 2002, CURR OPIN IMMUNOL, V14, P235, DOI 10.1016/S0952-7915(02)00327-8
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   NAKAMUTA M, 1995, J BIOL CHEM, V270, P13042
   SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522
   Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2
NR 33
TC 23
Z9 24
U1 3
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 28
PY 2003
VL 100
IS 22
BP 12895
EP 12898
DI 10.1073/pnas.2135587100
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 738RF
UT WOS:000186301100070
PM 14559972
ER

PT J
AU Blank, C
   Brown, I
   Marks, R
   Nishimura, H
   Honjo, T
   Gajewski, TF
AF Blank, C
   Brown, I
   Marks, R
   Nishimura, H
   Honjo, T
   Gajewski, TF
TI Absence of programmed death receptor 1 alters thymic development and
   enhances generation of CD4/CD8 double-negative TCR-transgenic T cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID DOUBLE-POSITIVE THYMOCYTES; HEAT-STABLE ANTIGEN; PD-1-DEFICIENT MICE;
   LYMPHOCYTES-T; B7 FAMILY; SELECTION; EXPRESSION; PD-1; MATURATION;
   ACTIVATION
AB Programmed death receptor 1 (PD-1) is expressed on thymocytes in addition to activated lymphocyte cells. Its ligation is thought to negatively regulate T cell activation, and PD-1(-/-) mice develop autoimmunity. To study the role of PD-1 on the development and function of a monoclonal CD8(+) T cell population, 2C TCR-transgenic/recombination-activating gene 2(-/-)/PD-1(-/-) mice were generated. Unexpectedly, similar to 30% of peripheral T cells in these mice were CD4/CD8 double negative (DN). Although the DN cells were not activated by Ag-expressing APCs, they functioned normally in response to anti-CD3/anti-CD28. These cells had a naive surface phenotype and lacked expression of NK1.1, B220, and gammadelta TCR; and the majority did not up-regulate CD8alphaalpha expression upon activation, arguing that they are not predominantly diverted gammadelta-lineage cells. The thymus was studied in detail to infer the mechanism of generation of DN peripheral T cells. Total thymus cellularity was reduced in 2C TCR-transgenic/recombination-activating gene 2(-/-)/PD-1(-/-) mice, and a relative increase in DN cells and decrease in double-positive (DP) cells were observed. Increased annexin V+ cells among the DP population argued for augmented negative selection in PD- mice. In addition, an increased fraction of the DN thymocytes was HSA negative, suggesting that they had undergone positive selection. This possibility was supported by decreased emergence of DN PD-1(-/-) 2C cells in H-2(k) bone marrow chimera recipients. Our results are consistent with a model in which absence of PD-1 leads to greater negative selection of strongly interacting DP cells as well as increased emergence of DN alphabeta peripheral T cells.
C1 Univ Chicago, Sect Hematol Oncol & Committee Immunol, Dept Med, Dept Pathol, Chicago, IL 60637 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
RP Gajewski, TF (reprint author), Univ Chicago, Sect Hematol Oncol & Committee Immunol, Dept Med, Dept Pathol, 5841 S Maryland Ave,MC2115, Chicago, IL 60637 USA.
CR ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0
   TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795
   Gajewski TF, 1996, J IMMUNOL, V156, P465
   VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1
   ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.immunol.12.1.675
   Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   LUCAS B, 1994, J IMMUNOL, V153, P53
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Zhang ZX, 2000, NAT MED, V6, P782
   SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0
   NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Azzam HS, 2001, J IMMUNOL, V166, P5464
   Gajewski TF, 2001, J IMMUNOL, V166, P3900
   GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537
   Burns RP, 1999, CELL IMMUNOL, V194, P162, DOI 10.1006/cimm.1999.1510
   EGERTON M, 1990, INT IMMUNOL, V2, P501, DOI 10.1093/intimm/2.6.501
   EICHMANN K, 1995, IMMUNOL LETT, V44, P87, DOI 10.1016/0165-2478(94)00197-Y
   Erman B, 2002, NAT IMMUNOL, V3, P564, DOI 10.1038/ni800
   Fallarino F, 1999, INT J CANCER, V80, P324, DOI 10.1002/(SICI)1097-0215(19990118)80:2<324::AID-IJC25>3.0.CO;2-D
   HOUGH MR, 1994, J EXP MED, V179, P177, DOI 10.1084/jem.179.1.177
   KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922
   LIEBERMAN SA, 1995, CELL IMMUNOL, V162, P56, DOI 10.1006/cimm.1995.1051
   NIKOLICZUGIC J, 1993, EUR J IMMUNOL, V23, P1699, DOI 10.1002/eji.1830230745
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   Saito T, 1998, CRIT REV IMMUNOL, V18, P359
   Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033
   Teh HS, 1998, J IMMUNOL, V160, P718
   Wack A, 2000, J IMMUNOL, V165, P1236
   Wang RF, 2002, P NATL ACAD SCI USA, V99, P2181, DOI 10.1073/pnas.042692799
   Wurch A, 1999, J IMMUNOL, V162, P2741
NR 43
TC 58
Z9 61
U1 2
U2 5
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD NOV 1
PY 2003
VL 171
IS 9
BP 4574
EP 4581
PG 8
WC Immunology
SC Immunology
GA 735WD
UT WOS:000186136800013
PM 14568931
ER

PT J
AU Ta, VT
   Honjo, T
AF Ta, VT
   Honjo, T
TI Domain organization of activation-induced cytidine deaminase - Reply
SO NATURE IMMUNOLOGY
LA English
DT Letter
C1 Kyoto Univ, Grad Sch Med, Dept Med Biochem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Ta, VT (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Biochem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
CR Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4
NR 1
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD DEC
PY 2003
VL 4
IS 12
BP 1154
EP 1154
DI 10.1038/ni1203-1154
PG 1
WC Immunology
SC Immunology
GA 746VZ
UT WOS:000186769500003
ER

PT J
AU Okazaki, T
   Tanaka, Y
   Nishio, R
   Mitsuiye, T
   Mizoguchi, A
   Wang, J
   Ishida, M
   Hiai, H
   Matsumori, A
   Minato, N
   Honjo, T
AF Okazaki, T
   Tanaka, Y
   Nishio, R
   Mitsuiye, T
   Mizoguchi, A
   Wang, J
   Ishida, M
   Hiai, H
   Matsumori, A
   Minato, N
   Honjo, T
TI Autoantibodies against cardiac troponin I are responsible for dilated
   cardiomyopathy in PD-1-deficient mice
SO NATURE MEDICINE
LA English
DT Article
ID CONGESTIVE-HEART-FAILURE; VIRUS MYOCARDITIS; ANTIBODIES; PROTEINS;
   MODEL; CELLS; IMMUNOADSORPTION; IDENTIFICATION; HYPERTROPHY; MUTATIONS
AB We recently reported that mice deficient in the programmed cell death- 1 (PD- 1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high- titer autoantibodies against a heart- specific, 30- kDa protein. In this study, we purified the 30- kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild- type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage- dependent L- type Ca (2+) current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
C1 Kyoto Univ, Dept Med Chem & Mol Biol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Dept Immunol & Cell Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan.
   Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan.
   Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ Hosp, Div Emergency Med, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Physiol & Biophys, Sakyo Ku, Kyoto 6068501, Japan.
   Mie Univ, Dept Anat, Grad Sch Med, Tsu, Mie 5148507, Japan.
   Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem & Mol Biol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
CR ALVAREZ FL, 1987, CLIN IMMUNOL IMMUNOP, V43, P129, DOI 10.1016/0090-1229(87)90164-4
   Staudt A, 2001, CIRCULATION, V103, P2681
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   POWELL T, 1980, J PHYSIOL-LONDON, V302, P131
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Matsumori A, 2002, CIRC J, V66, P323, DOI 10.1253/circj.66.323
   Cohn JN, 1997, CIRCULATION, V95, P766
   Pankuweit S, 1997, J MOL CELL CARDIOL, V29, P77, DOI 10.1006/jmcc.1996.0253
   MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063
   MAISCH B, 1983, AM J CARDIOL, V52, P1072, DOI 10.1016/0002-9149(83)90535-0
   Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379
   Shou WN, 1998, NATURE, V391, P489
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   NEU N, 1987, J IMMUNOL, V139, P3630
   Felix SB, 2002, J AM COLL CARDIOL, V39, P646, DOI 10.1016/S0735-1097(01)01794-6
   Staudt A, 2001, EUR J PHARMACOL, V423, P115, DOI 10.1016/S0014-2999(01)01113-X
   Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488
   Solaro RJ, 1998, CIRC RES, V83, P471
   Richardson P, 1996, CIRCULATION, V93, P841
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   HERSKOWITZ A, 1993, J AM COLL CARDIOL, V22, P1385
   ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963
   Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304
   Keffer JH, 1996, AM J CLIN PATHOL, V105, P305
   Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x
   Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200
   Matsui S, 1997, J MOL CELL CARDIOL, V29, P641, DOI 10.1006/jmcc.1996.0307
   MATSUMORI A, 1982, CIRCULATION, V65, P1230
   NEU N, 1990, J IMMUNOL, V145, P4094
   NEUMANN DA, 1990, J AM COLL CARDIOL, V16, P839
   Nishio R, 2002, J AM COLL CARDIOL, V40, P1506, DOI 10.1016/S0735-1097(02)02166-6
   SCHULTHEISS HP, 1988, J EXP MED, V168, P2105, DOI 10.1084/jem.168.6.2105
   SCHULTHEISS HP, 1986, ANN NY ACAD SCI, V488, P44
   Schulze K, 1999, CARDIOVASC RES, V44, P91, DOI 10.1016/S0008-6363(99)00204-7
   Solaro RJ, 1999, CIRC RES, V84, P122
   Takagi S, 1998, AM J PHYSIOL-REG I, V274, pR348
   Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3
NR 38
TC 239
Z9 252
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1078-8956
J9 NAT MED
JI Nat. Med.
PD DEC
PY 2003
VL 9
IS 12
BP 1477
EP 1483
DI 10.1038/nm955
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 748CV
UT WOS:000186845400030
PM 14595408
ER

PT J
AU Blank, C
   Brown, I
   Peterson, AC
   Spiotto, M
   Iwai, Y
   Honjo, T
   Gajewski, TF
AF Blank, C
   Brown, I
   Peterson, AC
   Spiotto, M
   Iwai, Y
   Honjo, T
   Gajewski, TF
TI PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell
   receptor (TCR) transgenic CD8(+) T cells
SO CANCER RESEARCH
LA English
DT Article
ID BLOOD MONONUCLEAR-CELLS; B7 FAMILY-MEMBER; MULTIPEPTIDE VACCINE; CANCER
   REGRESSION; LYMPHOCYTES-T; PD-1; ACTIVATION; MELANOMA; IMMUNORECEPTOR;
   INTERLEUKIN-12
AB Although increased circulating tumor antigen-specific CD8(+) T cells can be achieved by vaccination or adoptive transfer, tumor progression nonetheless often occurs through resistance to effector function. To develop a model for identifying mechanisms of resistance to antigen-specific CTLs, poorly immunogenic B16-F10 melanoma was transduced to express the K-b-binding peptide SIYRYYGL as a green fluorescent protein fusion protein that should be recognized by high-affinity 2C TCR transgenic T cells. Although B16.SIY cells expressed high levels of antigen and were induced to express K-b in response to IFN-gamma, they were poorly recognized by primed 2C/RAG2(-/-) T cells. A screen for candidate inhibitory ligands revealed elevated PD-L1/B7H-1 on IFN-gamma-treated B16-F10 cells and also on eight additional mouse tumors and seven human melanoma cell lines. Primed 2C/RAG2(-/-)/PD-1(-/-) T cells showed augmented cytokine production, proliferation, and cytolytic activity against tumor cells compared with wild-type 2C cells. This effect was reproduced with anti-PD-L1 antibody present during the effector phase but not during the priming culture. Adoptive transfer of 2C/RAG2(-/-)/PD-1(-/-) T cells in vivo caused tumor rejection under conditions in which wild-type 2C cells or CTLA-4-deficient 2C cells did not reject. Our results support interfering with PD-L1/PD-1 interactions to augment the effector function of tumor antigen-specific CD8(+) T cells in the tumor microenvironment.
C1 Univ Chicago, Dept Pathol, Sect Hematol Oncol, Chicago, IL 60637 USA.
   Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
RP Gajewski, TF (reprint author), Univ Chicago, Dept Pathol, Sect Hematol Oncol, 5841 S Maryland Ave,MC2115, Chicago, IL 60637 USA.
EM tgajewsk@medicine.bsd.uchicago.edu
CR Yamazaki T, 2002, J IMMUNOL, V169, P5538
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Weber J, 2003, CANCER, V97, P186, DOI 10.1002/cncr.11045
   Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944
   Gajewski TF, 1996, J IMMUNOL, V156, P465
   Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991
   Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100
   Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734
   Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9
   SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0
   Liu XL, 2003, J EXP MED, V197, P1721, DOI 10.1084/jem.20022089
   Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Peterson AC, 2003, J CLIN ONCOL, V21, P2342, DOI 10.1200/JCO.2003.12.144
   Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Seliger B, 2001, CANCER RES, V61, P1095
   Gajewski TF, 2001, J IMMUNOL, V166, P3900
   Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514
   Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Kiessling R, 1999, CANCER IMMUNOL IMMUN, V48, P353, DOI 10.1007/s002620050586
   Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO;2-X
   Fallarino F, 1999, INT J CANCER, V80, P324, DOI 10.1002/(SICI)1097-0215(19990118)80:2<324::AID-IJC25>3.0.CO;2-D
   Hayashi RJ, 1998, J IMMUNOL, V160, P33
   KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922
   Lee P, 2001, J CLIN ONCOL, V19, P3836
   Nielsen MB, 2000, J IMMUNOL, V165, P2287
   OSSEVOORT MA, 1995, J IMMUNOTHER, V18, P86, DOI 10.1097/00002371-199508000-00002
   Udaka K, 1996, J IMMUNOL, V157, P670
   Ugolini S, 2000, CURR OPIN IMMUNOL, V12, P295, DOI 10.1016/S0952-7915(00)00090-X
NR 40
TC 254
Z9 266
U1 5
U2 25
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
J9 CANCER RES
JI Cancer Res.
PD FEB 1
PY 2004
VL 64
IS 3
BP 1140
EP 1145
DI 10.1158/0008-5472.CAN-03-3259
PG 6
WC Oncology
SC Oncology
GA 771VF
UT WOS:000188806200051
PM 14871849
ER

PT J
AU Ito, S
   Nagaoka, H
   Shinkura, R
   Begum, N
   Muramatsu, M
   Nakata, M
   Honjo, T
AF Ito, S
   Nagaoka, H
   Shinkura, R
   Begum, N
   Muramatsu, M
   Nakata, M
   Honjo, T
TI Activation-induced cytidine deaminase shuttles between nucleus and
   cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION;
   GENE CONVERSION; CHROMOSOMAL LOCALIZATION; ANTIBODY DIVERSIFICATION; AID
   GENE; PROTEIN; ENZYME; EXPRESSION
AB Activation-induced cytidine deaminase (AID) is a molecule central to initiating class switch recombination, somatic hypermutation, and gene conversion of Ig genes. However, its mechanism to initiate these genetic alterations is still unclear. AID can convert cytosine to uracil on either mRNA or DNA and is involved in DNA cleavage. Although these events are expected to take place in the nucleus, overexpressed AID was found predominantly in the cytoplasm. Here, we demonstrated that AID is a nucleocytoplasmic shuttling protein with a bipartite nuclear localization signal and a nuclear export signal in its N and C termini, respectively. In addition to previously identified genetic, structural, and biochemical similarities of AID with apolipoprotein B mRNA editing catalytic polypeptide 1, an RNA editing enzyme of ApoB100 mRNA, the present finding provides another aspect to their resemblance, suggesting that both may have homologous reaction mechanisms.
C1 Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Martin A, 2002, NATURE, V415, P802
   Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   NISHI K, 1994, J BIOL CHEM, V269, P6320
   Yang Y, 1997, P NATL ACAD SCI USA, V94, P13075, DOI 10.1073/pnas.94.24.13075
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4
   Bogerd HP, 1996, MOL CELL BIOL, V16, P4207
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100
   LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522
   Sowden MP, 2002, J CELL SCI, V115, P1027
   Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X
NR 37
TC 190
Z9 193
U1 2
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 17
PY 2004
VL 101
IS 7
BP 1975
EP 1980
DI 10.1073/pnas.0307335101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 775GP
UT WOS:000189032600034
PM 14769937
ER

PT J
AU Suzuki, K
   Meek, B
   Doi, Y
   Muramatsu, M
   Chiba, T
   Honjo, T
   Fagarasan, S
AF Suzuki, K
   Meek, B
   Doi, Y
   Muramatsu, M
   Chiba, T
   Honjo, T
   Fagarasan, S
TI Aberrant expansion of segmented filamentous bacteria in IgA-deficient
   gut
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID INDUCED CYTIDINE DEAMINASE; INTESTINAL IMMUNE-SYSTEM; CELLS; ACTIVATION;
   MICE; DEFENSIN; ROLES
AB The mechanism to maintain homeostasis of the gut microbiota remains largely unknown despite its critical role in the body defense. In the intestines of mice with deficiency of activation-induced cytidine deaminase (AID), the absence of hypermutated lgA is partially compensated for by the presence of large amounts of unmutated lgM and normal expression levels of defensins and angiogenins. We show here a predominant and persistent expansion of segmented filamentous bacteria throughout the small intestine of AID(-/-) mice. Reconstitution of lamina propria lgA production in AID(-/-) mice recovered the normal composition of gut flora and abolished the local and systemic activation of the immune system. The results indicate that secretions of lgAs rather than innate defense peptides are critical to regulation of commensal bacterial flora and that the segmented filamentous bacteria antigens are strong stimuli of the mucosal immune system.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
RP Fagarasan, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
EM sidonia@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015; Meek, Bob/C-5042-2015; Fagarasan,
   Sidonia/A-5258-2016
OI Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan,
   Sidonia/0000-0003-2086-6402
CR Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5
   Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783
   DONSKOY E, 1992, J IMMUNOL, V148, P1604
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   Umesaki Y, 1999, INFECT IMMUN, V67, P3504
   Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888
   Talham GL, 1999, INFECT IMMUN, V67, P1992
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Kamata T, 2000, J IMMUNOL, V165, P1387
   Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113
   Hamada H, 2002, J IMMUNOL, V168, P57
   Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982
   Yamauchi KE, 2000, INFECT IMMUN, V68, P6496, DOI 10.1128/IAI.68.11.6496-6504.2000
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Cebra J. J., 1994, HDB MUCOSAL IMMUNOLO, P151
   Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S
   Meyerholz DK, 2002, INFECT IMMUN, V70, P3277, DOI 10.1128/IAI.70.6.3277-3280.2002
   VANDERHEIJDEN PJ, 1987, IMMUNOLOGY, V62, P551
NR 23
TC 288
Z9 307
U1 1
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 17
PY 2004
VL 101
IS 7
BP 1981
EP 1986
DI 10.1073/pnas.0307317101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 775GP
UT WOS:000189032600035
PM 14766966
ER

PT J
AU Horiguchi, S
   Takahashi, J
   Kishi, Y
   Morizane, A
   Okamoto, Y
   Koyanagi, M
   Tsuji, M
   Tashiro, K
   Honjo, T
   Fujii, S
   Hashimoto, N
AF Horiguchi, S
   Takahashi, J
   Kishi, Y
   Morizane, A
   Okamoto, Y
   Koyanagi, M
   Tsuji, M
   Tashiro, K
   Honjo, T
   Fujii, S
   Hashimoto, N
TI Neural precursor cells derived from human embryonic brain retain
   regional specificity
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE dopaminergic neuron; GABA; astrocyte; differentation
ID PROGENITOR CELLS; STEM-CELLS; IN-VITRO; OLFACTORY-BULB; NEURONS;
   TRANSPLANTATION; CNS; DIFFERENTIATION; PROLIFERATION; DOPAMINE
AB Recent studies have revealed that neural precursor cells can be expanded not only from the subventricular zone and hippocampus but also from other regions of the human embryonic brain. To determine the regional differences of these precursor cells, we divided the brain of a 9-week-old human embryo into four parts, i.e., telencephalon, diencephalon, mesencephalon, and rhombencephalon. All cultures of the tissues yielded neurospheres, and these spheres gave rise to neurons, astrocytes, and oligodendrocytes. An analysis of clonal populations revealed that these precursor cells were multipotent, and two region-specific differences in neural precursor cells were revealed: 1) The precursor cells from the rostral part of the brain tended to proliferate faster than those from the caudal part, and 2) the precursor cells from the diencephalon and mesencephalon gave rise to more tyrosine hydoxylase (TH)-positive neurons than those from the telencephalon and rhombencephaIon. When 50-day-cultured spheres were caused to differentiate, the percentage of TH-positive cells per total cell population was 1.2% for diencephalic and mesencephalic precursors, whereas it was 0.4% for telencephalic and rhombencephalic ones. Furthermore, the TH-positive cells from diencephalic and mesencephalic precursors were large, multipolar, and gamma-aminobutyric acid (GABA)-negative, which suggested that these cells were midbrain dopaminergic neurons. In contrast, TH-positive cells from telencephalic and rhombencephalic precursors were small, bipolar, and GABA-positive. These results suggest that human neural precursor cells might have the potential to differentiate into a variety of cells but retain regional specificity. (C) 2004 Wiley-Liss, Inc.
C1 Kyoto Univ, Dept Neurosurg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Dept Med Chem, Grad Sch Med, Kyoto, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Grad Sch Med, Kyoto, Japan.
   Kyoto Univ, Dept Gynecol & Obstet, Grad Sch Med, Kyoto, Japan.
RP Takahashi, J (reprint author), Kyoto Univ, Dept Neurosurg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
EM jbtaka@kuhp.kyoto-u.ac.jp
CR Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Ohmachi S, 2003, J NEUROSCI RES, V72, P436, DOI 10.1002/jnr.10592
   Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X
   Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706
   Li JYH, 2001, DEVELOPMENT, V128, P4979
   Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3
   Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435
   Bishop KM, 2002, J NEUROSCI, V22, P7627
   Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098
   Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427
   Jain M, 2003, EXP NEUROL, V182, P113, DOI 10.1016/S0014-4886(03)00055-4
   GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302
   Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595
   Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141
   Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998
   Naviaux RK, 1996, J VIROL, V70, P5701
   Sanchez-Pernaute R, 2001, J NEUROSCI RES, V65, P284, DOI 10.1002/jnr.1152
   Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7
   Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634
   Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4
   Fricker RA, 1999, J NEUROSCI, V19, P5990
   Hitoshi S, 2002, DEVELOPMENT, V129, P233
   LANGMAN J, 1981, MED EMBRYOLOGY, P332
   Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7
NR 24
TC 41
Z9 62
U1 4
U2 4
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0360-4012
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD MAR 15
PY 2004
VL 75
IS 6
BP 817
EP 824
DI 10.1002/jnr.20046
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 800KY
UT WOS:000220028400009
PM 14994342
ER

PT J
AU Tanigaki, K
   Tsuji, M
   Yamamoto, N
   Han, H
   Tsukada, J
   Inoue, H
   Kubo, M
   Honjo, T
AF Tanigaki, K
   Tsuji, M
   Yamamoto, N
   Han, H
   Tsukada, J
   Inoue, H
   Kubo, M
   Honjo, T
TI Regulation of alpha beta/gamma delta, T cell lineage commitment and
   peripheral T cell responses by Notch/RBP-J signaling
SO IMMUNITY
LA English
DT Article
ID ZONE B-CELLS; GAMMA-DELTA; THYMOCYTE DEVELOPMENT; GENE REARRANGEMENTS;
   FATE SPECIFICATION; MAMMALIAN NOTCH; DROSOPHILA EYE; RBP-J; RECEPTOR;
   EXPRESSION
AB RBP-J is a key mediator of Notch signaling that regulates a large spectrum of cell fate determinations. To elucidate the functions of Notch signaling in T cell development, we inactivated RBP-J specifically at two stages of T cell development by crossing RBP-J floxed mice with Ick-cre or CD4-cre transgenic mice. The loss of RBP-J at an earlier developmental stage resulted in enhanced generation and accelerated emigration of gammadelta T cells, whereas alphabeta T cell development was arrested at the double-negative 3 stage. The loss of RBP-J at a later stage did not affect the absolute number or the production rate of CD4 or CD8-positive mature T cells but enhanced Th1 cell response and reduced CD4(+) T cell proliferation. Our data demonstrated that Notch/RBP-J signaling regulates gammadelta T cell generation and migration, up T cell maturation, terminal differentiation of CD4(+) T cells into Th1/Th2 cells, and activation of T cells.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Sci Univ Tokyo, Res Inst Biol Sci, Noda, Chiba 2780022, Japan.
   Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Higashi Ku, Fukuoka 8128582, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
OI , Norio/0000-0001-8924-0710
CR Aifantis L, 1998, IMMUNITY, V9, P649
   AMSEN D, 2004, IN PRESS CELL
   MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0
   SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8
   Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664
   Schroeter EH, 1998, NATURE, V393, P382
   Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5
   Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   MALISSEN M, 1995, EMBO J, V14, P4641
   Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689
   Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893
   Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8
   Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1
   Adler SH, 2003, J IMMUNOL, V171, P2896
   HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338
   Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0
   Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0
   Ordentlich P, 1998, MOL CELL BIOL, V18, P2230
   Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3
   Shawber C, 1996, DEVELOPMENT, V122, P3765
   Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8
   Fowlkes BJ, 2002, J IMMUNOL, V169, P1817
   LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3
   Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537
   Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954
   Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6
   Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289
   Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0
   Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9
   DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X
   FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0
   Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8
   Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426
   Lawrence N, 2001, CURR BIOL, V11, P375, DOI 10.1016/S0960-9822(01)00120-8
   Livak F, 1999, J IMMUNOL, V162, P2575
   MacDonald HR, 2001, CURR OPIN IMMUNOL, V13, P219, DOI 10.1016/S0952-7915(00)00207-7
   Palaga T, 2003, J IMMUNOL, V171, P3019
   PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0
   Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702
   Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9
   Rodewald HR, 1998, ADV IMMUNOL, V69, P1
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Tanigaki K, 2003, SEMIN IMMUNOL, V15, P113, DOI 10.1016/S1044-5323(03)00008-3
   Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7
   Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641
   Witt CM, 2003, J IMMUNOL, V171, P2783
NR 66
TC 228
Z9 235
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD MAY
PY 2004
VL 20
IS 5
BP 611
EP 622
DI 10.1016/S1074-7613(04)00109-8
PG 12
WC Immunology
SC Immunology
GA 823RX
UT WOS:000221631900011
PM 15142529
ER

PT J
AU Amsen, D
   Blander, JM
   Lee, GR
   Tanigaki, K
   Honjo, T
   Flavell, RA
AF Amsen, D
   Blander, JM
   Lee, GR
   Tanigaki, K
   Honjo, T
   Flavell, RA
TI Instruction of distinct CD4 T helper cell fates by different notch
   ligands on antigen-presenting cells
SO CELL
LA English
DT Article
ID NF-KAPPA-B; DENDRITIC CELLS; IN-VIVO; GENE-EXPRESSION; FUNCTIONAL
   DIVERSITY; PHYSICAL INTERACTION; NEURAL DEVELOPMENT; CUTTING EDGE; TH2
   CELLS; ACTIVATION
AB Antigen-presenting cells (APC) tailor immune responses to microbial encounters by stimulating differentiation of CD4 T cells into the Th1 and Th2 lineages. We demonstrate that APC use the Notch pathway to instruct T cell differentiation. Strikingly, of the two Notch ligand families, Delta induces Th1, while Jagged induces the alternate Th2 fate. Expression of these different Notch ligands on APC is induced by Th1- or Th2-promoting stimuli. Th2 differentiation has been considered a default process as APC-derived instructive signals are unknown. We demonstrate that Jagged constitutes an instructive signal for Th2 differentiation, which is independent of IL4/STAT6. Th2 differentiation induced by APC is abrogated in T cells lacking the Notch effector RBPJkappa. Notch directs Th2 differentiation by inducing GATA3 and by directly regulating il4 gene transcription through RBPJkappa sites in a 3' enhancer.
C1 Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Amsen, D (reprint author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.
EM richard.flavell@yale.edu
CR Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727
   Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528
   Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872.10880.2003
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201
   Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040
   d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661
   Beatus P, 2001, MECH DEVELOP, V104, P3, DOI 10.1016/S0925-4773(01)00373-2
   NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838
   Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158
   Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991
   Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019
   Finkelman FD, 2000, J IMMUNOL, V164, P2303
   Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340
   Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294
   Panin VM, 1997, NATURE, V387, P908
   de Jong EC, 2002, J IMMUNOL, V168, P1704
   Jarriault S, 1998, MOL CELL BIOL, V18, P7423
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X
   O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6
   Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D
   SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349
   OKA C, 1995, DEVELOPMENT, V121, P3291
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   Anastasi E, 2003, J IMMUNOL, V171, P4504
   Adler SH, 2003, J IMMUNOL, V171, P2896
   Fleming RJ, 1997, DEVELOPMENT, V124, P2973
   Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9
   Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712
   Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1
   Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000
   Cheng PY, 2001, J IMMUNOL, V167, P4458
   Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1
   Jankovic D, 2000, J IMMUNOL, V164, P3047
   Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177
   Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469
   BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609
   Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x
   Huppert SS, 1997, DEVELOPMENT, V124, P3283
   Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0
   Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0
   Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X
   Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229
   Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3
   Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0
   Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X
   Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100
   Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145
   Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Asnagli H, 2002, J IMMUNOL, V168, P4268
   Beatus P, 1999, DEVELOPMENT, V126, P3925
   Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262
   Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263
   Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039
   Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842
   Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7
   Nakamura T, 1997, J IMMUNOL, V158, P1085
   Newberry RD, 2001, J IMMUNOL, V166, P4465
   Palaga T, 2003, J IMMUNOL, V171, P3019
   Palmieri M, 1999, NUCLEIC ACIDS RES, V27, P2785, DOI 10.1093/nar/27.13.2785
   Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961
   Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
NR 79
TC 517
Z9 547
U1 4
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD MAY 14
PY 2004
VL 117
IS 4
BP 515
EP 526
DI 10.1016/S0092-8674(04)00451-9
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 821KB
UT WOS:000221458000011
PM 15137944
ER

PT J
AU Fagarasan, S
   Honjo, T
AF Fagarasan, S
   Honjo, T
TI Regulation of IgA synthesis at mucosal surfaces
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID SEGMENTED FILAMENTOUS BACTERIA; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH
   RECOMBINATION; INTESTINAL EPITHELIAL-CELLS; LT-BETA-R; LYMPHOID-TISSUE;
   PEYERS PATCH; DENDRITIC CELLS; T-CELLS; B-CELLS
AB Immunoglobulin A is the main element of the humoral immune response that has been selected through evolution, together with innate mucosal defences, to provide protection against microbial antigens at mucosal surfaces. IgA responses are initiated in organized inductive structures, such as Peyer's patches and nasal-associated lymphoid tissues, as well as diffuse effector tissues, such as gut lamina propria and nasal mucosa. Hypermutated secretory IgAs play a critical role in regulating the composition of the intestinal microflora. Dysregulation of gut homeostasis in IgA-deficient gut causes a continuous activation of the immune cells and induces inflammatory processes leading to lymphoneogenesis. Recent advances in this field include new insights into the role of IgA in the maintenance of gut homeostasis and the proposal of an updated model for the induction of IgA responses in the gut.
C1 RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Fagarasan, S (reprint author), RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
EM sidonia@mfour.med.kyoto-u.ac.jp
RI Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775
   Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670
   Lycke N, 1999, J IMMUNOL, V163, P913
   Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4
   Zuercher AW, 2002, J IMMUNOL, V168, P1796
   Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75
   Newberry RD, 2002, J IMMUNOL, V168, P4988
   Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761
   Coker HA, 2003, J IMMUNOL, V171, P5602
   Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X
   Lazarus NH, 2003, J IMMUNOL, V170, P3799
   Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3
   Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795
   He B, 2003, J IMMUNOL, V171, P5215
   Rey J, 2004, J IMMUNOL, V172, P3026
   Harriman GR, 1999, J IMMUNOL, V162, P2521
   BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A
   Harmsen A, 2002, J IMMUNOL, V168, P986
   Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915
   Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101
   Hamada H, 2002, J IMMUNOL, V168, P57
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   Lorenz RG, 2003, J IMMUNOL, V170, P5475
   Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1039/ni829
   Yamauchi KE, 2000, INFECT IMMUN, V68, P6496, DOI 10.1128/IAI.68.11.6496-6504.2000
   Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373
   Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   Uren TK, 2003, J IMMUNOL, V170, P2531
   Neish AS, 2002, MICROBES INFECT, V4, P309, DOI 10.1016/S1286-4579(02)01543-5
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036
   Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100
   DunnWalters DK, 1997, EUR J IMMUNOL, V27, P463, DOI 10.1002/eji.1830270217
   Gardby E, 2003, J IMMUNOL, V170, P55
   Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244
   LYCKE N, 1998, MUCOSAL T CELLS, P209
   Meyerholz DK, 2002, INFECT IMMUN, V70, P3277, DOI 10.1128/IAI.70.6.3277-3280.2002
   Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5
   Shimoda M, 2001, J EXP MED, V194, P1597, DOI 10.1084/jem.194.11.1597
   VANDERHEIJDEN PJ, 1987, IMMUNOLOGY, V62, P551
NR 51
TC 53
Z9 59
U1 0
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD JUN
PY 2004
VL 16
IS 3
BP 277
EP 283
DI 10.1016/j.coi.2004.03.005
PG 7
WC Immunology
SC Immunology
GA 825UW
UT WOS:000221784900005
PM 15134775
ER

PT J
AU Honjo, T
   Muramatsu, M
   Fagarasan, S
AF Honjo, T
   Muramatsu, M
   Fagarasan, S
TI AID: How does it aid antibody diversity?
SO IMMUNITY
LA English
DT Review
ID CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE; URACIL-DNA
   GLYCOSYLASE; B MESSENGER-RNA; DOUBLE-STRAND BREAKS; IMMUNOGLOBULIN GENE
   CONVERSION; MISMATCH-REPAIR PROTEIN; SOMATIC HYPERMUTATION; CHROMOSOMAL
   LOCALIZATION; V(D)J RECOMBINATION
AB Activation-induced cytidine deaminase (AID) is an essential enzyme to regulate class switch recombination (CSR), somatic hypermutation (SHM), and gene conversion (GC). AID is known to be required for DNA cleavage of S regions in CSR. However, its molecular mechanism is a focus of extensive debate. RNA editing hypothesis postulates that AID edits yet unknown mRNA to generate specific endonucleases for CSR and SHM. By contrast, DNA deamination hypothesis assumes that AID deaminates cytosine in DNA, followed by DNA cleavage by base excision repair enzymes. We discuss available evidence for the two proposed models. Recent findings, namely requirement of protein synthesis for DNA breakage and dispensability of U removal activity of uracil DNA glycosylase, force us to reconsider DNA deamination hypothesis.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016
OI Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan,
   Sidonia/0000-0003-2086-6402
CR Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996
   Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858
   Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Martin A, 2002, NATURE, V415, P802
   Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1
   MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858
   Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749
   Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418
   Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0
   MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Catalan N, 2003, J IMMUNOL, V171, P2504
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Diaz M, 2003, MOL IMMUNOL, V40, P261, DOI 10.1016/S0161-5890(03)00113-5
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871
   Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880
   Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4
   Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057
   Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni0902-826
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860
   Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894
   Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509
   De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003
   Diaz M, 2001, J IMMUNOL, V167, P327
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9
   Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100
   Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457
   LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522
   MAIZELS N, 2000, GENOME BIOL, V1, P1025
   SEKIGUCHI J, 2004, MOL BIOL B CELLS, P62
   SHINKURA R, 2004, IN PRESS NAT IMMUNOL
   Stavnezer J., 2004, MOL BIOL B CELLS, P307
   Yavuz S, 2002, J IMMUNOL, V169, P3825
   Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200
NR 81
TC 132
Z9 132
U1 2
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD JUN
PY 2004
VL 20
IS 6
BP 659
EP 668
DI 10.1016/j.immuni.2004.05.011
PG 10
WC Immunology
SC Immunology
GA 831OY
UT WOS:000222205300003
PM 15189732
ER

PT J
AU Shinkura, R
   Ito, S
   Begum, NA
   Nagaoka, H
   Muramatsu, M
   Kinoshita, K
   Sakakibara, Y
   Hijikata, H
   Honjo, T
AF Shinkura, R
   Ito, S
   Begum, NA
   Nagaoka, H
   Muramatsu, M
   Kinoshita, K
   Sakakibara, Y
   Hijikata, H
   Honjo, T
TI Separate domains of AID are required for somatic hypermutation and
   class-switch recombination
SO NATURE IMMUNOLOGY
LA English
DT Article
ID SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; ANTIBODY DIVERSIFICATION;
   REGION; ENZYME; URACIL; GLYCOSYLASE; FIBROBLASTS; MECHANISM; CELLS
AB Activation-induced cytidine deaminase (AID) is essential for class-switch recombination (CSR) and somatic hypermutation (SHM). Mutants with changes in the C-terminal region of AID retain SHM but lose CSR activity. Here we describe five mutants with alterations in the N-terminal region of AID that caused selective deficiency in SHM but retained CSR, suggesting that the CSR and SHM activities of AID may dissociate via interaction of CSR- or SHM-specific cofactors with different domains of AID. Unlike cells expressing C-terminal AID mutants, B cells expressing N-terminal AID mutants had mutations in the switch mu region, indicating that such mutations are generated by reactions involved in CSR but not SHM. Thus, we propose that separate domains of AID interact with specific cofactors to regulate these two distinct genetic events in a target-specific way.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Martin A, 2002, NATURE, V415, P802
   Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Rogozin IB, 2004, J IMMUNOL, V172, P3382
   Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159
NR 31
TC 136
Z9 139
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD JUL
PY 2004
VL 5
IS 7
BP 707
EP 712
DI 10.1038/ni1086
PG 6
WC Immunology
SC Immunology
GA 833IO
UT WOS:000222331200023
PM 15195091
ER

PT J
AU Nishio, R
   Matsumori, A
   Okazaki, T
   Tanaka, Y
   Mitsuiye, T
   Mizoguchi, A
   Hiai, H
   Minato, N
   Honjo, T
AF Nishio, R
   Matsumori, A
   Okazaki, T
   Tanaka, Y
   Mitsuiye, T
   Mizoguchi, A
   Hiai, H
   Minato, N
   Honjo, T
TI The role of autoantibodies against cardiac troponin I in autoimmune
   dilated cardiomyopathy
SO JOURNAL OF CARDIAC FAILURE
LA English
DT Meeting Abstract
CT 8th Annual Scientific Meeting of the Heart-Failure-Society-of-American
CY SEP 12-15, 2004
CL Toronto, CANADA
SP Heart Failure Soc Amer
C1 Kyoto Univ Hosp, Div Emergency Med, Kyoto 606, Japan.
   Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Physiol & Biophys, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan.
   Mie Univ, Grad Sch Med, Dept Anat, Tsu, Mie, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 1071-9164
J9 J CARD FAIL
JI J. Card. Fail.
PD AUG
PY 2004
VL 10
IS 4
SU S
MA 140
BP S56
EP S56
DI 10.1016/j.cardfail.2004.06.137
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 853VV
UT WOS:000223857900139
ER

PT J
AU Begum, NA
   Kinoshita, K
   Kakazu, N
   Muramatsu, M
   Nagaoka, H
   Shinkura, R
   Biniszkiewicz, D
   Boyer, LA
   Jaenisch, R
   Honjo, T
AF Begum, NA
   Kinoshita, K
   Kakazu, N
   Muramatsu, M
   Nagaoka, H
   Shinkura, R
   Biniszkiewicz, D
   Boyer, LA
   Jaenisch, R
   Honjo, T
TI Uracil DNA glycosylase activity is dispensable for immunloglobulin class
   switch
SO SCIENCE
LA English
DT Article
ID SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION;
   CRYSTAL-STRUCTURE; HISTONE H2AX; RECOMBINATION; ENZYME; MICE;
   REPLICATION; MUTATIONS
AB Activation-induced cytidine deaminase (AID) is required for the DNA cleavage step in immunoglobulin class switch recombination (CSR). AID is proposed to deaminate cytosine to generate uracil (U) in either mRNA or DNA. In the second instance, DNA cleavage depends on uracil DNA glycosylase (UNG) for removal of U. Using phosphorylated histone gamma-H2AX focus formation as a marker of DNA cleavage, we found that the UNG inhibitor Ugi did not inhibit DNA cleavage in immunoglobulin heavy chain (IgH) locus during CSR, even though Ugi blocked UNG binding to DNA and strongly inhibited CSR. Strikingly, UNG mutants that had lost the capability of removing U rescued CSR in UNG(-/-) B cells. These results indicate that UNG is involved in the repair step of CSR yet by an unknown mechanism. The dispensability of U removal in the DNA cleavage step of CSR requires a reconsideration of the model of DNA deamination by AID.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto 6028566, Japan.
   Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009
   Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011
   MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0
   Downs JA, 2000, NATURE, V408, P1001
   MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0
   Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871
   Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880
   Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
NR 29
TC 85
Z9 85
U1 0
U2 3
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD AUG 20
PY 2004
VL 305
IS 5687
BP 1160
EP 1163
DI 10.1126/science.1098444
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 849RD
UT WOS:000223557400050
PM 15326357
ER

PT J
AU Begum, NA
   Kinoshita, K
   Muramatsu, M
   Nagaoka, H
   Shinkura, R
   Honjo, T
AF Begum, NA
   Kinoshita, K
   Muramatsu, M
   Nagaoka, H
   Shinkura, R
   Honjo, T
TI De novo protein synthesis is required for activation-induced cytidine
   deaminase-dependent DNA cleavage in immunoglobulin class switch
   recombination
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SINGLE-STRANDED-DNA; RNA EDITING ENZYME; SOMATIC HYPERMUTATION; ANTIBODY
   DIVERSIFICATION; GENE CONVERSION; MU REGION; B-CELLS; AID; REPAIR;
   MECHANISM
AB Activation-induced cytidine deaminase is required for the DNA cleavage step of Ig class switch recombination (CSR). However, its molecular mechanism is controversial. RNA-editing hypothesis postulates that activation-induced cytidine deaminase deaminates cytosine in an unknown mRNA to generate a new mRNA encoding an endonuclease for CSR and thus predicts that DNA cleavage depends on de novo protein synthesis. On the other hand, DNA deamination hypothesis proposes that DNA cleavage is initiated by cytosine deamination in DNA, followed by uracil removal by uracil DNA glycosylase. By using the chromatin immunoprecipitation assay to detect gamma-H2AX focus formation as a marker for DNA cleavage, we found that cycloheximide inhibited DNA cleavage in the Ig heavy-chain locus during CSR. Requirement of protein synthesis in the DNA cleavage step of CSR strengthens the RNA-editing hypothesis.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418
   Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0
   Downs JA, 2000, NATURE, V408, P1001
   Catalan N, 2003, J IMMUNOL, V171, P2504
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   BEGUM N, IN PRESS SCIENCE
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100
   Kuhne C, 2003, NUCLEIC ACIDS RES, V31, P7227, DOI 10.1093/nar/gkg937
   Stavnezer J., 2004, MOL BIOL B CELLS, P307
NR 37
TC 33
Z9 33
U1 1
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 31
PY 2004
VL 101
IS 35
BP 13003
EP 13007
DI 10.1073/pnas.0405219101
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 851OP
UT WOS:000223694700042
PM 15317942
ER

PT J
AU Alugupalli, KR
   Leong, JM
   Woodland, RT
   Muramatsu, M
   Honjo, T
   Gerstein, RM
AF Alugupalli, KR
   Leong, JM
   Woodland, RT
   Muramatsu, M
   Honjo, T
   Gerstein, RM
TI B1b lymphocytes confer T cell-independent long-lasting immunity
SO IMMUNITY
LA English
DT Article
ID RELAPSING FEVER BORRELIOSIS; B-CELLS; IN-VIVO; ANTIBODY-RESPONSES;
   MARGINAL ZONE; B-1 CELLS; ANTIGENS; MEMORY; MICE; DIFFERENTIATION
AB Many microbial pathogens employ antigenic variation as a strategy to evade the immune system, posing a challenge in vaccine development. To understand the requirements for immunity against such pathogens, we studied Borrelia hermsii, a relapsing fever bacterium. We found that mice deficient in T, follicular B, marginal zone B, or B1 a lymphocytes resolved B. hermsii bacteremia and became resistant to reinfection. The resolution of bacteremia coincided with an expansion and persistence of B1b lymphocytes, and purified B1b lymphocytes from convalescent wild-type or TCR-betaxdelta(-/-) mice conferred immunity to Rag1(-/-) mice. The B1b lymphocytes in the reconstituted Rag1(-/-) mice provided long-lasting immunity by rapidly generating B. hermsii-specific IgM but not IgG upon bacterial challenge. Unmutated IgM is sufficient to eliminate B. hermsii, because AID(-/-) mice deficient in somatic hypermutation and class switch recombination efficiently resolved all bacteremic episodes. These data demonstrate that B1b lymphocytes can provide long-lasting T cell-independent IgM memory.
C1 Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Alugupalli, KR (reprint author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.
EM kishore.alugupalli@umassmed.edu
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Alugupalli KR, 2001, MOL MICROBIOL, V39, P330, DOI 10.1046/j.1365-2958.2001.02201.x
   ZHANG J, 1988, EUR J IMMUNOL, V18, P1417, DOI 10.1002/eji.1830180918
   Connolly SE, 2004, J IMMUNOL, V172, P1191
   Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577
   KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55
   STALL AM, 1992, ANN NY ACAD SCI, V651, P33
   Alugupalli KR, 2003, J IMMUNOL, V170, P3819
   Vos Q, 2000, IMMUNOL REV, V176, P154
   KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0
   Casali P, 1996, CURR TOP MICROBIOL, V210, P167
   Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5
   RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353
   BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155
   Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1
   Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1
   Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833
   Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001
   THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900
   KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320
   Alugupalli KR, 2003, BLOOD, V102, P2843, DOI 10.1182/blood-2003-02-0426
   Yokota M, 1997, J MED MICROBIOL, V46, P675
   Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141
   Vink A, 1999, J EXP MED, V189, P1413, DOI 10.1084/jem.189.9.1413
   Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938
   Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8
   Connolly SE, 2001, J IMMUNOL, V167, P3029
   Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140
   Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4
   Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0
   BURGDORFER W, 1976, BIOL PARASITIC SPIRO, P191
   BURLEN O, 1988, EUR J IMMUNOL, V18, P1433, DOI 10.1002/eji.1830180920
   Chelvarajan RL, 1998, J IMMUNOL, V161, P3315
   COLLE JH, 1988, EUR J IMMUNOL, V18, P1307, DOI 10.1002/eji.1830180902
   COUDERC J, 1987, IMMUNOLOGY, V61, P71
   MacLennan ICM, 2000, PHILOS T ROY SOC B, V355, P345
   McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3
   NEWMAN K, 1984, INFECT IMMUN, V45, P572
   Vinuesa CG, 2001, EUR J IMMUNOL, V31, P1340, DOI 10.1002/1521-4141(200105)31:5<1340::AID-IMMU1340>3.0.CO;2-H
   VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519
NR 41
TC 217
Z9 220
U1 1
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD SEP
PY 2004
VL 21
IS 3
BP 379
EP 390
DI 10.1016/j.immuni.2004.06.019
PG 12
WC Immunology
SC Immunology
GA 856GY
UT WOS:000224034900009
PM 15357949
ER

PT J
AU Michishita, M
   Ikeda, T
   Nakashiba, T
   Ogawa, M
   Tashiro, K
   Honjo, T
   Doi, K
   Itohara, S
   Endo, S
AF Michishita, M
   Ikeda, T
   Nakashiba, T
   Ogawa, M
   Tashiro, K
   Honjo, T
   Doi, K
   Itohara, S
   Endo, S
TI Expression of Btcl2, a novel member of Btcl gene family, during
   development of the central nervous system
SO DEVELOPMENTAL BRAIN RESEARCH
LA English
DT Article
DE BTCL; signal sequence trap; neuropilin; in situ hybridization; cerebral
   cortex; subplate
ID TRANSMEMBRANE PROTEIN; SEMAPHORIN-III; NEUROPILIN; RECEPTOR; DOMAINS;
   CONNECTIONS; PLEXIN; BRAIN; CUB
AB Cell-cell interactions are primarily mediated by secreted and transmembrane proteins which play essential roles in the neuronal circuit formation. However, molecular mechanisms underlying neuronal circuit formation, which is mediated by the cell-cell interactions, remain largely elusive. We isolated and characterized a novel gene, Btcl2 (brain-specific transmembrane protein containing CUB [complement subcomponent C1r/C1s, sea urchin protein Uegf, and BMP-1] and LDLa [low-density lipoprotein receptor domain class A] domains 2), using the signal sequence trap (SST) method. The extracellular domain of BTCL2 contains two CUB domains and an LDLa domain. BTCL2 and BTCL1 have similar domain structures, sharing 51% overall identity. The CUB1, CUB2, and LDLa domains of these two proteins share 63%, 72%, and 84% identity, respectively. The CUB domains of BTCL1 and BTCL2 share significant identity with those of neuropilins. Btcl2 mRNA was detected as a single 6-kb transcript in Northern blot analysis. In situ hybridization (ISH) analysis revealed that both Btcl1 and Btcl2 rnRNAs were observed restrictively in brain throughout embryonic and postnatal stages. Btcl1 and Btel2 mRNAs were expressed uniquely in the pontine nucleus and subplate, which are required for establishing the neuronal circuit formation. These results will aid in resolving the mechanisms underlying neuronal circuit formations (e.g., pontocerebellar and thalamocortical axon guidance) and permit more precise studies aimed at understanding the role of BTCL1 and BTCL2 in the central nervous system. (C) 2004 Elsevier B.V. All rights reserved.
C1 RIKEN, Brain Sci Inst, Neuronal Circuit Mech Res Grp, Wako, Saitama 3510198, Japan.
   RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan.
   RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan.
   Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Endo, S (reprint author), RIKEN, Brain Sci Inst, Neuronal Circuit Mech Res Grp, Hirosawa 2-1, Wako, Saitama 3510198, Japan.
EM sendo@riken.jp
RI Itohara, Shigeyoshi/I-8769-2012
CR Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8
   He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6
   NIWA H, 1991, GENE, V108, P193
   ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185
   Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5
   Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498
   Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551
   Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2
   DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0
   Nakashiba T, 2000, J NEUROSCI, V20, P6540
   Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9
   Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200
   Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2
   Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891
   Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F
   Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0
   Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0
   Reaves BJ, 1998, MOL BIOL CELL, V9, P1107
   TISSERLAVIGNE M, 1996, SCIENCE, V274, P1123
NR 19
TC 13
Z9 15
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-3806
J9 DEV BRAIN RES
JI Dev. Brain Res.
PD OCT 15
PY 2004
VL 153
IS 1
BP 135
EP 142
DI 10.1016/j.devbrainres.2004.06.012
PG 8
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 862DS
UT WOS:000224470600016
ER

PT J
AU Krebs, LT
   Shutter, JR
   Tanigaki, K
   Honjo, T
   Stark, KL
   Gridley, T
AF Krebs, LT
   Shutter, JR
   Tanigaki, K
   Honjo, T
   Stark, KL
   Gridley, T
TI Haploinsufficient lethality and formation of arteriovenous malformations
   in Notch pathway mutants
SO GENES & DEVELOPMENT
LA English
DT Article
DE Notch signaling; haploinsufficiency; vascular remodeling; arteriovenous
   malformation; Dll4; RBP-J
ID ENDOTHELIAL-GROWTH-FACTOR; LEFT-RIGHT ASYMMETRY; CARDIOVASCULAR
   DEVELOPMENT; VASCULAR MORPHOGENESIS; EMBRYONIC LETHALITY; NODAL
   EXPRESSION; CELL FATE; RBP-J; MOUSE; MICE
AB The Notch signaling pathway is essential for embryonic vascular development in vertebrates. Here we show that mouse embryos heterozygous for a targeted mutation in the gene encoding the DLL4 ligand exhibit haploinsufficient lethality because of defects in vascular remodeling. We also describe vascular defects in embryos homozygous for a mutation in the Rbpsuh gene, which encodes the primary transcriptional mediator of Notch signaling. Conditional inactivation of Rpbsuh function demonstrates that Notch activation is essential in the endothelial cell lineage. Notch pathway mutant embryos exhibit defects in arterial specification of nascent blood vessels and develop arteriovenous malformations. These results demonstrate that vascular remodeling in the mouse embryo is sensitive to Dll4 gene dosage and that Notch activation in endothelial cells is essential for embryonic vascular remodeling.
C1 Jackson Lab, Bar Harbor, ME 04609 USA.
   Amgen Inc, Dept Metab Dis, Thousand Oaks, CA 91320 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Gridley, T (reprint author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
EM gridley@jax.org
CR Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703
   Shutter JR, 2000, GENE DEV, V14, P1313
   Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004
   Barrantes ID, 1999, CURR BIOL, V9, P470
   Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3
   Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI [10.1016/j.cub.2004.01.023, 10.1016/S0960-9822(04)00038-7]
   Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004
   Krebs LT, 2000, GENE DEV, V14, P1343
   Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052
   WHEATLEY SC, 1993, DEVELOPMENT, V119, P295
   Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888
   Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723
   Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741
   Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074
   Lawson ND, 2001, DEVELOPMENT, V128, P3675
   Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598
   Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003
   Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0
   Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1
   Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825
   Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1
   Nakayama H, 1997, DEV GENET, V21, P21, DOI 10.1002/(SICI)1520-6408(1997)21:1<21::AID-DVG3>3.0.CO;2-A
   ORENSEN LK, 2003, DEV BIOL, V261, P235
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
NR 30
TC 291
Z9 303
U1 1
U2 3
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0890-9369
J9 GENE DEV
JI Genes Dev.
PD OCT 15
PY 2004
VL 18
IS 20
BP 2469
EP 2473
DI 10.1101/gad.1239204
PG 5
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 862TO
UT WOS:000224514200003
PM 15466160
ER

PT J
AU Nishida, AT
   Kobuke, K
   Kojima, K
   Ito, J
   Honjo, T
   Tashiro, K
AF Nishida, AT
   Kobuke, K
   Kojima, K
   Ito, J
   Honjo, T
   Tashiro, K
TI OC29 is preferentially expressed in the presumptive sensory organ region
   of the otocyst
SO DEVELOPMENTAL DYNAMICS
LA English
DT Article
DE inner ear development; otocyst; OC29; secreted protein; vestibule;
   crista; hindbrain; neural tube
ID INNER-EAR DEVELOPMENT; SEMICIRCULAR CANAL FORMATION; PROTEASE-INHIBITORY
   MODULES; CELL FATE SPECIFICATION; SIGNAL SEQUENCE TRAP; SECRETED
   PROTEINS; HOMEOBOX GENES; MULTIPLE TYPES; DIFFERENTIATION; CLONING
AB The mammalian inner ear derives from the otocyst. Molecular mechanisms underlying inner ear development are largely unknown. We have isolated a secreted molecule, OC29, from a rat otocyst cDNA library by the signal sequence trap method. OC29 was revealed to be a rat homologue of human WFIKKN. OC29 is preferentially expressed in the developing inner ear and the dorsal neural tube. In the inner ear, the expression of OC29 is first detectable at embryonic day 11.5 (E11.5), broadly in the dorsolateral region of the otocyst, which gives rise to the vestibular organ. At E12.5, the expression of OC29 becomes restricted to the presumptive sensory region, mainly to the BMP4-positive presumptive cristae, and expression becomes reduced at later stages. These results suggest that OC29 may have a role in the early development of the inner ear sensory organ, particularly in the formation of the cristae of the semicircular canals. (C) 2004 Wiley-Liss, Inc.
C1 Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Genom Med Sch, Kamigyo Ku, Kyoto 6028566, Japan.
   Kyoto Univ, Ctr Mol Biol & Genet, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan.
RP Tashiro, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Genom Med Sch, Kamigyo Ku, Kyoto 6028566, Japan.
EM tashiro@koto.kpu-m.ac.jp
CR Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3
   Herbrand H, 1998, DEVELOPMENT, V125, P645
   Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8
   Fekete DM, 1996, CURR OPIN NEUROBIOL, V6, P533, DOI 10.1016/S0959-4388(96)80061-4
   Morsli H, 1998, J NEUROSCI, V18, P3327
   Brigande JV, 2000, DEV BIOL, V227, P256, DOI 10.1006/dbio.2000.9914
   Kil SH, 2001, DEV BIOL, V233, P365, DOI 10.1006/dbio.2001.0211
   Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457
   Oh SH, 1996, J NEUROSCI, V16, P6463
   LI CW, 1978, J MORPHOL, V157, P249, DOI 10.1002/jmor.1051570302
   Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366
   Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232
   Gerlach LM, 2000, DEVELOPMENT, V127, P45
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Nakashiba T, 2000, J NEUROSCI, V20, P6540
   Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707
   Gerlach-Bank LM, 2002, DEV DYNAM, V224, P109, DOI 10.1002/dvdy.10079
   Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4
   NORNES HO, 1990, DEVELOPMENT, V109, P797
   Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003
   Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X
   Brigande JV, 2000, P NATL ACAD SCI USA, V97, P11700, DOI 10.1073/pnas.97.22.11700
   Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476
   Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39
   Hadrys T, 1998, DEVELOPMENT, V125, P33
   Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2
   Kato K, 2000, BLOOD, V96, P362
   Kiernan AE, 1997, DEV BIOL, V191, P215, DOI 10.1006/dbio.1997.8716
   Kil SH, 2002, J NEUROBIOL, V53, P129, DOI 10.1002/neu.10127
   Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200
   MICHISHITA M, 2000, BIOCHEM BIOPH RES CO, V306, P680
   Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x
   Nakamura T, 1998, GENOMICS, V54, P89, DOI 10.1006/geno.1998.5571
   Noramly S, 2002, J NEUROBIOL, V53, P100, DOI 10.1002/neu.10131
   Represa J, 2000, ACTA OTO-LARYNGOL, V120, P5
   Rinkwitz S, 2001, ANN NY ACAD SCI, V942, P1
   RINKWITZBRANDT S, 1995, MECH DEVELOP, V52, P371, DOI 10.1016/0925-4773(95)00414-V
   RinkwitzBrandt S, 1996, HEARING RES, V99, P129, DOI 10.1016/S0378-5955(96)00093-7
   [Anonymous], 1989, MOL CLONING LAB MANU
   Tashiro K, 1999, METHOD ENZYMOL, V303, P479
   Toda H, 2003, J BIOL CHEM, V278, P35491, DOI 10.1074/jbc.M305342200
   Torres MA, 1996, DEVELOPMENT, V122, P3381
   Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023
   Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398
   VANDEWATER TR, 1991, ANN NY ACAD SCI, V630, P116
   Wilkinson DG, 1992, IN SITU HYBRIDIZATIO, P75
NR 48
TC 3
Z9 4
U1 1
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1058-8388
J9 DEV DYNAM
JI Dev. Dyn.
PD DEC
PY 2004
VL 231
IS 4
BP 766
EP 774
DI 10.1002/dvdy.20180
PG 9
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA 874DM
UT WOS:000225331100012
PM 15497143
ER

PT J
AU Begum, NA
   Honjo, T
AF Begum, NA
   Honjo, T
TI Response to comment on "uracil DNA glycosylase activity is dispensable
   for immunoglobulin class switch"
SO SCIENCE
LA English
DT Editorial Material
ID VACCINIA VIRUS; SPECIFICITY; REPLICATION; MUTATIONS; ENZYME; SITE
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Yoshida Sakyo Ku, Kyoto 6068501, Japan.
RP Begum, NA (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Yoshida Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200
   MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2
   Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200
   Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444
   De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003
   Ellison KS, 1996, J VIROL, V70, P7965
   Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672
   Stivers James T, 2004, Science, V306, P2042
NR 10
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD DEC 17
PY 2004
VL 306
IS 5704
BP 2042B
EP 2042B
DI 10.1126/science.1105225
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 881CM
UT WOS:000225841000042
ER

PT J
AU Honjo, T
AF Honjo, T
TI Yasutomi Nishizuka (1932-2004) - Obituary
SO NATURE
LA English
DT Biographical-Item
C1 Kyoto Univ, Fac Med, Dept Med Chem & Mol Biol, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Fac Med, Dept Med Chem & Mol Biol, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD DEC 23
PY 2004
VL 432
IS 7020
BP 966
EP 966
DI 10.1038/432966a
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 881RL
UT WOS:000225887000028
PM 15616548
ER

PT J
AU Hano, T
   Oshima, Y
   Oe, T
   Kinoshita, M
   Tanaka, M
   Wakamatsu, Y
   Ozato, K
   Honjo, T
AF Hano, T
   Oshima, Y
   Oe, T
   Kinoshita, M
   Tanaka, M
   Wakamatsu, Y
   Ozato, K
   Honjo, T
TI Quantitative bio-imaging analysis for evaluation of sexual
   differentiation in germ cells of olvas-GFP/ST-II Yi medaka (Oryzias
   latipes) nanoinjected in ovo with ethinylestradiol
SO ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
LA English
DT Article
DE transgenic fish; nanoinjection; endocrine disruptor
ID MINNOWS PIMEPHALES-PROMELAS; JAPANESE MEDAKA; TRANSGENIC ZEBRAFISH;
   ESTROGENIC ACTIVITY; LIFE-CYCLE; BISPHENOL-A; VIVO MODEL; FISH;
   REPRODUCTION; EXPOSURE
AB We examined the effects on sexual differentiation of nanoinjecting ethinylestradiol (EE2,) into embryos ofolvas-GFP/STII YI medaka (Onzias latipes). This strain contains the green fluorescent protein (GFP) gene fused to the regulatory region of the medaka vasa gene, and germ-cell-specific expression of GFP can be visualized in living (transparent) individuals. The number of germ cells in untreated genotypic females (XX) was approximately 10-fold that in untreated genotypic males (XY) at 10 d posthatch (dph). Germ cell proliferation was prevented in XX females that developed from embryos nanoinjected with 0.5, 2.5, or 5.0 ng of EE2. Some 10-dph XY males from embryos injected with 0.5 ng or more of EE2 showed a larger fluorescent area and more germ cells than those of pooled control groups. Males and females from embryos injected with 5.0 ng of EE, had no significant difference in germ cell number or fluorescent area. Thus, EE2 injection into embryos caused abnormal gonadal development in both sexes. Observations of external secondary sex characteristics and histological examination of adult gonads showed complete sex reversal in some males after 0.5-, 2.5, and 5.0-ng treatments but no changes in XX females after any treatment. Thus, quantitative bioimaging can aid in evaluating the effects of endocrine-disrupting chemicals on fish within 10 dph.
C1 Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Div Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan.
   Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan.
   Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Nagoya Univ, Biosci & Biotechnol Ctr, Lab Freshwater Fish Stocks, Chikusa Ku, Nagoya, Aichi 4648601, Japan.
RP Oshima, Y (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Div Biosci & Biotechnol, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.
EM yoshima@agr.kyushu-u.ac.jp
RI Oshima, Yuji/C-7701-2011; Perez , Claudio Alejandro/F-8310-2010; U-ID,
   Kyushu/C-5291-2016
OI Perez , Claudio Alejandro/0000-0001-9688-184X; 
CR Zillioux EJ, 2001, ENVIRON TOXICOL CHEM, V20, P1968, DOI 10.1897/1551-5028(2001)020<1968:TSMAAI>2.0.CO;2
   Papoulias DM, 2000, MAR ENVIRON RES, V50, P181, DOI 10.1016/S0141-1136(00)00076-3
   Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298
   Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498
   Papoulias DM, 2000, AQUAT TOXICOL, V48, P37, DOI 10.1016/S0166-445X(99)00026-0
   Amanuma K, 2000, NAT BIOTECHNOL, V18, P62, DOI 10.1038/71938
   Aida T, 1921, GENETICS, V6, P554
   Schreurs R, 2002, ARCH TOXICOL, V76, P257, DOI 10.1007/s00204-002-0348-4
   SATOH N, 1972, J EMBRYOL EXP MORPH, V28, P385
   Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870
   Kang IJ, 2003, ENVIRON TOXICOL CHEM, V22, P2438, DOI 10.1897/02-225
   Miura T, 2001, ZOOL SCI, V18, P1055, DOI 10.2108/zsj.18.1055
   Kawamura T, 2002, ZOOL SCI, V19, P1355, DOI 10.2108/zsj.19.1355
   Harries JE, 1996, ENVIRON TOXICOL CHEM, V15, P1993, DOI 10.1897/1551-5028(1996)015<1993:ASOEAI>2.3.CO;2
   Kang IJ, 2002, ENVIRON TOXICOL CHEM, V21, P2394, DOI 10.1897/1551-5028(2002)021<2394:EOBAOT>2.0.CO;2
   Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a
   Metcalfe TL, 2000, ENVIRON TOXICOL CHEM, V19, P1893, DOI 10.1897/1551-5028(2000)019<1893:GDAERI>2.3.CO;2
   Kang IJ, 2002, CHEMOSPHERE, V47, P71, DOI 10.1016/S0045-6535(01)00205-3
   Lange R, 2001, ENVIRON TOXICOL CHEM, V20, P1216, DOI 10.1897/1551-5028(2001)020<1216:EOTSEE>2.0.CO;2
   Matsuda M, 1997, GENES GENET SYST, V72, P263, DOI 10.1266/ggs.72.263
   SATOH N, 1974, J EMBRYOL EXP MORPH, V32, P195
   Edmunds JSG, 2000, ENVIRON HEALTH PERSP, V108, P219, DOI 10.2307/3454437
   Seki M, 2002, ENVIRON TOXICOL CHEM, V21, P1692, DOI 10.1897/1551-5028(2002)021<1692:EOEOTR>2.0.CO;2
   Holthaus KIE, 2002, ENVIRON TOXICOL CHEM, V21, P2526, DOI 10.1897/1551-5028(2002)021<2526:TPFEAE>2.0.CO;2
   Yokota H, 2000, ENVIRON TOXICOL CHEM, V19, P1925, DOI 10.1897/1551-5028(2000)019<1925:EOBAOT>2.3.CO;2
   FOLMAR LC, 2002, AQUAT TOXICOL, V27, P361
   Ishaq R, 1999, ENVIRON TOXICOL CHEM, V18, P533, DOI 10.1897/1551-5028(1999)018<0533:OPCATT>2.3.CO;2
   Kramer VJ, 1998, AQUAT TOXICOL, V40, P335, DOI 10.1016/S0166-445X(97)00060-X
   Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605
   Miles-Richardson SR, 1999, AQUAT TOXICOL, V47, P129, DOI 10.1016/S0166-445X(99)00009-0
   NAKAMURA M, 1973, Bulletin of the Faculty of Fisheries Hokkaido University, V24, P1
   *ORG EC COOP DEV, 1999, FIN REP OECD EXP CON
   Paparella M, 2002, TOXICOL IN VITRO, V16, P589, DOI 10.1016/S0887-2333(02)00052-8
   Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554
   Schorr S, 2000, EWEEK, V17, P50
   Wakamatsu Yuko, 2003, Environmental Sciences, V10, P291
   WALKER MK, 1996, TECHNIQUES AQUATIC T, P41
   Wilson PJ, 1996, MAR ENVIRON RES, V42, P129, DOI 10.1016/0141-1136(95)00047-X
   Yamamoto T, 1975, MEDAKA KILLIFISH BIO
   Yokota H, 2001, ENVIRON TOXICOL CHEM, V20, P2552, DOI 10.1897/1551-5028(2001)020<2552:LCTONT>2.0.CO;2
NR 40
TC 10
Z9 12
U1 1
U2 9
PU SETAC
PI PENSACOLA
PA 1010 NORTH 12TH AVE, PENSACOLA, FL 32501-3367 USA
SN 0730-7268
J9 ENVIRON TOXICOL CHEM
JI Environ. Toxicol. Chem.
PD JAN
PY 2005
VL 24
IS 1
BP 70
EP 77
DI 10.1897/03-610.1
PG 8
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 880XW
UT WOS:000225824600010
PM 15683169
ER

PT J
AU Iwai, Y
   Terawaki, S
   Honjo, T
AF Iwai, Y
   Terawaki, S
   Honjo, T
TI PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor
   cells by enhanced recruitment of effector T cells
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE CTL; cytokine production; immunothrapy; metastatic tumors; T cell
   proliferation
ID COLONY-STIMULATING FACTOR; ENDOTHELIAL-CELLS; B7 FAMILY; DILATED
   CARDIOMYOPATHY; IMMUNE-RESPONSES; CYTO-TOXICITY; IMMUNOTHERAPY; CTLA-4;
   COSTIMULATION; RECEPTOR
AB Since metastasis is the major cause of death for cancer patients, there is an urgent need to develop new therapies to control hematogenous dissemination of cancer cells. Previously we and others demonstrated a novel mechanism that allows tumors to escape from the host immune response by expressing PD-L1 which can negatively regulate immune response through the interaction with PD-1, an immunoinhibitory receptor belonging to the CD28 family. In this study, we report that hematogenous spread of poorly immunogenic B16 melanoma cells to the liver was inhibited in PD-1-deficient mice. After inoculation to spleen, PD-L1 was induced on tumor cells, which did not express PD-L1 in vitro. As compared with wild-type mice, intrasplenic injection of B16 cells into PD-1-deficient mice showed enhanced induction of effector T cells in spleen, prolonged T cell proliferation and cytokine production, and augmented homing of effector T cells to tumor sites in the liver, resulting in accumulation of effector T cells in the tumor sites. PD-1 blockade by genetic manipulation or antibody treatment inhibited not only hematogenous dissemination of B16 melanoma cells to the liver on the C57BL/6 background, but also dissemination of CT26 colon cancer cells to the lung on the BALB/c background. These results suggest that PD-1 blockade may be a powerful tool for treatment of hematogenous spread of various tumor cells.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Kawai T, 2000, INT IMMUNOL, V12, P937, DOI 10.1093/intimm/12.6.937
   Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727
   Hurwitz AA, 2000, CURR OPIN IMMUNOL, V12, P589, DOI 10.1016/S0952-7915(00)00147-3
   Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355
   Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953
   Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351
   Abken H, 2002, TRENDS IMMUNOL, V23, P240, DOI 10.1016/S1471-4906(02)02180-4
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3
   Strome SE, 2003, CANCER RES, V63, P6501
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4
   DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Mazanet MM, 2002, J IMMUNOL, V169, P3581
   Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5
   Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8
   Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x
   Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.3.CO;2-O
   Bachmann MF, 1998, J IMMUNOL, V160, P95
   Filder IJ, 1982, SCIENCE, V217, P998
   HELLSTROM KE, 1995, IMMUNOL REV, V145, P123, DOI 10.1111/j.1600-065X.1995.tb00079.x
   Iwaia Y, 2002, IMMUNOL LETT, V83, P215, DOI 10.1016/S0165-2478(02)00088-3
   Katakai T, 2002, J BIOL CHEM, V277, P50948, DOI 10.1074/jbc.M204133200
   KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6
   SCHMIDT A, 1985, NATURE, V314, P286, DOI 10.1038/314286a0
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Wang JC, 2003, AIDS BEHAV, V7, P1, DOI 10.1023/A:1022541504943
   WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G
   Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k
NR 49
TC 122
Z9 125
U1 7
U2 18
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD FEB
PY 2005
VL 17
IS 2
BP 133
EP 144
DI 10.1093/intimm/dxh194
PG 12
WC Immunology
SC Immunology
GA 889XX
UT WOS:000226477300004
PM 15611321
ER

PT J
AU Kishi, Y
   Takahashi, J
   Koyanagi, M
   Morizane, A
   Okamoto, Y
   Horiguchi, S
   Tashiro, K
   Honjo, T
   Fujii, S
   Hashimoto, N
AF Kishi, Y
   Takahashi, J
   Koyanagi, M
   Morizane, A
   Okamoto, Y
   Horiguchi, S
   Tashiro, K
   Honjo, T
   Fujii, S
   Hashimoto, N
TI Estrogen promotes differentiation and survival of dopaminergic neurons
   derived from human neural stem cells
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE 17 beta-estradiol; human neural stem cell; dopaminergic neuron
ID BETA MESSENGER-RNA; PARKINSONS-DISEASE; PROGENITOR CELLS; PRECURSOR
   CELLS; INDUCED NEUROTOXICITY; NEUROTROPHIC FACTOR; CORTICAL-NEURONS;
   OXIDATIVE STRESS; RECEPTOR-ALPHA; MOUSE STRIATUM
AB To investigate the effect of estrogen on neuronal differentiation, especially on dopaminergic (DA) neurons, human neural stem cells (NSCs) were differentiated in the presence of 17beta-estradiol. NSCs gave rise to tyrosine hydroxylase (TH)-positive neurons in vitro, the proportion of which was increased by 17beta-estradiol. Increase in TH-positive neurons was abrogated by an estrogen receptor (ER) antagonist, ICI182780, suggesting ERs play a role in differentiation of DA neurons. The observation that ERs were expressed in both proliferating NSCs and postmitotic DA neurons suggested that increase in TH-positive neurons was due to induction and support of DA neurons. 17beta-Estradiol also increased the number of DA neurons derived from human NSCs in vivo when the cells were grafted into mouse brains. These results support a possible role for estrogen in the transplantation of NSCs for Parkinson's disease. (C) 2004 Wiley-Liss, Inc.
C1 Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto 6068507, Japan.
RP Takahashi, J (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
EM jbtaka@kuhp.kyoto-u.ac.jp
CR Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098
   Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720
   WAKELING AE, 1991, CANCER RES, V51, P3867
   Leranth C, 2000, J NEUROSCI, V20, P8604
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Blurton-Jones MM, 1999, J COMP NEUROL, V405, P529, DOI 10.1002/(SICI)1096-9861(19990322)405:4<529::AID-CNE6>3.0.CO;2-Y
   Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706
   Kuppers E, 1999, NEUROSCI LETT, V276, P95, DOI 10.1016/S0304-3940(99)00815-0
   Tanapat P, 1999, J NEUROSCI, V19, P5792
   Raab H, 1995, MOL BRAIN RES, V34, P333, DOI 10.1016/0169-328X(95)00196-Y
   Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788
   Kuppers E, 2000, J NEUROCYTOL, V29, P375, DOI 10.1023/A:1007165307652
   Jover T, 2002, J NEUROSCI, V22, P2115
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098
   Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000
   Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427
   Potter ED, 1999, CELL TISSUE RES, V296, P235, DOI 10.1007/s004410051285
   Studer L, 2000, J NEUROSCI, V20, P7377
   Ivanova T, 2001, J NEUROSCI RES, V66, P221, DOI 10.1002/jnr.1214
   Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141
   Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   Horiguchi S, 2004, J NEUROSCI RES, V75, P817, DOI 10.1002/jnr.20046
   Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846
   Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998
   SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110
   Behl C, 1997, MOL PHARMACOL, V51, P535
   Singer CA, 1999, J NEUROSCI, V19, P2455
   Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634
   Sawada H, 2002, NEUROPHARMACOLOGY, V42, P1056, DOI 10.1016/S0028-3908(02)00049-7
   Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367
   Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3
   Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194
   Carvey PM, 2001, EXP NEUROL, V171, P98, DOI 10.1006/exnr.2001.7735
   Daadi MM, 1999, J NEUROSCI, V19, P4484
   Dluzen D, 1997, BRAIN RES, V767, P340, DOI 10.1016/S0006-8993(97)00630-6
   Dluzen DE, 1996, J NEUROCHEM, V66, P658
   Dluzen D E, 2000, J Gend Specif Med, V3, P36
   Freed CR, 2002, P NATL ACAD SCI USA, V99, P1755, DOI 10.1073/pnas.062039699
   Fricker RA, 1999, J NEUROSCI, V19, P5990
   Gollapudi L, 1999, J NEUROSCI RES, V56, P99, DOI 10.1002/(SICI)1097-4547(19990401)56:1<99::AID-JNR13>3.0.CO;2-G
   GRANDBOID M, 2000, NEUROREPORT, V7, P343
   Howard SA, 2001, EXP NEUROL, V168, P385, DOI 10.1006/exnr.2000.7619
   Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631
   Kuppers E, 1998, MOL BRAIN RES, V63, P184, DOI 10.1016/S0169-328X(98)00279-4
   Lindvall O, 2003, P NATL ACAD SCI USA, V100, P7430, DOI 10.1073/pnas.1332673100
   NILSSON S, 2000, P SOC PHOTO-OPT INS, V1, P81
   Pérez Sylvia E, 2003, Brain Res Dev Brain Res, V145, P117
   Raab H, 1999, NEUROSCI LETT, V275, P21, DOI 10.1016/S0304-3940(99)00723-5
   Sawada H, 1998, J NEUROSCI RES, V54, P707, DOI 10.1002/(SICI)1097-4547(19981201)54:5<707::AID-JNR16>3.0.CO;2-T
   Zhang L, 2001, NEUROREPORT, V12, P1919, DOI 10.1097/00001756-200107030-00030
NR 51
TC 36
Z9 38
U1 1
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0360-4012
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD FEB 1
PY 2005
VL 79
IS 3
BP 279
EP 286
DI 10.1002/jnr.20362
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 892FG
UT WOS:000226634800002
PM 15614791
ER

PT J
AU Nagaoka, H
   Ito, S
   Muramatsu, M
   Nakata, M
   Honjo, T
AF Nagaoka, H
   Ito, S
   Muramatsu, M
   Nakata, M
   Honjo, T
TI DNA cleavage in immunoglobulin somatic hypermutation depends on de novo
   protein synthesis but not on uracil DNA glycosylase
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; DOUBLE-STRAND
   BREAKS; ANTIBODY DIVERSIFICATION; GENE CONVERSION; GERMINAL CENTER;
   SERINE 139; CELL-LINE; IN-VIVO; CHROMATIN
AB Activation-induced cytidine deaminase (AID) is required for the DNA cleavage step of 19 somatic hypermutation (SHM). However, its molecular mechanism is controversial. The RNA editing hypothesis postulates that AID deaminates cytosine in an unknown mRNA to generate a new mRNA encoding SHM endonuclease. On the other hand, the DNA deamination hypothesis explains DNA cleavage by cytosine deamination in DNA, followed by uracil removal by uracil DNA glycosylase (UNG). By using the protein synthesis inhibitor cycloheximide, we showed that SHM requires de novo protein synthesis in accord with predictions by the RNA editing hypothesis. In addition, we found that cycloheximide but not Ugi (the specific inhibitor of UNG) inhibited AID-dependent DNA cleavage in the Ig gene during SHM, by using histone H2AX focus formation as a marker of DNA cleavage. The results indicate the following order of events: AID expression, protein synthesis, DNA cleavage, and SHM. The requirement of protein synthesis but not of UNG for the DNA cleavage step of SHM forces us to reconsider the DNA deamination hypothesis and strengthens the RNA editing hypothesis.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009
   Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Cerutti A, 1998, J IMMUNOL, V160, P2145
   Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni0902-826
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390
   Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101
   Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Kong QZ, 2001, GENETICS, V158, P369
   Kuhne C, 2003, NUCLEIC ACIDS RES, V31, P7227, DOI 10.1093/nar/gkg937
   Stavnezer J., 2004, MOL BIOL B CELLS, P307
NR 42
TC 26
Z9 26
U1 1
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 8
PY 2005
VL 102
IS 6
BP 2022
EP 2027
DI 10.1073/pnas.0409491102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 898JK
UT WOS:000227072900041
PM 15684068
ER

PT J
AU Suzuki, K
   Meek, B
   Doi, Y
   Honjo, T
   Fagarasan, S
AF Suzuki, K
   Meek, B
   Doi, Y
   Honjo, T
   Fagarasan, S
TI Two distinctive pathways for recruitment of naive and primed IgM(+) B
   cells to the gut lamina propria
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gut stromal cells; IgA; migration; NF-kappa B
ID LYMPHOTOXIN-BETA-RECEPTOR; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH
   RECOMBINATION; ANTIBODY-SECRETING CELLS; DENDRITIC CELLS; T-CELLS; IGA
   PRODUCTION; LYMPH-NODES; MICE; ACTIVATION
AB Intestinal IgA(+) B cells are generated from IgM(+) B cells by in situ class switching in two separate gut microenvironments: organized follicular structures and lamina propria (LP). However, the origin of IgM(+) B cells in the gut LP is unknown. Transfer experiments to reconstitute IgM(+) B cells and IgA plasma cells in LP of aly/aly mice, which are defective in all organized follicular structures because of an NF-kappaB-inducing kinase (NIK) mutation, revealed that naive B cells can directly migrate to the LP. This migration requires NIK-dependent activation of gut stromal cells. By contrast, the entry of gut-primed IgM(+) B cells to the LIP is independent of stromal cells with functional NIK. Our results indicate that naive B cells directly migrate to the LIP by a distinct pathway from gut-primed B cells.
C1 RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Fagarasan, S (reprint author), RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan.
EM sidonia-f@rcai.riken.jp
RI Meek, Bob/C-5042-2015; Fagarasan, Sidonia/A-5258-2016
OI Fagarasan, Sidonia/0000-0003-2086-6402
CR Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775
   Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477
   Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   DONSKOY E, 1992, J IMMUNOL, V148, P1604
   MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224
   Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5
   Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780
   Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795
   Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807
   Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472
   Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101
   Hamada H, 2002, J IMMUNOL, V168, P57
   Lorenz RG, 2003, J IMMUNOL, V170, P5475
   Koike R, 1996, EUR J IMMUNOL, V26, P669, DOI 10.1002/eji.1830260324
   Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453
   Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982
   Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726
   Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x
   Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631
   BUTCHER EC, 1999, MUCOSAL IMMUNOLOGY, P507
   Cebra J. J., 1994, HDB MUCOSAL IMMUNOLO, P151
   Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244
   Koike R, 1997, CELL IMMUNOL, V180, P62, DOI 10.1006/cimm.1997.1177
   Muller G, 2003, CURR OPIN IMMUNOL, V15, P217, DOI 10.1016/S0952-7915(03)00014-1
   Ryffel B, 1998, Dev Immunol, V6, P253, DOI 10.1155/1998/76963
NR 31
TC 30
Z9 35
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 15
PY 2005
VL 102
IS 7
BP 2482
EP 2486
DI 10.1073/pnas.0409539102
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 898JM
UT WOS:000227073100043
PM 15695334
ER

PT J
AU Probst, HC
   McCoy, K
   Okazaki, T
   Honjo, T
   van den Broek, M
AF Probst, HC
   McCoy, K
   Okazaki, T
   Honjo, T
   van den Broek, M
TI Resting dendritic cells induce peripheral CD8(+) T cell tolerance
   through PD-1 and CTLA-4
SO NATURE IMMUNOLOGY
LA English
DT Article
ID LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PROMISCUOUS GENE-EXPRESSION;
   IN-VIVO; ANTIGEN PRESENTATION; STEADY-STATE; CROSS-PRESENTATION;
   SELF-TOLERANCE; CUTTING EDGE; ACTIVATION; MICE
AB T cells recognizing self proteins exist without causing autoimmunity in healthy individuals. These autoreactive T cells are kept in check by peripheral tolerance. Using a model for peripheral CD8(+) T cell tolerance resulting from antigen presentation by resting dendritic cells in vivo, we show here that CD8(+) T cell tolerance operates through T cell-intrinsic mechanisms such as deletion or functional inactivation. Peripheral CD8(+) T cell tolerance depended on signaling via the costimulatory molecule PD-1, as an absence of PD-1 converted tolerance induction into priming. Blocking of the costimulatory molecule CTLA-4 resulted in impaired tolerance and enhanced the effect of the absence of PD-1, suggesting that PD-1 and CTLA-4 act synergistically. Thus PD-1 and CTLA-4 are crucial molecules for peripheral CD8(+) T cell tolerance induced by resting dendritic cells.
C1 Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.
   Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan.
RP van den Broek, M (reprint author), Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.
EM maries@pathol.unizh.ch
CR Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861
   Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707
   Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349
   Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213
   Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8
   Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   Brunner MC, 1999, J IMMUNOL, V162, P5813
   Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Misra N, 2004, J IMMUNOL, V172, P4676
   Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828
   BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U
   Groux H, 1999, J IMMUNOL, V162, P1723
   Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239
   Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1
   Morgan DJ, 1999, J IMMUNOL, V163, P723
   LINDSTEN T, 1993, J IMMUNOL, V151, P3489
   Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547
   Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071
   Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7
   Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2
   Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X
   Steinman RM, 2003, ANN NY ACAD SCI, V987, P15
   Blank C, 2003, J IMMUNOL, V171, P4574
   Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229
   Dhodapkar MV, 2002, BLOOD, V100, P174, DOI 10.1182/blood.V100.1.174
   Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598
   LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421
   Walunas TL, 1998, J IMMUNOL, V160, P3855
   Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308
   Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958
   Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991
   Lehmann-Grube F, 1971, VIROL MONOGR, V10, P1
   Lin YL, 2003, EUR J IMMUNOL, V33, P2736, DOI 10.1002/eji.200324087
   McCoy KD, 1999, J EXP MED, V189, P1157, DOI 10.1084/jem.189.7.1157
   Mondino A, 1996, P NATL ACAD SCI USA, V93, P2245, DOI 10.1073/pnas.93.6.2245
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   Probst HC, 2003, J IMMUNOL, V171, P5415
   Probst HC, 2002, J IMMUNOL, V168, P5387
   ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36
NR 56
TC 271
Z9 286
U1 5
U2 16
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD MAR
PY 2005
VL 6
IS 3
BP 280
EP 286
DI 10.1038/ni1165
PG 7
WC Immunology
SC Immunology
GA 899AN
UT WOS:000227117400020
PM 15685176
ER

PT J
AU Green, KA
   Okazaki, T
   Honjo, T
   Green, WR
AF Green, KA
   Okazaki, T
   Honjo, T
   Green, WR
TI The role of programmed death 1 (PD-1) receptor, its ligands PD-L1 and
   PD-L2, and IL-10 in LP-BM5 induced MAIDS
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology 2005 Meeting/35th International Congress of
   Physiological Sciences
CY MAR 31-APR 06, 2005
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Assoc Immunol, Amer Phtsiol Soc & Int Union Physiol Sci, Amer Soc Biochem & Mole Biol, Amer Soc Investigat Pathol, Amer Soc Nutr Sci, Amer Soc Pharmacol & Exptl Therapeut
C1 Dartmouth Coll Sch Med, Lebanon, NH 03756 USA.
   Kyoto Univ, Sakyo Ku, Kyoto 6068501, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 4
PY 2005
VL 19
IS 4
SU S
BP A963
EP A963
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 905ZQ
UT WOS:000227610706628
ER

PT J
AU Kotani, A
   Okazaki, I
   Muramatsu, M
   Kinoshita, K
   Begum, NA
   Nakajima, T
   Saito, H
   Honjo, T
AF Kotani, A
   Okazaki, I
   Muramatsu, M
   Kinoshita, K
   Begum, NA
   Nakajima, T
   Saito, H
   Honjo, T
TI A target selection of somatic hypermutations is regulated similarly
   between T and B cells upon activation-induced cytidine deaminase
   expression
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE CD4 and CD5 genes; E47 binding motif; T lymphoma
ID CLASS-SWITCH RECOMBINATION; P53 GENE-MUTATIONS; IMMUNOGLOBULIN GENES;
   C-MYC; LYMPHOCYTE DEVELOPMENT; COLORECTAL CARCINOMAS; BURKITT-LYMPHOMA;
   INTRON ENHANCER; BCL6 GENE; AID
AB Activation-induced cytidine deaminase (AID) is essential for somatic hypermutations (SHIM) and class switch recombination. Overexpression of AID in non-B cells can induce SHM in artificial constructs inserted in various loci in the genome. AID overexpression was thus proposed to introduce mutations in a wide variety of genes with little specificity. We previously showed that AID transgenic mice developed T cell lymphomas in which the variable region 13 genes of the T cell receptor and c-myc were mutated as frequently as SHM in activated B cells. To understand the target specificity of SHM in AID-expressing T lymphomas, we sequenced six oncogenes (c-myc, pim1, p53, atm, tgfbr-2, and k-ras) and two genes (cd4 and cd5) that are actively transcribed in T lymphomas. SHIM was found only in c-myc, pim1, cd4, and cd5, which share the E47 binding motif in the enhancer/promoter. The rest that are not mutated in B cells were not mutated in AID-induced T lymphomas either, although they are transcribed in T and B cells. Comparison of several features of SHM, including selection of targets and mutation distribution, suggests that the regulatory mechanism of SHIM is similar between T and B cells. SHIM base specificities in the CD4 and CD5 genes were biased to AT, indicating that the preference of target bases of the mutations generated by overexpression of AID is not always GC bases but variable between target genes.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   RIKEN Res Ctr Allergy & Immunol, Dept Allergy & Immunol, Natl Res Inst Child Hlth & Dev, Setagaya Ku, Tokyo 1548567, Japan.
   RIKEN Res Ctr Allergy & Immunol, Lab Allergy Transcriptome, Setagaya Ku, Tokyo 1548567, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Koneo Cho, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238
   Kerbauy FR, 2004, LEUKEMIA LYMPHOMA, V45, P2071, DOI 10.1080/10428190410001713170
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Kee BL, 2000, IMMUNOL REV, V175, P138, DOI 10.1111/j.1600-065X.2000.imr017514.x
   Martin A, 2002, NATURE, V415, P802
   Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111
   YELAMOS J, 1995, NATURE, V376, P225
   AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Dearden CE, 2003, HEMATOL ONCOL CLIN N, V17, P1351, DOI 10.1016/S0889-8588(03)00119-9
   Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520
   Malpeli G, 2004, HAEMATOLOGICA, V89, P1091
   ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441
   Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558
   Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9
   Leroy K, 2002, ANN ONCOL, V13, P1108, DOI 10.1093/annonc/mdf185
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6
   Gronbaek K, 2002, BLOOD, V100, P1430, DOI 10.1182/blood-2002-02-0382
   Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100
   Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101
   Besmer E, 2004, CURR OPIN IMMUNOL, V16, P241, DOI 10.1016/j.coi.2004.01.005
   CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977
   Davoodi-Semiromi A, 2004, J BIOL CHEM, V279, P11553, DOI 10.1074/jbc.M312110200
   Diaz M, 2003, DNA REPAIR, V2, P623, DOI 10.1016/S1568-7864(02)00240-9
   GIUSTI AM, 1993, J EXP MED, V177, P797, DOI 10.1084/jem.177.3.797
   GOLDING GB, 1987, GENETICS, V115, P169
   Greenbaum S, 2002, SEMIN IMMUNOL, V14, P405, DOI 10.1016/s1044-5323(02)00075-1
   HACKETT J, 1990, J EXP MED, V172, P131, DOI 10.1084/jem.172.1.131
   HOANG AT, 1995, MOL CELL BIOL, V15, P4031
   Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01<317::AID-IMMU317>3.0.CO;2-S
   Kodama M, 2001, INT IMMUNOL, V13, P1415, DOI 10.1093/intimm/13.11.1415
   Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8
   Nakajima T, 2004, J ALLERGY CLIN IMMUN, V113, P528, DOI 10.1016/j.jaci.2003.12.036
   Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000
   OBRIEN RL, 1987, NATURE, V326, P405, DOI 10.1038/326405a0
   Raffeld M, 1995, Curr Top Microbiol Immunol, V194, P265
   SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X
NR 59
TC 50
Z9 50
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 22
PY 2005
VL 102
IS 12
BP 4506
EP 4511
DI 10.1073/pnas.0500830102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 909IY
UT WOS:000227854800052
PM 15767564
ER

PT J
AU Shiraki, R
   Inoue, N
   Otsui, K
   Honjo, T
   Takahashi, M
   Hirata, K
   Kawashima, S
   Yokoyama, M
AF Shiraki, R
   Inoue, N
   Otsui, K
   Honjo, T
   Takahashi, M
   Hirata, K
   Kawashima, S
   Yokoyama, M
TI Toll-like receptor 4 expression on peripheral blood monocytes predicts
   the risk of coronary artery disease in patients with low C-reactive
   protein
SO ATHEROSCLEROSIS SUPPLEMENTS
LA English
DT Meeting Abstract
CT 75th Congress of the European-Atherosclerosis-Society
CY APR 23-26, 2005
CL Prague, CZECH REPUBLIC
SP European Atherosclerosis Soc
C1 Kobe Univ, Sch Med, Div Cardiovasc & Resp Med, Kobe, Hyogo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1567-5688
J9 ATHEROSCLEROSIS SUPP
JI Atheroscler. Suppl.
PD APR
PY 2005
VL 6
IS 1
BP 89
EP 90
DI 10.1016/S1567-5688(05)80355-1
PG 2
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 921BK
UT WOS:000228739000356
ER

PT J
AU Tao, R
   Ye, QR
   Wang, LQ
   Sedy, JS
   Hurchla, M
   Han, RX
   Wang, T
   Honjo, T
   Murphy, TL
   Murphy, KM
   Hancock, WW
AF Tao, R
   Ye, QR
   Wang, LQ
   Sedy, JS
   Hurchla, M
   Han, RX
   Wang, T
   Honjo, T
   Murphy, TL
   Murphy, KM
   Hancock, WW
TI Contrasting effects of targeting BTLA/HVEM and PD-1 in vivo depending
   upon the strength of T cell alloactivation.
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Meeting Abstract
CT 6th American Transplant Congress
CY MAY 21-25, 2005
CL Seattle, WA
SP Amer Soc Transplant Surg, Amer Soc Transplantat
C1 Childrens Hosp Philadelphia, Pathol & Lab Med, Philadelphia, PA 19104 USA.
   Childrens Hosp Philadelphia, Biesecker Pediat Liver Ctr, Philadelphia, PA 19104 USA.
   Washington Univ, Sch Med, St Louis, MO USA.
   Kyoto Univ, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1600-6135
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAY
PY 2005
VL 5
SU 11
MA 1025
BP 418
EP 418
PG 1
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 927WQ
UT WOS:000229231601443
ER

PT J
AU Xin, H
   Kikuchi, T
   Andarini, S
   Ohkouchi, S
   Suzuki, T
   Nukiwa, T
   Huqun
   Hagiwara, K
   Honjo, T
   Saijo, Y
AF Xin, H
   Kikuchi, T
   Andarini, S
   Ohkouchi, S
   Suzuki, T
   Nukiwa, T
   Huqun
   Hagiwara, K
   Honjo, T
   Saijo, Y
TI Antitumor immune response by CX3CL1 fractalkine gene transfer depends on
   both NK and T cells
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE chemokine; fractalkine; gene therapy; NK cells; T cells
ID MACROPHAGE-DERIVED CHEMOKINE; DENDRITIC CELLS; RECEPTOR CX(3)CR1;
   KILLER-CELLS; ADHESION; CANCER; ACTIVATION; EFFECTOR; CHEMOATTRACTION;
   IMMUNOTHERAPY
AB The CX3C chemokine fractalkine (CX3CL1) exists as both a membrane-bound form promoting firm cell-cell adhesion and a soluble form chemoattracting leukocytes expressing its receptor CX3CR1. When adenoviral vector expressing mouse fractalkine (AdFKN) was transduced to the tumor cells, fractalkine was expressed as both membrane-bound form on the tumor cells and soluble form in the supernatant in vitro. Intratumoral injection of AdFKN (1x10(9)PFU/tumor) into C26 and B16F10 tumors resulted in marked reduction of tumor growth compared to control (C26: 86.5%, p&LT; 0.001; B16F10: 85.5%,p&LT; 0.001). Histological examination of tumor tissues revealed abundant infiltration of NK cells, dendritic cells, and CD8(+) T lymphocytes 3 and/or 6 days after treatment with AdFKN. Splenocytes from mice treated by AdFKN developed tumor-specific cytotoxic T cells, and thereby protected from rechallenging with parental tumor cells. Antitumor effects by AdFKN were completely abrogated in both NK cell-depleted mice and CD8(-/-) mice, and partially blocked in CD4(-/-) mice. These data indicated that fractalkine mediates antitumor effects by both NK cell-dependent and T cell-dependent mechanisms. This study suggests that fractalkine can be a suitable candidate for immunogene therapy of cancer because fractalkine induces both innate and adaptive immunity.
C1 Tohoku Univ, Grad Sch Med, Dept Mol Med, Sendai, Miyagi 9808575, Japan.
   Tohoku Univ, Inst Dev, Dept Resp Oncol & Mol Med, Sendai, Miyagi 980, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
RP Saijo, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Mol Med, 21 Seiryomachi Aobaku, Sendai, Miyagi 9808575, Japan.
EM yasosj@idac.tohoku.ac.jp
CR Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593
   Guo J, 2003, IMMUNOL LETT, V89, P1, DOI 10.1016/S0165-2478(03)00101-9
   Goda S, 2000, J IMMUNOL, V164, P4313
   Ono SJ, 2003, J ALLERGY CLIN IMMUN, V111, P1185, DOI 10.1067/mai.2003.1594
   Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775
   Lavergne E, 2003, CANCER RES, V63, P7468
   Garton KJ, 2001, J BIOL CHEM, V276, P37993
   Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Belardelli F, 2002, TRENDS IMMUNOL, V23, P201, DOI 10.1016/S1471-4906(02)02195-6
   ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501
   Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246
   Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016
   CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652
   Ribas A, 2003, J CLIN ONCOL, V21, P2415, DOI 10.1200/JCO.2003.06.041
   Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1
   Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252
   Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517
   Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200
   Kanazawa N, 1999, EUR J IMMUNOL, V29, P1925, DOI 10.1002/(SICI)1521-4141(199906)29:06<1925::AID-IMMU1925>3.0.CO;2-U
   Nishimura M, 2002, J IMMUNOL, V168, P6173
   Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9
   Guo J, 2002, GENE THER, V9, P793, DOI 10.1038/sj/gt/3301688
   Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T
   Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156
   Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734
   Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000
   TAHARA H, 1995, J IMMUNOL, V154, P6466
   FOSSA SD, 1992, ANN ONCOL, V3, P301
   Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0
   CMBIEN B, 2001, BLOOD, V97, P2031
   Gao JQ, 2003, CANCER RES, V63, P4420
   Guo J, 2003, INT J CANCER, V103, P212, DOI 10.1002/ijc.10816
   Keilholz U, 2002, SEMIN ONCOL, V29, P456, DOI 10.1053/sonc.2002.35240
   Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6
   MIER JW, 1990, BLOOD, V76, P1933
   Natsume A, 1999, GENE THER, V6, P1626, DOI 10.1038/sj.gt.3300990
   SCHROERS R, 2000, GENE THER, V9, P889
   UCHIYAMA A, 1992, CANCER RES, V53, P946
   VOGELZANG PJ, 1992, CHEST, V101, P746, DOI 10.1378/chest.101.3.746
   Xia DJ, 2002, GENE THER, V9, P592, DOI 10.1038/sj.gt.3301694
   Zitvogel L., 2002, J EXP MED, V195, P9
NR 42
TC 38
Z9 41
U1 1
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD MAY
PY 2005
VL 35
IS 5
BP 1371
EP 1380
DI 10.1002/eji.200526042
PG 10
WC Immunology
SC Immunology
GA 926BG
UT WOS:000229097100005
PM 15789339
ER

PT J
AU Honjo, T
   Nagaoka, H
   Shinkura, R
   Muramatsu, M
AF Honjo, T
   Nagaoka, H
   Shinkura, R
   Muramatsu, M
TI AID to overcome the limitations of genomic information
SO NATURE IMMUNOLOGY
LA English
DT Review
ID CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE;
   SINGLE-STRANDED-DNA; ACTIVATION-INDUCED DEAMINASE; NOVO
   PROTEIN-SYNTHESIS; B MESSENGER-RNA; IMMUNOGLOBULIN SOMATIC
   HYPERMUTATION; INDUCED CYTOSINE DEAMINASE; ANTIBODY DIVERSIFICATION;
   MISMATCH REPAIR
AB The limitations of genomic information forced our ancestors to adopt a strategy for introducing somatic DNA alterations with the risk of genome instability. Although activation-induced deaminase ( AID) is involved in DNA cleavage in somatic hypermutation and class-switch recombination, its mechanism of action has been debated extensively, with the two main hypotheses being distinguished by the chief target of AID: RNA or DNA. The principle distinction between the two hypotheses is the requirement for translation of edited mRNA or uracil removal from DNA for DNA cleavage. Although a series of experiments has provided support for the `RNA-editing' hypothesis and requires reevaluation of the `DNA-deamination' hypothesis, definitive proof is yet to come.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101
   Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718
   Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974
   NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7
   Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553
   Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369
   Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   YELAMOS J, 1995, NATURE, V376, P225
   AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121
   Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200
   Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200
   LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858
   Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0
   Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Lee GS, 2004, MOL CELL, V16, P505, DOI 10.1016/j.molcel.2004.11.008
   Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x
   Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200
   Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558
   He B, 2003, J IMMUNOL, V171, P5215
   Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9
   Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011
   Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026
   Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200
   Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821
   Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066
   Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395
   REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0
   Storb U, 1998, IMMUNOL REV, V162, P153
   Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918
   Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919
   Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100
   Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Wu XS, 2005, J IMMUNOL, V174, P934
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O
   Barreto VM, 2005, TRENDS IMMUNOL, V26, P90, DOI 10.1016/j.it.2004.12.004
   Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101
   Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444
   Bemark M, 2003, GENE CHROMOSOME CANC, V38, P32, DOI 10.1002/gcc/10241
   Besmer E, 2004, CURR OPIN IMMUNOL, V16, P241, DOI 10.1016/j.coi.2004.01.005
   Bross Linda, 2003, Clin Dev Immunol, V10, P83, DOI 10.1080/10446670310001626571
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   GIUSTI AM, 1993, J EXP MED, V177, P797, DOI 10.1084/jem.177.3.797
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01<317::AID-IMMU317>3.0.CO;2-S
   Kodama M, 2001, INT IMMUNOL, V13, P1415, DOI 10.1093/intimm/13.11.1415
   Kong QZ, 2001, GENETICS, V158, P369
   Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102
   Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   Luo ZH, 2004, J ALLERGY CLIN IMMUN, V114, P726, DOI 10.1016/j.jaci.2004.07.049
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8
   Poltoratsky VP, 2004, J IMMUNOL, V172, P4308
   Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6
   Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
   Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200
NR 102
TC 77
Z9 77
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD JUL
PY 2005
VL 6
IS 7
BP 655
EP 661
DI 10.1038/ni1218
PG 7
WC Immunology
SC Immunology
GA 938BS
UT WOS:000229975500008
PM 15970938
ER

PT J
AU Okazaki, T
   Honjo, T
AF Okazaki, T
   Honjo, T
TI Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID SUBSEQUENT IMMUNOGLOBULIN SUBSTITUTION; AUTOIMMUNE-DISEASES;
   HEART-FAILURE; VIRUS MYOCARDITIS; STRESS PROTEINS; TROPONIN-I; B7
   FAMILY; ANTIBODIES; MICE; IMMUNOADSORPTION
AB Whether autoimmunity could cause dilated cardiomyopathy (DCM) was disputed for more than half a century. Autoantilbodies against various cardiac antigens have been found in the sera of patients with DCM but none of these autoantibodies has been shown to have a substantial role in the development of DCM. It was recently reported that the injection of autoantibodies; against cardiac troponin I (cTnI) can induce DCM in normal mice. This observation showed that autoantibodies can cause DCM and put an end to the controversy. Clinical trials of immunoglobulin-adsorption therapy for DCM have already started in Germany and the results seem promising. Here, we discuss the recent findings and possibilities of immunoglobulin-adsorption therapy for this deadly disease.
C1 Kyoto Univ, Grad Sch Med, 21st Century COE Format, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, 21st Century COE Format, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Abulafia-Lapid R, 2003, J AUTOIMMUN, V20, P313, DOI 10.1016/S0896-8411(03)00038-6
   ALVAREZ FL, 1987, CLIN IMMUNOL IMMUNOP, V43, P129, DOI 10.1016/0090-1229(87)90164-4
   LATIF N, 1993, J AM COLL CARDIOL, V22, P1378
   Staudt A, 2001, CIRCULATION, V103, P2681
   Kawai C, 1999, CIRCULATION, V99, P1091
   Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1
   Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Matsumori A, 2002, CIRC J, V66, P323, DOI 10.1253/circj.66.323
   Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111
   Cohn JN, 1997, CIRCULATION, V95, P766
   Muller J, 2000, CIRCULATION, V101, P385
   Pohlner K, 1997, AM J CARDIOL, V80, P1040, DOI 10.1016/S0002-9149(97)00600-0
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Felix SB, 2001, AUTOIMMUNITY, V34, P211, DOI 10.3109/08916930109007387
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   Reichlin M, 1998, J AUTOIMMUN, V11, P557, DOI 10.1006/jaut.1998.0219
   Wallukat G, 1996, INT J CARDIOL, V54, P191, DOI 10.1016/0167-5273(96)02598-3
   Staudt A, 2004, J AM COLL CARDIOL, V44, P829, DOI 10.1016/j.jacc.2004.04.055
   Shou WN, 1998, NATURE, V391, P489
   Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   NEU N, 1987, J IMMUNOL, V139, P3630
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Felix SB, 2000, J AM COLL CARDIOL, V35, P1590, DOI 10.1016/S0735-1097(00)00568-4
   Felix SB, 2002, J AM COLL CARDIOL, V39, P646, DOI 10.1016/S0735-1097(01)01794-6
   Staudt A, 2001, EUR J PHARMACOL, V423, P115, DOI 10.1016/S0014-2999(01)01113-X
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Portig I, 1997, J MOL CELL CARDIOL, V29, P2245, DOI 10.1006/jmcc.1997.0463
   Solaro RJ, 1998, CIRC RES, V83, P471
   Richardson P, 1996, CIRCULATION, V93, P841
   Bosch Thomas, 2003, J Artif Organs, V6, P1, DOI 10.1007/s100470300000
   CAFORIO ALP, 1992, CIRCULATION, V85, P1734
   Dörffel W V, 2000, Ther Apher, V4, P235, DOI 10.1046/j.1526-0968.2000.00177.x
   FU MLX, 1994, CLIN IMMUNOL IMMUNOP, V72, P15, DOI 10.1006/clin.1994.1101
   Grassl G, 1997, CIRCULATION, V95, P1773
   HERSKOWITZ A, 1993, J AM COLL CARDIOL, V22, P1385
   JARJOUR WN, 1991, ARTHRITIS RHEUM, V34, P1133, DOI 10.1002/art.1780340909
   Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x
   Malkiel S, 1999, J IMMUNOL, V163, P5265
   Matsui S, 1997, J MOL CELL CARDIOL, V29, P641, DOI 10.1006/jmcc.1996.0307
   MATSUMORI A, 1982, CIRCULATION, V65, P1230
   MINOTA S, 1988, J EXP MED, V168, P1475, DOI 10.1084/jem.168.4.1475
   NEU N, 1990, J IMMUNOL, V145, P4094
   SCHULTHEISS HP, 1988, J EXP MED, V168, P2105, DOI 10.1084/jem.168.6.2105
   SCHULTHEISS HP, 1986, ANN NY ACAD SCI, V488, P44
   Schulze K, 1999, CARDIOVASC RES, V44, P91, DOI 10.1016/S0008-6363(99)00204-7
   SCHULZE K, 1990, CIRCULATION, V81, P959
   Tishler M, 1996, SEMIN ARTHRITIS RHEU, V26, P558, DOI 10.1016/S0049-0172(96)80043-6
   Toyo-Oka T, 2004, P NATL ACAD SCI USA, V101, P7381, DOI 10.1073/pnas.0401944101
   Wallukat G, 1987, BIOMED BIOCHIM ACTA, V46, P634
NR 56
TC 29
Z9 31
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
J9 TRENDS MOL MED
JI Trends Mol. Med
PD JUL
PY 2005
VL 11
IS 7
BP 322
EP 326
DI 10.1016/j.molmed.2005.05.001
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 953OA
UT WOS:000231084900006
PM 15935731
ER

PT J
AU Wang, J
   Yoshida, T
   Nakaki, F
   Hiai, H
   Okazaki, T
   Honjo, T
AF Wang, J
   Yoshida, T
   Nakaki, F
   Hiai, H
   Okazaki, T
   Honjo, T
TI Establishment of NOD-Pdcd1(-/-) mice as an efficient animal model of
   type I diabetes
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE autoimmunity; coreceptor; Idd locus; th1; linkage analysis
ID NOD MICE; T-CELLS; PD-1-DEFICIENT MICE; DILATED CARDIOMYOPATHY;
   AUTOIMMUNE-DISEASES; GENETIC DISSECTION; SJOGRENS-SYNDROME; LOCAL
   EXPRESSION; DEFICIENT MICE; MOUSE MODELS
AB Mice deficient in programmed cell death 1 (PD-1, Pdcd1), an immunoinhibitory receptor belonging to the CD28/cytotoxic T lymphocyte-associated antigen-4 family, spontaneously develop lupus-like autoimmune disease and autoimmune dilated cardiomyopathy on C57BL/6 and BALB/c backgrounds, respectively. However, how PD-1 deficiency induces different forms of autoimmune diseases on these two strains was unknown. Here, we report that PD-1 deficiency specifically accelerates the onset and frequency of type I diabetes in NOD (nonobese diabetic) mice, with strong T helper 1 polarization of T cells infiltrating into islets. These results suggest that PD-1 deficiency accelerates autoimmune predisposition of the background strain, leading to the induction of different forms of autoimmune diseases depending on the genetic background of the strain. Using NOD-Pdcd1(-/-) mice as an efficient animal model of type I diabetes, we screened diabetes-susceptible loci by genetic linkage analysis. The diabetic incidence of NOD-Pdcd1(-/-) mice was controlled by five genetic loci, including three known recessive loci [Idd (insulin-dependent diabetes) 1, Idd17, and Idd20] and two previously unidentified dominant loci [Iddp (Idd under PD-1 deficiency) 1 and Iddp2].
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Century Ctr Excellence Program 21st, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Shiga Med Ctr Res Inst, Shiga 5248524, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Nakaki, Fumio/B-8284-2015
OI Nakaki, Fumio/0000-0003-4332-7735
CR Adorini L, 2002, TRENDS MOL MED, V8, P31, DOI 10.1016/S1471-4914(01)02193-1
   Mein CA, 1998, NAT GENET, V19, P297
   TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0
   Gregori S, 2003, J IMMUNOL, V171, P4040
   Kendall PL, 2004, EUR J IMMUNOL, V34, P2387, DOI 10.1002/eji.200324744
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241
   Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4
   Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101
   MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186
   Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228
   Subudhi SK, 2004, J CLIN INVEST, V113, P694, DOI 10.1172/JCI200419210
   Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   van Blokland SCA, 2002, CLIN IMMUNOL, V103, P111, DOI 10.1006/clim.2002.5189
   Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1
   Shim GJ, 2004, P NATL ACAD SCI USA, V101, P12628, DOI 10.1073/pnas.040599101
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Butterfield RJ, 1998, J IMMUNOL, V161, P1860
   Deruytter N, 2004, DIABETES, V53, P3323, DOI 10.2337/diabetes.53.12.3323
   Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2
   Morahan G, 2002, CURR OPIN IMMUNOL, V14, P803, DOI 10.1016/S0952791502004016
   Nguyen Charles, 2002, Arthritis Res, V4 Suppl 3, pS255, DOI 10.1186/ar583
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   Rothe H, 2001, J MOL MED-JMM, V79, P190, DOI 10.1007/s001090000182
   SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Verdaguer J, 1996, J IMMUNOL, V157, P4726
   Yang Y, 2003, DIABETOLOGIA, V46, P1447, DOI 10.1007/s00125-003-1218-1
NR 37
TC 123
Z9 131
U1 3
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 16
PY 2005
VL 102
IS 33
BP 11823
EP 11828
DI 10.1073/pnas.0505497102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 956RH
UT WOS:000231317000046
PM 16087865
ER

PT J
AU Honjo, T
AF Honjo, T
TI In search of the best grant system
SO SCIENCE
LA English
DT Article
C1 Japan Soc Promot Sci, Res Ctr Sci Syst, Tokyo, Japan.
   Kyoto Univ, Kyoto, Japan.
RP Honjo, T (reprint author), Japan Soc Promot Sci, Res Ctr Sci Syst, Tokyo, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR *JAP I SCI TECHN, 74 JAP I SCI TECHN
NR 1
TC 1
Z9 1
U1 0
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD AUG 26
PY 2005
VL 309
IS 5739
BP 1329
EP 1329
DI 10.1126/science.1115377
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TX
UT WOS:000231543300029
PM 16123288
ER

PT J
AU Otsui, K
   Inoue, N
   Shiraki, R
   Honjo, T
   Takahashi, M
   Kawashima, S
   Yokoyama, M
AF Otsui, K.
   Inoue, N.
   Shiraki, R.
   Honjo, T.
   Takahashi, M.
   Kawashima, S.
   Yokoyama, M.
TI Enhanced expression of TLR4 in smooth muscle cells in human
   atherosclerotic coronary arteries - role of inflammatory cytokines
SO EUROPEAN HEART JOURNAL
LA English
DT Meeting Abstract
CT 27th Congress of the European-Society-of-Cardiology
CY SEP 03-07, 2005
CL Stockholm, SWEDEN
SP European Soc Cardiol
C1 Kobe Univ, Grad Sch Med, Div Cardiovasc & Resp Me, Kobe, Hyogo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
J9 EUR HEART J
JI Eur. Heart J.
PD SEP
PY 2005
VL 26
SU 1
BP 265
EP 265
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 993WO
UT WOS:000233987101502
ER

PT J
AU Kikuchi, T
   Andarini, S
   Xin, H
   Gomi, K
   Tokue, Y
   Saijo, Y
   Honjo, T
   Watanabe, A
   Nukiwa, T
AF Kikuchi, T
   Andarini, S
   Xin, H
   Gomi, K
   Tokue, Y
   Saijo, Y
   Honjo, T
   Watanabe, A
   Nukiwa, T
TI Involvement of fractalkine/CX3CL1 expression by dendritic cells in the
   enhancement of host immunity against Legionella pneumophila
SO INFECTION AND IMMUNITY
LA English
DT Article
ID MACROPHAGE-DERIVED CHEMOKINE; CD40 LIGAND; RESPONSES; ELICIT; ANTIGEN;
   CX3CL1; INDUCTION; MIGRATION; CLEAVAGE; ADHESION
AB Legionnaires' disease is clinically manifested as severe pneumonia caused by Legionella pneumophila. However, the dendritic cell (DC)-centered immunological framework of the host defense against L. pneumophila has not been fully delineated. For this study, we focused on a potent chemoattractant for lymphocytes, fractalkine/CX3CL1, and observed that the fractalkine expression of DCs was somewhat up-regulated when they encountered L. pneumophila. We therefore hypothesized that fractalkine expressed by Legionella-capturing DCs is involved in the induction of T-cell-mediated immune responses against Legionella, which would be enhanced by a genetic modulation of DCs to overexpress fractalkine. In vivo immunization-challenge experiments demonstrated that DCs modified with a recombinant adenovirus vector to overexpress fractalkine (AdFKN) and pulsed with heat-killed Legionella protected immunized mice from a lethal Legionella infection and that the generation of in vivo protective immunity depended on the host lymphocyte subsets, including CD4(+) T cells, CD8(+) T cells, and B cells. Consistent with this, immunization with AdFKN/Legionella/DC induced significantly higher levels of serum anti-Legionella antibodies of several isotypes than those induced by control immunizations. Further analysis of spleen cells from the immunized mice indicated that the AdFKN/Legionella/DC immunization elicited Th1-dominated immune responses to L. pneumophila. These observations suggest that fractalkine may play an important role in the DC-mediated host defense against intracellular pathogens such as L. pneumophila.
C1 Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Sendai, Miyagi 9808575, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
RP Kikuchi, T (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, 4-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.
EM kikuchi@idac.tohoku.ac.jp
CR Andarini S, 2004, CANCER RES, V64, P3281, DOI 10.1158/0008-5472.CAN-03-3911
   Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4
   Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775
   Garton KJ, 2001, J BIOL CHEM, V276, P37993
   Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001
   Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098
   Neild AL, 2003, IMMUNITY, V18, P813, DOI 10.1016/S1074-7613(03)00140-7
   Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517
   Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5
   Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X
   Kanazawa N, 1999, EUR J IMMUNOL, V29, P1925, DOI 10.1002/(SICI)1521-4141(199906)29:06<1925::AID-IMMU1925>3.0.CO;2-U
   Murphy PM, 2000, PHARMACOL REV, V52, P145
   Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9
   Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x
   Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491
   Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0
   Davis A., 1997, HEALTH TECHNOL ASSES, V1, P1
   Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206
   Friedman H, 1998, Semin Respir Infect, V13, P100
   Kikuchi T, 2002, BLOOD, V100, P3950, DOI 10.1182/blood-2002-04-1096
   Kikuchi T, 2000, BLOOD, V96, P91
   Kikuchi T, 2004, J IMMUNOL, V172, P1727
   Kikuchi T, 2000, NAT MED, V6, P1154
   Kikuchi T, 2001, J CLIN INVEST, V108, P917, DOI 10.1172/JCI11564
   Menten P, 2001, EUR CYTOKINE NETW, V12, P554
   Nakachi N, 2000, INFECT IMMUN, V68, P6069, DOI 10.1128/IAI.68.10.6069-6072.2000
   Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5
   Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392
   Yamamoto Y, 1996, INFECT IMMUN, V64, P3062
   YU VL, 2000, PRINCIPLES PRACTICE, V2, P2424
NR 32
TC 14
Z9 16
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD SEP
PY 2005
VL 73
IS 9
BP 5350
EP 5357
DI 10.1128/IAI.73.9.5350-5357.2005
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 958PK
UT WOS:000231460000007
PM 16113250
ER

PT J
AU Kurihara, N
   Honjo, T
   Windle, JJ
   Roodman, GD
AF Kurihara, N
   Honjo, T
   Windle, JJ
   Roodman, GD
TI Inhibiting p62(ZIP) expression decreases OCL formation by blocking the
   effects of RANKL and TNF-alpha.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 27th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY SEP 23-27, 2005
CL Nashville, TN
SP Amer Soc Bone & Mineral Res
C1 Univ Pittsburgh, Pittsburgh, PA USA.
   Virginia Commonwealth Univ, Richmond, VA USA.
   VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2005
VL 20
IS 9
SU 1
BP S55
EP S55
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 987FM
UT WOS:000233503800218
ER

PT J
AU Shiraki, R
   Inoue, N
   Otsui, K
   Honjo, T
   Takahashi, M
   Hirata, KI
   Kawashima, S
   Yokoyama, M
AF Shiraki, R
   Inoue, N
   Otsui, K
   Honjo, T
   Takahashi, M
   Hirata, KI
   Kawashima, S
   Yokoyama, M
TI Toll-like receptor 4 expression on peripheral blood monocytes predicts
   the risk of coronary artery disease even in patients with low C-reactive
   protein
SO CIRCULATION
LA English
DT Meeting Abstract
CT 78th Annual Scientific Session of the American-Heart-Association
CY NOV 13-16, 2005
CL Dallas, TX
SP Amer Heart Assoc
C1 Kobe Univ, Grad Sch Med, Div Cardiovasc & Resp Med, Kobe, Hyogo, Japan.
   Natl Cardiovasc Ctr, Rsch Inst, Dept Vasc Physiol, Osaka, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT 25
PY 2005
VL 112
IS 17
SU S
MA 2766
BP U646
EP U646
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 979PD
UT WOS:000232956404070
ER

PT J
AU Tao, R
   Wang, LQ
   Han, RX
   Wang, T
   Ye, QR
   Honjo, T
   Murphy, TL
   Murphy, KM
   Hancock, WW
AF Tao, R
   Wang, LQ
   Han, RX
   Wang, T
   Ye, QR
   Honjo, T
   Murphy, TL
   Murphy, KM
   Hancock, WW
TI Differential effects of B and T lymphocyte attenutator and programmed
   death-1 on acceptance of partially versus fully MHC-mismatched cardiac
   allografts
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID COLONY-STIMULATING FACTOR; RESPONSES IN-VIVO; COSTIMULATORY PATHWAYS;
   DENDRITIC CELLS; BONE-MARROW; REJECTION; RECEPTOR; CTLA-4; PD-1;
   TRANSPLANTATION
AB Although fully MHC-mismatched murine cardiac allografts are rapidly rejected, allografts mismatched at only MHC class I or class II alleles survive long term; the immunologic basis for the long-term survival of MHC class I- or II-mismatched allografts is unknown. We examined the roles of two recently described inhibitory receptors, B and T lymphocyte attenuator (BTLA) and programmed death-1 (PD-1), in the survival of partially or fully MHC-mismatched allografts using gene-deficient recipients as well as through use of blocking mAbs in wild-type hosts. Partially MHC-mismatched allografts showed strong induction of BTLA, but not PD-1 mRNA and survived long term in wild-type recipients, whereas targeting of BTLA or its ligand, herpesvirus entry mediator, but not PD-1, prompted their rapid rejection. By contrast, fully MHC-mismatched cardiac allografts were acutely rejected in wild-type recipients despite the induction of both BTLA and PD-1. Targeting of PD-1 in several fully MHC-mismatched models accelerated rejection, whereas targeting of BTLA unexpectedly enhanced PD-1 induction by alloreactive CD4 and CD8 T cells and prolonged allograft survival. In vitro studies using allogeneic dendritic cells and T cells showed that at low levels of T cell activation, BTLA expression was primarily induced, but that with increasing degrees of T cell activation, the expression of PD-1 was strongly up-regulated. These data suggest that BTLA and PD-1 exert distinct inhibitory actions in vivo, with the BTLA/herpesvirus entry mediator pathway appearing to dominate in regulating responses against a restricted degree of allogeneic mismatch.
C1 Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Abramson Res Ctr 916B, Div Transplantat Immunol,Biesecker Pediat Liver C, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Kyoto, Japan.
   Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Hancock, WW (reprint author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Abramson Res Ctr 916B, Div Transplantat Immunol,Biesecker Pediat Liver C, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM whancock@mail.med.upenn.edu
CR Gao W, 2001, TRANSPLANTATION, V72, P1199, DOI 10.1097/00007890-200110150-00003
   Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727
   Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251
   Lee I, 2003, J IMMUNOL, V171, P6929
   Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944
   Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225
   Hurchla MA, 2005, J IMMUNOL, V174, P3377
   Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975
   WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985
   Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349
   CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010
   Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100
   TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6
   Sandner SE, 2005, J IMMUNOL, V174, P3408
   Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518
   Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731
   Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070
   Han P, 2004, J IMMUNOL, V172, P5931
   Ito T, 2005, J IMMUNOL, V174, P6648
   Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x
   Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144
   Ozkaynak E, 2002, J IMMUNOL, V169, P6546
   Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   JUNE CH, BLOOD, V105, P13
   KAST WM, 1984, J EXP MED, V160, P1752, DOI 10.1084/jem.160.6.1752
   Koga N, 2004, ARTERIOSCL THROM VAS, V24, P2057, DOI 10.1161/01.ATV.0000145015.23656.e4
   LU L, 1995, J EXP MED, V182, P379, DOI 10.1084/jem.182.2.379
   MAEDA H, 1994, INT IMMUNOL, V6, P855, DOI 10.1093/intimm/6.6.855
   Pietra B A, 2001, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V4, P123, DOI 10.1053/tc.2001.23734
   Racusen LC, 2003, SPRINGER SEMIN IMMUN, V25, P141, DOI 10.1007/s00281-003-0134-2
   ROLSTAD B, 1974, TRANSPLANTATION, V17, P405, DOI 10.1097/00007890-197404000-00012
   TOMITA Y, 1990, J IMMUNOL, V144, P2425
   WELLS AD, 2002, TRANSPLANT REV, V16, P205, DOI 10.1053/trte.2002.129629
NR 38
TC 88
Z9 98
U1 1
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD NOV 1
PY 2005
VL 175
IS 9
BP 5774
EP 5782
PG 9
WC Immunology
SC Immunology
GA 977EW
UT WOS:000232786300031
PM 16237069
ER

PT J
AU Kobayashi, M
   Kawano, S
   Hatachi, S
   Kurimoto, C
   Okazaki, T
   Iwai, Y
   Honjo, T
   Tanaka, Y
   Minato, N
   Komori, T
   Maeda, S
   Kumagai, S
AF Kobayashi, M
   Kawano, S
   Hatachi, S
   Kurimoto, C
   Okazaki, T
   Iwai, Y
   Honjo, T
   Tanaka, Y
   Minato, N
   Komori, T
   Maeda, S
   Kumagai, S
TI Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary
   glands of patients with Sjogren's syndrome
SO JOURNAL OF RHEUMATOLOGY
LA English
DT Article
DE Sjogren's syndrome; programmed death-1; programmed death-1 ligand;
   interferon-gamma
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL-ACTIVATION; EPITHELIAL-CELLS;
   LYMPHOCYTE-ACTIVATION; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISM; B7
   FAMILY; PD-1; RECEPTOR; ANTIGEN
AB Objective. Programmed death-1 (PD-1) mediates a negative signal and introduces tolerance for lymphocytes. Dysfunction of the PD-1 pathway is thought to result in autoimmune diseases such as rheumatoid arthritis (RA). To investigate the role of the PD-1/PD-L system in the pathology of Sjogren's syndrome (SS), we examined the expression of PD-1 and its ligand PD-L1 in salivary lymphocytes and salivary glands from patients with SS.
   Methods. Flow cytometry analysis was used to determine expression of PD-1 in SS salivary lymphocytes. Intracellular staining of interleukin 10 (IL-10) was performed after stimulation with PMA and ionomycin. Indirect immunohistochemistry was used to investigate the expression of PD-1 and PD-L1.
   Results. The mean fluorescence intensity of PD-1 expression in SS salivary lymphocytes was significantly higher than that from healthy controls and patients with RA or systemic lupus erythematosus. PD-1-positive SS salivary lymphocytes expressed IL-10 intracellularly upon PMA/ionomycin stimulation. Immunohistochemical analysis showed that PD-1 was expressed on infiltrating lymphocytes in salivary gland from 52% of SS patients, and PD-L1 was expressed on ductal and acinar epithelial cells from 68% of SS patients. In vitro analysis using HSG cells revealed that PD-L1 was induced by interferon-gamma but not by tumor necrosis factor-a and IL-1 beta.
   Conclusion. PD-1 is expressed on T lymphocytes and PD-L1 on epithelial cells from inflamed salivary glands of patients with SS, which suggests that dysfunction of the PD-1/PD-L1 pathway may be related to tolerance for lymphocytes, which causes SS.
C1 Kobe Univ, Grad Sch Med, Dept Clin Pathol & Immunol, Chuo Ku, Kobe, Hyogo 6500017, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan.
   Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto, Japan.
   Kobe Univ, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan.
   Kobe Univ, Div Mol Pathol, Dept Biomed Informat, Kobe, Hyogo, Japan.
RP Kumagai, S (reprint author), Kobe Univ, Grad Sch Med, Dept Clin Pathol & Immunol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.
EM kumagais@kobe-u.ac.jp
CR Anaya JM, 2002, J RHEUMATOL, V29, P1874
   Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Bolstad AI, 2003, ARTHRITIS RHEUM, V48, P174, DOI 10.1002/art.10734
   VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309
   Dong HD, 1999, NAT MED, V5, P1365
   Leibson PJ, 2004, CURR OPIN IMMUNOL, V16, P328, DOI 10.1016/j.coi.2004.03.006
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Hatachi S, 2003, J RHEUMATOL, V30, P1410
   CHISHOLM DM, 1968, J CLIN PATHOL, V21, P656, DOI 10.1136/jcp.21.5.656
   Brown JA, 2003, J IMMUNOL, V170, P1257
   Kapsogeorgou EK, 2001, J IMMUNOL, V166, P3107
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Griffith KJ, 1997, ARTHRITIS RHEUM, V40, P1693, DOI 10.1002/art.1780400920
   FOX RI, 1994, J IMMUNOL, V152, P5532
   Manoussakis MN, 1999, ARTHRITIS RHEUM, V42, P229, DOI 10.1002/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445
   Bacman S, 1998, INVEST OPHTH VIS SCI, V39, P151
   Lin SC, 2004, ARTHRITIS RHEUM, V50, P770, DOI 10.1002/art.20040
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8
   Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020
   Bertorello R, 2004, CLIN EXP MED, V4, P148, DOI 10.1007/s10238-004-0049-9
   Brookes SM, 1996, CLIN EXP IMMUNOL, V103, P268, DOI 10.1046/j.1365-2249.1996.d01-623.x
   BROOKES SM, 1995, BRIT J RHEUMATOL, V34, P226
   deWilde PCM, 1996, ARTHRITIS RHEUM, V39, P783, DOI 10.1002/art.1780390510
   FOX RI, 1986, ARTHRITIS RHEUM, V29, P1105, DOI 10.1002/art.1780290908
   GREENSPA.JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4
   GUERDER S, 1994, IMMUNITY, V1, P155
   MATTHEWS JB, 1991, VIRCHOWS ARCH A, V419, P191, DOI 10.1007/BF01626347
NR 37
TC 29
Z9 31
U1 1
U2 1
PU J RHEUMATOL PUBL CO
PI TORONTO
PA 920 YONGE ST, SUITE 115, TORONTO, ONTARIO M4W 3C7, CANADA
SN 0315-162X
J9 J RHEUMATOL
JI J. Rheumatol.
PD NOV
PY 2005
VL 32
IS 11
BP 2156
EP 2163
PG 8
WC Rheumatology
SC Rheumatology
GA 982DZ
UT WOS:000233139400018
PM 16265694
ER

PT J
AU Probst, HC
   McCoy, K
   Okazaki, T
   Honjo, T
   van den Broek, MF
AF Probst, HC
   McCoy, K
   Okazaki, T
   Honjo, T
   van den Broek, MF
TI Resting dendritic cells induce peripheral CD8+T cell tolerance through
   PD-1 and CTLA-4
SO IMMUNOLOGY
LA English
DT Meeting Abstract
C1 Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland.
   Kyoto Univ, Dept Med Chem, Kyoto 1244, Japan.
NR 0
TC 1
Z9 1
U1 3
U2 3
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2005
VL 116
SU 1
BP 43
EP 43
PG 1
WC Immunology
SC Immunology
GA 987QC
UT WOS:000233531400189
ER

PT J
AU Okazaki, T
   Otaka, Y
   Wang, J
   Hiai, H
   Takai, T
   Ravetch, JV
   Honjo, T
AF Okazaki, T
   Otaka, Y
   Wang, J
   Hiai, H
   Takai, T
   Ravetch, JV
   Honjo, T
TI Hydronephrosis associated with antiurothelial and antinuclear
   autoantibodies in BALB/c-Fcgr2b(-/-)Pdcd1(-/-) mice
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY POLYMORPHISM; DILATED
   CARDIOMYOPATHY; PD-1-DEFICIENT MICE; AUTOIMMUNE-DISEASES; DENDRITIC
   CELLS; DEFICIENT MICE; FC-RECEPTORS; PD-1 GENE; SUSCEPTIBILITY
AB The Journal of Experimental Medicine Because most autoimmune diseases are polygenic, analysis of the synergistic involvement of various immune regulators is essential for a complete understanding of the molecular pathology of these diseases. We report the regulation of autoimmune diseases by epistatic effects of two immunoinhibitory receptors, low affinity type IIb Fc receptor for IgG (Fc gamma RIIB) and programmed cell death 1 (PD-1). Approximately one third of the BALB/c-Fcgr2b(-/-) Pdcd1(-/-) mice developed autoimmune hydronephrosis, which is not observed in either BALB/c-Fcgr2b(-/-) or BALB/c-Pdcd1(-/-) mice. Hydronephrotic mice produced autoantibodies (autoAbs) against urothelial antigens, including uroplakin IIIa, and these antibodies were deposited on the urothelial cells of the urinary bladder. In addition, similar to 15% of the BALB/c-Fcgr2b(-/-) Pdcd1(-/-) mice produced antinuclear autoAbs. In contrast, the frequency of the autoimmune cardiomyopathy and the production of anti-parietal cell autoAb, which were observed in BALB/c-Pdcd1(-/-) mice, were not affected by the additional Fc gamma RIIB deficiency. These observations suggest cross talk between two immunoinhibitory receptors, Fc gamma RIIB and PD-1, on the regulation of autoimmune diseases.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, 21st Century Ctr Excellence Program, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Shiga Med Ctr Res Inst, Shiga 5248524, Japan.
   Tohoku Univ, Japan Sci & Technol Agcy, Inst Dev Aging & Canc, Dept Expt Immunol & Core Res Evolut Sci & Technol, Sendai, Miyagi 9808575, Japan.
   Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102
   Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637
   Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM, V50, P2590, DOI 10.1002/art.20436
   Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3
   Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151
   Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8
   Kong EKP, 2005, ARTHRITIS RHEUM, V52, P1058, DOI 10.1002/art.20966
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160
   Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275
   Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010
   Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020
   Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2
   Haarala M, 2000, INT UROGYNECOL J PEL, V11, P84, DOI 10.1007/s001920050075
   Lauder AJ, 2004, J IMMUNOL, V173, P113
   Meyers KEC, 2000, PEDIATR NEPHROL, V14, P416
   Morahan G, 2002, CURR OPIN IMMUNOL, V14, P803, DOI 10.1016/S0952791502004016
   Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891
   RENAULD JC, 1994, ONCOGENE, V9, P1327
   VICENCIO GP, 1989, J RHEUMATOL, V16, P250
NR 28
TC 22
Z9 24
U1 3
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD DEC 19
PY 2005
VL 202
IS 12
BP 1643
EP 1648
DI 10.1084/jem.20051984
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 994TH
UT WOS:000234053600005
PM 16352741
ER

PT J
AU Fujikura, J
   Hosoda, K
   Iwakura, H
   Tomita, T
   Noguchi, M
   Masuzaki, H
   Tanigaki, K
   Yabe, D
   Honjo, T
   Nakao, K
AF Fujikura, J
   Hosoda, K
   Iwakura, H
   Tomita, T
   Noguchi, M
   Masuzaki, H
   Tanigaki, K
   Yabe, D
   Honjo, T
   Nakao, K
TI Notch/Rbp-j signaling prevents premature endocrine and ductal cell
   differentiation in the pancreas
SO CELL METABOLISM
LA English
DT Article
ID BETA-CELLS; TRANSCRIPTION FACTOR; EMBRYONIC LETHALITY; EXPRESSION;
   MOUSE; MICE; LINEAGE; NEUROGENESIS; PROGENITORS; DISRUPTION
AB To investigate the precise role of Notch/Rbp-j signaling in the pancreas, we inactivated Rbp-j by crossing Rbp-j floxed mice with Pdx.cre or Rip.cre transgenic mice. The loss of Rbp-j at the initial stage of pancreatic development induced accelerated alpha and PP cell differentiation and a concomitant decrease in the number of Neurogenin3 (Ngn3)-positive cells at E11.5. Then at E15, elongated tubular structures expressing ductal cell markers were evident; however, differentiation of acinar and all types of endocrine cells were reduced. During later embryonic stages, compensatory acinar cell differentiation was observed. The resultant mice exhibited insulin-deficient diabetes with both endocrine and exocrine pancreatic hypoplasia. In contrast, the loss of Rbp-j specifically in beta cells did not affect beta cell number and function. Thus, our analyses indicate that Notch/Rbp-j signaling prevents premature differentiation of pancreatic progenitor cells into endocrine and ductal cells during early development of the pancreas.
C1 Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
RP Hosoda, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.
EM pekopaokuro@yahoo.co.jp
RI Yabe, Daisuke/J-6682-2014
OI Yabe, Daisuke/0000-0002-5334-7687
CR THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858
   Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003
   Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533
   Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0
   Apelqvist A, 1999, NATURE, V400, P877
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559
   Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520
   GUZ Y, 1995, DEVELOPMENT, V121, P11
   Gu GQ, 2002, DEVELOPMENT, V129, P2447
   Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136
   Hamada Y, 1999, DEVELOPMENT, V126, P3415
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100
   Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9
   Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752
   Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280
   Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3
   Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041
   Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460
   Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163
   AHMAD I, 1995, MECH DEVELOP, V53, P73, DOI 10.1016/0925-4773(95)00425-4
   deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0
   Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607
   Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720
   Jensen J, 2000, NAT GENET, V24, P36
   Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8
   MIYAMOTO Y, 2003, CANCER CELL, V6, P565
   PICTET R, 1972, HDB PHYSL ENDOCRINOL, V7, P25
NR 34
TC 56
Z9 57
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1550-4131
J9 CELL METAB
JI Cell Metab.
PD JAN
PY 2006
VL 3
IS 1
BP 59
EP 65
DI 10.1016/j.cmet.2005.12.005
PG 7
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 002CP
UT WOS:000234589300009
PM 16399505
ER

PT J
AU Wakae, K
   Magor, BG
   Saunders, H
   Nagaoka, H
   Kawamura, A
   Kinoshita, K
   Honjo, T
   Muramatsu, M
AF Wakae, K
   Magor, BG
   Saunders, H
   Nagaoka, H
   Kawamura, A
   Kinoshita, K
   Honjo, T
   Muramatsu, M
TI Evolution of class switch recombination function in fish
   activation-induced cytidine deaminase, AID
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE APOBEC-1; B cells; class switch recombination; immunoglobulin gene;
   somatic hypermutation
ID SOMATIC HYPERMUTATION; CHANNEL CATFISH; GENE CONVERSION; B-CELLS;
   EXPRESSION; ENZYME; DNA; DIVERSIFICATION; FIBROBLASTS; REQUIREMENT
AB Following activation of mammalian B cells, class switch recombination (CSR) and somatic hypermutation (SHM) of the Ig heavy chain (IgH) gene can improve the functions of the expressed antibodies. Activation-induced cytidine deaminase (AID) is the only known B cell-specific protein required for inducing CSR and SHM in mammals. Lower vertebrates have an AID homologue, and there is some evidence of SHM in vivo. However there is no evidence of CSR in the cartilaginous or bony fishes, and this may be due in part to a lack of cis-elements in the IgH gene that are the normal targets of AID-mediated recombination. We have tested whether bony fish (zebrafish and catfish) AID can mediate CSR and SHM in mammalian cells. As expected, ectopic expression of fish AID in mouse fibroblasts resulted in mutations in an introduced SHM reporter gene, indicating that fish AID can mediate SHM. Unexpectedly, expression of fish AID in mouse AID(-/-) B cells induced surface IgG expression as well as switched transcripts from Ig gene loci, clearly indicating that the fish AID protein can mediate CSR, at least in mouse cells. These results suggest that the AID protein acquired the ability to mediate CSR before the IgH locus evolved the additional exon clusters and switch regions that are the targets of recombination. We discuss how pleiotropic functions of specific domains within the AID protein may have facilitated the early evolution of CSR in lower vertebrates.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Yoshida Sakyo Ku, Kyoto 6068501, Japan.
   Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.
   Kyoto Univ, Grad Sch Med, Dept Evolutionary Genet, Yoshida Sakyo Ku, Kyoto 6068501, Japan.
RP Muramatsu, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Yoshida Sakyo Ku, Kyoto 6068501, Japan.
EM muramatu@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Saunders HL, 2004, DEV COMP IMMUNOL, V28, P657, DOI 10.1016/j.dci.2004.01.002
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Martin A, 2002, NATURE, V415, P802
   Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x
   Du Pasquier L, 2000, IMMUNOL REV, V175, P201, DOI 10.1034/j.1600-065X.2000.017501.x
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Bachl J, 2001, J IMMUNOL, V166, P5051
   MILLER NW, 1994, J IMMUNOL, V152, P2180
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011
   Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101
   Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Wu XS, 2005, J IMMUNOL, V174, P934
   McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101
   DANILOVA N, 2005, Z NAT IMMUNOL, V6, P295
   Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470
   Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159
   MAGOR BG, 1994, J IMMUNOL, V153, P5556
   Zhao YF, 2005, DEV COMP IMMUNOL, V29, P61, DOI 10.1016/j.dci.2004.05.005
NR 39
TC 49
Z9 51
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JAN
PY 2006
VL 18
IS 1
BP 41
EP 47
DI 10.1093/intimm/dxh347
PG 7
WC Immunology
SC Immunology
GA 000BS
UT WOS:000234436500005
PM 16291656
ER

PT J
AU Yamamoto, N
   Tanigaki, K
   Tsuji, M
   Yabe, D
   Ito, J
   Honjo, T
AF Yamamoto, N
   Tanigaki, K
   Tsuji, M
   Yabe, D
   Ito, J
   Honjo, T
TI Inhibition of Notch/RBP-J signaling induces hair cell formation in
   neonate mouse cochleas
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Article
DE cochlea; hair cells; Notch protein; RBP-J protein; gamma-secretase;
   regeneration
ID MAMMALIAN INNER-EAR; TRANSCRIPTION FACTOR; FATE DETERMINATION; FAMILY
   MEMBERS; STEM-CELLS; GENE; DIFFERENTIATION; CONSERVATION; EXPRESSION;
   HES1
AB Mammalian inner ear hair cells in cochleas are believed to be incapable of regeneration after birth, which hampers treatment of sensorineural hearing impairment mainly caused by hair cell loss. Sensory epithelia of cochleas are composed of hair cells and supporting cells, both of which originate from common progenitors. Notch/RBP-J signaling is an evolutionally conserved pathway involved in specification of various cell types in developmental stage and even in some of postnatal mammalian organs. The specification of hair cell fate from the progenitors is inhibited by Notch/RBP-J signaling in embryonic inner ears. However, its function in postnatal inner ears is unknown. We showed that inhibition of Notch/RBP-J signaling, by either conditional disruption of the Rbpsuh gene or treatment with a gamma-secretase inhibitor, could give rise to ectopic hair cells in the supporting cell region in organs of Corti from neonatal mouse cochleas where hair cells have not been considered to regenerate after birth. We also showed that down-regulation of Hes5 and up-regulation of Math1 were associated with ectopic hair cell induction. These results suggest that Notch/RBP-J signaling inhibits supporting cells from differentiation into hair cells even in postnatal days, implying that inhibitors of Notch/RBP-J signaling can be used to help regenerating hair cells after birth and thus serve for potential treatment of intractable sensorineural hearing impairment caused by hair cell loss without genetical manipulation.
C1 Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068501, Japan.
   Shiga Med Ctr, Res Inst, Moriyama 5248524, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Yabe, Daisuke/J-6682-2014; 
OI Yabe, Daisuke/0000-0002-5334-7687; , Norio/0000-0001-8924-0710
CR Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0
   Zheng JL, 2000, NAT NEUROSCI, V3, P580
   Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213
   Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8
   SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707
   Shou JY, 2003, MOL CELL NEUROSCI, V23, P169, DOI 10.1016/S1044-7431(03)00066-6
   Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Kawamoto K, 2003, J NEUROSCI, V23, P4395
   Hamada Y, 1999, DEVELOPMENT, V126, P3415
   Zine A, 2000, DEVELOPMENT, V127, P3373
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196
   Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100
   Lanford PJ, 1999, NAT GENET, V21, P289
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Lefebvre PP, 2000, ACTA OTO-LARYNGOL, V120, P142
   HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4
   KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816
   Xiang MQ, 1998, DEVELOPMENT, V125, P3935
   Zheng JL, 2000, DEVELOPMENT, V127, P4551
   Zine A, 2001, J NEUROSCI, V21, P4712
   Fekete DM, 1998, J NEUROSCI, V18, P7811
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   De S. B., 1999, NATURE, V398, P518
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Lanford Pamela J., 2000, JARO Journal of the Association for Research in Otolaryngology, V1, P161, DOI 10.1007/s101620010023
   MALGRANGE B, 1908, CELL MOL LIFE SCI, V59, P1744
   Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998
   Ruben R. J., 1967, ACTA OTO-LARYNGOL, V220, P221
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2
NR 35
TC 70
Z9 80
U1 3
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0946-2716
J9 J MOL MED-JMM
JI J. Mol. Med.
PD JAN
PY 2006
VL 84
IS 1
BP 37
EP 45
DI 10.1007/s00109-005-0706-9
PG 9
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 002HQ
UT WOS:000234602700005
PM 16283144
ER

PT J
AU Tanigaki, K
   Muraki, K
   Yarnamoto, N
   Honjo, T
AF Tanigaki, Kenji
   Muraki, Kazue
   Yarnamoto, Norio
   Honjo, Tasuku
TI RBP-J regulates the cortical laminar formation
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 Shiga Med Ctr, Res Inst, Shiga, Japan.
   Kyoto Univ, Dept Med Chem, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2006
VL 55
SU 1
BP S242
EP S242
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 057QG
UT WOS:000238609702382
ER

PT J
AU Okazaki, T
   Honjo, T
AF Okazaki, T
   Honjo, T
TI Rejuvenating exhausted T cells during chronic viral infection
SO CELL
LA English
DT Editorial Material
ID DENDRITIC CELLS; PD-1; PERSISTENCE; EXPRESSION; LIVER
AB In a recent paper in Nature, Barber et al. (2005) show that the immunoreceptor PD-1 is upregulated by "exhausted" T cells during the chronic phase of viral infection in mice. Remarkably, blocking the interaction between PD-1 and its ligand, PD-L1, reactivates these T cells and reduces viral load.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Century COE Format 21st, Sakyo Ku, Kyoto 6068501, Japan.
RP Okazaki, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR ISHIDA Y, 1992, EMBO J, V11, P3887
   Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102
   Kirchberger S, 2005, J IMMUNOL, V175, P1145
   Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165
   Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Prokunina L, 2004, HUM MOL GENET, V13, pR143, DOI 10.1093/hmg/ddh076
   BARBER DL, 2005, NATURE
   Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005
NR 11
TC 25
Z9 28
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD FEB 10
PY 2006
VL 124
IS 3
BP 459
EP 461
DI 10.1016/j.cell.2006.01.022
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 014FG
UT WOS:000235464000006
PM 16469690
ER

PT J
AU Muto, T
   Okazaki, IM
   Yamada, S
   Tanaka, Y
   Kinoshita, K
   Muramatsu, M
   Nagaoka, H
   Honjo, T
AF Muto, T
   Okazaki, IM
   Yamada, S
   Tanaka, Y
   Kinoshita, K
   Muramatsu, M
   Nagaoka, H
   Honjo, T
TI Negative regulation of activation-induced cytidine deaminase in B cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE antibodies; protein modification; transgenic/knockout mice
ID CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; AID; EXPRESSION;
   GENE; TRANSCRIPTION; INDUCTION; SELECTION; MUTATION; ENZYME
AB Both class switch recombination (CSR) and somatic hypermutation (SHIM) of the Ig genes require the activity of activation-induced cytidine deaminase (AID). Expression of AID is restricted to B cells in the germinal centers of the lymphoid organs, where activated B cells undergo CSR and SHM. We previously showed that constitutive and systemic expression of AID leads to tumorigenesis in T cells and lung epithelium, but not in B cells. This finding led us to suspect that transgenic AID may be inactivated at least in part in B cells. To address this issue, we generated conditional AID-transgenic mice that constitutively express AID only in B cells. Studies on the cross between the AID-transgenic and AID-deficient mice showed that abundant AID protein accumulated by constitutive expression is inactivated in B cells, possibly providing an explanation for the absence of deregulation of CSR and SHM in AID-transgenic B cells.
C1 Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, PRESTO, Japan Sci & Technol Corp, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Lab Immunol & Cell Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan.
   Akita Univ, Anim Res Lab, Biosci Res & Educ Ctr, Akita 0108543, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   NIWA H, 1991, GENE, V108, P193
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Martin A, 2002, NATURE, V415, P802
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7
   Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829
   Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100
   FEARON DT, 1993, CURR OPIN IMMUNOL, V5, P341, DOI 10.1016/0952-7915(93)90051-S
   GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862
   Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102
   RADA C, 1991, P NATL ACAD SCI USA, V88, P5508, DOI 10.1073/pnas.88.13.5508
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   TURNASBRUNDAGE K, 1997, J EXP MED, V185, P239
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
NR 36
TC 58
Z9 60
U1 1
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 21
PY 2006
VL 103
IS 8
BP 2752
EP 2757
DI 10.1073/pnas.0510970103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015MG
UT WOS:000235554900050
PM 16477013
ER

PT J
AU Honjo, T
   Muramatsu, M
   Nagaoka, H
   Kinoshita, K
   Shinkura, R
AF Honjo, T
   Muramatsu, M
   Nagaoka, H
   Kinoshita, K
   Shinkura, R
TI AID to overcome the limitations of genomic information by introducing
   somatic DNA alterations
SO PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL
   SCIENCES
LA English
DT Review
DE activation induced cytidine deaminase; class switch recombination;
   somatic hypermutation; RNA editing; DNA deamination; genome instability
ID CLASS-SWITCH RECOMBINATION; IMMUNOGLOBULIN HEAVY-CHAIN; INDUCED CYTIDINE
   DEAMINASE; ANTIBODY CLASS SWITCH; B MESSENGER-RNA; ACTIVATION-INDUCED
   DEAMINASE; DOUBLE-STRAND BREAKS; NF-KAPPA-B/REL; MATRIX-ATTACHMENT
   REGIONS; NOVO PROTEIN-SYNTHESIS
AB The immune system has adopted somatic DNA alterations to overcome the limitations of the genomic information. Activation induced cytidine deaminase (AID) is an essential enzyme to regulate class switch recombination (CSR), somatic hypermutation (SHM) and gene conversion (GC) of the immunoglobulin gene. AID is known to be required for DNA cleavage of S regions in CSR and V regions in SHM. However, its molecular mechanism is a focus of extensive debate. RNA editing hypothesis postulates that AID edits yet unknown mRNA, to generate specific endonucleases for GSR and SHM. By contrast, DNA hypothesis assumes that AID deaminates cytosine in DNA, followed by DNA cleavage by base deamination excision repair enzymes. We summarize the basic knowledge for molecular mechanisms for CSR and SHM and then discuss the importance of AID not only in the immune regulation but also in the genome instability.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101
   Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858
   Diaz M, 2005, TRENDS IMMUNOL, V26, P215, DOI 10.1016/j.it.2005.02.008
   Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2
   Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59
   Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526
   Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   YELAMOS J, 1995, NATURE, V376, P225
   AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121
   Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1
   Kingzette M, 1998, P NATL ACAD SCI USA, V95, P11840, DOI 10.1073/pnas.95.20.11840
   Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9
   MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7
   van der Stoep N, 1998, IMMUNITY, V8, P743, DOI 10.1016/S1074-7613(00)80579-8
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717
   Dorner T, 1998, EUR J IMMUNOL, V28, P3384
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Klotz EL, 1998, J IMMUNOL, V161, P782
   Qiu G, 1999, INT IMMUNOL, V11, P37, DOI 10.1093/intimm/11.1.37
   Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552
   Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Seidl KJ, 1998, INT IMMUNOL, V10, P1683, DOI 10.1093/intimm/10.11.1683
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607
   Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011
   SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Lin SC, 1998, MOL CELL BIOL, V18, P5523
   Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858
   Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749
   BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0
   ZHANG J, 1993, EMBO J, V12, P3529
   Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463
   ARAKAWA H, 1993, J BIOL CHEM, V268, P4651
   Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740
   Sun JS, 1997, IMMUNOGENETICS, V46, P452, DOI 10.1007/s002510050305
   Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Lee GS, 2004, MOL CELL, V16, P505, DOI 10.1016/j.molcel.2004.11.008
   Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x
   Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005
   He B, 2003, J IMMUNOL, V171, P5215
   Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385
   Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102
   Yang RC, 2005, J IMMUNOL, V174, P7912
   COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4
   Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599
   Linehan LA, 1998, J IMMUNOL, V161, P302
   Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871
   ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833
   Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101
   Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x
   BOTTARO A, 1994, EMBO J, V13, P665
   Zan H, 1998, J IMMUNOL, V161, P5217
   Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421
   Faili A, 2004, J EXP MED, V199, P265, DOI 10.1084/jem.20031831
   Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821
   Matsuda T, 2000, NATURE, V404, P1011
   Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395
   REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0
   Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021
   Storb U, 1998, IMMUNOL REV, V162, P153
   Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100
   Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918
   Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447
   Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Foster SJ, 1999, EUR J IMMUNOL, V29, P4011, DOI 10.1002/(SICI)1521-4141(199912)29:12<4011::AID-IMMU4011>3.0.CO;2-W
   Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x
   Iciek LA, 1997, J IMMUNOL, V158, P4769
   Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982
   BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6
   Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833
   Dorner T, 1997, J IMMUNOL, V158, P2779
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041
   Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495
   Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007
   Nguyen VK, 1999, MOL IMMUNOL, V36, P515
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4
   Bachl J, 1997, EUR J IMMUNOL, V27, P3398, DOI 10.1002/eji.1830271239
   Bachl J, 1998, P NATL ACAD SCI USA, V95, P2396, DOI 10.1073/pnas.95.5.2396
   Ballantyne J, 1998, J IMMUNOL, V161, P1336
   Ballantyne J, 1997, INT IMMUNOL, V9, P963, DOI 10.1093/intimm/9.7.963
   Barreto VM, 2005, TRENDS IMMUNOL, V26, P90, DOI 10.1016/j.it.2004.12.004
   Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101
   Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444
   Bemark M, 2003, GENE CHROMOSOME CANC, V38, P32, DOI 10.1002/gcc/10241
   Besmer E, 2004, CURR OPIN IMMUNOL, V16, P241, DOI 10.1016/j.coi.2004.01.005
   Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799
   DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625
   DUNNICK W, 1989, MOL CELL BIOL, V9, P1850
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Ezernieks J, 1996, EUR J BIOCHEM, V240, P667, DOI 10.1111/j.1432-1033.1996.0667h.x
   Ferlin WG, 1996, EUR J IMMUNOL, V26, P2911, DOI 10.1002/eji.1830261216
   Ford GS, 1998, J IMMUNOL, V160, P595
   Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397
   Fujieda S, 1996, MOL IMMUNOL, V33, P1335, DOI 10.1016/S0161-5890(96)00092-2
   GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S
   Goyenechea B, 1996, P NATL ACAD SCI USA, V93, P13979, DOI 10.1073/pnas.93.24.13979
   Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987
   Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457
   Harriman GR, 1996, J CLIN INVEST, V97, P477, DOI 10.1172/JCI118438
   ISHIGURO H, 1989, FEBS LETT, V247, P317, DOI 10.1016/0014-5793(89)81360-2
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Jumper MD, 1996, MOL IMMUNOL, V33, P965, DOI 10.1016/S0161-5890(96)00045-4
   KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8
   Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470
   KINOSHITA K, 1991, IMMUNOL LETT, V27, P151, DOI 10.1016/0165-2478(91)90143-X
   Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0
   Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2
   Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8
   Kitao H, 2000, INT IMMUNOL, V12, P959, DOI 10.1093/intimm/12.7.959
   Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01<317::AID-IMMU317>3.0.CO;2-S
   KNIGHT KL, 1995, J IMMUNOL, V155, P684
   KNIGHT KL, 1987, VET IMMUNOL IMMUNOP, V17, P17, DOI 10.1016/0165-2427(87)90123-1
   KOLCHANOV NA, 1987, FEBS LETT, V214, P87, DOI 10.1016/0014-5793(87)80018-2
   Kong QZ, 2001, GENETICS, V158, P369
   Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102
   Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211
   LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522
   Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365
   Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9
   LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151
   LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154
   Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X
   Lin SC, 1996, MOL CELL BIOL, V16, P4591
   Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159
   Luo ZH, 2004, J ALLERGY CLIN IMMUN, V114, P726, DOI 10.1016/j.jaci.2004.07.049
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Messner B, 1997, J IMMUNOL, V159, P3330
   Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8
   Mizoguchi C, 1999, J IMMUNOL, V162, P2812
   Monson NL, 2000, EUR J IMMUNOL, V30, P1597, DOI 10.1002/1521-4141(200006)30:6<1597::AID-IMMU1597>3.0.CO;2-R
   MUTO T, 2006, IN PRESS P NATL ACAD
   NIKAIDO T, 1982, J BIOL CHEM, V257, P7322
   NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0
   Oprea M, 2001, J IMMUNOL, V166, P892
   OTT DE, 1987, EMBO J, V6, P557
   Ott D E, 1989, Int Immunol, V1, P582, DOI 10.1093/intimm/1.6.582
   Pan Q, 1999, EUR J IMMUNOL, V29, P2779
   Pan Q, 2000, EUR J IMMUNOL, V30, P1019, DOI 10.1002/(SICI)1521-4141(200004)30:4<1019::AID-IMMU1019>3.0.CO;2-W
   Pan Q, 2000, EUR J IMMUNOL, V30, P2388, DOI 10.1002/1521-4141(2000)30:8<2388::AID-IMMU2388>3.0.CO;2-C
   Petry Katja, 1999, International Immunology, V11, P753, DOI 10.1093/intimm/11.5.753
   RABBITTS TH, 1983, NATURE, V306, P806, DOI 10.1038/306806a0
   Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206
   Reynaud S, 2005, J IMMUNOL, V174, P6176
   Sakai E, 1999, INT IMMUNOL, V11, P1709, DOI 10.1093/intimm/11.10.1709
   Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365
   Stavnezer J, 1999, J IMMUNOL, V163, P2028
   STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95
   Strom L, 1999, SCAND J IMMUNOL, V49, P523
   TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0
   TAKAHASHI N, 1980, NUCLEIC ACIDS RES, V8, P5983, DOI 10.1093/nar/8.24.5983
   Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495
   TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7
   Tokuyama H, 1997, CELL IMMUNOL, V176, P14, DOI 10.1006/cimm.1996.1069
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   Warren WD, 1999, MOL IMMUNOL, V36, P31, DOI 10.1016/S0161-5890(98)00114-X
   Willers J, 1999, IMMUNOBIOLOGY, V200, P150
   Winter DB, 1997, MOL IMMUNOL, V34, P359, DOI 10.1016/S0161-5890(97)00073-4
   WU TT, 1979, P NATL ACAD SCI USA, V76, P4617, DOI 10.1073/pnas.76.9.4617
   Xie XQ, 1999, EUR J IMMUNOL, V29, P488, DOI 10.1002/(SICI)1521-4141(199902)29:02<488::AID-IMMU488>3.0.CO;2-N
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
   Xu ZM, 2005, ANN NY ACAD SCI, V1050, P146, DOI 10.1196/annals.1313.119
   Yanagihara Y, 1997, CELL IMMUNOL, V176, P66, DOI 10.1006/cimm.1996.1071
   YANCOPOULOS GD, 1986, EMBO J, V5, P3259
   Zelazowski P, 1997, J IMMUNOL, V159, P3133
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
NR 217
TC 0
Z9 0
U1 1
U2 1
PU JAPAN ACAD
PI TOKYO
PA 7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN
SN 0386-2208
J9 P JPN ACAD B-PHYS
JI Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.
PD MAR
PY 2006
VL 82
IS 3
BP 104
EP 120
DI 10.2183/pjab.82.104
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 034IH
UT WOS:000236922000002
PM 25873751
ER

PT J
AU Okazaki, T
   Honjo, T
AF Okazaki, T
   Honjo, T
TI The PD-1-PD-L pathway in immunological tolerance
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID T-CELL PROLIFERATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROGRAMMED DEATH-1 LIGAND-2; DENDRITIC
   CELLS; DILATED CARDIOMYOPATHY; B7 FAMILY; REGULATORY POLYMORPHISM;
   POTENTIAL MECHANISM; PD-1-DEFICIENT MICE
AB Since the first observation of spontaneous autoimmune diseases in programmed cell death 1 (PD-1) knockout mice, PD-1 has been postulated to have essential roles in the regulation of autoimmunity but the precise mechanism was largely unknown. Recent studies clearly demonstrated that PD-1 has dual roles in immunological tolerance: induction and maintenance of peripheral tolerance. PD-1 ligands (PD-Ls) on antigen-presenting cells have been shown to switch off autoreactive T cells and induce peripheral tolerance, whereas those on parenchymal cells prevent tissue destruction by suppressing effector T cells to maintain tolerance. In addition, PDA and other immuno-inhibitory receptors have been shown to collaborate in the regulation of tolerance. Here, we review recent studies on the role of PDA in immunological tolerance and discuss possible clinical applications of PD-1 manipulation.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Century Ctr Excellence Program 21st, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019
   Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   Hirata S, 2005, J IMMUNOL, V174, P1888
   Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Hirano F, 2005, CANCER RES, V65, P1089
   Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954
   He YF, 2004, J IMMUNOL, V173, P4919
   Kirchberger S, 2005, J IMMUNOL, V175, P1145
   Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944
   Khoury SJ, 2004, IMMUNITY, V20, P529, DOI 10.1016/S1074-7613(04)00116-5
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM, V50, P2590, DOI 10.1002/art.20436
   Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9
   Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3
   Wintterle S, 2003, CANCER RES, V63, P7462
   Smith P, 2004, J IMMUNOL, V173, P1240
   Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347
   Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Kong EKP, 2005, ARTHRITIS RHEUM, V52, P1058, DOI 10.1002/art.20966
   Strome SE, 2003, CANCER RES, V63, P6501
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Tan JKH, 2005, J LEUKOCYTE BIOL, V78, P319, DOI 10.1189/jlb.1104664
   Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228
   Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259
   Subudhi SK, 2004, J CLIN INVEST, V113, P694, DOI 10.1172/JCI200419210
   Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125
   Kanai T, 2003, J IMMUNOL, V171, P4156
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Okazaki T, 2005, TRENDS MOL MED, V11, P322, DOI 10.1016/j.molmed.2005.05.001
   Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197
   Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863
   Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje
   Matsumoto K, 2004, J IMMUNOL, V172, P2530
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275
   Tao R, 2005, J IMMUNOL, V175, P5774
   Petrie C, 2003, IEEE INTERNET COMPUT, V7, P68, DOI 10.1109/MIC.2003.1215662
   Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119
   Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
   Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101
   Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x
   Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020
   Chemnitz JM, 2004, J IMMUNOL, V173, P945
   Hackstein H, 2001, TRENDS IMMUNOL, V22, P437, DOI 10.1016/S1471-4906(01)01959-7
   Okazaki T, 2005, J EXP MED, V202, P1643, DOI 10.1084/jem.20051984
   Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2554
   Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072
   Wang W, 2005, DYNAM CONT DIS SER B, V1, P102
   Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k
   Yamazaki H, 2005, J IMMUNOL, V175, P1586
NR 66
TC 257
Z9 302
U1 12
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD APR
PY 2006
VL 27
IS 4
BP 195
EP 201
DI 10.1016/j.it.2006.02.001
PG 7
WC Immunology
SC Immunology
GA 037KN
UT WOS:000237145700008
PM 16500147
ER

PT J
AU Ikuta, K
   Kageyama, R
   Honjo, T
AF Ikuta, K
   Kageyama, R
   Honjo, T
TI The 20th IUBMB International Congress in Kyoto
SO IUBMB LIFE
LA English
DT Editorial Material
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
NR 0
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1521-6543
J9 IUBMB LIFE
JI IUBMB Life
PD MAY-JUN
PY 2006
VL 58
IS 5-6
BP 258
EP 258
DI 10.1080/15216540600719663
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 050SF
UT WOS:000238107700006
PM 16754309
ER

PT J
AU Umeki, K
   Seino, T
   Lim, EM
   Honjo, T
AF Umeki, K
   Seino, T
   Lim, EM
   Honjo, T
TI Patterns of shoot mortality in Betula platyphylla in northern Japan
SO TREE PHYSIOLOGY
LA English
DT Article
DE bud formation; correlative inhibition; crown development; crown
   structure; light conditions; spatial pattern
ID BUD DEMOGRAPHY; CORRELATIVE INHIBITION; STRUCTURAL DYNAMICS; 1ST-ORDER
   BRANCHES; MOUNTAIN BIRCH; SILVER BIRCH; TREE LINE; GROWTH; LIGHT; PLANT
AB To understand the development of crown structure in Betula platyphylla Sukatch., mortality patterns of long shoots were analyzed quantitatively. We selected 25 saplings growing under various light conditions and measured the relative photosynthetically active radiation (WAR) at, and the three-dimensional position of, first-order branches. A long shoot was assigned "no buds" (NB) status if it lacked buds at the end of the growing season, including at the tips of short shoots. A long shoot was classified as dead if it was NB and all the offspring long shoots issuing from it were NB. The probability that a leafy long shoot (a current-year long shoot with leaves or an older long shoot with short shoots with leaves) would become NB by the end of the season was positively dependent on shoot age and branch age, and negatively dependent on shoot length, centripetal shoot order, branch height and WAR at the branch. Randomization tests revealed that shoots became NB and dead in clusters of connected shoots. In particular, shoot clusters originating from 3-year-old shoots were more likely to die than expected if each shoot was assumed to become NB regardless of the connection. Stepwise logistic regression revealed that the maximum WAR within the crown of an individual tree had a significant effect on the mortality rate of 3-year-old shoot clusters, together with the WAR at the level of the branch and other structural entities. Correlative inhibition is an important mechanism for determining shoot mortality patterns.
C1 Chiba Univ, Grad Sch Sci & Technol, Matsudo, Chiba 2718510, Japan.
   Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.
   Chiba Univ, Fac Hort, Matsudo, Chiba 2718510, Japan.
RP Umeki, K (reprint author), Chiba Univ, Grad Sch Sci & Technol, Matsudo 648, Matsudo, Chiba 2718510, Japan.
EM umeki@faculty.chiba-u.jp
CR KIRA T, 1991, ECOL RES, V6, P185, DOI 10.1007/BF02347161
   Godin C, 2005, NEW PHYTOL, V166, P705, DOI 10.1111/j.1469-8137.2005.01445.x
   Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9
   JONES M, 1987, PROC R SOC SER B-BIO, V232, P19, DOI 10.1098/rspb.1987.0059
   Stoll P, 1998, J ECOL, V86, P934, DOI 10.1046/j.1365-2745.1998.00313.x
   Takenaka A, 2000, TREE PHYSIOL, V20, P987
   Sprugel DG, 2002, TREE PHYSIOL, V22, P1119
   KOIKE T, 1985, CAN J FOREST RES, V15, P631, DOI 10.1139/x85-103
   Bosc A, 2000, ANN FOR SCI, V57, P555
   Kull O, 1999, FUNCT ECOL, V13, P24, DOI 10.1046/j.1365-2435.1999.00292.x
   Davis SD, 2002, AM J BOT, V89, P820, DOI 10.3732/ajb.89.5.820
   REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116
   Le Roux X, 2001, ANN FOR SCI, V58, P469, DOI 10.1051/forest:2001140
   JONES M, 1987, PROC R SOC SER B-BIO, V232, P1, DOI 10.1098/rspb.1987.0058
   Buck-Sorlin GH, 1998, BOT J LINN SOC, V127, P371, DOI 10.1111/j.1095-8339.1998.tb02103.x
   DEWIT L, 1992, INT J PLANT SCI, V153, P556, DOI 10.1086/297079
   Frazer G.W., 1999, GAP LIGHT ANAL GLA V
   Henriksson J, 2001, OECOLOGIA, V126, P482, DOI 10.1007/s004420000547
   Ishihara M, 2004, CAN J BOT, V82, P1393, DOI [10.1139/B04-099, 10.1139/b04-099]
   Karlsson PS, 2003, FUNCT ECOL, V17, P841, DOI 10.1111/j.1365-2435.2003.00792.x
   KIKUZAWA K, 1982, ANN BOT-LONDON, V50, P345
   KUKUZAWA K, 1995, T M HOKKAIDO BRANCH, V43, P178
   Kull O, 2000, ANN FOR SCI, V57, P611
   LEHTILA K, 1994, ECOLOGY, V75, P945, DOI 10.2307/1939418
   MAILLETTE L, 1982, J APPL ECOL, V19, P203, DOI 10.2307/2403005
   MAILLETTE L, 1982, J APPL ECOL, V19, P219, DOI 10.2307/2403006
   MAILLETTE L, 1987, ECOLOGY, V68, P1251, DOI 10.2307/1939209
   MARSCHNER H., 1986, MINERAL NUTR HIGHER
   Masaka K, 2000, ECOGRAPHY, V23, P547, DOI 10.1034/j.1600-0587.2000.230505.x
   MORI T, 1998, SEEDS WOODY PLANTS J, P39
   NOVOPLANSKY A, 1989, PHYSIOL PLANTARUM, V77, P136, DOI 10.1111/j.1399-3054.1989.tb05989.x
   SACHS T, 1995, ISRAEL J PLANT SCI, V43, P203
   Sievanen R, 2000, ANN FOREST SCI, V57, P399
   SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.ecolsys.22.1.309
   STEINGRAEBER DA, 1979, AM J BOT, V66, P441, DOI 10.2307/2442397
   Sumida A, 2003, MORPHOGENESIS AND PATTERN FORMATION IN BIOLOGICAL SYSTEMS: EXPERIMENTS AND MODELS, P247
   Thomas P.A., 2000, TREES THEIR NATURAL
   Tolvanen A, 2001, EVOL ECOL, V15, P443, DOI 10.1023/A:1016049301905
   Umeki K, 2003, CAN J FOREST RES, V33, P1276, DOI 10.1139/X03-058
   Umeki K, 2000, ANN FOR SCI, V57, P587
NR 40
TC 10
Z9 13
U1 1
U2 9
PU HERON PUBLISHING
PI VICTORIA
PA 202, 3994 SHELBOURNE ST, VICTORIA, BC V8N 3E2, CANADA
SN 0829-318X
J9 TREE PHYSIOL
JI Tree Physiol.
PD MAY
PY 2006
VL 26
IS 5
BP 623
EP 632
PG 10
WC Forestry
SC Forestry
GA 040HK
UT WOS:000237369400009
PM 16452076
ER

PT J
AU Buono, KD
   Robinson, GW
   Martin, C
   Shi, SL
   Stanley, P
   Tanigaki, K
   Honjo, T
   Hennighausen, L
AF Buono, KD
   Robinson, GW
   Martin, C
   Shi, SL
   Stanley, P
   Tanigaki, K
   Honjo, T
   Hennighausen, L
TI The canonical Notch/RBP-J signaling pathway controls the balance of cell
   lineages in mammary epithelium during pregnancy
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Notch; myoepithelium; basal cells; Pofut1; RBP-J; mammary epithelium;
   cytokeratins
ID STEM-CELLS; RBP-J; MYOEPITHELIAL CELLS; FATE DETERMINATION; GLAND
   DEVELOPMENT; KNOCKOUT MICE; GENE; MOUSE; DIFFERENTIATION; PROLIFERATION
AB Mammary alveoli are composed of luminal (secretory) and basal (myoepithelial) cells, which are descendants of a common stem cell. This study addressed the role of RBP-J-dependent Notch signaling in the formation, maintenance and cellular composition of alveoli during pregnancy. For this purpose, tire genes encoding RBP-J, the shared transcriptional mediator of Notch receptors, and Pofut1, a fucosyltransferase required for the activity of Notch receptors, were deleted in mammary progenitor cells in the mouse using Cre-mediated recombination. Loss of RBP-J and Pofut1 led to an accumulation of basal cell clusters characterized by the presence of cytokeratins (K5) and K14 and smooth muscle actin (SMA) during pregnancy. Hormonal stimulation of mutant tissue induced the expression of the basal cell transcription factor p63 in luminal cells and excessive proliferation of basal cells. A transient enrichment of K6-positive luminal cells was observed upon hormonal treatment suggesting a temporary arrest at an immature stage prior to transdifferentiation and expansion as basal cells. Despite the extensive proliferation of RBP-J-null basal cells during pregnancy, hormonal withdrawal during involution resulted in complete remodeling and the restoration of normal tissue architecture. We propose that the Notch-RBP-J pathway regulates alveolar development during pregnancy by maintaining luminal cell fate and preventing uncontrolled basal cell proliferation. (c) 2006 Elsevier Inc. All rights reserved.
C1 NIDDKD, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA.
   Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.
RP Hennighausen, L (reprint author), NIDDKD, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA.
EM lotharh@mail.nih.gov
RI Robinson, Gertraud/I-2136-2012
CR Yang A, 1999, NATURE, V398, P714
   Kordon EC, 1998, DEVELOPMENT, V125, P1921
   DEOME KB, 1959, CANCER RES, V19, P515
   Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065
   Gallahan D, 1996, CANCER RES, V56, P1775
   McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504
   MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200
   Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5
   Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239
   Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220
   Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0
   Pechoux C, 1999, DEV BIOL, V206, P88, DOI 10.1006/dbio.1998.9133
   Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167
   van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659
   Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100
   Krebs LT, 2000, GENE DEV, V14, P1343
   Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920
   Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Deugnier MA, 2002, BREAST CANCER RES, V4, P224, DOI 10.1186/bcr459
   Gallahan D, 1987, J Virol, V61, P66
   Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820
   OKA C, 1995, DEVELOPMENT, V121, P3291
   Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007
   Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679
   Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006
   Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099
   Shyamala G, 2002, J STEROID BIOCHEM, V80, P137, DOI 10.1016/S0960-0760(01)00182-0
   Shillingford JM, 2002, MOL ENDOCRINOL, V16, P563, DOI 10.1210/me.16.3.563
   Mills AA, 1999, NATURE, V398, P708
   Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323
   Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714
   Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104
   Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009
   Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496
   Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8
   Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035
   Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100
   Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000
   Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004
   JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345
   JOSHI K, 1986, AM J PATHOL, V124, P199
   KORDON EC, 1995, J VIROL, V69, P8066
   Raafat A, 2004, ONCOGENE, V23, P9401, DOI 10.1038/sj.onc.1208187
   Robinson GW, 2001, ONCOGENE, V20, P7115, DOI 10.1038/sj.onc.1204888
   SAPINO A, 1990, J HISTOCHEM CYTOCHEM, V38, P1541
   Schweisguth F., 2004, CURR BIOL, V14, P129
   Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005
   SMITH GH, 1990, CELL GROWTH DIFFER, V1, P161
   Smith GH, 2003, CELL PROLIFERAT, V36, P3, DOI 10.1046/j.1365-2184.36.s.1.2.x
   Tanigaki K, 2003, SEMIN IMMUNOL, V15, P113, DOI 10.1016/S1044-5323(03)00008-3
   Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2
NR 54
TC 76
Z9 78
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD MAY 15
PY 2006
VL 293
IS 2
BP 565
EP 580
DI 10.1016/j.ydbio.2006.02.043
PG 16
WC Developmental Biology
SC Developmental Biology
GA 045BF
UT WOS:000237716900024
PM 16581056
ER

PT J
AU Tanaka, S
   Tsukada, J
   Suzuki, W
   Hayashi, K
   Tanigaki, K
   Tsuji, M
   Inoue, H
   Honjo, T
   Kubo, M
AF Tanaka, S
   Tsukada, J
   Suzuki, W
   Hayashi, K
   Tanigaki, K
   Tsuji, M
   Inoue, H
   Honjo, T
   Kubo, M
TI The interleukin-4 enhancer CNS-2 is regulated by Notch signals and
   controls initial expression in NKT cells and memory-type CD4 T cells
SO IMMUNITY
LA English
DT Article
ID CYTOKINE GENE-EXPRESSION; IN-VIVO; TRANSCRIPTION FACTOR; IL-4 GENE;
   COORDINATE REGULATOR; LOCUS ACCESSIBILITY; MAST-CELLS; DIFFERENTIATION;
   GATA-3; HYPERREACTIVITY
AB Epigenetic changes in chromatin structure at the T helper (Th2) locus correlate with interukin-4 (IL-4) and IL-13 expression during Th2 differentiation. By using a transgenic green fluorescence protein (GFP) reporter system, we show that conserved noncoding sequence-2 (CNS-2), located downstream of the 114 locus, is a constitutively active enhancer in NKT cells as well as in a subset of CD44(hi) memory phenotype CD4(+) T cells. CNS-2 enhancer activity and initial IL-4 expression in CD44(hi) CD4(+) T cells were abolished in mice with a CD4-specific deletion of the transcriptional mediator of Notch signalling, Rbp-j. Depletion of CNS-2 active CD4(+) T cells markedly decreased Th2 differentiation from naive CD4(+) T cells and antigen-specific IgE production after in vivo priming. These findings indicate that Notch-regulated CNS-2 enhancer controls initial IL-4 expression In NKT and memory phenotype CD4(+) T cells and that CNS-2 active CD44(hi) memory phenotype T cells are important in facilitating Th2 differentiation of naive CD4(+) T cells in allergic responses.
C1 RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa 2300045, Japan.
   Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2780022, Japan.
   Univ Cambridge, Henry Wellcome Bldg Canc & Dev Biol, Cambridge CB2 1QN, England.
   Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.
   Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Higashi Ku, Fukuoka 8128582, Japan.
RP Kubo, M (reprint author), RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Suehiro Cho 1-7-22, Yokohama, Kanagawa 2300045, Japan.
EM raysolfc@rcai.riken.jp
CR Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872
   Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851
   Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X
   Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8
   Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9
   Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128
   Schroeter EH, 1998, NATURE, V393, P382
   Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9
   Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136
   Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352
   Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8
   Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148
   Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007
   Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D
   Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9
   Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8
   YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285
   Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304
   Hural JA, 2000, J IMMUNOL, V165, P3239
   Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981
   Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209
   Lisbonne M, 2003, J IMMUNOL, V171, P1637
   Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004
   Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1
   Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0
   Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X
   Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0
   Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X
   Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783
   Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0
   GUO L, 2004, IMMUNITY, V290, P193
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842
   Nakayama T, 2001, INT ARCH ALLERGY IMM, V124, P38, DOI 10.1159/000053663
   Palaga T, 2003, J IMMUNOL, V171, P3019
   Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8
   Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5
   Tough DF, 2000, VACCINE, V18, P1642, DOI 10.1016/S0264-410X(99)00500-9
   Yagi R, 2002, INT IMMUNOL, V14, P1, DOI 10.1093/intimm/14.1.1
   Yamada S, 2006, INT IMMUNOL, V18, P335, DOI 10.1093/intimm/dxh372
NR 44
TC 75
Z9 78
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1074-7613
J9 IMMUNITY
JI Immunity
PD JUN
PY 2006
VL 24
IS 6
BP 689
EP 701
DI 10.1016/j.immuni.2006.04.009
PG 13
WC Immunology
SC Immunology
GA 057JN
UT WOS:000238592200008
PM 16782026
ER

PT J
AU Lim, EM
   Honjo, T
   Umeki, K
AF Lim, EM
   Honjo, T
   Umeki, K
TI The validity of VRML images as a stimulus for landscape assessment
SO LANDSCAPE AND URBAN PLANNING
LA English
DT Article
DE virtual reality modeling language; landscape assessment; walk-through
   simulation; semantic differential method
ID VISUALIZATION; ENVIRONMENT; REALISM; CHOICES; FOREST
AB this study, we conducted evaluation experiments by semantic differential method to examine the validity of utilizing three-dimensional (3D) computer graphic images made with virtual reality modeling language (VRML) as a stimulus for landscape assessment both in the laboratory and on the Internet. The results of the laboratory experiment and the Internet experiment were compared. In both experiments, we simulated a garden landscape at Chiba University by using VRML. With three media representing the landscape (Photographs, Static images of VRML and Walk-Through images by VRML), we recorded respondents' impressions of each scene. Their responses to the three stimuli were analyzed statistically with profile analysis, ANOVA and T-test. We also asked respondents which media best represented the actual landscape.
   The results of the profile analysis in the laboratory experiment were similar to those of the Internet experiment. The level of reality was the order of the Photographs, Walk-Through images and Static images in both experiments. The results showed that the VRML images could be used as an effective stimulus for landscape assessment both on the Internet and in the laboratory. The level of reality of Walk-Through images in the Internet experiment was almost the same as that of photographs. The results also indicated that respondents realized garden landscapes easily by Walk-Through simulation using VRML. (c) 2005 Elsevier B.V. All rights reserved.
C1 Chiba Univ, Fac Hort, Matsudo, Chiba 2718510, Japan.
   Chiba Univ, Grad Sch Sci & Technol, Inage Ku, Chiba 263, Japan.
RP Honjo, T (reprint author), Chiba Univ, Fac Hort, 648 Matsudo, Matsudo, Chiba 2718510, Japan.
EM honjo@faculty.chiba-u.jp
CR ABE D, 1995, J JPN I LANDSCAPE AR, V58, P185
   Honjo T, 2001, LANDSCAPE URBAN PLAN, V55, P175, DOI 10.1016/S0169-2046(01)00152-9
   SHUTTLEWORTH S, 1980, J ENVIRON MANAGE, V11, P61
   Bishop ID, 2001, LANDSCAPE URBAN PLAN, V52, P225, DOI 10.1016/S0169-2046(00)00118-3
   Lange E, 2001, LANDSCAPE URBAN PLAN, V54, P163, DOI 10.1016/S0169-2046(01)00134-7
   Danahy JW, 2001, LANDSCAPE URBAN PLAN, V54, P125
   Perrin L, 2001, LANDSCAPE URBAN PLAN, V54, P33, DOI 10.1016/S0169-2046(01)00124-4
   Pullar DV, 2001, LANDSCAPE URBAN PLAN, V55, P29, DOI 10.1016/S0169-2046(00)00148-1
   Bergen SD, 1998, LANDSCAPE URBAN PLAN, V40, P283, DOI 10.1016/S0169-2046(97)00091-1
   BERGEN SD, 1995, J ENVIRON PSYCHOL, V15, P135, DOI 10.1016/0272-4944(95)90021-7
   Bishop ID, 2001, LANDSCAPE URBAN PLAN, V56, P97, DOI 10.1016/S0169-2046(01)00177-3
   FRIDLEY JL, 1991, 1991 ASAE ANN INT M
   HONJO T, 1999, J JPN I LANDSCAPE AR, V62, P665
   HONJO T, 1998, J JPN I LANDSCAPE AR, V61, P605
   LIM E, 2000, J JPN I LANDSCAPE AR, V63, P799
   Lim EM, 2003, LANDSCAPE URBAN PLAN, V63, P175, DOI 10.1016/S0169-2046(02)00189-5
   OH K, 1994, LANDSCAPE URBAN PLAN, V28, P201, DOI 10.1016/0169-2046(94)90008-6
   Saito K., 1993, NICONGRAPH PAPER CON, V9, P226
   SHIMOMURA Y, 1996, J JPN I LANDSCAPE AR, V59, P173
NR 19
TC 12
Z9 12
U1 4
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2046
J9 LANDSCAPE URBAN PLAN
JI Landsc. Urban Plan.
PD JUN 15
PY 2006
VL 77
IS 1-2
BP 80
EP 93
DI 10.1016/j.landurbplan.2005.01.007
PG 14
WC Ecology; Environmental Studies; Geography; Geography, Physical; Urban
   Studies
SC Environmental Sciences & Ecology; Geography; Physical Geography; Urban
   Studies
GA 053JP
UT WOS:000238301700007
ER

PT J
AU Wang, JS
   Shinkura, R
   Muramatsu, M
   Nagaoka, H
   Kinoshita, K
   Honjo, T
AF Wang, Jishu
   Shinkura, Reiko
   Muramatsu, Masamichi
   Nagaoka, Hitoshi
   Kinoshita, Kazuo
   Honjo, Tasuku
TI Identification of a specific domain required for dimerization of
   activation-induced cytidine deaminase (Retracted Article. See vol 283,
   pg 660, 2008)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CLASS-SWITCH RECOMBINATION; RNA EDITING ENZYME; SINGLE-STRANDED-DNA;
   SOMATIC HYPERMUTATION; ESCHERICHIA-COLI; GENE CONVERSION; ANTIBODY
   DIVERSIFICATION; AID GENE; FIBROBLASTS; MECHANISM
AB Activation-induced cytidine deaminase (AID) is essential to all three genetic alterations required for generation of antigen-specific immunoglobulin: class switch recombination, somatic hypermutation, and gene conversion. Here we demonstrate that AID molecules form a homodimer autonomously in the absence of RNA, DNA, other cofactors, or post-translational modifications. Studies on serial deletion mutants revealed the minimum region between Thr(27) and His(56) responsible for dimerization. Analyses of point mutations within this region revealed that the residues between Gly(47) and Gly(54) are most important for the dimer formation. Functional analyses of these mutations indicate that all mutations impairing the dimer formation are inefficient for class switching, suggesting that dimer formation is required for class switching activity. Dimer formation and its requirement for the function of AID are features that AID shares with APOBEC-1, an RNAediting enzyme of apolipoprotein B100 mRNA.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3
   Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Martin A, 2002, NATURE, V415, P802
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279
   Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011
   Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Carlow DC, 1999, BIOCHEMISTRY-US, V38, P12258, DOI 10.1021/bi990819t
   Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026
   Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003
   Durandy A, 2003, EUR J IMMUNOL, V33, P2069, DOI 10.1002/eji.200324133
   Teng BB, 1999, J LIPID RES, V40, P623
   Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297
   Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h
   Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373
   Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506
   Barreto VM, 2005, TRENDS IMMUNOL, V26, P90, DOI 10.1016/j.it.2004.12.004
   DANCE GS, 2001, NUCLEIC ACIDS RES, V29, P1172
   NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709
   Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101
NR 36
TC 14
Z9 14
U1 1
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 14
PY 2006
VL 281
IS 28
BP 19115
EP 19123
DI 10.1074/jbc.M601645200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 061BU
UT WOS:000238847000026
PM 16687409
ER

PT J
AU Honjo, T
AF Honjo, Tasuku
TI Molecular strategy to cure autoimmune diseases
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Meeting Abstract
CT 8th International Conference of Neuroimmunology
CY OCT 15-19, 2006
CL Nagoya, JAPAN
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD SEP
PY 2006
VL 178
SU 1
BP 9
EP 9
PG 1
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA 099YG
UT WOS:000241633100004
ER

PT S
AU Shinkura, R
   Okazaki, IM
   Muto, T
   Begum, NA
   Honjo, T
AF Shinkura, Reiko
   Okazaki, Il-mi
   Muto, Taro
   Begum, Nasim A.
   Honjo, Tasuku
BE Gupta, S
   Alt, F
   Cooper, M
   Melchers, F
   Rajewsky, K
TI Regulation of AID Function In Vivo
SO MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION XI: B CELL
   BIOLOGY
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; HEAVY-CHAIN
   LOCUS; SOMATIC HYPERMUTATION; B-CELLS; GENE; EXPRESSION; ENZYME;
   PHOSPHORYLATION; TRANSCRIPTION
C1 [Shinkura, Reiko; Okazaki, Il-mi; Muto, Taro; Begum, Nasim A.; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan.
RP Shinkura, R (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan.
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   NIWA H, 1991, GENE, V108, P193
   Martin A, 2002, NATURE, V415, P802
   JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159
   Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347
   Bachl J, 2001, J IMMUNOL, V166, P5051
   Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0
   TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103
   Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7
   Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086
   Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8
   Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100
   FEARON DT, 1993, CURR OPIN IMMUNOL, V5, P341, DOI 10.1016/0952-7915(93)90051-S
   GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862
   Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102
   Peverali FA, 1996, EMBO J, V15, P3943
   RADA C, 1991, P NATL ACAD SCI USA, V88, P5508, DOI 10.1073/pnas.88.13.5508
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   Schulenberg B, 2004, ELECTROPHORESIS, V25, P2526, DOI 10.1002/elps.200406007
   XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705
NR 33
TC 9
Z9 10
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
BN 978-0-387-46530-2
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2007
VL 596
BP 71
EP 81
D2 10.1007/0-387-46530-8
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BLQ19
UT WOS:000270764700008
PM 17338177
ER

PT J
AU Tanigaki, K
   Muraki, K
   Honjo, T
AF Tanigaki, Kenji
   Muraki, Kazue
   Honjo, Tasuku
TI The regulation of cortical neuronal migration by RBP-J
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 Shiga Med Ctr, Res Inst, Shiga, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2007
VL 58
SU 1
BP S10
EP S10
DI 10.1016/j.neures.2007.06.053
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 207TA
UT WOS:000249272800050
ER

PT J
AU Begum, NA
   Izumi, N
   Nishikori, M
   Nagaoka, H
   Shinkura, R
   Honjo, T
AF Begum, Nasim A.
   Izumi, Nakako
   Nishikori, Momoko
   Nagaoka, Hitoshi
   Shinkura, Reiko
   Honjo, Tasuku
TI Requirement of non-canonical activity of uracil DNA glycosylase for
   class switch recombination
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; MISMATCH REPAIR PROTEIN; CYTIDINE
   DEAMINASE AID; BASE EXCISION-REPAIR; SOMATIC HYPERMUTATION; B-CELLS;
   MICE DEFICIENT; CIRCULAR DNA; ANTIBODY DIVERSIFICATION; REGION
   RECOMBINATION
AB Activation-induced cytidine deaminase (AID) and uracil DNA glycosylase (UNG) are required for class switch recombination (CSR). AID is involved in the DNA cleavage step of CSR, but the precise role of UNG is not yet understood. Mutations and deletions are footprints of abortive DNA cleavage in the immunoglobulin switch region in splenic B cells stimulated to undergo CSR. However, a UNG deficiency did not reduce the number of such footprints, indicating UNG is dispensable for the DNA cleavage step. Mutagenesis experiments revealed that the role of UNG in CSR depends on its WXXF motif This motif is also essential for the interaction of UNG with the HIV viral peptide Vpr, which recruits UNG to the HIV particle. Furthermore, exogenous Vpr had a dominant-negative effect on CSR. These results suggest that UNG is recruited to the CSR machinery through its WXXF motif by a Vpr-like host factor and plays a novel non-canonical role in a CSR step that follows DNA cleavage.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u-ac.jp
CR GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6
   Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996
   Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102
   Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974
   Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218
   Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579
   Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404
   Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834
   Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081
   Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102
   Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0
   Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067
   Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582
   Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0
   Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Selig L, 1997, J VIROL, V71, P4842
   Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292
   Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011
   Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000
   Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872
   Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858
   Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0
   Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323
   Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499
   Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495
   Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569
   Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011
   Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066
   Li ZQ, 2006, IMMUNITY, V24, P393, DOI 10.1016/j.immuni.2006.02.011
   Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998
   Endres M, 2004, J CLIN INVEST, V113, P1711, DOI 10.1172/JCI200420926
   Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207
   Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200
   Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200
   Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7
   BouHamdan M, 1998, J BIOL CHEM, V273, P8009, DOI 10.1074/jbc.273.14.8009
   Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898
   Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691
   Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6
   Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074
   Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745
   Schrader CE, 2003, J EXP MED, V197, P1377, DOI 10.1084/jem.20022190
   Ko R, 2005, DNA REPAIR, V4, P1421, DOI 10.1016/j.dnarep.2005.08.006
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101
   Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444
   Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799
   De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003
   DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365
   Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009
   Ho PJ, 2001, BLOOD, V97, P490, DOI 10.1182/blood.V97.2.490
   IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D
   Jiang YL, 2002, J BIOL CHEM, V277, P15385, DOI 10.1074/jbc.M200634200
   Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21
   Lahdesmaki A, 2004, J BIOL CHEM, V279, P16479, DOI 10.1074/jbc.M312796200
   MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C
   Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016
   Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877
   Schrader CE, 2003, EMBO J, V22, P5893, DOI 10.1093/emboj/cdg550
   Stivers James T, 2004, Science, V306, P2042
   STUDEBAKER AW, 2003, THESIS OHIO STATE U
   WINTER E, 1987, EMBO J, V6, P1663
NR 70
TC 27
Z9 27
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 5
PY 2007
VL 282
IS 1
BP 731
EP 742
DI 10.1074/jbc.M607439200
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 121OI
UT WOS:000243166500078
PM 17090531
ER

PT J
AU Tsuji, M
   Shinkura, R
   Kuroda, K
   Yabe, D
   Honjo, T
AF Tsuji, Masayuki
   Shinkura, Reiko
   Kuroda, Kazuki
   Yabe, Daisuke
   Honjo, Tasuku
TI Msx2-interacting nuclear target protein (Mint) deficiency reveals
   negative regulation of early thyrnocyte differentiation by Notch/RBP-J
   signaling
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE development; T cell
ID T-CELL DEVELOPMENT; ZONE B-CELLS; MAMMALIAN NOTCH; LINEAGE PROGENITORS;
   FAMILY MEMBERS; EXPRESSION; PATHWAY; THYMUS; FATE; GENE
AB Notch/RBP-J signaling is required for generation of early T progenitors (ETP) and promotion of double-negative (DN) 4 cells from DN3 cells in thymocyte differentiation. However, whether Notch affects other steps during thymocyte differentiation remains unknown. Msx2-interacting nuclear target protein (Mint) is an endogenous inhibitor of Notch regulation. Concordantly, by ex vivo analyses of embryonic thymi and in vitro differentiation studies of fetal liver progenitors, we find that Mint deficiency enhances generation of ETP and DN4 cells. Unexpectedly, however, Mint deficiency impairs differentiation of ETP into DN2 cells, suggesting that Notch/RBP-J signaling negatively regulates DN1-DN2 transition.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157
   Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241
   Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003
   Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216
   Uyttendaele H, 1996, DEVELOPMENT, V122, P2251
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   Bain G, 1997, MOL CELL BIOL, V17, P4782
   Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8
   Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8
   Schroeter EH, 1998, NATURE, V393, P382
   Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146
   Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9
   Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017
   Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Yun TJ, 2003, J IMMUNOL, V170, P5834
   Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567
   Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100
   Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004
   Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200
   Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878
   Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074
   Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0
   Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0
   Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3
   Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3
   Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549
   Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075
   Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349
   Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045
   Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201
   Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217
   Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009
   Wu L, 2006, CURR OPIN IMMUNOL, V18, P121, DOI 10.1016/j.coi.2006.01.006
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7
   Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878
   Masuda K, 2005, J IMMUNOL, V174, P2525
   Miyazaki M, 2005, J IMMUNOL, V174, P2507
   Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998
   Schmitt TM, 2005, CRIT REV IMMUNOL, V25, P141, DOI 10.1615/CritRevImmunol.v25.i2.40
   Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Wilson A, 2000, J IMMUNOL, V165, P5397
   Witt CM, 2003, J IMMUNOL, V171, P2783
NR 51
TC 33
Z9 33
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 30
PY 2007
VL 104
IS 5
BP 1610
EP 1615
DI 10.1073/pnas.0610520104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 134KD
UT WOS:000244081000032
PM 17242367
ER

PT J
AU Kotani, A
   Kakazu, N
   Tsuruyama, T
   Okazaki, IM
   Muramatsu, M
   Kinoshita, K
   Nagaoka, H
   Yabe, D
   Honjo, T
AF Kotani, Ai
   Kakazu, Naoki
   Tsuruyama, Tatsuaki
   Okazaki, Il-mi
   Muramatsu, Masamichi
   Kinoshita, Kazuo
   Nagaoka, Hitoshi
   Yabe, Daisuke
   Honjo, Tasuku
TI Activation-induced cytidine deaminase (AID) promotes B cell
   lymphomagenesis in Emu-cmyc transgenic mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE somatic hypermutation; Pim1; secondary hit; clonal expansion
ID CHRONIC LYMPHOCYTIC-LEUKEMIA; CLASS SWITCH RECOMBINATION; SOMATIC
   HYPERMUTATION; C-MYC; GENE CONVERSION; EXPRESSION; ANTIBODY; MUTATION;
   MOUSE; RNA
AB Activation-induced cytidine deaminase (AID), which is essential to both class switch recombination and somatic hypermutation of the Ig gene, is expressed in many types of human B cell lymphoma/ leukemia. AID is a potent mutator because it is involved in DNA breakage not only of Ig but also of other genes, including proto-oncogenes. Recent studies suggest that AID is required for chromosomal translocation involving cmyc and Ig loci. However, it is unclear whether AID plays other roles in tumorigenesis. We examined the effect of AID deficiency on the generation of surface Ig-positive B cell lymphomas in Emu-cmyc transgenic mice. Almost all lymphomas that developed in AID-deficient transgenic mice were pre-B cell lymphomas, whereas control transgenic mice had predominantly B cell lymphomas, indicating that AID is required for development of B but not pre-B cell lymphomas from cmyc overexpressing tumor progenitors. Thus, AID may play multiple roles in B cell lymphomagenesis.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan.
   Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane 6938501, Japan.
   Shiga Med Inst, Shiga 5248524, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Muramatsu, Masamichi/C-4339-2015; Yabe, Daisuke/J-6682-2014
OI Muramatsu, Masamichi/0000-0002-0153-3533; Yabe,
   Daisuke/0000-0002-5334-7687
CR MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x
   Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127
   Greiner A, 2005, J PATHOL, V205, P541, DOI 10.1002/path.1746
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006
   Forconi F, 2004, BLOOD, V104, P3312, DOI 10.1182/blood-2004-03-0950
   Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4
   Tsuruyama T, 2002, P NATL ACAD SCI USA, V99, P8253, DOI 10.1073/pnas.112202899
   Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170
   Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101
   Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011
   Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175
   He B, 2003, J IMMUNOL, V171, P5215
   Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100
   GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0
   Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424
   Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133
   CATTORETTI G, 1995, BLOOD, V86, P45
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6
   HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353
   Zhu D, 2005, BLOOD, V105, P2135, DOI 10.1182/blood-2004-07-2573
   Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595
   Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100
   ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0
   Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Cerutti A, 2002, J IMMUNOL, V169, P6594
   Hardianti MS, 2005, EUR J HAEMATOL, V74, P11, DOI 10.1111/j.1600-0609.2004.00338.x
   Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102
   Lu LM, 1997, LEUKEMIA RES, V21, P337, DOI 10.1016/S0145-2126(96)00124-5
   Poltoratsky V, 2001, P NATL ACAD SCI USA, V98, P7976, DOI 10.1073/pnas.141222198
   Sahota SS, 2000, BLOOD, V95, P3534
   Smit LA, 2003, CANCER RES, V63, P3894
   Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9
NR 46
TC 39
Z9 39
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 30
PY 2007
VL 104
IS 5
BP 1616
EP 1620
DI 10.1073/pnas.0610732104
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 134KD
UT WOS:000244081000033
PM 17251349
ER

PT J
AU Haspot, F
   Fehr, T
   Hogan, T
   Honjo, T
   Sykes, M
AF Haspot, F.
   Fehr, T.
   Hogan, T.
   Honjo, T.
   Sykes, M.
TI PD-I is required to induce peripheral CD8 T cell tolerance in recipients
   of allogeneic bone marrow transplantation with anti-CD154
SO BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
LA English
DT Meeting Abstract
CT Tandem BMT Meeting 2007
CY FEB 08-12, 2007
CL Keystone, CO
SP Amer Soc Blood & Marrow Transplantat, Ctr Int Blood & Marrow Transplantat Res, Pfizer Inc
C1 Massachusetts Gen Hosp, Harvard Med Sch, BMT TBRC, Boston, MA 02114 USA.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1083-8791
J9 BIOL BLOOD MARROW TR
JI Biol. Blood Marrow Transplant.
PD FEB
PY 2007
VL 13
IS 2
SU 2
MA 24
BP 11
EP 11
DI 10.1016/j.bbmt.2006.12.027
PG 1
WC Hematology; Immunology; Transplantation
SC Hematology; Immunology; Transplantation
GA 133QU
UT WOS:000244028300025
ER

PT J
AU Hano, T
   Oshima, Y
   Kinoshita, M
   Tanaka, M
   Mishima, N
   Ohyama, T
   Yanagawa, T
   Wakamatsu, Y
   Ozato, K
   Honjo, T
AF Hano, Takeshi
   Oshima, Yuji
   Kinoshita, Masato
   Tanaka, Minoru
   Mishima, Noriko
   Ohyama, Tetsuji
   Yanagawa, Takashi
   Wakamatsu, Yuko
   Ozato, Kenjiro
   Honjo, Tsuneo
TI Quantitative bioimaging analysis of gonads in olvas-GFP/ST-II YI medaka
   (transgenic Oryzias latipes) exposed to ethinylestradiol
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID SEXUAL-DIFFERENTIATION; WASTE-WATER; GERM-CELLS; VITELLOGENIN;
   REPRODUCTION; FISH; INDUCTION; HORMONES; SYSTEM; MODEL
AB This study investigates the adverse and persistent effects of ethinylestradiol (EE2) on mature gonads of transgenic olvas-GFP/ST II-YI medaka (Oryzias latipes). The measurement of gonadal size calculating the GFP-fluorescent area was used as a technique that enabled monitoring gonads in living specimens by GFP fluorescence. First, mature medaka were exposed to EE2 (47.8-522 ng/L) for 4 weeks. The gonads showed a significant reduction of the GFP-fluorescent area and Gonadosomatic Index in males exposed to EE2 at > 216 ng/L and females exposed at 522 ng/L. Histologically, males at all treatments exhibited testis-ova and additionally, high connective tissue prevalence at >= 216 ng/L. Next, mature male medaka were exposed to EE2 (43.7-473 ng/L) for 3 weeks and allowed to depurate for 6 weeks, to investigate persistent effects of EE2. Continuous gonad observation showed that GFP began to decline 3 weeks after initial exposure to >= 215 ng/L. After depuration, the gonad's fluorescent areas gradually recovered, with no statistical difference at the end of the depuration period; normal spermatogenesis was present in these individuals. Alterations in GFP fluorescence clearly indicate the condition of the gonad in transgenic medaka and this strain showed a facilitated screening fish model to detect the adverse effects on the gonad by estrogenic chemicals.
C1 Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan.
   Kyoto Univ, Div Appl Biosci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.
   Hokkaido Univ, Div Biol Sci, Grad Sch Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Nagoya Univ, Lab Freshwater Fish Stocks, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan.
   Kurume Univ, Inst Biostat, Grad Sch Med, Kurume, Fukuoka 8300011, Japan.
RP Oshima, Y (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.
EM yoshima@agr.kyushu-u.ac.jp
RI Oshima, Yuji/C-7701-2011; U-ID, Kyushu/C-5291-2016
CR Scholz S, 2000, AQUAT TOXICOL, V50, P363, DOI 10.1016/S0166-445X(00)00090-4
   Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI 10.1897/1551-5028(2001)020<0297:EPOCDI>2.0.CO;2
   Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298
   Belfroid AC, 1999, SCI TOTAL ENVIRON, V225, P101, DOI 10.1016/S0048-9697(98)00336-2
   Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870
   Hashimoto S, 2000, MAR ENVIRON RES, V49, P37, DOI 10.1016/S0141-1136(99)00047-1
   Schultz IR, 2003, ENVIRON TOXICOL CHEM, V22, P1272, DOI 10.1897/1551-5028(2003)022<1272:STETED>2.0.CO;2
   Miura T, 2001, ZOOL SCI, V18, P1055, DOI 10.2108/zsj.18.1055
   Fenske M, 2005, ENVIRON TOXICOL CHEM, V24, P1088, DOI 10.1897/04-096R1.1
   Kurauchi K, 2005, ENVIRON SCI TECHNOL, V39, P2762, DOI 10.1021/es0486465
   BENOIT DA, 1982, WATER RES, V16, P457, DOI 10.1016/0043-1354(82)90171-3
   YAMAMOTO TO, 1953, J EXP ZOOL, V123, P571, DOI 10.1002/jez.1401230309
   Kang IJ, 2002, CHEMOSPHERE, V47, P71, DOI 10.1016/S0045-6535(01)00205-3
   Cavaco JEB, 1999, CELL TISSUE RES, V297, P291, DOI 10.1007/s004410051357
   Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317
   Seki M, 2003, ENVIRON TOXICOL CHEM, V22, P1507, DOI 10.1897/1551-5028(2003)22<1507:EONATO>2.0.CO;2
   Seki M, 2002, ENVIRON TOXICOL CHEM, V21, P1692, DOI 10.1897/1551-5028(2002)021<1692:EOEOTR>2.0.CO;2
   Holthaus KIE, 2002, ENVIRON TOXICOL CHEM, V21, P2526, DOI 10.1897/1551-5028(2002)021<2526:TPFEAE>2.0.CO;2
   CHAN KK, 1976, CAN J ZOOL, V55, P155
   FOLMAR LC, 2002, AQUAT TOXICOL, V27, P361
   Gill ME, 2002, J EXP MAR BIOL ECOL, V281, P41, DOI 10.1016/S0022-0981(02)00396-9
   Hano T, 2005, ENVIRON TOXICOL CHEM, V24, P70, DOI 10.1897/03-610.1
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   SHIBATA N, 1988, J EXP ZOOL, V245, P71, DOI 10.1002/jez.1402450111
   Wakamatsu Yuko, 2003, Environmental Sciences, V10, P291
NR 25
TC 3
Z9 4
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD FEB 15
PY 2007
VL 41
IS 4
BP 1473
EP 1479
DI 10.1021/es0620134
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 135NZ
UT WOS:000244161600065
PM 17593759
ER

PT J
AU Kumazaki, K
   Tirosh, B
   Maehr, R
   Boes, M
   Honjo, T
   Ploegh, HL
AF Kumazaki, Kaori
   Tirosh, Boaz
   Maehr, Ren
   Boes, Marianne
   Honjo, Tasuku
   Ploegh, Hidde L.
TI AID(-/-)-mu s(-/-) mice are agammaglobulinemic and fail to maintain
   B220(-)CD138(+) plasma cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; ZONE B-CELLS; FOLLICULAR DENDRITIC CELLS;
   TRANSCRIPTION FACTOR XBP-1; CYTIDINE DEAMINASE AID; MARGINAL ZONE;
   ENDOPLASMIC-RETICULUM; BONE-MARROW; ANTIBODY-RESPONSES; IMMUNE-COMPLEXES
AB The terminal stage of B cell differentiation culminates in the formation of plasma cells (PC), which secrete large quantities of Igs. Despite recent progress in understanding the molecular aspect of PC differentiation and maintenance, the requirement for the synthesis of secretory Igs as a contributing factor has not been explored. To address this issue, we generated activation-induced cytidine deaminase (AID)/secretory mu-chain (mu s) double-knockout mice, in which a normally diverse repertoire of B cell receptors is retained, yet B cells are unable to synthesize secretory Igs. These mice possess polyclonal B cells but have no serum Igs. Following immunization in vivo, PCs, identified by CD138 expression and loss of the B220 marker, were starkly reduced in number in spleen and bone marrow of AID(-/-)mu s(-/-) agammaglobulinemic mice compared with wild-type mice. Upon mitogenic stimulation in vitro, AID(-/-)mu s(-/-) B cells differentiated into plasmablasts to some extent, but showed reduced survival compared with wild-type B cells. We found no evidence that this reduced survival was attributable to accumulation of membrane IgM. Our results indicate that the synthesis of secretory Igs is a requirement for maintenance of B220(-)CD138(+) PCs. The Journal of Immunology, 2007, 178: 2192-2203.
C1 Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
   Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.
   Harvard Univ, Inst Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
RP Ploegh, HL (reprint author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
EM ploegh@wi.mit.edu
CR Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907
   MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x
   Anderson SM, 2006, J IMMUNOL, V176, P4515
   Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138
   Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509
   KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0
   Amano M, 1998, J IMMUNOL, V161, P1710
   Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728
   Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226
   Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935
   SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295
   William J, 2005, J IMMUNOL, V174, P6879
   Boes M, 1998, J IMMUNOL, V160, P4776
   Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003
   HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213
   Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149
   Finke D, 2001, EUR J IMMUNOL, V31, P2603
   Roark JH, 1998, J IMMUNOL, V160, P3121
   Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012
   Kamata T, 2000, J IMMUNOL, V165, P1387
   CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572
   Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jcm.20040973
   Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200
   Zhang K, 2006, HANDB EXP PHARM, V172, P69
   Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262
   Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540
   Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595
   Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154
   Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624
   Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7
   Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Ardavin C, 1999, J IMMUNOL, V162, P2538
   EDWALDSGILBERT G, 1995, MOL CELL BIOL, V15, P6420
   Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931
   Maehr R, 2004, EUR J IMMUNOL, V34, P2230, DOI 10.1002/eji.200425246
   MASON JO, 1988, GENE DEV, V2, P1003, DOI 10.1101/gad.2.8.1003
   McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3
   Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575
   Underhill GH, 2003, BLOOD, V102, P4076, DOI 10.1182/blood-2003-03-0947
   van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4
NR 45
TC 20
Z9 20
U1 1
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD FEB 15
PY 2007
VL 178
IS 4
BP 2192
EP 2203
PG 12
WC Immunology
SC Immunology
GA 133QF
UT WOS:000244026800026
PM 17277124
ER

PT J
AU Hamanishi, J
   Mandai, M
   Iwasaki, M
   Okazaki, T
   Tanaka, Y
   Yamaguchi, K
   Higuchi, T
   Yagi, H
   Takakura, K
   Minato, N
   Honjo, T
   Fujii, S
AF Hamanishi, Junzo
   Mandai, Masaki
   Iwasaki, Masashi
   Okazaki, Taku
   Tanaka, Yoshimasa
   Yamaguchi, Ken
   Higuchi, Toshihiro
   Yagi, Haruhiko
   Takakura, Kenji
   Minato, Nagahiro
   Honjo, Tasuku
   Fujii, Shingo
TI Programmed cell death 1 ligand 1 and tumor-infiltrating CD8(+) T
   lymphocytes are prognostic factors of human ovarian cancer
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE costimulation; tumor immunity; immunohistochemistry
ID RENAL-CELL CARCINOMA; B7 FAMILY; CLINICAL-SIGNIFICANCE; POTENTIAL
   MECHANISM; ANTITUMOR IMMUNITY; DEATH-1 LIGAND-1; PD-1 EXPRESSION;
   FOLLOW-UP; B7-H1; BLOCKADE
AB The ligands for programmed cell death 1 (PID-1), an immunoinhibitory receptor belonging to CD28/cytotoxic T lymphocyte antigen 4 family, are PD-1 ligand 1 and 2 (PD-Ls). Recent reports suggest that the aberrant expression of PD-Ls on tumor cells impairs antitumor immunity, resulting in the immune evasion of the tumor cells. Although an inverse correlation between the expression level of PD-Ls and patients' prognosis has been reported for several malignant tumors, the follow-up period was limited because of the lack of the antibody (Ab) applicable to paraffin-embedded specimens. Here we generated a new Ab against PD-1 ligand 1 (PID-1-11) and analyzed the expression level of PD-Ls in human ovarian cancer using paraff in-embedded specimens. Patients with higher expression of PD-L1 had a significantly poorer prognosis than patients with lower expression. Although patients with higher expression of PD-1 ligand 2 also had a poorer prognosis, the difference was not statistically significant. A significant inverse correlation was observed between PD-L1 expression and the intraepithelial CD8(+) T lymphocyte count, suggesting that PID-L1 on tumor cells directly suppresses antitumor CD8(+) T cells. Multivariate analysis showed the expression of PID-L1 on tumor cells and intraepithelial CID8+ T lymphocyte count are independent prognostic factors. The PD-1/ PD-L pathway can be a good target for restoring antitumor immunity in ovarian cancer.
C1 Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Mandai, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.
EM mandai@kuhp.kyoto-u.ac.jp; honjo@mfour.med.kyoto-u.ac.jp
CR Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5
   JASS JR, 1986, J CLIN PATHOL, V39, P585, DOI 10.1136/jcp.39.6.585
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112
   Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   McGuire WP, 1996, SEMIN ONCOL, V23, P40
   Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Hirano F, 2005, CANCER RES, V65, P1089
   Naito Y, 1998, CANCER RES, V58, P3491
   Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075
   Wintterle S, 2003, CANCER RES, V63, P7462
   Nakano O, 2001, CANCER RES, V61, P5132
   Dong HD, 1999, NAT MED, V5, P1365
   Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774
   Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102
   Strome SE, 2003, CANCER RES, V63, P6501
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733
   Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Jemal A, 2005, CA-CANCER J CLIN, V55, P10
   Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177
   Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863
   Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194
   Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003
   Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565
   Schumacher K, 2001, CANCER RES, V61, P3932
   Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101
   Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093
   Lang K, 2006, CANCER IMMUNOL IMMUN, V55, P749, DOI 10.1007/s00262-006-0126-x
   Vaidya AP, 2003, SEMIN ONCOL, V30, P401, DOI 10.1016/S0093-7754(03)00100-3
NR 42
TC 361
Z9 387
U1 7
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 27
PY 2007
VL 104
IS 9
BP 3360
EP 3365
DI 10.1073/pnas.0611533104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 142PG
UT WOS:000244661400061
PM 17360651
ER

PT J
AU Komori, J
   Marusawa, H
   Machimoto, T
   Endo, Y
   Kinoshita, K
   Kou, T
   Haga, H
   Ikai, I
   Uemoto, S
   Honjo, T
   Chiba, T
AF Komori, Junji
   Marusawa, Hiroyuki
   Machimoto, Takafumi
   Endo, Yoko
   Kinoshita, Kazuo
   Kou, Tadayuki
   Haga, Hironori
   Ikai, Iwao
   Uemoto, Shinji
   Honjo, Tasuku
   Chiba, Tsutomu
TI High expression of activation induced cytidine deaminase in human bile
   duct epithelium during cholangiocarcinogenesis
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting
CY MAY 19-24, 2007
CL Washington, DC
SP ASGE
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD APR
PY 2007
VL 132
IS 4
SU 2
BP A730
EP A730
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 160FZ
UT WOS:000245927606092
ER

PT J
AU Kou, T
   Marusawa, H
   Endo, Y
   Nakase, H
   Fujii, S
   Kinoshita, K
   Fujimori, T
   Honjo, T
   Chiba, T
AF Kou, Tadayuki
   Marusawa, Hiroyuki
   Endo, Yoko
   Nakase, Hiroshi
   Fujii, Shigehiko
   Kinoshita, Kazuo
   Fujimori, Takahiro
   Honjo, Tasuku
   Chiba, Tsutomu
TI Ectopic expression of activation-induced cytidine deaminase in
   ulcerative colitis-associated colorectal cancers
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting
CY MAY 19-24, 2007
CL Washington, DC
SP ASGE
NR 0
TC 0
Z9 0
U1 1
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD APR
PY 2007
VL 132
IS 4
SU 2
BP A633
EP A633
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 160FZ
UT WOS:000245927605223
ER

PT J
AU Matsumoto, Y
   Marusawa, H
   Kinoshita, K
   Endo, Y
   Kou, T
   Morisawa, T
   Azuma, T
   Okazaki, IM
   Honjo, T
   Chiba, T
AF Matsumoto, Yuko
   Marusawa, Hiroyuki
   Kinoshita, Kazuo
   Endo, Yoko
   Kou, Tadayuki
   Morisawa, Toshiyuki
   Azuma, Takeshi
   Okazaki, Il-Mi
   Honjo, Tasuku
   Chiba, Tsutomu
TI Helicobacter pylori infection triggers aberrant expression of
   activation-induced cytidine deaminase in gastric epithelium
SO NATURE MEDICINE
LA English
DT Article
ID NF-KAPPA-B; CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; P53
   MUTATIONS; CELL-LINES; AID; CANCER; DNA; PROTEIN; MICE
AB Infection with Helicobacter pylori (H. pylori) is a risk factor for the development of gastric cancer. Here we show that infection of gastric epithelial cells with 'cag' pathogenicity island (cagPAI)-positive H. pylori induced aberrant expression of activation-induced cytidine deaminase (AID), a member of the cytidine-deaminase family that acts as a DNA- and RNA-editing enzyme, via the I kappa B kinase-dependent nuclear factor-kappa B activation pathway. H. pylori-mediated upregulation of AID resulted in the accumulation of nucleotide alterations in the TP53 tumor suppressor gene in gastric cells in vitro. Our findings provide evidence that aberrant AID expression caused by H. pylori infection might be a mechanism of mutation accumulation in the gastric mucosa during H. pylori-associated gastric carcinogenesis.
C1 Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan.
   Shiga Med Ctr Res Inst, Shiga 5248524, Japan.
   Kobe Univ, Sch Med, Int Ctr Med Res & Treatment, Chuo Ku, Kobe, Hyogo 6500017, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Chiba, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
EM chiba@kuhp.kyoto-u.ac.jp
CR Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131
   Peek RM, 1995, LAB INVEST, V73, P760
   Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Morgan C, 2003, BRIT J CANCER, V89, P1314, DOI 10.1038/sj.bjc.6601302
   Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504
   Uchida K, 2001, INFECT IMMUN, V69, P6749, DOI 10.1128/IAI.69.11.6749-6754.2001
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558
   Matsumoto Y, 2005, HELICOBACTER, V10, P407, DOI 10.1111/j.1523-5378.2005.00349.x
   Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424
   Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703
   Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180
   Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042
   Cascalho M, 2004, J IMMUNOL, V172, P6513
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Iwai A, 2003, J GASTROENTEROL, V38, P751, DOI 10.1007/s00535-003-1141-8
   Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870
   Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704
   BLASER MJ, 1995, CANCER RES, V55, P2111
   Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni0902-826
   Stock M, 2005, GENE, V360, P1, DOI 10.1016/j.gene.2005.06.026
   Albesiano E, 2003, BLOOD, V102, P3333, DOI 10.1182/blood-2003-05-1585
   Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292
   Lossos IS, 2004, LEUKEMIA, V18, P1775, DOI 10.1038/sj.leu.2403488
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x
   Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4
   Parsonnet J, 1997, GUT, V40, P297
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Blaser MJ, 1998, BRIT MED J, V316, P1507
   Chiba T, 2006, J GASTROENTEROL, V41, P1, DOI 10.1007/s00535-005-1743-4
   CRABTREE JE, 1993, GUT, V34, P1339, DOI 10.1136/gut.34.10.1339
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   Glickman J N, 2001, Gastrointest Endosc Clin N Am, V11, P717
   Kanda N, 2006, AM J PHYSIOL-GASTR L, V290, pG519, DOI 10.1152/ajpgi.00113.2005
   Kinoshita K, 2006, INT J HEMATOL, V83, P201, DOI 10.1532/ijh97.060-11
   Marusawa H, 2001, MICROBIOL IMMUNOL, V45, P483
   Peek RM, 2001, AM J PHYSIOL-GASTR L, V280, pG525
   Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259
   1994, IACR MONOGR EVAL CAR, V61, P1
NR 45
TC 250
Z9 261
U1 4
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
J9 NAT MED
JI Nat. Med.
PD APR
PY 2007
VL 13
IS 4
BP 470
EP 476
DI 10.1038/nm1566
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 154YG
UT WOS:000245543900036
PM 17401375
ER

PT J
AU Wu, YL
   Li, Y
   Okazaki, T
   Honjo, T
   Minato, N
   Sakaguchi, S
   Pirenne, J
   Koshiba, T
AF Wu, Yanling
   Li, Ying
   Okazaki, Taku
   Honjo, Tasuku
   Minato, Nagahiro
   Sakaguchi, Shimon
   Pirenne, Jacques
   Koshiba, Takaaki
TI Intragraft immunoregulation-differential mechanisms of tolerance between
   human liver transplantation and intestinal transplantation.
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Meeting Abstract
CT Annual American Transplant Congress
CY MAY 05-09, 2007
CL San Francisco, CA
C1 Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.
   Univ Hosp Leuven, Abdominal Transplant Surg Dept, Louvain, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1600-6135
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAY
PY 2007
VL 7
SU 2
MA 736
BP 338
EP 338
PG 1
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 166HQ
UT WOS:000246370201172
ER

PT J
AU Yabe, D
   Fukuda, H
   Aoki, M
   Yamada, S
   Takebayashi, S
   Shinkura, R
   Yamamoto, N
   Honjo, T
AF Yabe, Daisuke
   Fukuda, Hitoshi
   Aoki, Misayo
   Yamada, Shuichi
   Takebayashi, Shinji
   Shinkura, Reiko
   Yamamoto, Norio
   Honjo, Tasuku
TI Generation of a conditional knockout allele for mammalian Spen protein
   Mint/SHARP
SO GENESIS
LA English
DT Article
DE Spen; Mint; SHARP; conditional knockout; Cre/loxP
ID ZONE B-CELLS; TRANSCRIPTIONAL REPRESSION; NEURAL DEVELOPMENT; SIGNALING
   PATHWAY; BINDING-PROTEIN; IN-VIVO; NOTCH; REVEALS; DOMAIN; MINT
AB The Spen protein family is found in worms, flies, and mammals, and is implicated in diverse biological processes from embryogenesis to aging. Spen proteins have three N-terminal RNA recognition motifs and a C-terminal SPOC domain. The mammalian Spen proteins Mint and its human ortholog SHARP interact with the Notch-signaling mediator RBP-J as well as Msx2 and several unliganded nuclear hormone receptors, and impart transcription-repressing activity to these molecules by recruiting corepressors through the SPOC domain. Despite these in vitro findings, Mint/SHARP's physiological role is largely unknown, because Mint germline knockouts are embryonic lethal. To analyze Mint/SHARP function in postnatal mice, we created Mint-floxed mice that allow the Cre/loxP-mediated conditional knockout of Mint. We analyzed Mint and RBP-J epistasis during Notch-dependent splenic B-lymphocyte development, and found that Mint suppresses Notch signaling through RBP-J. In addition, Mint deficiency caused severe hypoplasia in postnatal brain, suggesting it may regulate neuronal cell survival.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan.
   Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Yabe, Daisuke/J-6682-2014; 
OI Yabe, Daisuke/0000-0002-5334-7687; , Norio/0000-0001-8924-0710
CR Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   Schroeter EH, 1998, NATURE, V393, P382
   Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747
   Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200
   Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0
   Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3
   Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549
   Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075
   Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099
   Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201
   YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458
   Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203
   Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2
   Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   Kurooka Hisanori, 2000, Journal of Biological Chemistry, V275, P17211, DOI 10.1074/jbc.M000909200
   Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104
NR 27
TC 15
Z9 15
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1526-954X
J9 GENESIS
JI Genesis
PD MAY
PY 2007
VL 45
IS 5
BP 300
EP 306
DI 10.1002/dvg.20296
PG 7
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 170LX
UT WOS:000246666000007
PM 17457934
ER

PT J
AU Tanigaki, K
   Honjo, T
AF Tanigaki, Kenji
   Honjo, Tasuku
TI Regulation of lymphocyte development by Notch signaling
SO NATURE IMMUNOLOGY
LA English
DT Review
ID ZONE B-CELLS; HEMATOPOIETIC PROGENITOR CELLS; MARGINAL ZONE; ALPHA-BETA;
   T-CELLS; TRANSCRIPTIONAL REPRESSION; LINEAGE SPECIFICATION; NEGATIVE
   REGULATION; IN-VITRO; DIFFERENTIATION
AB Notch molecules are well conserved from Drosophila melanogaster to mammals and regulate a broad spectrum of various cell lineage commitment processes. Recent studies using inhibitors, transgenic mice and conditional loss-of-function approaches have demonstrated essential roles for Notch signaling in the differentiation of thymocytes and peripheral T cells, as well as B cells. Here we highlight parallels in the developmental regulation of mammalian lymphocytes and the D. melanogaster nervous system through Notch cooperation with the transcriptional regulators RBP-J (Su( H)), MINT (Hairless) and E2A (Ac-Sc-Da).
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Shiga Med Ctr, Res Inst, Shiga 5248524, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268
   Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620
   Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003
   Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216
   Bain G, 1997, MOL CELL BIOL, V17, P4782
   Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X
   Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8
   Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8
   Schroeter EH, 1998, NATURE, V393, P382
   Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3
   Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083
   Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005
   Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9
   Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0
   Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474
   Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75
   Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0
   Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046
   delaPompa J, 1997, DEVELOPMENT, V124, P1139
   Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030
   Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567
   Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9
   Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2
   Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448
   Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878
   Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1
   Adler SH, 2003, J IMMUNOL, V171, P2896
   Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0
   Engel I, 2002, P NATL ACAD SCI USA, V99, P11322, DOI 10.1073/pnas.162373999
   Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0
   Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3
   Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855
   Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3
   Ordentlich P, 1998, MOL CELL BIOL, V18, P2230
   Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075
   Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010
   Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217
   Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847
   Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004
   Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X
   Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009
   HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102
   Guinamard R, 2000, NAT IMMUNOL, V1, P31
   Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394
   Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591
   ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513
   Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289
   Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920
   Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234
   Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0
   Hoebeke I, 2006, BLOOD, V107, P2879, DOI 10.1182/blood-2005-05-1815
   Hoflinger S, 2004, J IMMUNOL, V173, P3935
   Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8
   Jones P, 1998, BLOOD, V92, P1505
   Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238
   Kurooka Hisanori, 2000, Journal of Biological Chemistry, V275, P17211, DOI 10.1074/jbc.M000909200
   Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.0.CO;2-P
   Palaga T, 2003, J IMMUNOL, V171, P3019
   Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180
   Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085
   Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702
   Robey E, 1998, CURR OPIN IMMUNOL, V10, P181, DOI 10.1016/S0952-7915(98)80247-1
   Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101
   Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305
   Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Tanigaki K, 2003, SEMIN IMMUNOL, V15, P113, DOI 10.1016/S1044-5323(03)00008-3
   Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104
   Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7
NR 73
TC 107
Z9 117
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD MAY
PY 2007
VL 8
IS 5
BP 451
EP 456
DI 10.1038/ni1453
PG 6
WC Immunology
SC Immunology
GA 158YM
UT WOS:000245831600005
PM 17440450
ER

PT J
AU Takebayashi, S
   Yamamoto, N
   Yabe, D
   Fukuda, H
   Kojima, K
   Ito, J
   Honjo, T
AF Takebayashi, Shinji
   Yamamoto, Norio
   Yabe, Daisuke
   Fukuda, Hitoshi
   Kojima, Ken
   Ito, Juichi
   Honjo, Tasuku
TI Multiple roles of Notch signaling in cochlear development
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE cochlea; hair cell; supporting cell; progenitor cell; organ culture;
   notch signal; gamma-secretase inhibitor; TACE inhibitor
ID HAIR CELL-DEVELOPMENT; MAMMALIAN INNER-EAR; INTRACELLULAR DOMAIN;
   TRANSCRIPTION FACTOR; SUPPORTING CELLS; ACOUSTIC TRAUMA;
   DIFFERENTIATION; LIGANDS; ORGAN; CORTI
AB Notch signaling inhibits hair cell differentiation, based on studies on mice deficient in Notch signaling-related genes and its downstream genes. However, the precise mechanisms of this inhibition are unknown because it is difficult to control the timing and duration of the suppression of Notch signaling. Here, we developed a novel in vitro culture and analysis method for mouse fetal cochleae and examined the roles of Notch signaling by its reversible inhibition through the use of Notch signaling inhibitors of gamma-secretase and TNF-alpha-converting enzyme. Notch inhibition with Notch signaling inhibitor treatment increases the number of cochlear hair cells, as observed in gene deletion experiments. We elucidated that this increase is regulated by the dichotomy between hair cells and supporting cells from common progenitors. We also propose other roles of Notch signaling in cochlear development. First, Notch signaling arrests the cell cycle of the cochlear epithelium containing putative hair cells and supporting cell progenitors because Notch inhibition with inhibitor treatment increases the number of 5-bromo-2'-deoxyuridine (BrdU)-positive cells that can differentiate into hair cells or supporting cells. Second, Notch signaling is required for the induction of Prox I positive supporting cells. Third, Notch signaling is required for the maintenance of supporting cells. (c) 2007 Elsevier Inc. All rights reserved.
C1 Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Dept Neurosurg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
RI Yabe, Daisuke/J-6682-2014; 
OI Yabe, Daisuke/0000-0002-5334-7687; , Norio/0000-0001-8924-0710
CR TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0
   Montcouquiol M, 2003, J NEUROSCI, V23, P9469
   De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083
   Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002
   Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965
   Schroeter EH, 1998, NATURE, V393, P382
   Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284
   Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084
   Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349
   KELLEY MW, 1993, DEVELOPMENT, V119, P1041
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196
   White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849
   Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260
   CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100
   Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998
   Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X
   Lanford PJ, 1999, NAT GENET, V21, P289
   Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910
   Gale JE, 2001, J NEUROSCI, V21, P7013
   Zheng JL, 2000, DEVELOPMENT, V127, P4551
   Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837
   Zine A, 2001, J NEUROSCI, V21, P4712
   RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101
   Yamamoto N, 2006, J MOL MED-JMM, V84, P37, DOI 10.1007/s00109-005-0706-9
   Fekete DM, 1998, J NEUROSCI, V18, P7811
   McKenzie E, 2004, DEV DYNAM, V229, P802, DOI 10.1002/dvdy.10500
   Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944
   Chen HC, 1999, DECIS SUPPORT SYST, V27, P1
   Gestwa G, 1999, J COMP NEUROL, V414, P33, DOI 10.1002/(SICI)1096-9861(19991108)414:1<33::AID-CNE3>3.0.CO;2-M
   Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x
   JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0
   KIEMAN A, 2006, PLOS GENET, V2, pE4
   Lanford Pamela J., 2000, JARO Journal of the Association for Research in Otolaryngology, V1, P161, DOI 10.1007/s101620010023
   Miura T, 2004, J ANAT, V205, P297, DOI 10.1111/j.0021-8782.2004.00335.x
   Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998
   Ruben RJ, 1967, ACTA OTO-LARYNGOL, V220, P1
   VANDEWATER TR, 1973, ANN OTOL RHINOL L S4, V82, P3
   Zhang N, 2000, CURR BIOL, V10, P659, DOI 10.1016/S0960-9822(00)00522-4
NR 41
TC 60
Z9 68
U1 2
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD JUL 1
PY 2007
VL 307
IS 1
BP 165
EP 178
DI 10.1016/j.ydbio.2007.04.035
PG 14
WC Developmental Biology
SC Developmental Biology
GA 181TO
UT WOS:000247459200014
PM 17531970
ER

PT J
AU Okazaki, T
   Honjo, T
AF Okazaki, Taku
   Honjo, Tasuku
TI PD-1 and PD-1 ligands: from discovery to clinical application
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Review
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL-ACTIVATION; LYMPHOCYTE-ASSOCIATED
   ANTIGEN-4; CARDIAC TROPONIN-I; PROGRAMMED DEATH-1 LIGAND-1; RUNX1
   BINDING-SITE; DILATED CARDIOMYOPATHY; DENDRITIC CELLS;
   RHEUMATOID-ARTHRITIS; B7-H1 EXPRESSION
AB Programmed cell death-1 (PD-1, Pdcd1), an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L-2. Because of the wide range of ligand distribution in the body, its biological significance pervades almost every aspect of immune responses including autoimmunity, tumor immunity, infectious immunity, transplantation immunity, allergy and immunological privilege. In this review, we would like to summarize the history of PDA research since its discovery and recent findings that suggest promising future for the clinical application of PDA agonists and antagonists to various human diseases.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genome Med, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Century Ctr Excellence Format 21st, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genome Med, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR Abelson AK, 2007, GENES IMMUN, V8, P69, DOI 10.1038/sj.gene.6364360
   Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267
   Wan B, 2006, J IMMUNOL, V177, P8844
   Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Maker AV, 2005, ANN SURG ONCOL, V12, P1005, DOI 10.1245/ASO.2005.03.536
   Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019
   Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428
   Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   Das S, 2006, J IMMUNOL, V176, P3000
   Raimondi G, 2006, J IMMUNOL, V176, P2808
   Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8
   Hirata S, 2005, J IMMUNOL, V174, P1888
   Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Hirano F, 2005, CANCER RES, V65, P1089
   Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954
   Okazaki T, 2005, AUTOIMMUNITY, V38, P353, DOI 10.1080/08916930500124072
   Wang SC, 2006, J CLIN IMMUNOL, V26, P506, DOI 10.1007/s10875-006-9048-9
   He YF, 2004, J IMMUNOL, V173, P4919
   Kirchberger S, 2005, J IMMUNOL, V175, P1145
   Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944
   Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2
   Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842
   Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599
   Ni RH, 2007, HUM GENET, V121, P223, DOI 10.1007/s00439-006-0309-8
   Tsushima F, 2006, ORAL ONCOL, V42, P268, DOI 10.1016/j.oraloncology.2005.07.013
   Bolstad AI, 2003, ARTHRITIS RHEUM, V48, P174, DOI 10.1002/art.10734
   Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM, V50, P2590, DOI 10.1002/art.20436
   Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3
   Wintterle S, 2003, CANCER RES, V63, P7462
   Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809
   Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517
   Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819
   Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496
   Geng L, 2006, J VIRAL HEPATITIS, V13, P725, DOI 10.1111/j.1365-2893.2006.00746.x
   Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8
   Dong HD, 1999, NAT MED, V5, P1365
   Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776
   Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146
   Kong EKP, 2005, ARTHRITIS RHEUM, V52, P1058, DOI 10.1002/art.20966
   Strome SE, 2003, CANCER RES, V63, P6501
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Prokunina L, 2004, ARTHRITIS RHEUM, V50, P1770, DOI 10.1002/art.20280
   Nguyen LT, 2002, J EXP MED, V196, P1393, DOI 10.1084/jem.20021466
   Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733
   Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228
   Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259
   Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875
   Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Hatachi S, 2003, J RHEUMATOL, V30, P1410
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664
   AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521
   Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Brown JA, 2003, J IMMUNOL, V170, P1257
   Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268
   Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643
   Okazaki T, 2005, TRENDS MOL MED, V11, P322, DOI 10.1016/j.molmed.2005.05.001
   Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106
   Wallukat G, 1996, INT J CARDIOL, V54, P191, DOI 10.1016/0167-5273(96)02598-3
   Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06
   Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065
   Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773
   Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863
   Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194
   Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2
   Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Mataki N, 2007, AM J GASTROENTEROL, V102, P302, DOI 10.1111/j.1572-0241.2006.00948.x
   Radhakrishnan S, 2003, J IMMUNOL, V170, P1830
   Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275
   Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482
   Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083
   Kobayashi M, 2005, J RHEUMATOL, V32, P2156
   Felix SB, 2000, J AM COLL CARDIOL, V35, P1590, DOI 10.1016/S0735-1097(00)00568-4
   Tao R, 2005, J IMMUNOL, V175, P5774
   Ozkaynak E, 2002, J IMMUNOL, V169, P6546
   Petrie C, 2003, IEEE INTERNET COMPUT, V7, P68, DOI 10.1109/MIC.2003.1215662
   Felix SB, 2002, J AM COLL CARDIOL, V39, P646, DOI 10.1016/S0735-1097(01)01794-6
   Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
   Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101
   Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100
   Felix SB, 2006, INT J CARDIOL, V112, P30, DOI 10.1016/j.ijcard.2006.05.014
   Lin SC, 2004, ARTHRITIS RHEUM, V50, P770, DOI 10.1002/art.20040
   Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x
   Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005
   Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.0177-06
   Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020
   Bennet AM, 2006, HUM IMMUNOL, V67, P700, DOI 10.1016/j.humimm.2006.05.005
   Ding HL, 2006, CLIN IMMUNOL, V118, P258, DOI 10.1016/j.clim.2005.10.017
   Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005
   James ES, 2005, GENES IMMUN, V6, P430, DOI 10.1038/sj.gene.6364223
   Lee SH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2071
   Maier SA, 2005, CURR NANOSCI, V1, P17, DOI 10.2174/1573413052953165
   Nogid A, 2006, CLIN THER, V28, P1764, DOI 10.1016/j.clinthera.2006.11.020
   OKAZAKI T, 2006, CELL, V124, P549
   Okazaki T, 2005, J EXP MED, V202, P1643, DOI 10.1084/jem.20051984
   Ruderman EM, 2006, NAT CLIN PRACT RHEUM, V2, P654, DOI 10.1038/noprheum0345
   Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2554
   Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072
   SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562
   Wang SC, 2007, J RHEUMATOL, V34, P721
   Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k
   Zhong XM, 2004, INT IMMUNOL, V16, P1181, DOI 10.1093/intimm/dxh121
NR 126
TC 222
Z9 243
U1 17
U2 39
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUL
PY 2007
VL 19
IS 7
BP 813
EP 824
DI 10.1093/intimm/dxm057
PG 12
WC Immunology
SC Immunology
GA 205PU
UT WOS:000249127900001
PM 17606980
ER

PT J
AU Terawaki, S
   Tanaka, Y
   Nagakura, T
   Hayashi, T
   Shibayama, S
   Muroi, K
   Okazaki, T
   Mikami, B
   Garboczi, DN
   Honjo, T
   Minato, N
AF Terawaki, Selgo
   Tanaka, Yoshimasa
   Nagakura, Tornokazu
   Hayashi, Tarnon
   Shibayama, Shiro
   Muroi, Kaori
   Okazaki, Taku
   Mikami, Bunzo
   Garboczi, David N.
   Honjo, Tasuku
   Minato, Nagahiro
TI Specific and high-affinity binding of tetramerized PD-L1 extracellular
   domain to PD-1-expressing cells: possible application to enhance T cell
   function
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE affinity; cancer; immunoreceptor; infection; tetramer
ID PROGRAMMED DEATH-1; B7 FAMILY; DILATED CARDIOMYOPATHY; TUMOR-CELLS; YVKM
   MOTIF; RECEPTOR; EXPRESSION; B7-H1; MICE; BLOCKADE
AB The negative co-stimulatory receptor, programmed cell death 1 (PD-1), is induced on activated T cells and delivers inhibitory signals upon engagement with its ligands PD-L1 and PD-L2, which are expressed on various somatic cells and certain cancers. Accumulating evidence suggests that interfering with the PD-1-PD-L1 interaction may result in the restoration of defective T cell functions in cancer and chronic viral infection. Herein, we established procedures to produce large amounts of renatured recombinant extracellular domain proteins of mouse PDA (mPD-1) and PD-L1. While monomeric mPD-1 and mouse PD-L1 (mPD-L1) only marginally interacted with the cells expressing their counterpart proteins, their tetramerization markedly enhanced the affinity with the K(d) of mPD-L1 tetramer being nearly 1 00-fold lower than that of the corresponding monomer. The affinity of mPD-L1 tetramer was even higher than a high-affinity anti-PD-1 mAb, and it efficiently inhibited the binding of mPD-L1/Fc-chimeric protein to mPD-1(+) cells. Functionally, mPD-L1 tetramer significantly enhanced the proliferative responses as well as the cytotoxic activity of T cells against specific target cells in vitro. The results suggest that oligomeric PD-L1 extracellular domains may provide a potential means to restore T cell functions in cancer and viral infection in humans.
C1 Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immuol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan.
   Ono Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3004247, Japan.
   Kyoto Univ, Grad Sch Med, Century Ctr Excellence Program, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Agr, Lab Food Qual Design & Dev, Kyoto 6000011, Japan.
   NIAID, Immunogenet Lab, Sturct Biol Sect, Rockville, MD 20852 USA.
RP Minato, N (reprint author), Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.
EM minato@imm.med.kyoto-u.ac.jp
CR Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0
   Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428
   Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Hirano F, 2005, CANCER RES, V65, P1089
   Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2
   Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496
   Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3
   VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5
   Strome SE, 2003, CANCER RES, V63, P6501
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138
   Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228
   Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125
   Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235
   Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863
   Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482
   Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119
   PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834
   STEIN PH, 1994, MOL CELL BIOL, V14, P3392
   Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Chemnitz JM, 2004, J IMMUNOL, V173, P945
   Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170
   GOLD L, 1990, METHOD ENZYMOL, V185, P89
   Okazaki T, 2005, J EXP MED, V202, P1643, DOI 10.1084/jem.20051984
   Schneider H, 2001, EUR J IMMUNOL, V31, P2042, DOI 10.1002/1521-4141(200107)31:7<2042::AID-IMMU2042>3.0.CO;2-D
   Schneider H, 1998, BIOCHEM BIOPH RES CO, V252, P14, DOI 10.1006/bbrc.1998.9559
NR 45
TC 3
Z9 3
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
J9 INT IMMUNOL
JI Int. Immunol.
PD JUL
PY 2007
VL 19
IS 7
BP 881
EP 890
DI 10.1093/intimm/dxm059
PG 10
WC Immunology
SC Immunology
GA 205PU
UT WOS:000249127900007
PM 17606978
ER

PT J
AU Endo, Y
   Marusawa, H
   Kinoshita, K
   Morisawa, T
   Sakurai, T
   Okazaki, IM
   Watashi, K
   Shimotohno, K
   Honjo, T
   Chiba, T
AF Endo, Y.
   Marusawa, H.
   Kinoshita, K.
   Morisawa, T.
   Sakurai, T.
   Okazaki, I-M
   Watashi, K.
   Shimotohno, K.
   Honjo, T.
   Chiba, T.
TI Expression of activation-induced cytidine deaminase in human hepatocytes
   via NF-kappa B signaling
SO ONCOGENE
LA English
DT Article
DE activation-induced cytidine deaminase; TNF-alpha; NF-kappa B;
   hepatocellular carcinoma; hepatitis C virus; chronic hepatitis
ID CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION;
   HEPATOCELLULAR-CARCINOMA; FACTOR-ALPHA; MEDIATED APOPTOSIS;
   GENE-EXPRESSION; MESSENGER-RNA; MOUSE MODEL; C-MYC; AID
AB Activation-induced cytidine deaminase (AID) is involved in somatic DNA alterations of the immunoglobulin gene for amplification of immune diversity. The fact that constitutive expression of AID in mice causes tumors in various organs, including lymphoid tissues and lungs, suggests the important role of the aberrant editing activity of AID on various tumor-related genes for carcinogenesis. AID expression, however, is restricted to activated B cells under physiological conditions. We demonstrate here that ectopic AID expression is induced in response to tumor necrosis factor-alpha stimulation in cultured human hepatocytes. The proinflammatory cytokine-mediated expression of AID is achieved by I kappa B kinase-dependent nuclear factor (NF)-kappa B signaling pathways. Hepatitis C virus, one of the leading causes of hepatocellular carcinoma (HCC), enhanced AID expression via NF-kappa B activation through expression of viral core protein. The aberrant expression of AID in hepatoma-derived cells resulted in accumulation of genetic alterations in the c-myc and pim1 genes, suggesting that inappropriate expression of AID acts as a DNA mutator that enhances the genetic susceptibility to mutagenesis in human hepatocytes. Our current findings indicate that the inappropriate expression of AID is induced by proinflammatory cytokine stimulation and may provide the link between hepatic inflammation and the development of HCC.
C1 Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan.
   Shiga Med Ctr Res Inst, Moriyama, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
   Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses, Kyoto 606, Japan.
RP Chiba, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Kawara Cho,Shogoin, Kyoto 6068507, Japan.
EM chiba@kuhp.kyoto-u.ac.jp
CR Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101
   Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904
   Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Martin A, 2002, NATURE, V415, P802
   Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006
   TILG H, 1992, GASTROENTEROLOGY, V103, P264
   Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049
   Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0
   Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.034858100
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964
   Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009
   Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424
   Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033
   Marusawa H, 1999, J VIROL, V73, P4713
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042
   TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501
   MURAKAMI H, 1993, CANCER RES, V53, P1719
   Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292
   Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
   Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899
   Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018
   Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192
   Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Matsumoto T, 2006, FEBS LETT, V580, P731, DOI 10.1016/j.febslet.2005.12.081
   Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292
   Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339
   Heintel D, 2004, LEUKEMIA, V18, P756, DOI 10.1038/sj.leu.2403294
   Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841
   Kinoshita K, 2006, INT J HEMATOL, V83, P201, DOI 10.1532/ijh97.060-11
   Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102
   Marusawa H, 2001, MICROBIOL IMMUNOL, V45, P483
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Tateno C, 2000, HEPATOLOGY, V31, P65, DOI 10.1002/hep.510310113
NR 44
TC 92
Z9 94
U1 5
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
J9 ONCOGENE
JI Oncogene
PD AUG
PY 2007
VL 26
IS 38
BP 5587
EP 5595
DI 10.1038/sj.onc.1210344
PG 9
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 200ZS
UT WOS:000248801900004
PM 17404578
ER

PT J
AU Kroner, A
   Schwab, N
   Ip, CW
   Nave, KA
   Honjo, T
   Wiendl, H
   Martini, R
AF Kroner, A.
   Schwab, N.
   Ip, C. W.
   Nave, K. A.
   Honjo, T.
   Wiendl, H.
   Martini, R.
TI Programmed cell death 1 is a key regulator of tissue immune-homeostasis
   in the CNS: lessons from a model of oligendropathy-induced inflammation
SO MULTIPLE SCLEROSIS
LA English
DT Meeting Abstract
CT 23rd Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th
   Annual Conference of Rehabilitation in MS
CY OCT 11-14, 2007
CL Prague, CZECH REPUBLIC
SP European Comm Treatment & Res Multiple Sclerosis
C1 Univ Wurzburg, D-97070 Wurzburg, Germany.
   Max Planck Inst Expt Med, Gottingen, Germany.
   Kyoto Univ, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER
JI Mult. Scler.
PD OCT
PY 2007
VL 13
SU 2
BP S7
EP S7
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 238BX
UT WOS:000251423400002
ER

PT J
AU Komine, O
   Nagaoka, M
   Watase, K
   Gutmann, DH
   Tanigaki, K
   Honjo, T
   Radtke, F
   Saito, T
   Chiba, S
   Tanaka, K
AF Komine, Okiru
   Nagaoka, Mai
   Watase, Kei
   Gutmann, David H.
   Tanigaki, Kenji
   Honjo, Tasuku
   Radtke, Freddy
   Saito, Toshiki
   Chiba, Shigeru
   Tanaka, Kohichi
TI The monolayer formation of Bergmann glial cells is regulated by
   Notch/RBP-J signaling
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Bergmann glia; Notch; RBP-J; conditional knockout mouse; monolayer
   formation
ID EXPRESSION PATTERNS; BRAIN-DEVELOPMENT; PROGENITOR CELLS; MOUSE-BRAIN;
   B-CELLS; FATE; RECEPTOR; MICE; INACTIVATION; CEREBELLUM
AB The Bergmann glia is a unipolar astrocyte in the cerebellar cortex, displaying a tight association with Purkinje cells. The cell bodies of Bergmann glia are located in a row around Purkinje cell somata; they extend radially arranged Bergmann fibers which enwrap the synapses on the Purkinje cell dendrites. It is well known that Bergmann glial somata migrate from the ventricular zone through the mantle zone, forming an epithelium-like lining in the Purkinje cell layer during development. However, the mechanism of the monolayer formation of Bergmann glia is poorly understood. Several reports have suggested that Notch signaling plays instructive roles in promoting the identities of several types of glial cells, including Bergmann glia. Moreover. Notch receptors are expressed in Bergmann glia during development. Here, we have deleted the Notch 1, Notch2 and RBP-J genes in the Bergmann glia by GFAP-driven, Cre-mediated recombination, to study the role of Notch-RBP-J-signaling in the monolayer formation of Bergmann glia. Notch 1/2- and RBP-J-conditional mutant mice showed disorganization of Bergmann fibers, irregularities of the Bergmann glial lining and aberrant localization of Bergmann glia in the molecular layer. Thus, Notch-RBP-J signaling plays crucial roles in the monolayer formation and morphogenesis of Bergmann glia. (C) 2007 Elsevier Inc. All rights reserved.
C1 Tokyo Med & Dent Univ, Lab Mol Neurosci, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan.
   Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan.
   Tokyo Med & Dent Univ, COE Program Brain Integrat & Disorders, Bunkyo Ku, Tokyo 1138510, Japan.
   Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.
   Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.
   Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, VA, Switzerland.
   Univ Tokyo, Dept Hematol & Oncol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan.
RP Tanaka, K (reprint author), Tokyo Med & Dent Univ, Lab Mol Neurosci, Sch Biomed Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
EM tanaka.aud@mri.tmd.ac.jp
RI Komine, Okiru/I-6155-2014
CR ALTMAN J, 1997, DEV CEREBELLER SYSTE, P252
   Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X
   Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823
   Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200
   Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040
   Yamada K, 2000, J COMP NEUROL, V418, P106
   Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X
   Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Matsugami TR, 2006, P NATL ACAD SCI USA, V103, P12161, DOI 10.1073/pnas.0509144103
   Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5
   Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1
   Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002
   Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0
   MATSUNO K, 1995, DEVELOPMENT, V121, P2633
   HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B
   Tohgo A, 2006, MOL CELL NEUROSCI, V31, P326, DOI 10.1016/j.mcn.2005.10.003
   Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6
   Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H
   HIGUCHI M, 1995, MOL BRAIN RES, V29, P263, DOI 10.1016/0169-328X(94)00257-F
   Huard JMT, 1999, DEVELOPMENT, V126, P1927
   Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs
   Lutolf S, 2002, DEVELOPMENT, V129, P373
   Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793
   Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754
   Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x
NR 29
TC 16
Z9 16
U1 2
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD NOV 1
PY 2007
VL 311
IS 1
BP 238
EP 250
DI 10.1016/j.ydbio.2007.08.042
PG 13
WC Developmental Biology
SC Developmental Biology
GA 228CC
UT WOS:000250703700019
PM 17915208
ER

PT J
AU Kovalchuk, AL
   Dubois, W
   Mushinski, E
   McNeil, NE
   Hirt, C
   Qi, CF
   Li, ZY
   Janz, S
   Honjo, T
   Muramatsu, M
   Ried, T
   Behrens, T
   Potter, M
AF Kovalchuk, Alexander L.
   Dubois, Wendy
   Mushinski, Elizabeth
   McNeil, Nicole E.
   Hirt, Carsten
   Qi, Chen-Feng
   Li, Zhaoyang
   Janz, Siegfried
   Honjo, Tasuku
   Muramatsu, Masamichi
   Ried, Thomas
   Behrens, Timothy
   Potter, Michael
TI AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma
   cell tumors with unusual Ig/Myc chromosomal rearrangements
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND
   BREAKS; WILD-TYPE P53; C-MYC; DNA-DAMAGE; GENE AMPLIFICATION; MURINE
   PLASMACYTOMA; MOUSE PLASMACYTOMA; B-CELLS
AB Activation-induced cytidine deaminase (AID) is required for immunoglobulin (Ig) class switch recombination and somatic hypermutation, and has also been implicated in translocations between Ig switch regions and c-Myc in plasma cell tumors in mice. We asked if AID is required for accelerated tumor development in pristane-treated Bcl-xL transgenic BALB/c mice deficient in AID (pBxAicda-/-). pBxAicda-/- mice developed tumors with a lower frequency (24 vs. 62%) and a longer mean latency (108 vs. 36 d) than AID-sufficient mice. The tumors appeared in oil granuloma tissue and did not form ascites. By interphase fluorescence in situ hybridization, six out of nine pBx Aicda-/- primary tumors had T(12; 15) and one had T(6; 15) chromosomal translocations. Two tumors were transplantable and established as stable cell lines. Molecular and cytogenetic analyses showed that one had an unusual unbalanced T(12; 15) translocation, with IgH C mu and Pvt-1 oriented head to tail at the breakpoint, resulting in an elevated expression of c-Myc. In contrast, the second was T(12; 15) negative, but had an elevated N-Myc expression caused by a paracentric inversion of chromosome 12. Thus, novel mechanisms juxtapose Ig and Myc-family genes in AID-deficient plasma cell tumors.
C1 Natl Inst Hlth, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.
   Natl Inst Hlth, Natl Canc Inst, Canc Genom Sect, Genet Branch, Bethesda, MD 20892 USA.
   Ernst Moritz Arndt Univ Greifswald, D-17487 Greifswald, Germany.
   Natl Inst Hlth, NIAID, Immunopathol Lab, Rockville, MD 20852 USA.
   Univ Iowa, Carver Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan.
   Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa 9208640, Japan.
   Genentech Inc, San Francisco, CA 94080 USA.
RP Potter, M (reprint author), Natl Inst Hlth, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.
EM potter@helix.nih.gov
RI Muramatsu, Masamichi/C-4339-2015
OI Muramatsu, Masamichi/0000-0002-0153-3533
CR Alves NL, 2007, TRENDS IMMUNOL, V28, P26, DOI 10.1016/j.it.2006.11.003
   ANDERSON AO, 1985, CURR TOP MICROBIOL, V122, P242
   POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681
   Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670
   Fang W, 1998, IMMUNITY, V9, P35, DOI 10.1016/S1074-7613(00)80586-5
   Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127
   Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191
   Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9
   Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002
   ASKEW DS, 1991, ONCOGENE, V6, P1915
   Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006
   LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6
   Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013
   Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100
   Cheung WC, 2004, J CLIN INVEST, V113, P1763, DOI 10.1172/JCI200420369
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1
   Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89
   Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312
   Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851
   OHNO S, 1979, CELL, V18, P1001, DOI 10.1016/0092-8674(79)90212-5
   YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7
   ROTH DB, 1985, MOL CELL BIOL, V5, P2599
   Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786
   Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Hamada H, 2002, J IMMUNOL, V168, P57
   BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N
   SHACTER E, 1988, CARCINOGENESIS, V9, P2297, DOI 10.1093/carcin/9.12.2297
   Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330
   Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689
   Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024
   EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T
   Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101
   WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X
   Roth DB, 2002, MOL CELL, V10, P1, DOI 10.1016/S1097-2765(02)00573-7
   Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5
   Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   AXELSON H, 1994, GENE CHROMOSOME CANC, V11, P85, DOI 10.1002/gcc.2870110204
   Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200
   BYRD LG, 1991, J IMMUNOL, V147, P3632
   CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978
   CORCORAN LM, 1985, CELL, V40, P71, DOI 10.1016/0092-8674(85)90310-1
   CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6
   Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100
   FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746
   Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024
   Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381
   Kovalchuk AL, 2000, LEUKEMIA, V14, P909, DOI 10.1038/sj.leu.2401676
   Kovalchuk AL, 2000, LEUKEMIA, V14, P1127, DOI 10.1038/sj.leu.2401767
   MULLER JR, 1995, CANCER RES, V55, P5012
   Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055
   OHNO S, 1991, INT J CANCER, V49, P102, DOI 10.1002/ijc.2910490119
   POTTER M, 1984, CANCER SURV, V3, P247
   Ramiro AR, 2006, CANCER RES, V66, P7837, DOI 10.1158/0008-5472.CAN-06-0863
   SHACTER E, 1990, J BIOL CHEM, V265, P6693
   SHAPIRO MA, 1987, MOL CELL BIOL, V7, P4130
   SHAUGHNESSY J, 1994, ONCOGENE, V9, P247
   Silva S, 2003, CANCER RES, V63, P8656
   Straizys V., 1993, BALT ASTRON, V2, P1
   SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232
   WANG YS, 1992, ONCOGENE, V7, P1241
   Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005
   WIENER F, 1993, CAUSES CONSEQUENCES
   WIENER F, 1990, CURR TOP MICROBIOL, V166, P107
   Woo Y, 2007, ONCOGENE, V26, P6010, DOI 10.1038/sj.onc.1210430
NR 70
TC 30
Z9 31
U1 0
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD NOV 26
PY 2007
VL 204
IS 12
BP 2989
EP 3001
DI 10.1084/jem.20070882
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 236RE
UT WOS:000251320300022
PM 17998390
ER

PT J
AU Morisawa, T
   Marusawa, H
   Okazaki, IM
   Honjo, T
   Chiba, T
AF Morisawa, Toshiyuki
   Marusawa, Hiroyuki
   Okazaki, Il-mi
   Honjo, Tasuku
   Chiba, Tsutomu
TI A mouse model for inflammation-associated carcinogenesis in digestive
   organs; the AID-transgenic mouse
SO JOURNAL OF PHARMACOLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 81st Annual Meeting of the Japanese-Pharmacological-Society
CY MAR 17-19, 2008
CL Yokohama, JAPAN
SP Japanese Pharmacol Soc
C1 [Morisawa, Toshiyuki; Marusawa, Hiroyuki; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan.
   [Okazaki, Il-mi] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Sci, Kyoto 6068507, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU JAPANESE PHARMACOLOGICAL SOC
PI KYOTO
PA EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604,
   JAPAN
SN 1347-8613
J9 J PHARMACOL SCI
JI J. Pharmacol. Sci.
PY 2008
VL 106
SU 1
BP 19P
EP 19P
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 278ED
UT WOS:000254265900043
ER

PT J
AU Pasqualucci, L
   Bhagat, G
   Jankovic, M
   Compagno, M
   Smith, P
   Muramatsu, M
   Honjo, T
   Morse, HC
   Nussenzweig, MC
   Dalla-Favera, R
AF Pasqualucci, Laura
   Bhagat, Govind
   Jankovic, Mila
   Compagno, Mara
   Smith, Paula
   Muramatsu, Masamichi
   Honjo, Tasuku
   Morse, Herbert C., III
   Nussenzweig, Michel C.
   Dalla-Favera, Riccardo
TI AID is required for germinal center-derived lymphomagenesis
SO NATURE GENETICS
LA English
DT Article
ID CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA;
   CENTER B-CELLS; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION;
   EXPRESSION; TRANSLOCATIONS; PHENOTYPE; REGION
AB Most human B cell non-Hodgkin's lymphomas (B-NHLs) derive from germinal centers (GCs), the structure in which B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR) before being selected for high-affinity antibody production(1). The pathogenesis of B-NHL is associated with distinct genetic lesions, including chromosomal translocations and aberrant SHM, which arise from mistakes occurring during CSR and SHM2-4. A direct link between these DNA remodeling events and GC lymphoma development, however, has not been demonstrated. Here we have crossed three mouse models of B cell lymphoma driven by oncogenes (Myc, Bcl6 and Myc/Bcl6; refs. 5,6) with mice lacking activation-induced cytidine deaminase (AID), the enzyme required for both CSR and SHM7,8. We show that AID deficiency prevents Bcl6-dependent, GC-derived B-NHL, but has no impact on Myc-driven, pre-GC lymphomas. Accordingly, abrogation of AID is associated with the disappearance of CSR- and SHM-mediated structural alterations. These results show that AID is required for GC-derived lymphomagenesis, supporting the notion that errors in AID-mediated antigen-receptor gene modification processes are principal contributors to the pathogenesis of human B-NHL.
C1 [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.
   [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA.
   [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA.
   [Jankovic, Mila; Muramatsu, Masamichi] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.
   [Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa 9208640, Japan.
   [Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan.
   [Morse, Herbert C., III] NIAID, NIH, Immunopathol Lab, Bethesda, MD 20892 USA.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
RP Pasqualucci, L (reprint author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.
EM lp171@columbia.edu; rd10@columbia.edu
RI Muramatsu, Masamichi/C-4339-2015; 
OI Muramatsu, Masamichi/0000-0002-0153-3533; Morse,
   Herbert/0000-0002-9331-3705; Bhagat, Govind/0000-0001-6250-048X
CR Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0
   Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006
   Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005
   Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478
   Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981
   Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100
   Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558
   Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495
   Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569
   Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183
   Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144
   Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953
   Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640
   Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625
   Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245
   Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481
   Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037
   Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a
   Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   DALLAFAVERA R, 2004, NON HODGKINS LYMPHOM, P825
   Mollejo M, 2005, HEMATOL ONCOL, V23, P108, DOI 10.1002/hon.762
NR 30
TC 182
Z9 183
U1 2
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
J9 NAT GENET
JI Nature Genet.
PD JAN
PY 2008
VL 40
IS 1
BP 108
EP 112
DI 10.1038/ng.2007.35
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA 247YN
UT WOS:000252118600026
PM 18066064
ER

PT J
AU Wang, J
   Shinkura, R
   Muramatsu, M
   Nagaoka, H
   Kinoshita, K
   Honjo, T
AF Wang, Jishu
   Shinkura, Reiko
   Muramatsu, Masamichi
   Nagaoka, Hitoshi
   Kinoshita, Kazuo
   Honjo, Tasuku
TI Identification of a specific domain required for dimerization of
   activation-induced cytidine deaminase (Retraction of vol 281, pg 19115,
   2006)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Correction
CR Wang JS, 2006, J BIOL CHEM, V281, P19115, DOI 10.1074/jbc.M601645200
NR 1
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 4
PY 2008
VL 283
IS 1
BP 660
EP 660
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 245MV
UT WOS:000251940300070
PM 18210667
ER

PT J
AU Lin, DYW
   Tanaka, Y
   Iwasaki, M
   Gittis, AG
   Su, HP
   Mikami, B
   Okazaki, T
   Honjo, T
   Minato, N
   Garboczi, DN
AF Lin, David Yin-Wei
   Tanaka, Yoshimasa
   Iwasaki, Masashi
   Gittis, Apostolos G.
   Su, Hua-Poo
   Mikami, Bunzo
   Okazaki, Taku
   Honjo, Tasuku
   Minato, Nagahiro
   Garboczi, David N.
TI The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of
   antibodies and T cell receptors
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE coreceptor; costimulation; inhibitory receptor
ID B7 FAMILY; PD-1; MEMBER; IMMUNORECEPTOR; ACTIVATION; EXPRESSION;
   TOLERANCE; RESPONSES; MOLECULE; SYSTEM
AB Signaling through the programmed death 1 (PD-1) inhibitory receptor upon binding its ligand, PD-L1, suppresses immune responses against autoantigens and tumors and plays an important role in the maintenance of peripheral immune tolerance. Release from PD-1 inhibitory signaling revives "exhausted" virus-specific T cells in chronic viral infections. Here we present the crystal structure of murine PD-1 in complex with human PD-L1. PD-1 and PD-L1 interact through the conserved front and side of their Ig variable (IgV) domains, as do the IgV domains of antibodies and T cell receptors. This places the loops at the ends of the IgV domains on the same side of the PD-1/PD-L1 complex, forming a surface that is similar to the antigen-binding surface of antibodies and T cell receptors. Mapping conserved residues allowed the identification of residues that are important in forming the PD-1/PD-L1 interface. Based on the structure, we show that some reported loss-of-binding mutations involve the PD-1/PD-L1 interaction but that others compromise protein folding. The PD-1/PD-L1 interaction described here may be blocked by antibodies or by designed small-molecule drugs to lower inhibitory signaling that results in a stronger immune response. The immune receptor-like loops offer a new surface for further study and potentially the design of molecules that would affect PD-1/PD-L1 complex formation and thereby modulate the immune response.
C1 [Okazaki, Taku; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   [Tanaka, Yoshimasa; Iwasaki, Masashi; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto 6068501, Japan.
   [Okazaki, Taku] Kyoto Univ, Grad Sch Med, Century Ctr Excellence Format 21, Kyoto 6068501, Japan.
   [Lin, David Yin-Wei; Gittis, Apostolos G.; Su, Hua-Poo; Garboczi, David N.] NIAID, Struct Biol Sect, Immunogenet Lab, Natl Inst Hlth, Rockville, MD 20852 USA.
   [Tanaka, Yoshimasa] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 1900012, Japan.
   [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp; dgarbacozi@niaid.nih.gov
CR Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019
   [Anonymous], 2006, METHOD MOL BIOL, DOI DOI 10.1385/1-59745-266-1:215
   Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101
   Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349
   Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118
   Dong HD, 1999, NAT MED, V5, P1365
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323
   Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839
   Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112
   DeLano W.L., 2002, PYMOL USERS MANUAL
   Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   SODEOKA M, 1993, BIOORG MED CHEM LETT, V3, P1089, DOI 10.1016/S0960-894X(00)80293-0
NR 32
TC 51
Z9 55
U1 6
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 26
PY 2008
VL 105
IS 8
BP 3011
EP 3016
DI 10.1073/pnas.0712278105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 268GQ
UT WOS:000253567900048
PM 18287011
ER

PT J
AU Green, KA
   Okazaki, T
   Honjo, T
   Cook, WJ
   Green, WR
AF Green, Kathy A.
   Okazaki, Taku
   Honjo, Tasuku
   Cook, W. James
   Green, William R.
TI The programmed death-1 and interleukin-10 pathways play a
   down-modulatory role in LP-BM5 retrovirus-induced murine
   immunodeficiency syndrome
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID CHRONIC VIRAL-INFECTION; T-CELL PROLIFERATION; HUMAN B-CELLS; C57BL/6
   MICE; LEUKEMIA-VIRUS; DEFECTIVE RETROVIRUS; IMMUNE-RESPONSES; PD-1
   EXPRESSION; UP-REGULATION; CD40 LIGAND
AB Pathology due to the immune system's response to viral infections often represents a delicate balance between inhibition of viral pathogenesis and regulation of protective immunity. In susceptible C57BL/6 (B6) mice, the murine retroviral isolate LP-BM5 induces splenomegaly, hypergammaglobulinemia, profound B- and T-cell immunodeficiency, and increased susceptibility to opportunistic pathogens and terminal B-cell lymphomas. Here, we report that B6.PD-1 (programmed death-1) and B6.IL-10 knockout mice are substantially more susceptible to LP-BM5-induced disease than wild-type B6 mice. LP-BM5-infected B6.PD-1(-/-) mice developed more severe splenomegaly, hypergammaglobulinemia, and immunodeficiency than infected B6 mice: PD-1(-/-) mice are more susceptible to lower doses of LP-BM5 and show more exaggerated disease early postinfection. LP-BM5-infected B6.IL-10(-/-) mice also develop exaggerated LP-BM5-induced disease, compared to B6 mice, without a significant change in the retroviral load. By reciprocal reconstitution experiments, comparing wild-type versus PD-1(-/-) sources of the requisite cells for LP-BM5 pathogenesis-CD4 T and B cells, PD-1(+) B cells appear to be crucial in the normal limitation of LP-BM5-induced disease in B6 mice. Also, infected B6 mice have increased CD11b(+) spleen cells that express interleukin-10 (IL-10). However, PD-1(-/-) mice, though showing an even greater expansion of CD11b(+) cells after LP-BMS inoculation, did not show an equivalent increase in IL-10-producing cells. Thus, it appears that PD-1/PD-L interactions and IL-10 are primarily important in moderating the effects of LP-BM5-induced disease in B6 mice.
C1 [Green, Kathy A.; Cook, W. James; Green, William R.] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
   [Green, Kathy A.; Cook, W. James; Green, William R.] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA.
   [Okazaki, Taku; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Green, WR (reprint author), Dartmouth Med Sch, Dept Microbiol & Immunol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.
EM kathy.a.green@dartmouth.edu
CR KLINKEN SP, 1988, J IMMUNOL, V140, P1123
   Green KA, 1998, VIROLOGY, V241, P260, DOI 10.1006/viro.1997.8970
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   ISHIDA Y, 1992, EMBO J, V11, P3887
   Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765
   Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462
   Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6
   Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637
   Ho O, 2006, J IMMUNOL, V176, P2470
   Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792
   Simard C, 1997, J VIROL, V71, P3013
   Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337
   Muller F, 1998, BLOOD, V92, P3721
   Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9
   Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800
   KLINMAN DM, 1989, J IMMUNOL, V142, P1144
   YETTER RA, 1988, J EXP MED, V168, P623, DOI 10.1084/jem.168.2.623
   Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809
   Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496
   Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492
   Van Keulen VP, 2006, CLIN EXP IMMUNOL, V143, P314, DOI 10.1111/j.1365-2249.2005.02992.x
   Li W, 2006, J VIROL, V80, P5777, DOI 10.1128/JVI.02711-05
   Strome SE, 2003, CANCER RES, V63, P6501
   Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330
   AZIZ DC, 1989, NATURE, V338, P505, DOI 10.1038/338505a0
   Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246
   Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806
   MORSE HC, 1989, J IMMUNOL, V143, P844
   Green KA, 2001, J VIROL, V75, P3581, DOI 10.1128/JVI.75.8.3581-3589.2001
   Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q
   Green KA, 2002, J VIROL, V76, P13106, DOI 10.1128/JVI.76.24.13106-13110.2002
   Green KA, 1996, J VIROL, V70, P2569
   Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   CERNY A, 1990, J EXP MED, V171, P315, DOI 10.1084/jem.171.1.315
   Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598
   Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482
   MOSIER DE, 1985, J EXP MED, V161, P766, DOI 10.1084/jem.161.4.766
   Green KA, 2004, J VIROL, V78, P6055, DOI 10.1128/JVI.78.11.6055-6060.2004
   Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978
   Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000
   Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027
   Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563
   Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.0177-06
   RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925
   Blocki FA, 2006, FASEB J, V20, P2408, DOI 10.1096/fj.06-6171fje
   BULLER RML, 1987, J VIROL, V61, P383
   CHATTOPADHYAY SK, 1989, P NATL ACAD SCI USA, V86, P3862, DOI 10.1073/pnas.86.10.3862
   Cook WJ, 2003, J VIROL METHODS, V108, P49, DOI 10.1016/S0166-0934(02)00256-2
   HARTLEY JW, 1989, J VIROL, V63, P1223
   HUANG M, 1989, SCIENCE, V246, P1614, DOI 10.1126/science.2480643
   Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005
   Jones KW, 1996, CELL IMMUNOL, V174, P42, DOI 10.1006/cimm.1996.0292
   Knoetig SM, 2002, J IMMUNOL, V169, P5607
   LEGRAND E, 1981, LEUKEMIA RES, V5, P223, DOI 10.1016/0145-2126(81)90107-7
   Li W, 2007, VIROLOGY, V360, P58, DOI 10.1016/j.virol.2006.10.002
   MACCHIA D, 1991, J IMMUNOL, V146, P3413
   Mayrand SM, 1998, J IMMUNOL, V160, P39
   Mayrand SM, 2000, VIROLOGY, V272, P438, DOI 10.1006/viro.2000.0339
   MOSIER DE, 1987, J EXP MED, V165, P1732
   PATTENGALE PK, 1982, AM J PATHOL, V107, P362
   RANHEIM EA, 1995, CELL IMMUNOL, V161, P226, DOI 10.1006/cimm.1995.1031
   ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4
   ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243
   SCHWARZ DA, 1994, J IMMUNOL, V153, P436
   Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k
   Yu P, 1999, EUR J IMMUNOL, V29, P615, DOI 10.1002/(SICI)1521-4141(199902)29:02<615::AID-IMMU615>3.0.CO;2-I
NR 74
TC 8
Z9 10
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD MAR
PY 2008
VL 82
IS 5
BP 2456
EP 2469
DI 10.1128/JV1.01665-07
PG 14
WC Virology
SC Virology
GA 267AR
UT WOS:000253481000041
PM 18094175
ER

PT J
AU Yoshida, T
   Jiang, F
   Honjo, T
   Okazaki, T
AF Yoshida, Taku
   Jiang, Fang
   Honjo, Tasuku
   Okazaki, Taku
TI PD-1 deficiency reveals various tissue-specific autoimmunity by H-2(b)
   and dose-dependent requirement of H-2(g7) for diabetes in NOD mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE costimulation; MHC; PD-L1; polyneuropathy; Th1/Th2
ID REGULATORY T-CELLS; CYTOKINE PROFILE; GENETIC-CONTROL; MOUSE; MHC;
   EXPRESSION; PROTECTION; TRANSGENE; TOLERANCE; MOLECULES
AB Although many autoimmune diseases are associated with particular HLA/H-2 haplotypes, the mechanisms through which specific HLA/H-2 haplotypes afford autoimmune susceptibility remain enigmatic. Here, we analyzed the effects of the diabetes-associated (H-2(g7)) and an antidiabetogenic (H-2(b)) H-2 haplotypes in NOD mice deficient for programmed cell death-1 (PD-1, Pdcd1), a unique model of type 1 diabetes that confers complete penetrance and rapid onset of the disease. NOD-H2(b/b)Pdcd1(-/-) mice were completely protected from diabetes, confirming that H-2(g7) is indispensable for diabetes even in the absence of PD-1. However, NOD-H2(b/b)Pdcd1(-/-) mice developed autoimmune inflammation in multiple tissues including peripheral nerves, stomachs, and exocrine tissues, demonstrating that autoreactive T cells are generated in the context of H-2(b). These autoreactive T cells damaged target tissues only in the absence of PD-1, confirming that PD-1 deficiency unravels the hidden autoimmune susceptibility of the strain by reducing the threshold of T cell activation. Transfer experiments revealed that CD4 T cells are the effector cells of neuritis, and nerve-infiltrating CD4 T cells are strongly deviated toward Th1. Interestingly, neuritogenic T cells were also generated in the context of H-2(g7), in sharp contrast to the strict requirement of H-2(g7) for diabetes. In addition, 60% of the NOD-H2(b/g7)Pdcd1(-/-) mice developed diabetes, suggesting that H-2(b) does not dominantly suppress diabetes and that H-2(g7) induces diabetes in a dose-dependent fashion.
C1 [Yoshida, Taku; Jiang, Fang; Honjo, Tasuku; Okazaki, Taku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
   [Okazaki, Taku] Kyoto Univ, Grad Sch Med, 21st Century Ctr Excellence Format, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E
   Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577
   Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677
   Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102
   DENG HK, 1993, J EXP MED, V178, P1675, DOI 10.1084/jem.178.5.1675
   WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.immunol.13.1.179
   Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735
   Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776
   Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001
   CarrascoMarin E, 1996, J IMMUNOL, V156, P450
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643
   BOHME J, 1990, SCIENCE, V249, P293, DOI 10.1126/science.2115690
   Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059
   Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087
   Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Hartung HP, 1998, CURR OPIN NEUROL, V11, P497, DOI 10.1097/00019052-199810000-00013
   Kanagawa O, 1998, P NATL ACAD SCI USA, V95, P1721, DOI 10.1073/pnas.95.4.1721
   Liston A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r12
   NEPOM GT, 1990, DIABETES, V39, P1153, DOI 10.2337/diabetes.39.10.1153
   Okazaki T, 2005, J EXP MED, V202, P1643, DOI 10.1084/jem.20051984
   Oono T, 2001, J CLIN INVEST, V108, P1589, DOI 10.1172/JCI13256
   REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0
   Ridgway WM, 1998, J EXP MED, V188, P2267, DOI 10.1084/jem.188.12.2267
   Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982
   Simpson PB, 2003, J IMMUNOL, V171, P3333
   SINGER SM, 1993, P NATL ACAD SCI USA, V90, P9566, DOI 10.1073/pnas.90.20.9566
   Singer SM, 1998, DIABETES, V47, P1570, DOI 10.2337/diabetes.47.10.1570
   TAKACS K, 1995, EUR J IMMUNOL, V25, P3134, DOI 10.1002/eji.1830251122
   WICKER LS, 1989, J IMMUNOL, V142, P781
   WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67
   Yang Y, 2003, DIABETOLOGIA, V46, P1447, DOI 10.1007/s00125-003-1218-1
NR 35
TC 21
Z9 21
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 4
PY 2008
VL 105
IS 9
BP 3533
EP 3538
DI 10.1073/pnas.0710951105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 272FY
UT WOS:000253846500064
PM 18299579
ER

PT J
AU Riccio, O
   van Gijn, ME
   Bezdek, AC
   Pellegrinet, L
   van Es, JH
   Zimber-Strobl, U
   Strobl, LJ
   Honjo, T
   Clevers, H
   Radtke, F
AF Riccio, Orbicia
   van Gijn, Marielle E.
   Bezdek, April C.
   Pellegrinet, Luca
   van Es, Johan H.
   Zimber-Strobl, Ursula
   Strobl, Lothar J.
   Honjo, Tasuku
   Clevers, Hans
   Radtke, Freddy
TI Loss of intestinal crypt progenitor cells owing to inactivation of both
   Notch1 and Notch2 is accompanied by derepression of CDK inhibitors
   p27(Kip1) and p57(Kip2)
SO EMBO REPORTS
LA English
DT Article
DE notch; intestine; CDKI; growth arrest; differentiation
ID LINEAGE COMMITMENT; SELF-RENEWAL; GUT; DIFFERENTIATION; FATE; CANCER;
   GENES; CYCLE; HES-1
AB The crucial role of individual Notch receptors and the mechanism by which they maintain intestinal crypt progenitor cells were assessed by using a series of inducible gut-specific Notch mutant mice. We found that Notch1 and Notch2 receptors function redundantly in the gut, as only simultaneous loss of both receptors results in complete conversion of proliferating crypt progenitors into post-mitotic goblet cells. This conversion correlates with the loss of Hes1 expression and derepression of the cyclin-dependent kinase (CDK) inhibitors p27(Kip1) and p57(Kip2). We also found that the promoter of both CDK inhibitor genes is occupied by the Notch effector Hes1 in wild-type crypt progenitor cells. Thus, our results indicate that Notch-mediated Hes1 expression contributes to the maintenance of the proliferative crypt compartment of the small intestine by transcriptionally repressing two CDK inhibitors.
C1 [Riccio, Orbicia; Bezdek, April C.; Pellegrinet, Luca; Radtke, Freddy] Ecole Polytech Fed Lausanne, ISREC, CH-1066 Epalinges, Switzerland.
   [van Gijn, Marielle E.; van Es, Johan H.; Clevers, Hans] Hubrecht Inst, NL-3548 CT Utrecht, Netherlands.
   [Zimber-Strobl, Ursula; Strobl, Lothar J.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Clin Mol Biol, Munich, Germany.
   [Honjo, Tasuku] Shiga Med Ctr, Res Inst, Moriyama, Shiga, Japan.
RP Radtke, F (reprint author), Ecole Polytech Fed Lausanne, ISREC, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.
EM freddy.radtke@epfl.ch
RI Pellegrinet, Luca/K-8561-2012
OI Pellegrinet, Luca/0000-0003-2081-8531
CR Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644
   Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442
   Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015
   Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718
   Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254
   Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861
   Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005
   van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659
   Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0
   Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815
   Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099
   El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042
   Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911
   Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1
   van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0
   Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036
   Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589
   Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200
   Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Aster JC, 2005, INT J HEMATOL, V82, P295, DOI 10.1532/IJH97.05096
   Jensen J, 2000, NAT GENET, V24, P36
   Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509
NR 23
TC 169
Z9 173
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1469-221X
J9 EMBO REP
JI EMBO Rep.
PD APR
PY 2008
VL 9
IS 4
BP 377
EP 383
DI 10.1038/embor.2008.7
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 282IO
UT WOS:000254561300015
PM 18274550
ER

PT J
AU Green, KA
   Okazaki, T
   Honjo, T
   Cook, WJ
   Green, WR
AF Green, Kathy Ann
   Okazaki, Taku
   Honjo, Tasuku
   Cook, W. James
   Green, William R.
TI The PD-1 and IL-10 pathways play a down-modulatory role in LP-BM5
   retrovirus-induced murine immunodeficiency syndrome
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Green, Kathy Ann; Green, William R.] Dartmouth Med Sch, Lebanon, NH USA.
   [Okazaki, Taku] Kyoto Univ, Kyoto, Japan.
   [Cook, W. James] GlycoFi Merck & Co Inc, Lebanon, NH USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467803500
ER

PT J
AU Honjo, T
AF Honjo, Tasuku
TI A memoir of AID, which engraves antibody memory on DNA
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
ID INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY-CHAIN; V(D)J
   RECOMBINATION; EXPRESSION; GENES; ORGANIZATION; FAMILY; CELLS; RAG-1;
   IGM
AB Tasuku Honjo recounts his work aimed at unraveling the molecular mystery of how antibodies undergo antigen-induced maturation.
C1 Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
RP Honjo, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.
EM honjo@mfour.med.kyoto-u.ac.jp
CR HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435
   Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193
   Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862
   SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344
   Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275
   WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566
   Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268
   SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5
   Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336
   NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   WANG AC, 1969, IMMUNOCHEMISTRY, V6, P451, DOI 10.1016/0019-2791(69)90301-2
   ZHANG J, 1995, IMMUNOGLOBULIN GENES, P235, DOI 10.1016/B978-012053640-5/50014-8
NR 21
TC 7
Z9 7
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD APR
PY 2008
VL 9
IS 4
BP 335
EP 337
DI 10.1038/ni0408-335
PG 3
WC Immunology
SC Immunology
GA 276ED
UT WOS:000254123200004
PM 18349808
ER

PT J
AU Komeno, Y
   Kitaura, J
   Watanabe-Okochi, N
   Kato, N
   Oki, T
   Honjo, T
   Kitamura, T
AF Komeno, Yukiko
   Kitaura, Jiro
   Watanabe-Okochi, Naoko
   Kato, Naoko
   Oki, Toshihiko
   Honjo, Tasuku
   Kitamura, Toshio
TI Overexpression of AID causes both T and B leukemia/lymphoma in a mouse
   bmt model
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Scientific Meeting of the
   International-Society-for-Experimental-Hematology/6th International
   Neonatal Hematology and Immunology Meeting
CY JUL 09-12, 2008
CL Boston, MA
SP Int Soc Expt Hematol
C1 [Komeno, Yukiko; Kitaura, Jiro; Watanabe-Okochi, Naoko; Kato, Naoko; Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan.
   [Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD JUL
PY 2008
VL 36
IS 7
SU 1
BP S37
EP S37
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 322BF
UT WOS:000257349500086
ER

EF